Rank,Task,ID,Name,Similarity,z-score,p-adjusted
1,Biological Process,GO:0032944,regulation of mononuclear cell proliferation,0.2784073197604371,4.174921001624169,0.1311295608791311
2,Biological Process,GO:0070663,regulation of leukocyte proliferation,0.27775698373067104,4.163734813521771,0.13772553048913727
3,Biological Process,GO:0050670,regulation of lymphocyte proliferation,0.2763673058499867,4.139831481300319,0.15289210423983327
4,Biological Process,GO:0042129,regulation of T cell proliferation,0.27065730935174204,4.041615955833614,0.23351704514452906
5,Biological Process,GO:0043903,regulation of biological process involved in symbiotic interaction,0.2641886467010566,3.930350896126621,0.37313189621665577
6,Biological Process,GO:0070665,positive regulation of leukocyte proliferation,0.2635925149661513,3.920097055934408,0.3893700710607189
7,Biological Process,GO:0032946,positive regulation of mononuclear cell proliferation,0.25945826077955036,3.8489852877442243,0.5217571640723944
8,Biological Process,GO:0052372,modulation by symbiont of entry into host,0.25814260203749284,3.8263551311888278,0.5721103116877412
9,Biological Process,GO:0050671,positive regulation of lymphocyte proliferation,0.2577104285573927,3.818921475939852,0.5896262006003676
10,Biological Process,GO:0046598,positive regulation of viral entry into host cell,0.25662011702296117,3.80016743286653,0.6360881677070078
10,Biological Process,GO:0075294,positive regulation by symbiont of entry into host,0.25662011702296117,3.80016743286653,0.6360881677070078
12,Biological Process,GO:0042102,positive regulation of T cell proliferation,0.24925244872086916,3.673438911408277,1
13,Biological Process,GO:0001906,cell killing,0.2414042195680398,3.5384444415403533,1
14,Biological Process,GO:0050865,regulation of cell activation,0.23899568677025396,3.497016164936147,1
15,Biological Process,GO:0032729,positive regulation of type II interferon production,0.23841356712402506,3.487003341468315,1
16,Phenotype,HP:0100758,Gangrene,0.2379640285262381,3.479270995290382,1
17,Biological Process,GO:0032649,regulation of type II interferon production,0.23710640487949508,3.4645193300059236,1
18,Biological Process,GO:0002694,regulation of leukocyte activation,0.23460235144989716,3.4214480385506194,1
19,Biological Process,GO:0032673,regulation of interleukin-4 production,0.2326860772886281,3.38848691961733,1
20,Biological Process,GO:0032740,positive regulation of interleukin-17 production,0.23252520583839797,3.3857198296511974,1
21,Biological Process,GO:0006959,humoral immune response,0.22620240837405325,3.2769637427479807,1
22,Biological Process,GO:0051249,regulation of lymphocyte activation,0.2262010025021589,3.276939560868555,1
23,Phenotype,HP:0002103,Abnormal pleura morphology,0.22543548047617157,3.263772101297994,1
24,Biological Process,GO:0046596,regulation of viral entry into host cell,0.22405511011050416,3.2400288641796577,1
25,Biological Process,GO:0050863,regulation of T cell activation,0.2232920905580945,3.226904448726107,1
26,Biological Process,GO:0141060,disruption of anatomical structure in another organism,0.22260116717324696,3.2150201326287333,1
27,Biological Process,GO:0071634,regulation of transforming growth factor beta production,0.22117283387552522,3.1904519029598615,1
28,Biological Process,GO:0046641,positive regulation of alpha-beta T cell proliferation,0.22105867975633087,3.1884883804245483,1
29,Biological Process,GO:0050870,positive regulation of T cell activation,0.2191743554466692,3.1560768190024002,1
30,Biological Process,GO:0032660,regulation of interleukin-17 production,0.2190054040779552,3.153170749364413,1
31,Biological Process,GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,0.21859229001364822,3.1460649280357886,1
32,Biological Process,GO:0009617,response to bacterium,0.2181908931085651,3.13916064920382,1
33,Biological Process,GO:1903039,positive regulation of leukocyte cell-cell adhesion,0.21788439386496927,3.133888669742157,1
34,Biological Process,GO:0019730,antimicrobial humoral response,0.2172180529626494,3.12242718778128,1
35,Biological Process,GO:0141061,disruption of cell in another organism,0.2171441242998935,3.1211555683570205,1
35,Biological Process,GO:0031640,killing of cells of another organism,0.2171441242998935,3.1211555683570205,1
37,Biological Process,GO:0051251,positive regulation of lymphocyte activation,0.21689124107596303,3.1168058181027636,1
38,Phenotype,HP:0004420,Arterial thrombosis,0.21591085341672767,3.099942534711526,1
39,Phenotype,HP:0004936,Venous thrombosis,0.2124180846964222,3.039864719374174,1
40,Biological Process,GO:0045953,negative regulation of natural killer cell mediated cytotoxicity,0.21151401633292544,3.0243141757957406,1
40,Biological Process,GO:0002716,negative regulation of natural killer cell mediated immunity,0.21151401633292544,3.0243141757957406,1
42,Phenotype,HP:0002105,Hemoptysis,0.21074815260316437,3.011140838705692,1
43,Biological Process,GO:0002501,peptide antigen assembly with MHC protein complex,0.21059914101998967,3.008577745900534,1
43,Biological Process,GO:0002396,MHC protein complex assembly,0.21059914101998967,3.008577745900534,1
45,Biological Process,GO:0043123,positive regulation of canonical NF-kappaB signal transduction,0.21037596931055802,3.0047390523535467,1
46,Biological Process,GO:0046640,regulation of alpha-beta T cell proliferation,0.20991858629374716,2.996871777242356,1
47,Biological Process,GO:1902230,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,0.20875203682473964,2.976806393819319,1
48,Biological Process,GO:0022409,positive regulation of cell-cell adhesion,0.208529187246574,2.972973241132395,1
49,Biological Process,GO:0043122,regulation of canonical NF-kappaB signal transduction,0.20823943137255163,2.9679892581417016,1
50,Biological Process,GO:0002761,regulation of myeloid leukocyte differentiation,0.20768480510459575,2.958449338045136,1
51,Biological Process,GO:0046006,regulation of activated T cell proliferation,0.20766741871520367,2.9581502812294906,1
52,Biological Process,GO:0030449,regulation of complement activation,0.20746487766755872,2.9546664480206366,1
53,Phenotype,HP:0005244,Gastrointestinal infarctions,0.20660172343076288,2.939819653114234,1
54,Phenotype,HP:0200040,Epidermoid cyst,0.20642635530308107,2.9368032111924784,1
55,Biological Process,GO:0002250,adaptive immune response,0.20620267937017545,2.9329558446851025,1
56,Biological Process,GO:0046635,positive regulation of alpha-beta T cell activation,0.2048536971518531,2.9097525034118634,1
57,Biological Process,GO:0010720,positive regulation of cell development,0.20465763176492913,2.90638005563392,1
58,Biological Process,GO:0002696,positive regulation of leukocyte activation,0.20429917611623816,2.9002143933776448,1
59,Phenotype,HP:0002102,Pleuritis,0.20228240854381474,2.865524724665822,1
60,Biological Process,GO:0030225,macrophage differentiation,0.2022690336583035,2.8652946682360247,1
61,Biological Process,GO:0002763,positive regulation of myeloid leukocyte differentiation,0.20182602288653495,2.8576746047648762,1
62,Biological Process,GO:0042742,defense response to bacterium,0.20003133903996106,2.8268049155992094,1
63,Biological Process,GO:0002711,positive regulation of T cell mediated immunity,0.1995843915494131,2.8191171380929205,1
64,Phenotype,HP:0002239,Gastrointestinal hemorrhage,0.19917002562351704,2.811989783958835,1
65,Phenotype,HP:0100820,Glomerulopathy,0.1984918938991621,2.8003254924546916,1
66,Biological Process,GO:0032655,regulation of interleukin-12 production,0.19827463058039563,2.7965884269374275,1
67,Biological Process,GO:0050866,negative regulation of cell activation,0.197972597305901,2.7913932649487925,1
68,Biological Process,GO:0098543,detection of other organism,0.19775068708915577,2.787576269868189,1
69,Biological Process,GO:0016045,detection of bacterium,0.19749831250453198,2.7832352685294164,1
70,Phenotype,HP:0001977,Abnormal thrombosis,0.19671482770127957,2.769758837909841,1
71,Phenotype,HP:0045073,Serositis,0.19656396640973461,2.7671639289591563,1
72,Phenotype,HP:0001701,Pericarditis,0.19646968613943228,2.7655422491049335,1
73,Phenotype,HP:0011506,Choroidal neovascularization,0.19572947929987794,2.752810226638155,1
74,Biological Process,GO:1903708,positive regulation of hemopoiesis,0.19554459205860375,2.749630049984909,1
74,Biological Process,GO:1902107,positive regulation of leukocyte differentiation,0.19554459205860375,2.749630049984909,1
76,Biological Process,GO:0070664,negative regulation of leukocyte proliferation,0.1954395002857724,2.7478224054979057,1
77,Biological Process,GO:0045589,regulation of regulatory T cell differentiation,0.1946481392139887,2.7342104981135456,1
78,Biological Process,GO:0046634,regulation of alpha-beta T cell activation,0.19447900406466756,2.7313012673337065,1
79,Biological Process,GO:0045824,negative regulation of innate immune response,0.19421783862833442,2.7268090578251565,1
80,Biological Process,GO:1902229,regulation of intrinsic apoptotic signaling pathway in response to DNA damage,0.19412908794324157,2.7252824903089414,1
81,Biological Process,GO:0032945,negative regulation of mononuclear cell proliferation,0.1937614413916292,2.718958738750822,1
82,Biological Process,GO:0002834,regulation of response to tumor cell,0.19327588120971928,2.7106067987055606,1
83,Biological Process,GO:0050727,regulation of inflammatory response,0.19276799451352744,2.701870828594307,1
84,Biological Process,GO:0071345,cellular response to cytokine stimulus,0.19240930635450781,2.695701167014369,1
85,Biological Process,GO:0002837,regulation of immune response to tumor cell,0.19226555618067964,2.69322857375397,1
86,Biological Process,GO:2000514,"regulation of CD4-positive, alpha-beta T cell activation",0.19129578921136314,2.6765479728987938,1
87,Biological Process,GO:0050867,positive regulation of cell activation,0.1908826178403955,2.6694411658596198,1
88,Biological Process,GO:0002832,negative regulation of response to biotic stimulus,0.190810942720947,2.668208308795401,1
89,Biological Process,GO:0050672,negative regulation of lymphocyte proliferation,0.19078619518905082,2.667782635706121,1
90,Biological Process,GO:0042531,positive regulation of tyrosine phosphorylation of STAT protein,0.1905562813918924,2.6638279740164155,1
91,Biological Process,GO:0002698,negative regulation of immune effector process,0.19045939687993318,2.662161499570313,1
92,Phenotype,HP:0200097,Oral mucosal blisters,0.1895912965160308,2.6472296281716665,1
93,Phenotype,HP:0033800,Blistering by anatomical location,0.18935623824093173,2.643186478230813,1
94,Biological Process,GO:0019221,cytokine-mediated signaling pathway,0.189051180481576,2.6379392932032864,1
95,Phenotype,HP:0032016,Abnormal sputum,0.18870665972351042,2.6320133198164375,1
96,Biological Process,GO:1902105,regulation of leukocyte differentiation,0.18814948452503766,2.622429556514334,1
97,Biological Process,GO:0050832,defense response to fungus,0.18799585213401182,2.6197869829124154,1
98,Biological Process,GO:1903902,positive regulation of viral life cycle,0.1879783948997159,2.6194867075199357,1
99,Biological Process,GO:0060284,regulation of cell development,0.18671155755041735,2.5976963095782812,1
100,Biological Process,GO:0002683,negative regulation of immune system process,0.18633432911116676,2.5912077435356626,1
101,Biological Process,GO:0002824,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,0.1857844483649178,2.5817494493924937,1
102,Biological Process,GO:0042509,regulation of tyrosine phosphorylation of STAT protein,0.18473196550084248,2.563646083204504,1
103,Biological Process,GO:0009595,detection of biotic stimulus,0.18443640765420155,2.5585623026413162,1
104,Biological Process,GO:0045639,positive regulation of myeloid cell differentiation,0.18440041240085114,2.5579431616798107,1
105,Biological Process,GO:0002704,negative regulation of leukocyte mediated immunity,0.1831079677998766,2.5357123029287867,1
106,Biological Process,GO:0032653,regulation of interleukin-10 production,0.18302655041416682,2.5343118727670397,1
107,Biological Process,GO:0002706,regulation of lymphocyte mediated immunity,0.18256532921897006,2.5263785785773574,1
108,Biological Process,GO:0051873,killing by host of symbiont cells,0.1820369763908527,2.517290578144902,1
109,Biological Process,GO:2000516,"positive regulation of CD4-positive, alpha-beta T cell activation",0.18183152218394227,2.51375663676731,1
110,Biological Process,GO:0042104,positive regulation of activated T cell proliferation,0.18177000928632236,2.512698576300097,1
111,Biological Process,GO:0090199,regulation of release of cytochrome c from mitochondria,0.18174132538008103,2.5122051951001616,1
112,Phenotype,HP:0008066,Abnormal blistering of the skin,0.18149637568182309,2.5079919064694747,1
113,Phenotype,HP:0007906,Ocular hypertension,0.18082497725096003,2.496443431841687,1
114,Biological Process,GO:0009620,response to fungus,0.1802638602355432,2.4867918668128093,1
115,Biological Process,GO:0043370,"regulation of CD4-positive, alpha-beta T cell differentiation",0.18014364580443099,2.4847241031068252,1
116,Phenotype,HP:0012633,Asymmetry of intraocular pressure,0.17981939449066653,2.4791467768905244,1
117,Biological Process,GO:0090200,positive regulation of release of cytochrome c from mitochondria,0.17940628815036996,2.4720410884197297,1
118,Biological Process,GO:0042130,negative regulation of T cell proliferation,0.178878300389833,2.462959367378908,1
119,Biological Process,GO:0045591,positive regulation of regulatory T cell differentiation,0.178537118902782,2.4570908315504667,1
120,Phenotype,HP:0001426,Non-Mendelian inheritance,0.178251002298646,2.4521694462871646,1
121,Biological Process,GO:0001775,cell activation,0.17799516380585434,2.44776886355268,1
122,Biological Process,GO:0002822,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,0.1777301640844694,2.44321070193343,1
123,Biological Process,GO:0002695,negative regulation of leukocyte activation,0.17745241407830203,2.438433227409147,1
124,Biological Process,GO:2001198,regulation of dendritic cell differentiation,0.17743581777506312,2.438147760571485,1
125,Biological Process,GO:0045087,innate immune response,0.1773667350471193,2.436959494269087,1
126,Biological Process,GO:0002819,regulation of adaptive immune response,0.17724336675730323,2.434837482212873,1
127,Biological Process,GO:0050777,negative regulation of immune response,0.17705086495230116,2.4315263302818027,1
128,Phenotype,HP:0000123,Nephritis,0.17613832625924786,2.415830091715898,1
129,Biological Process,GO:0032720,negative regulation of tumor necrosis factor production,0.17550368499002755,2.4049138633506986,1
130,Biological Process,GO:0002821,positive regulation of adaptive immune response,0.17508598531980324,2.3977291667206813,1
131,Biological Process,GO:0001916,positive regulation of T cell mediated cytotoxicity,0.17350156133717398,2.370476079251395,1
132,Biological Process,GO:0002709,regulation of T cell mediated immunity,0.17335087432631469,2.367884168037946,1
133,Biological Process,GO:0050729,positive regulation of inflammatory response,0.1729821780029165,2.361542359745887,1
134,Biological Process,GO:0019731,antibacterial humoral response,0.17295094310484316,2.3610050998844994,1
135,Phenotype,HP:0002637,Cerebral ischemia,0.17281277699025588,2.3586285559496556,1
135,Phenotype,HP:0033401,Tissue ischemia,0.17281277699025588,2.3586285559496556,1
137,Biological Process,GO:0032102,negative regulation of response to external stimulus,0.17217571598126835,2.34767070654094,1
138,Phenotype,HP:0012735,Cough,0.17208062184729167,2.3460350277204376,1
139,Biological Process,GO:0098581,detection of external biotic stimulus,0.1719828552052085,2.3443533800822536,1
140,Biological Process,GO:1903037,regulation of leukocyte cell-cell adhesion,0.17166772511883632,2.3389329447049416,1
141,Phenotype,HP:0100749,Chest pain,0.17131420347361326,2.3328521504067123,1
142,Biological Process,GO:0002703,regulation of leukocyte mediated immunity,0.17099085285942772,2.3272903167887797,1
143,Biological Process,GO:0032735,positive regulation of interleukin-12 production,0.17083408523373833,2.32459381518182,1
144,Phenotype,HP:0000975,Hyperhidrosis,0.17072813161657918,2.3227713464311677,1
145,Phenotype,HP:0100679,Lack of skin elasticity,0.1700177013380756,2.310551499513199,1
146,Biological Process,GO:2001233,regulation of apoptotic signaling pathway,0.16988652401564297,2.3082951671921554,1
147,Phenotype,HP:0000979,Purpura,0.16983776069020007,2.3074564073727144,1
148,Biological Process,GO:0002708,positive regulation of lymphocyte mediated immunity,0.16974672779374933,2.3058905843879867,1
149,Biological Process,GO:0046649,lymphocyte activation,0.16950587790532012,2.301747815060905,1
150,Phenotype,HP:0100806,Sepsis,0.16942963146105894,2.3004363283392615,1
151,Phenotype,HP:0001697,Abnormal pericardium morphology,0.16929907891974305,2.2981907426457684,1
152,Biological Process,GO:0051090,regulation of DNA-binding transcription factor activity,0.16913033445212733,2.2952882318365986,1
153,Biological Process,GO:1903556,negative regulation of tumor necrosis factor superfamily cytokine production,0.16838128448276413,2.282404101983902,1
154,Biological Process,GO:0050830,defense response to Gram-positive bacterium,0.16817645459614283,2.2788808993073366,1
155,Biological Process,GO:0045785,positive regulation of cell adhesion,0.16800882907615733,2.27599763510007,1
156,Biological Process,GO:1902165,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,0.1679163704591472,2.2744072888264135,1
157,Biological Process,GO:0040029,epigenetic regulation of gene expression,0.16773697840501955,2.271321632842892,1
158,Biological Process,GO:1902253,regulation of intrinsic apoptotic signaling pathway by p53 class mediator,0.16773630508617798,2.271310051335994,1
159,Biological Process,GO:0002825,regulation of T-helper 1 type immune response,0.16718183469167802,2.2617728123607534,1
160,Phenotype,HP:0025568,Abnormal morphology of the choroidal vasculature,0.16707784072657228,2.259984050856019,1
161,Phenotype,HP:0200041,Skin erosion,0.16703435017969137,2.259235986138982,1
162,Biological Process,GO:0070374,positive regulation of ERK1 and ERK2 cascade,0.16677193396464296,2.25472226245108,1
163,Biological Process,GO:0050792,regulation of viral process,0.16641307834369423,2.2485497204208014,1
164,Biological Process,GO:1903131,mononuclear cell differentiation,0.16641155781425176,2.248523566359547,1
165,Biological Process,GO:1903706,regulation of hemopoiesis,0.16632993463335344,2.247119596391324,1
166,Phenotype,HP:0000095,Abnormal renal glomerulus morphology,0.16614018426102906,2.2438557708301223,1
167,Disease,MONDO:0002531,skin neoplasm,0.16606071234175968,2.242488803912842,1
168,Phenotype,HP:0100634,Neuroendocrine neoplasm,0.1660028543664056,2.241493610403776,1
169,Disease,MONDO:0002082,endocrine gland neoplasm,0.1659711386729994,2.240948080560739,1
170,Phenotype,HP:0001287,Meningitis,0.1656529235340244,2.235474580341343,1
171,Disease,MONDO:0017672,focal palmoplantar keratoderma,0.16541013770076185,2.231298511547416,1
172,Phenotype,HP:0031263,Abnormal renal corpuscle morphology,0.16523048682614472,2.228208403688944,1
173,Biological Process,GO:0002221,pattern recognition receptor signaling pathway,0.16517103261256338,2.2271857538799824,1
174,Phenotype,HP:0032158,Unusual infection by anatomical site,0.16494371154756116,2.2232756888115173,1
175,Biological Process,GO:0031348,negative regulation of defense response,0.164626619086092,2.217821499350228,1
176,Phenotype,HP:0002633,Vasculitis,0.1643628619273536,2.2132847105887885,1
177,Phenotype,HP:0002202,Pleural effusion,0.16420911418033246,2.210640152791311,1
178,Biological Process,GO:0032689,negative regulation of type II interferon production,0.163975723120645,2.2066256800024955,1
179,Biological Process,GO:0032656,regulation of interleukin-13 production,0.16369476347337275,2.2017929976356556,1
180,Disease,MONDO:0024477,liver and intrahepatic bile duct neoplasm,0.16362552233216887,2.2006020065257057,1
180,Disease,MONDO:0002514,hepatobiliary neoplasm,0.16362552233216887,2.2006020065257057,1
182,Phenotype,HP:0003204,Intracellular accumulation of autofluorescent lipopigment storage material,0.16350925209947842,2.1986020855094077,1
183,Phenotype,HP:0025323,Abnormal arterial physiology,0.16347631778690674,2.19803559465147,1
184,Biological Process,GO:0002839,positive regulation of immune response to tumor cell,0.16331738369090287,2.1953018283946264,1
184,Biological Process,GO:0002836,positive regulation of response to tumor cell,0.16331738369090287,2.1953018283946264,1
186,Biological Process,GO:0002707,negative regulation of lymphocyte mediated immunity,0.16321429675212995,2.1935286683124007,1
187,Phenotype,HP:0002204,Pulmonary embolism,0.16289032396431136,2.1879561329172743,1
188,Phenotype,HP:0003075,Hypoproteinemia,0.16270294798189167,2.1847331483534753,1
189,Phenotype,HP:0000529,Progressive visual loss,0.16239269725461158,2.1793966410166306,1
190,Biological Process,GO:0051250,negative regulation of lymphocyte activation,0.16214793936128435,2.1751866515511997,1
191,Biological Process,GO:0061844,antimicrobial humoral immune response mediated by antimicrobial peptide,0.16197862462429746,2.1722743317507343,1
192,Biological Process,GO:1902166,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,0.1614013163844179,2.1623442674935216,1
193,Phenotype,HP:0100796,Orchitis,0.16128317973123463,2.160312242872694,1
194,Phenotype,HP:0002039,Anorexia,0.16124760255183102,2.1597002930456104,1
195,Phenotype,HP:0011035,Abnormal renal cortex morphology,0.16114877096483493,2.1580003276861723,1
196,Phenotype,HP:0002600,Hyporeflexia of lower limbs,0.1611450349932071,2.1579360666281016,1
197,Phenotype,HP:0005112,Abdominal aortic aneurysm,0.16100400826637418,2.155510318366259,1
198,Phenotype,HP:0010990,Abnormality of the common coagulation pathway,0.16065731896928048,2.149547044746353,1
199,Biological Process,GO:0032674,regulation of interleukin-5 production,0.16054530984328408,2.1476204174410323,1
200,Biological Process,GO:0030574,collagen catabolic process,0.16005398984843533,2.139169404996243,1
201,Disease,MONDO:0005165,benign neoplasm,0.1598314939122497,2.1353423351734517,1
202,Phenotype,HP:0000967,Petechiae,0.1596174416539633,2.1316605019128887,1
203,Biological Process,GO:0009615,response to virus,0.15948345290405486,2.129355811273774,1
204,Phenotype,HP:0000099,Glomerulonephritis,0.15940630320804283,2.128028788054802,1
205,Biological Process,GO:1905710,positive regulation of membrane permeability,0.15924615625626315,2.1252741599169798,1
206,Phenotype,HP:0003205,Curvilinear intracellular accumulation of autofluorescent lipopigment storage material,0.15915918956350972,2.1237782781892927,1
207,Biological Process,GO:0002705,positive regulation of leukocyte mediated immunity,0.1591266047576132,2.123217799065647,1
208,Phenotype,HP:0001047,Atopic dermatitis,0.15879757085009327,2.117558209233435,1
209,Disease,MONDO:0006181,digestive system carcinoma,0.15834415508216793,2.109759173294382,1
210,Biological Process,GO:0050728,negative regulation of inflammatory response,0.15812678317700035,2.10602024002283,1
211,Biological Process,GO:2001242,regulation of intrinsic apoptotic signaling pathway,0.15810549993411216,2.1056541548799506,1
212,Phenotype,HP:0500022,Abnormal circulating dehydroepiandrosterone concentration,0.15794229167970197,2.1028468704144827,1
213,Biological Process,GO:0002724,regulation of T cell cytokine production,0.15740012243741286,2.0935212189820027,1
214,Phenotype,HP:0040154,Acne inversa,0.15737529002188744,2.0930940858409954,1
215,Phenotype,HP:0012632,Abnormal intraocular pressure,0.1573595047648514,2.0928225695073337,1
216,Biological Process,GO:0043270,positive regulation of monoatomic ion transport,0.15715579139721902,2.0893185716585165,1
217,Biological Process,GO:0140448,signaling receptor ligand precursor processing,0.15628950859483481,2.074417963459354,1
218,Biological Process,GO:0001667,ameboidal-type cell migration,0.15628432531745018,2.074328807833404,1
219,Phenotype,HP:0002829,Arthralgia,0.1561700474663542,2.0723631570316834,1
220,Phenotype,HP:0011898,Abnormality of circulating fibrinogen,0.15602393429196482,2.0698499186777415,1
221,Phenotype,HP:0011900,Hypofibrinogenemia,0.15594648577111603,2.068517755483925,1
222,Biological Process,GO:0002697,regulation of immune effector process,0.15583868432705028,2.0666635029501026,1
223,Biological Process,GO:2001234,negative regulation of apoptotic signaling pathway,0.1553797730703016,2.0587699411522955,1
224,Disease,MONDO:0021583,melanocytic skin neoplasm,0.1553235385647782,2.057802672343805,1
224,Disease,MONDO:0005073,melanocytic nevus,0.1553235385647782,2.057802672343805,1
224,Disease,MONDO:0021143,melanocytic neoplasm,0.1553235385647782,2.057802672343805,1
227,Phenotype,HP:0003256,Abnormality of the coagulation cascade,0.1551265092947195,2.0544136451706563,1
228,Biological Process,GO:0031341,regulation of cell killing,0.15439666249805906,2.0418598219474315,1
229,Biological Process,GO:0033674,positive regulation of kinase activity,0.15409873763100346,2.0367353271466975,1
230,Phenotype,HP:0002524,Cataplexy,0.15407580469568538,2.0363408662580698,1
231,Phenotype,HP:0011450,Unusual CNS infection,0.15379705185908654,2.03154614242062,1
232,Biological Process,GO:0036293,response to decreased oxygen levels,0.15351008168975,2.026610075299857,1
232,Biological Process,GO:0001666,response to hypoxia,0.15351008168975,2.026610075299857,1
234,Biological Process,GO:0046637,regulation of alpha-beta T cell differentiation,0.15317791945574655,2.0208966762876384,1
235,Biological Process,GO:0045321,leukocyte activation,0.1526895395155582,2.012496234629269,1
236,Biological Process,GO:0031349,positive regulation of defense response,0.15268631041634428,2.0124406920950175,1
237,Biological Process,GO:0046039,GTP metabolic process,0.15240810909644154,2.0076554546910756,1
238,Biological Process,GO:0001911,negative regulation of leukocyte mediated cytotoxicity,0.15228573272654167,2.005550504280315,1
239,Phenotype,HP:0011034,Amyloidosis,0.15208461609619628,2.002091171943502,1
240,Phenotype,HP:0000572,Visual loss,0.152026050606614,2.001083808745415,1
241,Biological Process,GO:1900015,regulation of cytokine production involved in inflammatory response,0.15199436008624323,2.0005387118943947,1
242,Phenotype,HP:0007543,Epidermal hyperkeratosis,0.15191236713365297,1.9991283816208658,1
243,Biological Process,GO:1901797,negative regulation of signal transduction by p53 class mediator,0.15146268225723114,1.991393519358555,1
244,Biological Process,GO:0051098,regulation of binding,0.15131723129142105,1.9888916714080231,1
245,Biological Process,GO:0022407,regulation of cell-cell adhesion,0.1513014236782373,1.988619770534582,1
246,Biological Process,GO:0045723,positive regulation of fatty acid biosynthetic process,0.15113064375441565,1.9856822486004684,1
247,Biological Process,GO:0030522,intracellular receptor signaling pathway,0.15088314992725382,1.9814251993550027,1
248,Biological Process,GO:0010712,regulation of collagen metabolic process,0.1507482619892575,1.9791050421161145,1
249,Biological Process,GO:0071071,regulation of phospholipid biosynthetic process,0.15072669957342077,1.9787341550232087,1
250,Disease,MONDO:0021069,malignant endocrine neoplasm,0.1505962805790938,1.9764908664217882,1
251,Biological Process,GO:1902254,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator,0.15053944305854206,1.975513225376136,1
252,Phenotype,HP:0001065,Striae distensae,0.15020906955996893,1.9698305937365883,1
253,Biological Process,GO:0002699,positive regulation of immune effector process,0.15013197636624043,1.9685045423923748,1
254,Phenotype,HP:0100584,Endocarditis,0.15009650006766195,1.9678943277788334,1
255,Disease,MONDO:0004993,carcinoma,0.14962743760161967,1.9598261588065384,1
256,Biological Process,GO:0055082,intracellular chemical homeostasis,0.14958583363642508,1.9591105444792194,1
257,Biological Process,GO:0043269,regulation of monoatomic ion transport,0.1494807326377483,1.9573027413018815,1
258,Biological Process,GO:0034138,toll-like receptor 3 signaling pathway,0.14945446994712497,1.9568510065310225,1
259,Biological Process,GO:1901550,regulation of endothelial cell development,0.14941259148711328,1.9561306707204753,1
259,Biological Process,GO:1903140,regulation of establishment of endothelial barrier,0.14941259148711328,1.9561306707204753,1
261,Phenotype,HP:0031365,Macular purpura,0.1492957635544081,1.954121156913706,1
262,Biological Process,GO:0045766,positive regulation of angiogenesis,0.14929293655161047,1.9540725306903184,1
263,Biological Process,GO:1904018,positive regulation of vasculature development,0.14922870056863924,1.952967631445051,1
264,Phenotype,HP:0001061,Acne,0.1491701790127511,1.951961023934092,1
265,Biological Process,GO:0051347,positive regulation of transferase activity,0.14914454168724578,1.9515200458359725,1
266,Biological Process,GO:0070482,response to oxygen levels,0.14905601492311416,1.9499973299009055,1
267,Phenotype,HP:0000022,Abnormal male internal genitalia morphology,0.14894441729953733,1.948077780695612,1
268,Biological Process,GO:0033209,tumor necrosis factor-mediated signaling pathway,0.14890397886575324,1.9473822142404704,1
269,Biological Process,GO:0043433,negative regulation of DNA-binding transcription factor activity,0.1488492714814289,1.9464412128755877,1
270,Biological Process,GO:0031342,negative regulation of cell killing,0.14883733957321754,1.946235976561492,1
271,Phenotype,HP:0030318,Angular cheilitis,0.1487507632814853,1.9447468099765288,1
272,Biological Process,GO:0045670,regulation of osteoclast differentiation,0.14866069449878416,1.9431975703537276,1
273,Phenotype,HP:0001931,Hypochromic anemia,0.1486113465417802,1.942348754504306,1
274,Phenotype,HP:0004970,Ascending tubular aorta aneurysm,0.14828814893537023,1.9367895527161973,1
275,Biological Process,GO:0042110,T cell activation,0.1477984892669234,1.9283670989281536,1
276,Phenotype,HP:0030348,Increased circulating androgen concentration,0.14778707809767788,1.9281708196512777,1
277,Phenotype,HP:0032169,Severe infection,0.14777719789420452,1.928000873947081,1
278,Phenotype,HP:0001933,Subcutaneous hemorrhage,0.14774155085787333,1.927387722536975,1
279,Phenotype,HP:0410019,Epigastric pain,0.1476598214617213,1.9259819255996888,1
280,Biological Process,GO:0046636,negative regulation of alpha-beta T cell activation,0.14732573555579798,1.9202354382224434,1
281,Disease,MONDO:0021440,benign neoplasm of skin,0.147174099933985,1.917627210304894,1
282,Biological Process,GO:0002726,positive regulation of T cell cytokine production,0.14714326226084362,1.9170967829617804,1
283,Biological Process,GO:0006954,inflammatory response,0.14708716280511291,1.9161318370945315,1
284,Biological Process,GO:0016241,regulation of macroautophagy,0.14699235972595925,1.9145011645997583,1
285,Biological Process,GO:0042269,regulation of natural killer cell mediated cytotoxicity,0.1469330912680431,1.9134817099048866,1
285,Biological Process,GO:0002715,regulation of natural killer cell mediated immunity,0.1469330912680431,1.9134817099048866,1
287,Biological Process,GO:0045655,regulation of monocyte differentiation,0.1469127840117591,1.9131324123444884,1
288,Biological Process,GO:0034110,regulation of homotypic cell-cell adhesion,0.14689278940278472,1.9127884925141478,1
289,Biological Process,GO:0030888,regulation of B cell proliferation,0.14684429015131406,1.9119542749328593,1
290,Biological Process,GO:0046364,monosaccharide biosynthetic process,0.14677730578430326,1.9108021017562131,1
291,Disease,MONDO:0005626,epithelial neoplasm,0.14671696136211854,1.9097641398002507,1
292,Biological Process,GO:0042113,B cell activation,0.14669857731955582,1.9094479227235757,1
293,Biological Process,GO:0034341,response to type II interferon,0.1466850530929441,1.9092152975330683,1
294,Biological Process,GO:0010575,positive regulation of vascular endothelial growth factor production,0.146682032692814,1.9091633447541148,1
295,Biological Process,GO:0032663,regulation of interleukin-2 production,0.14654915037277227,1.9068776854035103,1
296,Biological Process,GO:1901099,negative regulation of signal transduction in absence of ligand,0.14635450506060155,1.9035296638030845,1
296,Biological Process,GO:2001240,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,0.14635450506060155,1.9035296638030845,1
298,Biological Process,GO:0035710,"CD4-positive, alpha-beta T cell activation",0.14633806173099329,1.9032468282079325,1
299,Biological Process,GO:0033993,response to lipid,0.1461659945145326,1.9002871640320482,1
300,Biological Process,GO:0045672,positive regulation of osteoclast differentiation,0.1461302532525458,1.899672391881495,1
301,Biological Process,GO:0006956,complement activation,0.1458365403393007,1.8946203453312753,1
302,Phenotype,HP:0030247,Splanchnic vein thrombosis,0.1456529377372915,1.8914622652800996,1
303,Phenotype,HP:0000622,Blurred vision,0.14557362375533278,1.890098014983742,1
304,Biological Process,GO:1903900,regulation of viral life cycle,0.14556233402294072,1.8899038244970043,1
305,Biological Process,GO:0032693,negative regulation of interleukin-10 production,0.14556198213830318,1.8898977718602663,1
306,Phenotype,HP:0002113,Pulmonary infiltrates,0.1455042144850991,1.8889041319489,1
307,Phenotype,HP:0006744,Adrenocortical carcinoma,0.1454478981644829,1.8879354558694361,1
308,Biological Process,GO:0046631,alpha-beta T cell activation,0.14505876421566022,1.881242107585895,1
309,Phenotype,HP:0030500,Yellow/white lesions of the macula,0.14504327007018591,1.8809755985539045,1
310,Biological Process,GO:0002521,leukocyte differentiation,0.1450016103739028,1.8802590256168654,1
311,Biological Process,GO:0009725,response to hormone,0.1445748043267855,1.8729176935857723,1
312,Phenotype,HP:0002797,Osteolysis,0.1445667344379128,1.8727788864295274,1
313,Disease,MONDO:0005385,vascular disorder,0.14420521116667628,1.866560459139099,1
314,Phenotype,HP:0002586,Peritonitis,0.14402478184688805,1.8634569615348449,1
315,Phenotype,HP:0004306,Abnormal endocardium morphology,0.1440129744512667,1.8632538669154874,1
316,Biological Process,GO:0045580,regulation of T cell differentiation,0.1439701585906733,1.862517407226277,1
317,Phenotype,HP:0100654,Retrobulbar optic neuritis,0.14390183253438715,1.8613421561515564,1
318,Biological Process,GO:0071214,cellular response to abiotic stimulus,0.14388960857831157,1.8611318964307992,1
318,Biological Process,GO:0104004,cellular response to environmental stimulus,0.14388960857831157,1.8611318964307992,1
320,Biological Process,GO:0033500,carbohydrate homeostasis,0.14366531943077787,1.857273982246741,1
321,Biological Process,GO:1901224,positive regulation of non-canonical NF-kappaB signal transduction,0.14339279636065805,1.852586414304826,1
322,Phenotype,HP:0010789,Abnormality of the Leydig cells,0.14333818393188758,1.851647046235099,1
323,Biological Process,GO:0042304,regulation of fatty acid biosynthetic process,0.14306378440391154,1.8469272020397012,1
324,Disease,MONDO:0007179,autoimmune disease,0.1429714335857324,1.8453387099736318,1
325,Phenotype,HP:0002647,Aortic dissection,0.1428346326026837,1.842985647158511,1
326,Biological Process,GO:0051926,negative regulation of calcium ion transport,0.14279921617807567,1.8423764624148604,1
327,Biological Process,GO:0050679,positive regulation of epithelial cell proliferation,0.1426358246200219,1.8395660250116135,1
328,Phenotype,HP:0030875,Abnormality of pulmonary circulation,0.14250747349530413,1.837358305066028,1
329,Phenotype,HP:0002585,Abnormal peritoneum morphology,0.14235694253807762,1.8347690780730603,1
330,Biological Process,GO:2001243,negative regulation of intrinsic apoptotic signaling pathway,0.14222366337076664,1.832476592700217,1
331,Biological Process,GO:0030003,intracellular monoatomic cation homeostasis,0.1422136797833754,1.832304868727711,1
332,Biological Process,GO:0002253,activation of immune response,0.14159882903409138,1.821729049733235,1
333,Phenotype,HP:0002028,Chronic diarrhea,0.14159089435989802,1.8215925683543854,1
334,Biological Process,GO:0031638,zymogen activation,0.14135408189929777,1.8175192453213385,1
335,Biological Process,GO:0034767,positive regulation of monoatomic ion transmembrane transport,0.14111470724087227,1.8134018508767182,1
336,Biological Process,GO:0032814,regulation of natural killer cell activation,0.1409995557096222,1.8114211722277036,1
337,Phenotype,HP:0002170,Intracranial hemorrhage,0.14093795212228055,1.8103615518403262,1
338,Biological Process,GO:0061138,morphogenesis of a branching epithelium,0.14085120654768768,1.8088694734838562,1
338,Biological Process,GO:0048754,branching morphogenesis of an epithelial tube,0.14085120654768768,1.8088694734838562,1
340,Biological Process,GO:0002456,T cell mediated immunity,0.14072929928797562,1.806772592062912,1
341,Phenotype,HP:0001891,Iron deficiency anemia,0.1407050953911264,1.8063562698378253,1
342,Phenotype,HP:0012575,Abnormal nephron morphology,0.14040370921423306,1.8011722383342892,1
343,Phenotype,HP:0045049,Abnormal DLCO,0.14038215045122104,1.8008014140722624,1
343,Phenotype,HP:0045051,Decreased DLCO,0.14038215045122104,1.8008014140722624,1
345,Biological Process,GO:2001239,regulation of extrinsic apoptotic signaling pathway in absence of ligand,0.1403813893881697,1.8007883233098554,1
346,Phenotype,HP:0200034,Papule,0.14029634120660217,1.7993254411793307,1
347,Phenotype,HP:0004948,Vascular tortuosity,0.1402712566537918,1.798893971118688,1
348,Biological Process,GO:0006873,intracellular monoatomic ion homeostasis,0.14023575596824078,1.7982833370339046,1
349,Biological Process,GO:0002474,antigen processing and presentation of peptide antigen via MHC class I,0.14022676035455184,1.7981286068294944,1
350,Biological Process,GO:0050868,negative regulation of T cell activation,0.1400180662577747,1.7945389373116465,1
351,Biological Process,GO:0002758,innate immune response-activating signaling pathway,0.13995117665094214,1.7933883940695727,1
352,Phenotype,HP:0012200,Abnormality of prothrombin,0.13988963157483725,1.7923297801122107,1
353,Biological Process,GO:0030099,myeloid cell differentiation,0.1397904681178438,1.790624106380414,1
354,Biological Process,GO:0002755,MyD88-dependent toll-like receptor signaling pathway,0.13953802888688738,1.7862819930841243,1
355,Biological Process,GO:0032691,negative regulation of interleukin-1 beta production,0.1395227193797024,1.7860186599466572,1
356,Biological Process,GO:0062098,regulation of programmed necrotic cell death,0.13942793098905548,1.7843882401034241,1
357,Biological Process,GO:0042593,glucose homeostasis,0.1392298223263959,1.7809806466997158,1
358,Biological Process,GO:0002252,immune effector process,0.13901059083732503,1.7772097274172673,1
359,Biological Process,GO:0006874,intracellular calcium ion homeostasis,0.13899475938511008,1.7769374164975196,1
360,Phenotype,HP:0032973,Abnormal bronchoalveolar lavage fluid morphology,0.1387752651357017,1.7731619775722611,1
361,Biological Process,GO:0010574,regulation of vascular endothelial growth factor production,0.1387021445626201,1.771904257797854,1
362,Biological Process,GO:0002833,positive regulation of response to biotic stimulus,0.13855602020901692,1.769390827154415,1
363,Biological Process,GO:2001237,negative regulation of extrinsic apoptotic signaling pathway,0.13848757293511937,1.7682134910606577,1
364,Biological Process,GO:0019883,antigen processing and presentation of endogenous antigen,0.13825837636600014,1.7642711661436228,1
365,Biological Process,GO:0045765,regulation of angiogenesis,0.13822780060775886,1.7637452439012653,1
366,Biological Process,GO:0045089,positive regulation of innate immune response,0.13817788834721256,1.762886721676551,1
367,Biological Process,GO:0051281,positive regulation of release of sequestered calcium ion into cytosol,0.13791234746369185,1.7583192517287327,1
368,Biological Process,GO:0090201,negative regulation of release of cytochrome c from mitochondria,0.13777282391078205,1.7559193590023132,1
369,Biological Process,GO:0045860,positive regulation of protein kinase activity,0.1377675744447665,1.7558290648903476,1
370,Phenotype,HP:0002494,Abnormal rapid eye movement sleep,0.13770085103586838,1.7546813803571129,1
371,Phenotype,HP:0025456,Abnormal CSF protein concentration,0.13767461790544555,1.7542301540402656,1
372,Biological Process,GO:0051960,regulation of nervous system development,0.13762530700261422,1.753381975545882,1
373,Biological Process,GO:0034765,regulation of monoatomic ion transmembrane transport,0.13753939172091556,1.75190417874859,1
374,Biological Process,GO:0006094,gluconeogenesis,0.13753702424853975,1.7518634567370286,1
375,Biological Process,GO:0070301,cellular response to hydrogen peroxide,0.13739127454170674,1.7493564702533024,1
376,Phenotype,HP:0030838,Hip pain,0.13734168085993204,1.7485034277835165,1
377,Phenotype,HP:0005294,Arterial dissection,0.1373073882853314,1.7479135739657352,1
378,Biological Process,GO:0055080,monoatomic cation homeostasis,0.13727622308210852,1.7473775128995415,1
379,Biological Process,GO:0031281,positive regulation of cyclase activity,0.13716036997083014,1.74538476663347,1
380,Biological Process,GO:0035194,regulatory ncRNA-mediated post-transcriptional gene silencing,0.137075340160427,1.7439222004985089,1
381,Biological Process,GO:0043367,"CD4-positive, alpha-beta T cell differentiation",0.13703849546520352,1.743288448603364,1
382,Biological Process,GO:0032757,positive regulation of interleukin-8 production,0.13699191238906905,1.742487190441155,1
383,Biological Process,GO:0090559,regulation of membrane permeability,0.13699120014939803,1.7424749394715495,1
384,Biological Process,GO:0048002,antigen processing and presentation of peptide antigen,0.13696907646878176,1.7420943982719792,1
385,Biological Process,GO:0046889,positive regulation of lipid biosynthetic process,0.13693199120235477,1.7414565084010627,1
386,Biological Process,GO:0006636,unsaturated fatty acid biosynthetic process,0.13685968916372382,1.7402128679332207,1
387,Biological Process,GO:0050731,positive regulation of peptidyl-tyrosine phosphorylation,0.13678117131092038,1.7388623115582775,1
388,Biological Process,GO:0010821,regulation of mitochondrion organization,0.13666526654669753,1.7368686768291246,1
389,Phenotype,HP:0006562,Viral hepatitis,0.136612957110256,1.7359689216736616,1
390,Biological Process,GO:0051928,positive regulation of calcium ion transport,0.1363495785729938,1.7314386454393746,1
391,Biological Process,GO:1901342,regulation of vasculature development,0.13631021791608688,1.7307616174233302,1
392,Biological Process,GO:0050767,regulation of neurogenesis,0.13619537597332987,1.728786263890808,1
393,Biological Process,GO:0045216,cell-cell junction organization,0.13616775783389468,1.728311214549206,1
394,Biological Process,GO:1904062,regulation of monoatomic cation transmembrane transport,0.1360950002558725,1.727059738517771,1
395,Biological Process,GO:0002718,regulation of cytokine production involved in immune response,0.13598419972927533,1.7251538998810791,1
396,Biological Process,GO:0070486,leukocyte aggregation,0.13565294626083202,1.7194561322071709,1
397,Biological Process,GO:0032642,regulation of chemokine production,0.13560458674085918,1.7186243180953915,1
398,Biological Process,GO:1904035,regulation of epithelial cell apoptotic process,0.13532428580070466,1.7138029659046239,1
399,Biological Process,GO:0010631,epithelial cell migration,0.13526242076140083,1.7127388483793133,1
399,Biological Process,GO:0090130,tissue migration,0.13526242076140083,1.7127388483793133,1
399,Biological Process,GO:0090132,epithelium migration,0.13526242076140083,1.7127388483793133,1
402,Biological Process,GO:0071492,cellular response to UV-A,0.13499188134866502,1.7080854005900776,1
403,Biological Process,GO:0032680,regulation of tumor necrosis factor production,0.13491714755144502,1.7067999323474365,1
404,Phenotype,HP:0002922,Increased CSF protein concentration,0.1348365209662571,1.7054131044512633,1
405,Phenotype,HP:0010534,Transient global amnesia,0.1348225387256049,1.7051726011316415,1
406,Biological Process,GO:0001954,positive regulation of cell-matrix adhesion,0.1348141624059851,1.7050285231741173,1
407,Biological Process,GO:0019319,hexose biosynthetic process,0.1347789271498827,1.704422454642532,1
408,Biological Process,GO:1905048,regulation of metallopeptidase activity,0.13472658312221497,1.7035221044962559,1
409,Phenotype,HP:0006725,Pancreatic adenocarcinoma,0.1346730918914132,1.7026020217356668,1
410,Phenotype,HP:0010758,Abnormality of the premaxilla,0.13446135626085776,1.6989600359268457,1
411,Biological Process,GO:0010959,regulation of metal ion transport,0.13445857856850962,1.6989122578741551,1
412,Biological Process,GO:0002573,myeloid leukocyte differentiation,0.13439303460157592,1.6977848604833607,1
413,Phenotype,HP:0002666,Pheochromocytoma,0.13437176405300977,1.6974189936907922,1
414,Phenotype,HP:0003341,Lamina lucida cleavage,0.13427498805054638,1.6957543856761585,1
415,Biological Process,GO:0046638,positive regulation of alpha-beta T cell differentiation,0.13427165477636605,1.6956970512670662,1
416,Phenotype,HP:0002617,Vascular dilatation,0.1342554573301208,1.6954184450201646,1
417,Biological Process,GO:0002757,immune response-activating signaling pathway,0.13409788775015852,1.6927081492961096,1
418,Biological Process,GO:0034644,cellular response to UV,0.13403794692941928,1.6916771295384583,1
419,Phenotype,HP:0003528,Elevated circulating calcitonin concentration,0.13401462076573067,1.6912759048749224,1
419,Phenotype,HP:0034902,Abnormal circulating calcitonin concentration,0.13401462076573067,1.6912759048749224,1
421,Biological Process,GO:0002764,immune response-regulating signaling pathway,0.13401271008611992,1.6912430399857714,1
422,Phenotype,HP:0040223,Pulmonary hemorrhage,0.13391390571565853,1.6895435427678211,1
423,Phenotype,HP:0030242,Portal vein thrombosis,0.13381028873637013,1.6877612656558805,1
424,Phenotype,HP:0000989,Pruritus,0.13366593572793528,1.6852783032616852,1
425,Biological Process,GO:0051091,positive regulation of DNA-binding transcription factor activity,0.13365755074825647,1.6851340763457079,1
426,Biological Process,GO:0051702,biological process involved in interaction with symbiont,0.13352988946451283,1.6829382220980758,1
427,Biological Process,GO:0071902,positive regulation of protein serine/threonine kinase activity,0.13348630495811975,1.6821885412184256,1
428,Biological Process,GO:0010544,negative regulation of platelet activation,0.13342831534944366,1.68119108353356,1
429,Disease,MONDO:0004970,adenocarcinoma,0.1334249747580658,1.6811336232640752,1
429,Disease,MONDO:0024276,glandular cell neoplasm,0.1334249747580658,1.6811336232640752,1
431,Biological Process,GO:0002237,response to molecule of bacterial origin,0.13341035005158897,1.6808820691288213,1
432,Biological Process,GO:0030097,hemopoiesis,0.13332756627003461,1.6794581361004943,1
433,Biological Process,GO:0002762,negative regulation of myeloid leukocyte differentiation,0.13329216865553994,1.6788492749026056,1
434,Biological Process,GO:0010518,positive regulation of phospholipase activity,0.13329119457166216,1.678832520048214,1
435,Phenotype,HP:0009926,Epiphora,0.1332742184670943,1.678540520389191,1
436,Phenotype,HP:0002896,Neoplasm of the liver,0.13319643199838493,1.6772025442799519,1
437,Biological Process,GO:0034764,positive regulation of transmembrane transport,0.13311962652082499,1.6758814418345143,1
438,Biological Process,GO:0032870,cellular response to hormone stimulus,0.13309752494921168,1.6755012809236784,1
439,Biological Process,GO:0030308,negative regulation of cell growth,0.133092422525103,1.6754135160248487,1
440,Phenotype,HP:0003724,Shoulder girdle muscle atrophy,0.1330193093012747,1.6741559226622138,1
441,Biological Process,GO:1901222,regulation of non-canonical NF-kappaB signal transduction,0.132918527452078,1.672422411568222,1
442,Phenotype,HP:0033804,Subepidermal blistering,0.13281262985609688,1.6706009064170115,1
443,Biological Process,GO:0045806,negative regulation of endocytosis,0.13280528438430994,1.6704745596895527,1
444,Biological Process,GO:0032677,regulation of interleukin-8 production,0.1327816316648558,1.670067718061783,1
445,Phenotype,HP:0008954,Intrinsic hand muscle atrophy,0.1327006437277607,1.6686746746858885,1
446,Biological Process,GO:0001818,negative regulation of cytokine production,0.13264982500943112,1.6678005608180748,1
447,Phenotype,HP:0030140,Oral cavity bleeding,0.13261552817641986,1.6672106337529566,1
448,Biological Process,GO:0001909,leukocyte mediated cytotoxicity,0.13258374425626418,1.6666639303669841,1
449,Biological Process,GO:0032743,positive regulation of interleukin-2 production,0.1325505620804711,1.6660931761059883,1
450,Biological Process,GO:0048525,negative regulation of viral process,0.13253921982087524,1.6658980821183595,1
451,Biological Process,GO:0045745,positive regulation of G protein-coupled receptor signaling pathway,0.13252633468642172,1.6656764497143028,1
452,Phenotype,HP:0100576,Amaurosis fugax,0.13246426593004335,1.6646088281273823,1
453,Biological Process,GO:0048524,positive regulation of viral process,0.13236625428353954,1.662922966259308,1
454,Phenotype,HP:0025245,Cutaneous cyst,0.13229610594942098,1.6617163708615375,1
455,Phenotype,HP:0005421,Decreased circulating complement C3 concentration,0.13229531485969037,1.6617027636213917,1
456,Phenotype,HP:0032148,Episodic pain,0.13224843832432687,1.6608964577761602,1
457,Biological Process,GO:0051607,defense response to virus,0.13222941332899818,1.6605692159094125,1
458,Phenotype,HP:0031364,Ecchymosis,0.13210084558317692,1.6583577699448158,1
459,Phenotype,HP:0003118,Increased circulating cortisol level,0.1320136044068866,1.6568571669279273,1
460,Biological Process,GO:0032731,positive regulation of interleukin-1 beta production,0.13194611139550638,1.6556962447487151,1
461,Phenotype,HP:0006783,Posterior pharyngeal cleft,0.13194264378265474,1.655636599630116,1
462,Biological Process,GO:0019884,antigen processing and presentation of exogenous antigen,0.1319162799074558,1.6551831244210158,1
463,Biological Process,GO:0050850,positive regulation of calcium-mediated signaling,0.13190540072233203,1.6549959956051032,1
464,Biological Process,GO:0002224,toll-like receptor signaling pathway,0.13178599913442623,1.6529422133127092,1
465,Biological Process,GO:0051100,negative regulation of binding,0.13174375235409064,1.6522155421612974,1
466,Biological Process,GO:0016486,peptide hormone processing,0.13173911361954427,1.6521357530141214,1
467,Biological Process,GO:0050829,defense response to Gram-negative bacterium,0.13152556125297954,1.6484625182050878,1
468,Phenotype,HP:0005387,Combined immunodeficiency,0.13145864956459852,1.6473115951465138,1
469,Biological Process,GO:0097193,intrinsic apoptotic signaling pathway,0.1314583198566327,1.6473059239624555,1
470,Biological Process,GO:0031279,regulation of cyclase activity,0.13138981482459533,1.6461275943924232,1
471,Biological Process,GO:0071219,cellular response to molecule of bacterial origin,0.13137888979692947,1.6459396770559989,1
472,Biological Process,GO:1903555,regulation of tumor necrosis factor superfamily cytokine production,0.13136915552170048,1.645772241409244,1
473,Biological Process,GO:0071453,cellular response to oxygen levels,0.13135680424548846,1.645559791702187,1
474,Phenotype,HP:0100014,Epiretinal membrane,0.1312686747031886,1.644043908232069,1
475,Biological Process,GO:0050856,regulation of T cell receptor signaling pathway,0.1312551436060354,1.6438111648639337,1
476,Biological Process,GO:0002449,lymphocyte mediated immunity,0.1312283660266993,1.6433505736838812,1
477,Disease,MONDO:0005070,neoplasm,0.13118608916702024,1.642623385148873,1
478,Biological Process,GO:0033135,regulation of peptidyl-serine phosphorylation,0.13116996643009915,1.6423460639492622,1
479,Biological Process,GO:0010721,negative regulation of cell development,0.13109514721028737,1.6410591263844,1
480,Biological Process,GO:1903169,regulation of calcium ion transmembrane transport,0.1310940522761791,1.6410402928301537,1
481,Phenotype,HP:0045027,Abnormality of the thoracic cavity,0.1310108793914495,1.6396096669828684,1
482,Phenotype,HP:0011958,Retinal perforation,0.1309844411164709,1.6391549120508373,1
483,Phenotype,HP:0007379,Neoplasm of the genitourinary tract,0.13082732068928826,1.6364523420366455,1
484,Phenotype,HP:0003834,Shoulder dislocation,0.13078352084677147,1.6356989572404435,1
485,Biological Process,GO:0050769,positive regulation of neurogenesis,0.13076577883057394,1.6353937834204217,1
486,Biological Process,GO:0051402,neuron apoptotic process,0.13069559037563383,1.634186497919326,1
487,Biological Process,GO:0030518,intracellular steroid hormone receptor signaling pathway,0.13061715296207732,1.6328373251499433,1
487,Biological Process,GO:0141193,nuclear receptor signaling pathway,0.13061715296207732,1.6328373251499433,1
489,Disease,MONDO:0015974,severe combined immunodeficiency,0.13057065527216072,1.6320375356843015,1
490,Phenotype,HP:0002107,Pneumothorax,0.13043399350734142,1.629686867510151,1
491,Phenotype,HP:0000834,Abnormality of the adrenal glands,0.1303973543225705,1.629056650523844,1
492,Disease,MONDO:0045024,cancer or benign tumor,0.13039038471054987,1.6289367688203935,1
492,Disease,MONDO:0023370,neoplastic disease or syndrome,0.13039038471054987,1.6289367688203935,1
494,Biological Process,GO:1904064,positive regulation of cation transmembrane transport,0.13038539576558827,1.6288509558341548,1
495,Phenotype,HP:0007446,Palmoplantar blistering,0.1303346874560367,1.6279787410666562,1
496,Biological Process,GO:0002719,negative regulation of cytokine production involved in immune response,0.13028924566804767,1.6271971137772414,1
497,Biological Process,GO:0010635,regulation of mitochondrial fusion,0.13028212248856408,1.6270745906169926,1
498,Biological Process,GO:0098930,axonal transport,0.13012068117704978,1.624297698678918,1
499,Biological Process,GO:0002483,antigen processing and presentation of endogenous peptide antigen,0.13000495229797127,1.6223070892846978,1
500,Biological Process,GO:0050730,regulation of peptidyl-tyrosine phosphorylation,0.12998915808286937,1.6220354188666786,1
501,Biological Process,GO:0070141,response to UV-A,0.12997261799005067,1.6217509188835426,1
502,Biological Process,GO:1902686,mitochondrial outer membrane permeabilization involved in programmed cell death,0.12986844191453617,1.6199590249654183,1
503,Biological Process,GO:0051133,regulation of NK T cell activation,0.1298053320657223,1.6188734959348343,1
504,Phenotype,HP:0009123,Mixed hypo- and hyperpigmentation of the skin,0.1296729885851292,1.6165971049611203,1
505,Biological Process,GO:0006826,iron ion transport,0.12954859909270344,1.6144575275787367,1
506,Biological Process,GO:1905898,positive regulation of response to endoplasmic reticulum stress,0.12953547736779836,1.6142318256703416,1
507,Biological Process,GO:0032651,regulation of interleukin-1 beta production,0.12942103431566887,1.6122633333071035,1
508,Biological Process,GO:0043434,response to peptide hormone,0.12933032800139088,1.6107031277408306,1
509,Biological Process,GO:0008544,epidermis development,0.12926394507781258,1.609561299768911,1
510,Biological Process,GO:0043410,positive regulation of MAPK cascade,0.12918923288473005,1.6082762031310012,1
511,Phenotype,HP:0002076,Migraine,0.12909333897534458,1.6066267676712342,1
512,Disease,MONDO:0000652,integumentary system benign neoplasm,0.12904248220712733,1.6057519993214582,1
513,Phenotype,HP:0004942,Aortic aneurysm,0.12903831025650625,1.6056802391509228,1
514,Biological Process,GO:0043518,"negative regulation of DNA damage response, signal transduction by p53 class mediator",0.1289742631721812,1.604578589080992,1
515,Phenotype,HP:0003493,Antinuclear antibody positivity,0.12875077784151667,1.6007345010518552,1
516,Biological Process,GO:0045814,"negative regulation of gene expression, epigenetic",0.1287460551332864,1.6006532675045835,1
517,Disease,MONDO:0019707,primary osteolysis,0.12866996193908986,1.5993444167802877,1
518,Phenotype,HP:0002185,Neurofibrillary tangles,0.12866486610355687,1.599256765209097,1
519,Biological Process,GO:0071478,cellular response to radiation,0.12866188968694892,1.599205568974345,1
520,Phenotype,HP:0006844,Absent patellar reflexes,0.12861899757872308,1.5984677977779755,1
521,Phenotype,HP:0001733,Pancreatitis,0.12856725683178105,1.5975778244390226,1
522,Biological Process,GO:0042542,response to hydrogen peroxide,0.12852592623559222,1.5968669122302699,1
523,Phenotype,HP:0003002,Breast carcinoma,0.12840041257686485,1.594707998481558,1
524,Phenotype,HP:0002645,Wormian bones,0.12839150630264096,1.594554804972049,1
525,Biological Process,GO:0072678,T cell migration,0.12828952796823467,1.5928007135810978,1
526,Phenotype,HP:0002716,Lymphadenopathy,0.1282696500333994,1.592458800619218,1
527,Biological Process,GO:0050801,monoatomic ion homeostasis,0.12823279389766107,1.5918248519400329,1
528,Phenotype,HP:0008775,Abnormal prostate morphology,0.1280096361839138,1.587986399127606,1
529,Biological Process,GO:0032817,regulation of natural killer cell proliferation,0.12797187202259608,1.5873368318382441,1
530,Biological Process,GO:0045621,positive regulation of lymphocyte differentiation,0.12796241641691208,1.5871741894826585,1
531,Biological Process,GO:0071677,positive regulation of mononuclear cell migration,0.1278886285585854,1.5859049919830024,1
532,Biological Process,GO:0016441,post-transcriptional gene silencing,0.1277742781961504,1.5839380939407155,1
533,Biological Process,GO:0001910,regulation of leukocyte mediated cytotoxicity,0.12776745918722,1.583820802704991,1
534,Biological Process,GO:1903659,regulation of complement-dependent cytotoxicity,0.12773298959572976,1.5832279040855477,1
535,Phenotype,HP:0011713,Left bundle branch block,0.12771867612661025,1.582981703428287,1
536,Biological Process,GO:0001558,regulation of cell growth,0.12770304741469718,1.5827128797690462,1
537,Disease,MONDO:0019289,hyperpigmentation of the skin,0.12770160010442377,1.5826879851234787,1
538,Phenotype,HP:0100570,Carcinoid tumor,0.12759180030259698,1.5807993595812608,1
539,Biological Process,GO:0002218,activation of innate immune response,0.12750693646309308,1.5793396482499913,1
540,Biological Process,GO:0045637,regulation of myeloid cell differentiation,0.1274924314397653,1.5790901527400583,1
541,Phenotype,HP:0001482,Subcutaneous nodule,0.1273618603790816,1.5768442485018093,1
542,Phenotype,HP:0031538,Abnormal dermoepidermal junction morphology,0.12728910057196874,1.5755927341286144,1
543,Phenotype,HP:0012030,Increased urinary cortisol level,0.12720954814960794,1.574224382507608,1
544,Biological Process,GO:0051924,regulation of calcium ion transport,0.12715215336652785,1.573237156196525,1
545,Phenotype,HP:0100555,Asymmetric growth,0.1270942688623078,1.5722415063743052,1
546,Biological Process,GO:0032733,positive regulation of interleukin-10 production,0.12702765700348773,1.5710957405724633,1
547,Biological Process,GO:0035794,positive regulation of mitochondrial membrane permeability,0.12701181316379362,1.5708232165802951,1
548,Biological Process,GO:1903317,regulation of protein maturation,0.12692512215643237,1.5693320768144756,1
549,Phenotype,HP:0000615,Abnormal pupil morphology,0.12692395878704232,1.5693120661304076,1
550,Biological Process,GO:0044283,small molecule biosynthetic process,0.12677310776447215,1.5667173338125377,1
551,Phenotype,HP:0001030,Fragile skin,0.12665253059566628,1.564643330790435,1
552,Disease,MONDO:0005552,ocular vascular disorder,0.12660663707542552,1.5638539334226174,1
553,Phenotype,HP:0007078,Decreased amplitude of sensory action potentials,0.12659097464465274,1.5635845297778153,1
554,Phenotype,HP:0100526,Neoplasm of the lung,0.12655352454957347,1.5629403646249784,1
555,Biological Process,GO:0034762,regulation of transmembrane transport,0.12629360967683567,1.558469665595583,1
556,Biological Process,GO:0071396,cellular response to lipid,0.12629269014679712,1.558453849101484,1
557,Biological Process,GO:0009755,hormone-mediated signaling pathway,0.12619091130255677,1.5567031890666605,1
558,Biological Process,GO:0002720,positive regulation of cytokine production involved in immune response,0.12619084915754564,1.556702120133444,1
559,Biological Process,GO:0032722,positive regulation of chemokine production,0.12617919477749584,1.556501657478006,1
560,Phenotype,HP:0040186,Maculopapular exanthema,0.1260618148487369,1.554482648992476,1
561,Biological Process,GO:0032732,positive regulation of interleukin-1 production,0.12600983701765855,1.553588597657497,1
562,Biological Process,GO:0019724,B cell mediated immunity,0.12588465824809958,1.5514354442127813,1
563,Phenotype,HP:0000098,Tall stature,0.12581215340515162,1.5501883153833322,1
564,Phenotype,HP:0000591,Abnormal sclera morphology,0.12579473079538517,1.5498886355545023,1
565,Phenotype,HP:4000054,Exanthem,0.1256151063898875,1.5467989829815063,1
566,Biological Process,GO:0050854,regulation of antigen receptor-mediated signaling pathway,0.125471068821133,1.5443214463478998,1
567,Phenotype,HP:0200035,Skin plaque,0.12536878487826963,1.542562098299574,1
568,Biological Process,GO:0001816,cytokine production,0.12534692958339644,1.5421861735033222,1
569,Phenotype,HP:0012163,Carotid artery dilatation,0.12524520733318312,1.5404364869213028,1
570,Phenotype,HP:0001056,Milia,0.12524209426698918,1.5403829402278602,1
571,Phenotype,HP:0000845,Elevated circulating growth hormone concentration,0.1252130782322035,1.5398838462083961,1
572,Biological Process,GO:0001649,osteoblast differentiation,0.1252046709135326,1.5397392350477266,1
573,Phenotype,HP:0012122,Anterior uveitis,0.1251798758488878,1.539312744365321,1
574,Biological Process,GO:0002712,regulation of B cell mediated immunity,0.12511071729928913,1.538123173882846,1
575,Biological Process,GO:0010762,regulation of fibroblast migration,0.1250975728455076,1.537897081023503,1
576,Biological Process,GO:0034612,response to tumor necrosis factor,0.12498771002192599,1.5360073714675269,1
577,Biological Process,GO:0060193,positive regulation of lipase activity,0.1248476231996487,1.5335977901542714,1
578,Biological Process,GO:0042093,T-helper cell differentiation,0.12480306711948974,1.5328313975957306,1
578,Biological Process,GO:0002294,"CD4-positive, alpha-beta T cell differentiation involved in immune response",0.12480306711948974,1.5328313975957306,1
580,Phenotype,HP:0007550,Hypohidrosis or hyperhidrosis,0.12456958939211527,1.5288154340682738,1
581,Biological Process,GO:0034121,regulation of toll-like receptor signaling pathway,0.12454438699049053,1.5283819369340186,1
582,Phenotype,HP:0032449,Abnormal dermoepidermal hemidesmosome morphology,0.12446819382775665,1.5270713666881035,1
583,Biological Process,GO:0071675,regulation of mononuclear cell migration,0.12442244297769023,1.5262844233368769,1
584,Biological Process,GO:0001763,morphogenesis of a branching structure,0.12432447083174136,1.5245992409031526,1
585,Phenotype,HP:0003401,Paresthesia,0.12431198292781453,1.5243844411136032,1
586,Biological Process,GO:0032897,negative regulation of viral transcription,0.12427232526779652,1.5237023044575393,1
587,Phenotype,HP:0100598,Pulmonary edema,0.12426181311662166,1.5235214888560338,1
588,Phenotype,HP:0030001,Lagophthalmos,0.12422594285458177,1.5229044978235597,1
589,Biological Process,GO:0002478,antigen processing and presentation of exogenous peptide antigen,0.12419326682077358,1.5223424495225448,1
590,Phenotype,HP:0000790,Hematuria,0.12412378132259372,1.5211472553191596,1
590,Phenotype,HP:0012614,Abnormal urine cytology,0.12412378132259372,1.5211472553191596,1
592,Biological Process,GO:0051101,regulation of DNA binding,0.12401827954468447,1.5193325584873467,1
593,Biological Process,GO:0048146,positive regulation of fibroblast proliferation,0.1239242623382798,1.5177154034973594,1
594,Biological Process,GO:0071900,regulation of protein serine/threonine kinase activity,0.12392061422508227,1.5176526536594623,1
595,Biological Process,GO:0035195,miRNA-mediated post-transcriptional gene silencing,0.12369610659096919,1.513790981369036,1
596,Phenotype,HP:0040160,Generalized osteoporosis,0.12361193707924634,1.5123432129116163,1
597,Biological Process,GO:0045619,regulation of lymphocyte differentiation,0.12358934072687733,1.511954541461076,1
598,Phenotype,HP:0031941,Abnormal portal venous system morphology,0.12353456210741909,1.5110123148071566,1
599,Biological Process,GO:0031343,positive regulation of cell killing,0.12346064143535351,1.5097408328277888,1
600,Phenotype,HP:0012115,Hepatitis,0.12343777987557225,1.5093475996432157,1
601,Disease,MONDO:0043218,neurovascular disorder,0.12334504881790886,1.5077525672192391,1
602,Biological Process,GO:0016051,carbohydrate biosynthetic process,0.12332524682944024,1.5074119605825576,1
603,Biological Process,GO:0051606,detection of stimulus,0.12330952445859744,1.5071415259309107,1
604,Biological Process,GO:0030890,positive regulation of B cell proliferation,0.12325798115296382,1.5062549487064494,1
605,Biological Process,GO:0001914,regulation of T cell mediated cytotoxicity,0.1232557422721201,1.5062164385499912,1
606,Phenotype,HP:0003208,Fingerprint intracellular accumulation of autofluorescent lipopigment storage material,0.12325388048171582,1.506184414585892,1
606,Disease,MONDO:0016295,neuronal ceroid lipofuscinosis,0.12325388048171582,1.506184414585892,1
608,Biological Process,GO:0043062,extracellular structure organization,0.12315687118175433,1.5045157937077878,1
609,Phenotype,HP:0012091,Abnormality of pancreas physiology,0.12311354570647604,1.503770568325975,1
610,Phenotype,HP:0002091,Restrictive ventilatory defect,0.12302287247790211,1.5022109318545889,1
611,Biological Process,GO:1902175,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,0.12301317522058797,1.5020441329392151,1
612,Phenotype,HP:0012763,Paroxysmal dyspnea,0.12300907144067075,1.501973545347595,1
613,Phenotype,HP:0004313,Decreased circulating antibody level,0.12290941719655946,1.500259429769173,1
614,Phenotype,HP:0100607,Dysmenorrhea,0.1228951973136515,1.5000148388535202,1
615,Biological Process,GO:0019079,viral genome replication,0.12282498352460902,1.4988071175899544,1
616,Phenotype,HP:0002733,Abnormal lymph node morphology,0.1228189366896385,1.4987031082312408,1
617,Biological Process,GO:0050848,regulation of calcium-mediated signaling,0.12276516460536768,1.4977781946146174,1
618,Phenotype,HP:0001342,Cerebral hemorrhage,0.1227503359716059,1.4975231328020024,1
619,Biological Process,GO:0040008,regulation of growth,0.12258537292680138,1.494685664839799,1
620,Biological Process,GO:0010506,regulation of autophagy,0.12258498061347578,1.4946789168042385,1
621,Phenotype,HP:0045026,Abnormal mediastinum morphology,0.12255174560644677,1.494107253812808,1
622,Phenotype,HP:0100776,Recurrent pharyngitis,0.1224869849664183,1.492993330136688,1
623,Disease,MONDO:0021094,immunodeficiency disease,0.12246664320684908,1.492643439098117,1
624,Phenotype,HP:0004950,Peripheral arterial stenosis,0.12237621932934817,1.491088091621771,1
625,Biological Process,GO:0070372,regulation of ERK1 and ERK2 cascade,0.12230626500494657,1.4898848333129642,1
626,Biological Process,GO:0043406,positive regulation of MAP kinase activity,0.12226362700299243,1.4891514329040385,1
627,Biological Process,GO:0042762,regulation of sulfur metabolic process,0.1222630295921362,1.4891411570621562,1
628,Phenotype,HP:0012767,Abnormal placental size,0.1222466217039293,1.4888589310813638,1
629,Phenotype,HP:0012432,Chronic fatigue,0.12222593017591843,1.4885030238059527,1
630,Biological Process,GO:0032682,negative regulation of chemokine production,0.12222259809263314,1.4884457098810029,1
631,Biological Process,GO:0043516,"regulation of DNA damage response, signal transduction by p53 class mediator",0.12204818488880742,1.4854456932492344,1
632,Biological Process,GO:0002768,immune response-regulating cell surface receptor signaling pathway,0.12198518588685803,1.4843620708543275,1
633,Phenotype,HP:0007418,Alopecia totalis,0.12195992664266253,1.4839275959921598,1
634,Biological Process,GO:0030098,lymphocyte differentiation,0.12189895766470349,1.4828788912846778,1
635,Biological Process,GO:1900017,positive regulation of cytokine production involved in inflammatory response,0.1217603497569083,1.4804947482292259,1
636,Phenotype,HP:0100724,Hypercoagulability,0.12171250765410135,1.4796718340176216,1
637,Biological Process,GO:0044403,biological process involved in symbiotic interaction,0.12167062370417514,1.4789514037770972,1
638,Biological Process,GO:2000352,negative regulation of endothelial cell apoptotic process,0.12163594050420068,1.4783548309575856,1
639,Biological Process,GO:0032088,negative regulation of NF-kappaB transcription factor activity,0.12162153554869692,1.4781070566770653,1
640,Biological Process,GO:0050851,antigen receptor-mediated signaling pathway,0.12139299539560511,1.4741760225279106,1
641,Phenotype,HP:0012029,Abnormal urine hormone level,0.12135501538266102,1.4735227424550277,1
642,Biological Process,GO:0043124,negative regulation of canonical NF-kappaB signal transduction,0.12128996649710255,1.4724038607747827,1
643,Biological Process,GO:0022898,regulation of transmembrane transporter activity,0.12128783442575275,1.4723671878086928,1
644,Biological Process,GO:0032496,response to lipopolysaccharide,0.12128525874926255,1.472322884555618,1
645,Disease,MONDO:0015977,agammaglobulinemia,0.12127901201579827,1.4722154368172817,1
646,Phenotype,HP:0001369,Arthritis,0.12122534539408414,1.4712923372228606,1
647,Biological Process,GO:0045582,positive regulation of T cell differentiation,0.12122083910681081,1.4712148262519535,1
648,Phenotype,HP:0003651,Foam cells,0.12113929434937254,1.4698122052164913,1
649,Phenotype,HP:0033801,Blistering by histological location,0.12112941060859472,1.4696421986684367,1
650,Biological Process,GO:0032675,regulation of interleukin-6 production,0.1210092324875246,1.4675750595179782,1
651,Phenotype,HP:0100699,Scarring,0.12098013912265682,1.4670746353725408,1
652,Biological Process,GO:1904427,positive regulation of calcium ion transmembrane transport,0.12086318123278483,1.4650628862208934,1
653,Biological Process,GO:0032872,regulation of stress-activated MAPK cascade,0.12072650498623183,1.462711968951829,1
654,Biological Process,GO:0018108,peptidyl-tyrosine phosphorylation,0.1206416002551357,1.4612515542594946,1
655,Phenotype,HP:0030179,Abnormal peripheral action potential amplitude,0.12063039992718261,1.4610589015852502,1
656,Biological Process,GO:0046902,regulation of mitochondrial membrane permeability,0.12059402621605142,1.4604332509122555,1
657,Biological Process,GO:0031453,positive regulation of heterochromatin formation,0.12051352400954074,1.4590485624074367,1
658,Biological Process,GO:0031214,biomineral tissue development,0.12050794800175813,1.4589526515720195,1
659,Biological Process,GO:1903038,negative regulation of leukocyte cell-cell adhesion,0.1203954498770875,1.4570176131824266,1
660,Phenotype,HP:0032324,Non-periodic recurrent fever,0.12039177956183922,1.4569544814553144,1
661,Phenotype,HP:0032199,Abnormal prothrombin time,0.12026906663743553,1.4548437420957423,1
662,Phenotype,HP:0005116,Arterial tortuosity,0.12026277474719171,1.454735517632441,1
663,Biological Process,GO:0045229,external encapsulating structure organization,0.12021121065429197,1.4538485828539487,1
664,Phenotype,HP:0008364,Abnormality of the calcaneus,0.12019415401394495,1.4535551979289503,1
665,Disease,MONDO:0018102,corneal dystrophy,0.12017688281399808,1.4532581224440975,1
666,Disease,MONDO:0020074,progressive myoclonus epilepsy,0.11996976224167877,1.449695518535048,1
667,Biological Process,GO:2000273,positive regulation of signaling receptor activity,0.11995594428374834,1.449457840981405,1
668,Biological Process,GO:0045762,positive regulation of adenylate cyclase activity,0.11991640630927658,1.4487777629918952,1
669,Biological Process,GO:0050678,regulation of epithelial cell proliferation,0.11991524280288957,1.4487577499513935,1
670,Disease,MONDO:0002305,thrombophilia,0.11984938011167989,1.4476248703029038,1
671,Biological Process,GO:0002685,regulation of leukocyte migration,0.11968602700232378,1.4448150942414013,1
672,Biological Process,GO:0071356,cellular response to tumor necrosis factor,0.11958412943492891,1.4430623920937655,1
673,Phenotype,HP:0000592,Blue sclerae,0.1195422707026661,1.4423423956128876,1
674,Phenotype,HP:0012040,Corneal stromal edema,0.11953704421271016,1.4422524967035752,1
675,Phenotype,HP:0004431,Reduced circulating complement concentration,0.11949584593654017,1.4415438604822393,1
676,Phenotype,HP:0000964,Eczematoid dermatitis,0.11947017043846286,1.4411022257919102,1
677,Disease,MONDO:0015131,combined immunodeficiency,0.11928086245443215,1.4378460095871657,1
678,Phenotype,HP:0002574,Episodic abdominal pain,0.11921011007445292,1.43662902422127,1
679,Phenotype,HP:0030878,Abnormality on pulmonary function testing,0.11918548396846163,1.4362054397338053,1
680,Disease,MONDO:0002350,familial nephrotic syndrome,0.11915646609406294,1.435706314071842,1
681,Biological Process,GO:0050819,negative regulation of coagulation,0.11915444122074736,1.435671484979258,1
682,Phenotype,HP:0001978,Extramedullary hematopoiesis,0.11913372924074295,1.4353152259167148,1
683,Biological Process,GO:0002443,leukocyte mediated immunity,0.11906022007499906,1.4340508221044925,1
684,Phenotype,HP:0100832,Vitreous floaters,0.11905311929567086,1.4339286842409833,1
685,Phenotype,HP:0033811,Abnormal circulating androstenedione concentration,0.11904796190937628,1.4338399739580412,1
686,Biological Process,GO:0003013,circulatory system process,0.11898332323681071,1.432728148198875,1
687,Biological Process,GO:1902110,positive regulation of mitochondrial membrane permeability involved in apoptotic process,0.11895091323729234,1.4321706758547061,1
688,Biological Process,GO:0002701,negative regulation of production of molecular mediator of immune response,0.11892104359323241,1.4316568992196852,1
689,Phenotype,HP:0005339,Abnormality of complement system,0.11887599615317435,1.4308820549623213,1
690,Phenotype,HP:0001596,Alopecia,0.11882225335062357,1.4299576450096707,1
691,Biological Process,GO:0043271,negative regulation of monoatomic ion transport,0.11880352814335016,1.429635559685731,1
692,Phenotype,HP:0002717,Adrenal overactivity,0.11876730972051996,1.4290125800690296,1
693,Biological Process,GO:0072332,intrinsic apoptotic signaling pathway by p53 class mediator,0.11875927508558815,1.428874379302706,1
694,Biological Process,GO:0055123,digestive system development,0.11871296619141503,1.42807783724241,1
694,Biological Process,GO:0048565,digestive tract development,0.11871296619141503,1.42807783724241,1
696,Phenotype,HP:0008069,Neoplasm of the skin,0.1187031896320837,1.427909674282542,1
697,Biological Process,GO:1903725,regulation of phospholipid metabolic process,0.11855991010227884,1.425445176394893,1
698,Biological Process,GO:0031047,regulatory ncRNA-mediated gene silencing,0.11855288392147967,1.425324321672928,1
699,Biological Process,GO:0033138,positive regulation of peptidyl-serine phosphorylation,0.11849648696244142,1.4243542585619668,1
700,Phenotype,HP:0010754,Abnormality of the temporomandibular joint,0.1184341994907977,1.423282874935136,1
701,Phenotype,HP:0100631,Neoplasm of the adrenal gland,0.1184300789157482,1.423211998456694,1
702,Phenotype,HP:0007661,Abnormality of chorioretinal pigmentation,0.11836749477283182,1.4221355118976733,1
703,Phenotype,HP:0000488,Retinopathy,0.11835691330164988,1.4219535039485154,1
704,Biological Process,GO:0051092,positive regulation of NF-kappaB transcription factor activity,0.1182998572450461,1.4209721039455345,1
705,Phenotype,HP:0000977,Soft skin,0.11828269173301542,1.420676846359209,1
706,Phenotype,HP:0001325,Hypoglycemic coma,0.11814179087469301,1.4182532631147886,1
707,Biological Process,GO:0070302,regulation of stress-activated protein kinase signaling cascade,0.11811234474754362,1.417746771236584,1
708,Biological Process,GO:0051962,positive regulation of nervous system development,0.11800543185324175,1.4159078023166816,1
709,Phenotype,HP:0005521,Disseminated intravascular coagulation,0.11800251612820745,1.4158576500151088,1
710,Biological Process,GO:0070555,response to interleukin-1,0.11798409584933722,1.4155408096511892,1
711,Biological Process,GO:0034975,protein folding in endoplasmic reticulum,0.11793232227942962,1.414650271736617,1
712,Biological Process,GO:0032409,regulation of transporter activity,0.11788108196566582,1.413768906162586,1
713,Biological Process,GO:0071637,regulation of monocyte chemotactic protein-1 production,0.11783402633208528,1.4129595197155536,1
714,Phenotype,HP:0100721,Mediastinal lymphadenopathy,0.1178203227490956,1.412723809482715,1
715,Biological Process,GO:0009988,cell-cell recognition,0.11774998010468907,1.4115138718259708,1
716,Biological Process,GO:0009411,response to UV,0.11768269084399219,1.4103564542864604,1
717,Disease,MONDO:0002331,nephrosis,0.11767803738728388,1.4102764119088542,1
717,Disease,MONDO:0005377,nephrotic syndrome,0.11767803738728388,1.4102764119088542,1
719,Biological Process,GO:0048662,negative regulation of smooth muscle cell proliferation,0.11764680277847828,1.409739157023053,1
720,Biological Process,GO:0032755,positive regulation of interleukin-6 production,0.11747835112210625,1.406841682751151,1
721,Phenotype,HP:0011493,Central opacification of the cornea,0.11728234794487291,1.403470305018952,1
722,Phenotype,HP:0002703,Abnormality of skull ossification,0.11722057047713685,1.4024076937795993,1
723,Phenotype,HP:0001531,Failure to thrive in infancy,0.11718476075446738,1.401791744062313,1
724,Phenotype,HP:0003481,Segmental peripheral demyelination/remyelination,0.11706841230561427,1.3997904776788999,1
725,Phenotype,HP:0030088,Increased serum testosterone level,0.11702851056759977,1.3991041427280233,1
726,Phenotype,HP:0007376,Abnormal choroid plexus morphology,0.11696670282352284,1.3980410107165948,1
727,Biological Process,GO:0072384,organelle transport along microtubule,0.11690900789396341,1.3970486216975848,1
728,Phenotype,HP:0031446,Erosion of oral mucosa,0.11683440747244711,1.3957654476008032,1
729,Phenotype,HP:0030057,Autoimmune antibody positivity,0.11662988224337945,1.3922474852254754,1
730,Biological Process,GO:0032652,regulation of interleukin-1 production,0.11652660662421832,1.3904710797220872,1
731,Phenotype,HP:0000706,Eruption failure,0.11651514679252406,1.3902739634205348,1
732,Phenotype,HP:0009726,Renal neoplasm,0.11648287283922454,1.3897188311567628,1
733,Biological Process,GO:0019882,antigen processing and presentation,0.11644481497015668,1.3890642119096597,1
734,Biological Process,GO:0097190,apoptotic signaling pathway,0.11638889419138132,1.388102339398246,1
735,Biological Process,GO:0043467,regulation of generation of precursor metabolites and energy,0.11630208218251004,1.3866091183304687,1
736,Phenotype,HP:0000225,Gingival bleeding,0.11627979174668879,1.3862257088366559,1
737,Disease,MONDO:0003004,macular degeneration,0.11627006236847615,1.3860583574216572,1
738,Biological Process,GO:0032147,activation of protein kinase activity,0.11618048970639228,1.3845176513850206,1
739,Disease,MONDO:0015626,Charcot-Marie-Tooth disease,0.11611922884180204,1.3834639260441863,1
740,Phenotype,HP:0012125,Prostate cancer,0.1160558751788412,1.3823742032571666,1
740,Phenotype,HP:0100787,Prostate neoplasm,0.1160558751788412,1.3823742032571666,1
742,Phenotype,HP:0011813,Increased cerebral lipofuscin,0.11602874810518349,1.3819076005553113,1
743,Biological Process,GO:0050847,progesterone receptor signaling pathway,0.11600925643323501,1.3815723315576451,1
744,Biological Process,GO:0002429,immune response-activating cell surface receptor signaling pathway,0.11600075940918142,1.3814261774080614,1
745,Phenotype,HP:0002570,Steatorrhea,0.1159680578398008,1.3808636898791653,1
746,Biological Process,GO:2001026,regulation of endothelial cell chemotaxis,0.11577798192634803,1.377594264806126,1
747,Phenotype,HP:5200297,Abnormal hypnopompia,0.11568367163414262,1.3759720685563173,1
748,Biological Process,GO:0045600,positive regulation of fat cell differentiation,0.11562134227573062,1.3748999644507687,1
749,Phenotype,HP:0010303,Abnormal spinal meningeal morphology,0.11558974632878394,1.374356494322032,1
750,Biological Process,GO:1903054,negative regulation of extracellular matrix organization,0.11555717465967752,1.3737962411594253,1
751,Biological Process,GO:0043401,steroid hormone mediated signaling pathway,0.11553070351043448,1.373340920769402,1
752,Biological Process,GO:0010224,response to UV-B,0.11552766854756646,1.3732887175022117,1
753,Biological Process,GO:0033628,regulation of cell adhesion mediated by integrin,0.11548528596809227,1.3725597105203382,1
754,Biological Process,GO:0032703,negative regulation of interleukin-2 production,0.11537943413048612,1.3707389924419122,1
755,Biological Process,GO:1905269,positive regulation of chromatin organization,0.11535638477058163,1.3703425289772873,1
756,Phenotype,HP:0000048,Bifid scrotum,0.11534481461373469,1.370143515013828,1
757,Biological Process,GO:0030195,negative regulation of blood coagulation,0.115311689459484,1.3695737415591687,1
757,Biological Process,GO:1900047,negative regulation of hemostasis,0.115311689459484,1.3695737415591687,1
759,Disease,MONDO:0021058,neoplastic syndrome,0.11523589364900733,1.3682700060216022,1
760,Biological Process,GO:0071456,cellular response to hypoxia,0.11521662520562659,1.3679385766954815,1
760,Biological Process,GO:0036294,cellular response to decreased oxygen levels,0.11521662520562659,1.3679385766954815,1
762,Biological Process,GO:0070613,regulation of protein processing,0.11510916079813449,1.3660901214023744,1
763,Biological Process,GO:0010738,regulation of protein kinase A signaling,0.11501916369385767,1.3645421146934829,1
764,Phenotype,HP:0030078,Lung adenocarcinoma,0.11500696633042651,1.364332312382909,1
765,Phenotype,HP:0025276,Abnormality of skin adnexa physiology,0.1149454764489185,1.363274647807274,1
766,Phenotype,HP:0034784,Vasculitis by anatomical site,0.11488278264034035,1.3621962749300043,1
767,Biological Process,GO:0045923,positive regulation of fatty acid metabolic process,0.11485481125670594,1.3617151495663495,1
768,Biological Process,GO:0002820,negative regulation of adaptive immune response,0.11483876121431913,1.3614390787583783,1
769,Biological Process,GO:0032695,negative regulation of interleukin-12 production,0.11475173309718567,1.3599421404927825,1
770,Biological Process,GO:2001244,positive regulation of intrinsic apoptotic signaling pathway,0.11465047543016726,1.358200445033459,1
771,Biological Process,GO:0010332,response to gamma radiation,0.11454799506455327,1.3564377183904754,1
772,Biological Process,GO:0032725,positive regulation of granulocyte macrophage colony-stimulating factor production,0.11454113499479857,1.3563197208827882,1
773,Biological Process,GO:0045761,regulation of adenylate cyclase activity,0.1144842379041412,1.3553410551939111,1
774,Phenotype,HP:0045059,Hyperkeratotic papule,0.11447809484433868,1.355235390707661,1
775,Phenotype,HP:0002665,Lymphoma,0.11441246837452068,1.3541065742154474,1
776,Phenotype,HP:0032367,Abnormal growth hormone level,0.1144009558018424,1.3539085507358501,1
777,Biological Process,GO:0002920,regulation of humoral immune response,0.11438864200565169,1.353696745708696,1
778,Biological Process,GO:0098609,cell-cell adhesion,0.11430998720375296,1.3523438337233142,1
779,Biological Process,GO:0032816,positive regulation of natural killer cell activation,0.11427325769739594,1.3517120631490072,1
780,Phenotype,HP:0003596,Middle age onset,0.1142698284731053,1.3516530783377638,1
781,Phenotype,HP:0045080,Decreased proportion of CD3-positive T cells,0.11419739718477395,1.3504072146939106,1
782,Biological Process,GO:0002504,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,0.11415873151434042,1.3497421408816377,1
782,Biological Process,GO:0002495,antigen processing and presentation of peptide antigen via MHC class II,0.11415873151434042,1.3497421408816377,1
784,Biological Process,GO:0071493,cellular response to UV-B,0.11413613276885315,1.3493534282679605,1
785,Disease,MONDO:0031520,familial severe combined immunodeficiency,0.11406260084350994,1.3480886329763377,1
786,Biological Process,GO:0071482,cellular response to light stimulus,0.11405456980636541,1.347950494094215,1
787,Biological Process,GO:0051961,negative regulation of nervous system development,0.11403632148727161,1.3476366115464353,1
787,Biological Process,GO:0050768,negative regulation of neurogenesis,0.11403632148727161,1.3476366115464353,1
789,Phenotype,HP:0200036,Skin nodule,0.11398685719719714,1.3467857946951476,1
790,Biological Process,GO:0007158,neuron cell-cell adhesion,0.11375133294701179,1.342734629690192,1
791,Phenotype,HP:0004490,Calvarial hyperostosis,0.1137430665704503,1.3425924428223122,1
792,Disease,MONDO:0018993,Charcot-Marie-Tooth disease type 2,0.11373395521100649,1.3424357217182334,1
793,Biological Process,GO:0045913,positive regulation of carbohydrate metabolic process,0.11372147717603065,1.3422210916808384,1
794,Disease,MONDO:0017855,T-B- severe combined immunodeficiency,0.11357605693268469,1.3397197721759821,1
795,Biological Process,GO:0061515,myeloid cell development,0.11347669565591012,1.3380106958197258,1
796,Biological Process,GO:0032411,positive regulation of transporter activity,0.11329863631462167,1.3349479633339394,1
797,Disease,MONDO:0015517,common variable immunodeficiency,0.11319769333751617,1.3332116807387333,1
797,Disease,MONDO:0016463,syndromic agammaglobulinemia,0.11319769333751617,1.3332116807387333,1
799,Phenotype,HP:0001402,Hepatocellular carcinoma,0.11319615134833994,1.3331851575565816,1
800,Biological Process,GO:0032645,regulation of granulocyte macrophage colony-stimulating factor production,0.113180965717669,1.3329239551729468,1
801,Biological Process,GO:0001912,positive regulation of leukocyte mediated cytotoxicity,0.11313992560080977,1.3322180393910747,1
802,Phenotype,HP:0100606,Neoplasm of the respiratory system,0.11312386974641375,1.3319418686128954,1
803,Phenotype,HP:0000421,Epistaxis,0.11309543324625881,1.3314527429530094,1
804,Biological Process,GO:0071347,cellular response to interleukin-1,0.1130833730373958,1.3312452997871362,1
805,Biological Process,GO:0072359,circulatory system development,0.1130033451298944,1.329868769523122,1
806,Biological Process,GO:1905897,regulation of response to endoplasmic reticulum stress,0.11297041372660177,1.3293023287066108,1
807,Biological Process,GO:0060765,regulation of androgen receptor signaling pathway,0.11278788378528226,1.326162699092895,1
808,Disease,MONDO:0002334,hematopoietic and lymphoid system neoplasm,0.11277972622808152,1.3260223839863547,1
809,Phenotype,HP:0100013,Neoplasm of the breast,0.11277209866764015,1.3258911851568969,1
810,Biological Process,GO:0072526,pyridine-containing compound catabolic process,0.11274299736047821,1.3253906243990126,1
811,Biological Process,GO:0010906,regulation of glucose metabolic process,0.11273564635247446,1.3252641824451479,1
812,Phenotype,HP:0002729,Follicular hyperplasia,0.11259599252465546,1.322862048908482,1
813,Phenotype,HP:0001634,Mitral valve prolapse,0.11258690032416407,1.3227056573504161,1
814,Phenotype,HP:0005584,Renal cell carcinoma,0.1125655419209528,1.3223382794027818,1
815,Phenotype,HP:0012727,Thoracic aortic aneurysm,0.11255531107390959,1.3221623024089908,1
816,Phenotype,HP:0002046,Heat intolerance,0.11254094824723859,1.3219152527708493,1
817,Biological Process,GO:0051560,mitochondrial calcium ion homeostasis,0.1125254120790089,1.3216480209210772,1
818,Biological Process,GO:1900544,positive regulation of purine nucleotide metabolic process,0.11252170035082121,1.3215841768654013,1
818,Biological Process,GO:0045981,positive regulation of nucleotide metabolic process,0.11252170035082121,1.3215841768654013,1
820,Biological Process,GO:0014013,regulation of gliogenesis,0.11234560636562463,1.3185552497385764,1
821,Biological Process,GO:0048660,regulation of smooth muscle cell proliferation,0.11226855699766947,1.3172299522251856,1
822,Biological Process,GO:0045862,positive regulation of proteolysis,0.11222334147941126,1.3164522169172317,1
823,Biological Process,GO:0034113,heterotypic cell-cell adhesion,0.11214151448923615,1.3150447413014623,1
824,Biological Process,GO:0010755,regulation of plasminogen activation,0.11207692732999985,1.3139338016039082,1
825,Biological Process,GO:0007259,cell surface receptor signaling pathway via JAK-STAT,0.11207440474738772,1.3138904115988776,1
826,Phenotype,HP:0000723,Restrictive behavior,0.1120148062481513,1.3128652799860419,1
827,Biological Process,GO:0032692,negative regulation of interleukin-1 production,0.11200085063120391,1.3126252346108613,1
828,Biological Process,GO:0002507,tolerance induction,0.11199905006054423,1.3125942636648136,1
829,Biological Process,GO:0016239,positive regulation of macroautophagy,0.11193685192683511,1.3115244167065594,1
830,Biological Process,GO:0010543,regulation of platelet activation,0.11193447525665412,1.3114835364869728,1
831,Biological Process,GO:1900016,negative regulation of cytokine production involved in inflammatory response,0.11189823401326293,1.3108601643422917,1
832,Biological Process,GO:0070936,protein K48-linked ubiquitination,0.11182844502676614,1.3096597499492744,1
833,Biological Process,GO:0060544,regulation of necroptotic process,0.1116908657242639,1.3072932995507927,1
834,Biological Process,GO:0050871,positive regulation of B cell activation,0.11167833890715595,1.3070778304300916,1
835,Phenotype,HP:0030137,Prolonged bleeding following circumcision,0.1116678793119914,1.3068979188249672,1
836,Phenotype,HP:0033754,Abnormal left ventricular end-diastolic volume,0.11163982825821195,1.3064154230847875,1
836,Phenotype,HP:0033755,Increased left ventricular end-diastolic volume,0.11163982825821195,1.3064154230847875,1
838,Biological Process,GO:0030217,T cell differentiation,0.11149616758074077,1.3039443692179291,1
839,Biological Process,GO:0070059,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,0.1114221191765925,1.3026706901665273,1
840,Phenotype,HP:0007924,Slow decrease in visual acuity,0.11141826971035829,1.3026044769299558,1
841,Biological Process,GO:0031334,positive regulation of protein-containing complex assembly,0.11140572070392418,1.3023886261389108,1
842,Biological Process,GO:0045071,negative regulation of viral genome replication,0.11139877154916544,1.3022690963132115,1
843,Phenotype,HP:0009130,Hand muscle atrophy,0.1113772887430492,1.3018995785574905,1
844,Phenotype,HP:0002783,Recurrent lower respiratory tract infections,0.11128221803509697,1.3002643026793195,1
845,Phenotype,HP:0002630,Fat malabsorption,0.11125159343844482,1.2997375403856262,1
846,Biological Process,GO:0071375,cellular response to peptide hormone stimulus,0.11122053336896542,1.299203287685841,1
847,Biological Process,GO:0090330,regulation of platelet aggregation,0.11109519217640929,1.2970473404635776,1
848,Biological Process,GO:0032148,activation of protein kinase B activity,0.11108301685867406,1.2968379173528177,1
849,Biological Process,GO:0045834,positive regulation of lipid metabolic process,0.11104554616443174,1.296193397881441,1
850,Phenotype,HP:0000978,Bruising susceptibility,0.11101142511117712,1.2956064943385213,1
851,Phenotype,HP:0010648,Dermal translucency,0.11090955089833865,1.2938541939039214,1
852,Biological Process,GO:1902653,secondary alcohol biosynthetic process,0.11088132399838901,1.293368673499189,1
852,Biological Process,GO:0006695,cholesterol biosynthetic process,0.11088132399838901,1.293368673499189,1
854,Biological Process,GO:0035821,modulation of process of another organism,0.11085164153832805,1.2928581165464959,1
855,Biological Process,GO:0050795,regulation of behavior,0.11079166801713236,1.2918265343204587,1
856,Biological Process,GO:0051339,regulation of lyase activity,0.11078167062565569,1.291654572909015,1
857,Biological Process,GO:0070269,pyroptosis,0.11072260790456667,1.290638657016766,1
858,Biological Process,GO:1904036,negative regulation of epithelial cell apoptotic process,0.11066023614592402,1.2895658236006242,1
859,Phenotype,HP:0000270,Delayed cranial suture closure,0.1106053938514997,1.2886225016973025,1
860,Phenotype,HP:0025420,Diffuse alveolar hemorrhage,0.11058508083978202,1.2882731051398306,1
861,Biological Process,GO:0002347,response to tumor cell,0.11057088570796147,1.2880289399584242,1
862,Disease,MONDO:0002211,B cell deficiency,0.11055474034523194,1.2877512295806999,1
863,Biological Process,GO:0051900,regulation of mitochondrial depolarization,0.11046169610657275,1.2861508102469277,1
864,Biological Process,GO:0061035,regulation of cartilage development,0.11043467239616267,1.2856859854578404,1
865,Biological Process,GO:0055074,calcium ion homeostasis,0.1104074461288942,1.2852176765635894,1
866,Phenotype,HP:0012180,Cystic medial necrosis,0.11036075346765317,1.2844145334687318,1
866,Phenotype,HP:0004959,Descending thoracic aorta aneurysm,0.11036075346765317,1.2844145334687318,1
866,Phenotype,HP:0032079,Medial degeneration,0.11036075346765317,1.2844145334687318,1
866,Phenotype,HP:0200146,Mucoid extracellular matrix accumulation,0.11036075346765317,1.2844145334687318,1
870,Biological Process,GO:0071222,cellular response to lipopolysaccharide,0.11033938800965393,1.2840470341743142,1
871,Biological Process,GO:0050857,positive regulation of antigen receptor-mediated signaling pathway,0.11022179382062403,1.2820243402775748,1
872,Phenotype,HP:0001394,Cirrhosis,0.11019541764409946,1.281570653477949,1
873,Biological Process,GO:0000097,sulfur amino acid biosynthetic process,0.11016270653486204,1.2810080018575252,1
874,Phenotype,HP:0003739,Myoclonic spasms,0.11009687439227056,1.279875647664452,1
875,Biological Process,GO:2000351,regulation of endothelial cell apoptotic process,0.11006136675414946,1.279264893991097,1
876,Biological Process,GO:0070371,ERK1 and ERK2 cascade,0.11005282478918244,1.279117966829581,1
877,Phenotype,HP:0011495,Abnormal corneal epithelium morphology,0.11002224064063149,1.2785919002686283,1
878,Biological Process,GO:0051282,regulation of sequestering of calcium ion,0.11002165886972681,1.2785818934437343,1
879,Phenotype,HP:0100775,Dural ectasia,0.10998794020066205,1.2780019111615644,1
880,Phenotype,HP:0030858,Addictive behavior,0.10996884353368086,1.277673436497386,1
881,Biological Process,GO:0018212,peptidyl-tyrosine modification,0.10994598770838326,1.2772803019495333,1
882,Phenotype,HP:0410067,Increased level of L-fucose in urine,0.10994052886754169,1.277186406459079,1
883,Phenotype,HP:0003040,Arthropathy,0.10993141400562789,1.2770296251103173,1
884,Phenotype,HP:0005372,Abnormality of B cell physiology,0.10979368264984823,1.2746605592999793,1
885,Phenotype,HP:0031983,Abnormal pulmonary thoracic imaging finding,0.10977059822632218,1.2742634927190446,1
886,Biological Process,GO:0097530,granulocyte migration,0.10975893398370296,1.2740628604212192,1
887,Biological Process,GO:0050818,regulation of coagulation,0.10971630693734058,1.2733296484553518,1
888,Phenotype,HP:0031035,Chronic infection,0.10968310968580886,1.2727586348821838,1
889,Biological Process,GO:0045601,regulation of endothelial cell differentiation,0.10967663452116971,1.2726472579841923,1
890,Phenotype,HP:0410240,Abnormal circulating IgA level,0.10959218529483583,1.271194678259811,1
891,Phenotype,HP:0003179,Protrusio acetabuli,0.10956010606601851,1.2706428953794138,1
892,Phenotype,HP:0002615,Hypotension,0.10952133865922309,1.2699760716378292,1
893,Biological Process,GO:0032965,regulation of collagen biosynthetic process,0.10936931998935195,1.2673612550531372,1
894,Biological Process,GO:0043457,regulation of cellular respiration,0.10933986552431241,1.2668546197579862,1
895,Biological Process,GO:0032007,negative regulation of TOR signaling,0.10932438230180663,1.2665882986079138,1
896,Biological Process,GO:0051147,regulation of muscle cell differentiation,0.10931526575681627,1.266431488309178,1
897,Biological Process,GO:0051349,positive regulation of lyase activity,0.10930202773414699,1.2662037860062076,1
898,Biological Process,GO:0010517,regulation of phospholipase activity,0.10921594479176122,1.2647231053398118,1
899,Phenotype,HP:0002522,Areflexia of lower limbs,0.1091550148977054,1.2636750729000088,1
900,Biological Process,GO:0008015,blood circulation,0.10911083011208167,1.262915066840635,1
901,Biological Process,GO:0071559,response to transforming growth factor beta,0.1090184999139111,1.261326929451662,1
902,Biological Process,GO:0030811,regulation of nucleotide catabolic process,0.10886132774221058,1.2586234693992686,1
902,Biological Process,GO:0033121,regulation of purine nucleotide catabolic process,0.10886132774221058,1.2586234693992686,1
902,Biological Process,GO:0006110,regulation of glycolytic process,0.10886132774221058,1.2586234693992686,1
905,Phenotype,HP:0001894,Thrombocytosis,0.1088170771393765,1.2578623312425459,1
906,Biological Process,GO:0050995,negative regulation of lipid catabolic process,0.10877586579246079,1.2571534701961755,1
907,Phenotype,HP:0010701,Abnormal immunoglobulin level,0.10872649701118653,1.2563042961562276,1
908,Phenotype,HP:0002624,Abnormal venous morphology,0.10870152971521796,1.2558748429868976,1
909,Phenotype,HP:0004334,Dermal atrophy,0.10867920167112854,1.2554907866072553,1
910,Biological Process,GO:0010507,negative regulation of autophagy,0.10867780773292468,1.2554668099947996,1
911,Phenotype,HP:0001805,Onychogryposis,0.10866126980912827,1.2551823473202093,1
912,Disease,MONDO:0042489,disease susceptibility,0.10863682799589425,1.2547619327838997,1
912,Disease,MONDO:0020573,inherited disease susceptibility,0.10863682799589425,1.2547619327838997,1
914,Phenotype,HP:0001015,Prominent superficial veins,0.1086046930715614,1.2542091919056604,1
915,Biological Process,GO:0007042,lysosomal lumen acidification,0.10854595396597255,1.253198842403235,1
916,Phenotype,HP:0001096,Keratoconjunctivitis,0.10853159465616036,1.2529518532572734,1
917,Biological Process,GO:1900225,regulation of NLRP3 inflammasome complex assembly,0.10847202573193104,1.2519272303531321,1
918,Phenotype,HP:0010286,Abnormal salivary gland morphology,0.10845207162594583,1.2515840071996402,1
919,Phenotype,HP:0001054,Numerous nevi,0.10839937542952438,1.2506775995296493,1
920,Phenotype,HP:5200293,Disturbance during transitions between sleep and wake states,0.1083731910132012,1.2502272111259067,1
921,Phenotype,HP:0005353,Recurrent herpes,0.10834148743126759,1.2496818896078037,1
922,Phenotype,HP:0008200,Primary hyperparathyroidism,0.1081732344269215,1.2467878322754948,1
923,Biological Process,GO:0002227,innate immune response in mucosa,0.1081720640521584,1.2467677010946112,1
924,Phenotype,HP:0100007,Neoplasm of the peripheral nervous system,0.10810783921595601,1.245662993580768,1
925,Biological Process,GO:0051151,negative regulation of smooth muscle cell differentiation,0.10804904031499674,1.2446516155604213,1
926,Phenotype,HP:0100641,Neoplasm of the adrenal cortex,0.10795613597692966,1.2430536026046868,1
927,Biological Process,GO:0071816,tail-anchored membrane protein insertion into ER membrane,0.10793003522964828,1.2426046533610047,1
928,Phenotype,HP:0025380,Increased circulating androstenedione concentration,0.10784603634493406,1.2411598197952818,1
929,Biological Process,GO:0030520,intracellular estrogen receptor signaling pathway,0.10782924468792066,1.2408709927500226,1
930,Biological Process,GO:0002687,positive regulation of leukocyte migration,0.10774649099646794,1.2394475772903393,1
931,Biological Process,GO:0071216,cellular response to biotic stimulus,0.1077238321323506,1.2390578305984723,1
932,Disease,MONDO:0003689,familial hemolytic anemia,0.10764214451596676,1.2376527522994354,1
933,Biological Process,GO:0033627,cell adhesion mediated by integrin,0.10764205013750239,1.2376511289305814,1
934,Biological Process,GO:0045926,negative regulation of growth,0.10763823916330839,1.2375855777812736,1
935,Biological Process,GO:0030949,positive regulation of vascular endothelial growth factor receptor signaling pathway,0.1075955969914042,1.2368521056465884,1
936,Phenotype,HP:0000763,Sensory neuropathy,0.10759420887606297,1.2368282291910269,1
937,Biological Process,GO:0071901,negative regulation of protein serine/threonine kinase activity,0.10759038600020987,1.2367624733257088,1
938,Phenotype,HP:0034317,Unusual viral infection,0.10747859822656591,1.2348396534198525,1
938,Phenotype,HP:0034318,Unusual virus reactivation,0.10747859822656591,1.2348396534198525,1
940,Biological Process,GO:0031330,negative regulation of cellular catabolic process,0.10733291552011881,1.2323338193848383,1
941,Biological Process,GO:1903580,positive regulation of ATP metabolic process,0.1072895185264886,1.2315873638424615,1
942,Biological Process,GO:0036314,response to sterol,0.1072375763369775,1.2306939255648213,1
943,Disease,MONDO:0016342,familial isolated arrhythmogenic right ventricular dysplasia,0.10722407306194326,1.2304616607546033,1
943,Disease,MONDO:0016587,arrhythmogenic right ventricular cardiomyopathy,0.10722407306194326,1.2304616607546033,1
945,Phenotype,HP:0001895,Normochromic anemia,0.10719893426861371,1.2300292577229694,1
946,Biological Process,GO:0031329,regulation of cellular catabolic process,0.10718866027230156,1.2298525385346561,1
947,Phenotype,HP:0011510,Drusen,0.10715042362142069,1.2291948441281,1
948,Biological Process,GO:0097191,extrinsic apoptotic signaling pathway,0.1071307367265496,1.2288562171735709,1
949,Phenotype,HP:0012499,Descending aortic dissection,0.10711568788033943,1.2285973675685573,1
950,Phenotype,HP:0001928,Abnormality of coagulation,0.10711363730387358,1.2285620963656476,1
951,Phenotype,HP:0001882,Leukopenia,0.10708900016547751,1.2281383221138928,1
952,Biological Process,GO:0030193,regulation of blood coagulation,0.10707151988773078,1.2278376503595885,1
952,Biological Process,GO:1900046,regulation of hemostasis,0.10707151988773078,1.2278376503595885,1
954,Phenotype,HP:0031071,Abnormal endocrine morphology,0.10703085335611406,1.2271381604784877,1
954,Phenotype,HP:0011732,Abnormal adrenal morphology,0.10703085335611406,1.2271381604784877,1
956,Biological Process,GO:0048545,response to steroid hormone,0.10697090912472229,1.226107082055471,1
957,Phenotype,HP:0011750,Neoplasm of the anterior pituitary,0.10695551084032162,1.2258422218941447,1
957,Phenotype,HP:0040277,Neoplasm of the pituitary gland,0.10695551084032162,1.2258422218941447,1
959,Phenotype,HP:0410299,Decreased specific antibody response to polysaccharide vaccine,0.10695509011227256,1.2258349851074968,1
960,Phenotype,HP:0040202,Abnormal consumption behavior,0.1069259067404209,1.2253330127854156,1
961,Disease,MONDO:0000015,classic complement early component deficiency,0.10685397196094093,1.2240956894055974,1
962,Biological Process,GO:0002688,regulation of leukocyte chemotaxis,0.10667834623693684,1.2210748166653367,1
963,Phenotype,HP:0025389,Pulmonary interstitial high-resolution computed tomography abnormality,0.10663999724536954,1.2204151899284275,1
964,Phenotype,HP:0009049,Peroneal muscle atrophy,0.10657465023992785,1.2192911803989812,1
965,Phenotype,HP:0030692,Brain neoplasm,0.1065391293445277,1.2186801986921016,1
966,Phenotype,HP:0010786,Urinary tract neoplasm,0.10652648959476929,1.2184627870588947,1
967,Biological Process,GO:0051150,regulation of smooth muscle cell differentiation,0.10650882053840482,1.2181588681938182,1
968,Biological Process,GO:1904063,negative regulation of cation transmembrane transport,0.10649266011276493,1.2178808987245766,1
969,Biological Process,GO:0008630,intrinsic apoptotic signaling pathway in response to DNA damage,0.10648499546400347,1.2177490619527231,1
970,Biological Process,GO:0071560,cellular response to transforming growth factor beta stimulus,0.10648378590378393,1.2177282567573815,1
971,Phenotype,HP:0031504,Foamy urine,0.10644928437078915,1.2171348087240017,1
972,Phenotype,HP:0002442,Dyscalculia,0.10641262660646511,1.2165042721577135,1
973,Biological Process,GO:2000677,regulation of transcription regulatory region DNA binding,0.10634399006932238,1.2153236806172878,1
974,Phenotype,HP:0100578,Lipoatrophy,0.1063109901317496,1.2147560609681207,1
975,Disease,MONDO:0004805,leukocyte disorder,0.10629931368619494,1.2145552187721427,1
976,Biological Process,GO:0000165,MAPK cascade,0.10629674393378308,1.2145110174169356,1
977,Phenotype,HP:0004927,Pulmonary artery dilatation,0.10625405470634608,1.2137767358975369,1
978,Phenotype,HP:0002720,Decreased circulating IgA level,0.1062161780037214,1.2131252328270232,1
979,Biological Process,GO:0010985,negative regulation of lipoprotein particle clearance,0.10590964629346555,1.20785269491842,1
980,Biological Process,GO:0051148,negative regulation of muscle cell differentiation,0.10590306602630517,1.2077395101910622,1
981,Phenotype,HP:0009129,Upper limb amyotrophy,0.10586609205468478,1.2071035346607089,1
982,Biological Process,GO:1904294,positive regulation of ERAD pathway,0.1058629566667938,1.2070496040200596,1
983,Phenotype,HP:0008065,Aplasia/Hypoplasia of the skin,0.10585202269270677,1.2068615327995735,1
984,Biological Process,GO:0050864,regulation of B cell activation,0.10577514156729306,1.2055391291635467,1
985,Phenotype,HP:0004900,Severe lactic acidosis,0.10575215510444214,1.2051437475677402,1
986,Biological Process,GO:1904753,negative regulation of vascular associated smooth muscle cell migration,0.10574616296142891,1.205040678945037,1
987,Phenotype,HP:0010526,Dysgraphia,0.1057234710319398,1.2046503635080112,1
988,Disease,MONDO:0019065,amyloidosis,0.10570750085779668,1.2043756664839862,1
988,Disease,MONDO:0018634,hereditary amyloidosis,0.10570750085779668,1.2043756664839862,1
990,Biological Process,GO:0002753,cytoplasmic pattern recognition receptor signaling pathway,0.10563966374341072,1.203208825516989,1
991,Biological Process,GO:0034116,positive regulation of heterotypic cell-cell adhesion,0.10562396009853114,1.202938712963669,1
992,Phenotype,HP:0001058,Poor wound healing,0.10556336331448457,1.2018964102252074,1
993,Biological Process,GO:0002548,monocyte chemotaxis,0.10555451805046512,1.2017442661295272,1
994,Biological Process,GO:0031445,regulation of heterochromatin formation,0.10552416902909512,1.2012222439037394,1
995,Biological Process,GO:0072676,lymphocyte migration,0.1055083053120307,1.2009493780083198,1
996,Phenotype,HP:0010885,Avascular necrosis,0.10545356529601735,1.2000078153578941,1
997,Phenotype,HP:0003715,Myofibrillar myopathy,0.10544640439969188,1.1998846434442803,1
998,Biological Process,GO:0030198,extracellular matrix organization,0.10541912428418942,1.1994154083265898,1
999,Phenotype,HP:0045042,Decreased circulating complement C4 concentration,0.10541908286384372,1.1994146958706329,1
1000,Biological Process,GO:0097202,activation of cysteine-type endopeptidase activity,0.10541477366199414,1.199340574892778,1
1001,Biological Process,GO:0046632,alpha-beta T cell differentiation,0.10526077664031319,1.1966917294146149,1
1002,Biological Process,GO:0071346,cellular response to type II interferon,0.10513135370119442,1.1944655735882665,1
1003,Biological Process,GO:0002251,organ or tissue specific immune response,0.1051261498051621,1.194376063308629,1
1004,Biological Process,GO:0072331,signal transduction by p53 class mediator,0.10503182365597319,1.1927535943087464,1
1005,Biological Process,GO:0032412,regulation of monoatomic ion transmembrane transporter activity,0.10496645702479068,1.1916292472042338,1
1006,Biological Process,GO:0010466,negative regulation of peptidase activity,0.10496075318374365,1.1915311375563935,1
1007,Biological Process,GO:2000209,regulation of anoikis,0.10495587669025508,1.1914472588061067,1
1008,Biological Process,GO:0034614,cellular response to reactive oxygen species,0.1049157603293247,1.1907572322063005,1
1009,Biological Process,GO:0019886,antigen processing and presentation of exogenous peptide antigen via MHC class II,0.10482202090288784,1.1891448552061965,1
1010,Biological Process,GO:1904645,response to amyloid-beta,0.104780913197981,1.1884377768674625,1
1011,Biological Process,GO:0062013,positive regulation of small molecule metabolic process,0.10477878331647827,1.1884011415681175,1
1012,Phenotype,HP:0040313,Oligoarthritis,0.10476468007425876,1.1881585569455526,1
1013,Biological Process,GO:0032943,mononuclear cell proliferation,0.10472075310695872,1.1874029855232482,1
1014,Phenotype,HP:0001901,Polycythemia,0.10468266634964984,1.1867478693802587,1
1015,Biological Process,GO:0045649,regulation of macrophage differentiation,0.10462868607357922,1.1858193747339407,1
1016,Phenotype,HP:0033429,Neuroinflammation,0.10453830063691294,1.18426468846409,1
1016,Phenotype,HP:0100653,Optic neuritis,0.10453830063691294,1.18426468846409,1
1018,Biological Process,GO:0006692,prostanoid metabolic process,0.10451571430298323,1.183876189336997,1
1019,Phenotype,HP:0003073,Hypoalbuminemia,0.10450564116993566,1.1837029251229703,1
1019,Phenotype,HP:0012116,Abnormal circulating albumin concentration,0.10450564116993566,1.1837029251229703,1
1021,Phenotype,HP:0006532,Recurrent pneumonia,0.10450185713370452,1.1836378373235399,1
1022,Biological Process,GO:0003018,vascular process in circulatory system,0.10448036916080927,1.1832682306959754,1
1023,Biological Process,GO:0043114,regulation of vascular permeability,0.10443438860020537,1.182477336179253,1
1024,Phenotype,HP:0012203,Onychomycosis,0.10442667630404101,1.1823446798421484,1
1025,Disease,MONDO:0001377,vitreous syneresis,0.1044023765345643,1.1819267085476635,1
1025,Disease,MONDO:0020248,vitreoretinal degeneration,0.1044023765345643,1.1819267085476635,1
1027,Biological Process,GO:1904030,negative regulation of cyclin-dependent protein kinase activity,0.1043955123150706,1.1818086396618597,1
1028,Biological Process,GO:0048762,mesenchymal cell differentiation,0.104385506929351,1.1816365407444172,1
1029,Biological Process,GO:0045744,negative regulation of G protein-coupled receptor signaling pathway,0.1043509772087815,1.1810426078670513,1
1030,Biological Process,GO:0032868,response to insulin,0.10435049371471838,1.1810342914655467,1
1031,Phenotype,HP:0011027,Abnormal fallopian tube morphology,0.10432898280931824,1.180664290384497,1
1032,Phenotype,HP:0007394,Prominent superficial blood vessels,0.1042318712100403,1.1789939098939088,1
1033,Disease,MONDO:0020584,anemia due to enzyme disorder,0.10423027197782098,1.1789664020954693,1
1034,Phenotype,HP:0002875,Exertional dyspnea,0.10417297216700272,1.1779808093669295,1
1035,Phenotype,HP:0002893,Pituitary adenoma,0.10414404356431817,1.1774832192345093,1
1036,Biological Process,GO:0033143,regulation of intracellular steroid hormone receptor signaling pathway,0.10413221352254431,1.1772797350871076,1
1037,Biological Process,GO:0051259,protein complex oligomerization,0.10411360514367318,1.1769596592850518,1
1038,Biological Process,GO:0099111,microtubule-based transport,0.10407182254968395,1.1762409724302916,1
1039,Biological Process,GO:0002385,mucosal immune response,0.10396567915923471,1.1744152394598784,1
1040,Phenotype,HP:0004396,Poor appetite,0.10395287289166577,1.1741949636157623,1
1041,Phenotype,HP:0031910,Abnormal cranial nerve physiology,0.10392488417494661,1.1737135401121654,1
1042,Phenotype,HP:0004398,Peptic ulcer,0.10388567680907967,1.1730391487982705,1
1043,Phenotype,HP:0002781,Upper airway obstruction,0.1038640119206291,1.1726664991120572,1
1044,Phenotype,HP:0002097,Emphysema,0.10386075596695887,1.1726104946642935,1
1045,Biological Process,GO:0046651,lymphocyte proliferation,0.10385213537469773,1.172462215063943,1
1046,Phenotype,HP:0100314,Cerebral inclusion bodies,0.1037880266195359,1.1713595042168923,1
1047,Biological Process,GO:0002889,regulation of immunoglobulin mediated immune response,0.10378096791986036,1.1712380901498332,1
1048,Biological Process,GO:0007035,vacuolar acidification,0.10375616662265863,1.1708114922635346,1
1049,Biological Process,GO:0009199,ribonucleoside triphosphate metabolic process,0.10369370685475765,1.1697371450328824,1
1050,Phenotype,HP:0001937,Microangiopathic hemolytic anemia,0.10367494317901271,1.1694143980270757,1
1051,Biological Process,GO:0043393,regulation of protein binding,0.10365043699740173,1.168992876314261,1
1052,Phenotype,HP:0006824,Cranial nerve paralysis,0.10358925171036093,1.1679404509547375,1
1053,Biological Process,GO:0050852,T cell receptor signaling pathway,0.10356210455064252,1.1674735027600247,1
1054,Phenotype,HP:0025337,Red eye,0.10350324174867598,1.1664610256022254,1
1055,Phenotype,HP:0000585,Band keratopathy,0.10349734492577045,1.1663595965452325,1
1056,Phenotype,HP:0025235,NREM parasomnia,0.10346080226016596,1.165731039749199,1
1057,Phenotype,HP:0002885,Medulloblastoma,0.10344193998072093,1.1654065966978304,1
1058,Phenotype,HP:0002894,Neoplasm of the pancreas,0.1034400989696318,1.1653749301510008,1
1059,Phenotype,HP:0003565,Elevated erythrocyte sedimentation rate,0.10335566311884137,1.1639225804943663,1
1060,Phenotype,HP:0001966,Abnormal glomerular mesangium morphology,0.10335025463052572,1.1638295510989776,1
1061,Biological Process,GO:0006109,regulation of carbohydrate metabolic process,0.10330804066448607,1.1631034443740624,1
1062,Biological Process,GO:0070848,response to growth factor,0.10329496148469042,1.1628784742682667,1
1063,Phenotype,HP:0040030,Chorioretinal hypopigmentation,0.10322979204315419,1.161757518949499,1
1064,Biological Process,GO:1903319,positive regulation of protein maturation,0.10320191040736404,1.1612779373051245,1
1065,Phenotype,HP:0002659,Increased susceptibility to fractures,0.10315145112094315,1.160410005891852,1
1066,Biological Process,GO:0045736,negative regulation of cyclin-dependent protein serine/threonine kinase activity,0.10307229410462593,1.1590484555030973,1
1067,Biological Process,GO:0016126,sterol biosynthetic process,0.10304269162297652,1.158539274229307,1
1068,Biological Process,GO:0072665,protein localization to vacuole,0.10302479960578648,1.1582315202980182,1
1069,Phenotype,HP:0002888,Ependymoma,0.10301719565605327,1.1581007275875677,1
1070,Biological Process,GO:0031295,T cell costimulation,0.10288543943146822,1.15583443778597,1
1071,Biological Process,GO:0050862,positive regulation of T cell receptor signaling pathway,0.10287147663268725,1.1555942688787422,1
1072,Biological Process,GO:0070661,leukocyte proliferation,0.102858127178445,1.1553646498827412,1
1073,Phenotype,HP:0002035,Rectal prolapse,0.10283712863388761,1.1550034617299332,1
1074,Biological Process,GO:0002714,positive regulation of B cell mediated immunity,0.10276004072012801,1.1536775012045006,1
1074,Biological Process,GO:0002891,positive regulation of immunoglobulin mediated immune response,0.10276004072012801,1.1536775012045006,1
1076,Phenotype,HP:0040131,Abnormal motor nerve conduction velocity,0.10275390402652995,1.1535719462209648,1
1077,Phenotype,HP:0001723,Restrictive cardiomyopathy,0.10271683788012986,1.1529343852265177,1
1078,Biological Process,GO:0007190,activation of adenylate cyclase activity,0.10270217008018023,1.1526820898564705,1
1079,Biological Process,GO:0007200,phospholipase C-activating G protein-coupled receptor signaling pathway,0.10264405482909988,1.151682471043352,1
1080,Biological Process,GO:1903707,negative regulation of hemopoiesis,0.10243595749636392,1.1481030662417613,1
1081,Biological Process,GO:0008286,insulin receptor signaling pathway,0.10240489989309254,1.1475688559623027,1
1082,Biological Process,GO:0035987,endodermal cell differentiation,0.10235735651486033,1.1467510800009735,1
1083,Biological Process,GO:2001235,positive regulation of apoptotic signaling pathway,0.10233265253744184,1.1463261560760603,1
1084,Biological Process,GO:0019318,hexose metabolic process,0.10226895235237787,1.1452304728912621,1
1085,Phenotype,HP:0100568,Neoplasm of the endocrine system,0.10225371816010753,1.1449684352176221,1
1086,Biological Process,GO:0046330,positive regulation of JNK cascade,0.10224010676043338,1.1447343105956989,1
1087,Disease,MONDO:0021635,neurocristopathy,0.10222869820177583,1.1445380762225756,1
1088,Phenotype,HP:0007126,Proximal amyotrophy,0.10222787596585059,1.1445239332483235,1
1089,Biological Process,GO:0046457,prostanoid biosynthetic process,0.10215930310302701,1.1433444369461725,1
1089,Biological Process,GO:0001516,prostaglandin biosynthetic process,0.10215930310302701,1.1433444369461725,1
1091,Phenotype,HP:0001442,Typified by somatic mosaicism,0.10209638284179767,1.1422621689410974,1
1092,Biological Process,GO:2001236,regulation of extrinsic apoptotic signaling pathway,0.10207422222047247,1.1418809923381357,1
1093,Biological Process,GO:0010907,positive regulation of glucose metabolic process,0.10205353347431712,1.1415251329123866,1
1094,Phenotype,HP:0031526,Subretinal fluid,0.10204220997091928,1.1413303615431425,1
1095,Phenotype,HP:0033747,Abnormal exteroceptive sensation,0.101933410493804,1.139458942214135,1
1096,Biological Process,GO:0006338,chromatin remodeling,0.10187087050418042,1.1383832151194773,1
1097,Phenotype,HP:0012338,Abnormal energy expenditure,0.10181787015825183,1.1374715758869676,1
1098,Biological Process,GO:0006693,prostaglandin metabolic process,0.1017406721170151,1.1361437210997716,1
1099,Phenotype,HP:0003376,Steppage gait,0.1016924808417562,1.1353148009027243,1
1100,Phenotype,HP:0025426,Abnormal bronchus morphology,0.10167851457777477,1.1350745723918725,1
1101,Biological Process,GO:0007018,microtubule-based movement,0.10167629869968975,1.135036457897309,1
1102,Disease,MONDO:0016419,hereditary breast carcinoma,0.10165626885454548,1.1346919319827196,1
1102,Disease,MONDO:0007254,breast cancer,0.10165626885454548,1.1346919319827196,1
1102,Disease,MONDO:0004989,breast carcinoma,0.10165626885454548,1.1346919319827196,1
1105,Phenotype,HP:0002044,Zollinger-Ellison syndrome,0.10161322976006881,1.133951632530533,1
1106,Phenotype,HP:0011134,Low-grade fever,0.1015604901667253,1.1330444784062308,1
1107,Biological Process,GO:0043567,regulation of insulin-like growth factor receptor signaling pathway,0.10147556615860787,1.1315837321370243,1
1108,Biological Process,GO:0061045,negative regulation of wound healing,0.10138683247565439,1.130057457068283,1
1109,Biological Process,GO:0043405,regulation of MAP kinase activity,0.10134821278539041,1.1293931741438006,1
1110,Biological Process,GO:0098771,inorganic ion homeostasis,0.1012806348633497,1.1282307914479066,1
1111,Phenotype,HP:0008391,Dystrophic fingernails,0.10111848098603193,1.1254416429305432,1
1112,Phenotype,HP:0031691,Severe viral infection,0.10108941750847267,1.1249417328655809,1
1113,Biological Process,GO:0000281,mitotic cytokinesis,0.10104021489054016,1.1240954169394564,1
1114,Biological Process,GO:0141091,transforming growth factor beta receptor superfamily signaling pathway,0.10102372598397591,1.1238117973920403,1
1115,Biological Process,GO:0007610,behavior,0.10091905159624226,1.1220113321908225,1
1116,Phenotype,HP:0001659,Aortic regurgitation,0.10090037985266032,1.1216901664759495,1
1117,Phenotype,HP:0011733,Abnormality of adrenal physiology,0.10080088000626919,1.119978706635271,1
1118,Disease,MONDO:0002242,coagulation protein disease,0.1007167242174335,1.118531174220128,1
1119,Biological Process,GO:0008037,cell recognition,0.10065410705310485,1.1174541196720797,1
1120,Biological Process,GO:0010800,positive regulation of peptidyl-threonine phosphorylation,0.10062312918431049,1.1169212808756968,1
1121,Biological Process,GO:0070498,interleukin-1-mediated signaling pathway,0.10061060418252499,1.116705842979682,1
1122,Biological Process,GO:0002689,negative regulation of leukocyte chemotaxis,0.10058730266230809,1.1163050421993346,1
1123,Phenotype,HP:0100725,Lichenification,0.10053125239370697,1.1153409423816025,1
1124,Biological Process,GO:0042330,taxis,0.10051964246849254,1.1151412443772493,1
1124,Biological Process,GO:0006935,chemotaxis,0.10051964246849254,1.1151412443772493,1
1126,Phenotype,HP:0005113,Aortic arch aneurysm,0.10051850974968501,1.1151217609024482,1
1127,Phenotype,HP:0030666,Retinal neovascularization,0.10039637623399345,1.1130209877365749,1
1128,Biological Process,GO:0050764,regulation of phagocytosis,0.10031209864759472,1.1115713603268624,1
1129,Biological Process,GO:0043470,regulation of carbohydrate catabolic process,0.1002819176577292,1.1110522283484703,1
1130,Biological Process,GO:1902106,negative regulation of leukocyte differentiation,0.10019973757231271,1.1096386792728166,1
1131,Biological Process,GO:1904996,positive regulation of leukocyte adhesion to vascular endothelial cell,0.10019129059987542,1.109493386042464,1
1132,Biological Process,GO:0050920,regulation of chemotaxis,0.10013791400747829,1.1085752751344244,1
1133,Biological Process,GO:2000811,negative regulation of anoikis,0.10006317031345224,1.1072896366605047,1
1134,Phenotype,HP:0007149,Distal upper limb amyotrophy,0.1000514700831604,1.107088385352111,1
1135,Phenotype,HP:0040148,Cortical myoclonus,0.10004340333020734,1.1069496321356531,1
1136,Phenotype,HP:0007502,Follicular hyperkeratosis,0.10002791996185412,1.106683308476913,1
1137,Biological Process,GO:0009067,aspartate family amino acid biosynthetic process,0.10001094800108701,1.106391380093865,1
1138,Biological Process,GO:1903170,negative regulation of calcium ion transmembrane transport,0.09997869919060742,1.105836680302385,1
1139,Phenotype,HP:0011194,EEG with series of focal spikes,0.09997331749220917,1.1057441117103988,1
1140,Phenotype,HP:0007754,Macular dystrophy,0.09986110212712274,1.103813936963218,1
1141,Biological Process,GO:0086069,bundle of His cell to Purkinje myocyte communication,0.09976690443902836,1.102193677574831,1
1142,Biological Process,GO:0034766,negative regulation of monoatomic ion transmembrane transport,0.09973390352821032,1.1016260411852343,1
1143,Phenotype,HP:0006707,Abnormality of the hepatic vasculature,0.0997105883794892,1.1012250059860564,1
1144,Biological Process,GO:0001678,intracellular glucose homeostasis,0.09956164135286938,1.0986630235941817,1
1145,Disease,MONDO:0002516,digestive system cancer,0.0995024585439015,1.0976450421150052,1
1146,Phenotype,HP:0012452,Restless legs,0.09940156602483663,1.095909627429784,1
1146,Phenotype,HP:0031943,Akathisia,0.09940156602483663,1.095909627429784,1
1148,Phenotype,HP:0002721,Immunodeficiency,0.09938535355792644,1.095630762818013,1
1149,Phenotype,HP:0010647,Abnormal elasticity of skin,0.09938233796792062,1.095578892776218,1
1150,Disease,MONDO:0019223,disorder of fatty acid and ketone body metabolism,0.09934640979986331,1.0949609057238812,1
1151,Biological Process,GO:0002700,regulation of production of molecular mediator of immune response,0.09933477553944581,1.094760789138753,1
1152,Biological Process,GO:1904292,regulation of ERAD pathway,0.09929785500155142,1.0941257327020415,1
1153,Biological Process,GO:0071480,cellular response to gamma radiation,0.0992859349527343,1.093920700376974,1
1154,Phenotype,HP:0020100,Unusual fungal infection,0.0992684287334481,1.0936195824119004,1
1155,Biological Process,GO:0002823,negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,0.09910357439115769,1.0907839842012013,1
1156,Biological Process,GO:0000041,transition metal ion transport,0.09903231401209356,1.0895582609320378,1
1157,Phenotype,HP:0002231,Sparse body hair,0.09901827020354559,1.089316698605946,1
1158,Disease,MONDO:0000462,eye adnexa disorder,0.09901136641422348,1.0891979490942447,1
1159,Biological Process,GO:0009205,purine ribonucleoside triphosphate metabolic process,0.09897758885741348,1.0886169539058772,1
1160,Biological Process,GO:0046890,regulation of lipid biosynthetic process,0.09894759198539094,1.0881009888700042,1
1161,Biological Process,GO:0032963,collagen metabolic process,0.09891985256278835,1.087623853381761,1
1162,Phenotype,HP:0012804,Corneal ulceration,0.09885321199153074,1.086477593707963,1
1163,Biological Process,GO:0098773,skin epidermis development,0.09882852593126501,1.0860529779693284,1
1164,Phenotype,HP:0004331,Decreased skull ossification,0.09872553878915225,1.0842815344523264,1
1165,Biological Process,GO:1903557,positive regulation of tumor necrosis factor superfamily cytokine production,0.09867233359446259,1.083366371692488,1
1166,Biological Process,GO:0051099,positive regulation of binding,0.09856446261830998,1.0815109231631075,1
1167,Disease,MONDO:0003382,eyelid disorder,0.09854680522359693,1.0812072048857586,1
1168,Biological Process,GO:0002702,positive regulation of production of molecular mediator of immune response,0.09852961098570934,1.0809114531966555,1
1169,Biological Process,GO:0010469,regulation of signaling receptor activity,0.09851202130700343,1.0806088996771528,1
1170,Biological Process,GO:0140894,endolysosomal toll-like receptor signaling pathway,0.09850182540399866,1.0804335237427667,1
1171,Biological Process,GO:1901020,negative regulation of calcium ion transmembrane transporter activity,0.09847315930247114,1.0799404487950897,1
1172,Biological Process,GO:0002009,morphogenesis of an epithelium,0.09842014272952382,1.0790285304476677,1
1173,Phenotype,HP:0001658,Myocardial infarction,0.09838101091076934,1.0783554385915484,1
1173,Phenotype,HP:0033678,Acute coronary syndrome,0.09838101091076934,1.0783554385915484,1
1175,Biological Process,GO:0034112,positive regulation of homotypic cell-cell adhesion,0.09830718881872036,1.077085652250371,1
1176,Disease,MONDO:0019040,chromosomal disorder,0.09829905571049236,1.076945757681515,1
1177,Biological Process,GO:0140374,antiviral innate immune response,0.09829366381949711,1.0768530137704602,1
1178,Biological Process,GO:2000106,regulation of leukocyte apoptotic process,0.09827778128946285,1.076579824280145,1
1179,Phenotype,HP:0003466,Paradoxical increased cortisol secretion on dexamethasone suppression test,0.09826984179969267,1.07644326007035,1
1180,Biological Process,GO:0045429,positive regulation of nitric oxide biosynthetic process,0.09824260949334018,1.0759748473000617,1
1180,Biological Process,GO:1904407,positive regulation of nitric oxide metabolic process,0.09824260949334018,1.0759748473000617,1
1182,Phenotype,HP:0007110,Central hypoventilation,0.09822820789622544,1.0757271307859413,1
1183,Phenotype,HP:0004332,Abnormal lymphocyte morphology,0.09818400648595582,1.0749668387722187,1
1184,Disease,MONDO:0021026,hereditary epidermal appendage anomaly,0.0981065473975481,1.0736344938097524,1
1185,Phenotype,HP:0100545,Arterial stenosis,0.09802305731285377,1.0721984119238819,1
1186,Phenotype,HP:0002043,Esophageal stricture,0.09801520891309523,1.0720634145194887,1
1187,Phenotype,HP:0032309,Abnormal granulocyte count,0.09800093696922774,1.0718179281226392,1
1188,Biological Process,GO:0010811,positive regulation of cell-substrate adhesion,0.09796433900934354,1.0711884202302717,1
1189,Biological Process,GO:0051788,response to misfolded protein,0.09795756210845263,1.0710718532792691,1
1190,Phenotype,HP:0005306,Capillary hemangioma,0.09794704473937454,1.0708909479265514,1
1191,Phenotype,HP:0007185,Loss of consciousness,0.09792365403387038,1.0704886131032576,1
1192,Phenotype,HP:0001370,Rheumatoid arthritis,0.09790367861517324,1.0701450233577368,1
1193,Biological Process,GO:0070228,regulation of lymphocyte apoptotic process,0.09790109989701201,1.0701006677860103,1
1194,Phenotype,HP:0100767,Abnormal placenta morphology,0.09788398913838303,1.0698063519925776,1
1195,Phenotype,HP:0000709,Psychosis,0.09788375062121868,1.0698022493475696,1
1196,Phenotype,HP:0000764,Peripheral axonal degeneration,0.0978792699887705,1.0697251796557656,1
1197,Biological Process,GO:0034314,Arp2/3 complex-mediated actin nucleation,0.0978465168015441,1.0691618042675077,1
1198,Phenotype,HP:0012640,Abnormality of intracranial pressure,0.09783433168963263,1.068952212690766,1
1198,Phenotype,HP:0002516,Increased intracranial pressure,0.09783433168963263,1.068952212690766,1
1200,Phenotype,HP:0012174,Glioblastoma multiforme,0.0978218996199054,1.0687383732845117,1
1201,Biological Process,GO:1903115,regulation of actin filament-based movement,0.09779782837191098,1.0683243327030267,1
1202,Biological Process,GO:0141085,regulation of inflammasome-mediated signaling pathway,0.09776633675708513,1.0677826571522857,1
1203,Biological Process,GO:0042267,natural killer cell mediated cytotoxicity,0.09776407883179383,1.0677438194193698,1
1204,Biological Process,GO:0051262,protein tetramerization,0.09774219945644425,1.0673674804238025,1
1205,Phenotype,HP:0002024,Malabsorption,0.09773411783613539,1.0672284714794886,1
1206,Biological Process,GO:0150077,regulation of neuroinflammatory response,0.09766103061255771,1.0659713253374916,1
1207,Phenotype,HP:0003144,Increased serum serotonin,0.09760049322428022,1.064930044243557,1
1208,Phenotype,HP:0001974,Leukocytosis,0.09756411922981734,1.0643043886970793,1
1209,Phenotype,HP:0002841,Recurrent fungal infections,0.09754643144914632,1.0640001477621719,1
1210,Biological Process,GO:1901796,regulation of signal transduction by p53 class mediator,0.09753384390017739,1.0637836340153244,1
1211,Biological Process,GO:2001252,positive regulation of chromosome organization,0.09751763014442227,1.0635047472346115,1
1212,Biological Process,GO:0010714,positive regulation of collagen metabolic process,0.09745828042943483,1.0624838948670867,1
1213,Biological Process,GO:0045861,negative regulation of proteolysis,0.09744123715456143,1.0621907398366277,1
1214,Biological Process,GO:0040011,locomotion,0.09738130597768357,1.0611598859594482,1
1215,Biological Process,GO:0035994,response to muscle stretch,0.09736180441088427,1.060824446764134,1
1216,Biological Process,GO:0097696,cell surface receptor signaling pathway via STAT,0.09733762188156514,1.0604084920739827,1
1217,Biological Process,GO:0051279,regulation of release of sequestered calcium ion into cytosol,0.09733613080133863,1.0603828445577355,1
1218,Phenotype,HP:0001097,Keratoconjunctivitis sicca,0.09733330693432307,1.060334272271769,1
1219,Phenotype,HP:0012872,Abnormal vas deferens morphology,0.09729198353084345,1.0596234837821312,1
1219,Phenotype,HP:0012873,Absent vas deferens,0.09729198353084345,1.0596234837821312,1
1221,Phenotype,HP:0011073,Abnormality of dental color,0.0972604947373712,1.0590818567604439,1
1222,Phenotype,HP:0000971,Abnormal sweat gland morphology,0.09722634520809548,1.058494463412079,1
1223,Disease,MONDO:0002561,lysosomal storage disease,0.09722124996925019,1.0584068221042915,1
1224,Biological Process,GO:0035966,response to topologically incorrect protein,0.09721471089724532,1.0582943459594776,1
1225,Phenotype,HP:0045056,Abnormal circulating alpha-fetoprotein concentration,0.09718646979774603,1.0578085813135742,1
1226,Phenotype,HP:0004430,Severe combined immunodeficiency,0.09707527790576076,1.0558960109464421,1
1227,Biological Process,GO:0007507,heart development,0.09706660820661905,1.0557468866769084,1
1228,Biological Process,GO:0010944,negative regulation of transcription by competitive promoter binding,0.09704172319947091,1.0553188489269643,1
1229,Phenotype,HP:0100257,Ectrodactyly,0.0970345641650806,1.0551957090398043,1
1230,Biological Process,GO:1901381,positive regulation of potassium ion transmembrane transport,0.09702454154974216,1.0550233137620981,1
1231,Biological Process,GO:1905064,negative regulation of vascular associated smooth muscle cell differentiation,0.09697001149324236,1.0540853625471538,1
1232,Biological Process,GO:0043542,endothelial cell migration,0.0969573623331148,1.053867789049688,1
1233,Phenotype,HP:0031869,Recurrent joint dislocation,0.09695719982182793,1.0538649937535018,1
1234,Biological Process,GO:0007189,adenylate cyclase-activating G protein-coupled receptor signaling pathway,0.09694205470438211,1.0536044882227797,1
1235,Phenotype,HP:0100669,Abnormal pigmentation of the oral mucosa,0.09693147369918598,1.0534224882888703,1
1236,Phenotype,HP:0001436,Abnormality of the foot musculature,0.09693014942044942,1.0533997098629964,1
1237,Phenotype,HP:0000169,Gingival fibromatosis,0.09692976311436652,1.0533930651557823,1
1238,Phenotype,HP:0003573,Increased total bilirubin,0.09687892420431954,1.0525186039777497,1
1239,Biological Process,GO:1904706,negative regulation of vascular associated smooth muscle cell proliferation,0.09685655788949743,1.0521338893174723,1
1240,Biological Process,GO:0009636,response to toxic substance,0.09682671764325579,1.0516206183433867,1
1241,Biological Process,GO:0010799,regulation of peptidyl-threonine phosphorylation,0.09674449874308355,1.0502064016295598,1
1242,Biological Process,GO:0071479,cellular response to ionizing radiation,0.09672595955018193,1.0498875158696261,1
1243,Biological Process,GO:0032413,negative regulation of ion transmembrane transporter activity,0.09668201344313898,1.0491316152317245,1
1244,Phenotype,HP:0001615,Hoarse cry,0.09660487733390899,1.0478048257139359,1
1245,Phenotype,HP:0003431,Decreased motor nerve conduction velocity,0.09658745282876924,1.047505113283495,1
1246,Phenotype,HP:0000695,Natal tooth,0.09654502107854435,1.046775260533832,1
1247,Biological Process,GO:0045671,negative regulation of osteoclast differentiation,0.09654060882995297,1.046699367087308,1
1248,Phenotype,HP:0001884,Talipes calcaneovalgus,0.09650193185281253,1.0460340987925763,1
1249,Biological Process,GO:0048644,muscle organ morphogenesis,0.09649797217512712,1.045965989849835,1
1249,Biological Process,GO:0060415,muscle tissue morphogenesis,0.09649797217512712,1.045965989849835,1
1251,Phenotype,HP:0009939,Mandibular aplasia,0.096497958568042,1.0459657557994262,1
1252,Phenotype,HP:0030358,Non-small cell lung carcinoma,0.09648356308290396,1.045718144415143,1
1253,Biological Process,GO:0043254,regulation of protein-containing complex assembly,0.09640087556899124,1.0442958672507054,1
1254,Biological Process,GO:0031507,heterochromatin formation,0.09634116718888963,1.0432688456179868,1
1255,Phenotype,HP:0030212,Collectionism,0.09628948044568886,1.0423798011772962,1
1256,Biological Process,GO:0035872,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway",0.09625631625834996,1.0418093563290083,1
1257,Phenotype,HP:0040085,Abnormal circulating aldosterone,0.09622730294437787,1.0413103091092464,1
1258,Phenotype,HP:0007183,Focal T2 hyperintense basal ganglia lesion,0.09617580875983178,1.0404245767983373,1
1259,Biological Process,GO:0009144,purine nucleoside triphosphate metabolic process,0.09616773343724405,1.0402856761787815,1
1260,Phenotype,HP:0008151,Prolonged prothrombin time,0.09611819898241036,1.0394336524495738,1
1261,Phenotype,HP:0005222,Bowel diverticulosis,0.0960831825945131,1.0388313485885585,1
1262,Phenotype,HP:0001259,Coma,0.0960813615404097,1.0388000253144158,1
1263,Biological Process,GO:1902108,regulation of mitochondrial membrane permeability involved in apoptotic process,0.09607000577189784,1.0386046989649491,1
1264,Phenotype,HP:0004796,Gastrointestinal obstruction,0.09604799620983062,1.0382261206760852,1
1265,Biological Process,GO:1902893,regulation of miRNA transcription,0.0959982604742251,1.0373706347912042,1
1266,Phenotype,HP:0000010,Recurrent urinary tract infections,0.0959763400872009,1.0369935903690795,1
1267,Phenotype,HP:0031803,Fundus hemorrhage,0.09597404776484875,1.0369541609851165,1
1267,Phenotype,HP:0000573,Retinal hemorrhage,0.09597404776484875,1.0369541609851165,1
1269,Phenotype,HP:0010972,Anemia of inadequate production,0.09595254555482036,1.0365843094699214,1
1270,Phenotype,HP:0100519,Anuria,0.09593056480979112,1.036206226852207,1
1271,Disease,MONDO:0044881,hematopoietic and lymphoid cell neoplasm,0.09591597210091107,1.0359552230957114,1
1272,Phenotype,HP:0005249,Functional intestinal obstruction,0.09584740201345332,1.0347757745315955,1
1273,Biological Process,GO:0014015,positive regulation of gliogenesis,0.09583542192702765,1.0345697095219595,1
1274,Phenotype,HP:0006519,Alveolar cell carcinoma,0.09582333971156798,1.0343618878288046,1
1275,Phenotype,HP:0002326,Transient ischemic attack,0.09574521687164572,1.0330181259234734,1
1276,Biological Process,GO:0007157,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,0.09574154148622482,1.0329549069862083,1
1277,Phenotype,HP:0008551,Microtia,0.09571623352074143,1.0325195940872935,1
1278,Biological Process,GO:0042445,hormone metabolic process,0.09565561306979464,1.031476884263286,1
1279,Biological Process,GO:0032414,positive regulation of ion transmembrane transporter activity,0.09562911004344654,1.0310210155670378,1
1280,Phenotype,HP:0002138,Subarachnoid hemorrhage,0.0956273083330702,1.0309900250171478,1
1281,Phenotype,HP:0001548,Overgrowth,0.09562649294509806,1.0309759998319892,1
1282,Phenotype,HP:0033019,Male reproductive system neoplasm,0.09559295439190674,1.0303991156559495,1
1283,Biological Process,GO:0030813,positive regulation of nucleotide catabolic process,0.09558753227617622,1.0303058518604677,1
1283,Biological Process,GO:0033123,positive regulation of purine nucleotide catabolic process,0.09558753227617622,1.0303058518604677,1
1283,Biological Process,GO:0045821,positive regulation of glycolytic process,0.09558753227617622,1.0303058518604677,1
1286,Biological Process,GO:0007043,cell-cell junction assembly,0.09557471681477925,1.030085417876736,1
1287,Phenotype,HP:0008208,Parathyroid hyperplasia,0.09554104953058007,1.0295063194465224,1
1288,Biological Process,GO:0030575,nuclear body organization,0.09551528783252583,1.0290632020624593,1
1289,Phenotype,HP:0001094,Iridocyclitis,0.09551220554520823,1.0290101847850177,1
1290,Biological Process,GO:0030183,B cell differentiation,0.09547201723789778,1.0283189206622942,1
1291,Biological Process,GO:0007631,feeding behavior,0.09546065960695627,1.028123562277868,1
1292,Biological Process,GO:0007229,integrin-mediated signaling pathway,0.09545032888421201,1.0279458673593,1
1293,Biological Process,GO:0055094,response to lipoprotein particle,0.0954406542046129,1.027779456794803,1
1293,Biological Process,GO:0071404,cellular response to low-density lipoprotein particle stimulus,0.0954406542046129,1.027779456794803,1
1295,Biological Process,GO:0032869,cellular response to insulin stimulus,0.09542992974788789,1.0275949894045138,1
1296,Disease,MONDO:0003274,thoracic cancer,0.09538553453530996,1.0268313638693864,1
1297,Biological Process,GO:0050766,positive regulation of phagocytosis,0.0952911437074192,1.0252077823552161,1
1298,Biological Process,GO:0043268,positive regulation of potassium ion transport,0.0952401970519039,1.0243314678874673,1
1299,Disease,MONDO:0003832,complement deficiency,0.09513098958949295,1.0224530309551725,1
1300,Biological Process,GO:0002286,T cell activation involved in immune response,0.09493211808967283,1.0190323162732653,1
1301,Biological Process,GO:0030856,regulation of epithelial cell differentiation,0.0948842328282471,1.0182086597063156,1
1302,Biological Process,GO:0052547,regulation of peptidase activity,0.09487045072335298,1.0179715988474116,1
1303,Phenotype,HP:0008110,Equinovarus deformity,0.09483920140204871,1.0174340908973944,1
1304,Biological Process,GO:0010744,positive regulation of macrophage derived foam cell differentiation,0.09483121709928943,1.0172967558760455,1
1305,Phenotype,HP:0003762,Uterus didelphys,0.09480283490149599,1.0168085642508773,1
1306,Phenotype,HP:0001848,Calcaneovalgus deformity,0.09461831930307918,1.0136347800881582,1
1307,Phenotype,HP:0031690,Opportunistic infection,0.0945873823364074,1.0131026448339688,1
1308,Phenotype,HP:0010975,Abnormal B cell count,0.09455581163157767,1.012559608885495,1
1309,Phenotype,HP:0002725,Systemic lupus erythematosus,0.0944733410963744,1.0111410638911154,1
1310,Biological Process,GO:0060353,regulation of cell adhesion molecule production,0.09446988997055317,1.0110817023597927,1
1311,Biological Process,GO:0006417,regulation of translation,0.09441553761102628,1.0101468076443703,1
1312,Phenotype,HP:0100256,Senile plaques,0.09439094932379155,1.0097238736632677,1
1313,Biological Process,GO:0001938,positive regulation of endothelial cell proliferation,0.09436678754589034,1.0093082759105358,1
1314,Biological Process,GO:0048247,lymphocyte chemotaxis,0.09430483745996943,1.0082426955300048,1
1315,Phenotype,HP:0001297,Stroke,0.09425017917486755,1.0073025387025814,1
1316,Phenotype,HP:0000719,Inappropriate behavior,0.09424785115999212,1.0072624953848044,1
1317,Phenotype,HP:0032560,Coiled sperm flagella,0.09419043857481935,1.006274962866548,1
1318,Phenotype,HP:0012334,Extrahepatic cholestasis,0.0940724745168473,1.0042459069917378,1
1319,Biological Process,GO:0022900,electron transport chain,0.09403823011117385,1.0036568817097524,1
1320,Biological Process,GO:0034109,homotypic cell-cell adhesion,0.09401328282443389,1.0032277727117196,1
1321,Phenotype,HP:0000878,11 pairs of ribs,0.09400159437713151,1.003026724078144,1
1322,Phenotype,HP:0012671,Abulia,0.09398770086112307,1.002787746878111,1
1323,Biological Process,GO:0018149,peptide cross-linking,0.09395437951580332,1.0022145988138622,1
1324,Biological Process,GO:0035295,tube development,0.0939406344558319,1.0019781751508914,1
1325,Biological Process,GO:0061041,regulation of wound healing,0.09393015898867896,1.0017979905375993,1
1326,Biological Process,GO:0032212,positive regulation of telomere maintenance via telomerase,0.09389403441070132,1.0011766251112937,1
1327,Biological Process,GO:0007006,mitochondrial membrane organization,0.09380219385767474,0.9995969099262788,1
1328,Phenotype,HP:0100326,Immunologic hypersensitivity,0.09377637467141631,0.9991528037090028,1
1329,Biological Process,GO:0046782,regulation of viral transcription,0.09376951127957578,0.9990347490593531,1
1330,Phenotype,HP:0100552,Neoplasm of the tracheobronchial system,0.09375048727916435,0.998707524305807,1
1331,Biological Process,GO:2000107,negative regulation of leukocyte apoptotic process,0.09370390825197661,0.9979063357880245,1
1332,Phenotype,HP:5200329,Problematic alcohol consumption,0.09365954646476127,0.9971432851901237,1
1332,Phenotype,HP:0030955,Addictive alcohol use,0.09365954646476127,0.9971432851901237,1
1332,Phenotype,HP:0430037,Abnormal alcohol consumption,0.09365954646476127,0.9971432851901237,1
1335,Phenotype,HP:0001457,Abnormality of the musculature of the upper arm,0.09359100627757566,0.9959643509294652,1
1336,Phenotype,HP:0006254,Elevated circulating alpha-fetoprotein concentration,0.09358316545789602,0.9958294839071891,1
1337,Phenotype,HP:0001004,Lymphedema,0.09353758798894318,0.9950455228199937,1
1338,Biological Process,GO:0007204,positive regulation of cytosolic calcium ion concentration,0.09352116989022075,0.994763121211922,1
1339,Biological Process,GO:0010977,negative regulation of neuron projection development,0.09351146237744445,0.9945961458961593,1
1340,Biological Process,GO:0043392,negative regulation of DNA binding,0.09350894532211618,0.9945528509638819,1
1341,Phenotype,HP:0001806,Onycholysis,0.09344421392812341,0.9934394303379418,1
1342,Biological Process,GO:0000902,cell morphogenesis,0.09344206821172873,0.9934025226685115,1
1343,Biological Process,GO:0060191,regulation of lipase activity,0.09341685037628589,0.9929687600628927,1
1344,Phenotype,HP:0003645,Prolonged partial thromboplastin time,0.09331254429544289,0.9911746299714791,1
1345,Biological Process,GO:0060538,skeletal muscle organ development,0.09325018426540566,0.9901019982947155,1
1346,Biological Process,GO:0042730,fibrinolysis,0.09323361905088401,0.9898170662025133,1
1347,Biological Process,GO:0001706,endoderm formation,0.09317510202526647,0.9888105366150534,1
1348,Biological Process,GO:0007159,leukocyte cell-cell adhesion,0.0931694267837746,0.9887129188975214,1
1349,Biological Process,GO:0043244,regulation of protein-containing complex disassembly,0.0931420163621498,0.9882414424326986,1
1350,Phenotype,HP:0002677,Small foramen magnum,0.09313954301800376,0.9881988993602048,1
1351,Biological Process,GO:0006469,negative regulation of protein kinase activity,0.09308012195509652,0.9871768197636553,1
1352,Biological Process,GO:0002526,acute inflammatory response,0.09306606594304023,0.986935047529557,1
1353,Disease,MONDO:0021350,neoplasm of thorax,0.0930643432033802,0.9869054153255784,1
1354,Biological Process,GO:0010988,regulation of low-density lipoprotein particle clearance,0.09304076137504835,0.9864997930696296,1
1355,Phenotype,HP:0006288,Advanced eruption of teeth,0.09302203181608282,0.9861776328938529,1
1356,Biological Process,GO:0010715,regulation of extracellular matrix disassembly,0.09301953981821931,0.9861347689657048,1
1357,Biological Process,GO:0032760,positive regulation of tumor necrosis factor production,0.09296363072383074,0.9851730974330813,1
1358,Biological Process,GO:0008360,regulation of cell shape,0.09295329952389819,0.9849953943065753,1
1359,Phenotype,HP:0500165,Abnormal blood oxygen level,0.09291639068525748,0.9843605391043738,1
1359,Phenotype,HP:0012418,Hypoxemia,0.09291639068525748,0.9843605391043738,1
1361,Phenotype,HP:0030880,Raynaud phenomenon,0.0928104001811132,0.9825374358744136,1
1362,Phenotype,HP:0000710,Hyperorality,0.09280822465553595,0.9825000154683239,1
1363,Biological Process,GO:0032967,positive regulation of collagen biosynthetic process,0.09278972753229053,0.9821818533328952,1
1364,Phenotype,HP:0008948,Proximal upper limb amyotrophy,0.09277182083006064,0.9818738468096994,1
1365,Biological Process,GO:0016485,protein processing,0.09274230048470766,0.9813660783317866,1
1366,Biological Process,GO:0097435,supramolecular fiber organization,0.09271755334822007,0.9809404120437824,1
1367,Phenotype,HP:0002550,Absent facial hair,0.09261465777759825,0.9791705436139286,1
1368,Biological Process,GO:0006809,nitric oxide biosynthetic process,0.09259321910475404,0.9788017849782009,1
1369,Biological Process,GO:0002287,alpha-beta T cell activation involved in immune response,0.09257031705862395,0.978407855403004,1
1369,Biological Process,GO:0002292,T cell differentiation involved in immune response,0.09257031705862395,0.978407855403004,1
1369,Biological Process,GO:0002293,alpha-beta T cell differentiation involved in immune response,0.09257031705862395,0.978407855403004,1
1372,Phenotype,HP:0011974,Myelofibrosis,0.09256087444798844,0.9782454365704129,1
1373,Phenotype,HP:0033726,Lupus nephritis,0.09255525964959821,0.9781488585121854,1
1374,Phenotype,HP:0011731,Abnormality of circulating cortisol level,0.09248710785820013,0.9769766049029727,1
1375,Biological Process,GO:0060485,mesenchyme development,0.09245704771503616,0.9764595515637348,1
1376,Biological Process,GO:1901096,regulation of autophagosome maturation,0.09239335967439066,0.9753640772705605,1
1377,Biological Process,GO:0071402,cellular response to lipoprotein particle stimulus,0.09234193670604163,0.9744795699229621,1
1378,Biological Process,GO:2001267,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,0.09233678362111752,0.9743909336262935,1
1379,Biological Process,GO:0002752,cell surface pattern recognition receptor signaling pathway,0.09230783810517884,0.9738930525752812,1
1380,Phenotype,HP:0001685,Myocardial fibrosis,0.09226775589485414,0.9732036133873382,1
1381,Biological Process,GO:0043536,positive regulation of blood vessel endothelial cell migration,0.09225978161044823,0.9730664506879586,1
1382,Phenotype,HP:0012703,Abnormal subarachnoid space morphology,0.09221420242872458,0.9722824601400296,1
1383,Phenotype,HP:0000859,Hyperaldosteronism,0.09221291719687041,0.9722603533450531,1
1384,Biological Process,GO:1900103,positive regulation of endoplasmic reticulum unfolded protein response,0.09208140266371656,0.9699982207878467,1
1385,Biological Process,GO:0038084,vascular endothelial growth factor signaling pathway,0.09207248143912317,0.969844770122594,1
1386,Phenotype,HP:0007410,Palmoplantar hyperhidrosis,0.09203494945042678,0.9691991963481164,1
1387,Biological Process,GO:0019364,pyridine nucleotide catabolic process,0.09196099334007757,0.9679271048080156,1
1388,Phenotype,HP:0012340,Decreased resting energy expenditure,0.09194328651369621,0.9676225362749302,1
1389,Phenotype,HP:0010783,Erythema,0.09192800026283232,0.9673596031607902,1
1390,Phenotype,HP:0002359,Frequent falls,0.09192117182281367,0.9672421497044255,1
1391,Biological Process,GO:0008361,regulation of cell size,0.09189665963931959,0.9668205247554525,1
1392,Biological Process,GO:0007519,skeletal muscle tissue development,0.0918744545166702,0.9664385827017695,1
1393,Biological Process,GO:0006694,steroid biosynthetic process,0.09185956521693983,0.9661824773963986,1
1394,Biological Process,GO:0031669,cellular response to nutrient levels,0.09185406385097172,0.9660878504470637,1
1395,Biological Process,GO:0071383,cellular response to steroid hormone stimulus,0.09182712697034878,0.9656245191848415,1
1396,Phenotype,HP:0007773,Vitreoretinopathy,0.09179728732982362,0.9651112586294598,1
1397,Phenotype,HP:0025179,Ground-glass opacification,0.09178136869291398,0.9648374480782144,1
1398,Phenotype,HP:0007064,Progressive language deterioration,0.09177856862881295,0.9647892852173251,1
1399,Phenotype,HP:0003387,Decreased number of large peripheral myelinated nerve fibers,0.09174591802737386,0.9642276743690296,1
1400,Biological Process,GO:0006937,regulation of muscle contraction,0.09163843890702206,0.9623789660054961,1
1401,Biological Process,GO:0035633,maintenance of blood-brain barrier,0.09162047389560668,0.9620699565276936,1
1402,Biological Process,GO:1905063,regulation of vascular associated smooth muscle cell differentiation,0.09157367799589933,0.9612650376663847,1
1403,Biological Process,GO:0002791,regulation of peptide secretion,0.09154553207876759,0.9607809102169745,1
1403,Biological Process,GO:0090087,regulation of peptide transport,0.09154553207876759,0.9607809102169745,1
1405,Biological Process,GO:0010212,response to ionizing radiation,0.0915072751363395,0.9601228667830636,1
1406,Biological Process,GO:0045840,positive regulation of mitotic nuclear division,0.09139395542084006,0.9581736965152821,1
1407,Biological Process,GO:1901890,positive regulation of cell junction assembly,0.09139377722249098,0.958170631391775,1
1408,Biological Process,GO:0045787,positive regulation of cell cycle,0.09137095004833673,0.9577779896615798,1
1409,Biological Process,GO:0006352,DNA-templated transcription initiation,0.09133097153854963,0.9570903341880042,1
1410,Biological Process,GO:0098586,cellular response to virus,0.0912725814800438,0.9560859885145971,1
1411,Biological Process,GO:0045069,regulation of viral genome replication,0.09126277661648874,0.9559173387043064,1
1412,Phenotype,HP:0030766,Ear pain,0.09124991449970976,0.955696102218706,1
1413,Biological Process,GO:0031294,lymphocyte costimulation,0.09117645206772207,0.9544325022564379,1
1414,Phenotype,HP:0006089,Palmar hyperhidrosis,0.09116859163722091,0.9542972979157167,1
1415,Biological Process,GO:0046390,ribose phosphate biosynthetic process,0.09112407715115745,0.9535316208017381,1
1416,Biological Process,GO:0090257,regulation of muscle system process,0.09111838408413131,0.9534336964738229,1
1417,Phenotype,HP:0008959,Distal upper limb muscle weakness,0.09109487154444429,0.9530292660260762,1
1418,Phenotype,HP:0006248,Limited wrist movement,0.09108317046008585,0.9528280000272007,1
1419,Disease,MONDO:0015756,myeloid hemopathy,0.09092358134794776,0.9500829670815193,1
1420,Biological Process,GO:0019058,viral life cycle,0.09090871753117014,0.9498273000989381,1
1421,Biological Process,GO:2000378,negative regulation of reactive oxygen species metabolic process,0.09087640977894007,0.9492715864723362,1
1422,Biological Process,GO:0010639,negative regulation of organelle organization,0.0908276724154835,0.9484332732153632,1
1423,Biological Process,GO:1901019,regulation of calcium ion transmembrane transporter activity,0.09082207348318472,0.9483369680638719,1
1424,Phenotype,HP:0006385,Short lower limbs,0.09081651139662794,0.9482412966822812,1
1425,Biological Process,GO:0070723,response to cholesterol,0.09079673566346047,0.9479011416532668,1
1426,Phenotype,HP:0009723,Abnormality of the subungual region,0.09079658516457012,0.9478985529778443,1
1427,Phenotype,HP:0006286,Yellow-brown discoloration of the teeth,0.09062388740956817,0.944928043143092,1
1428,Phenotype,HP:0004311,Abnormal macrophage morphology,0.0905574960045844,0.9437860692856723,1
1429,Biological Process,GO:0009141,nucleoside triphosphate metabolic process,0.09054531975336932,0.9435766301184729,1
1430,Biological Process,GO:0008088,axo-dendritic transport,0.0905270000233851,0.9432615192585342,1
1431,Phenotype,HP:0012697,Small basal ganglia,0.09052543832021409,0.9432346569832928,1
1432,Biological Process,GO:0010952,positive regulation of peptidase activity,0.09050127490513848,0.9428190310701333,1
1433,Biological Process,GO:1901605,alpha-amino acid metabolic process,0.09043285504950493,0.9416421665877346,1
1434,Biological Process,GO:0045058,T cell selection,0.09042344179514439,0.9414802527015077,1
1435,Biological Process,GO:1901800,positive regulation of proteasomal protein catabolic process,0.09042104670271944,0.9414390556077564,1
1436,Biological Process,GO:0009165,nucleotide biosynthetic process,0.0904054148132043,0.9411701772917646,1
1437,Phenotype,HP:0002018,Nausea,0.09036359933189264,0.9404509247544066,1
1438,Biological Process,GO:0030212,hyaluronan metabolic process,0.0903014966904041,0.9393827203223125,1
1439,Biological Process,GO:1902894,negative regulation of miRNA transcription,0.09029030809263938,0.9391902694146743,1
1440,Biological Process,GO:0019217,regulation of fatty acid metabolic process,0.09028326880095994,0.9390691891773357,1
1441,Biological Process,GO:0010310,regulation of hydrogen peroxide metabolic process,0.09025015899931532,0.9384996797971419,1
1442,Biological Process,GO:0051044,positive regulation of membrane protein ectodomain proteolysis,0.09015120039218993,0.9367975296117151,1
1443,Phenotype,HP:0006292,Abnormality of dental eruption,0.09012646355612952,0.9363720404975268,1
1444,Biological Process,GO:0120178,steroid hormone biosynthetic process,0.09008932767066657,0.9357332799474045,1
1445,Biological Process,GO:0007612,learning,0.09007595066342378,0.9355031870224917,1
1446,Phenotype,HP:0010976,B lymphocytopenia,0.0900251940979786,0.9346301422233196,1
1447,Biological Process,GO:1901293,nucleoside phosphate biosynthetic process,0.08999140881824319,0.9340490141957853,1
1448,Biological Process,GO:0051260,protein homooligomerization,0.08996365030729614,0.9335715503760306,1
1449,Phenotype,HP:0030498,Macular thickening,0.08995956892485935,0.9335013480351388,1
1450,Phenotype,HP:0200042,Skin ulcer,0.08992893299316296,0.9329743907715665,1
1451,Phenotype,HP:0012111,Abnormality of circulating glucocorticoid level,0.08992390328161692,0.9328878765744752,1
1452,Phenotype,HP:0001528,Hemihypertrophy,0.08991851175284027,0.9327951388938075,1
1453,Disease,MONDO:0005244,peripheral neuropathy,0.08991635335528314,0.9327580131004196,1
1454,Biological Process,GO:0032069,regulation of nuclease activity,0.08989014308647036,0.9323071800176215,1
1455,Biological Process,GO:1903035,negative regulation of response to wounding,0.08986653215690454,0.9319010572021736,1
1456,Biological Process,GO:0000302,response to reactive oxygen species,0.08978169930639512,0.9304418789010692,1
1457,Biological Process,GO:0007179,transforming growth factor beta receptor signaling pathway,0.08970214235492124,0.9290734493764734,1
1458,Biological Process,GO:0006816,calcium ion transport,0.08954031882547886,0.9262899830500149,1
1459,Phenotype,HP:0001291,Abnormal cranial nerve morphology,0.08953434948765393,0.926187306690871,1
1460,Phenotype,HP:0006716,Hereditary nonpolyposis colorectal carcinoma,0.08952256064631381,0.9259845312168021,1
1461,Phenotype,HP:0001541,Ascites,0.08945644501008132,0.9248473007550784,1
1462,Biological Process,GO:0030101,natural killer cell activation,0.08942110687508187,0.9242394626418586,1
1463,Disease,MONDO:0006541,epidermolysis bullosa,0.0893927357125649,0.9237514608303755,1
1463,Disease,MONDO:0019276,inherited epidermolysis bullosa,0.0893927357125649,0.9237514608303755,1
1465,Phenotype,HP:0011895,Anemia due to reduced life span of red cells,0.08935065189386782,0.9230275927214809,1
1466,Phenotype,HP:0100836,Malignant neoplasm of the central nervous system,0.08933819344379723,0.922813299556755,1
1467,Biological Process,GO:0043535,regulation of blood vessel endothelial cell migration,0.08933034352587255,0.9226782760389506,1
1468,Phenotype,HP:0001285,Spastic tetraparesis,0.08921490715276714,0.9206926979311526,1
1469,Biological Process,GO:0035751,regulation of lysosomal lumen pH,0.0892003057113755,0.9204415439699737,1
1470,Phenotype,HP:0010785,Gonadal neoplasm,0.08919801815879547,0.9204021966290866,1
1471,Phenotype,HP:0000509,Conjunctivitis,0.08917564636106945,0.920017387659419,1
1472,Phenotype,HP:0005403,T lymphocytopenia,0.08916581573901416,0.9198482947867489,1
1473,Phenotype,HP:0011703,Sinus tachycardia,0.0891616451056596,0.9197765572740249,1
1474,Biological Process,GO:0030513,positive regulation of BMP signaling pathway,0.08915105585090966,0.9195944154426092,1
1475,Biological Process,GO:0043517,"positive regulation of DNA damage response, signal transduction by p53 class mediator",0.08912434590091556,0.9191349875297083,1
1476,Phenotype,HP:0002859,Rhabdomyosarcoma,0.08911876104166172,0.9190389244434277,1
1477,Biological Process,GO:1903034,regulation of response to wounding,0.08911020728274432,0.9188917944185588,1
1478,Phenotype,HP:0001985,Hypoketotic hypoglycemia,0.08910897447818411,0.918870589405961,1
1479,Disease,MONDO:0002657,breast disorder,0.08909581232604158,0.9186441921236949,1
1480,Phenotype,HP:0007417,Discoid lupus rash,0.08909324381927453,0.9186000121943607,1
1481,Phenotype,HP:0001083,Ectopia lentis,0.08909205345400362,0.9185795371641894,1
1482,Biological Process,GO:1904646,cellular response to amyloid-beta,0.0890884471080895,0.9185175057497955,1
1483,Biological Process,GO:0042307,positive regulation of protein import into nucleus,0.08907699536607816,0.9183205285958694,1
1484,Biological Process,GO:0007162,negative regulation of cell adhesion,0.08904350264236582,0.9177444327156479,1
1485,Biological Process,GO:0043922,negative regulation by host of viral transcription,0.08904296842302661,0.9177352438075406,1
1486,Biological Process,GO:2001028,positive regulation of endothelial cell chemotaxis,0.08904214166925983,0.9177210231235768,1
1487,Phenotype,HP:0001677,Coronary artery atherosclerosis,0.08895988955083689,0.9163062350349778,1
1488,Biological Process,GO:1904262,negative regulation of TORC1 signaling,0.08895226638685572,0.9161751118273961,1
1489,Biological Process,GO:0003231,cardiac ventricle development,0.08893637367024887,0.9159017471216359,1
1490,Phenotype,HP:0009728,Neoplasm of striated muscle,0.08891530100648948,0.9155392840720091,1
1491,Disease,MONDO:0005523,steroid inherited metabolic disorder,0.08891505265178434,0.9155350122151219,1
1492,Disease,MONDO:0019588,"hearing loss, autosomal recessive",0.08889453163123029,0.9151820377750414,1
1493,Phenotype,HP:0002780,Bronchomalacia,0.0888749989133858,0.9148460627621882,1
1494,Disease,MONDO:0004992,cancer,0.08885612431894241,0.9145214078851146,1
1495,Disease,MONDO:0015128,primary adrenal insufficiency,0.0888537881486936,0.9144812242897942,1
1495,Disease,MONDO:0000004,adrenocortical insufficiency,0.0888537881486936,0.9144812242897942,1
1495,Disease,MONDO:0015129,chronic primary adrenal insufficiency,0.0888537881486936,0.9144812242897942,1
1498,Disease,MONDO:0006054,reproductive system neoplasm,0.0887995187491003,0.9135477565373259,1
1499,Phenotype,HP:0002576,Intussusception,0.08875655638734026,0.912808776936051,1
1500,Phenotype,HP:0032064,Gastrointestinal eosinophilia,0.08874276111416146,0.9125714895743813,1
1501,Phenotype,HP:0002034,Abnormal rectum morphology,0.08870757622188363,0.911966287332205,1
1502,Phenotype,HP:0010829,Impaired temperature sensation,0.08868499491881676,0.9115778747391119,1
1503,Biological Process,GO:0010718,positive regulation of epithelial to mesenchymal transition,0.08867827889947999,0.911462354989072,1
1504,Phenotype,HP:0030166,Night sweats,0.08864252140140017,0.9108473035675232,1
1505,Phenotype,HP:0005195,Polyarticular arthropathy,0.08862861462023974,0.9106080981985459,1
1506,Disease,MONDO:0019245,lysosomal lipid storage disorder,0.08862170734760788,0.9104892887717295,1
1507,Biological Process,GO:0006606,protein import into nucleus,0.0886173569364127,0.9104144589672521,1
1508,Phenotype,HP:0004375,Neoplasm of the nervous system,0.08860222341077362,0.9101541528228851,1
1509,Phenotype,HP:0002608,Celiac disease,0.08859949807140322,0.9101072752742875,1
1510,Biological Process,GO:0033630,positive regulation of cell adhesion mediated by integrin,0.08857655764893324,0.9097126856019454,1
1511,Biological Process,GO:0051898,negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction,0.08856447926951883,0.9095049298911778,1
1512,Biological Process,GO:0009314,response to radiation,0.08855861849458668,0.909404120881964,1
1513,Phenotype,HP:0025143,Chills,0.08855441033876044,0.909331737959164,1
1514,Phenotype,HP:0012579,Minimal change glomerulonephritis,0.08851538783031376,0.9086605263089823,1
1515,Phenotype,HP:0025318,Ovarian carcinoma,0.08847571750397953,0.9079781717843254,1
1516,Biological Process,GO:0051894,positive regulation of focal adhesion assembly,0.08847285650178549,0.9079289607499691,1
1517,Biological Process,GO:0007202,activation of phospholipase C activity,0.08842869359101946,0.9071693309518846,1
1518,Phenotype,HP:0030828,Wheezing,0.0883934237401246,0.9065626673681441,1
1519,Phenotype,HP:0000808,Penoscrotal hypospadias,0.0882654777216495,0.9043619155043263,1
1520,Disease,MONDO:0020127,hereditary peripheral neuropathy,0.08821306247624028,0.9034603403681742,1
1521,Disease,MONDO:0021223,digestive system neoplasm,0.08819788417762198,0.9031992641004488,1
1522,Biological Process,GO:1905521,regulation of macrophage migration,0.08818031550883076,0.9028970719646726,1
1523,Biological Process,GO:0016064,immunoglobulin mediated immune response,0.08817056581241423,0.9027293710638077,1
1524,Phenotype,HP:0031457,Pulmonary opacity,0.08812589864690623,0.9019610677675054,1
1525,Phenotype,HP:0002047,Malignant hyperthermia,0.08804378435552929,0.9005486503906485,1
1526,Phenotype,HP:0003477,Peripheral axonal neuropathy,0.0880318686302185,0.900343692432605,1
1527,Biological Process,GO:2000403,positive regulation of lymphocyte migration,0.08801937270357174,0.9001287546472347,1
1528,Biological Process,GO:0045598,regulation of fat cell differentiation,0.0880011198605698,0.8998147942853942,1
1529,Biological Process,GO:0031333,negative regulation of protein-containing complex assembly,0.08795395239193604,0.8990034842052176,1
1530,Phenotype,HP:0002183,Phonophobia,0.08793274664836837,0.8986387320993184,1
1531,Phenotype,HP:0001498,Carpal bone hypoplasia,0.087922078050363,0.8984552255140847,1
1532,Disease,MONDO:0005275,lung disorder,0.0878671296135285,0.8975100778946538,1
1533,Phenotype,HP:0002936,Distal sensory impairment,0.0878610451641112,0.8974054215438347,1
1534,Phenotype,HP:0025021,Abnormal erythrocyte sedimentation rate,0.08773958846249774,0.8953162900051227,1
1535,Phenotype,HP:0011043,Abnormal circulating adrenocorticotropin concentration,0.08770601254209731,0.8947387630896211,1
1536,Biological Process,GO:0032091,negative regulation of protein binding,0.08769691487508668,0.8945822775039917,1
1537,Biological Process,GO:0010759,positive regulation of macrophage chemotaxis,0.08769340105671097,0.8945218376213627,1
1538,Biological Process,GO:0030100,regulation of endocytosis,0.08768183441644872,0.8943228841453684,1
1539,Phenotype,HP:0003764,Nevus,0.08764691145535197,0.8937221872839912,1
1540,Biological Process,GO:0007178,cell surface receptor protein serine/threonine kinase signaling pathway,0.0875922567077988,0.8927820913046267,1
1541,Biological Process,GO:0010717,regulation of epithelial to mesenchymal transition,0.08759113437648902,0.89276278650131,1
1542,Biological Process,GO:0010508,positive regulation of autophagy,0.08757039929566168,0.8924061300901059,1
1543,Biological Process,GO:0045663,positive regulation of myoblast differentiation,0.0875634943565402,0.8922873608011336,1
1544,Biological Process,GO:0043255,regulation of carbohydrate biosynthetic process,0.08755751116638522,0.8921844461732139,1
1545,Phenotype,HP:0008197,Absence of pubertal development,0.08755078986697096,0.8920688356025256,1
1546,Phenotype,HP:0000100,Nephrotic syndrome,0.0875247500470474,0.8916209343476585,1
1547,Biological Process,GO:0005996,monosaccharide metabolic process,0.08750014771708092,0.8911977588227513,1
1548,Biological Process,GO:0002690,positive regulation of leukocyte chemotaxis,0.08749955480589988,0.891187560378108,1
1549,Phenotype,HP:0100027,Recurrent pancreatitis,0.08749483856537155,0.891106438079371,1
1550,Phenotype,HP:0100333,Unilateral cleft lip,0.08748707569702663,0.890972911869003,1
1551,Phenotype,HP:0010280,Stomatitis,0.08747990533560257,0.8908495771497493,1
1552,Biological Process,GO:0043388,positive regulation of DNA binding,0.08747880028745891,0.8908305696277432,1
1553,Biological Process,GO:0032410,negative regulation of transporter activity,0.08747235856057267,0.8907197678800995,1
1554,Biological Process,GO:0045732,positive regulation of protein catabolic process,0.08742125699248338,0.8898407888187979,1
1555,Biological Process,GO:0050796,regulation of insulin secretion,0.08741360408474474,0.8897091539999098,1
1556,Phenotype,HP:0100785,Insomnia,0.08739863120769664,0.8894516111121901,1
1557,Phenotype,HP:0001800,Hypoplastic toenails,0.08735395344892927,0.8886831256051742,1
1558,Biological Process,GO:0071326,cellular response to monosaccharide stimulus,0.08721328179098375,0.8862634847511669,1
1558,Biological Process,GO:0071331,cellular response to hexose stimulus,0.08721328179098375,0.8862634847511669,1
1558,Biological Process,GO:0071333,cellular response to glucose stimulus,0.08721328179098375,0.8862634847511669,1
1561,Biological Process,GO:0042303,molting cycle,0.08721033119798871,0.8862127326987733,1
1561,Biological Process,GO:0042633,hair cycle,0.08721033119798871,0.8862127326987733,1
1563,Phenotype,HP:0030830,Crackles,0.08719217093193121,0.8859003647185125,1
1564,Phenotype,HP:0001413,Micronodular cirrhosis,0.08718812488393402,0.8858307701521708,1
1565,Biological Process,GO:0051346,negative regulation of hydrolase activity,0.08716207389891528,0.8853826768506554,1
1566,Disease,MONDO:0000942,corneal disorder,0.08715286826685287,0.8852243341983366,1
1567,Phenotype,HP:0009125,Lipodystrophy,0.08714888983425317,0.8851559026592922,1
1568,Biological Process,GO:1901798,positive regulation of signal transduction by p53 class mediator,0.08710595128855803,0.8844173327092893,1
1569,Biological Process,GO:0046597,negative regulation of viral entry into host cell,0.08708459143065106,0.8840499297399755,1
1570,Biological Process,GO:1905562,regulation of vascular endothelial cell proliferation,0.08701816711017896,0.8829073897154865,1
1571,Phenotype,HP:0030872,Abnormal cardiac ventricular function,0.08701548221432076,0.882861207820696,1
1572,Biological Process,GO:0045815,transcription initiation-coupled chromatin remodeling,0.08701001368466899,0.8827671456766221,1
1572,Biological Process,GO:0141137,"positive regulation of gene expression, epigenetic",0.08701001368466899,0.8827671456766221,1
1574,Phenotype,HP:0100678,Premature skin wrinkling,0.08700853139663589,0.8827416493916229,1
1575,Disease,MONDO:0002908,glucose metabolism disease,0.08699396809456728,0.8824911514507505,1
1576,Biological Process,GO:2000810,regulation of bicellular tight junction assembly,0.08696857451334894,0.8820543659074306,1
1577,Phenotype,HP:0100649,Neoplasm of the oral cavity,0.08696348088188677,0.8819667522476421,1
1578,Phenotype,HP:0008772,Aplasia/Hypoplasia of the external ear,0.08695230975415413,0.8817746018355265,1
1579,Disease,MONDO:0019287,ectodermal dysplasia syndrome,0.08687235238072244,0.8803992848018041,1
1580,Biological Process,GO:0048261,negative regulation of receptor-mediated endocytosis,0.0868473336296145,0.8799689465717644,1
1581,Phenotype,HP:0006698,Dilatation of the ventricular cavity,0.08681907488332286,0.8794828783899508,1
1582,Biological Process,GO:0051223,regulation of protein transport,0.08680121194038148,0.879175624553997,1
1583,Biological Process,GO:0006027,glycosaminoglycan catabolic process,0.08677139287389202,0.8786627178849491,1
1584,Biological Process,GO:0009218,pyrimidine ribonucleotide metabolic process,0.08672719676111829,0.8779025169914824,1
1585,Phenotype,HP:0012176,Abnormal natural killer cell morphology,0.08671194193440734,0.8776401243925063,1
1586,Biological Process,GO:0150078,positive regulation of neuroinflammatory response,0.08668326783054692,0.8771469117996782,1
1587,Phenotype,HP:0004327,Abnormal vitreous humor morphology,0.08667189375487527,0.8769512705555668,1
1588,Biological Process,GO:0001944,vasculature development,0.08665090745610726,0.8765902930380262,1
1589,Phenotype,HP:0001433,Hepatosplenomegaly,0.08664833507943381,0.8765460465438718,1
1590,Disease,MONDO:0019006,familial idiopathic steroid-resistant nephrotic syndrome,0.08664523825778714,0.8764927792668431,1
1590,Disease,MONDO:0018170,idiopathic nephrotic syndrome,0.08664523825778714,0.8764927792668431,1
1592,Phenotype,HP:0000239,Large fontanelles,0.08662320826081749,0.876113849484825,1
1593,Biological Process,GO:0001503,ossification,0.08661078054728544,0.8759000850078634,1
1594,Biological Process,GO:0030111,regulation of Wnt signaling pathway,0.08657395907328058,0.8752667325322607,1
1595,Phenotype,HP:0100299,Muscle fiber inclusion bodies,0.0865738970913521,0.8752656664041683,1
1596,Disease,MONDO:0006573,lipodystrophy,0.08653623747047068,0.874617897275959,1
1596,Disease,MONDO:0020087,hereditary lipodystrophy,0.08653623747047068,0.874617897275959,1
1598,Biological Process,GO:0046931,pore complex assembly,0.0865323964457968,0.8745518292395265,1
1599,Phenotype,HP:0031329,Interstitial cardiac fibrosis,0.08651848188215516,0.8743124900069852,1
1600,Phenotype,HP:0002321,Vertigo,0.08647957008375173,0.8736431826390696,1
1601,Phenotype,HP:0012092,Abnormality of exocrine pancreas physiology,0.08647945230407883,0.8736411567547337,1
1602,Biological Process,GO:0010743,regulation of macrophage derived foam cell differentiation,0.08647626543622178,0.8735863406263404,1
1603,Phenotype,HP:0001836,Camptodactyly of toe,0.08647466542893711,0.8735588194962903,1
1604,Phenotype,HP:0032235,Anti-La/SS-B antibody positivity,0.08646993410479686,0.8734774377499563,1
1604,Phenotype,HP:0012085,Pyuria,0.08646993410479686,0.8734774377499563,1
1606,Biological Process,GO:0045648,positive regulation of erythrocyte differentiation,0.08641504484593343,0.8725333080287897,1
1607,Phenotype,HP:0001917,Renal amyloidosis,0.08640075665012392,0.8722875420883319,1
1608,Phenotype,HP:0005764,Polyarticular arthritis,0.08639006386458736,0.8721036194623726,1
1609,Biological Process,GO:0071674,mononuclear cell migration,0.08636476395052317,0.871668445052924,1
1610,Phenotype,HP:0430046,Small joint hypermobilty,0.08632406174633522,0.8709683415811966,1
1611,Phenotype,HP:0002757,Recurrent fractures,0.0862747719275847,0.8701205257462431,1
1612,Phenotype,HP:0000652,Lower eyelid coloboma,0.08627270439531776,0.8700849628929068,1
1613,Biological Process,GO:0010951,negative regulation of endopeptidase activity,0.08620164160205412,0.8688626382235896,1
1614,Biological Process,GO:0019722,calcium-mediated signaling,0.08617796546822554,0.8684553938538759,1
1615,Disease,MONDO:0021148,female reproductive system neoplasm,0.08613042260357595,0.8676376267264904,1
1616,Biological Process,GO:0060537,muscle tissue development,0.08611198813912002,0.8673205423615887,1
1617,Phenotype,HP:0001555,Asymmetry of the thorax,0.08609505673125006,0.8670293115138378,1
1618,Phenotype,HP:0002232,Patchy alopecia,0.08604976715532442,0.8662503023674978,1
1619,Phenotype,HP:0004972,Elevated mean arterial pressure,0.08601200709882673,0.8656008056836183,1
1620,Biological Process,GO:0060759,regulation of response to cytokine stimulus,0.08600484103990524,0.8654775449701109,1
1621,Biological Process,GO:0030947,regulation of vascular endothelial growth factor receptor signaling pathway,0.08597824477159,0.8650200724534748,1
1622,Disease,MONDO:0015356,hereditary neoplastic syndrome,0.08589600038520917,0.8636054173608556,1
1623,Biological Process,GO:0048514,blood vessel morphogenesis,0.0858919443011108,0.8635356501672713,1
1624,Phenotype,HP:0007002,Motor axonal neuropathy,0.08586458253482976,0.863065010604915,1
1625,Biological Process,GO:0080164,regulation of nitric oxide metabolic process,0.0858524892789061,0.8628569990088465,1
1626,Biological Process,GO:0048145,regulation of fibroblast proliferation,0.08582845615351264,0.8624436141600378,1
1627,Phenotype,HP:0006753,Neoplasm of the stomach,0.08580344201835499,0.8620133553272418,1
1628,Phenotype,HP:0002955,Granulomatosis,0.08578906801745023,0.8617661134852628,1
1629,Biological Process,GO:0060263,regulation of respiratory burst,0.08573081139702388,0.8607640630306175,1
1630,Phenotype,HP:0010696,Polar cataract,0.08571511295653189,0.8604940399960321,1
1631,Biological Process,GO:1900037,regulation of cellular response to hypoxia,0.08568774690282022,0.8600233266871765,1
1632,Phenotype,HP:0011885,Hemorrhage of the eye,0.0856805195112128,0.8598990110129562,1
1633,Biological Process,GO:0006111,regulation of gluconeogenesis,0.08567160033817678,0.8597455956357783,1
1634,Biological Process,GO:0046394,carboxylic acid biosynthetic process,0.08565858158878126,0.8595216649708133,1
1635,Biological Process,GO:0071349,cellular response to interleukin-12,0.08562992359431931,0.8590287294697553,1
1635,Biological Process,GO:0070671,response to interleukin-12,0.08562992359431931,0.8590287294697553,1
1637,Phenotype,HP:0012126,Stomach cancer,0.08561423861645456,0.8587589380008124,1
1638,Biological Process,GO:0032467,positive regulation of cytokinesis,0.0855392920571898,0.8574698101173936,1
1639,Phenotype,HP:0006536,Airway obstruction,0.08549464439406695,0.8567018422743629,1
1640,Phenotype,HP:0012108,Open angle glaucoma,0.08545251249914498,0.8559771472242098,1
1641,Phenotype,HP:0002354,Memory impairment,0.08541323573410253,0.8553015622009156,1
1642,Biological Process,GO:0006883,intracellular sodium ion homeostasis,0.08540790657620745,0.8552098973385778,1
1643,Biological Process,GO:0010661,positive regulation of muscle cell apoptotic process,0.08537575375765238,0.8546568486684792,1
1644,Biological Process,GO:1903318,negative regulation of protein maturation,0.08533758793082658,0.8540003724801453,1
1644,Biological Process,GO:0010955,negative regulation of protein processing,0.08533758793082658,0.8540003724801453,1
1646,Phenotype,HP:0004890,Elevated pulmonary artery pressure,0.08528649750299899,0.8531215850383409,1
1647,Biological Process,GO:0034763,negative regulation of transmembrane transport,0.08521140738648036,0.8518299878800063,1
1648,Phenotype,HP:0011226,Aplasia/Hypoplasia of the eyelid,0.08512407874247652,0.8503278803635185,1
1649,Phenotype,HP:0002862,Bladder carcinoma,0.0850562111443609,0.8491605150572284,1
1650,Phenotype,HP:0000586,Shallow orbits,0.08503057113807044,0.848719490847921,1
1650,Phenotype,HP:3000030,Abnormal morphology of bony orbit of skull,0.08503057113807044,0.848719490847921,1
1652,Biological Process,GO:1901028,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,0.08501561063045504,0.8484621607222113,1
1653,Phenotype,HP:0002092,Pulmonary arterial hypertension,0.08500615221290453,0.8482994700007559,1
1653,Phenotype,HP:0033578,Pre-capillary pulmonary hypertension,0.08500615221290453,0.8482994700007559,1
1655,Biological Process,GO:0007492,endoderm development,0.0849953398504043,0.8481134905759309,1
1656,Biological Process,GO:0007517,muscle organ development,0.08495772912201005,0.8474665624292039,1
1657,Biological Process,GO:0010984,regulation of lipoprotein particle clearance,0.08495412031966743,0.8474044887626972,1
1658,Biological Process,GO:0055117,regulation of cardiac muscle contraction,0.08488401776895715,0.8461986808682997,1
1659,Phenotype,HP:0012133,Erythroid hypoplasia,0.08488226512225505,0.846168534244417,1
1660,Biological Process,GO:0010863,positive regulation of phospholipase C activity,0.08488060052733437,0.8461399021664684,1
1661,Biological Process,GO:0086004,regulation of cardiac muscle cell contraction,0.08486298594412556,0.8458369202738766,1
1662,Biological Process,GO:0033157,regulation of intracellular protein transport,0.08483158589950535,0.8452968197881757,1
1663,Biological Process,GO:0019370,leukotriene biosynthetic process,0.08480854395205273,0.8449004838223777,1
1664,Phenotype,HP:0033040,Anti-Sm antibody positivity,0.08479979608956989,0.8447500150942924,1
1665,Disease,MONDO:0020683,acute disease,0.0847908455089822,0.844596059487503,1
1666,Phenotype,HP:0025546,Abnormal mean corpuscular hemoglobin concentration,0.08477149559854569,0.8442632288768644,1
1667,Phenotype,HP:0010299,Abnormal dentin morphology,0.08477102129960545,0.8442550706372477,1
1668,Biological Process,GO:0120193,tight junction organization,0.0847376031852799,0.8436802580853311,1
1668,Biological Process,GO:0120192,tight junction assembly,0.0847376031852799,0.8436802580853311,1
1670,Phenotype,HP:0011483,Anterior synechiae of the anterior chamber,0.08472619594199049,0.8434840463373658,1
1671,Biological Process,GO:0034198,cellular response to amino acid starvation,0.08472298040405368,0.8434287370655968,1
1672,Biological Process,GO:0150117,positive regulation of cell-substrate junction organization,0.08471766293645122,0.8433372732836333,1
1673,Biological Process,GO:0002691,regulation of cellular extravasation,0.08469092877262019,0.8428774288775317,1
1674,Biological Process,GO:0006006,glucose metabolic process,0.08468996465364331,0.8428608454256932,1
1675,Biological Process,GO:0005979,regulation of glycogen biosynthetic process,0.08465765478918508,0.8423050954674404,1
1675,Biological Process,GO:0010962,regulation of glucan biosynthetic process,0.08465765478918508,0.8423050954674404,1
1677,Biological Process,GO:1902176,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,0.08462658620664631,0.8417706963376881,1
1678,Phenotype,HP:0100006,Neoplasm of the central nervous system,0.08462584172139564,0.8417578907238634,1
1679,Phenotype,HP:0000883,Thin ribs,0.08459157008673346,0.8411683970861731,1
1680,Phenotype,HP:0001095,Hypertensive retinopathy,0.08458100980085648,0.840986753537564,1
1681,Biological Process,GO:0002228,natural killer cell mediated immunity,0.0845697143076719,0.8407924639615776,1
1682,Phenotype,HP:0001623,Breech presentation,0.08453653732726085,0.8402217990644149,1
1683,Phenotype,HP:0002383,Infectious encephalitis,0.08450622365219973,0.839700384817336,1
1684,Biological Process,GO:0032490,detection of molecule of bacterial origin,0.08448819199706348,0.8393902290256843,1
1685,Biological Process,GO:0051973,positive regulation of telomerase activity,0.08444146633092431,0.8385865182258526,1
1686,Phenotype,HP:0030237,Hand muscle weakness,0.0844231587296298,0.8382716159869935,1
1687,Biological Process,GO:0034331,cell junction maintenance,0.08436319098002332,0.8372401330359152,1
1688,Biological Process,GO:0048385,regulation of retinoic acid receptor signaling pathway,0.08435725983411668,0.8371381136017493,1
1689,Phenotype,HP:0000389,Chronic otitis media,0.08434752068136453,0.8369705940585329,1
1690,Phenotype,HP:0012734,Ketotic hypoglycemia,0.0843472291129348,0.8369655788984458,1
1691,Phenotype,HP:0002908,Conjugated hyperbilirubinemia,0.08434697380921441,0.8369611875141325,1
1692,Biological Process,GO:0009260,ribonucleotide biosynthetic process,0.08428264512273198,0.8358546937102577,1
1693,Biological Process,GO:0003007,heart morphogenesis,0.08427041928490475,0.8356444016221906,1
1694,Biological Process,GO:0002861,regulation of inflammatory response to antigenic stimulus,0.08423489110956006,0.8350332946956933,1
1695,Disease,MONDO:0003900,connective tissue disorder,0.08417047076311546,0.8339252242829095,1
1696,Biological Process,GO:0050858,negative regulation of antigen receptor-mediated signaling pathway,0.08416425222770108,0.833818261568739,1
1697,Biological Process,GO:0051896,regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction,0.08416198660239937,0.8337792913908088,1
1698,Phenotype,HP:0100000,Early onset of sexual maturation,0.08416012326449329,0.833747240808707,1
1699,Biological Process,GO:0002710,negative regulation of T cell mediated immunity,0.08412759156779015,0.8331876751965381,1
1700,Biological Process,GO:0014070,response to organic cyclic compound,0.08408080403142759,0.8323829001900116,1
1701,Biological Process,GO:0006090,pyruvate metabolic process,0.08407072472562849,0.8322095298007823,1
1702,Disease,MONDO:0002515,hepatobiliary disorder,0.08406648516930737,0.832136606769752,1
1703,Phenotype,HP:0005344,Abnormal carotid artery morphology,0.08406297765495829,0.83207627532034,1
1704,Biological Process,GO:0042476,odontogenesis,0.08402165520668692,0.831365503260884,1
1705,Biological Process,GO:2000108,positive regulation of leukocyte apoptotic process,0.08392736523901045,0.8297436566057365,1
1706,Phenotype,HP:0002923,Rheumatoid factor positive,0.08390470954170182,0.8293539643849678,1
1707,Phenotype,HP:0000502,Abnormal conjunctiva morphology,0.0838970285251539,0.8292218460769086,1
1708,Phenotype,HP:0008221,Adrenal hyperplasia,0.08387232415327117,0.8287969153669628,1
1709,Biological Process,GO:0043409,negative regulation of MAPK cascade,0.08384317998153112,0.8282956173114174,1
1710,Biological Process,GO:1905709,negative regulation of membrane permeability,0.0838173343502292,0.8278510562227868,1
1711,Phenotype,HP:0033028,Anti-U1 ribonucleoprotein antibody positivity,0.08379648582530974,0.8274924485019589,1
1712,Biological Process,GO:0010970,transport along microtubule,0.08374726489102191,0.8266458175230209,1
1713,Phenotype,HP:0001293,Cranial nerve compression,0.08371067065264837,0.8260163736429736,1
1714,Biological Process,GO:0010758,regulation of macrophage chemotaxis,0.08369963813287296,0.8258266073747638,1
1715,Biological Process,GO:0032801,receptor catabolic process,0.08369181164083606,0.82569198679694,1
1716,Phenotype,HP:0001803,Nail pits,0.08358166063801442,0.823797320377068,1
1717,Biological Process,GO:0043266,regulation of potassium ion transport,0.08354513987504286,0.823169140320075,1
1718,Disease,MONDO:0019060,bone neoplasm,0.08352715734427407,0.8228598294983922,1
1719,Phenotype,HP:0030347,Abnormal circulating androgen level,0.08351893932999577,0.8227184744921529,1
1720,Phenotype,HP:0010669,Hypoplasia of the zygomatic bone,0.08351608529795485,0.8226693833488072,1
1721,Biological Process,GO:0097529,myeloid leukocyte migration,0.08351339975533745,0.8226231903293523,1
1722,Phenotype,HP:0000433,Abnormal nasal mucosa morphology,0.08350728922201456,0.8225180853189773,1
1723,Phenotype,HP:0001129,Large central visual field defect,0.083486764768812,0.8221650518351871,1
1724,Phenotype,HP:0012330,Pyelonephritis,0.08347321026379473,0.8219319058370902,1
1725,Phenotype,HP:0001810,Dystrophic toenail,0.08347315423601409,0.8219309421240796,1
1726,Biological Process,GO:0010447,response to acidic pH,0.0834613062552656,0.8217271494150489,1
1727,Biological Process,GO:0048872,homeostasis of number of cells,0.08339433105467942,0.8205751339066625,1
1728,Biological Process,GO:0034144,negative regulation of toll-like receptor 4 signaling pathway,0.08336973942505388,0.820152142434339,1
1729,Biological Process,GO:1905563,negative regulation of vascular endothelial cell proliferation,0.08336845819900784,0.8201301045417778,1
1730,Phenotype,HP:0002215,Sparse axillary hair,0.0833664075977929,0.8200948329131682,1
1731,Phenotype,HP:0001653,Mitral regurgitation,0.08328450521572339,0.8186860605094716,1
1732,Biological Process,GO:1900227,positive regulation of NLRP3 inflammasome complex assembly,0.08326814701753893,0.8184046892282686,1
1732,Biological Process,GO:0141087,positive regulation of inflammasome-mediated signaling pathway,0.08326814701753893,0.8184046892282686,1
1734,Biological Process,GO:0085020,protein K6-linked ubiquitination,0.08326158734687639,0.8182918587736075,1
1735,Biological Process,GO:0051292,nuclear pore complex assembly,0.08323749406962844,0.817877439275128,1
1736,Biological Process,GO:0006515,protein quality control for misfolded or incompletely synthesized proteins,0.08321376845454387,0.8174693437967389,1
1737,Biological Process,GO:0071363,cellular response to growth factor stimulus,0.0831836353107338,0.8169510348005461,1
1738,Phenotype,HP:0100244,Fibrosarcoma,0.08318305029442996,0.8169409721527483,1
1739,Biological Process,GO:0086064,cell communication by electrical coupling involved in cardiac conduction,0.08313795215999575,0.8161652559202803,1
1740,Phenotype,HP:0008366,Foot joint contracture,0.08306588295454453,0.8149256203293416,1
1741,Biological Process,GO:2000774,positive regulation of cellular senescence,0.08304787843596761,0.8146159313035514,1
1742,Biological Process,GO:0002091,negative regulation of receptor internalization,0.08303608530872653,0.8144130821092943,1
1743,Phenotype,HP:0011124,Abnormal epidermal morphology,0.08303128090169865,0.8143304432913994,1
1744,Biological Process,GO:0071322,cellular response to carbohydrate stimulus,0.0830002248784435,0.8137962601892121,1
1745,Disease,MONDO:0000761,syndrome caused by partial chromosomal deletion,0.08297762640312645,0.8134075522226324,1
1746,Phenotype,HP:0002212,Curly hair,0.08295943155768748,0.8130945894552957,1
1747,Biological Process,GO:0050708,regulation of protein secretion,0.08293492005263192,0.8126729761758915,1
1748,Phenotype,HP:0410151,Eosinophilic infiltration of the esophagus,0.08293176908441868,0.8126187775439155,1
1749,Biological Process,GO:1902808,positive regulation of cell cycle G1/S phase transition,0.08290118444651473,0.8120927025657839,1
1750,Biological Process,GO:0051917,regulation of fibrinolysis,0.08287288015585959,0.8116058509923176,1
1751,Phenotype,HP:0046506,Pain in head and neck region,0.08283908174237875,0.8110244970561145,1
1752,Phenotype,HP:0008944,Distal lower limb amyotrophy,0.08283594020624818,0.8109704606618835,1
1753,Phenotype,HP:0003003,Colon cancer,0.08283497887353963,0.81095392513561,1
1754,Biological Process,GO:1900746,regulation of vascular endothelial growth factor signaling pathway,0.08283483491081878,0.8109514488864072,1
1755,Disease,MONDO:0002243,hemorrhagic disease,0.082818101151237,0.8106636177133298,1
1756,Phenotype,HP:0002846,Abnormal B cell morphology,0.08281563476242382,0.810621194276929,1
1757,Biological Process,GO:0016242,negative regulation of macroautophagy,0.08280616637092919,0.8104583319973716,1
1758,Biological Process,GO:0061136,regulation of proteasomal protein catabolic process,0.08273294886628246,0.8091989449391747,1
1759,Biological Process,GO:0055008,cardiac muscle tissue morphogenesis,0.08273075485901904,0.8091612066364767,1
1760,Phenotype,HP:0100723,Gastrointestinal stroma tumor,0.08272494652057472,0.8090612995677818,1
1761,Biological Process,GO:1901888,regulation of cell junction assembly,0.08271406091085365,0.8088740602447614,1
1762,Phenotype,HP:0100242,Sarcoma,0.08270210471383987,0.8086684061480116,1
1763,Phenotype,HP:0001082,Cholecystitis,0.08269005256100181,0.8084611015508268,1
1763,Phenotype,HP:0012438,Abnormal gallbladder physiology,0.08269005256100181,0.8084611015508268,1
1765,Biological Process,GO:0050817,coagulation,0.082686523003768,0.8084003909499551,1
1766,Phenotype,HP:0009714,Abnormal epididymis morphology,0.08266910567125973,0.8081008018932799,1
1767,Biological Process,GO:0061640,cytoskeleton-dependent cytokinesis,0.0826548064316297,0.8078548459921739,1
1768,Phenotype,HP:0001633,Abnormal mitral valve morphology,0.08265222009653561,0.807810359404419,1
1769,Biological Process,GO:0046328,regulation of JNK cascade,0.08265025144522697,0.8077764973656598,1
1770,Biological Process,GO:0022904,respiratory electron transport chain,0.08264312136890195,0.8076538555754074,1
1771,Phenotype,HP:0002692,Hypoplastic facial bones,0.08262445375952765,0.8073327609715022,1
1772,Phenotype,HP:0045082,Decreased body mass index,0.0826146951530552,0.8071649068120803,1
1773,Phenotype,HP:0000155,Oral ulcer,0.08261062646651562,0.8070949228485934,1
1774,Biological Process,GO:0001959,regulation of cytokine-mediated signaling pathway,0.08260721177687214,0.8070361880424085,1
1775,Biological Process,GO:0043243,positive regulation of protein-containing complex disassembly,0.08255376409982174,0.8061168544336937,1
1776,Phenotype,HP:0000847,Abnormality of renin-angiotensin system,0.08255025053238219,0.8060564188673245,1
1777,Biological Process,GO:1901379,regulation of potassium ion transmembrane transport,0.08253759854650877,0.8058387967652555,1
1778,Biological Process,GO:0007565,female pregnancy,0.08252855109638191,0.8056831749415614,1
1779,Phenotype,HP:0000606,Abnormality of the periorbital region,0.0824950881402694,0.80510759108275,1
1780,Phenotype,HP:0001055,Erysipelas,0.08249303083118509,0.8050722040745749,1
1781,Disease,MONDO:0044765,steroid-resistant nephrotic syndrome,0.08246613602102826,0.8046095964507887,1
1782,Biological Process,GO:0016053,organic acid biosynthetic process,0.08245922673213935,0.8044907523430849,1
1783,Phenotype,HP:0100608,Metrorrhagia,0.08243416373388324,0.8040596530343109,1
1784,Phenotype,HP:0002758,Osteoarthritis,0.08242104399663297,0.8038339853148271,1
1785,Phenotype,HP:0033476,Extractable nuclear antigen positivity,0.08241652973614777,0.803756337199669,1
1786,Phenotype,HP:0040170,Abnormality of hair growth,0.08241085580430974,0.8036587420090054,1
1787,Biological Process,GO:0007585,respiratory gaseous exchange by respiratory system,0.08237140847570423,0.8029802231853181,1
1788,Biological Process,GO:1902042,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,0.08236650977217408,0.8028959624083689,1
1789,Phenotype,HP:0200117,Recurrent upper and lower respiratory tract infections,0.08235941721038686,0.8027739658917248,1
1790,Phenotype,HP:0010301,Spinal dysraphism,0.0823518194921844,0.802643280367516,1
1791,Phenotype,HP:0000577,Exotropia,0.08233799378720508,0.802405469559767,1
1792,Phenotype,HP:0006740,Transitional cell carcinoma of the bladder,0.08233078376215142,0.8022814526011767,1
1793,Phenotype,HP:0005268,Miscarriage,0.08233050418344301,0.8022766436718255,1
1794,Phenotype,HP:0001738,Exocrine pancreatic insufficiency,0.08227878314764125,0.8013870093768635,1
1795,Biological Process,GO:0090026,positive regulation of monocyte chemotaxis,0.08227133626775207,0.8012589183663649,1
1796,Disease,MONDO:0003620,peripheral nervous system disorder,0.08225474343517425,0.8009735112262532,1
1797,Phenotype,HP:0030350,Erythematous papule,0.0822347850217251,0.8006302139816764,1
1798,Biological Process,GO:0051170,import into nucleus,0.08222977581042556,0.8005440524016986,1
1799,Biological Process,GO:1902806,regulation of cell cycle G1/S phase transition,0.08222020030180122,0.8003793476402437,1
1800,Biological Process,GO:1903715,regulation of aerobic respiration,0.08219990379311448,0.8000302349452675,1
1801,Disease,MONDO:0001223,parathyroid gland disorder,0.08219723683127478,0.799984361526857,1
1802,Phenotype,HP:0030223,Perseverative thought,0.08216056061661048,0.7993535076031302,1
1803,Phenotype,HP:0000826,Precocious puberty,0.0821038427608013,0.7983779248661957,1
1804,Phenotype,HP:0002668,Paraganglioma,0.08209869645869428,0.7982894052382403,1
1805,Phenotype,HP:0025104,Capillary malformation,0.08209543578014677,0.7982333195196205,1
1806,Phenotype,HP:0009918,Ectopia pupillae,0.08207482834871893,0.7978788587582475,1
1807,Phenotype,HP:0000988,Skin rash,0.08205973303832748,0.7976192099401378,1
1808,Biological Process,GO:0050926,regulation of positive chemotaxis,0.08198659167960409,0.7963611326396396,1
1809,Phenotype,HP:0032170,Severe varicella zoster infection,0.08198443856803794,0.796324097768616,1
1810,Phenotype,HP:0000017,Nocturia,0.08197418679224244,0.796147760787143,1
1811,Biological Process,GO:0003229,ventricular cardiac muscle tissue development,0.08196133920127835,0.7959267741546805,1
1812,Phenotype,HP:0040088,Abnormal lymphocyte count,0.08194237792135894,0.7956006282329837,1
1813,Biological Process,GO:0010595,positive regulation of endothelial cell migration,0.081927853968079,0.7953508071159862,1
1814,Biological Process,GO:0046031,ADP metabolic process,0.0819255439016382,0.7953110725225558,1
1815,Disease,MONDO:0020585,anemia due to erythrocyte enzyme disorder,0.0819230396137618,0.7952679971984682,1
1816,Phenotype,HP:0004372,Reduced consciousness,0.0819100059171809,0.7950438094325283,1
1817,Biological Process,GO:0006999,nuclear pore organization,0.08189563855894966,0.7947966818487052,1
1818,Phenotype,HP:0001787,Abnormal delivery,0.08186796403885832,0.7943206627244124,1
1819,Biological Process,GO:0002639,positive regulation of immunoglobulin production,0.08183015933796878,0.7936703981289578,1
1820,Biological Process,GO:1903019,negative regulation of glycoprotein metabolic process,0.08179621536259063,0.7930865404367126,1
1821,Biological Process,GO:1904029,regulation of cyclin-dependent protein kinase activity,0.08175238399238871,0.7923326133445278,1
1822,Biological Process,GO:0043923,positive regulation by host of viral transcription,0.08163342689069508,0.7902864764941062,1
1823,Phenotype,HP:0006705,Abnormal atrioventricular valve morphology,0.08157959141014337,0.7893604724216406,1
1824,Biological Process,GO:0090308,regulation of DNA methylation-dependent heterochromatin formation,0.08154230815050889,0.7887191769432218,1
1825,Phenotype,HP:0001609,Hoarse voice,0.08149271578496287,0.7878661571133958,1
1826,Disease,MONDO:0000621,immune system cancer,0.08143239207682385,0.7868285514520271,1
1827,Phenotype,HP:0001279,Syncope,0.08143042477966833,0.7867947127055519,1
1828,Biological Process,GO:0043161,proteasome-mediated ubiquitin-dependent protein catabolic process,0.0814260117732245,0.7867188062234899,1
1829,Biological Process,GO:0000079,regulation of cyclin-dependent protein serine/threonine kinase activity,0.08141498939483405,0.7865292143934697,1
1830,Phenotype,HP:0008291,Pituitary corticotropic cell adenoma,0.08137477940320825,0.7858375772869052,1
1831,Biological Process,GO:0044057,regulation of system process,0.08136645111290719,0.7856943254638245,1
1832,Phenotype,HP:0001640,Cardiomegaly,0.08135724480139417,0.7855359711245284,1
1833,Disease,MONDO:0024634,large intestine disorder,0.08129109395572387,0.7843981350383641,1
1833,Disease,MONDO:0005575,colorectal cancer,0.08129109395572387,0.7843981350383641,1
1833,Disease,MONDO:0005335,colorectal neoplasm,0.08129109395572387,0.7843981350383641,1
1833,Disease,MONDO:0005814,intestinal cancer,0.08129109395572387,0.7843981350383641,1
1837,Phenotype,HP:0004552,Scarring alopecia of scalp,0.08125198516955989,0.783725439357265,1
1838,Phenotype,HP:0001052,Nevus flammeus,0.08124023136453595,0.7835232665298361,1
1839,Biological Process,GO:1900542,regulation of purine nucleotide metabolic process,0.08118973529077667,0.7826547023512418,1
1840,Biological Process,GO:0035020,regulation of Rac protein signal transduction,0.08116182300551944,0.7821745935167868,1
1841,Phenotype,HP:0000974,Hyperextensible skin,0.08114978479657209,0.7819675287632785,1
1842,Phenotype,HP:0031886,Abnormal LDL cholesterol concentration,0.081116419200154,0.7813936195523499,1
1843,Phenotype,HP:0002718,Recurrent bacterial infections,0.08110643610883517,0.781221904112601,1
1844,Phenotype,HP:0040089,Abnormal natural killer cell count,0.0810893154659289,0.7809274183033919,1
1845,Biological Process,GO:0043954,cellular component maintenance,0.08107755329159216,0.7807251015185271,1
1846,Phenotype,HP:0005214,Intestinal obstruction,0.08100350253743893,0.779451382045564,1
1847,Phenotype,HP:0000171,Microglossia,0.08098829704726906,0.7791898380660762,1
1848,Biological Process,GO:0001933,negative regulation of protein phosphorylation,0.08097407824201641,0.7789452656867714,1
1849,Disease,MONDO:0002049,thrombocytopenia,0.08095333956779993,0.7785885474670176,1
1849,Disease,MONDO:0100241,inherited thrombocytopenia,0.08095333956779993,0.7785885474670176,1
1851,Disease,MONDO:0005154,liver disorder,0.08091721300638033,0.7779671479242644,1
1852,Phenotype,HP:0100559,Lower limb asymmetry,0.0808839762921103,0.7773954555672163,1
1853,Phenotype,HP:0004319,Decreased circulating aldosterone level,0.08084102274903227,0.77665662765281,1
1854,Phenotype,HP:0000015,Bladder diverticulum,0.08077031509785704,0.7754404116504312,1
1855,Phenotype,HP:0003447,Axonal loss,0.08075647601018976,0.7752023706520454,1
1856,Biological Process,GO:0045428,regulation of nitric oxide biosynthetic process,0.08074692613162815,0.7750381067437646,1
1857,Disease,MONDO:0005453,congenital heart disease,0.08074258576117055,0.7749634496462787,1
1858,Biological Process,GO:0007188,adenylate cyclase-modulating G protein-coupled receptor signaling pathway,0.08073507615091713,0.7748342796341225,1
1859,Biological Process,GO:0034393,positive regulation of smooth muscle cell apoptotic process,0.08071604256626175,0.7745068900255618,1
1860,Biological Process,GO:0007169,cell surface receptor protein tyrosine kinase signaling pathway,0.08070295002407468,0.7742816900782427,1
1861,Biological Process,GO:0048729,tissue morphogenesis,0.08067439614236316,0.7737905453818714,1
1862,Biological Process,GO:0014912,negative regulation of smooth muscle cell migration,0.08064889969473954,0.7733519904717838,1
1863,Phenotype,HP:0007902,Vitreous hemorrhage,0.08062202197676815,0.7728896768443206,1
1864,Biological Process,GO:0051604,protein maturation,0.08061022602004309,0.7726867789811623,1
1865,Biological Process,GO:0090276,regulation of peptide hormone secretion,0.08060444250671506,0.7725872989200572,1
1866,Disease,MONDO:0044986,lymphoid system disorder,0.08060288864059373,0.7725605714469915,1
1866,Disease,MONDO:0005833,lymphatic system disorder,0.08060288864059373,0.7725605714469915,1
1868,Phenotype,HP:0000260,Wide anterior fontanel,0.08059527938566713,0.7724296874838831,1
1869,Biological Process,GO:0000422,autophagy of mitochondrion,0.08058759870111176,0.7722975748863042,1
1870,Phenotype,HP:0002980,Femoral bowing,0.08057958712316893,0.7721597707146703,1
1871,Biological Process,GO:0042391,regulation of membrane potential,0.08050703059875719,0.7709117529315899,1
1872,Phenotype,HP:0002621,Atherosclerosis,0.0804899924054353,0.7706186853070078,1
1873,Disease,MONDO:0021581,connective tissue neoplasm,0.08047688117163232,0.7703931638521571,1
1874,Disease,MONDO:0021100,breast neoplasm,0.08045748500165473,0.7700595375483622,1
1875,Biological Process,GO:0051851,modulation by host of symbiont process,0.08040392809582286,0.7691383251360141,1
1876,Biological Process,GO:0090025,regulation of monocyte chemotaxis,0.0803694660206653,0.7685455558022127,1
1877,Phenotype,HP:0001131,Corneal dystrophy,0.0803335447043585,0.767927686604287,1
1878,Biological Process,GO:0009185,ribonucleoside diphosphate metabolic process,0.08032823225867547,0.7678363092024914,1
1879,Phenotype,HP:0008730,"Female external genitalia in individual with 46,XY karyotype",0.08032352645995822,0.7677553665094621,1
1880,Biological Process,GO:2000242,negative regulation of reproductive process,0.08030474141803179,0.7674322519919164,1
1881,Phenotype,HP:0001441,Abnormality thigh musculature morphology,0.08019132656090688,0.765481445228431,1
1882,Biological Process,GO:0062197,cellular response to chemical stress,0.08015475798960248,0.764852442838091,1
1883,Biological Process,GO:0019433,triglyceride catabolic process,0.08015401488621399,0.7648396609931636,1
1884,Biological Process,GO:0032688,negative regulation of interferon-beta production,0.08011279728205778,0.7641306923183272,1
1885,Biological Process,GO:0055092,sterol homeostasis,0.08007992909474937,0.7635653388564423,1
1885,Biological Process,GO:0042632,cholesterol homeostasis,0.08007992909474937,0.7635653388564423,1
1887,Biological Process,GO:0009081,branched-chain amino acid metabolic process,0.0800730422988305,0.7634468816419481,1
1888,Biological Process,GO:2000234,positive regulation of rRNA processing,0.08004394065406983,0.7629463150771537,1
1889,Phenotype,HP:0008119,Deformed tarsal bones,0.079948193191828,0.7612993986002213,1
1890,Biological Process,GO:0051701,biological process involved in interaction with host,0.07991476262309039,0.7607243718245964,1
1891,Phenotype,HP:0100848,Neoplasm of the male external genitalia,0.07991358791150982,0.7607041660477291,1
1892,Biological Process,GO:0051149,positive regulation of muscle cell differentiation,0.0799017824086854,0.7605011039856672,1
1893,Phenotype,HP:0000757,Lack of insight,0.07988293660593837,0.7601769443438513,1
1894,Phenotype,HP:0007720,Flat cornea,0.07983053131682849,0.7592755404623001,1
1895,Phenotype,HP:0005117,Elevated diastolic blood pressure,0.07979943279517698,0.7587406263610078,1
1896,Phenotype,HP:0008398,Hypoplastic fifth fingernail,0.07979363950319973,0.7586409781009953,1
1897,Phenotype,HP:0005227,Adenomatous colonic polyposis,0.07974865325366953,0.7578671863591364,1
1898,Biological Process,GO:1902235,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,0.07971549532547939,0.7572968491721376,1
1899,Biological Process,GO:0040007,growth,0.07971226782224228,0.7572413340896895,1
1899,Biological Process,GO:0048589,developmental growth,0.07971226782224228,0.7572413340896895,1
1901,Biological Process,GO:0045103,intermediate filament-based process,0.07968758272644927,0.7568167349405917,1
1901,Biological Process,GO:0045104,intermediate filament cytoskeleton organization,0.07968758272644927,0.7568167349405917,1
1903,Biological Process,GO:0006140,regulation of nucleotide metabolic process,0.07966139692973417,0.7563663227932413,1
1904,Biological Process,GO:0001568,blood vessel development,0.07965005925573576,0.7561713076807686,1
1905,Phenotype,HP:0002110,Bronchiectasis,0.07963744806868955,0.7559543873441479,1
1906,Phenotype,HP:0006530,Abnormal pulmonary interstitial morphology,0.07960251826360709,0.7553535727619186,1
1907,Phenotype,HP:0009053,Distal lower limb muscle weakness,0.07957920001957364,0.7549524843214247,1
1908,Biological Process,GO:0000209,protein polyubiquitination,0.07955991133659124,0.7546207068614456,1
1909,Biological Process,GO:0090322,regulation of superoxide metabolic process,0.07955927173748889,0.7546097053552373,1
1910,Biological Process,GO:1902807,negative regulation of cell cycle G1/S phase transition,0.07954931682790045,0.7544384746589483,1
1911,Biological Process,GO:0042953,lipoprotein transport,0.07952189850420988,0.7539668622736317,1
1912,Biological Process,GO:2001238,positive regulation of extrinsic apoptotic signaling pathway,0.07942687400052728,0.7523323811379135,1
1913,Phenotype,HP:0011891,Post-partum hemorrhage,0.07940821680011922,0.7520114655747641,1
1914,Phenotype,HP:0001878,Hemolytic anemia,0.07936619431630332,0.751288652464342,1
1915,Phenotype,HP:0002224,Woolly hair,0.07935110899220366,0.7510291754167222,1
1916,Biological Process,GO:1904951,positive regulation of establishment of protein localization,0.07932907415279111,0.7506501623416454,1
1917,Biological Process,GO:0010954,positive regulation of protein processing,0.07929615498942588,0.7500839320595718,1
1918,Biological Process,GO:0006520,amino acid metabolic process,0.07927409485695636,0.7497044839280317,1
1919,Phenotype,HP:0003584,Late onset,0.07926844966086777,0.7496073830103037,1
1920,Biological Process,GO:0032330,regulation of chondrocyte differentiation,0.07926270067611196,0.7495084968623236,1
1921,Biological Process,GO:0070873,regulation of glycogen metabolic process,0.07925623850584362,0.7493973434756699,1
1922,Phenotype,HP:0001171,Split hand,0.07923717803222985,0.7490694913601395,1
1923,Biological Process,GO:0043304,regulation of mast cell degranulation,0.07923589246387852,0.7490473787772004,1
1924,Biological Process,GO:2000628,regulation of miRNA metabolic process,0.07922564605339055,0.7488711340823863,1
1925,Phenotype,HP:0012316,Fibrous tissue neoplasm,0.07921508693088875,0.7486895105445607,1
1926,Phenotype,HP:0010787,Genital neoplasm,0.07913661864219568,0.7473398067034407,1
1927,Phenotype,HP:0011040,Abnormal intrahepatic bile duct morphology,0.07912453549342913,0.7471319689568214,1
1928,Biological Process,GO:0002064,epithelial cell development,0.0791237369867207,0.7471182341399997,1
1929,Phenotype,HP:0100792,Acantholysis,0.07909335605592083,0.7465956630519798,1
1930,Phenotype,HP:0001102,Angioid streaks of the fundus,0.07908994750707454,0.7465370338713629,1
1931,Phenotype,HP:0012232,Shortened QT interval,0.07905354831178624,0.7459109448548626,1
1932,Biological Process,GO:0009070,serine family amino acid biosynthetic process,0.07904311864912339,0.745731548107564,1
1933,Biological Process,GO:0050994,regulation of lipid catabolic process,0.07901331010813273,0.7452188224837053,1
1934,Biological Process,GO:0009612,response to mechanical stimulus,0.0789886176858362,0.7447940973141461,1
1935,Biological Process,GO:0002686,negative regulation of leukocyte migration,0.07898791716708231,0.7447820479516756,1
1936,Biological Process,GO:0046456,icosanoid biosynthetic process,0.07892463399156757,0.7436935375929928,1
1937,Phenotype,HP:0002225,Sparse pubic hair,0.07890686333816033,0.7433878711949808,1
1938,Biological Process,GO:0086065,cell communication involved in cardiac conduction,0.07889916886459802,0.7432555214178237,1
1939,Phenotype,HP:0007499,Recurrent staphylococcal infections,0.0788816275058245,0.7429537990315015,1
1940,Biological Process,GO:0010633,negative regulation of epithelial cell migration,0.07885805648729605,0.7425483627109593,1
1941,Disease,MONDO:0005044,hypertensive disorder,0.07884533855044185,0.7423296062106056,1
1942,Phenotype,HP:0012715,Profound hearing impairment,0.07883419879153275,0.7421379953619535,1
1943,Disease,MONDO:0100036,variable age onset epilepsy,0.07882837363709883,0.7420377990476775,1
1944,Biological Process,GO:0062207,regulation of pattern recognition receptor signaling pathway,0.07881080063328394,0.7417355323467718,1
1945,Phenotype,HP:0010702,Increased circulating antibody level,0.07879701791770788,0.7414984609837548,1
1946,Biological Process,GO:0009593,detection of chemical stimulus,0.0787755981105207,0.7411300268491752,1
1947,Biological Process,GO:0010594,regulation of endothelial cell migration,0.07875014776100375,0.7406922648554705,1
1948,Biological Process,GO:1903018,regulation of glycoprotein metabolic process,0.07873342569631181,0.7404046348418422,1
1949,Phenotype,HP:5200204,Disturbed perception with a stimulus,0.07873340377818305,0.7404042578362637,1
1949,Phenotype,HP:0010524,Disturbed sensory perception,0.07873340377818305,0.7404042578362637,1
1949,Phenotype,HP:5200202,Abnormal interpretation of external stimuli,0.07873340377818305,0.7404042578362637,1
1952,Biological Process,GO:0045217,cell-cell junction maintenance,0.07871157630722325,0.7400288116287949,1
1953,Biological Process,GO:0061387,regulation of extent of cell growth,0.07869340077493714,0.7397161810598153,1
1954,Phenotype,HP:0000823,Delayed puberty,0.07869217003760898,0.7396950116049069,1
1955,Phenotype,HP:0000307,Pointed chin,0.07869164503820647,0.7396859812855008,1
1956,Biological Process,GO:0051646,mitochondrion localization,0.07866331659510051,0.7391987142747134,1
1957,Phenotype,HP:0001406,Intrahepatic cholestasis,0.07864951659311537,0.7389613455746049,1
1958,Biological Process,GO:0048871,multicellular organismal-level homeostasis,0.07862936252110242,0.7386146828798635,1
1959,Phenotype,HP:0012181,Entrapment neuropathy,0.07862685530374613,0.7385715571668824,1
1960,Biological Process,GO:0002886,regulation of myeloid leukocyte mediated immunity,0.07857265717821926,0.7376393153731146,1
1961,Biological Process,GO:0061077,chaperone-mediated protein folding,0.07855691019322775,0.7373684573426528,1
1962,Phenotype,HP:0009592,Astrocytoma,0.07853466875872617,0.7369858907023094,1
1963,Phenotype,HP:0003072,Hypercalcemia,0.0784798922085036,0.7360436996405431,1
1964,Phenotype,HP:0033834,Malaise,0.07847590604665855,0.7359751351536249,1
1965,Biological Process,GO:0070098,chemokine-mediated signaling pathway,0.07844417373137902,0.7354293194039283,1
1966,Biological Process,GO:0046825,regulation of protein export from nucleus,0.07843165024453524,0.7352139075658625,1
1967,Biological Process,GO:1903975,regulation of glial cell migration,0.07839342098946611,0.7345563403719124,1
1968,Phenotype,HP:0001907,Thromboembolism,0.07837789294912711,0.7342892483269643,1
1969,Disease,MONDO:0100510,spondyloepimetaphyseal dysplasia,0.07836584067297137,0.7340819416086378,1
1970,Biological Process,GO:1902547,regulation of cellular response to vascular endothelial growth factor stimulus,0.07832089237048412,0.7333088025797472,1
1971,Biological Process,GO:0060828,regulation of canonical Wnt signaling pathway,0.07831188505246733,0.7331538710535482,1
1972,Biological Process,GO:1904994,regulation of leukocyte adhesion to vascular endothelial cell,0.07829017076623201,0.7327803716944169,1
1973,Phenotype,HP:0000987,Atypical scarring of skin,0.07827090967024297,0.7324490687480473,1
1974,Biological Process,GO:0022408,negative regulation of cell-cell adhesion,0.07825978824012292,0.7322577731660767,1
1975,Phenotype,HP:0001085,Papilledema,0.07824605964334774,0.7320216326804198,1
1976,Biological Process,GO:0051291,protein heterooligomerization,0.07824375930784078,0.7319820654651622,1
1977,Phenotype,HP:0002960,Autoimmunity,0.07822047134816257,0.7315814979345961,1
1978,Biological Process,GO:0070741,response to interleukin-6,0.0782174750305411,0.7315299593899144,1
1979,Biological Process,GO:0042771,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,0.07821654374680065,0.7315139407247618,1
1980,Biological Process,GO:0140895,cell surface toll-like receptor signaling pathway,0.07819602093646272,0.7311609354992747,1
1981,Biological Process,GO:0006563,L-serine metabolic process,0.07807002412825392,0.7289937112760798,1
1982,Biological Process,GO:0032885,regulation of polysaccharide biosynthetic process,0.07806770310034761,0.7289537881385592,1
1983,Biological Process,GO:0045912,negative regulation of carbohydrate metabolic process,0.07805384722333386,0.728715458352871,1
1984,Biological Process,GO:0015872,dopamine transport,0.07805368754547892,0.7287127117934934,1
1984,Biological Process,GO:0051937,catecholamine transport,0.07805368754547892,0.7287127117934934,1
1986,Biological Process,GO:0034142,toll-like receptor 4 signaling pathway,0.07803511036150312,0.7283931725632267,1
1987,Biological Process,GO:2000479,regulation of cAMP-dependent protein kinase activity,0.07795493240922002,0.7270140614347436,1
1988,Phenotype,HP:0100031,Neoplasm of the thyroid gland,0.07795491967705404,0.7270138424334931,1
1989,Phenotype,HP:0003010,Prolonged bleeding time,0.07795196053693465,0.7269629433651935,1
1990,Phenotype,HP:0001581,Recurrent skin infections,0.07792564560592818,0.7265103100269393,1
1991,Phenotype,HP:0005830,Flexion contracture of toe,0.07792519063465697,0.7265024842353669,1
1992,Phenotype,HP:0000245,Abnormal paranasal sinus morphology,0.07790124025138123,0.7260905226029423,1
1993,Phenotype,HP:0002756,Pathologic fracture,0.07789597377784074,0.7259999359508673,1
1994,Phenotype,HP:0100539,Periorbital edema,0.077870572058089,0.7255630104196622,1
1995,Disease,MONDO:0020076,myeloproliferative neoplasm,0.07786647126599278,0.7254924742204396,1
1995,Disease,MONDO:0005374,bone marrow neoplasm,0.07786647126599278,0.7254924742204396,1
1995,Disease,MONDO:0005170,myeloid neoplasm,0.07786647126599278,0.7254924742204396,1
1995,Disease,MONDO:0021138,bone marrow cancer,0.07786647126599278,0.7254924742204396,1
1999,Phenotype,HP:0006515,Interstitial pneumonitis,0.07783953027109836,0.7250290721901643,1
2000,Biological Process,GO:1903901,negative regulation of viral life cycle,0.07783483590655871,0.7249483261721701,1
2001,Biological Process,GO:0042306,regulation of protein import into nucleus,0.07779749842740469,0.7243060980839671,1
2002,Biological Process,GO:0010155,regulation of proton transport,0.07779288478238255,0.7242267404923635,1
2003,Biological Process,GO:0097300,programmed necrotic cell death,0.07778345665543385,0.7240645707882807,1
2004,Biological Process,GO:0033673,negative regulation of kinase activity,0.07777475856153815,0.7239149581111473,1
2005,Biological Process,GO:0050921,positive regulation of chemotaxis,0.07775354162957882,0.7235500135578856,1
2006,Biological Process,GO:0050860,negative regulation of T cell receptor signaling pathway,0.07775139326262481,0.7235130602971704,1
2007,Biological Process,GO:0000096,sulfur amino acid metabolic process,0.07770225122181507,0.722667786335598,1
2008,Phenotype,HP:0033763,Death in adulthood,0.0776758923416685,0.7222143970445354,1
2009,Phenotype,HP:0000246,Sinusitis,0.07766982112147913,0.7221099682447444,1
2010,Phenotype,HP:0006682,Premature ventricular contraction,0.07764478287525678,0.7216792946864946,1
2011,Phenotype,HP:5201016,Submucous cleft palate,0.07755432745213808,0.7201234046057131,1
2012,Phenotype,HP:0011228,Horizontal eyebrow,0.07752168884849919,0.7195620001271152,1
2013,Phenotype,HP:0030780,Abnormality of the protein C anticoagulant pathway,0.07750198402702213,0.7192230648237061,1
2014,Biological Process,GO:1903578,regulation of ATP metabolic process,0.07750163051086556,0.7192169841238162,1
2015,Biological Process,GO:0002220,innate immune response activating cell surface receptor signaling pathway,0.07748424641386009,0.7189179667386599,1
2016,Phenotype,HP:0034376,Atrioventricular valve regurgitation,0.07740195337545241,0.717502474800627,1
2017,Phenotype,HP:0001838,Rocker bottom foot,0.07739361186565952,0.7173589955939853,1
2018,Phenotype,HP:0025667,Fetal neck anomaly,0.07736859147708441,0.7169286291984822,1
2019,Biological Process,GO:0030509,BMP signaling pathway,0.07731026207695113,0.7159253268871745,1
2020,Phenotype,HP:0010444,Pulmonary insufficiency,0.07730988803635708,0.7159188931540711,1
2021,Phenotype,HP:0003326,Myalgia,0.0773069773373195,0.7158688273027981,1
2022,Biological Process,GO:0032770,positive regulation of monooxygenase activity,0.0773026557173041,0.7157944927246926,1
2023,Phenotype,HP:0008771,Aplasia/Hypoplasia of the ear,0.0772210408247106,0.7143906653205175,1
2024,Phenotype,HP:0002495,Impaired vibratory sensation,0.07713774860590872,0.7129579868522508,1
2025,Phenotype,HP:0034398,Toe deformity,0.07711925546304765,0.7126398931819327,1
2026,Biological Process,GO:0072006,nephron development,0.07711590587383721,0.712582278144077,1
2027,Phenotype,HP:0010788,Testicular neoplasm,0.07710860939376663,0.7124567741049047,1
2028,Biological Process,GO:0032570,response to progesterone,0.0770794915553994,0.7119559289999083,1
2029,Phenotype,HP:0004400,Abnormality of the pylorus,0.07707302246403236,0.7118446565660109,1
2030,Biological Process,GO:0090316,positive regulation of intracellular protein transport,0.07704749096563068,0.7114054987605299,1
2031,Biological Process,GO:0045786,negative regulation of cell cycle,0.07702211644929458,0.7109690411451566,1
2032,Phenotype,HP:0034675,Toe joint contracture,0.07699970349192597,0.7105835242037896,1
2033,Phenotype,HP:0100728,Germ cell neoplasia,0.0769989690114532,0.7105708906784274,1
2034,Phenotype,HP:0000846,Adrenal insufficiency,0.07699174326175962,0.7104466032461558,1
2035,Biological Process,GO:1905564,positive regulation of vascular endothelial cell proliferation,0.0769667667216054,0.7100169910710276,1
2036,Biological Process,GO:0048640,negative regulation of developmental growth,0.07691368209052685,0.7091039020810098,1
2037,Biological Process,GO:0044790,suppression of viral release by host,0.07691207638640374,0.7090762829617611,1
2038,Phenotype,HP:0001057,Aplasia cutis congenita,0.07690564284668744,0.7089656220385816,1
2039,Phenotype,HP:0002699,Abnormal foramen magnum morphology,0.07690126789499663,0.7088903701221686,1
2040,Phenotype,HP:0410291,Negativism,0.07689877973348846,0.7088475721817415,1
2041,Biological Process,GO:0045717,negative regulation of fatty acid biosynthetic process,0.07688898067036287,0.7086790221424801,1
2042,Phenotype,HP:0001598,Concave nail,0.0768753582093864,0.7084447072592109,1
2043,Phenotype,HP:0031245,Productive cough,0.07682142299126327,0.7075169876378848,1
2044,Biological Process,GO:0007596,blood coagulation,0.07681395245287281,0.7073884896863076,1
2045,Disease,MONDO:0003916,overnutrition,0.07678704252058166,0.7069256219523149,1
2046,Phenotype,HP:0011772,Abnormal thyroid morphology,0.0767739529027035,0.7067004723049453,1
2047,Phenotype,HP:0007210,Lower limb amyotrophy,0.07672974008461675,0.7059399840696041,1
2048,Biological Process,GO:0016540,protein autoprocessing,0.07672821578144584,0.7059137650978504,1
2049,Biological Process,GO:0098869,cellular oxidant detoxification,0.07672723789228442,0.7058969447901905,1
2050,Biological Process,GO:0048588,developmental cell growth,0.07671262199643769,0.7056455422033072,1
2051,Biological Process,GO:2001056,positive regulation of cysteine-type endopeptidase activity,0.07666350910955433,0.7048007697075764,1
2052,Biological Process,GO:0035967,cellular response to topologically incorrect protein,0.07662237850049658,0.7040932974030638,1
2053,Biological Process,GO:0039532,negative regulation of cytoplasmic pattern recognition receptor signaling pathway,0.07661715984991013,0.7040035333358297,1
2054,Disease,MONDO:0021106,laminopathy,0.07660525314626132,0.7037987305560375,1
2055,Phenotype,HP:0012732,Anorectal anomaly,0.07659786020570436,0.7036715673359253,1
2056,Phenotype,HP:0011819,Submucous cleft soft palate,0.07657613472179603,0.7032978753697864,1
2057,Disease,MONDO:0019272,hereditary palmoplantar keratoderma,0.07655972696849023,0.7030156517093774,1
2057,Disease,MONDO:0006590,palmoplantar keratosis,0.07655972696849023,0.7030156517093774,1
2059,Biological Process,GO:0031331,positive regulation of cellular catabolic process,0.07654688641104235,0.7027947860578105,1
2060,Disease,MONDO:0015979,hereditary predisposition to infections,0.07651760514479888,0.7022911298907155,1
2061,Phenotype,HP:0000179,Thick lower lip vermilion,0.07651008110155333,0.7021617116220311,1
2062,Phenotype,HP:0000280,Coarse facial features,0.07648953454287932,0.7018082979102503,1
2063,Phenotype,HP:0040218,Reduced natural killer cell count,0.07647931751689852,0.7016325586474119,1
2064,Phenotype,HP:0005855,Multiple prenatal fractures,0.07645642731593227,0.7012388328164715,1
2065,Disease,MONDO:0006295,malignant urinary system neoplasm,0.07642880022944065,0.7007636295798806,1
2065,Disease,MONDO:0021066,urinary system neoplasm,0.07642880022944065,0.7007636295798806,1
2067,Phenotype,HP:0100243,Leiomyosarcoma,0.07642715472401018,0.7007353258531512,1
2067,Phenotype,HP:0002891,Uterine leiomyosarcoma,0.07642715472401018,0.7007353258531512,1
2069,Biological Process,GO:1900745,positive regulation of p38MAPK cascade,0.076303235244648,0.6986038329906146,1
2070,Biological Process,GO:0030510,regulation of BMP signaling pathway,0.07629823681290859,0.6985178568258401,1
2071,Disease,MONDO:0002356,pancreas disorder,0.0762752760820955,0.6981229178372435,1
2072,Phenotype,HP:0002634,Arteriosclerosis,0.0762736191810236,0.6980944180983254,1
2073,Biological Process,GO:0043525,positive regulation of neuron apoptotic process,0.07622455105061166,0.6972504154420086,1
2074,Biological Process,GO:0070830,bicellular tight junction assembly,0.07620913450454103,0.6969852411684914,1
2075,Phenotype,HP:0000282,Facial edema,0.07612525673966775,0.6955424909400919,1
2076,Biological Process,GO:0061462,protein localization to lysosome,0.07606055821684976,0.6944296357190001,1
2077,Phenotype,HP:0100613,Death in early adulthood,0.07603121614297226,0.6939249336224143,1
2078,Phenotype,HP:0030949,Glomerular deposits,0.07600365574014634,0.6934508773867486,1
2079,Phenotype,HP:0001922,Vacuolated lymphocytes,0.07599092889132852,0.6932319675950244,1
2080,Phenotype,HP:0001845,Overlapping toe,0.0759602165252522,0.6927036956121188,1
2081,Disease,MONDO:0024481,skin appendage disorder,0.07592605578788203,0.692116109477491,1
2082,Phenotype,HP:0008956,Proximal lower limb amyotrophy,0.07590824617824021,0.6918097730077811,1
2083,Phenotype,HP:0100273,Neoplasm of the colon,0.07590344054591991,0.6917271131140871,1
2084,Biological Process,GO:0070201,regulation of establishment of protein localization,0.07586914518029075,0.6911372112888625,1
2085,Phenotype,HP:0001645,Sudden cardiac death,0.07586032362301298,0.6909854749640264,1
2086,Phenotype,HP:0002253,Colonic diverticula,0.0758259295019359,0.6903938744830822,1
2087,Phenotype,HP:0012780,Neoplasm of the ear,0.07578884948655074,0.6897560749333825,1
2088,Biological Process,GO:1901570,fatty acid derivative biosynthetic process,0.07578556986472207,0.6896996633784308,1
2089,Phenotype,HP:0010797,Hemangioblastoma,0.07574479930339073,0.688998384120911,1
2090,Phenotype,HP:0012227,Urethral stricture,0.07574401123100694,0.6889848287810253,1
2091,Phenotype,HP:0005216,Impaired mastication,0.0757314283327648,0.6887683950295992,1
2092,Biological Process,GO:0015669,gas transport,0.07569077404763624,0.6880691157957849,1
2093,Biological Process,GO:2000401,regulation of lymphocyte migration,0.07566554988043883,0.6876352442800115,1
2094,Biological Process,GO:0051051,negative regulation of transport,0.07564629014295521,0.6873039647007883,1
2095,Phenotype,HP:0001409,Portal hypertension,0.07562206475099043,0.6868872727462153,1
2096,Phenotype,HP:0034261,Aplasia/Hypoplasia of facial bones,0.07561026619478772,0.6866843301704094,1
2097,Biological Process,GO:0010561,negative regulation of glycoprotein biosynthetic process,0.0756052963196191,0.6865988451965849,1
2098,Phenotype,HP:0000105,Enlarged kidney,0.0755320536207138,0.6853390247813194,1
2099,Phenotype,HP:0012657,Abnormal brain positron emission tomography,0.07552600428542489,0.6852349724155591,1
2099,Phenotype,HP:0012658,Abnormal brain FDG positron emission tomography,0.07552600428542489,0.6852349724155591,1
2101,Phenotype,HP:0002843,Abnormal T cell morphology,0.07549172783544544,0.6846453959513881,1
2102,Biological Process,GO:0044703,multi-organism reproductive process,0.07547776069606904,0.6844051523831929,1
2103,Biological Process,GO:0019693,ribose phosphate metabolic process,0.07543572936847287,0.6836821871541967,1
2104,Phenotype,HP:0009896,Abnormal antitragus morphology,0.07541450054678844,0.6833170380901971,1
2105,Biological Process,GO:1990748,cellular detoxification,0.07539835530596473,0.6830393298093295,1
2106,Phenotype,HP:0008843,Hip osteoarthritis,0.07539758639313321,0.6830261040257745,1
2107,Phenotype,HP:0100685,Abnormal Sharpey fiber morphology,0.07537841216960928,0.6826962953403579,1
2108,Phenotype,HP:0006748,Adrenal pheochromocytoma,0.07537652400555883,0.682663817732983,1
2108,Phenotype,HP:0100642,Neoplasm of the adrenal medulla,0.07537652400555883,0.682663817732983,1
2110,Biological Process,GO:0090398,cellular senescence,0.07537386298211057,0.6826180464586346,1
2111,Disease,MONDO:0019297,lymphedema,0.07536480027873449,0.6824621622694754,1
2111,Disease,MONDO:0019313,lymphatic malformation,0.07536480027873449,0.6824621622694754,1
2111,Disease,MONDO:0019175,primary lymphedema,0.07536480027873449,0.6824621622694754,1
2114,Biological Process,GO:0032890,regulation of organic acid transport,0.07534539800771811,0.6821284310239821,1
2115,Phenotype,HP:0009733,Glioma,0.07530908439313033,0.681503814049273,1
2116,Phenotype,HP:0002077,Migraine with aura,0.07529424614464164,0.6812485868573175,1
2117,Disease,MONDO:0005045,hypertrophic cardiomyopathy,0.07528461757646576,0.6810829694382566,1
2117,Disease,MONDO:0024573,familial hypertrophic cardiomyopathy,0.07528461757646576,0.6810829694382566,1
2119,Phenotype,HP:0100735,Hypertensive crisis,0.07526300600870228,0.6807112369013449,1
2120,Biological Process,GO:0045646,regulation of erythrocyte differentiation,0.07526206496148602,0.6806950502982774,1
2121,Biological Process,GO:0019646,aerobic electron transport chain,0.07526092406675411,0.6806754261924427,1
2122,Biological Process,GO:0046209,nitric oxide metabolic process,0.07525578929664412,0.6805871049220779,1
2123,Phenotype,HP:0020072,Persistent EBV viremia,0.07524414309426641,0.6803867829277352,1
2124,Biological Process,GO:2000573,positive regulation of DNA biosynthetic process,0.07523410678726627,0.68021415214485,1
2125,Phenotype,HP:0011109,Chronic sinusitis,0.07522528906245907,0.6800624817409143,1
2126,Phenotype,HP:0006749,Malignant gastrointestinal tract tumors,0.07521623449512105,0.6799067374967189,1
2126,Phenotype,HP:0002672,Gastrointestinal carcinoma,0.07521623449512105,0.6799067374967189,1
2128,Biological Process,GO:0009566,fertilization,0.07520738373176228,0.6797544988089491,1
2129,Biological Process,GO:0042446,hormone biosynthetic process,0.0752064104157315,0.6797377571620082,1
2130,Disease,MONDO:0000270,lower respiratory tract disorder,0.07517904465718805,0.6792670489302315,1
2131,Phenotype,HP:0006886,Impaired distal vibration sensation,0.07516078848755359,0.6789530313482225,1
2132,Biological Process,GO:0009268,response to pH,0.07515748639376019,0.6788962332613657,1
2133,Biological Process,GO:1903573,negative regulation of response to endoplasmic reticulum stress,0.07514431193771298,0.6786696243442129,1
2134,Phenotype,HP:0100303,Muscle fiber cytoplasmatic inclusion bodies,0.07513382940127133,0.6784893181347157,1
2135,Biological Process,GO:0060560,developmental growth involved in morphogenesis,0.07509469556942572,0.6778161916521646,1
2136,Phenotype,HP:0002021,Pyloric stenosis,0.0750682813946103,0.6773618512580745,1
2137,Phenotype,HP:0011227,Elevated circulating C-reactive protein concentration,0.07504149595782517,0.6769011249249645,1
2138,Phenotype,HP:0025085,Bloody diarrhea,0.07501180762237969,0.6763904669119681,1
2139,Biological Process,GO:1900744,regulation of p38MAPK cascade,0.07494743156459227,0.6752831582918999,1
2140,Phenotype,HP:0007957,Corneal opacity,0.07489922831075646,0.6744540320558077,1
2141,Biological Process,GO:0009083,branched-chain amino acid catabolic process,0.07489280631162365,0.6743435696379114,1
2142,Biological Process,GO:0051289,protein homotetramerization,0.07489197449452012,0.6743292618613759,1
2143,Phenotype,HP:0000613,Photophobia,0.07485776932839261,0.6737409115242221,1
2144,Phenotype,HP:0025234,Parasomnia,0.07483490772068979,0.6733476775153683,1
2145,Phenotype,HP:0001217,Clubbing,0.07481898026536793,0.6730737152818949,1
2146,Biological Process,GO:0045737,positive regulation of cyclin-dependent protein serine/threonine kinase activity,0.07479462649963531,0.6726548152179005,1
2147,Biological Process,GO:0002285,lymphocyte activation involved in immune response,0.0746889020334266,0.6708362880074955,1
2148,Phenotype,HP:0003444,EMG,0.07466513764938143,0.6704275256786384,1
2149,Biological Process,GO:0086011,membrane repolarization during action potential,0.07464404207769049,0.6700646685982035,1
2150,Biological Process,GO:0010719,negative regulation of epithelial to mesenchymal transition,0.07463716570457535,0.6699463906624786,1
2151,Phenotype,HP:0010816,Epidermal nevus,0.07463499820691799,0.6699091083416522,1
2152,Biological Process,GO:0030808,regulation of nucleotide biosynthetic process,0.07462845184655953,0.6697965068325797,1
2152,Biological Process,GO:1900371,regulation of purine nucleotide biosynthetic process,0.07462845184655953,0.6697965068325797,1
2154,Biological Process,GO:2000629,negative regulation of miRNA metabolic process,0.07457506101151434,0.6688781509420497,1
2155,Biological Process,GO:0000910,cytokinesis,0.07455075758107332,0.6684601166766798,1
2156,Biological Process,GO:0017148,negative regulation of translation,0.07450757429637023,0.6677173370620519,1
2157,Phenotype,HP:0010830,Impaired tactile sensation,0.07450172984227876,0.6676168087815467,1
2158,Biological Process,GO:0030656,regulation of vitamin metabolic process,0.07449874933806089,0.667565542237337,1
2159,Phenotype,HP:0040185,Macrothrombocytopenia,0.0744975692758496,0.6675452444262613,1
2160,Phenotype,HP:0010614,Fibroma,0.07449693536939372,0.667534340837147,1
2161,Biological Process,GO:1902895,positive regulation of miRNA transcription,0.0744874075454165,0.667370456281567,1
2162,Biological Process,GO:0050878,regulation of body fluid levels,0.07444026136770421,0.6665595124186098,1
2163,Biological Process,GO:0016049,cell growth,0.07440749850986461,0.665995970689732,1
2164,Biological Process,GO:0044272,sulfur compound biosynthetic process,0.07438914136304231,0.6656802162366818,1
2165,Biological Process,GO:0051222,positive regulation of protein transport,0.07433674306327176,0.6647789325761562,1
2166,Biological Process,GO:0043297,apical junction assembly,0.07433141242516317,0.6646872422532165,1
2167,Phenotype,HP:0009098,Chronic oral candidiasis,0.07429806879932521,0.6641137109500631,1
2168,Biological Process,GO:1900226,negative regulation of NLRP3 inflammasome complex assembly,0.07428894488950755,0.663956773971673,1
2169,Biological Process,GO:0030177,positive regulation of Wnt signaling pathway,0.07425749425592554,0.6634158033240609,1
2170,Phenotype,HP:0000127,Renal salt wasting,0.07423865078719905,0.6630916838288639,1
2171,Biological Process,GO:0097746,blood vessel diameter maintenance,0.07423261429339245,0.6629878523446636,1
2171,Biological Process,GO:0035150,regulation of tube size,0.07423261429339245,0.6629878523446636,1
2171,Biological Process,GO:0035296,regulation of tube diameter,0.07423261429339245,0.6629878523446636,1
2174,Biological Process,GO:0001960,negative regulation of cytokine-mediated signaling pathway,0.074227584719321,0.6629013405122216,1
2175,Biological Process,GO:0042178,xenobiotic catabolic process,0.07417236596578447,0.6619515432757654,1
2176,Phenotype,HP:0011363,Abnormality of hair growth rate,0.07416355032386013,0.6617999086987228,1
2176,Phenotype,HP:0002217,Slow-growing hair,0.07416355032386013,0.6617999086987228,1
2178,Phenotype,HP:0001750,Single ventricle,0.07416086382829756,0.6617536992880126,1
2179,Biological Process,GO:1903432,regulation of TORC1 signaling,0.07406853147954606,0.6601655249076971,1
2180,Disease,MONDO:0002220,tooth hard tissue disease,0.07405849057550218,0.6599928150527727,1
2181,Phenotype,HP:0010615,Angiofibromas,0.0740510787994415,0.6598653278501686,1
2182,Phenotype,HP:0001446,Abnormality of the musculature of the upper limbs,0.07403959537475324,0.6596678057343036,1
2183,Biological Process,GO:0002263,cell activation involved in immune response,0.07402247357534275,0.6593733000324955,1
2184,Phenotype,HP:0003154,Increased circulating ACTH level,0.07401999136349036,0.659330604429884,1
2185,Biological Process,GO:2001258,negative regulation of cation channel activity,0.07401295960605048,0.6592096537861971,1
2186,Phenotype,HP:0002427,Expressive aphasia,0.07400034099382546,0.6589926057318383,1
2187,Biological Process,GO:0050927,positive regulation of positive chemotaxis,0.07399724775333205,0.6589394000528945,1
2188,Biological Process,GO:0032717,negative regulation of interleukin-8 production,0.07391989076648353,0.6576088113013631,1
2189,Biological Process,GO:0043491,phosphatidylinositol 3-kinase/protein kinase B signal transduction,0.07391219491666123,0.6574764378516696,1
2190,Phenotype,HP:0001648,Cor pulmonale,0.07387626950597781,0.6568584982278951,1
2191,Biological Process,GO:0009187,cyclic nucleotide metabolic process,0.07377452873492762,0.6551084930758511,1
2191,Biological Process,GO:0052652,cyclic purine nucleotide metabolic process,0.07377452873492762,0.6551084930758511,1
2193,Phenotype,HP:0025116,Fetal distress,0.07371118961363887,0.654019020414723,1
2194,Phenotype,HP:0040273,Adenocarcinoma of the intestines,0.0736880945322953,0.6536217705126343,1
2195,Phenotype,HP:0000678,Dental crowding,0.07364410792572751,0.6528651732574728,1
2196,Phenotype,HP:0040275,Adenocarcinoma of the large intestine,0.07363735173862818,0.6527489625966929,1
2197,Biological Process,GO:0007088,regulation of mitotic nuclear division,0.07361051239646788,0.6522873090572792,1
2198,Biological Process,GO:0006986,response to unfolded protein,0.07354192225256884,0.6511075155097784,1
2199,Biological Process,GO:1905523,positive regulation of macrophage migration,0.07345273315201117,0.6495734069722572,1
2200,Biological Process,GO:0046685,response to arsenic-containing substance,0.0734305794546648,0.6491923494660795,1
2201,Phenotype,HP:0002726,Recurrent Staphylococcus aureus infections,0.07338842336724938,0.648467238289847,1
2202,Phenotype,HP:0033072,Abnormal macroscopic urine appearance,0.0733880669845326,0.6484611082833213,1
2203,Biological Process,GO:0042326,negative regulation of phosphorylation,0.07335173942956297,0.64783625152529,1
2204,Disease,MONDO:0002245,blood platelet disease,0.07333223286674939,0.6475007263953931,1
2205,Phenotype,HP:0001927,Acanthocytosis,0.07329371396691231,0.6468381771295466,1
2206,Phenotype,HP:0006256,Abnormality of hand joint mobility,0.07326725855521043,0.646383127435114,1
2207,Phenotype,HP:0000491,Keratitis,0.07317035543957218,0.6447163329940494,1
2208,Biological Process,GO:0170033,L-amino acid metabolic process,0.07311738952632374,0.6438052860252608,1
2209,Biological Process,GO:0050853,B cell receptor signaling pathway,0.07308534441642545,0.6432540900116964,1
2210,Biological Process,GO:0009152,purine ribonucleotide biosynthetic process,0.07306968631624888,0.6429847608558686,1
2211,Biological Process,GO:0051043,regulation of membrane protein ectodomain proteolysis,0.07306810280081755,0.6429575233960522,1
2212,Phenotype,HP:0010807,Open bite,0.07306019147008891,0.6428214435394546,1
2213,Biological Process,GO:0072593,reactive oxygen species metabolic process,0.07305332389823793,0.6427033169910001,1
2214,Biological Process,GO:0006942,regulation of striated muscle contraction,0.07302441528081582,0.6422060706176441,1
2215,Phenotype,HP:0001904,Neutropenia in presence of anti-neutropil antibodies,0.07302287820337039,0.6421796319203467,1
2216,Biological Process,GO:0010039,response to iron ion,0.07301033669060208,0.6419639100250591,1
2217,Biological Process,GO:0090207,regulation of triglyceride metabolic process,0.07293661413965236,0.6406958358532975,1
2218,Biological Process,GO:0030516,regulation of axon extension,0.07290824577519162,0.6402078821701387,1
2219,Phenotype,HP:0000291,Abnormality of facial adipose tissue,0.07288715176872507,0.6398450520125463,1
2220,Biological Process,GO:0032881,regulation of polysaccharide metabolic process,0.07286548111570645,0.6394723031721427,1
2221,Biological Process,GO:0034446,substrate adhesion-dependent cell spreading,0.07286355539378087,0.6394391795457302,1
2222,Biological Process,GO:0009266,response to temperature stimulus,0.07285167854578789,0.6392348903019667,1
2223,Biological Process,GO:0032355,response to estradiol,0.0727944676403498,0.6382508268017956,1
2224,Biological Process,GO:0032309,icosanoid secretion,0.07279445081749691,0.6382505374381616,1
2225,Phenotype,HP:0002778,Abnormal tracheal morphology,0.07277617874090936,0.6379362462465705,1
2226,Biological Process,GO:0031146,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,0.07275591951630411,0.6375877748612091,1
2227,Biological Process,GO:0060416,response to growth hormone,0.07271499451681351,0.6368838391703676,1
2228,Phenotype,HP:0012056,Cutaneous melanoma,0.07271171255001074,0.6368273872803888,1
2229,Biological Process,GO:0051783,regulation of nuclear division,0.07271114918442423,0.6368176970385251,1
2230,Phenotype,HP:0001635,Congestive heart failure,0.07270476316174224,0.6367078534381748,1
2231,Biological Process,GO:0035239,tube morphogenesis,0.0727020432087484,0.6366610685386366,1
2232,Biological Process,GO:0055078,sodium ion homeostasis,0.07270114103066572,0.6366455505090751,1
2233,Biological Process,GO:0046337,phosphatidylethanolamine metabolic process,0.07264406857556382,0.635663868441629,1
2234,Biological Process,GO:0014910,regulation of smooth muscle cell migration,0.07263958467590237,0.635586742551705,1
2235,Biological Process,GO:0044872,lipoprotein localization,0.07261716330097234,0.6352010808229955,1
2236,Biological Process,GO:0042176,regulation of protein catabolic process,0.0725611847677986,0.6342382148996618,1
2237,Disease,MONDO:0045011,keratinization disease,0.0725561892938631,0.6341522896109717,1
2238,Phenotype,HP:0004944,Dilatation of the cerebral artery,0.07255061447323974,0.6340563991954393,1
2239,Phenotype,HP:0010562,Keloids,0.07250134467064218,0.6332089276508861,1
2240,Disease,MONDO:0015362,"neuronopathy, distal hereditary motor, autosomal dominant",0.07247863012519262,0.6328182232051389,1
2241,Phenotype,HP:0100533,Inflammatory abnormality of the eye,0.07246967067395826,0.6326641150176564,1
2242,Disease,MONDO:0006566,keratosis,0.07246890363741731,0.6326509215074775,1
2243,Biological Process,GO:0045109,intermediate filament organization,0.0724495191997544,0.6323174970068626,1
2244,Biological Process,GO:0070304,positive regulation of stress-activated protein kinase signaling cascade,0.07244177721496836,0.6321843300068216,1
2245,Phenotype,HP:0031284,Flushing,0.07241506381463114,0.6317248427458524,1
2246,Biological Process,GO:0007034,vacuolar transport,0.07240052319891976,0.6314747350245706,1
2247,Biological Process,GO:0070229,negative regulation of lymphocyte apoptotic process,0.072400066868051,0.6314668858470667,1
2248,Phenotype,HP:0003453,Antineutrophil antibody positivity,0.07236943678122953,0.6309400291190133,1
2249,Biological Process,GO:0098780,response to mitochondrial depolarisation,0.07234390574971794,0.630500879344335,1
2250,Biological Process,GO:0071621,granulocyte chemotaxis,0.07233997322136476,0.6304332373871571,1
2251,Phenotype,HP:0000703,Dentinogenesis imperfecta,0.07232514659312694,0.6301782100708138,1
2252,Phenotype,HP:0011839,Abnormal T cell count,0.07230155679603467,0.6297724507471816,1
2253,Biological Process,GO:0048511,rhythmic process,0.07227964979922186,0.6293956366451012,1
2254,Biological Process,GO:0072073,kidney epithelium development,0.0722774820068649,0.6293583492552567,1
2255,Phenotype,HP:0100530,Abnormal circulating calcium-phosphate regulating hormone concentration,0.07226197074839447,0.6290915458689863,1
2256,Biological Process,GO:0007292,female gamete generation,0.07226003630610478,0.6290582722468352,1
2257,Biological Process,GO:0071391,cellular response to estrogen stimulus,0.07224638384349868,0.6288234413166963,1
2258,Phenotype,HP:0002311,Incoordination,0.07223050899979166,0.6285503840360367,1
2259,Disease,MONDO:0002149,reproductive system cancer,0.0722268845085392,0.6284880405104287,1
2260,Phenotype,HP:0000561,Absent eyelashes,0.0722122333659514,0.628236031657465,1
2261,Phenotype,HP:0031105,Abnormal uterus morphology,0.0721801288418632,0.6276838136825241,1
2262,Phenotype,HP:0002663,Delayed epiphyseal ossification,0.0720654775750812,0.6257117398965104,1
2263,Phenotype,HP:0009594,Retinal hamartoma,0.07202834609943742,0.6250730551980473,1
2264,Phenotype,HP:0000206,Glossitis,0.07199690416527449,0.6245322341859063,1
2265,Biological Process,GO:0060339,negative regulation of type I interferon-mediated signaling pathway,0.07198083140553957,0.6242557726252819,1
2266,Biological Process,GO:0009895,negative regulation of catabolic process,0.07196733791277832,0.6240236760763024,1
2267,Biological Process,GO:0034643,"establishment of mitochondrion localization, microtubule-mediated",0.07196062326896269,0.6239081799860899,1
2267,Biological Process,GO:0047497,mitochondrion transport along microtubule,0.07196062326896269,0.6239081799860899,1
2269,Phenotype,HP:0001289,Confusion,0.07195138723791816,0.6237493144521892,1
2270,Phenotype,HP:0011807,Type 1 muscle fiber atrophy,0.07190748428746063,0.6229941561346577,1
2271,Biological Process,GO:0009259,ribonucleotide metabolic process,0.07189212825898217,0.6227300228017288,1
2272,Phenotype,HP:0500093,Food allergy,0.07187544300201765,0.6224430259041263,1
2273,Biological Process,GO:0071417,cellular response to organonitrogen compound,0.07179780739631392,0.6211076447333214,1
2274,Disease,MONDO:0011348,non-syndromic polydactyly,0.0717185052802014,0.6197435985369697,1
2275,Phenotype,HP:0003657,Vascular granular osmiophilic material deposition,0.07171168884073176,0.6196263514975838,1
2276,Biological Process,GO:1901654,response to ketone,0.0716518602890901,0.6185972628389123,1
2277,Phenotype,HP:0001747,Accessory spleen,0.07160786999075519,0.6178406020830383,1
2278,Biological Process,GO:0022404,molting cycle process,0.07160157773357678,0.6177323713082314,1
2278,Biological Process,GO:0022405,hair cycle process,0.07160157773357678,0.6177323713082314,1
2280,Disease,MONDO:0002917,disorder of pilosebaceous unit,0.07159125282321188,0.6175547763662386,1
2281,Biological Process,GO:1904031,positive regulation of cyclin-dependent protein kinase activity,0.07150435572617342,0.6160600917285531,1
2282,Phenotype,HP:0001218,Autoamputation,0.07145728962351727,0.6152505252068461,1
2283,Phenotype,HP:0011937,Hypoplastic fifth toenail,0.07143482942401902,0.6148641956711824,1
2284,Biological Process,GO:0032874,positive regulation of stress-activated MAPK cascade,0.07140398985715857,0.6143337357549118,1
2285,Phenotype,HP:0010450,Esophageal stenosis,0.07139367260718288,0.6141562725764238,1
2286,Phenotype,HP:5200123,Abnormal response to social norms,0.07138793531742416,0.6140575875897376,1
2286,Phenotype,HP:5200029,Social disinhibition,0.07138793531742416,0.6140575875897376,1
2288,Biological Process,GO:0033623,regulation of integrin activation,0.07137822058871368,0.6138904881553756,1
2289,Disease,MONDO:0044347,erythrocyte disorder,0.07137554917530908,0.6138445381672535,1
2289,Disease,MONDO:0044348,hemoglobinopathy,0.07137554917530908,0.6138445381672535,1
2289,Disease,MONDO:0019050,inherited hemoglobinopathy,0.07137554917530908,0.6138445381672535,1
2292,Disease,MONDO:0017713,disorder of fatty acid oxidation and ketogenesis,0.07136724778588055,0.6137017490560732,1
2293,Disease,MONDO:0003664,hemolytic anemia,0.07134279299081436,0.6132811112240982,1
2293,Disease,MONDO:0004139,normocytic anemia,0.07134279299081436,0.6132811112240982,1
2295,Disease,MONDO:0005586,head and neck neoplasm,0.07130950798270685,0.6127085881827186,1
2296,Phenotype,HP:0004363,Abnormal circulating calcium concentration,0.07129450596673426,0.6124505440871991,1
2297,Biological Process,GO:0002637,regulation of immunoglobulin production,0.07127914750594644,0.6121863689170219,1
2298,Biological Process,GO:0032928,regulation of superoxide anion generation,0.07127697453898518,0.6121489925207338,1
2299,Phenotype,HP:0000740,Episodic paroxysmal anxiety,0.07119981064068004,0.610821725013402,1
2299,Phenotype,HP:0002640,Hypertension associated with pheochromocytoma,0.07119981064068004,0.610821725013402,1
2299,Phenotype,HP:0006737,Extraadrenal pheochromocytoma,0.07119981064068004,0.610821725013402,1
2299,Phenotype,HP:0008629,Pulsatile tinnitus,0.07119981064068004,0.610821725013402,1
2299,Phenotype,HP:0003639,Elevated urinary epinephrine level,0.07119981064068004,0.610821725013402,1
2299,Phenotype,HP:0002864,Paraganglioma of head and neck,0.07119981064068004,0.610821725013402,1
2299,Phenotype,HP:0003574,Positive regitine blocking test,0.07119981064068004,0.610821725013402,1
2306,Biological Process,GO:1990138,neuron projection extension,0.07117047297770274,0.6103170987870695,1
2307,Phenotype,HP:0031979,Abnormal urine carbohydrate level,0.07115432222783868,0.6100392957472486,1
2308,Biological Process,GO:0001885,endothelial cell development,0.07109842393016985,0.6090778099249847,1
2309,Phenotype,HP:0031865,Abnormal liver physiology,0.07101267613946172,0.6076028940779089,1
2310,Biological Process,GO:0046034,ATP metabolic process,0.07100264111691079,0.6074302853883567,1
2311,Phenotype,HP:0005054,Metaphyseal spurs,0.07098272843586662,0.6070877747698641,1
2312,Phenotype,HP:0001988,Recurrent hypoglycemia,0.07097956125862759,0.6070332973324659,1
2313,Phenotype,HP:0002837,Recurrent bronchitis,0.07097299142753899,0.6069202921120962,1
2314,Phenotype,HP:0011991,Abnormal neutrophil count,0.07094057672561882,0.6063627388836634,1
2315,Phenotype,HP:0003641,Hemoglobinuria,0.07093238933708168,0.606221910659404,1
2316,Phenotype,HP:0005390,Recurrent opportunistic infections,0.07091864535975967,0.6059855056186831,1
2317,Disease,MONDO:0003240,thyroid gland disorder,0.07088644090650253,0.6054315687992841,1
2318,Phenotype,HP:0012387,Bronchitis,0.07087216839749466,0.6051860726816652,1
2319,Biological Process,GO:0061448,connective tissue development,0.070872093460987,0.6051847837266756,1
2320,Biological Process,GO:0099601,regulation of neurotransmitter receptor activity,0.07087190291237044,0.6051815061708123,1
2321,Phenotype,HP:0100755,Abnormality of salivation,0.07084578101454186,0.6047321931244366,1
2322,Biological Process,GO:0010563,negative regulation of phosphorus metabolic process,0.07082493942468093,0.6043737046909704,1
2323,Phenotype,HP:0011705,First degree atrioventricular block,0.07079869749470613,0.6039223270163032,1
2324,Biological Process,GO:0009069,serine family amino acid metabolic process,0.07077700660316466,0.6035492300605972,1
2325,Biological Process,GO:0060761,negative regulation of response to cytokine stimulus,0.07076283167692798,0.6033054124279218,1
2326,Biological Process,GO:0045936,negative regulation of phosphate metabolic process,0.07075299977509286,0.6031362975422349,1
2327,Phenotype,HP:0100835,Benign neoplasm of the central nervous system,0.070747036791176,0.6030337304742999,1
2328,Disease,MONDO:0020049,autosomal anomaly,0.07071794183033853,0.6025332788771818,1
2329,Phenotype,HP:0001765,Hammertoe,0.07070103639796321,0.6022424948242504,1
2330,Biological Process,GO:0008625,extrinsic apoptotic signaling pathway via death domain receptors,0.07068070181897002,0.601892727296096,1
2331,Disease,MONDO:0009453,immune deficiency disease,0.07062172745397288,0.6008783311841126,1
2331,Disease,MONDO:0003778,inborn error of immunity,0.07062172745397288,0.6008783311841126,1
2333,Biological Process,GO:1990266,neutrophil migration,0.07061583094907764,0.6007769075970961,1
2334,Biological Process,GO:0007338,single fertilization,0.07057859279114531,0.6001363878962767,1
2335,Phenotype,HP:0002979,Bowing of the legs,0.07057134695621547,0.6000117549853288,1
2336,Biological Process,GO:0045725,positive regulation of glycogen biosynthetic process,0.07051880617437534,0.599108020543732,1
2337,Biological Process,GO:0009132,nucleoside diphosphate metabolic process,0.07051876875891361,0.5991073769742945,1
2338,Biological Process,GO:0032092,positive regulation of protein binding,0.0704712034961158,0.5982892245846941,1
2339,Biological Process,GO:0061337,cardiac conduction,0.07043355267024531,0.597641606736196,1
2340,Biological Process,GO:0010644,cell communication by electrical coupling,0.07042606047425626,0.5975127362603225,1
2341,Phenotype,HP:0005595,Generalized hyperkeratosis,0.07042605569076343,0.5975126539812421,1
2342,Biological Process,GO:2000630,positive regulation of miRNA metabolic process,0.07042247300470528,0.5974510295312284,1
2343,Biological Process,GO:0010035,response to inorganic substance,0.07042107653602625,0.5974270093930111,1
2344,Phenotype,HP:0002289,Alopecia universalis,0.07041099580932353,0.5972536145633472,1
2345,Biological Process,GO:1903845,negative regulation of cellular response to transforming growth factor beta stimulus,0.07040010755202064,0.597066329700257,1
2346,Biological Process,GO:0060338,regulation of type I interferon-mediated signaling pathway,0.07038741682314731,0.59684804119426,1
2347,Biological Process,GO:0071354,cellular response to interleukin-6,0.07033843808088525,0.5960055760702542,1
2348,Phenotype,HP:0002149,Hyperuricemia,0.07029581883174696,0.5952724982215374,1
2349,Phenotype,HP:0002616,Aortic root aneurysm,0.07028902247236646,0.5951555965722944,1
2350,Biological Process,GO:0007611,learning or memory,0.07026266639725565,0.5947022555296083,1
2351,Disease,MONDO:0019288,skin pigmentation disorder,0.07022946141335928,0.5941311089549131,1
2352,Biological Process,GO:0007041,lysosomal transport,0.07021123117626371,0.5938175374288578,1
2353,Phenotype,HP:0000684,Delayed eruption of teeth,0.07020231073461825,0.5936641002308011,1
2354,Biological Process,GO:0045596,negative regulation of cell differentiation,0.07019945436429198,0.5936149688674792,1
2355,Biological Process,GO:0070232,regulation of T cell apoptotic process,0.07019792080002785,0.5935885905991064,1
2356,Biological Process,GO:0006968,cellular defense response,0.07015326088275575,0.5928204119770133,1
2357,Phenotype,HP:0031652,Abnormal aortic valve physiology,0.07013815981116411,0.5925606640626425,1
2358,Phenotype,HP:0000934,Chondrocalcinosis,0.0701121960053569,0.592114070298311,1
2359,Phenotype,HP:0001601,Laryngomalacia,0.07010492081542186,0.5919889324628395,1
2360,Biological Process,GO:0007623,circadian rhythm,0.0701044337470722,0.5919805545813619,1
2361,Phenotype,HP:0100797,Toenail dysplasia,0.07009107211586107,0.5917507261338495,1
2362,Phenotype,HP:0006640,Multiple rib fractures,0.07007349069679836,0.5914483146853966,1
2363,Biological Process,GO:0071467,cellular response to pH,0.07006583691129631,0.5913166647684265,1
2364,Phenotype,HP:0100560,Upper limb asymmetry,0.07005903537650737,0.5911996740989085,1
2365,Disease,MONDO:0006617,vesiculobullous skin disease,0.07005564097567862,0.5911412882730778,1
2366,Phenotype,HP:0002249,Melena,0.07004317940001525,0.5909269413461932,1
2367,Phenotype,HP:0200065,Chorioretinal degeneration,0.07003422068728604,0.590772845861463,1
2368,Phenotype,HP:0030060,Nervous tissue neoplasm,0.0700276783458944,0.5906603134811437,1
2368,Phenotype,HP:0030061,Neuroectodermal neoplasm,0.0700276783458944,0.5906603134811437,1
2370,Biological Process,GO:1901380,negative regulation of potassium ion transmembrane transport,0.06999742228504213,0.5901398902346369,1
2371,Phenotype,HP:0012263,Immotile cilia,0.06998854561206713,0.5899872058851975,1
2372,Phenotype,HP:0007430,Generalized edema,0.06998795431990146,0.5899770352886352,1
2373,Biological Process,GO:0032372,negative regulation of sterol transport,0.06996541224926689,0.5895892975180144,1
2373,Biological Process,GO:0032375,negative regulation of cholesterol transport,0.06996541224926689,0.5895892975180144,1
2375,Phenotype,HP:0009711,Retinal capillary hemangioma,0.06996479927320054,0.5895787539447437,1
2376,Phenotype,HP:0000236,Abnormality of the anterior fontanelle,0.06993517719633036,0.5890692356208507,1
2377,Biological Process,GO:0043507,positive regulation of JUN kinase activity,0.06989013969115287,0.5882945622496717,1
2378,Biological Process,GO:0071622,regulation of granulocyte chemotaxis,0.06988017116858292,0.588123097401552,1
2379,Phenotype,HP:0000134,Female hypogonadism,0.06982069763820076,0.5871001153314861,1
2380,Biological Process,GO:0045807,positive regulation of endocytosis,0.06980895378838448,0.5868981137398804,1
2381,Biological Process,GO:1900274,regulation of phospholipase C activity,0.06980355802044325,0.5868053031429199,1
2382,Disease,MONDO:0018874,acute myeloid leukemia,0.06975421170864204,0.5859565155920189,1
2382,Disease,MONDO:0010643,acute leukemia,0.06975421170864204,0.5859565155920189,1
2384,Biological Process,GO:0050922,negative regulation of chemotaxis,0.06975019598171528,0.5858874425671292,1
2385,Phenotype,HP:0004326,Cachexia,0.06972347652338962,0.5854278511049545,1
2386,Biological Process,GO:2000232,regulation of rRNA processing,0.06971174307679595,0.5852260284553108,1
2387,Biological Process,GO:0099518,vesicle cytoskeletal trafficking,0.06968208065811787,0.5847158162269886,1
2388,Biological Process,GO:0051785,positive regulation of nuclear division,0.06965219332503703,0.5842017353296998,1
2389,Disease,MONDO:0044137,vitreous body disorder,0.06963744374635727,0.58394803331414,1
2389,Disease,MONDO:0004860,vitreous disorder,0.06963744374635727,0.58394803331414,1
2391,Biological Process,GO:0006633,fatty acid biosynthetic process,0.06961500367137463,0.5835620499327824,1
2392,Biological Process,GO:0046032,ADP catabolic process,0.06956464049886202,0.5826957717390887,1
2392,Biological Process,GO:0006096,glycolytic process,0.06956464049886202,0.5826957717390887,1
2394,Biological Process,GO:0043032,positive regulation of macrophage activation,0.06955746215430991,0.5825722997050196,1
2395,Biological Process,GO:0006446,regulation of translational initiation,0.06954609290445135,0.5823767414679235,1
2396,Phenotype,HP:0033129,Abnormal shoulder physiology,0.06953310184228167,0.5821532870406296,1
2397,Biological Process,GO:0032930,positive regulation of superoxide anion generation,0.06950868445611103,0.5817332926651496,1
2398,Biological Process,GO:0044706,multi-multicellular organism process,0.06947072361097628,0.5810803422906239,1
2399,Phenotype,HP:0001647,Bicuspid aortic valve,0.06944542659590602,0.5806452177456914,1
2400,Phenotype,HP:0100759,Clubbing of fingers,0.06943906599464678,0.5805358114097764,1
2401,Phenotype,HP:0001007,Hirsutism,0.06943177171717618,0.580410345256707,1
2402,Phenotype,HP:0006858,Impaired distal proprioception,0.0693650774668465,0.5792631622691603,1
2403,Phenotype,HP:0002876,Episodic tachypnea,0.06930261108769942,0.5781887013209234,1
2404,Phenotype,HP:0001888,Lymphopenia,0.0692991195522652,0.5781286447188811,1
2405,Biological Process,GO:1904037,positive regulation of epithelial cell apoptotic process,0.06926508957509159,0.5775433077417476,1
2406,Phenotype,HP:0011328,Abnormality of fontanelles,0.06925154519627297,0.5773103359206265,1
2407,Biological Process,GO:0098754,detoxification,0.0692304065431808,0.5769467378130368,1
2408,Phenotype,HP:0025406,Asthenia,0.06919989832492313,0.5764219773008104,1
2409,Biological Process,GO:0071773,cellular response to BMP stimulus,0.06918328028725529,0.5761361366173223,1
2409,Biological Process,GO:0071772,response to BMP,0.06918328028725529,0.5761361366173223,1
2411,Biological Process,GO:2000406,positive regulation of T cell migration,0.06917741262922195,0.5760352092144455,1
2412,Biological Process,GO:0052548,regulation of endopeptidase activity,0.06915371390533886,0.5756275762816088,1
2413,Phenotype,HP:0025575,Abnormal superior vena cava morphology,0.06914103393272786,0.5754094727900784,1
2414,Biological Process,GO:0033137,negative regulation of peptidyl-serine phosphorylation,0.06907505678946846,0.574274624494461,1
2415,Biological Process,GO:0071786,endoplasmic reticulum tubular network organization,0.06905411716622445,0.5739144498252441,1
2416,Phenotype,HP:0032436,Abnormal circulating C-reactive protein concentration,0.06903733461749428,0.5736257794481764,1
2417,Phenotype,HP:0025300,Malar rash,0.06902438947982747,0.5734031149511709,1
2418,Biological Process,GO:0006164,purine nucleotide biosynthetic process,0.06897080077043705,0.5724813554976439,1
2419,Biological Process,GO:0055088,lipid homeostasis,0.06896096156453047,0.572312114977341,1
2420,Biological Process,GO:0010565,regulation of cellular ketone metabolic process,0.0689426699229374,0.571997487255369,1
2421,Biological Process,GO:0086013,membrane repolarization during cardiac muscle cell action potential,0.06886945962307278,0.5707382241239487,1
2421,Biological Process,GO:0099622,cardiac muscle cell membrane repolarization,0.06886945962307278,0.5707382241239487,1
2423,Phenotype,HP:0007461,Hemangiomatosis,0.06879803744190516,0.5695097177569985,1
2424,Phenotype,HP:0100827,Lymphocytosis,0.06876251926608457,0.5688987828285953,1
2425,Disease,MONDO:0005093,skin disorder,0.06875277920850853,0.5687312477218399,1
2426,Biological Process,GO:0008277,regulation of G protein-coupled receptor signaling pathway,0.06872745109572265,0.5682955882766703,1
2427,Biological Process,GO:2000341,regulation of chemokine (C-X-C motif) ligand 2 production,0.06870599799917931,0.56792658154426,1
2428,Phenotype,HP:0002411,Myokymia,0.06869489211413082,0.567735553347282,1
2429,Biological Process,GO:0034599,cellular response to oxidative stress,0.06868009310566114,0.5674810011082951,1
2430,Biological Process,GO:0019216,regulation of lipid metabolic process,0.06859516072606786,0.566020110844447,1
2431,Phenotype,HP:0000962,Hyperkeratosis,0.06858700397791917,0.5658798096541102,1
2432,Phenotype,HP:0002002,Deep philtrum,0.06850509749965594,0.5644709667933093,1
2433,Biological Process,GO:0098742,cell-cell adhesion via plasma-membrane adhesion molecules,0.06849058454834889,0.5642213349171543,1
2434,Biological Process,GO:0009267,cellular response to starvation,0.06848577690223878,0.564138640385011,1
2435,Phenotype,HP:0033331,Acute phase response,0.06847082236070079,0.5638814128795793,1
2436,Phenotype,HP:0001361,Nystagmus-induced head nodding,0.06842428799868316,0.5630809926307712,1
2437,Biological Process,GO:0090311,regulation of protein deacetylation,0.06842035195804363,0.5630132902600624,1
2438,Biological Process,GO:0016579,protein deubiquitination,0.06841006970593833,0.5628364290669226,1
2439,Phenotype,HP:0001850,Abnormality of the tarsal bones,0.06840792108858973,0.562799471499263,1
2440,Biological Process,GO:0051897,positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction,0.06840720869091288,0.562787217811858,1
2441,Phenotype,HP:0003261,Increased circulating IgA level,0.0684048321185613,0.5627463392749987,1
2442,Phenotype,HP:0000385,Small earlobe,0.06839800530805018,0.5626289138471868,1
2443,Phenotype,HP:0011897,Neutrophilia,0.0683845783891589,0.562397962410577,1
2444,Phenotype,HP:0020049,Exodeviation,0.06838195325236152,0.5623528084091594,1
2445,Biological Process,GO:0016032,viral process,0.06834026578836716,0.5616357578500498,1
2446,Phenotype,HP:0030065,Primitive neuroectodermal tumor,0.06833445379030767,0.5615357878336759,1
2447,Phenotype,HP:0031567,Abnormal aortic valve cusp morphology,0.06831512922504346,0.5612033931759167,1
2448,Biological Process,GO:1900747,negative regulation of vascular endothelial growth factor signaling pathway,0.06824055985034672,0.559920753103928,1
2449,Phenotype,HP:0031095,Abnormal humerus morphology,0.06823029908973188,0.5597442615779202,1
2450,Biological Process,GO:1904355,positive regulation of telomere capping,0.06819496841461425,0.5591365517793524,1
2451,Phenotype,HP:0001423,X-linked dominant inheritance,0.06818140761310942,0.5589032974777156,1
2452,Biological Process,GO:0002262,myeloid cell homeostasis,0.06814079457563138,0.5582047277293924,1
2453,Biological Process,GO:0007599,hemostasis,0.06811186080435572,0.5577070486939594,1
2454,Biological Process,GO:0001961,positive regulation of cytokine-mediated signaling pathway,0.06810630945996321,0.5576115620843398,1
2455,Phenotype,HP:0012888,Abnormal uterine cervix morphology,0.0681028365280163,0.5575518254739618,1
2456,Biological Process,GO:0015867,ATP transport,0.06808291928077048,0.5572092363139335,1
2457,Phenotype,HP:0100133,Abnormality of the pubic hair,0.06806448361308703,0.5568921312527629,1
2458,Biological Process,GO:0045494,photoreceptor cell maintenance,0.06806017784998242,0.5568180694234807,1
2459,Biological Process,GO:0071168,protein localization to chromatin,0.06803003278788089,0.5562995554251905,1
2460,Phenotype,HP:0002209,Sparse scalp hair,0.06800419904483879,0.5558551988220941,1
2461,Phenotype,HP:0010784,Uterine neoplasm,0.0679920654445374,0.5556464932773937,1
2462,Biological Process,GO:0007265,Ras protein signal transduction,0.06797371756852111,0.5553308982880286,1
2463,Phenotype,HP:0025423,Abnormal larynx morphology,0.06790156863374275,0.5540898913025957,1
2464,Biological Process,GO:0045618,positive regulation of keratinocyte differentiation,0.06783520121352504,0.5529483299982139,1
2465,Disease,MONDO:0021060,RASopathy,0.06781311169425963,0.5525683763953305,1
2466,Biological Process,GO:0009142,nucleoside triphosphate biosynthetic process,0.06775997373633413,0.5516543701500579,1
2467,Phenotype,HP:0030631,Hyperautofluorescent macular lesion,0.06774715018107369,0.5514337969467918,1
2468,Phenotype,HP:0002623,Overriding aorta,0.0676932474320513,0.5505066358143881,1
2469,Biological Process,GO:0033866,nucleoside bisphosphate biosynthetic process,0.06765681816708768,0.5498800295805897,1
2469,Biological Process,GO:0034030,ribonucleoside bisphosphate biosynthetic process,0.06765681816708768,0.5498800295805897,1
2469,Biological Process,GO:0034033,purine nucleoside bisphosphate biosynthetic process,0.06765681816708768,0.5498800295805897,1
2472,Phenotype,HP:0002480,Hepatic encephalopathy,0.06765169795688042,0.549791958749695,1
2473,Phenotype,HP:0001997,Gout,0.06763520969083525,0.5495083502196094,1
2474,Phenotype,HP:0001025,Urticaria,0.06761791428860431,0.5492108584402725,1
2475,Phenotype,HP:0100605,Neoplasm of the larynx,0.06760310649018975,0.5489561550087138,1
2476,Phenotype,HP:5200060,Auditory hypersensitivity,0.06757658324353089,0.5484999385104228,1
2477,Biological Process,GO:0032774,RNA biosynthetic process,0.06753076067317987,0.5477117615252629,1
2478,Biological Process,GO:0045454,cell redox homeostasis,0.06752677171697008,0.5476431489735164,1
2479,Disease,MONDO:0023603,hereditary disorder of connective tissue,0.06742138620179083,0.5458304519336686,1
2480,Biological Process,GO:0000423,mitophagy,0.06741900670834866,0.5457895231522168,1
2481,Biological Process,GO:0036230,granulocyte activation,0.06741096377231914,0.5456511796018001,1
2482,Phenotype,HP:0430030,Positive infectious agent test,0.06738157024596247,0.5451455924902621,1
2482,Phenotype,HP:0430150,Positive blood infectious agent test,0.06738157024596247,0.5451455924902621,1
2482,Phenotype,HP:0031863,Bloodstream infectious agent,0.06738157024596247,0.5451455924902621,1
2485,Phenotype,HP:0004421,Elevated systolic blood pressure,0.06737538571586588,0.5450392146889117,1
2486,Phenotype,HP:0100134,Abnormality of the axillary hair,0.06737281987040922,0.5449950805357875,1
2487,Phenotype,HP:0000126,Hydronephrosis,0.06736019514902458,0.5447779274000467,1
2488,Disease,MONDO:0020143,cerebral lipidosis with dementia,0.0673243419449907,0.5441612297759878,1
2489,Biological Process,GO:0032535,regulation of cellular component size,0.06726018244738718,0.5430576461270754,1
2490,Phenotype,HP:0030462,Abnormal amplitude of flash visual evoked potentials,0.06722767362650062,0.5424984739933169,1
2491,Biological Process,GO:0006367,transcription initiation at RNA polymerase II promoter,0.06721135061012584,0.5422177078613336,1
2492,Phenotype,HP:0008052,Retinal fold,0.06718364945881239,0.5417412306632968,1
2493,Phenotype,HP:0011476,Profound sensorineural hearing impairment,0.06718151223912194,0.5417044691425149,1
2494,Phenotype,HP:0000787,Nephrolithiasis,0.06714737522803094,0.5411172911147882,1
2495,Phenotype,HP:0031481,Abnormal mitral valve physiology,0.06714019394485793,0.5409937685345941,1
2496,Biological Process,GO:0031053,primary miRNA processing,0.06712171094707997,0.5406758493660763,1
2497,Phenotype,HP:3000050,Abnormal odontoid tissue morphology,0.06711881550915821,0.5406260460155787,1
2498,Biological Process,GO:0009150,purine ribonucleotide metabolic process,0.06711102253332957,0.5404920019375841,1
2499,Phenotype,HP:0003199,Decreased muscle mass,0.06708173952677177,0.5399883158359896,1
2500,Phenotype,HP:0010982,Polygenic inheritance,0.0670660110798057,0.5397177766712068,1
2501,Biological Process,GO:0030001,metal ion transport,0.06705756356807768,0.5395724741647152,1
2502,Phenotype,HP:0031845,Abnormal libido,0.06698148166783047,0.5382638177034402,1
2503,Phenotype,HP:0031958,Spastic paraparetic gait,0.0669755422417685,0.5381616558454029,1
2504,Biological Process,GO:0003205,cardiac chamber development,0.0669626815585469,0.5379404440178898,1
2505,Biological Process,GO:0034330,cell junction organization,0.06694681852110329,0.5376675898123748,1
2506,Biological Process,GO:0010888,negative regulation of lipid storage,0.06692460163717007,0.5372854454572241,1
2507,Biological Process,GO:0090090,negative regulation of canonical Wnt signaling pathway,0.06692291408413098,0.537256418485222,1
2508,Phenotype,HP:0001897,Normocytic anemia,0.06691738726592533,0.5371613537414182,1
2509,Biological Process,GO:0050821,protein stabilization,0.0669067791234611,0.536978887029456,1
2510,Biological Process,GO:1904358,positive regulation of telomere maintenance via telomere lengthening,0.06690395800730076,0.5369303620599265,1
2511,Biological Process,GO:2001057,reactive nitrogen species metabolic process,0.06689127353262803,0.5367121811301073,1
2512,Phenotype,HP:0100008,Schwannoma,0.06686208275192662,0.5362100813711577,1
2513,Biological Process,GO:1902236,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,0.06685625914374327,0.5361099116533625,1
2514,Biological Process,GO:0048638,regulation of developmental growth,0.06685406150098949,0.5360721108179476,1
2515,Biological Process,GO:0043462,regulation of ATP-dependent activity,0.06683527914215337,0.53574904245124,1
2516,Biological Process,GO:0045638,negative regulation of myeloid cell differentiation,0.0668260369007132,0.5355900700946343,1
2517,Phenotype,HP:0004933,Ascending aortic dissection,0.06678958492554776,0.5349630732311033,1
2518,Phenotype,HP:0000610,Abnormal choroid morphology,0.06675066373351135,0.5342936042868014,1
2519,Biological Process,GO:0051489,regulation of filopodium assembly,0.06671855661484372,0.5337413416834648,1
2520,Biological Process,GO:0034114,regulation of heterotypic cell-cell adhesion,0.06668902271727462,0.5332333400989243,1
2521,Phenotype,HP:0001958,Nonketotic hypoglycemia,0.06666402753845535,0.5328034073270526,1
2522,Biological Process,GO:0050855,regulation of B cell receptor signaling pathway,0.06664315713562896,0.5324444232924869,1
2523,Biological Process,GO:0006979,response to oxidative stress,0.06660722330077784,0.5318263387677378,1
2524,Biological Process,GO:0019081,viral translation,0.0666006804944036,0.5317137983894257,1
2525,Phenotype,HP:0020071,Viremia,0.06656537163086229,0.5311064637636675,1
2525,Phenotype,HP:0032248,Persistent viremia,0.06656537163086229,0.5311064637636675,1
2527,Disease,MONDO:0004689,inborn metal metabolism disorder,0.06654693553595137,0.5307893513539162,1
2528,Phenotype,HP:0000603,Central scotoma,0.06652509898734249,0.5304137490051828,1
2529,Phenotype,HP:0011565,Common atrium,0.06650352662548165,0.5300426908344165,1
2530,Biological Process,GO:0062012,regulation of small molecule metabolic process,0.0664934054576235,0.5298686003914836,1
2531,Biological Process,GO:0008217,regulation of blood pressure,0.06648120816630132,0.5296587993212296,1
2532,Disease,MONDO:0002525,inherited lipid metabolism disorder,0.06648050933833238,0.5296467790413221,1
2533,Biological Process,GO:0042119,neutrophil activation,0.06644231490958585,0.5289898108819906,1
2534,Phenotype,HP:0002788,Recurrent upper respiratory tract infections,0.06636533520388754,0.5276657116031633,1
2535,Biological Process,GO:0007005,mitochondrion organization,0.06634108512002312,0.527248594932411,1
2536,Biological Process,GO:0010559,regulation of glycoprotein biosynthetic process,0.06628252848750293,0.5262413840813537,1
2537,Phenotype,HP:0030200,Fatiguable weakness of proximal limb muscles,0.0662509965651139,0.5256990152152142,1
2538,Biological Process,GO:0009611,response to wounding,0.06623733113649355,0.5254639612614878,1
2539,Phenotype,HP:0001646,Abnormal aortic valve morphology,0.066207283636043,0.5249471253848601,1
2540,Phenotype,HP:0010585,Small epiphyses,0.06620410747799998,0.5248924934719935,1
2541,Biological Process,GO:2000059,negative regulation of ubiquitin-dependent protein catabolic process,0.06620290861678246,0.5248718723062054,1
2542,Phenotype,HP:0011979,Elevated urinary dopamine level,0.06619898379458156,0.5248043628996857,1
2543,Biological Process,GO:0060562,epithelial tube morphogenesis,0.06619151238294552,0.5246758499277361,1
2544,Phenotype,HP:0000858,Irregular menstruation,0.06618917149958992,0.5246355852640191,1
2545,Phenotype,HP:0003380,Decreased number of peripheral myelinated nerve fibers,0.06618080566865858,0.5244916877185234,1
2546,Biological Process,GO:0010817,regulation of hormone levels,0.06612702545524907,0.5235666342756096,1
2547,Phenotype,HP:0001644,Dilated cardiomyopathy,0.06610077973706763,0.5231151914414094,1
2548,Phenotype,HP:0009763,Limb pain,0.06608095994402663,0.5227742785549021,1
2549,Biological Process,GO:2000404,regulation of T cell migration,0.06607870797672843,0.522735543303209,1
2550,Phenotype,HP:0020080,Erythrocyte inclusion bodies,0.06607712152107403,0.5227082552697094,1
2551,Biological Process,GO:0044406,adhesion of symbiont to host,0.06607280669058857,0.5226340374757826,1
2552,Phenotype,HP:0034274,Gastrointestinal ulcer,0.06601265908504217,0.5215994608895939,1
2553,Biological Process,GO:0042594,response to starvation,0.06600050894319787,0.5213904708199677,1
2554,Phenotype,HP:0002789,Tachypnea,0.06599493203579687,0.5212945445105495,1
2555,Phenotype,HP:0100803,Abnormality of the periungual region,0.06597082436200186,0.5208798773824198,1
2556,Disease,MONDO:0019701,chondrodysplasia punctata,0.06594272689176717,0.520396583250062,1
2557,Phenotype,HP:0001771,Achilles tendon contracture,0.0659260760211351,0.5201101778189712,1
2558,Phenotype,HP:0100542,Abnormal localization of kidney,0.06590758083840664,0.519792049061653,1
2559,Biological Process,GO:1901989,positive regulation of cell cycle phase transition,0.06590438251702857,0.5197370359255057,1
2560,Phenotype,HP:0002761,Generalized joint hypermobility,0.0658763163025432,0.5192542794116639,1
2561,Disease,MONDO:0024239,congenital anomaly of cardiovascular system,0.06585131981921799,0.5188243242014706,1
2562,Phenotype,HP:0032255,Opportunistic fungal infection,0.06581721906966631,0.5182377698949914,1
2563,Phenotype,HP:0001788,Premature rupture of membranes,0.06573563078327005,0.5168344001341167,1
2564,Biological Process,GO:2001257,regulation of cation channel activity,0.06571154169315285,0.5164200526569156,1
2565,Biological Process,GO:0060326,cell chemotaxis,0.06570526831348122,0.5163121465870799,1
2566,Phenotype,HP:0000629,Periorbital fullness,0.06561603743208666,0.5147773193929269,1
2567,Phenotype,HP:0001396,Cholestasis,0.06561513291364929,0.5147617611077951,1
2568,Phenotype,HP:0011748,Adrenocorticotropic hormone deficiency,0.06554777814239399,0.5136032167455415,1
2569,Phenotype,HP:0004840,Hypochromic microcytic anemia,0.06554478260398566,0.5135516916038152,1
2570,Phenotype,HP:0100705,Abnormal glial cell morphology,0.06553733671520778,0.5134236176410534,1
2571,Phenotype,HP:0007588,Reticular hyperpigmentation,0.06552812782483985,0.5132652189438336,1
2572,Phenotype,HP:0011421,Death in adolescence,0.06552299496191871,0.5131769304783147,1
2573,Phenotype,HP:0030063,Neuroepithelial neoplasm,0.06551651671508907,0.513065500564711,1
2574,Phenotype,HP:5200300,Abnormal movement during sleep,0.06548822353297645,0.5125788400651521,1
2575,Phenotype,HP:0001075,Atrophic scars,0.06546450118910885,0.5121708008537489,1
2576,Phenotype,HP:0001879,Abnormal eosinophil morphology,0.0654601588359548,0.512096109652639,1
2577,Phenotype,HP:0000854,Thyroid adenoma,0.06541237148520551,0.511274137210809,1
2578,Biological Process,GO:0006163,purine nucleotide metabolic process,0.06538663040753923,0.5108313745103676,1
2579,Biological Process,GO:0071715,icosanoid transport,0.06536752901986209,0.5105028186472547,1
2580,Phenotype,HP:0031784,Abnormal ascending aorta morphology,0.0653643450476753,0.5104480523262082,1
2581,Phenotype,HP:0100582,Nasal polyposis,0.06535681469782495,0.510318525579961,1
2582,Phenotype,HP:0003797,Limb-girdle muscle atrophy,0.06535606762957324,0.5103056755368965,1
2583,Phenotype,HP:0000912,Sprengel anomaly,0.06534382643863679,0.5100951193657094,1
2584,Phenotype,HP:0004376,Neuroblastic tumor,0.06529149650277077,0.5091950116072722,1
2584,Phenotype,HP:0003006,Neuroblastoma,0.06529149650277077,0.5091950116072722,1
2586,Biological Process,GO:1902751,positive regulation of cell cycle G2/M phase transition,0.06528894166002752,0.5091510667077279,1
2587,Phenotype,HP:0001827,Genital tract atresia,0.06526796178067984,0.5087901996082482,1
2587,Phenotype,HP:0000148,Vaginal atresia,0.06526796178067984,0.5087901996082482,1
2589,Biological Process,GO:0014032,neural crest cell development,0.06525666643787886,0.5085959126189541,1
2590,Biological Process,GO:0002862,negative regulation of inflammatory response to antigenic stimulus,0.06522744816944992,0.5080933400538293,1
2591,Biological Process,GO:0031667,response to nutrient levels,0.06522064247315174,0.5079762778037389,1
2592,Phenotype,HP:0010927,Abnormal blood inorganic cation concentration,0.06521502543271984,0.5078796611809869,1
2593,Biological Process,GO:0031345,negative regulation of cell projection organization,0.06520794082183778,0.5077578014249043,1
2594,Biological Process,GO:0034394,protein localization to cell surface,0.06517185305012274,0.5071370690894283,1
2595,Biological Process,GO:1903052,positive regulation of proteolysis involved in protein catabolic process,0.0651707564815387,0.5071182074211724,1
2596,Phenotype,HP:0009486,Radial deviation of the hand,0.06516858237664491,0.5070808114517303,1
2597,Biological Process,GO:0043537,negative regulation of blood vessel endothelial cell migration,0.06515682411837598,0.506878562025691,1
2598,Phenotype,HP:0010310,Chylothorax,0.06515615342964598,0.5068670257583637,1
2599,Biological Process,GO:0048666,neuron development,0.06508921139260926,0.5057155806838538,1
2600,Phenotype,HP:0012222,Arachnoid hemangiomatosis,0.06508779358100292,0.5056911934338839,1
2601,Phenotype,HP:0003383,Onion bulb formation,0.06503212621715249,0.5047336798183156,1
2602,Biological Process,GO:0009416,response to light stimulus,0.06496725504749146,0.5036178549631066,1
2603,Biological Process,GO:0051403,stress-activated MAPK cascade,0.06495910916908465,0.5034777407391561,1
2604,Phenotype,HP:0010852,EEG with photoparoxysmal response,0.0649552941626722,0.5034121202331588,1
2605,Biological Process,GO:0051058,negative regulation of small GTPase mediated signal transduction,0.06492098818158032,0.5028220358153092,1
2606,Phenotype,HP:0005376,Recurrent Haemophilus influenzae infections,0.06490043322573669,0.5024684776669376,1
2607,Biological Process,GO:0022604,regulation of cell morphogenesis,0.06489877809434486,0.502440008367628,1
2608,Phenotype,HP:0002999,Patellar dislocation,0.06488602549371059,0.5022206556284895,1
2609,Biological Process,GO:1901016,regulation of potassium ion transmembrane transporter activity,0.0648822976448874,0.5021565342877596,1
2610,Biological Process,GO:2000116,regulation of cysteine-type endopeptidase activity,0.06485604775528164,0.5017050197024416,1
2611,Biological Process,GO:0046823,negative regulation of nucleocytoplasmic transport,0.06485441912150303,0.501677006178719,1
2612,Phenotype,HP:0033020,Female reproductive system neoplasm,0.06481726984750136,0.5010380153373233,1
2613,Biological Process,GO:1902430,negative regulation of amyloid-beta formation,0.0648122452677502,0.5009515894103265,1
2614,Biological Process,GO:1900182,positive regulation of protein localization to nucleus,0.06478000959276642,0.5003971155576228,1
2615,Phenotype,HP:0001900,Increased circulating hemoglobin concentration,0.06474294217025833,0.49975953261331674,1
2616,Biological Process,GO:2000679,positive regulation of transcription regulatory region DNA binding,0.06472027486728427,0.4993696407678147,1
2617,Biological Process,GO:0090100,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,0.06467179036841209,0.498535676940484,1
2618,Biological Process,GO:0045933,positive regulation of muscle contraction,0.06464334027231045,0.4980463174217768,1
2619,Phenotype,HP:0010944,Abnormal renal pelvis morphology,0.06464333172932146,0.49804617047700156,1
2620,Phenotype,HP:0010894,Abnormal circulating serine family amino acid concentration,0.06463285664478535,0.49786599244495927,1
2621,Phenotype,HP:0012236,Elevated sweat chloride,0.06461199061676648,0.4975070836598301,1
2622,Phenotype,HP:0030629,Perifoveal ring of hyperautofluorescence,0.0645882208505385,0.4970982287540488,1
2623,Biological Process,GO:0002673,regulation of acute inflammatory response,0.0645312243795817,0.49611785366161376,1
2624,Biological Process,GO:0035278,miRNA-mediated gene silencing by inhibition of translation,0.06451030091068177,0.4957579568572595,1
2625,Biological Process,GO:0043547,positive regulation of GTPase activity,0.06450536492186199,0.4956730547499145,1
2626,Phenotype,HP:0010459,True hermaphroditism,0.06448282917491177,0.4952854257506358,1
2627,Phenotype,HP:0031650,Abnormal atrioventricular valve physiology,0.06442614538482982,0.49431042896560196,1
2628,Biological Process,GO:0048259,regulation of receptor-mediated endocytosis,0.06441533817790601,0.49412453821992885,1
2629,Biological Process,GO:0048010,vascular endothelial growth factor receptor signaling pathway,0.06439781483577234,0.49382312573112597,1
2630,Biological Process,GO:0006513,protein monoubiquitination,0.06439439720892515,0.4937643404031929,1
2631,Phenotype,HP:0003049,Ulnar deviation of the wrist,0.06438490680271647,0.4936010994567292,1
2632,Phenotype,HP:0003613,Antiphospholipid antibody positivity,0.0643533259265231,0.4930578885544135,1
2633,Phenotype,HP:0000952,Jaundice,0.06428859093398542,0.4919444060312412,1
2634,Disease,MONDO:0000904,complex cortical dysplasia with other brain malformations,0.06427294362487013,0.4916752624884437,1
2635,Phenotype,HP:0011496,Corneal neovascularization,0.06423236683600297,0.4909773162389908,1
2636,Phenotype,HP:0012852,Hepatic bridging fibrosis,0.06423079252312658,0.4909502370688982,1
2637,Biological Process,GO:0048639,positive regulation of developmental growth,0.06421809941632384,0.4907319076610221,1
2638,Biological Process,GO:1990000,amyloid fibril formation,0.06420894979414693,0.4905745284139065,1
2639,Phenotype,HP:0003396,Syringomyelia,0.06419178875857501,0.49027934782548277,1
2640,Phenotype,HP:0012393,Allergy,0.06419027621413964,0.4902533311113645,1
2641,Phenotype,HP:0001262,Excessive daytime somnolence,0.06415183200274632,0.4895920665336526,1
2642,Biological Process,GO:0046620,regulation of organ growth,0.06410769768969515,0.4888329286342222,1
2643,Phenotype,HP:0005345,Abnormal vena cava morphology,0.06410043082289751,0.4887079339619407,1
2644,Biological Process,GO:0032368,regulation of lipid transport,0.06407518474572171,0.48827368558078027,1
2645,Biological Process,GO:0019677,NAD catabolic process,0.0640654026832389,0.4881054279632506,1
2646,Phenotype,HP:0030670,Hamartoma of the orbital region,0.06405644316024728,0.4879513185414981,1
2646,Phenotype,HP:0010568,Hamartoma of the eye,0.06405644316024728,0.4879513185414981,1
2648,Biological Process,GO:1990776,response to angiotensin,0.06402822846272616,0.48746600802619866,1
2649,Biological Process,GO:0034504,protein localization to nucleus,0.06399456619299326,0.486886995847954,1
2650,Biological Process,GO:0015909,long-chain fatty acid transport,0.06398265598359099,0.4866821327670007,1
2651,Biological Process,GO:0009156,ribonucleoside monophosphate biosynthetic process,0.06389738007574974,0.4852153336015629,1
2652,Phenotype,HP:0009916,Anisocoria,0.0638951763357336,0.48517742788940643,1
2653,Phenotype,HP:0100814,Blue nevus,0.06383923287845805,0.48421516529354813,1
2654,Phenotype,HP:0011107,Recurrent aphthous stomatitis,0.063832806527235,0.48410462801696663,1
2655,Biological Process,GO:0030858,positive regulation of epithelial cell differentiation,0.06382866129819831,0.4840333274744631,1
2656,Phenotype,HP:0034207,Abnormal fetal gastrointestinal system morphology,0.06382418587674799,0.48395634741509463,1
2657,Phenotype,HP:0007485,Absence of subcutaneous fat,0.06382192610055404,0.4839174778454909,1
2658,Biological Process,GO:1905314,semi-lunar valve development,0.06380106712909783,0.4835586904376709,1
2659,Biological Process,GO:0051654,establishment of mitochondrion localization,0.0637877644531567,0.48332987605782446,1
2660,Phenotype,HP:0030796,Increased C-peptide level,0.06377211721972109,0.4830607338167651,1
2661,Biological Process,GO:0060070,canonical Wnt signaling pathway,0.06373976371454193,0.4825042332107073,1
2662,Phenotype,HP:0003765,Psoriasiform dermatitis,0.06367142877998577,0.4813288294241675,1
2663,Phenotype,HP:0002308,Chiari malformation,0.06365985441887034,0.48112974314465,1
2664,Phenotype,HP:0005420,Recurrent gram-negative bacterial infections,0.06364499322509187,0.48087412127930146,1
2665,Phenotype,HP:0006892,Frontotemporal cerebral atrophy,0.06363026523403759,0.480620790584456,1
2666,Phenotype,HP:0001153,Septate vagina,0.06361481393008006,0.4803550184534572,1
2667,Biological Process,GO:0045879,negative regulation of smoothened signaling pathway,0.0636110557321885,0.4802903750896932,1
2668,Biological Process,GO:0032878,regulation of establishment or maintenance of cell polarity,0.06359903413534707,0.4800835960748385,1
2669,Biological Process,GO:0002027,regulation of heart rate,0.063556764666995,0.4793565346752961,1
2670,Biological Process,GO:0009887,animal organ morphogenesis,0.06350837782250862,0.478524250564725,1
2671,Biological Process,GO:0018904,ether metabolic process,0.06344351377340085,0.4774085481875035,1
2672,Biological Process,GO:0070373,negative regulation of ERK1 and ERK2 cascade,0.0633974304349827,0.4766158858278347,1
2673,Biological Process,GO:0043588,skin development,0.0633838805911956,0.47638282000582405,1
2674,Biological Process,GO:1902275,regulation of chromatin organization,0.06338232319914061,0.47635603188448544,1
2675,Phenotype,HP:0004418,Thrombophlebitis,0.06334794505209351,0.47576470616688815,1
2676,Phenotype,HP:0001435,Abnormality of the shoulder girdle musculature,0.06332091866875489,0.47529983540175136,1
2677,Phenotype,HP:0200101,Decreased/absent ankle reflexes,0.06331071375030173,0.4751243043959915,1
2678,Biological Process,GO:0030336,negative regulation of cell migration,0.06329020934887464,0.47477161581533106,1
2679,Biological Process,GO:0046883,regulation of hormone secretion,0.06328833276299539,0.4747393373597716,1
2680,Biological Process,GO:0042274,ribosomal small subunit biogenesis,0.06320759061624104,0.47335052173208664,1
2681,Phenotype,HP:0002898,Embryonal neoplasm,0.06317376044619061,0.47276862156294425,1
2682,Phenotype,HP:0003738,Exercise-induced myalgia,0.06316485850336317,0.47261550255617435,1
2683,Phenotype,HP:0032153,Joint subluxation,0.06316440133875134,0.4726076390377659,1
2684,Biological Process,GO:0046718,symbiont entry into host cell,0.06315177839316521,0.47239051644687463,1
2685,Phenotype,HP:0000262,Turricephaly,0.06314434311923778,0.47226262506620625,1
2686,Biological Process,GO:0043407,negative regulation of MAP kinase activity,0.06313423815899732,0.47208881340447556,1
2687,Phenotype,HP:0030167,Antimitochondrial antibody positivity,0.06308964171084075,0.47132172649102594,1
2688,Biological Process,GO:0007369,gastrulation,0.06305162348516002,0.47066778913507623,1
2689,Biological Process,GO:0090279,regulation of calcium ion import,0.06303975023214903,0.4704635617272604,1
2690,Biological Process,GO:0051865,protein autoubiquitination,0.06302814465061579,0.4702639384369512,1
2691,Biological Process,GO:0043030,regulation of macrophage activation,0.06296850230976814,0.4692380527208711,1
2692,Biological Process,GO:1902916,positive regulation of protein polyubiquitination,0.06294175512252487,0.46877798430390066,1
2693,Biological Process,GO:0015844,monoamine transport,0.06294065916143554,0.46875913308493544,1
2694,Biological Process,GO:0070588,calcium ion transmembrane transport,0.06293352408730402,0.4686364053292727,1
2695,Phenotype,HP:0031020,Bone marrow hypercellularity,0.0629018025349668,0.4680907747089427,1
2696,Phenotype,HP:0000711,Restlessness,0.06289243435180214,0.46792963607558835,1
2697,Biological Process,GO:1902548,negative regulation of cellular response to vascular endothelial growth factor stimulus,0.06288016148555708,0.4677185350692022,1
2698,Biological Process,GO:0006457,protein folding,0.06287840381748944,0.4676883020746788,1
2699,Biological Process,GO:0045091,regulation of single stranded viral RNA replication via double stranded DNA intermediate,0.06287268993409678,0.4675900196921874,1
2700,Disease,MONDO:0004038,dental enamel hypoplasia,0.06284401708668441,0.4670968287110549,1
2700,Disease,MONDO:0019507,amelogenesis imperfecta,0.06284401708668441,0.4670968287110549,1
2702,Biological Process,GO:0030218,erythrocyte differentiation,0.06283265998445986,0.4669014794208922,1
2703,Phenotype,HP:0034241,Prenatal death,0.0628277954048635,0.4668178055970329,1
2704,Biological Process,GO:0090068,positive regulation of cell cycle process,0.06281389594321907,0.4665787261283271,1
2705,Biological Process,GO:2000047,regulation of cell-cell adhesion mediated by cadherin,0.06281386540602041,0.4665782008693338,1
2706,Phenotype,HP:0100614,Myositis,0.06273589896968523,0.46523712920391697,1
2707,Phenotype,HP:0003693,Distal amyotrophy,0.06269144863905296,0.4644725556036425,1
2708,Phenotype,HP:0007325,Generalized dystonia,0.06269121657476318,0.46446856395212915,1
2709,Phenotype,HP:0010622,Neoplasm of the skeletal system,0.06268546905539307,0.4643697030097033,1
2710,Phenotype,HP:0002156,Homocystinuria,0.06267679325078013,0.46422047372223024,1
2711,Phenotype,HP:6000231,Abnormal tissue enzyme concentration or activity,0.06267261381132605,0.46414858473906456,1
2712,Phenotype,HP:0012841,Retinal vascular tortuosity,0.062664641434236,0.46401145484671547,1
2713,Phenotype,HP:0007987,Progressive visual field defects,0.06262835270236788,0.46338726587040996,1
2714,Phenotype,HP:0003388,Easy fatigability,0.06261465394582655,0.4631516386555139,1
2715,Phenotype,HP:0012514,Lower limb pain,0.0626008399992346,0.4629140300994116,1
2716,Biological Process,GO:0002520,immune system development,0.06258376207326943,0.46262027904841424,1
2717,Biological Process,GO:0002274,myeloid leukocyte activation,0.06251846714375842,0.4614971652576777,1
2718,Biological Process,GO:0051781,positive regulation of cell division,0.06251582352939578,0.4614516934305342,1
2719,Biological Process,GO:0032648,regulation of interferon-beta production,0.06247719236428717,0.4607872131315185,1
2720,Phenotype,HP:0010741,Pedal edema,0.06246874959495763,0.4606419921972587,1
2721,Biological Process,GO:0009161,ribonucleoside monophosphate metabolic process,0.06243582848212281,0.460075728383084,1
2722,Phenotype,HP:0001050,Plethora,0.06242219954021633,0.45984130202374873,1
2723,Biological Process,GO:1905330,regulation of morphogenesis of an epithelium,0.06242148341255971,0.4598289841783494,1
2724,Biological Process,GO:0002756,MyD88-independent toll-like receptor signaling pathway,0.06239889721923331,0.4594404874697215,1
2725,Biological Process,GO:0090022,regulation of neutrophil chemotaxis,0.06239888524220971,0.45944028145739446,1
2726,Biological Process,GO:0072522,purine-containing compound biosynthetic process,0.06237256299940619,0.4589875223516393,1
2727,Phenotype,HP:0003141,Increased LDL cholesterol concentration,0.06236659885582441,0.45888493533673946,1
2728,Phenotype,HP:0009891,Underdeveloped supraorbital ridges,0.062365170656866975,0.45886036941780795,1
2729,Biological Process,GO:1900120,regulation of receptor binding,0.0623536692457104,0.45866253792339295,1
2730,Phenotype,HP:0012569,Delayed menarche,0.06233650696168147,0.4583673358607248,1
2731,Phenotype,HP:0030405,Pancreatic endocrine tumor,0.062306859408120085,0.45785737932174464,1
2732,Phenotype,HP:0031273,Shock,0.06230552842772907,0.4578344856232057,1
2733,Biological Process,GO:0043200,response to amino acid,0.062305323021479064,0.45783095250671696,1
2734,Biological Process,GO:1903894,regulation of IRE1-mediated unfolded protein response,0.062302619096785694,0.4577844433040119,1
2735,Biological Process,GO:0009201,ribonucleoside triphosphate biosynthetic process,0.062296002338796064,0.4576706309114759,1
2736,Phenotype,HP:0012230,Rhegmatogenous retinal detachment,0.06224695327345908,0.4568269561864208,1
2737,Phenotype,HP:0000474,Thickened nuchal skin fold,0.06223200922855787,0.45656990922973323,1
2738,Phenotype,HP:0012508,Metamorphopsia,0.062223896584639005,0.4564303666598453,1
2739,Phenotype,HP:5200261,Abnormal affect,0.06222021025459057,0.4563669594681138,1
2740,Phenotype,HP:0001069,Episodic hyperhidrosis,0.06220740181650364,0.45614664628972523,1
2741,Biological Process,GO:0010596,negative regulation of endothelial cell migration,0.06219199990136792,0.4558817236774762,1
2742,Phenotype,HP:0002613,Biliary cirrhosis,0.062176597552194846,0.45561679359951196,1
2743,Biological Process,GO:0141086,negative regulation of inflammasome-mediated signaling pathway,0.062128848839660966,0.45479548575925055,1
2744,Biological Process,GO:1902992,negative regulation of amyloid precursor protein catabolic process,0.06211888022913237,0.4546240193981871,1
2745,Biological Process,GO:0003208,cardiac ventricle morphogenesis,0.062104293375120134,0.4543731163490945,1
2746,Biological Process,GO:0036159,inner dynein arm assembly,0.062096789740769376,0.4542440491262168,1
2747,Biological Process,GO:0060760,positive regulation of response to cytokine stimulus,0.06209563592974299,0.45422420285200615,1
2748,Phenotype,HP:0002298,Absent hair,0.06209309155012188,0.45418043792473334,1
2749,Biological Process,GO:0014074,response to purine-containing compound,0.0620901389938735,0.45412965210314943,1
2750,Disease,MONDO:0100118,hereditary skin disorder,0.062071877941590414,0.453815550536518,1
2751,Biological Process,GO:0001837,epithelial to mesenchymal transition,0.062056847896575396,0.45355702432386763,1
2752,Phenotype,HP:0008365,Abnormal talus morphology,0.062055835238108314,0.4535396059623164,1
2753,Phenotype,HP:0010646,Cervical spine instability,0.06204317686152283,0.4533218739359866,1
2754,Biological Process,GO:0009179,purine ribonucleoside diphosphate metabolic process,0.06203003475721214,0.45309582148901756,1
2755,Biological Process,GO:0097035,regulation of membrane lipid distribution,0.06202669893306223,0.4530384432188473,1
2756,Phenotype,HP:0011370,Recurrent cutaneous fungal infections,0.06202005187687176,0.45292410967823055,1
2757,Biological Process,GO:0032434,regulation of proteasomal ubiquitin-dependent protein catabolic process,0.061955395888049325,0.4518119860685721,1
2758,Phenotype,HP:0002164,Nail dysplasia,0.06193355553998936,0.4514363183668941,1
2759,Biological Process,GO:0032070,regulation of deoxyribonuclease activity,0.061932614797737484,0.4514201370094055,1
2760,Biological Process,GO:0008016,regulation of heart contraction,0.061885661200606235,0.45061250565337657,1
2761,Biological Process,GO:0072091,regulation of stem cell proliferation,0.061883982348360234,0.4505836283404793,1
2762,Phenotype,HP:0100684,Salivary gland neoplasm,0.06183487326906911,0.44973892133772614,1
2763,Disease,MONDO:0002129,bone cancer,0.06181204292358722,0.4493462250587039,1
2763,Disease,MONDO:0000637,musculoskeletal system cancer,0.06181204292358722,0.4493462250587039,1
2765,Biological Process,GO:1903053,regulation of extracellular matrix organization,0.06180221185684065,0.4491771245370645,1
2766,Phenotype,HP:0025132,Abnormal circulating estrogen level,0.06179147318104061,0.44899241256975564,1
2767,Phenotype,HP:0005301,Persistent left superior vena cava,0.06178441111163391,0.44887094054120447,1
2768,Phenotype,HP:0001269,Hemiparesis,0.06176987926317057,0.4486209836220946,1
2769,Phenotype,HP:0001875,Neutropenia,0.06170009641898788,0.4474206748807371,1
2770,Phenotype,HP:0001123,Visual field defect,0.06169853993078411,0.447393902306207,1
2771,Biological Process,GO:0070536,protein K63-linked deubiquitination,0.061682019335910776,0.4471097376999755,1
2772,Phenotype,HP:0000892,Bifid ribs,0.061663215075910216,0.4467862926194863,1
2773,Phenotype,HP:0000096,Glomerular sclerosis,0.06166174172145589,0.4467609499976519,1
2774,Biological Process,GO:0044088,regulation of vacuole organization,0.06161968072666657,0.44603747447430353,1
2775,Biological Process,GO:0044090,positive regulation of vacuole organization,0.06160304393158489,0.4457513111515184,1
2776,Phenotype,HP:0002625,Deep venous thrombosis,0.061479224793891785,0.44362154422870137,1
2777,Biological Process,GO:0036295,cellular response to increased oxygen levels,0.06146610265136243,0.4433958351369067,1
2777,Biological Process,GO:0036296,response to increased oxygen levels,0.06146610265136243,0.4433958351369067,1
2779,Biological Process,GO:1903533,regulation of protein targeting,0.06144695833663705,0.443066540901607,1
2780,Phenotype,HP:0009725,Bladder neoplasm,0.06143031741892602,0.4427803066670082,1
2781,Phenotype,HP:0031878,Acromicria,0.06141857762928049,0.4425783749128892,1
2782,Biological Process,GO:0045214,sarcomere organization,0.06138420532145761,0.4419871496336153,1
2783,Phenotype,HP:0100658,Cellulitis,0.06138079155534448,0.4419284307127326,1
2784,Phenotype,HP:0030067,Peripheral primitive neuroectodermal neoplasm,0.06137099552319025,0.44175993280808196,1
2785,Phenotype,HP:0008067,Abnormally lax or hyperextensible skin,0.061360529165590094,0.44157990488481824,1
2786,Phenotype,HP:0003247,Overgrowth of external genitalia,0.06132860987515831,0.44103087304508853,1
2787,Phenotype,HP:0430050,Anti-thyroid antibody positivity,0.061312659695860416,0.4407565199449574,1
2788,Biological Process,GO:0034249,negative regulation of amide metabolic process,0.061301511634890504,0.44056476629564584,1
2789,Phenotype,HP:0004736,Crossed fused renal ectopia,0.061298830552761974,0.4405186499994005,1
2790,Biological Process,GO:0000398,"mRNA splicing, via spliceosome",0.061294426342528574,0.4404428948176815,1
2790,Biological Process,GO:0000377,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile",0.061294426342528574,0.4404428948176815,1
2792,Biological Process,GO:0035094,response to nicotine,0.0612930448173542,0.4404191317171283,1
2793,Phenotype,HP:0005547,Myeloproliferative disorder,0.06123313961530763,0.43938872462335826,1
2794,Biological Process,GO:0090066,regulation of anatomical structure size,0.061225924011309885,0.43926461170342634,1
2795,Phenotype,HP:0009591,Abnormality of the vestibulocochlear nerve,0.061199391155465244,0.4388082299211057,1
2796,Biological Process,GO:2001259,positive regulation of cation channel activity,0.061173017902018456,0.43835459340025335,1
2797,Biological Process,GO:0045931,positive regulation of mitotic cell cycle,0.06116396680437808,0.43819890883703627,1
2798,Phenotype,HP:0025133,Abnormal serum estradiol,0.061146675576244536,0.4379014888547959,1
2799,Phenotype,HP:0007460,Autoamputation of digits,0.061097491632379874,0.43705549413436523,1
2800,Phenotype,HP:0100012,Neoplasm of the eye,0.06103871213384138,0.43604444984784024,1
2801,Phenotype,HP:0002654,Multiple epiphyseal dysplasia,0.06100449153059784,0.43545583398259674,1
2802,Disease,MONDO:0019695,acromelic dysplasia,0.06096102614383625,0.4347082020354116,1
2803,Disease,MONDO:0005308,ciliopathy,0.060956720824514865,0.4346341478394797,1
2804,Phenotype,HP:0025580,Abnormal right atrium morphology,0.060937534387756065,0.4343041290787539,1
2804,Phenotype,HP:0030718,Right atrial enlargement,0.060937534387756065,0.4343041290787539,1
2806,Phenotype,HP:0002669,Osteosarcoma,0.0609347466304998,0.43425617790332294,1
2807,Biological Process,GO:0034440,lipid oxidation,0.060927840759760876,0.4341373925899454,1
2808,Disease,MONDO:0004868,biliary tract disorder,0.060911511435878474,0.43385651796487,1
2809,Biological Process,GO:0039531,regulation of cytoplasmic pattern recognition receptor signaling pathway,0.060860870960899316,0.43298546999461457,1
2810,Phenotype,HP:0007447,Diffuse palmoplantar hyperkeratosis,0.06082580109108848,0.4323822462111011,1
2811,Phenotype,HP:0005109,Abnormality of the Achilles tendon,0.060820990693249866,0.4322995043474995,1
2812,Biological Process,GO:0006026,aminoglycan catabolic process,0.06078041917626387,0.431601648777713,1
2813,Phenotype,HP:0000738,Hallucinations,0.06076303797378013,0.43130268118014825,1
2814,Biological Process,GO:0032206,positive regulation of telomere maintenance,0.060754812642468625,0.43116120031634286,1
2815,Phenotype,HP:0032012,Heterotropia,0.06074123534286491,0.43092766223704493,1
2816,Biological Process,GO:0032469,endoplasmic reticulum calcium ion homeostasis,0.0607369041306669,0.4308531626673752,1
2817,Biological Process,GO:0090314,positive regulation of protein targeting to membrane,0.06072982803607285,0.43073144939679436,1
2818,Biological Process,GO:0006997,nucleus organization,0.06071652726689125,0.43050266781440916,1
2819,Biological Process,GO:0045927,positive regulation of growth,0.06070530030120891,0.43030955695449413,1
2820,Phenotype,HP:0100833,Neoplasm of the small intestine,0.06068402333396361,0.4299435797566136,1
2821,Biological Process,GO:0010950,positive regulation of endopeptidase activity,0.060673918610578026,0.42976977216893547,1
2822,Biological Process,GO:0090313,regulation of protein targeting to membrane,0.06053886880865833,0.42744683076891976,1
2823,Biological Process,GO:0006623,protein targeting to vacuole,0.06053233725593754,0.427334483960514,1
2823,Biological Process,GO:0072666,establishment of protein localization to vacuole,0.06053233725593754,0.427334483960514,1
2825,Biological Process,GO:0034976,response to endoplasmic reticulum stress,0.060529123413149644,0.4272792038463707,1
2826,Biological Process,GO:0044458,motile cilium assembly,0.06052456106486248,0.42720072859082137,1
2827,Phenotype,HP:0001967,Diffuse mesangial sclerosis,0.060498244838627535,0.42674807297382394,1
2828,Phenotype,HP:0100646,Thyroiditis,0.06049731595655883,0.42673209561893366,1
2829,Biological Process,GO:0005975,carbohydrate metabolic process,0.06048149039108175,0.4264598859547742,1
2830,Biological Process,GO:0045581,negative regulation of T cell differentiation,0.06047949855098178,0.42642562505424225,1
2831,Disease,MONDO:0037858,inherited fatty acid metabolism disorder,0.060477907328211455,0.42639825502335515,1
2832,Biological Process,GO:1905952,regulation of lipid localization,0.06044612178229025,0.4258515236731947,1
2833,Biological Process,GO:0051988,regulation of attachment of spindle microtubules to kinetochore,0.060419428187269975,0.42539237707611394,1
2834,Phenotype,HP:0001421,Abnormality of the musculature of the hand,0.060405795626552905,0.42515788847096414,1
2835,Disease,MONDO:0002816,adrenal cortex disorder,0.060388868140168084,0.42486672507522005,1
2836,Phenotype,HP:0025487,Abnormal bladder morphology,0.060369506838617304,0.4245336985302627,1
2837,Phenotype,HP:0000843,Hyperparathyroidism,0.06035469279262262,0.4242788876364026,1
2838,Phenotype,HP:0025074,Abnormal QRS complex,0.06034515756262937,0.42411487569269635,1
2839,Biological Process,GO:0019320,hexose catabolic process,0.06032766363897579,0.42381396922022496,1
2840,Biological Process,GO:0030199,collagen fibril organization,0.060322844129157116,0.4237310706248443,1
2841,Phenotype,HP:0000965,Cutis marmorata,0.06030725622631561,0.4234629489072612,1
2842,Biological Process,GO:0050869,negative regulation of B cell activation,0.06028794611965271,0.4231308029465242,1
2843,Disease,MONDO:0018921,Meckel syndrome,0.06023592732936989,0.4222360470875074,1
2844,Biological Process,GO:0003254,regulation of membrane depolarization,0.06017596384244939,0.42120463745730474,1
2845,Biological Process,GO:0055010,ventricular cardiac muscle tissue morphogenesis,0.06012383327698079,0.4203079589949013,1
2846,Biological Process,GO:2000134,negative regulation of G1/S transition of mitotic cell cycle,0.060116780290593086,0.4201866431999809,1
2847,Phenotype,HP:0040189,Scaling skin,0.06011392873325361,0.42013759462305417,1
2848,Biological Process,GO:0070266,necroptotic process,0.06010727194506238,0.42002309368591295,1
2849,Phenotype,HP:0004437,Cranial hyperostosis,0.06009539771832617,0.419818849529412,1
2850,Phenotype,HP:0010946,Dilatation of the renal pelvis,0.06007775281966521,0.41951534619200614,1
2851,Biological Process,GO:0043267,negative regulation of potassium ion transport,0.0600681951862041,0.419350948894584,1
2852,Disease,MONDO:0009332,congenital hematological disorder,0.060045738010001015,0.41896467136149584,1
2853,Phenotype,HP:0004315,Decreased circulating IgG level,0.06003690884109336,0.41881280411184585,1
2854,Biological Process,GO:0035723,interleukin-15-mediated signaling pathway,0.06001139275962453,0.41837391148729114,1
2854,Biological Process,GO:0071350,cellular response to interleukin-15,0.06001139275962453,0.41837391148729114,1
2854,Biological Process,GO:0070672,response to interleukin-15,0.06001139275962453,0.41837391148729114,1
2857,Biological Process,GO:1902414,protein localization to cell junction,0.059991501954399284,0.41803177714662143,1
2858,Phenotype,HP:0009139,Osteolysis involving bones of the lower limbs,0.05998542952722219,0.4179273275858835,1
2859,Phenotype,HP:0006361,Irregular femoral epiphysis,0.059949442430770494,0.41730832692815795,1
2860,Phenotype,HP:0001695,Cardiac arrest,0.059939019279233285,0.41712904217630903,1
2861,Phenotype,HP:0032260,Opportunistic bacterial infection,0.0599262021512359,0.41690857952600363,1
2862,Biological Process,GO:0009799,specification of symmetry,0.05991760457700368,0.4167606958502053,1
2862,Biological Process,GO:0009855,determination of bilateral symmetry,0.05991760457700368,0.4167606958502053,1
2864,Phenotype,HP:0001739,Abnormal nasopharynx morphology,0.059910105316800966,0.41663170386542075,1
2865,Disease,MONDO:0017731,glycoproteinosis,0.05988456257595154,0.41619235268277865,1
2866,Phenotype,HP:0007605,Excessive wrinkling of palmar skin,0.05986595877122236,0.4158723555588368,1
2867,Biological Process,GO:0042407,cristae formation,0.059865925734838066,0.41587178731228114,1
2868,Biological Process,GO:0002444,myeloid leukocyte mediated immunity,0.05984088919919539,0.4154411431770759,1
2869,Biological Process,GO:0070670,response to interleukin-4,0.05979720716562986,0.41468978476881574,1
2869,Biological Process,GO:0071353,cellular response to interleukin-4,0.05979720716562986,0.41468978476881574,1
2871,Disease,MONDO:0020058,gonosome anomaly,0.059756975339927854,0.4139977721024293,1
2872,Biological Process,GO:0042475,odontogenesis of dentin-containing tooth,0.059740366850700055,0.41371209565810607,1
2873,Phenotype,HP:0000085,Horseshoe kidney,0.059728868513636235,0.413514317040017,1
2874,Biological Process,GO:0051341,regulation of oxidoreductase activity,0.05972103505591031,0.4133795766479678,1
2875,Biological Process,GO:0045669,positive regulation of osteoblast differentiation,0.059712759498330215,0.4132372318608022,1
2876,Phenotype,HP:0012605,Hypernatriuria,0.05970092090241286,0.4130336005767605,1
2877,Phenotype,HP:0032558,Absent sperm flagella,0.05968981685956343,0.4128426040667632,1
2878,Biological Process,GO:0010971,positive regulation of G2/M transition of mitotic cell cycle,0.05966421028957025,0.4124021549827659,1
2879,Phenotype,HP:0008499,High hypermetropia,0.059610502195571624,0.41147834203900807,1
2880,Biological Process,GO:0001525,angiogenesis,0.05960848780392325,0.4114436932376819,1
2881,Phenotype,HP:0045081,Abnormality of body mass index,0.059606485013941723,0.41140924399231094,1
2882,Phenotype,HP:0100315,Lewy bodies,0.059599066019694336,0.41128163263236256,1
2883,Biological Process,GO:0036315,cellular response to sterol,0.05956943044149399,0.41077188207711235,1
2884,Phenotype,HP:0011407,Proportionate tall stature,0.05956258169141504,0.4106540792749564,1
2885,Phenotype,HP:0000454,Flared nostrils,0.05955744682278541,0.4105657563099919,1
2886,Phenotype,HP:0008404,Nail dystrophy,0.0595327242897018,0.4101405132159863,1
2887,Phenotype,HP:0001194,Abnormalities of placenta or umbilical cord,0.05948463798190584,0.40931339852521803,1
2888,Phenotype,HP:0200106,Absent/shortened dynein arms,0.0594626338844324,0.40893491423079886,1
2889,Disease,MONDO:0021179,proteostasis deficiencies,0.0594606952380925,0.408901568296344,1
2890,Phenotype,HP:0001707,Abnormal right ventricle morphology,0.059458496677276096,0.4088637516696753,1
2891,Biological Process,GO:1904705,regulation of vascular associated smooth muscle cell proliferation,0.05942919369149724,0.4083597219129323,1
2892,Phenotype,HP:0002944,Thoracolumbar scoliosis,0.05942119533517187,0.40822214516142163,1
2893,Phenotype,HP:0012253,Abnormal respiratory epithelium morphology,0.0593899607123245,0.4076848900340932,1
2893,Phenotype,HP:0005938,Abnormal respiratory motile cilium morphology,0.0593899607123245,0.4076848900340932,1
2895,Phenotype,HP:0009134,Osteolysis involving bones of the feet,0.05938934646377736,0.40767432457335384,1
2896,Phenotype,HP:0001231,Abnormal fingernail morphology,0.05930779329253666,0.406271558815206,1
2897,Biological Process,GO:0030705,cytoskeleton-dependent intracellular transport,0.059294624126348894,0.4060450408869573,1
2898,Phenotype,HP:0001386,Joint swelling,0.05928755557963583,0.40592345744466923,1
2899,Biological Process,GO:0042773,ATP synthesis coupled electron transport,0.0592815142162485,0.40581954220062233,1
2899,Biological Process,GO:0042775,mitochondrial ATP synthesis coupled electron transport,0.0592815142162485,0.40581954220062233,1
2901,Biological Process,GO:0061178,regulation of insulin secretion involved in cellular response to glucose stimulus,0.05926653455726194,0.40556188265930226,1
2902,Biological Process,GO:0060260,regulation of transcription initiation by RNA polymerase II,0.05924791518892669,0.4052416178315626,1
2903,Biological Process,GO:0051703,biological process involved in intraspecies interaction between organisms,0.05919160412894431,0.40427303223830396,1
2903,Biological Process,GO:0035176,social behavior,0.05919160412894431,0.40427303223830396,1
2905,Biological Process,GO:0051453,regulation of intracellular pH,0.05915867895118321,0.40370669850484453,1
2906,Phenotype,HP:0003345,Elevated urinary norepinephrine level,0.059132125019614956,0.4032499542068429,1
2907,Phenotype,HP:0002938,Lumbar hyperlordosis,0.05912371334937139,0.4031052681963911,1
2908,Biological Process,GO:0043524,negative regulation of neuron apoptotic process,0.05907274298889087,0.40222854598835467,1
2909,Phenotype,HP:0007440,Generalized hyperpigmentation,0.05902556734112796,0.40141709522202046,1
2910,Biological Process,GO:0060323,head morphogenesis,0.05901736212374342,0.4012759603303898,1
2910,Biological Process,GO:0010171,body morphogenesis,0.05901736212374342,0.4012759603303898,1
2912,Phenotype,HP:0030794,Abnormal circulating C-peptide concentration,0.059006960967210254,0.40109705390642253,1
2913,Biological Process,GO:0050770,regulation of axonogenesis,0.059002706134487215,0.40102386811168617,1
2914,Phenotype,HP:0011360,Acquired abnormal hair pattern,0.05899135874564598,0.4008286858978163,1
2915,Biological Process,GO:0051491,positive regulation of filopodium assembly,0.058990564937523304,0.40081503189961987,1
2916,Phenotype,HP:0100686,Enthesitis,0.05895511897573136,0.4002053390978574,1
2917,Biological Process,GO:1901021,positive regulation of calcium ion transmembrane transporter activity,0.058952759520841,0.4001647549920803,1
2918,Biological Process,GO:0031647,regulation of protein stability,0.05892741225963516,0.3997287661820628,1
2919,Phenotype,HP:0008828,Delayed proximal femoral epiphyseal ossification,0.05892570045178491,0.39969932201207753,1
2920,Phenotype,HP:0001681,Angina pectoris,0.058915260640186484,0.3995197506967136,1
2921,Biological Process,GO:1902882,regulation of response to oxidative stress,0.058876674784180794,0.39885604974272065,1
2922,Biological Process,GO:0034368,protein-lipid complex remodeling,0.05887609250034187,0.39884603409503533,1
2922,Biological Process,GO:0034369,plasma lipoprotein particle remodeling,0.05887609250034187,0.39884603409503533,1
2924,Biological Process,GO:0043117,positive regulation of vascular permeability,0.05886324207463578,0.39862499870323037,1
2925,Disease,MONDO:0021003,polydactyly,0.058822894407718374,0.39793099349519445,1
2926,Phenotype,HP:0001880,Eosinophilia,0.058773471266869604,0.397080884436429,1
2927,Phenotype,HP:0008438,Vertebral arch anomaly,0.058763573855895035,0.3969106427524059,1
2928,Phenotype,HP:0011459,Esophageal carcinoma,0.05875722884080048,0.3968015045083111,1
2929,Phenotype,HP:0030448,Soft tissue sarcoma,0.05872846766182194,0.396306794168771,1
2930,Biological Process,GO:0046427,positive regulation of receptor signaling pathway via JAK-STAT,0.0587204891611075,0.39616955894623707,1
2931,Biological Process,GO:0010827,regulation of glucose transmembrane transport,0.05871345892687985,0.396048634502757,1
2932,Phenotype,HP:0000581,Blepharophimosis,0.05870319644523536,0.3958721133739585,1
2933,Phenotype,HP:0001973,Autoimmune thrombocytopenia,0.05869427182853171,0.3957186043622791,1
2934,Biological Process,GO:0035384,thioester biosynthetic process,0.05864368053902247,0.39484840241299324,1
2934,Biological Process,GO:0071616,acyl-CoA biosynthetic process,0.05864368053902247,0.39484840241299324,1
2936,Phenotype,HP:0003416,Spinal canal stenosis,0.0586112531588312,0.394290631110336,1
2937,Phenotype,HP:0000444,Convex nasal ridge,0.058606968730777864,0.3942169362573336,1
2938,Phenotype,HP:0040197,Encephalomalacia,0.05859943875358409,0.39408741592101354,1
2939,Biological Process,GO:0046822,regulation of nucleocytoplasmic transport,0.05859210499397527,0.3939612706503732,1
2940,Biological Process,GO:0016525,negative regulation of angiogenesis,0.058583765292506085,0.3938178225480349,1
2941,Phenotype,HP:0008940,Generalized lymphadenopathy,0.058536737974682285,0.39300892314979985,1
2942,Phenotype,HP:0005575,Hemolytic-uremic syndrome,0.0585335435969927,0.39295397784757097,1
2943,Disease,MONDO:0002367,kidney cancer,0.05852976192132375,0.3928889306512926,1
2943,Disease,MONDO:0021163,kidney neoplasm,0.05852976192132375,0.3928889306512926,1
2945,Biological Process,GO:0007368,determination of left/right symmetry,0.058500561221193736,0.3923866602719418,1
2945,Biological Process,GO:0060972,left/right pattern formation,0.058500561221193736,0.3923866602719418,1
2947,Biological Process,GO:0051152,positive regulation of smooth muscle cell differentiation,0.05847775553586665,0.39199438816306803,1
2948,Biological Process,GO:0016055,Wnt signaling pathway,0.05847368449480028,0.3919243637002417,1
2949,Phenotype,HP:0002858,Meningioma,0.05846155980963119,0.3917158115014152,1
2950,Phenotype,HP:0031404,Impaired antigen-specific response,0.05844372882060933,0.39140910729294304,1
2951,Biological Process,GO:0001936,regulation of endothelial cell proliferation,0.058433325730293695,0.391230167606703,1
2952,Phenotype,HP:0002754,Osteomyelitis,0.05840290244573132,0.39070686800737126,1
2953,Phenotype,HP:0002331,Recurrent paroxysmal headache,0.058360480759093836,0.3899771883577314,1
2954,Biological Process,GO:0042752,regulation of circadian rhythm,0.0583173634766635,0.38923554402364224,1
2955,Phenotype,HP:0002273,Tetraparesis,0.05827080140005603,0.3884346470664848,1
2956,Phenotype,HP:0006956,Lateral ventricle dilatation,0.05821703510976872,0.3875098331100163,1
2957,Phenotype,HP:0003445,EMG,0.05820276760483134,0.38726442306555225,1
2958,Phenotype,HP:0004307,Abnormal anatomic location of the heart,0.05820033542475367,0.3872225880408843,1
2959,Phenotype,HP:0000575,Scotoma,0.05818167554364506,0.38690162636800207,1
2960,Phenotype,HP:0020110,Bone fracture,0.05818109052922005,0.3868915637525213,1
2961,Phenotype,HP:0002724,Recurrent Aspergillus infections,0.05816769597335425,0.38666116898027286,1
2962,Phenotype,HP:0001704,Tricuspid valve prolapse,0.05815100387306371,0.38637405437316547,1
2963,Phenotype,HP:0000682,Abnormal dental enamel morphology,0.05808820125977343,0.38529380998652124,1
2964,Phenotype,HP:0012751,Abnormal basal ganglia MRI signal intensity,0.05808689023988978,0.3852712596212434,1
2965,Phenotype,HP:0004626,Lumbar scoliosis,0.05806719159047047,0.3849324304811036,1
2966,Phenotype,HP:0025158,Hyperautofluorescent retinal lesion,0.058058093908440744,0.3847759446371362,1
2967,Biological Process,GO:0006120,"mitochondrial electron transport, NADH to ubiquinone",0.05803638402256128,0.384402520966889,1
2968,Phenotype,HP:0010981,Hypolipoproteinemia,0.05797852902224754,0.3834073786303854,1
2969,Biological Process,GO:1901699,cellular response to nitrogen compound,0.05793941508302647,0.38273459431346835,1
2970,Phenotype,HP:0030352,Abnormal serum insulin-like growth factor 1 level,0.05793474898280104,0.3826543344594279,1
2971,Biological Process,GO:0051000,positive regulation of nitric-oxide synthase activity,0.05785732599691973,0.3813226104830871,1
2972,Biological Process,GO:0043506,regulation of JUN kinase activity,0.05785596731825393,0.3812992403568282,1
2973,Phenotype,HP:0030146,Abnormal liver parenchyma morphology,0.05783940417934885,0.3810143439665344,1
2974,Biological Process,GO:0032386,regulation of intracellular transport,0.05782234525161478,0.38072091969704225,1
2975,Phenotype,HP:0000943,Dysostosis multiplex,0.05781481658349241,0.3805914218775724,1
2976,Biological Process,GO:0031664,regulation of lipopolysaccharide-mediated signaling pathway,0.057801179440924555,0.3803568544617118,1
2977,Phenotype,HP:0005750,Lower-limb joint contracture,0.05779673363906135,0.3802803838778419,1
2978,Biological Process,GO:2000114,regulation of establishment of cell polarity,0.05778907344587769,0.3801486237447244,1
2979,Phenotype,HP:0002857,Genu valgum,0.05778448540937675,0.38006970663576667,1
2980,Biological Process,GO:2000045,regulation of G1/S transition of mitotic cell cycle,0.05776956962121815,0.37981314571279634,1
2981,Biological Process,GO:0010660,regulation of muscle cell apoptotic process,0.057747789641639624,0.3794385163869085,1
2982,Biological Process,GO:2000377,regulation of reactive oxygen species metabolic process,0.05770949314969387,0.3787797926764579,1
2983,Phenotype,HP:0005561,Abnormal bone marrow cell morphology,0.05770151515954969,0.37864256623605297,1
2984,Biological Process,GO:0006195,purine nucleotide catabolic process,0.05770098382851885,0.3786334270086634,1
2985,Phenotype,HP:0009816,Lower limb undergrowth,0.05770055821703124,0.37862610622380605,1
2986,Phenotype,HP:0000403,Recurrent otitis media,0.057683122257476294,0.37832619677023077,1
2987,Biological Process,GO:1905459,regulation of vascular associated smooth muscle cell apoptotic process,0.05767445888715528,0.37817718136038725,1
2988,Phenotype,HP:0003756,Skeletal myopathy,0.057617273171572614,0.3771935511415478,1
2989,Biological Process,GO:0046425,regulation of receptor signaling pathway via JAK-STAT,0.057598499660553526,0.37687063496284934,1
2990,Biological Process,GO:2000146,negative regulation of cell motility,0.05755793550440158,0.37617290600403097,1
2991,Biological Process,GO:0006351,DNA-templated transcription,0.0575458671304141,0.37596532239288977,1
2992,Phenotype,HP:0002839,Urinary bladder sphincter dysfunction,0.05748886824694455,0.3749849058037205,1
2993,Phenotype,HP:0002573,Hematochezia,0.05748306697930483,0.37488512035730515,1
2994,Phenotype,HP:0007352,Cerebellar calcifications,0.05748243410338649,0.3748742344940837,1
2995,Biological Process,GO:0046033,AMP metabolic process,0.0574584506968463,0.37446170484077285,1
2996,Phenotype,HP:0030839,Knee pain,0.05743622786673863,0.3740794582076878,1
2997,Phenotype,HP:0040126,Abnormal circulating vitamin B12 concentration,0.05743362740254121,0.374034728590483,1
2998,Phenotype,HP:0010582,Irregular epiphyses,0.05743244360886712,0.37401436659590376,1
2999,Biological Process,GO:0031175,neuron projection development,0.05741298474632606,0.3736796619406483,1
3000,Phenotype,HP:0005162,Abnormal left ventricular function,0.05739192608757737,0.37331743978600035,1
3001,Phenotype,HP:0006094,Finger joint hypermobility,0.05737474813368082,0.37302196819176886,1
3002,Biological Process,GO:0032715,negative regulation of interleukin-6 production,0.057359705288871576,0.3727632218146199,1
3003,Disease,MONDO:0015547,hereditary dementia,0.057344224675130784,0.37249694553694335,1
3003,Disease,MONDO:0001627,dementia,0.057344224675130784,0.37249694553694335,1
3003,Disease,MONDO:0002039,cognitive disorder,0.057344224675130784,0.37249694553694335,1
3006,Phenotype,HP:0009113,Diaphragmatic weakness,0.057327360064259425,0.3722068636395146,1
3007,Biological Process,GO:0016925,protein sumoylation,0.05732576771750697,0.3721794742754291,1
3008,Phenotype,HP:0000851,Congenital hypothyroidism,0.05732047196665002,0.37208838403512584,1
3009,Phenotype,HP:0002953,Vertebral compression fracture,0.057300726023345794,0.3717487414104663,1
3010,Phenotype,HP:0012255,Dynein arm defect of respiratory motile cilia,0.05728222165249863,0.3714304546117365,1
3011,Phenotype,HP:0000593,Abnormal anterior chamber morphology,0.05727727965726359,0.37134544919027734,1
3012,Phenotype,HP:0002860,Squamous cell carcinoma,0.05727698815425408,0.37134043515545917,1
3013,Biological Process,GO:1904894,positive regulation of receptor signaling pathway via STAT,0.05722005687275322,0.37036118136260326,1
3014,Phenotype,HP:0100817,Renovascular hypertension,0.05718293991121115,0.3697227463158037,1
3015,Biological Process,GO:0000375,"RNA splicing, via transesterification reactions",0.05716904995153349,0.36948383028689336,1
3016,Biological Process,GO:0032388,positive regulation of intracellular transport,0.05716832406057837,0.3694713445066287,1
3017,Biological Process,GO:0008207,C21-steroid hormone metabolic process,0.057159084920897274,0.3693124255022269,1
3018,Phenotype,HP:0100834,Neoplasm of the large intestine,0.05715657318712686,0.3692692221040865,1
3019,Biological Process,GO:0010632,regulation of epithelial cell migration,0.057154331445203765,0.36923066273526645,1
3020,Phenotype,HP:0005659,Thoracic kyphoscoliosis,0.05714770137632219,0.36911662138703016,1
3021,Phenotype,HP:0002751,Kyphoscoliosis,0.05711606572912664,0.36857246838908253,1
3022,Biological Process,GO:0033700,phospholipid efflux,0.05710820010376838,0.3684371746935569,1
3023,Disease,MONDO:0019278,hair anomaly,0.057100122138006415,0.36829822860974454,1
3024,Phenotype,HP:0010295,Aplasia/Hypoplasia of the tongue,0.05705524177866794,0.3675262582456791,1
3025,Biological Process,GO:0043280,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,0.05702332273351651,0.3669772306249254,1
3026,Disease,MONDO:0016175,cutis laxa,0.05699850974424703,0.3665504316277191,1
3026,Disease,MONDO:0100237,inherited cutis laxa,0.05699850974424703,0.3665504316277191,1
3028,Phenotype,HP:0009836,Broad distal phalanx of finger,0.0569495077824661,0.3657075671134077,1
3029,Biological Process,GO:0051384,response to glucocorticoid,0.056925713213366924,0.3652982855826663,1
3030,Biological Process,GO:0120032,regulation of plasma membrane bounded cell projection assembly,0.05692313820346584,0.365253993795343,1
3031,Biological Process,GO:0006270,DNA replication initiation,0.056896740794382006,0.36479994178236447,1
3032,Phenotype,HP:0010314,Premature thelarche,0.056885126283200194,0.3646001648964923,1
3033,Biological Process,GO:0007249,canonical NF-kappaB signal transduction,0.05683953780249351,0.36381601440021577,1
3034,Phenotype,HP:0002141,Gait imbalance,0.0568356187364254,0.3637486040027949,1
3035,Phenotype,HP:0010566,Hamartoma,0.056825253599322556,0.3635703171356483,1
3036,Biological Process,GO:0045747,positive regulation of Notch signaling pathway,0.05677326934689386,0.3626761553494112,1
3037,Phenotype,HP:0011971,Dermatographic urticaria,0.056735932170060566,0.3620339324613144,1
3038,Phenotype,HP:0100643,Abnormality of nail color,0.056721780443409586,0.3617905138760816,1
3039,Phenotype,HP:0001699,Sudden death,0.05672021224127077,0.36176353981451276,1
3040,Phenotype,HP:0012733,Macule,0.05670876344801823,0.36156661338108953,1
3041,Phenotype,HP:0005086,Knee osteoarthritis,0.05669232900336485,0.36128393061274083,1
3042,Phenotype,HP:0012415,Abnormal blood gas level,0.05663686589541328,0.36032993032689925,1
3043,Biological Process,GO:0090557,establishment of endothelial intestinal barrier,0.0566169837080267,0.35998794421846636,1
3044,Biological Process,GO:0032526,response to retinoic acid,0.05661657619479965,0.35998093473505566,1
3045,Disease,MONDO:0002661,uveal disorder,0.05661548222351931,0.3599621177420545,1
3046,Disease,MONDO:0016139,qualitative or quantitative protein defects in neuromuscular diseases,0.05659301926367466,0.3595757407266994,1
3047,Phenotype,HP:0009063,Progressive distal muscle weakness,0.056551364768085755,0.3588592572448667,1
3048,Biological Process,GO:0040013,negative regulation of locomotion,0.05654317488796179,0.35871838616374924,1
3049,Phenotype,HP:0100615,Ovarian neoplasm,0.05654269361600528,0.35871010798387376,1
3050,Biological Process,GO:0031344,regulation of cell projection organization,0.056439513495685434,0.3569353451205258,1
3051,Biological Process,GO:0044409,symbiont entry into host,0.056421407820368974,0.3566239161352922,1
3052,Phenotype,HP:0002307,Drooling,0.05634958900075393,0.35538858733797013,1
3053,Phenotype,HP:0009888,Abnormality of secondary sexual hair,0.056322270287693876,0.3549186883180509,1
3054,Phenotype,HP:0004341,Abnormality of vitamin B12 metabolism,0.056294611474592915,0.35444293936385607,1
3055,Biological Process,GO:0008333,endosome to lysosome transport,0.05628913565830573,0.35434875188507736,1
3056,Phenotype,HP:0000176,Submucous cleft hard palate,0.05626988374215014,0.35401760683760775,1
3057,Phenotype,HP:0001934,Persistent bleeding after trauma,0.056242414455184186,0.3535451178519515,1
3058,Disease,MONDO:0000591,intrinsic cardiomyopathy,0.05623293294281695,0.3533820298851456,1
3059,Disease,MONDO:0021118,intestinal neoplasm,0.05619131531082333,0.352666180480301,1
3060,Biological Process,GO:0033146,regulation of intracellular estrogen receptor signaling pathway,0.056188695303975966,0.35262111471724505,1
3061,Phenotype,HP:0000125,Pelvic kidney,0.056185419498870126,0.3525647688123228,1
3062,Biological Process,GO:0120035,regulation of plasma membrane bounded cell projection organization,0.05618022910601228,0.35247549079576557,1
3063,Phenotype,HP:0001651,Dextrocardia,0.05616925060646594,0.35228665370941853,1
3064,Biological Process,GO:0072595,maintenance of protein localization in organelle,0.05609879120111172,0.35107470769105176,1
3065,Phenotype,HP:0020064,Abnormal eosinophil count,0.05608733233106322,0.35087760793041023,1
3066,Phenotype,HP:0012090,Abnormal pancreas morphology,0.05608570817847991,0.3508496714860609,1
3067,Phenotype,HP:0011037,Decreased urine output,0.05607816726402626,0.3507199630220027,1
3068,Biological Process,GO:0051457,maintenance of protein location in nucleus,0.056042862588657094,0.3501127004354355,1
3069,Phenotype,HP:0011890,Prolonged bleeding following procedure,0.05603182053089162,0.34992277010780687,1
3070,Phenotype,HP:0012475,Decreased circulating level of specific antibody,0.05603079225651242,0.3499050831427609,1
3071,Biological Process,GO:0140131,positive regulation of lymphocyte chemotaxis,0.05597556923046376,0.34895521241641325,1
3072,Phenotype,HP:0008207,Primary adrenal insufficiency,0.055939066246004865,0.3483273381610025,1
3073,Phenotype,HP:0001211,Abnormal fingertip morphology,0.05593533956432295,0.3482632368958355,1
3074,Biological Process,GO:2000272,negative regulation of signaling receptor activity,0.055920610311237406,0.34800988449325987,1
3075,Phenotype,HP:0001727,Thromboembolic stroke,0.05589453721396609,0.34756141084711417,1
3076,Phenotype,HP:0003233,Decreased HDL cholesterol concentration,0.05588676800707426,0.34742777560975896,1
3077,Phenotype,HP:0010451,Aplasia/Hypoplasia of the spleen,0.0558790191505425,0.3472944904113762,1
3078,Biological Process,GO:1903055,positive regulation of extracellular matrix organization,0.055878969628590625,0.3472936386027058,1
3079,Phenotype,HP:0001751,Abnormal vestibular function,0.05584257067263154,0.34666755370281843,1
3080,Biological Process,GO:0043627,response to estrogen,0.055837887149184695,0.3465869941584283,1
3081,Phenotype,HP:0030016,Dyspareunia,0.05582484313943148,0.34636262899944814,1
3082,Phenotype,HP:0002553,Highly arched eyebrow,0.05576657705286492,0.3453604157212469,1
3083,Biological Process,GO:0019934,cGMP-mediated signaling,0.0557551512967458,0.3451638855409852,1
3084,Biological Process,GO:0032970,regulation of actin filament-based process,0.055750054903277,0.34507622437294827,1
3085,Phenotype,HP:0100650,Vaginal neoplasm,0.05573963140706217,0.34489693369242785,1
3086,Biological Process,GO:0009303,rRNA transcription,0.055683172310593054,0.3439258017786352,1
3087,Phenotype,HP:0033109,Abnormal circulating non-proteinogenic amino acid concentration,0.05562103669149698,0.34285703011098256,1
3088,Phenotype,HP:0000963,Thin skin,0.055561882805271634,0.3418395461211401,1
3089,Phenotype,HP:0009699,Osteolytic defects of the hand bones,0.0554929640932571,0.3406541009957225,1
3089,Phenotype,HP:0009771,Osteolytic defects of the phalanges of the hand,0.0554929640932571,0.3406541009957225,1
3091,Phenotype,HP:0001450,Y-linked inheritance,0.05549185188542316,0.3406349703225474,1
3092,Phenotype,HP:0001734,Annular pancreas,0.05548647048534994,0.34054240686193926,1
3093,Biological Process,GO:0006476,protein deacetylation,0.055485019724635376,0.340517452866617,1
3094,Biological Process,GO:0002366,leukocyte activation involved in immune response,0.055482923448981536,0.3404813956089763,1
3095,Phenotype,HP:0009110,Diaphragmatic eventration,0.05545835669036758,0.3400588319336702,1
3096,Phenotype,HP:0011499,Mydriasis,0.055402692631988604,0.3391013751742867,1
3097,Phenotype,HP:0004295,Abnormal gastric mucosa morphology,0.05535547277828057,0.33828916403793635,1
3098,Biological Process,GO:2000379,positive regulation of reactive oxygen species metabolic process,0.0553418572613158,0.338054968596029,1
3099,Phenotype,HP:0011800,Midface retrusion,0.05531862632677287,0.33765538193359973,1
3100,Phenotype,HP:0005262,Abnormal synovial membrane morphology,0.055312572962270434,0.33755126026283677,1
3101,Biological Process,GO:0034101,erythrocyte homeostasis,0.055310870441667714,0.33752197583934096,1
3102,Phenotype,HP:0002667,Nephroblastoma,0.05530695180171319,0.3374545727713414,1
3103,Biological Process,GO:1905953,negative regulation of lipid localization,0.05529402118488591,0.3372321580418945,1
3104,Disease,MONDO:0020297,Noonan syndrome and Noonan-related syndrome,0.055256749844811215,0.336591067587389,1
3105,Biological Process,GO:0009117,nucleotide metabolic process,0.05524837513057501,0.3364470172434711,1
3106,Phenotype,HP:0000685,Hypoplasia of teeth,0.055237829606402,0.3362656276054402,1
3107,Phenotype,HP:0001059,Pterygium,0.05521342517341521,0.3358458560328567,1
3108,Phenotype,HP:0002890,Thyroid carcinoma,0.055209031317847046,0.3357702789578822,1
3109,Disease,MONDO:0004643,myeloid leukemia,0.05520478653156091,0.3356972659681694,1
3110,Phenotype,HP:0002943,Thoracic scoliosis,0.05519450998358,0.3355205028895511,1
3111,Phenotype,HP:0040276,Adenocarcinoma of the colon,0.05517028686142467,0.33510384997712617,1
3112,Biological Process,GO:0002922,positive regulation of humoral immune response,0.05515159114072965,0.3347822718408516,1
3113,Phenotype,HP:0200043,Verrucae,0.055127478655385254,0.3343675219510511,1
3114,Biological Process,GO:0071233,cellular response to L-leucine,0.05511393003021059,0.33413447708993954,1
3114,Biological Process,GO:0043201,response to L-leucine,0.05511393003021059,0.33413447708993954,1
3116,Phenotype,HP:0009887,Abnormality of hair pigmentation,0.05511108938860121,0.3340856162704252,1
3117,Biological Process,GO:0001952,regulation of cell-matrix adhesion,0.05510688524941221,0.3340133024363082,1
3118,Biological Process,GO:0045050,protein insertion into ER membrane by stop-transfer membrane-anchor sequence,0.05506498135417903,0.333292529123979,1
3119,Biological Process,GO:1901201,regulation of extracellular matrix assembly,0.05505690623776405,0.33315363205072396,1
3120,Phenotype,HP:0100761,Visceral angiomatosis,0.05505179841006358,0.33306577420672195,1
3121,Phenotype,HP:0000737,Irritability,0.05504428137742867,0.33293647652494324,1
3122,Biological Process,GO:0048675,axon extension,0.05503929379575623,0.3328506869881339,1
3123,Phenotype,HP:0012398,Peripheral edema,0.055029029686436415,0.33267413786229766,1
3124,Phenotype,HP:0002460,Distal muscle weakness,0.054982896921372926,0.33188062533329077,1
3125,Phenotype,HP:0100766,Abnormal lymphatic vessel morphology,0.054973531246313656,0.3317195298409241,1
3126,Phenotype,HP:0012591,Abnormal urinary electrolyte concentration,0.0549418465287852,0.33117453280243586,1
3127,Biological Process,GO:0006221,pyrimidine nucleotide biosynthetic process,0.054910682379616826,0.33063848986664157,1
3128,Phenotype,HP:0000961,Cyanosis,0.05488211396900633,0.33014709526408426,1
3129,Biological Process,GO:0006555,methionine metabolic process,0.05485930914969461,0.3297548380512187,1
3130,Biological Process,GO:0050680,negative regulation of epithelial cell proliferation,0.05485695632652399,0.3297143680151855,1
3131,Phenotype,HP:0001742,Nasal congestion,0.05483887488100858,0.3294033557977456,1
3132,Phenotype,HP:0100831,Abnormality of vitamin K metabolism,0.0548282038127027,0.3292198067217917,1
3132,Phenotype,HP:0011892,Decreased circulating vitamin K concentration,0.0548282038127027,0.3292198067217917,1
3134,Phenotype,HP:0003781,Excessive salivation,0.05479103783315842,0.32858052853457237,1
3135,Phenotype,HP:0032342,Reduced forced expiratory volume in one second,0.05477109974526695,0.32823758090235156,1
3136,Phenotype,HP:0000013,Hypoplasia of the uterus,0.054761772144017784,0.3280771403034279,1
3137,Biological Process,GO:0034356,NAD biosynthesis via nicotinamide riboside salvage pathway,0.054729533888225435,0.3275226220591962,1
3138,Phenotype,HP:0100626,Chronic hepatic failure,0.05471818017890995,0.3273273311292001,1
3139,Biological Process,GO:0009135,purine nucleoside diphosphate metabolic process,0.05463832426209292,0.32595375921296144,1
3140,Phenotype,HP:0025548,Increased mean corpuscular hemoglobin concentration,0.05463674976346011,0.3259266768477419,1
3141,Phenotype,HP:0002694,Sclerosis of skull base,0.05460009368891261,0.3252961693466714,1
3142,Phenotype,HP:0100733,Neoplasm of the parathyroid gland,0.054589345132073475,0.3251112874192851,1
3143,Biological Process,GO:0043045,epigenetic programming of gene expression,0.05457021300751008,0.32478220286242665,1
3144,Biological Process,GO:1901017,negative regulation of potassium ion transmembrane transporter activity,0.05456533559738386,0.3246983083453966,1
3145,Biological Process,GO:0015908,fatty acid transport,0.0545604882375893,0.3246149307129418,1
3146,Phenotype,HP:0045039,Osteolysis involving bones of the upper limbs,0.05448859345847623,0.32337829536455354,1
3147,Disease,MONDO:0005087,respiratory system disorder,0.054487480247716547,0.3233591474404259,1
3148,Biological Process,GO:0090092,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,0.054461044917649915,0.32290444316273004,1
3149,Biological Process,GO:1990928,response to amino acid starvation,0.05445912859481994,0.3228714812066644,1
3150,Biological Process,GO:1901607,alpha-amino acid biosynthetic process,0.05442239312079089,0.32223960798465096,1
3151,Phenotype,HP:0000044,Hypogonadotropic hypogonadism,0.054362182220043076,0.3212039426812505,1
3152,Phenotype,HP:0002248,Hematemesis,0.054337090367188035,0.32077234705525515,1
3153,Biological Process,GO:0048863,stem cell differentiation,0.054331793518403226,0.3206812379299032,1
3154,Biological Process,GO:0097237,cellular response to toxic substance,0.054328554087014314,0.32062551767575365,1
3155,Phenotype,HP:0004259,Abnormality of the hamate bone,0.054317043307974044,0.3204275250478565,1
3155,Phenotype,HP:0004262,Abnormality of the capitate bone,0.054317043307974044,0.3204275250478565,1
3155,Phenotype,HP:0001241,Capitate-hamate fusion,0.054317043307974044,0.3204275250478565,1
3158,Disease,MONDO:0019236,inborn disorder of purine metabolism,0.05426477802025442,0.3195285292781342,1
3158,Disease,MONDO:0037829,purine metabolism disease,0.05426477802025442,0.3195285292781342,1
3160,Biological Process,GO:0043010,camera-type eye development,0.05422424142074178,0.31883127431081654,1
3161,Biological Process,GO:0007173,epidermal growth factor receptor signaling pathway,0.054222628065419776,0.318803523586142,1
3162,Phenotype,HP:0002577,Abnormal stomach morphology,0.05420117267299818,0.3184344773631838,1
3163,Biological Process,GO:1903588,negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,0.05418275019914409,0.31811759924416366,1
3164,Biological Process,GO:0002717,positive regulation of natural killer cell mediated immunity,0.05417959091802482,0.3180632576249838,1
3165,Phenotype,HP:0001649,Tachycardia,0.05415565598308336,0.3176515617136098,1
3166,Biological Process,GO:0050900,leukocyte migration,0.05413502190621089,0.3172966426338567,1
3167,Phenotype,HP:0005483,Abnormal epiglottis morphology,0.05412522681460208,0.317128160907178,1
3168,Phenotype,HP:0004722,Thickened glomerular basement membrane,0.05409055278203734,0.3165317457728705,1
3169,Biological Process,GO:0046824,positive regulation of nucleocytoplasmic transport,0.054076307818944236,0.31628672346228365,1
3170,Biological Process,GO:0071695,anatomical structure maturation,0.05407530650436876,0.31626950022279166,1
3171,Biological Process,GO:0070527,platelet aggregation,0.05405887103172924,0.31598679977243577,1
3172,Phenotype,HP:0009799,Supernumerary spleens,0.05403162168570297,0.31551809390905794,1
3173,Phenotype,HP:0003301,Irregular vertebral endplates,0.0540089302700576,0.3151277873104675,1
3174,Biological Process,GO:2000181,negative regulation of blood vessel morphogenesis,0.05396974345282757,0.31445374944603127,1
3175,Phenotype,HP:0007495,Prematurely aged appearance,0.053912700524015866,0.31347257524931793,1
3176,Biological Process,GO:1903036,positive regulation of response to wounding,0.053837750499111325,0.31218338775471877,1
3176,Biological Process,GO:0090303,positive regulation of wound healing,0.053837750499111325,0.31218338775471877,1
3178,Biological Process,GO:0035270,endocrine system development,0.05381313464055948,0.31175997952964773,1
3179,Disease,MONDO:0015762,progressive familial intrahepatic cholestasis,0.053812920955179755,0.31175630400692883,1
3179,Disease,MONDO:0001751,cholestasis,0.053812920955179755,0.31175630400692883,1
3179,Disease,MONDO:0017290,familial intrahepatic cholestasis,0.053812920955179755,0.31175630400692883,1
3179,Disease,MONDO:0019072,intrahepatic cholestasis,0.053812920955179755,0.31175630400692883,1
3183,Phenotype,HP:0009720,Adenoma sebaceum,0.05381143275738398,0.31173070607030046,1
3184,Phenotype,HP:0100825,Cheilitis,0.05379815542373567,0.31150232759380464,1
3185,Biological Process,GO:0008631,intrinsic apoptotic signaling pathway in response to oxidative stress,0.05379066204668581,0.31137343680294366,1
3186,Phenotype,HP:0005502,Increased red cell osmotic fragility,0.053759654027447645,0.31084007939999353,1
3187,Biological Process,GO:0048609,multicellular organismal reproductive process,0.05374616897727713,0.31060812806887644,1
3188,Phenotype,HP:0003215,Dicarboxylic aciduria,0.05373804704517737,0.3104684257364445,1
3189,Phenotype,HP:0200102,Sparse or absent eyelashes,0.05373343315973611,0.31038906400948096,1
3190,Biological Process,GO:0010828,positive regulation of glucose transmembrane transport,0.05373287786305225,0.3103795125578099,1
3191,Phenotype,HP:0001896,Reticulocytopenia,0.053707476749267014,0.30994259744960906,1
3192,Biological Process,GO:1904385,cellular response to angiotensin,0.053692091097064965,0.30967795457003167,1
3193,Biological Process,GO:0006631,fatty acid metabolic process,0.05366011614731192,0.3091279653550239,1
3194,Phenotype,HP:0000608,Macular degeneration,0.05358774257415655,0.30788309444844053,1
3195,Biological Process,GO:0071468,cellular response to acidic pH,0.05357799472305924,0.3077154252882252,1
3196,Phenotype,HP:0008180,Mildly elevated creatine kinase,0.053560256485863156,0.30741031646940153,1
3197,Biological Process,GO:0060491,regulation of cell projection assembly,0.05355701882449049,0.3073546266606429,1
3198,Phenotype,HP:0010044,Short 4th metacarpal,0.05352818174646379,0.30685861080981225,1
3199,Phenotype,HP:0012588,Steroid-resistant nephrotic syndrome,0.05351078918852792,0.30655944789134,1
3200,Disease,MONDO:0045012,steroid metabolism disease,0.05349188298973484,0.30623424939960514,1
3201,Phenotype,HP:0002188,Delayed CNS myelination,0.05344239010495888,0.3053829407014951,1
3202,Biological Process,GO:0086001,cardiac muscle cell action potential,0.05341205025841289,0.3048610762884416,1
3203,Phenotype,HP:0003547,Shoulder girdle muscle weakness,0.05341158690931003,0.3048531063929038,1
3204,Biological Process,GO:0090263,positive regulation of canonical Wnt signaling pathway,0.053402111529764706,0.30469012391448613,1
3205,Phenotype,HP:0001641,Abnormal pulmonary valve morphology,0.05339603976224372,0.3045856857002475,1
3206,Biological Process,GO:1903522,regulation of blood circulation,0.05338235236493827,0.3043502538713419,1
3207,Disease,MONDO:0043009,hereditary lethal multiple congenital anomalies/dysmorphic syndrome,0.0533455560765268,0.3037173346037613,1
3208,Phenotype,HP:0009046,Difficulty running,0.05334053818205731,0.3036310236678073,1
3209,Biological Process,GO:0014033,neural crest cell differentiation,0.05333298335080161,0.30350107582601465,1
3210,Phenotype,HP:0001972,Macrocytic anemia,0.05333133464714268,0.30347271708774737,1
3211,Biological Process,GO:0034103,regulation of tissue remodeling,0.05331422927188845,0.30317849389174084,1
3212,Phenotype,HP:0010548,Percussion myotonia,0.05331333064286137,0.30316303690816454,1
3213,Biological Process,GO:0043281,regulation of cysteine-type endopeptidase activity involved in apoptotic process,0.053310882244481106,0.3031209229185074,1
3214,Phenotype,HP:0001785,Ankle swelling,0.05328666427418505,0.30270435862129713,1
3215,Phenotype,HP:0009789,Perianal abscess,0.05328502050173389,0.30267608470290025,1
3216,Phenotype,HP:0000550,Undetectable electroretinogram,0.05327610771020108,0.3025227790915852,1
3217,Biological Process,GO:0086009,membrane repolarization,0.053264172886216876,0.3023174926243655,1
3218,Biological Process,GO:0046470,phosphatidylcholine metabolic process,0.053258404205267396,0.30221826768948556,1
3219,Phenotype,HP:0033282,Abnormal glomerular basement membrane morphology,0.053248650888040205,0.3020505045084037,1
3220,Phenotype,HP:0410242,Abnormal circulating IgG level,0.05323681436199135,0.3018469088274,1
3221,Phenotype,HP:0031654,Abnormal pulmonary valve physiology,0.05321106781623397,0.3014040520723581,1
3222,Biological Process,GO:0006753,nucleoside phosphate metabolic process,0.053211052378808854,0.30140378653895183,1
3223,Phenotype,HP:0000075,Renal duplication,0.053202686270925836,0.3012598842297133,1
3224,Phenotype,HP:0010871,Sensory ataxia,0.053195588778047975,0.3011378028952134,1
3225,Biological Process,GO:0035924,cellular response to vascular endothelial growth factor stimulus,0.05317935372989113,0.3008585498718198,1
3226,Biological Process,GO:0042060,wound healing,0.05317060066026946,0.3007079915776767,1
3227,Biological Process,GO:0072376,protein activation cascade,0.05316164594417783,0.30055396483762253,1
3228,Biological Process,GO:0006977,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest",0.0531439597239699,0.3002497507436603,1
3229,Biological Process,GO:0045943,positive regulation of transcription by RNA polymerase I,0.05300259652184758,0.29781821489554405,1
3230,Phenotype,HP:0000625,Eyelid coloboma,0.05296551101837044,0.297180320947216,1
3231,Phenotype,HP:0200114,Metabolic alkalosis,0.05295384425440686,0.29697964528068427,1
3232,Phenotype,HP:0002970,Genu varum,0.05294369796786558,0.2968051227806278,1
3233,Biological Process,GO:0007029,endoplasmic reticulum organization,0.05293790645268215,0.29670550508258475,1
3234,Phenotype,HP:0003298,Spina bifida occulta,0.052876540952672024,0.2956499799468208,1
3235,Phenotype,HP:0004054,Sclerosis of hand bone,0.05287377162483253,0.2956023457689314,1
3236,Phenotype,HP:0002132,Porencephalic cyst,0.05287360372387484,0.2955994577670226,1
3237,Phenotype,HP:0002254,Intermittent diarrhea,0.05286522162079732,0.2954552803303941,1
3238,Biological Process,GO:0072330,monocarboxylic acid biosynthetic process,0.05284970997036742,0.2951884702021748,1
3239,Biological Process,GO:0030521,androgen receptor signaling pathway,0.05284188012173763,0.2950537918888455,1
3240,Biological Process,GO:0008637,apoptotic mitochondrial changes,0.05283967397869249,0.29501584484308124,1
3241,Phenotype,HP:0002651,Spondyloepimetaphyseal dysplasia,0.0527737664278225,0.2938821935802635,1
3242,Phenotype,HP:0040188,Osteochondrosis,0.052754893916240886,0.2935575745297204,1
3243,Biological Process,GO:0030595,leukocyte chemotaxis,0.052698525977979416,0.29258801059434375,1
3244,Biological Process,GO:0010883,regulation of lipid storage,0.05263503515158119,0.2914959285100668,1
3245,Phenotype,HP:0000053,Macroorchidism,0.052616263659143625,0.2911730470522382,1
3246,Phenotype,HP:0010980,Hyperlipoproteinemia,0.05261306422877077,0.2911180148406841,1
3247,Biological Process,GO:0060627,regulation of vesicle-mediated transport,0.05259319379148364,0.2907762308413404,1
3248,Phenotype,HP:0006554,Acute hepatic failure,0.052586021015284645,0.2906528545864415,1
3249,Biological Process,GO:1902041,regulation of extrinsic apoptotic signaling pathway via death domain receptors,0.05255551943653969,0.2901282082780032,1
3250,Biological Process,GO:0070875,positive regulation of glycogen metabolic process,0.05252837518736053,0.2896613101463932,1
3251,Biological Process,GO:0030514,negative regulation of BMP signaling pathway,0.05250484133234301,0.28925651306157646,1
3252,Phenotype,HP:0006487,Bowing of the long bones,0.052428802456058965,0.28794859663948563,1
3253,Phenotype,HP:0410005,Cleft hard palate,0.05240161098711249,0.28748088629822527,1
3254,Phenotype,HP:0000825,Hyperinsulinemic hypoglycemia,0.05239794912295792,0.287417899935232,1
3255,Biological Process,GO:0071218,cellular response to misfolded protein,0.05239729697704765,0.28740668261604835,1
3256,Phenotype,HP:0032261,Nontuberculous mycobacterial pulmonary infection,0.05239011360398216,0.2872831240883912,1
3257,Phenotype,HP:0012440,Abnormal biliary tract morphology,0.05230975152905559,0.2859008459348173,1
3258,Biological Process,GO:0031665,negative regulation of lipopolysaccharide-mediated signaling pathway,0.05229669168250595,0.2856762083729935,1
3259,Phenotype,HP:0010937,Abnormal nasal skeleton morphology,0.05229427818024579,0.28563469461851587,1
3260,Phenotype,HP:0030310,Upper extremity joint dislocation,0.05228370078856803,0.2854527568393916,1
3261,Phenotype,HP:0009107,Abnormal ossification involving the femoral head and neck,0.05225619459065034,0.2849796329621864,1
3262,Disease,MONDO:0016056,isolated congenital microcephaly,0.05225501775350683,0.28495939062430153,1
3263,Phenotype,HP:0002656,Epiphyseal dysplasia,0.05219398379955442,0.28390956828893077,1
3264,Phenotype,HP:0004374,Hemiplegia/hemiparesis,0.05218164219188326,0.2836972848868482,1
3265,Phenotype,HP:0008628,Abnormality of the stapes,0.052133144857516966,0.28286310028095846,1
3266,Biological Process,GO:0009299,mRNA transcription,0.05213203534881594,0.2828440160345645,1
3267,Biological Process,GO:0009261,ribonucleotide catabolic process,0.05211999969247261,0.2826369951874483,1
3268,Biological Process,GO:0009166,nucleotide catabolic process,0.05211403774496093,0.28253444594633326,1
3269,Phenotype,HP:0002591,Polyphagia,0.05211370594425191,0.28252873876577783,1
3270,Biological Process,GO:0007219,Notch signaling pathway,0.05207337631406672,0.28183504380086255,1
3271,Phenotype,HP:0001971,Hypersplenism,0.052064206091544385,0.28167731021486914,1
3271,Phenotype,HP:0025409,Abnormal spleen physiology,0.052064206091544385,0.28167731021486914,1
3273,Biological Process,GO:0033344,cholesterol efflux,0.05205762243541867,0.2815640671951794,1
3274,Biological Process,GO:0038127,ERBB signaling pathway,0.0520550653524654,0.2815200837626161,1
3275,Phenotype,HP:0005406,Recurrent bacterial skin infections,0.052044937490206555,0.2813458781717873,1
3276,Biological Process,GO:0170039,proteinogenic amino acid metabolic process,0.05203621780416767,0.28119589409623197,1
3277,Biological Process,GO:0051205,protein insertion into membrane,0.05202419064725616,0.2809890194446805,1
3278,Disease,MONDO:0005495,adrenal gland disorder,0.05200257896268057,0.28061728489852705,1
3279,Biological Process,GO:1903828,negative regulation of protein localization,0.05199695589041031,0.2805205645243674,1
3280,Biological Process,GO:0071625,vocalization behavior,0.051996028207481726,0.28050460779544023,1
3281,Biological Process,GO:0006919,activation of cysteine-type endopeptidase activity involved in apoptotic process,0.05197894838318429,0.28021082409193576,1
3282,Biological Process,GO:0036152,phosphatidylethanolamine acyl-chain remodeling,0.051896131432631165,0.27878632053600094,1
3283,Phenotype,HP:0012189,Hodgkin lymphoma,0.051879765088273966,0.2785048091355114,1
3284,Phenotype,HP:0012304,Hypoplastic aortic arch,0.051870993462615145,0.27835393166587663,1
3285,Phenotype,HP:0002705,"High, narrow palate",0.05184516150382179,0.27790960575297924,1
3286,Phenotype,HP:0001036,Parakeratosis,0.051787086336408716,0.2769106764041092,1
3287,Phenotype,HP:0030353,Decreased serum insulin-like growth factor 1,0.05178086836117923,0.27680372332547065,1
3288,Biological Process,GO:0031960,response to corticosteroid,0.05175366088382549,0.2763357376295525,1
3289,Phenotype,HP:0033479,Abnormal circulating bilirubin concentration,0.05175118145947566,0.2762930899737354,1
3290,Biological Process,GO:0051216,cartilage development,0.05174755290028954,0.27623067647711397,1
3291,Phenotype,HP:0031292,Cutaneous abscess,0.05172620553873042,0.2758634884528304,1
3292,Phenotype,HP:0030532,Visual acuity test abnormality,0.05168523046830764,0.27515869151051253,1
3293,Biological Process,GO:0051348,negative regulation of transferase activity,0.05168479649411506,0.2751512268818781,1
3294,Phenotype,HP:0000418,Narrow nasal ridge,0.05166838862949619,0.27486900130681435,1
3295,Biological Process,GO:0033044,regulation of chromosome organization,0.05153572987852917,0.2725871874846889,1
3296,Phenotype,HP:0001519,Disproportionate tall stature,0.051519895463119636,0.27231482559613374,1
3297,Disease,MONDO:0800066,polydactyly-syndactyly-triphalangism,0.05150975100328237,0.27214033451653336,1
3298,Biological Process,GO:0031648,protein destabilization,0.05149823528393349,0.2719422569122258,1
3299,Disease,MONDO:0015161,multiple congenital anomalies/dysmorphic syndrome without intellectual disability,0.05149805043280298,0.2719390773567003,1
3300,Phenotype,HP:0002728,Chronic mucocutaneous candidiasis,0.05145878197508158,0.27126363522454494,1
3301,Phenotype,HP:0001737,Pancreatic cysts,0.05142861420390832,0.27074473061596027,1
3302,Biological Process,GO:0042908,xenobiotic transport,0.051370531201291425,0.26974566649666426,1
3303,Phenotype,HP:0010984,Digenic inheritance,0.05136465830646575,0.26964464901767077,1
3304,Phenotype,HP:0100777,Exostoses,0.05135247933595277,0.26943516307683996,1
3305,Biological Process,GO:0061098,positive regulation of protein tyrosine kinase activity,0.05131346855954555,0.2687641532251041,1
3306,Biological Process,GO:0090235,regulation of metaphase plate congression,0.0513002684388324,0.26853710285958027,1
3307,Phenotype,HP:0002230,Generalized hirsutism,0.05128302425915643,0.2682404921403551,1
3308,Phenotype,HP:0001808,Fragile nails,0.051254151600101494,0.26774386427349506,1
3309,Biological Process,GO:0043331,response to dsRNA,0.05123801501339942,0.2674663048489542,1
3310,Phenotype,HP:0002842,Recurrent Burkholderia cepacia infections,0.051232840890010234,0.2673773066774746,1
3311,Biological Process,GO:0010498,proteasomal protein catabolic process,0.051232507409425865,0.2673715706020082,1
3312,Phenotype,HP:0002414,Spina bifida,0.05123016889858978,0.26733134674711684,1
3313,Biological Process,GO:0001890,placenta development,0.05122778976718945,0.267290424193012,1
3314,Phenotype,HP:0100707,Abnormal astrocyte morphology,0.05120807567682384,0.2669513294588994,1
3315,Biological Process,GO:0048469,cell maturation,0.05118999001512481,0.2666402447204535,1
3316,Biological Process,GO:1901343,negative regulation of vasculature development,0.05111759627422097,0.26539502691593175,1
3317,Phenotype,HP:0012504,Abnormal size of pituitary gland,0.0511143110970258,0.26533851980518763,1
3318,Phenotype,HP:0010743,Short metatarsal,0.05109426758015023,0.26499375872823433,1
3319,Phenotype,HP:0011794,Embryonal renal neoplasm,0.05108648069902488,0.26485981948296367,1
3320,Biological Process,GO:1990869,cellular response to chemokine,0.05107545723640694,0.26467020900354976,1
3320,Biological Process,GO:1990868,response to chemokine,0.05107545723640694,0.26467020900354976,1
3322,Biological Process,GO:1901018,positive regulation of potassium ion transmembrane transporter activity,0.051063368897338646,0.26446228198048116,1
3323,Biological Process,GO:0043502,regulation of muscle adaptation,0.05106147675460648,0.26442973593728225,1
3324,Biological Process,GO:1903050,regulation of proteolysis involved in protein catabolic process,0.0510544542532233,0.2643089445035832,1
3325,Phenotype,HP:0030047,Abnormal lateral ventricle morphology,0.05102489805866539,0.26380055939683333,1
3326,Biological Process,GO:0070252,actin-mediated cell contraction,0.05102183594952059,0.2637478891966352,1
3327,Phenotype,HP:0002904,Hyperbilirubinemia,0.05101125040672394,0.26356581121314737,1
3328,Biological Process,GO:0046653,tetrahydrofolate metabolic process,0.050981061422267104,0.263046541722764,1
3329,Biological Process,GO:0001704,formation of primary germ layer,0.05092765360154139,0.2621278936678624,1
3330,Phenotype,HP:0000150,Gonadoblastoma,0.050923317909404964,0.26205331704043855,1
3331,Phenotype,HP:0010827,Abnormal seventh cranial physiology,0.05092253917587164,0.26203992233464535,1
3332,Biological Process,GO:0034502,protein localization to chromosome,0.05090744973800876,0.2617803745277149,1
3333,Biological Process,GO:0051055,negative regulation of lipid biosynthetic process,0.05087456243411059,0.26121469224848154,1
3334,Phenotype,HP:0002748,Rickets,0.050864522374949095,0.2610419969260647,1
3335,Biological Process,GO:0009124,nucleoside monophosphate biosynthetic process,0.050849835087987794,0.2607893663671795,1
3336,Phenotype,HP:0011482,Abnormal lacrimal gland morphology,0.05084809979616878,0.2607595182581841,1
3337,Phenotype,HP:0000086,Ectopic kidney,0.0508316249591555,0.26047614071588,1
3338,Biological Process,GO:0140861,DNA repair-dependent chromatin remodeling,0.05080564834606838,0.2600293266582915,1
3339,Phenotype,HP:0006958,Abnormal auditory evoked potentials,0.05076738244162837,0.25937112907214777,1
3340,Biological Process,GO:0015914,phospholipid transport,0.050680184416949214,0.2578712682900694,1
3341,Phenotype,HP:0010535,Sleep apnea,0.050655941661463144,0.2574542776720266,1
3342,Phenotype,HP:0000130,Abnormality of the uterus,0.05063485642374144,0.25709159834235196,1
3343,Biological Process,GO:0086091,regulation of heart rate by cardiac conduction,0.05063014906878893,0.2570106288810991,1
3344,Biological Process,GO:0009167,purine ribonucleoside monophosphate metabolic process,0.05058753861647336,0.2562777023432572,1
3345,Biological Process,GO:0032925,regulation of activin receptor signaling pathway,0.05058221514089256,0.25618613522029343,1
3346,Phenotype,HP:0011001,Increased bone mineral density,0.050573386655952235,0.256034279735311,1
3347,Phenotype,HP:0030517,Heteronymous hemianopia,0.0505598312147677,0.25580111763454944,1
3347,Phenotype,HP:0030521,Bitemporal hemianopia,0.0505598312147677,0.25580111763454944,1
3349,Phenotype,HP:0002878,Respiratory failure,0.05052114713593481,0.2551357271862477,1
3350,Phenotype,HP:0000751,Personality changes,0.05051148892703128,0.25496959992805784,1
3351,Biological Process,GO:0070646,protein modification by small protein removal,0.050510031766489494,0.25494453585168847,1
3352,Biological Process,GO:0046660,female sex differentiation,0.05050589434312691,0.2548733695716813,1
3353,Phenotype,HP:0002378,Hand tremor,0.050497262025586354,0.2547248882891618,1
3354,Biological Process,GO:0170038,proteinogenic amino acid biosynthetic process,0.05046876596058525,0.25423473807651675,1
3354,Biological Process,GO:0170034,L-amino acid biosynthetic process,0.05046876596058525,0.25423473807651675,1
3356,Biological Process,GO:0045445,myoblast differentiation,0.050468260172320756,0.25422603820074846,1
3357,Disease,MONDO:0021248,nervous system neoplasm,0.050413352875622874,0.2532815982175022,1
3358,Phenotype,HP:0004692,4-5 toe syndactyly,0.05038642397545068,0.2528184042240443,1
3359,Biological Process,GO:0046434,organophosphate catabolic process,0.050370134828362834,0.25253822066506504,1
3360,Phenotype,HP:0009004,Hypoplasia of the musculature,0.05035968665894197,0.2523585055899068,1
3361,Biological Process,GO:0071407,cellular response to organic cyclic compound,0.05033939831715872,0.2520095333707991,1
3362,Phenotype,HP:0008800,Limited hip movement,0.05033164658024014,0.2518761986279543,1
3363,Biological Process,GO:1902116,negative regulation of organelle assembly,0.0503157697990303,0.25160310802102936,1
3364,Biological Process,GO:0015740,C4-dicarboxylate transport,0.05031294898985805,0.251554588331888,1
3365,Biological Process,GO:0045185,maintenance of protein location,0.0503006419604477,0.25134289969760537,1
3366,Phenotype,HP:0034391,Elbow contracture,0.050299855024564244,0.2513293639062391,1
3367,Phenotype,HP:0009237,Short 5th finger,0.05028865621418943,0.25113673733529424,1
3368,Disease,MONDO:0015159,multiple congenital anomalies/dysmorphic syndrome-intellectual disability,0.05028712830283033,0.25111045630043777,1
3369,Phenotype,HP:0012721,Venous malformation,0.050271885496648516,0.2508482704621112,1
3370,Phenotype,HP:0100571,Cardiac diverticulum,0.05023428531365315,0.25020152370286725,1
3371,Disease,MONDO:0016333,familial dilated cardiomyopathy,0.050219572768613885,0.24994845868917973,1
3371,Disease,MONDO:0005021,dilated cardiomyopathy,0.050219572768613885,0.24994845868917973,1
3373,Disease,MONDO:0005059,leukemia,0.05020294520495838,0.2496624541527219,1
3374,Biological Process,GO:0003170,heart valve development,0.0501967947856552,0.24955666307843863,1
3374,Biological Process,GO:0003179,heart valve morphogenesis,0.0501967947856552,0.24955666307843863,1
3376,Biological Process,GO:0055002,striated muscle cell development,0.05016226315593397,0.24896269736246415,1
3376,Biological Process,GO:0030239,myofibril assembly,0.05016226315593397,0.24896269736246415,1
3378,Biological Process,GO:0072528,pyrimidine-containing compound biosynthetic process,0.05010752124376194,0.24802110209691874,1
3379,Phenotype,HP:0005474,Decreased calvarial ossification,0.050101478035539326,0.24791715512054643,1
3380,Biological Process,GO:2000058,regulation of ubiquitin-dependent protein catabolic process,0.05009894792881353,0.2478736356960359,1
3381,Biological Process,GO:0044060,regulation of endocrine process,0.05009230769018935,0.24775941942184054,1
3382,Phenotype,HP:0004312,Abnormal reticulocyte morphology,0.050088893000869605,0.2477006846212242,1
3383,Biological Process,GO:0098659,inorganic cation import across plasma membrane,0.05008073430158466,0.2475603498701185,1
3383,Biological Process,GO:0099587,inorganic ion import across plasma membrane,0.05008073430158466,0.2475603498701185,1
3385,Phenotype,HP:0030588,Abnormal visual field test,0.05001138827147833,0.2463675546051797,1
3386,Phenotype,HP:0032559,Short sperm flagella,0.05000235189793867,0.24621212330574124,1
3387,Biological Process,GO:0001101,response to acid chemical,0.04999247306785026,0.24604220122462836,1
3388,Phenotype,HP:0011335,Frontal hirsutism,0.04997538035681581,0.24574819586115482,1
3389,Phenotype,HP:0004381,Supravalvular aortic stenosis,0.049877625682319904,0.24406675407298667,1
3390,Phenotype,HP:0100769,Synovitis,0.0498725637925479,0.24397968639020176,1
3391,Phenotype,HP:0004422,Biparietal narrowing,0.04986860393259607,0.24391157431236368,1
3392,Phenotype,HP:0000142,Abnormal vagina morphology,0.0498527412328994,0.24363872591630817,1
3393,Biological Process,GO:0046794,transport of virus,0.04983266108219586,0.24329333471450884,1
3394,Biological Process,GO:0032781,positive regulation of ATP-dependent activity,0.049830573231203656,0.24325742236633865,1
3395,Biological Process,GO:0035082,axoneme assembly,0.0498264249922844,0.24318607005196485,1
3396,Biological Process,GO:0019395,fatty acid oxidation,0.049816147116380605,0.2430092841322391,1
3397,Phenotype,HP:0002840,Lymphadenitis,0.04981603994670092,0.24300744074644934,1
3398,Phenotype,HP:0032140,Decreased specific antibody response to vaccination,0.04980450827719274,0.24280908878938554,1
3399,Biological Process,GO:0051046,regulation of secretion,0.04978839343123265,0.24253190331925925,1
3400,Disease,MONDO:0016660,autosomal recessive primary microcephaly,0.04961196291897374,0.23949718771563405,1
3401,Phenotype,HP:0000162,Glossoptosis,0.049610576873758916,0.2394733468675466,1
3402,Biological Process,GO:0001937,negative regulation of endothelial cell proliferation,0.049605111482116104,0.23937933869919745,1
3403,Biological Process,GO:0034248,regulation of amide metabolic process,0.04960344394625271,0.2393506560351874,1
3404,Phenotype,HP:0040084,Abnormal circulating renin,0.049587822862973696,0.23908196359324294,1
3405,Phenotype,HP:0008187,Absence of secondary sex characteristics,0.04957345834411664,0.23883488484843882,1
3406,Phenotype,HP:0025352,Typically de novo,0.049569274748417325,0.23876292437524504,1
3407,Phenotype,HP:0007401,Macular atrophy,0.04954657127073725,0.23837241030208306,1
3408,Biological Process,GO:0106058,positive regulation of calcineurin-mediated signaling,0.04954557519392078,0.23835527715533505,1
3408,Biological Process,GO:0070886,positive regulation of calcineurin-NFAT signaling cascade,0.04954557519392078,0.23835527715533505,1
3410,Phenotype,HP:0100625,Enlarged thorax,0.04953310358569929,0.23814075766215065,1
3411,Disease,MONDO:0056803,sulfur metabolism disease,0.049465537839565754,0.2369785843995059,1
3412,Biological Process,GO:0010745,negative regulation of macrophage derived foam cell differentiation,0.049410267700564114,0.23602790330078147,1
3413,Biological Process,GO:0030970,"retrograde protein transport, ER to cytosol",0.04939449537877871,0.2357566094615542,1
3413,Biological Process,GO:1903513,endoplasmic reticulum to cytosol transport,0.04939449537877871,0.2357566094615542,1
3415,Biological Process,GO:1901659,glycosyl compound biosynthetic process,0.049369523929353454,0.23532708485016063,1
3416,Phenotype,HP:0008684,Aplasia/hypoplasia of the uterus,0.04936190201923896,0.23519598320987323,1
3417,Biological Process,GO:1900101,regulation of endoplasmic reticulum unfolded protein response,0.049328176776873955,0.23461588786281148,1
3418,Biological Process,GO:0030330,"DNA damage response, signal transduction by p53 class mediator",0.04932650740738309,0.23458717365925746,1
3419,Biological Process,GO:0045661,regulation of myoblast differentiation,0.04932471116353643,0.2345562771371106,1
3420,Phenotype,HP:0002777,Tracheal stenosis,0.049316236309468575,0.2344105043252037,1
3421,Phenotype,HP:0000041,Chordee,0.04931199081304749,0.2343374791207238,1
3422,Phenotype,HP:0002763,Abnormal cartilage morphology,0.04931014911204479,0.23430580070694743,1
3423,Phenotype,HP:0005264,Abnormality of the gallbladder,0.04926790593551811,0.23357919154331203,1
3424,Phenotype,HP:0410134,Physical urticaria,0.04921383993241901,0.23264922233827057,1
3425,Phenotype,HP:0000055,Abnormal female external genitalia morphology,0.04915437511730858,0.23162639017635123,1
3426,Phenotype,HP:0200026,Ocular pain,0.049137234417214404,0.2313315593709148,1
3427,Phenotype,HP:0003554,Type 2 muscle fiber atrophy,0.04913721864977583,0.23133128816106982,1
3428,Phenotype,HP:0033222,Decreased CD4:CD8 ratio,0.049122058841631455,0.2310705299411074,1
3429,Disease,MONDO:0020242,hereditary macular dystrophy,0.0490892516989192,0.2305062264846104,1
3430,Biological Process,GO:0032369,negative regulation of lipid transport,0.049024026726232295,0.22938431599517925,1
3431,Biological Process,GO:1903020,positive regulation of glycoprotein metabolic process,0.04901967193923096,0.22930941092408796,1
3432,Biological Process,GO:0030323,respiratory tube development,0.04899787201687811,0.22893443856995838,1
3432,Biological Process,GO:0030324,lung development,0.04899787201687811,0.22893443856995838,1
3434,Biological Process,GO:0060047,heart contraction,0.04899525083230438,0.22888935254926943,1
3435,Phenotype,HP:0006970,Periventricular leukomalacia,0.0489933448077271,0.22885656772961716,1
3436,Phenotype,HP:0003292,Decreased serum leptin,0.0489581102132296,0.2282505105780511,1
3437,Phenotype,HP:0012093,Abnormality of endocrine pancreas physiology,0.04895541587728525,0.22820416630785062,1
3438,Phenotype,HP:0003112,Abnormal circulating amino acid concentration,0.0488358846761664,0.2261481545867991,1
3439,Phenotype,HP:0007266,Cerebral dysmyelination,0.048829764684656274,0.2260428868896642,1
3440,Biological Process,GO:0061028,establishment of endothelial barrier,0.048823220347471885,0.2259303201804563,1
3441,Biological Process,GO:0060324,face development,0.04879461351629255,0.2254382647199881,1
3442,Disease,MONDO:0018997,Noonan syndrome,0.048773820709002824,0.22508061537738058,1
3443,Phenotype,HP:0010628,Facial palsy,0.04876856892918069,0.22499028146648853,1
3444,Phenotype,HP:0011167,Focal tonic seizure,0.04875550197758527,0.22476552169341568,1
3445,Disease,MONDO:0000473,arterial disorder,0.04872723825130276,0.22427936785263192,1
3446,Phenotype,HP:0030215,Inappropriate crying,0.04869202980634291,0.22367376048953447,1
3447,Biological Process,GO:0002446,neutrophil mediated immunity,0.04867101201616586,0.2233122412999829,1
3448,Biological Process,GO:0033233,regulation of protein sumoylation,0.04865999649134656,0.2231227673556903,1
3449,Phenotype,HP:0003107,Abnormal circulating cholesterol concentration,0.04864701955258377,0.22289955585986396,1
3450,Phenotype,HP:0040049,Macular edema,0.04863163420077443,0.22263491814722985,1
3451,Phenotype,HP:0001923,Reticulocytosis,0.04861866346699806,0.22241181338106636,1
3452,Phenotype,HP:0031850,Abnormal hematocrit,0.048614408978529644,0.22233863350772567,1
3453,Biological Process,GO:0009190,cyclic nucleotide biosynthetic process,0.0485975882565064,0.2220493065260453,1
3454,Biological Process,GO:0044843,cell cycle G1/S phase transition,0.04857823572370712,0.22171643080912026,1
3455,Phenotype,HP:0012324,Myeloid leukemia,0.04857762136024968,0.2217058633718515,1
3456,Biological Process,GO:0018126,protein hydroxylation,0.04855021859317055,0.22123451857002088,1
3457,Phenotype,HP:0002505,Loss of ambulation,0.04854736667032056,0.22118546370608386,1
3458,Phenotype,HP:0000045,Abnormal scrotum morphology,0.04853593659061761,0.22098885915746527,1
3459,Phenotype,HP:0012410,Pure red cell aplasia,0.04853205460561272,0.2209220865776175,1
3460,Phenotype,HP:0000189,Narrow palate,0.048527121342813895,0.220837231359545,1
3461,Phenotype,HP:0031094,Abnormal breast physiology,0.04849474219466399,0.2202802896782874,1
3461,Phenotype,HP:0100829,Galactorrhea,0.04849474219466399,0.2202802896782874,1
3463,Biological Process,GO:0010884,positive regulation of lipid storage,0.04845752693541705,0.21964016384923635,1
3464,Phenotype,HP:0012764,Orthopnea,0.048456684466129496,0.2196256728484464,1
3465,Disease,MONDO:0037940,inherited auditory system disease,0.04842113806002779,0.2190142523414802,1
3465,Disease,MONDO:0002409,auditory system disorder,0.04842113806002779,0.2190142523414802,1
3465,Disease,MONDO:0005365,hearing loss disorder,0.04842113806002779,0.2190142523414802,1
3465,Disease,MONDO:0021945,hearing disorder,0.04842113806002779,0.2190142523414802,1
3469,Phenotype,HP:0100592,Peritoneal abscess,0.048414013285460245,0.2188917017447857,1
3470,Phenotype,HP:0002257,Chronic rhinitis,0.04841092733606134,0.21883862147724606,1
3471,Phenotype,HP:0001946,Ketosis,0.048372257975935584,0.21817348419995006,1
3472,Phenotype,HP:0000891,Cervical ribs,0.048366756554882984,0.2180788563031272,1
3473,Biological Process,GO:0034139,regulation of toll-like receptor 3 signaling pathway,0.0483660135376065,0.2180660759393804,1
3474,Phenotype,HP:0012622,Chronic kidney disease,0.04835838655665181,0.21793488707745734,1
3475,Biological Process,GO:0038083,peptidyl-tyrosine autophosphorylation,0.04835087139443883,0.21780562156811034,1
3476,Biological Process,GO:0070102,interleukin-6-mediated signaling pathway,0.04833092684949081,0.21746256287046195,1
3477,Biological Process,GO:0045954,positive regulation of natural killer cell mediated cytotoxicity,0.04831748082471443,0.21723128280063073,1
3478,Biological Process,GO:1903311,regulation of mRNA metabolic process,0.0483097131213962,0.21709767342568562,1
3479,Phenotype,HP:0000768,Pectus carinatum,0.048308594616516376,0.21707843443936697,1
3480,Biological Process,GO:0045920,negative regulation of exocytosis,0.048289589696451696,0.21675153787976678,1
3481,Biological Process,GO:0060429,epithelium development,0.048274523281832904,0.2164923860870925,1
3482,Biological Process,GO:0086005,ventricular cardiac muscle cell action potential,0.04826293376818336,0.21629303917447293,1
3483,Biological Process,GO:0071276,cellular response to cadmium ion,0.04822935696913844,0.2157154971457343,1
3484,Biological Process,GO:0000305,response to oxygen radical,0.04820638621662965,0.2153203857776783,1
3485,Disease,MONDO:0020159,congenital entropion,0.048205875417641875,0.215311599714323,1
3485,Disease,MONDO:0001519,entropion,0.048205875417641875,0.215311599714323,1
3487,Phenotype,HP:0002823,Abnormal femur morphology,0.04819371304852138,0.21510239932786804,1
3488,Phenotype,HP:0006467,Limited shoulder movement,0.048183798254248345,0.21493185864019515,1
3489,Biological Process,GO:1903146,regulation of autophagy of mitochondrion,0.04816822543297883,0.2146639963351211,1
3490,Biological Process,GO:0045606,positive regulation of epidermal cell differentiation,0.048161427710567084,0.21454707124088476,1
3490,Biological Process,GO:0045684,positive regulation of epidermis development,0.048161427710567084,0.21454707124088476,1
3492,Phenotype,HP:0000363,Abnormal earlobe morphology,0.04815668157460662,0.21446543472194177,1
3493,Phenotype,HP:0012548,Fatty replacement of skeletal muscle,0.04815426507318643,0.2144238693800282,1
3494,Biological Process,GO:0045010,actin nucleation,0.048147592987159205,0.21430910531050126,1
3495,Biological Process,GO:1903530,regulation of secretion by cell,0.0481343797526439,0.2140818293793453,1
3496,Biological Process,GO:0070633,transepithelial transport,0.04811856056457209,0.21380972941056128,1
3497,Biological Process,GO:1903670,regulation of sprouting angiogenesis,0.04808044792216393,0.21315416802760898,1
3498,Biological Process,GO:0043523,regulation of neuron apoptotic process,0.0480771592700614,0.21309760114627616,1
3499,Phenotype,HP:0011760,Pituitary growth hormone cell adenoma,0.04804169194157937,0.21248754082402663,1
3500,Phenotype,HP:0003417,Coronal cleft vertebrae,0.048026232869517904,0.21222163507676198,1
3501,Phenotype,HP:0006101,Finger syndactyly,0.04802204451925596,0.21214959282210522,1
3502,Phenotype,HP:0007099,Chiari type I malformation,0.048013909427820134,0.21200966414082936,1
3503,Biological Process,GO:0006851,mitochondrial calcium ion transmembrane transport,0.04801120037040929,0.21196306665216064,1
3504,Biological Process,GO:0032006,regulation of TOR signaling,0.04800672399937567,0.21188607025936312,1
3505,Biological Process,GO:0032480,negative regulation of type I interferon production,0.04799046499591886,0.21160640518976695,1
3506,Biological Process,GO:0006359,regulation of transcription by RNA polymerase III,0.04797588724201296,0.21135565866821793,1
3507,Phenotype,HP:0500183,Abnormal CSF carboxylic acid concentration,0.04795945907142829,0.21107308381779094,1
3508,Biological Process,GO:1901623,regulation of lymphocyte chemotaxis,0.04794925530905403,0.21089757269731416,1
3509,Disease,MONDO:0019716,overgrowth syndrome,0.047948785627498935,0.21088949387962141,1
3510,Phenotype,HP:0002171,Gliosis,0.04794807170229942,0.21087721391786737,1
3511,Disease,MONDO:0100473,disorder of peptide and amine metabolism,0.04793987629856067,0.21073624782710693,1
3512,Phenotype,HP:0012505,Enlarged pituitary gland,0.047932408898772816,0.21060780386146535,1
3513,Biological Process,GO:0044793,negative regulation by host of viral process,0.04789603137967502,0.2099820876890538,1
3514,Biological Process,GO:0006662,glycerol ether metabolic process,0.04789008362632918,0.20987978259650475,1
3514,Biological Process,GO:0046485,ether lipid metabolic process,0.04789008362632918,0.20987978259650475,1
3516,Phenotype,HP:0006758,Malignant genitourinary tract tumor,0.04785118842329583,0.20921076067937588,1
3517,Phenotype,HP:0100590,Rectal fistula,0.047845497480597854,0.20911287289123895,1
3518,Biological Process,GO:0009181,purine ribonucleoside diphosphate catabolic process,0.04783530232914557,0.2089375098840275,1
3518,Biological Process,GO:0009137,purine nucleoside diphosphate catabolic process,0.04783530232914557,0.2089375098840275,1
3520,Phenotype,HP:0100798,Fingernail dysplasia,0.04782870018778407,0.2088239489066741,1
3521,Phenotype,HP:0000122,Unilateral renal agenesis,0.04781408131049458,0.20857249503710318,1
3522,Biological Process,GO:0044839,cell cycle G2/M phase transition,0.047814006461245784,0.2085712075830209,1
3523,Biological Process,GO:0140888,interferon-mediated signaling pathway,0.0478083633989792,0.2084741433683714,1
3524,Phenotype,HP:0001460,Aplasia/Hypoplasia involving the skeletal musculature,0.047785794856748054,0.20808595026966611,1
3525,Biological Process,GO:0034620,cellular response to unfolded protein,0.04777816294796933,0.2079546766460751,1
3526,Phenotype,HP:0031685,Abnormal stool composition,0.04777794647957534,0.20795095325376323,1
3527,Biological Process,GO:2000117,negative regulation of cysteine-type endopeptidase activity,0.047703398773235706,0.20666868589112378,1
3528,Biological Process,GO:1901655,cellular response to ketone,0.04769631703953614,0.20654687562438684,1
3529,Biological Process,GO:0031400,negative regulation of protein modification process,0.04763551783447173,0.20550109111730447,1
3530,Phenotype,HP:0100648,Neoplasm of the tongue,0.047614595536507265,0.2051412144537754,1
3531,Phenotype,HP:0009102,Anterior open-bite malocclusion,0.04757679080643917,0.20449094935643147,1
3532,Biological Process,GO:0030851,granulocyte differentiation,0.0475695425956526,0.20436627557925574,1
3533,Biological Process,GO:0001578,microtubule bundle formation,0.04756829233017379,0.20434477022789302,1
3534,Biological Process,GO:1901292,nucleoside phosphate catabolic process,0.04756228483667735,0.20424143756723867,1
3535,Phenotype,HP:0000360,Tinnitus,0.04752209973263588,0.20355022854275323,1
3536,Biological Process,GO:0014742,positive regulation of muscle hypertrophy,0.047520103842523476,0.2035158979794641,1
3536,Biological Process,GO:0010613,positive regulation of cardiac muscle hypertrophy,0.047520103842523476,0.2035158979794641,1
3538,Phenotype,HP:0001187,Hyperextensibility of the finger joints,0.04750548654429532,0.2032644712707396,1
3539,Phenotype,HP:0003811,Neonatal death,0.04750536690761176,0.20326241344465432,1
3540,Biological Process,GO:0000082,G1/S transition of mitotic cell cycle,0.04750454546088756,0.2032482840451556,1
3541,Phenotype,HP:0001136,Retinal arteriolar tortuosity,0.047501616147622716,0.20319789801748436,1
3542,Phenotype,HP:0000973,Cutis laxa,0.04746491511351503,0.20256661718374547,1
3543,Biological Process,GO:0046040,IMP metabolic process,0.047423540241905204,0.201854943409948,1
3544,Biological Process,GO:0032956,regulation of actin cytoskeleton organization,0.047412525492665614,0.2016654828061135,1
3545,Biological Process,GO:0042177,negative regulation of protein catabolic process,0.0473897390535456,0.20127354174408738,1
3546,Phenotype,HP:0011840,Abnormality of T cell physiology,0.0473886695883039,0.20125514627033989,1
3547,Phenotype,HP:0004426,Abnormal cheek morphology,0.04736038696927747,0.20076866746249655,1
3548,Biological Process,GO:0008209,androgen metabolic process,0.04735639517558854,0.200700006104327,1
3549,Phenotype,HP:0008163,Decreased circulating cortisol level,0.047341381230204815,0.20044175681544493,1
3550,Phenotype,HP:0003551,Difficulty climbing stairs,0.04730907978418741,0.1998861516596609,1
3551,Biological Process,GO:1990849,vacuolar localization,0.04726579071650194,0.1991415525113078,1
3551,Biological Process,GO:0032418,lysosome localization,0.04726579071650194,0.1991415525113078,1
3553,Biological Process,GO:0045048,protein insertion into ER membrane,0.047224328695762985,0.19842837971776228,1
3554,Phenotype,HP:0007328,Impaired pain sensation,0.047222109289715375,0.19839020454002673,1
3555,Phenotype,HP:0410243,Abnormal circulating IgM level,0.04722075495369227,0.19836690910994917,1
3556,Phenotype,HP:0030724,Central nervous system cyst,0.047173203945080955,0.1975490019013077,1
3557,Phenotype,HP:0000869,Secondary amenorrhea,0.04715280097833374,0.19719805806083893,1
3558,Phenotype,HP:0100323,Juvenile aseptic necrosis,0.04714914538818382,0.1971351796146655,1
3559,Phenotype,HP:0002488,Acute leukemia,0.04710169116698859,0.19631893721036006,1
3560,Biological Process,GO:0022008,neurogenesis,0.047022611471585596,0.19495871678988524,1
3561,Phenotype,HP:0003678,Rapidly progressive,0.047020272114401296,0.1949184783772731,1
3562,Biological Process,GO:0002026,regulation of the force of heart contraction,0.04699742374292537,0.19452547203983378,1
3563,Biological Process,GO:0010803,regulation of tumor necrosis factor-mediated signaling pathway,0.046987303644362544,0.1943513999894519,1
3564,Disease,MONDO:0002468,hyperimmunoglobulin syndrome,0.04697982278239565,0.19422272446587707,1
3565,Biological Process,GO:1904263,positive regulation of TORC1 signaling,0.04694209903454871,0.1935738523135912,1
3566,Biological Process,GO:0045620,negative regulation of lymphocyte differentiation,0.04690189235325026,0.19288227214673587,1
3567,Biological Process,GO:0044319,"wound healing, spreading of cells",0.04688707754516375,0.19262744814441765,1
3567,Biological Process,GO:0090505,epiboly involved in wound healing,0.04688707754516375,0.19262744814441765,1
3569,Disease,MONDO:0021002,syndactyly,0.04686609523826135,0.1922665392894725,1
3570,Biological Process,GO:0018107,peptidyl-threonine phosphorylation,0.04686101987987057,0.19217923993798677,1
3571,Phenotype,HP:0001639,Hypertrophic cardiomyopathy,0.046860629821382616,0.1921725306870496,1
3572,Biological Process,GO:0034367,protein-containing complex remodeling,0.04685388869936946,0.1920565791552123,1
3573,Biological Process,GO:0008652,amino acid biosynthetic process,0.04684561986575486,0.19191435002447566,1
3574,Phenotype,HP:0002579,Gastrointestinal dysmotility,0.04682217956808932,0.19151116218486397,1
3575,Biological Process,GO:0010948,negative regulation of cell cycle process,0.04680324518619161,0.1911854789260315,1
3576,Biological Process,GO:0060249,anatomical structure homeostasis,0.04679805140524618,0.19109614263224015,1
3576,Biological Process,GO:0001894,tissue homeostasis,0.04679805140524618,0.19109614263224015,1
3578,Phenotype,HP:0010500,Hyperextensibility of the knee,0.0467953811550712,0.19105021265239808,1
3579,Phenotype,HP:0007086,Social and occupational deterioration,0.04677850921024551,0.19076000460634937,1
3580,Biological Process,GO:0060325,face morphogenesis,0.04676921316825189,0.19060010684643922,1
3581,Phenotype,HP:5200430,Abnormal psychotic pattern,0.04675470994424724,0.19035064228599408,1
3582,Phenotype,HP:0020061,Abnormal hemoglobin concentration,0.0467247800344297,0.1898358290420973,1
3583,Biological Process,GO:0050709,negative regulation of protein secretion,0.046680464866746596,0.18907358032942656,1
3584,Phenotype,HP:0040132,Abnormal sensory nerve conduction velocity,0.04664720528007493,0.18850149455270726,1
3585,Biological Process,GO:0048661,positive regulation of smooth muscle cell proliferation,0.04664189069686875,0.188410080384171,1
3586,Biological Process,GO:0071378,cellular response to growth hormone stimulus,0.04662869302046613,0.1881830720623233,1
3586,Biological Process,GO:0060396,growth hormone receptor signaling pathway,0.04662869302046613,0.1881830720623233,1
3588,Biological Process,GO:0048008,platelet-derived growth factor receptor signaling pathway,0.046624266974340745,0.18810694128954997,1
3589,Phenotype,HP:0010995,Abnormal circulating dicarboxylic acid concentration,0.046614311874648484,0.18793570732335588,1
3590,Phenotype,HP:0002312,Clumsiness,0.04659008968799927,0.18751907050222358,1
3591,Phenotype,HP:0002870,Obstructive sleep apnea,0.04658892949411064,0.18749911443877418,1
3592,Phenotype,HP:0001618,Dysphonia,0.04658079034631557,0.187359115985572,1
3593,Phenotype,HP:0005565,Reduced renal corticomedullary differentiation,0.04656044540201665,0.1870091701676501,1
3594,Biological Process,GO:0035891,exit from host cell,0.04654179562487837,0.1866883822894025,1
3594,Biological Process,GO:0019076,viral release from host cell,0.04654179562487837,0.1866883822894025,1
3596,Biological Process,GO:0010885,regulation of cholesterol storage,0.046537531452136016,0.18661503584046865,1
3597,Phenotype,HP:0200039,Pustule,0.0465266082595821,0.1864271500691225,1
3598,Phenotype,HP:0000992,Cutaneous photosensitivity,0.04649818031743358,0.18593817161232087,1
3599,Biological Process,GO:0098901,regulation of cardiac muscle cell action potential,0.04648266229383857,0.1856712518616596,1
3600,Disease,MONDO:0000688,inborn organic aciduria,0.046482609056005875,0.1856703361375055,1
3601,Biological Process,GO:2000353,positive regulation of endothelial cell apoptotic process,0.04647960789389727,0.18561871426460275,1
3602,Phenotype,HP:0002145,Frontotemporal dementia,0.046472676507244626,0.18549949006148608,1
3603,Phenotype,HP:0001696,Situs inversus totalis,0.04646166540765051,0.18531009223384562,1
3604,Phenotype,HP:0000748,Inappropriate laughter,0.04645844129375898,0.1852546354502699,1
3605,Phenotype,HP:0011078,Abnormality of canine,0.04644190392931058,0.1849701823968165,1
3606,Biological Process,GO:0001508,action potential,0.04643185611360989,0.18479735365705477,1
3607,Phenotype,HP:0003084,Fractures of the long bones,0.04641031223024583,0.18442678533431672,1
3608,Phenotype,HP:0002134,Abnormal basal ganglia morphology,0.04640613024346041,0.18435485253545222,1
3609,Phenotype,HP:0005266,Intestinal polyp,0.0464009994585215,0.18426659981253257,1
3610,Phenotype,HP:0003689,Multiple mitochondrial DNA deletions,0.04635670430439354,0.18350469534557823,1
3611,Biological Process,GO:0010804,negative regulation of tumor necrosis factor-mediated signaling pathway,0.04634758073637213,0.18334776424629834,1
3612,Biological Process,GO:0046426,negative regulation of receptor signaling pathway via JAK-STAT,0.046327204163995495,0.18299727440557836,1
3613,Biological Process,GO:0010927,cellular component assembly involved in morphogenesis,0.04631855204690494,0.18284845255836535,1
3613,Biological Process,GO:0032989,cellular anatomical entity morphogenesis,0.04631855204690494,0.18284845255836535,1
3615,Phenotype,HP:0031692,Severe cytomegalovirus infection,0.04629440043757038,0.18243302971136552,1
3616,Biological Process,GO:1901889,negative regulation of cell junction assembly,0.04627677215410153,0.18212981216569776,1
3617,Biological Process,GO:0045947,negative regulation of translational initiation,0.046269415154360005,0.18200326715018075,1
3618,Biological Process,GO:0009225,nucleotide-sugar metabolic process,0.04626380846217171,0.18190682852371698,1
3619,Phenotype,HP:0003563,Decreased LDL cholesterol concentration,0.046205173766917684,0.18089827494461683,1
3620,Biological Process,GO:0050999,regulation of nitric-oxide synthase activity,0.0462049101530545,0.18089374062062893,1
3621,Phenotype,HP:0011304,Broad thumb,0.046170415512752694,0.1803004111458966,1
3622,Biological Process,GO:0009066,aspartate family amino acid metabolic process,0.04617004596071739,0.18029405461882236,1
3623,Disease,MONDO:0045010,glycoprotein metabolism disease,0.046155612692686865,0.18004579334506232,1
3624,Phenotype,HP:0011409,Abnormal placental membrane morphology,0.04611796167287052,0.17939817216057366,1
3625,Biological Process,GO:0051353,positive regulation of oxidoreductase activity,0.04606169459611065,0.17843034310636227,1
3626,Biological Process,GO:0030178,negative regulation of Wnt signaling pathway,0.0460543915865812,0.17830472675639716,1
3627,Biological Process,GO:2000622,"regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",0.04604229779650004,0.17809670597248423,1
3628,Biological Process,GO:0034329,cell junction assembly,0.04603659509343927,0.1779986158987221,1
3629,Phenotype,HP:0002438,Cerebellar malformation,0.04601766464740653,0.17767300033923863,1
3630,Biological Process,GO:0016052,carbohydrate catabolic process,0.046007964127401046,0.17750614530352507,1
3631,Phenotype,HP:0012156,Hemophagocytosis,0.04600719347673132,0.17749288962806162,1
3632,Phenotype,HP:0000621,Entropion,0.04593414926100037,0.17623648324803592,1
3633,Phenotype,HP:0031101,Abnormal circulating antimullerian hormone concentration,0.04592389337892411,0.17606007563595524,1
3634,Biological Process,GO:0042063,gliogenesis,0.0459185721041796,0.17596854636875775,1
3635,Biological Process,GO:0051224,negative regulation of protein transport,0.045918072416045064,0.1759599514190554,1
3636,Biological Process,GO:0043116,negative regulation of vascular permeability,0.04590611244388032,0.17575423238733823,1
3637,Phenotype,HP:0100026,Arteriovenous malformation,0.0458867211582169,0.1754206900968144,1
3638,Phenotype,HP:0011534,Abnormal spatial orientation of the cardiac segments,0.04587222671391056,0.17517137655269346,1
3639,Phenotype,HP:0030829,Abnormal breath sound,0.04581127767609294,0.17412301482816572,1
3640,Disease,MONDO:0005564,embryonal neoplasm,0.04579315708146481,0.1738113292214025,1
3641,Phenotype,HP:0032179,Abnormal circulating globulin concentration,0.04575866013508301,0.1732179600806461,1
3642,Biological Process,GO:0015031,protein transport,0.04574581880542872,0.17299708114664414,1
3643,Biological Process,GO:0051452,intracellular pH reduction,0.04574012172826292,0.1728990878418084,1
3644,Phenotype,HP:0410263,Brain imaging abnormality,0.04571290795652316,0.1724309938784982,1
3645,Biological Process,GO:1901163,regulation of trophoblast cell migration,0.04568603260032056,0.17196872087494117,1
3646,Biological Process,GO:0007194,negative regulation of adenylate cyclase activity,0.04567754472514585,0.17182272409181942,1
3647,Phenotype,HP:0002515,Waddling gait,0.045639127987056716,0.17116193207219196,1
3648,Phenotype,HP:0025439,Pharyngitis,0.0456110493793771,0.17067896238762656,1
3649,Phenotype,HP:0001949,Hypokalemic alkalosis,0.04560592410512465,0.17059080445197458,1
3650,Biological Process,GO:1903376,regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,0.04559973656048255,0.17048437479854847,1
3651,Biological Process,GO:0033119,negative regulation of RNA splicing,0.04557806553190491,0.17011161949829368,1
3652,Biological Process,GO:0032435,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,0.04557670024987981,0.1700881357901081,1
3653,Phenotype,HP:0025125,White lesion of the oral mucosa,0.045573421390617375,0.1700317373517745,1
3653,Phenotype,HP:0002745,Oral leukoplakia,0.045573421390617375,0.1700317373517745,1
3655,Phenotype,HP:0000211,Trismus,0.04557197951091685,0.17000693611547066,1
3656,Biological Process,GO:0045123,cellular extravasation,0.04554872751932615,0.16960698725859658,1
3657,Phenotype,HP:0001909,Leukemia,0.045540594282004854,0.16946709046925493,1
3658,Phenotype,HP:0001028,Hemangioma,0.04552658077658833,0.16922604937605334,1
3659,Biological Process,GO:0009168,purine ribonucleoside monophosphate biosynthetic process,0.04551692469836599,0.16905995876691787,1
3660,Phenotype,HP:5200283,Sleep-related breathing disorders,0.04548755834081397,0.168554838975881,1
3661,Biological Process,GO:0090317,negative regulation of intracellular protein transport,0.0454491923355298,0.1678949195923574,1
3662,Biological Process,GO:0019674,NAD metabolic process,0.04544892203865092,0.1678902703163028,1
3663,Biological Process,GO:0035567,non-canonical Wnt signaling pathway,0.045419167712799524,0.16737847722688487,1
3664,Disease,MONDO:0005500,congenital disorder of glycosylation type I,0.04540198767066661,0.1670829697136766,1
3665,Biological Process,GO:0006084,acetyl-CoA metabolic process,0.045399459964862054,0.16703949158651907,1
3666,Phenotype,HP:0100279,Ulcerative colitis,0.04539345389448257,0.16693618340437005,1
3666,Phenotype,HP:0100281,Chronic colitis,0.04539345389448257,0.16693618340437005,1
3668,Disease,MONDO:0002545,spinal cord disorder,0.04539253337206295,0.16692034984069362,1
3668,Disease,MONDO:0003182,anterior horn disorder,0.04539253337206295,0.16692034984069362,1
3670,Disease,MONDO:0007794,hypogonadotropic hypogonadism 7 with or without anosmia,0.04539187653290322,0.16690905179467208,1
3671,Phenotype,HP:0010880,Increased nuchal translucency,0.04535905700238818,0.16634453526018805,1
3672,Phenotype,HP:0030014,Female sexual dysfunction,0.045358269509703564,0.1663309898914922,1
3673,Phenotype,HP:0002300,Mutism,0.045348432740275,0.16616179128014139,1
3674,Biological Process,GO:0010820,positive regulation of T cell chemotaxis,0.04532691849156578,0.16579173269207623,1
3675,Biological Process,GO:0030048,actin filament-based movement,0.04530829584492779,0.16547141147547073,1
3676,Biological Process,GO:0061013,regulation of mRNA catabolic process,0.04529951349560135,0.1653203495520188,1
3677,Phenotype,HP:0003448,Decreased sensory nerve conduction velocity,0.04528966282664071,0.16515091185998773,1
3678,Biological Process,GO:0060766,negative regulation of androgen receptor signaling pathway,0.04528908567071177,0.16514098441557434,1
3679,Phenotype,HP:0500184,Abnormal CSF amino acid concentration,0.04520208854402541,0.16364457920512965,1
3680,Phenotype,HP:0002483,Bulbar signs,0.045201315645093,0.16363128485813613,1
3681,Biological Process,GO:0050820,positive regulation of coagulation,0.04513409759999165,0.16247509227159024,1
3681,Biological Process,GO:1900048,positive regulation of hemostasis,0.04513409759999165,0.16247509227159024,1
3681,Biological Process,GO:0030194,positive regulation of blood coagulation,0.04513409759999165,0.16247509227159024,1
3684,Phenotype,HP:0012463,Elevated transferrin saturation,0.04511434720083862,0.16213537300353323,1
3685,Biological Process,GO:0051085,chaperone cofactor-dependent protein refolding,0.04510466451307016,0.1619688246934945,1
3686,Biological Process,GO:0018210,peptidyl-threonine modification,0.04506904182635052,0.16135609211199806,1
3687,Phenotype,HP:0000805,Enuresis,0.04505529211663384,0.16111958847048904,1
3688,Biological Process,GO:0090504,epiboly,0.04503697101658233,0.16080445404453267,1
3689,Phenotype,HP:0033603,Glomerular subepithelial deposits,0.045032431662085703,0.16072637429661993,1
3690,Biological Process,GO:0032365,intracellular lipid transport,0.04501455549689215,0.16041889302962542,1
3691,Phenotype,HP:0008661,Urethral stenosis,0.044996671224740936,0.16011127231786826,1
3692,Disease,MONDO:0016537,lymphoproliferative syndrome,0.04499391917962736,0.16006393541371763,1
3693,Biological Process,GO:0072521,purine-containing compound metabolic process,0.04498556871064774,0.15992030210343816,1
3694,Disease,MONDO:0016763,spondylometaphyseal dysplasia,0.04497812395273859,0.1597922475923287,1
3695,Biological Process,GO:0071692,protein localization to extracellular region,0.044962273249179896,0.1595196055373795,1
3696,Phenotype,HP:0008034,Abnormal iris pigmentation,0.044954700692162786,0.15938935280135932,1
3697,Biological Process,GO:0034284,response to monosaccharide,0.04493669066526762,0.1590795690290362,1
3697,Biological Process,GO:0009749,response to glucose,0.04493669066526762,0.1590795690290362,1
3697,Biological Process,GO:0009746,response to hexose,0.04493669066526762,0.1590795690290362,1
3700,Phenotype,HP:0010831,Impaired proprioception,0.04490921479197818,0.15860696675447988,1
3701,Disease,MONDO:0002887,bile duct disorder,0.04489320373583916,0.15833156653445274,1
3702,Biological Process,GO:0150116,regulation of cell-substrate junction organization,0.044876856452731984,0.15805038299943344,1
3703,Phenotype,HP:0000033,"Ambiguous genitalia, male",0.044870167623599855,0.15793533093798803,1
3704,Phenotype,HP:0000293,Full cheeks,0.0448519757988145,0.15762242012779037,1
3705,Phenotype,HP:0005599,Hypopigmentation of hair,0.04484432188400622,0.15749076798667194,1
3706,Biological Process,GO:0018208,peptidyl-proline modification,0.044831112770485904,0.15726356293921767,1
3707,Biological Process,GO:0042982,amyloid precursor protein metabolic process,0.0448165398639655,0.15701289979574312,1
3708,Biological Process,GO:0031098,stress-activated protein kinase signaling cascade,0.04478832109178632,0.15652751919376634,1
3709,Phenotype,HP:0006000,Ureteral obstruction,0.044786731449549255,0.15650017634904387,1
3710,Phenotype,HP:0000926,Platyspondyly,0.044779128571141524,0.15636940206606412,1
3711,Biological Process,GO:0048260,positive regulation of receptor-mediated endocytosis,0.04476324554668787,0.1560962040714251,1
3712,Phenotype,HP:0002173,Hypoglycemic seizures,0.04475687481791124,0.15598662353585127,1
3713,Disease,MONDO:0018555,hypogonadotropic hypogonadism,0.04474570859870386,0.15579455755345242,1
3714,Phenotype,HP:0003103,Abnormal cortical bone morphology,0.04473936936573719,0.15568551876558828,1
3715,Biological Process,GO:0042743,hydrogen peroxide metabolic process,0.04470986364367202,0.15517800181740868,1
3716,Phenotype,HP:0003413,Atlantoaxial abnormality,0.0446894610849512,0.15482706499525006,1
3717,Biological Process,GO:0071825,protein-lipid complex organization,0.04468033761814161,0.15467013563687698,1
3718,Phenotype,HP:0010915,Abnormal circulating pyruvate family amino acid concentration,0.044652054132760965,0.15418364192719722,1
3718,Phenotype,HP:0010916,Abnormal circulating alanine concentration,0.044652054132760965,0.15418364192719722,1
3720,Biological Process,GO:0070534,protein K63-linked ubiquitination,0.044624590555646826,0.15371125115457768,1
3721,Phenotype,HP:0000178,Abnormal lower lip morphology,0.044594780556186264,0.1531985004441208,1
3722,Biological Process,GO:0032273,positive regulation of protein polymerization,0.0445903106069756,0.15312161451071093,1
3723,Biological Process,GO:0051084,'de novo' post-translational protein folding,0.04453544736425841,0.15217793228359694,1
3724,Biological Process,GO:0045653,negative regulation of megakaryocyte differentiation,0.04452863106377514,0.15206068763486394,1
3725,Phenotype,HP:0006739,Squamous cell carcinoma of the skin,0.04451570535316085,0.15183835729536146,1
3726,Biological Process,GO:0160049,negative regulation of cGAS/STING signaling pathway,0.04448531303855141,0.1513155903986684,1
3727,Biological Process,GO:0071318,cellular response to ATP,0.04445306647037117,0.15076092917614514,1
3728,Biological Process,GO:0006998,nuclear envelope organization,0.04445136570754349,0.1507316749874838,1
3729,Phenotype,HP:0100512,Decreased circulating vitamin D concentration,0.044418967127391906,0.15017439906359473,1
3730,Biological Process,GO:0032984,protein-containing complex disassembly,0.04440987982609923,0.15001809177482336,1
3731,Biological Process,GO:0031579,membrane raft organization,0.04439962493719707,0.14984170124596086,1
3732,Biological Process,GO:0010819,regulation of T cell chemotaxis,0.04439230588285992,0.14971580891522762,1
3733,Phenotype,HP:0003265,Neonatal hyperbilirubinemia,0.04436104666036522,0.1491781306585175,1
3734,Phenotype,HP:0008450,Narrow vertebral interpedicular distance,0.04431879632928182,0.1484513984320136,1
3735,Biological Process,GO:1900117,regulation of execution phase of apoptosis,0.044264786621513896,0.14752239754202,1
3736,Biological Process,GO:0007193,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway,0.04425587576772627,0.14736912526113902,1
3737,Phenotype,HP:0000081,Duplicated collecting system,0.044250567438549715,0.1472778186658397,1
3738,Phenotype,HP:0001698,Pericardial effusion,0.04424800650794314,0.1472337690512233,1
3739,Phenotype,HP:0001437,Abnormality of the musculature of the lower limbs,0.04423626879246678,0.14703187297411652,1
3740,Biological Process,GO:0043154,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,0.0442129206342442,0.1466302699907845,1
3741,Phenotype,HP:0011274,Recurrent mycobacterial infections,0.04420836188949373,0.14655185671832913,1
3742,Phenotype,HP:0002949,Fused cervical vertebrae,0.04417954908768751,0.14605625843373543,1
3743,Phenotype,HP:0000991,Xanthomatosis,0.044178513370735195,0.1460384434517582,1
3744,Biological Process,GO:0043242,negative regulation of protein-containing complex disassembly,0.04417266041606471,0.1459377689559558,1
3745,Biological Process,GO:2001222,regulation of neuron migration,0.044171438076618386,0.14591674394988852,1
3746,Biological Process,GO:0051881,regulation of mitochondrial membrane potential,0.04411558578823471,0.14495604951622176,1
3747,Phenotype,HP:0011470,Nasogastric tube feeding in infancy,0.044087123707872045,0.14446648386069916,1
3748,Biological Process,GO:0072523,purine-containing compound catabolic process,0.044060869952697757,0.14401490278517493,1
3749,Phenotype,HP:0001138,Optic neuropathy,0.04404527549806414,0.1437466683726533,1
3750,Biological Process,GO:0042572,retinol metabolic process,0.04404001494912513,0.1436561836274442,1
3751,Phenotype,HP:0012135,Abnormal granulocytopoietic cell morphology,0.04399874594479569,0.14294633083735067,1
3752,Biological Process,GO:0042759,long-chain fatty acid biosynthetic process,0.04398659665370097,0.1427373554011516,1
3753,Biological Process,GO:0030511,positive regulation of transforming growth factor beta receptor signaling pathway,0.04398358161224947,0.1426854947948352,1
3753,Biological Process,GO:1903846,positive regulation of cellular response to transforming growth factor beta stimulus,0.04398358161224947,0.1426854947948352,1
3755,Phenotype,HP:0011219,Short face,0.04396725290333403,0.14240463074757784,1
3756,Phenotype,HP:0000506,Telecanthus,0.04396518610211775,0.14236908046877209,1
3757,Biological Process,GO:0071827,plasma lipoprotein particle organization,0.043917945644247114,0.14155651492788632,1
3758,Phenotype,HP:0002206,Pulmonary fibrosis,0.04391491145417903,0.14150432495334,1
3759,Disease,MONDO:0000412,neonatal period electroclinical syndrome,0.043900531120527386,0.14125697418413782,1
3760,Phenotype,HP:0005293,Venous insufficiency,0.04390013573712492,0.14125017334132722,1
3761,Phenotype,HP:0003037,Enlarged joints,0.043898943445032534,0.14122966516861646,1
3762,Phenotype,HP:0040252,Abnormal size of the clitoris,0.0438979359840157,0.14121233620647333,1
3762,Phenotype,HP:0008665,Clitoral hypertrophy,0.0438979359840157,0.14121233620647333,1
3762,Phenotype,HP:0040253,Increased size of the clitoris,0.0438979359840157,0.14121233620647333,1
3765,Phenotype,HP:0000559,Corneal scarring,0.043892479486048686,0.14111848101493282,1
3766,Phenotype,HP:0011002,Osteopetrosis,0.043891298499148745,0.1410981672986315,1
3767,Biological Process,GO:0030641,regulation of cellular pH,0.0438138364334586,0.13976577112503785,1
3768,Phenotype,HP:0002339,Abnormal caudate nucleus morphology,0.04379172935715281,0.13938551553003478,1
3769,Biological Process,GO:1904377,positive regulation of protein localization to cell periphery,0.043745266026507745,0.13858631706544008,1
3770,Phenotype,HP:0003409,Distal sensory impairment of all modalities,0.043727088241159784,0.13827364774238188,1
3771,Phenotype,HP:0009777,Absent thumb,0.04370052130041968,0.137816679678455,1
3772,Phenotype,HP:0032120,Abnormal peripheral nervous system physiology,0.043666270414263963,0.13722754292810532,1
3773,Biological Process,GO:0043949,regulation of cAMP-mediated signaling,0.043658471796022114,0.1370934017970603,1
3774,Phenotype,HP:0006262,Aplasia/Hypoplasia of the 5th finger,0.0436361659072696,0.1367097265031256,1
3775,Biological Process,GO:0010875,positive regulation of cholesterol efflux,0.043622382856436714,0.13647264937348078,1
3776,Phenotype,HP:0012741,Unilateral cryptorchidism,0.043608453500394884,0.136233055702367,1
3777,Phenotype,HP:0000212,Gingival overgrowth,0.04360466131111573,0.13616782766539087,1
3778,Phenotype,HP:0006477,Abnormal alveolar ridge morphology,0.043591223750489516,0.1359366931842576,1
3779,Phenotype,HP:0025474,Erythematous plaque,0.04357367280979052,0.13563480598280017,1
3780,Phenotype,HP:0033044,Motor regression,0.043562487098361746,0.13544240472195287,1
3781,Phenotype,HP:0011147,Typical absence seizure,0.04354265954255454,0.13510135831099207,1
3782,Phenotype,HP:0033799,Abnormal circulating sex hormone concentration,0.04354171109187477,0.135085044363703,1
3783,Biological Process,GO:0046683,response to organophosphorus,0.04353317665474932,0.1349382466857891,1
3784,Phenotype,HP:0002920,Decreased circulating ACTH concentration,0.04352763245937996,0.13484288304385716,1
3785,Biological Process,GO:1903672,positive regulation of sprouting angiogenesis,0.04351278577530626,0.1345875107545423,1
3786,Phenotype,HP:0200008,Intestinal polyposis,0.04351128943508964,0.13456177276316214,1
3787,Phenotype,HP:0040072,Abnormal forearm bone morphology,0.043504979017790046,0.13445322962286702,1
3788,Phenotype,HP:0012377,Hemianopia,0.04350454049389785,0.13444568673654209,1
3789,Biological Process,GO:0042789,mRNA transcription by RNA polymerase II,0.04348803667029444,0.1341618106066851,1
3790,Biological Process,GO:0002028,regulation of sodium ion transport,0.04347708245728077,0.13397339126395127,1
3791,Disease,MONDO:0015607,partial chromosome Y deletion,0.043417612116995574,0.13295046406555636,1
3791,Disease,MONDO:0700028,chromosome Y disorder,0.043417612116995574,0.13295046406555636,1
3791,Disease,MONDO:0010767,"spermatogenic failure, Y-linked, 2",0.043417612116995574,0.13295046406555636,1
3794,Phenotype,HP:0500011,Moon facies,0.04337749995438511,0.13226050967948916,1
3795,Biological Process,GO:0038061,non-canonical NF-kappaB signal transduction,0.0433601987854767,0.13196291870967852,1
3796,Phenotype,HP:0008048,Abnormal line of Schwalbe morphology,0.043355574822060094,0.13188338363521038,1
3796,Phenotype,HP:0000627,Posterior embryotoxon,0.043355574822060094,0.13188338363521038,1
3798,Phenotype,HP:0003561,Birth length less than 3rd percentile,0.04334297566677725,0.1316666702524751,1
3799,Biological Process,GO:0009154,purine ribonucleotide catabolic process,0.0433293482496212,0.13143227011980485,1
3800,Phenotype,HP:0003237,Increased circulating IgG level,0.04331868840112185,0.13124891403156888,1
3801,Phenotype,HP:0010047,Short 5th metacarpal,0.04331561990554689,0.1311961339807615,1
3802,Biological Process,GO:0009206,purine ribonucleoside triphosphate biosynthetic process,0.043302611187846174,0.13097237586724667,1
3802,Biological Process,GO:0009145,purine nucleoside triphosphate biosynthetic process,0.043302611187846174,0.13097237586724667,1
3804,Biological Process,GO:0030593,neutrophil chemotaxis,0.04329419301162263,0.1308275779498537,1
3805,Biological Process,GO:0051283,negative regulation of sequestering of calcium ion,0.04322556535274569,0.12964713912117481,1
3805,Biological Process,GO:0051209,release of sequestered calcium ion into cytosol,0.04322556535274569,0.12964713912117481,1
3807,Phenotype,HP:0003438,Absent Achilles reflex,0.04320889987237131,0.12936048239334183,1
3808,Phenotype,HP:0011111,Abnormal immune serum protein physiology,0.043205599882368606,0.12930372049300617,1
3809,Phenotype,HP:0100742,Vascular neoplasm,0.043189269371809114,0.12902282545633967,1
3810,Phenotype,HP:0000092,Renal tubular atrophy,0.043159905445697255,0.12851774748760042,1
3810,Phenotype,HP:0032599,Abnormal renal tubular epithelial morphology,0.043159905445697255,0.12851774748760042,1
3812,Biological Process,GO:1905954,positive regulation of lipid localization,0.04313917085527119,0.12816109951160623,1
3813,Biological Process,GO:0050905,neuromuscular process,0.04310157121639124,0.12751436211148914,1
3814,Biological Process,GO:0043087,regulation of GTPase activity,0.04307280200536834,0.12701951361574212,1
3815,Phenotype,HP:0006380,Knee flexion contracture,0.04306266120141988,0.1268450854197251,1
3816,Biological Process,GO:0072378,"blood coagulation, fibrin clot formation",0.04305996938740808,0.1267987845283482,1
3817,Phenotype,HP:0034378,Urethrovesical occlusion,0.04300836027051658,0.125911075308924,1
3818,Biological Process,GO:0035023,regulation of Rho protein signal transduction,0.04296836808998461,0.12522318468995183,1
3819,Biological Process,GO:0003206,cardiac chamber morphogenesis,0.04296697082717249,0.12519915089214662,1
3820,Biological Process,GO:0048699,generation of neurons,0.04295653994948856,0.12501973324572227,1
3821,Biological Process,GO:0002407,dendritic cell chemotaxis,0.042945371371101104,0.12482762668394466,1
3821,Biological Process,GO:0036336,dendritic cell migration,0.042945371371101104,0.12482762668394466,1
3823,Biological Process,GO:0043300,regulation of leukocyte degranulation,0.042853662262112846,0.12325017241893173,1
3824,Phenotype,HP:0010522,Dyslexia,0.04285129901462281,0.12320952307805859,1
3825,Biological Process,GO:0010975,regulation of neuron projection development,0.042812274276628925,0.12253827307826466,1
3826,Biological Process,GO:0035329,hippo signaling,0.042800637166108935,0.12233810746958411,1
3827,Phenotype,HP:0005558,Chronic leukemia,0.04273758191220567,0.12125351750574621,1
3828,Phenotype,HP:0002804,Arthrogryposis multiplex congenita,0.04273285120170389,0.12117214631437934,1
3829,Phenotype,HP:0025540,Abnormal T cell subset distribution,0.04271957048438857,0.12094370963668608,1
3830,Phenotype,HP:0002333,Motor deterioration,0.042717944588321566,0.12091574320332239,1
3831,Phenotype,HP:0001602,Laryngeal stenosis,0.042704839263765115,0.12069032339122282,1
3832,Biological Process,GO:0010874,regulation of cholesterol efflux,0.042674769064814266,0.12017309708613597,1
3833,Phenotype,HP:0001847,Long hallux,0.04262685493241314,0.11934894392027945,1
3834,Phenotype,HP:0004482,Relative macrocephaly,0.04262337127048077,0.11928902274741339,1
3835,Biological Process,GO:0090287,regulation of cellular response to growth factor stimulus,0.04261368954308298,0.11912249095635329,1
3836,Phenotype,HP:0033151,Abnormal pharynx morphology,0.042609788027990425,0.11905538244673351,1
3837,Biological Process,GO:0071320,cellular response to cAMP,0.042607067122065745,0.1190085811561863,1
3838,Phenotype,HP:0025576,Abnormal inferior vena cava morphology,0.042603573045574494,0.11894848084636746,1
3839,Phenotype,HP:0001191,Abnormal carpal morphology,0.0425957600862551,0.1188140930397829,1
3840,Phenotype,HP:0000495,Recurrent corneal erosions,0.04256802747651467,0.11833707473704726,1
3841,Phenotype,HP:0005487,Prominent metopic ridge,0.042527100787702055,0.11763310998880636,1
3842,Biological Process,GO:0006691,leukotriene metabolic process,0.04252158694754582,0.11753826847560218,1
3843,Biological Process,GO:0046949,fatty-acyl-CoA biosynthetic process,0.042521125666103665,0.117530334145127,1
3844,Biological Process,GO:0009063,amino acid catabolic process,0.042482763645576904,0.11687048330193321,1
3845,Phenotype,HP:0006297,Enamel hypoplasia,0.04247814553324236,0.11679104886975085,1
3846,Biological Process,GO:0019229,regulation of vasoconstriction,0.04244951491578308,0.11629858427033055,1
3847,Biological Process,GO:0051354,negative regulation of oxidoreductase activity,0.04244591200666992,0.11623661197107134,1
3848,Biological Process,GO:0032479,regulation of type I interferon production,0.04244055572363781,0.116144480539343,1
3849,Biological Process,GO:0048646,anatomical structure formation involved in morphogenesis,0.04240922921445367,0.11560564490932056,1
3850,Phenotype,HP:0032218,Decreased proportion of CD4-positive T cells,0.042405645518320045,0.11554400308537459,1
3851,Phenotype,HP:0001719,Double outlet right ventricle,0.04239338879178567,0.11533317969214738,1
3852,Biological Process,GO:0030168,platelet activation,0.04232576757766893,0.11417005234535933,1
3853,Disease,MONDO:0018894,distal hereditary motor neuropathy,0.04232337139290543,0.11412883646269904,1
3854,Biological Process,GO:1901990,regulation of mitotic cell cycle phase transition,0.04230286039392661,0.11377603440000586,1
3855,Biological Process,GO:0060391,positive regulation of SMAD protein signal transduction,0.04229573709097456,0.11365350911602203,1
3856,Phenotype,HP:0001177,Preaxial hand polydactyly,0.04229495765075997,0.11364010225486726,1
3857,Biological Process,GO:0043094,cellular metabolic compound salvage,0.04213030777953941,0.11080802107497102,1
3858,Phenotype,HP:0011802,Hamartoma of tongue,0.04208559417733693,0.11003891903836273,1
3859,Phenotype,HP:0010780,Hyperacusis,0.042083758111472136,0.11000733755249713,1
3860,Biological Process,GO:0034063,stress granule assembly,0.042067167157665564,0.10972196272843074,1
3861,Biological Process,GO:0098657,import into cell,0.04203346385406448,0.1091422447418852,1
3862,Phenotype,HP:0010576,Intracranial cystic lesion,0.041989677101180733,0.10838908509559124,1
3863,Phenotype,HP:0002032,Esophageal atresia,0.04195836873342362,0.10785056150950591,1
3864,Biological Process,GO:0032328,alanine transport,0.041946968646658145,0.10765447285824636,1
3865,Disease,MONDO:0017666,diffuse palmoplantar keratoderma,0.04192319726214444,0.10724559011693431,1
3866,Phenotype,HP:0025169,Left ventricular systolic dysfunction,0.041904234939905693,0.10691942626669027,1
3867,Disease,MONDO:0005217,familial cardiomyopathy,0.041904233073877584,0.10691939416983497,1
3867,Disease,MONDO:0004994,cardiomyopathy,0.041904233073877584,0.10691939416983497,1
3869,Phenotype,HP:0031630,Abnormal subpleural morphology,0.041856922309518096,0.10610561931319068,1
3870,Biological Process,GO:0006890,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum",0.04184358340785521,0.10587618182818141,1
3871,Biological Process,GO:0006635,fatty acid beta-oxidation,0.04180650625886906,0.10523843158234471,1
3872,Biological Process,GO:0051290,protein heterotetramerization,0.041702314587669265,0.10344626940863975,1
3873,Phenotype,HP:0006298,Prolonged bleeding after dental extraction,0.04167756012437551,0.10302047709496853,1
3874,Phenotype,HP:0005518,Increased mean corpuscular volume,0.0416587597266056,0.10269709844727186,1
3875,Biological Process,GO:0003015,heart process,0.04164972490151153,0.10254169378206998,1
3876,Biological Process,GO:0006575,cellular modified amino acid metabolic process,0.04163966032278443,0.10236857670772732,1
3877,Disease,MONDO:0002280,anemia,0.041635175879000785,0.10229144145855996,1
3878,Biological Process,GO:0034340,response to type I interferon,0.04162567584560972,0.10212803491851369,1
3879,Phenotype,HP:0000544,External ophthalmoplegia,0.04162372417531468,0.10209446496385186,1
3880,Disease,MONDO:0004884,eye degenerative disorder,0.041618909916405045,0.10201165668740406,1
3881,Biological Process,GO:0070972,protein localization to endoplasmic reticulum,0.04159433609413332,0.1015889715127486,1
3882,Phenotype,HP:0007166,Paroxysmal dyskinesia,0.04159284663651541,0.10156335190638835,1
3883,Phenotype,HP:0031381,Decreased lymphocyte proliferation in response to mitogen,0.04157328802990734,0.10122693159054422,1
3884,Phenotype,HP:0030177,Abnormality of peripheral nervous system electrophysiology,0.04156570970142526,0.1010965795817022,1
3885,Disease,MONDO:0001516,spinal muscular atrophy,0.04155273842134055,0.10087346541869233,1
3886,Phenotype,HP:0011117,Abnormal circulating interleukin concentration,0.04151148513893388,0.1001638830555432,1
3887,Phenotype,HP:0000746,Delusion,0.041481600923176765,0.09964985577818014,1
3888,Biological Process,GO:0090101,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,0.04146260411309177,0.0993230987153234,1
3889,Phenotype,HP:0004447,Poikilocytosis,0.04141784180615948,0.09855315892677743,1
3890,Disease,MONDO:0019497,nonsyndromic genetic hearing loss,0.0414086144336272,0.09839444232472455,1
3891,Phenotype,HP:0009906,Aplasia/Hypoplasia of the earlobes,0.041402872519325506,0.09829567779299517,1
3892,Biological Process,GO:1901992,positive regulation of mitotic cell cycle phase transition,0.04140137637557417,0.09826994318094134,1
3893,Phenotype,HP:0030142,Abnormal bowel sounds,0.041380119923147274,0.09790431885082002,1
3894,Phenotype,HP:0001009,Telangiectasia,0.041368637245563944,0.09770680958562901,1
3895,Biological Process,GO:0010810,regulation of cell-substrate adhesion,0.041353594497789414,0.09744806487753808,1
3896,Phenotype,HP:0500267,Abnormal proportion of CD4-positive helper T cells,0.041318057905861516,0.09683681318052438,1
3896,Phenotype,HP:0005407,Decreased proportion of CD4-positive helper T cells,0.041318057905861516,0.09683681318052438,1
3898,Biological Process,GO:0009226,nucleotide-sugar biosynthetic process,0.041277899161714426,0.09614605756277543,1
3899,Biological Process,GO:0046329,negative regulation of JNK cascade,0.04125517146724089,0.09575512694555857,1
3900,Phenotype,HP:0003236,Elevated circulating creatine kinase concentration,0.04124938353314145,0.0956555708444089,1
3901,Biological Process,GO:0051220,cytoplasmic sequestering of protein,0.04119232442352949,0.09467411832777017,1
3902,Biological Process,GO:0000086,G2/M transition of mitotic cell cycle,0.04117824666225356,0.09443197199343606,1
3903,Phenotype,HP:0030080,Burkitt lymphoma,0.04116398311403535,0.09418663000702651,1
3904,Biological Process,GO:0006914,autophagy,0.041153859656785086,0.09401250018511152,1
3904,Biological Process,GO:0061919,process utilizing autophagic mechanism,0.041153859656785086,0.09401250018511152,1
3906,Biological Process,GO:0051493,regulation of cytoskeleton organization,0.04112387597544076,0.09349676203718718,1
3907,Disease,MONDO:0017740,disorder of protein N-glycosylation,0.04111266333224162,0.09330389753297723,1
3908,Disease,MONDO:0015905,syndromic dyslipidemia,0.04111028353832702,0.09326296358321097,1
3909,Biological Process,GO:0051893,regulation of focal adhesion assembly,0.04111024440368072,0.09326229044271926,1
3909,Biological Process,GO:0090109,regulation of cell-substrate junction assembly,0.04111024440368072,0.09326229044271926,1
3911,Biological Process,GO:0060261,positive regulation of transcription initiation by RNA polymerase II,0.0410928071563067,0.09296235883784723,1
3912,Phenotype,HP:0004308,Ventricular arrhythmia,0.041055011800349206,0.09231225498109226,1
3913,Phenotype,HP:0006476,Abnormality of the pancreatic islet cells,0.04104635431340109,0.09216334076895714,1
3914,Phenotype,HP:0100518,Dysuria,0.041026924013550126,0.09182912740990785,1
3915,Phenotype,HP:0009944,Partial duplication of thumb phalanx,0.04098193532185246,0.09105529366123492,1
3916,Phenotype,HP:0009473,Joint contracture of the hand,0.04097528131795947,0.09094084061577183,1
3917,Biological Process,GO:0034332,adherens junction organization,0.040963698046997954,0.09074160108130663,1
3918,Biological Process,GO:1901987,regulation of cell cycle phase transition,0.04095238478518515,0.09054700587375637,1
3919,Biological Process,GO:0010922,positive regulation of phosphatase activity,0.040940582955005245,0.0903440069834866,1
3920,Phenotype,HP:0100651,Type I diabetes mellitus,0.040925674461945505,0.09008757154079777,1
3921,Phenotype,HP:0009775,Amniotic constriction ring,0.040918323456411776,0.08996112962941905,1
3922,Biological Process,GO:0050918,positive chemotaxis,0.04090099484774079,0.08966306667846086,1
3923,Biological Process,GO:0070884,regulation of calcineurin-NFAT signaling cascade,0.04089488117000506,0.08955790758221037,1
3923,Biological Process,GO:0106056,regulation of calcineurin-mediated signaling,0.04089488117000506,0.08955790758221037,1
3925,Phenotype,HP:0034198,Second trimester onset,0.04088867297367649,0.08945112270680833,1
3926,Phenotype,HP:0002895,Papillary thyroid carcinoma,0.040887541906678426,0.08943166764416743,1
3927,Biological Process,GO:1901875,positive regulation of post-translational protein modification,0.04088449397863414,0.08937924136780345,1
3928,Phenotype,HP:0006392,Increased density of long bones,0.04087634760758396,0.08923911867007749,1
3929,Biological Process,GO:1905906,regulation of amyloid fibril formation,0.040816436320410765,0.08820860690830826,1
3930,Biological Process,GO:0051301,cell division,0.04080989301769877,0.0880960579926752,1
3931,Phenotype,HP:0000326,Abnormal maxilla morphology,0.04075832399527768,0.08720903842332012,1
3932,Biological Process,GO:0061061,muscle structure development,0.04075632096056925,0.08717458496849277,1
3933,Biological Process,GO:0032780,negative regulation of ATP-dependent activity,0.04069055306504432,0.08604333586530931,1
3934,Phenotype,HP:0002335,Agenesis of cerebellar vermis,0.040684541596489376,0.08593993483115246,1
3935,Phenotype,HP:0011112,Abnormal circulating cytokine concentration,0.04064569232413051,0.08527170295046776,1
3936,Disease,MONDO:0005201,restrictive cardiomyopathy,0.04063607430207017,0.08510626693121674,1
3936,Disease,MONDO:0016340,familial restrictive cardiomyopathy,0.04063607430207017,0.08510626693121674,1
3938,Biological Process,GO:2001138,regulation of phospholipid transport,0.04062797566603937,0.08496696530580021,1
3939,Biological Process,GO:0090136,epithelial cell-cell adhesion,0.04062615270364134,0.08493560920779139,1
3940,Phenotype,HP:4000209,Abnormal erythrocyte adenosine deaminase activity,0.040599265686230845,0.08447313562413582,1
3941,Biological Process,GO:0008593,regulation of Notch signaling pathway,0.0405933303912569,0.08437104482340672,1
3942,Biological Process,GO:0010656,negative regulation of muscle cell apoptotic process,0.040562710755179365,0.08384436785471179,1
3943,Phenotype,HP:0009778,Short thumb,0.040540520768370114,0.08346268614698397,1
3944,Biological Process,GO:0019363,pyridine nucleotide biosynthetic process,0.0405255015560656,0.08320434626375689,1
3944,Biological Process,GO:0009435,NAD biosynthetic process,0.0405255015560656,0.08320434626375689,1
3944,Biological Process,GO:0019359,nicotinamide nucleotide biosynthetic process,0.0405255015560656,0.08320434626375689,1
3947,Biological Process,GO:0017015,regulation of transforming growth factor beta receptor signaling pathway,0.040493230710089034,0.08264926744789106,1
3948,Biological Process,GO:0051054,positive regulation of DNA metabolic process,0.04047472756234016,0.08233100168721989,1
3949,Biological Process,GO:0046686,response to cadmium ion,0.0404684538347011,0.08222308963212585,1
3950,Phenotype,HP:0011766,Abnormal parathyroid morphology,0.0404676442435109,0.08220916415525682,1
3951,Phenotype,HP:0040071,Abnormal morphology of ulna,0.04046545994917894,0.08217159292107941,1
3952,Phenotype,HP:0012345,Abnormal glycosylation,0.04044341474195157,0.0817924015130769,1
3953,Phenotype,HP:0007000,Morning myoclonic jerks,0.040442712232768185,0.08178031791396924,1
3954,Biological Process,GO:0003341,cilium movement,0.040418241763603535,0.08135941047765789,1
3955,Phenotype,HP:0034444,Abnormal gamma-glutamyltransferase level,0.04041115665488704,0.08123754215851033,1
3956,Phenotype,HP:0011069,Supernumerary tooth,0.04035097603501503,0.08020239770518917,1
3957,Phenotype,HP:0003701,Proximal muscle weakness,0.040278173601082656,0.07895015012393038,1
3958,Phenotype,HP:0001454,Abnormality of the upper arm,0.04026845566312731,0.0787829954885413,1
3959,Phenotype,HP:0000532,Abnormal chorioretinal morphology,0.04026723856420311,0.07876206062274549,1
3960,Biological Process,GO:2000241,regulation of reproductive process,0.040219601914667114,0.07794268033641964,1
3961,Disease,MONDO:0005015,diabetes mellitus,0.04021454391688917,0.07785567959837661,1
3962,Phenotype,HP:0009077,Weakness of long finger extensor muscles,0.04021271884168087,0.07782428715870453,1
3963,Phenotype,HP:0002588,Duodenal ulcer,0.04021255196709661,0.07782141681106328,1
3964,Biological Process,GO:0060306,regulation of membrane repolarization,0.04019572411214156,0.07753196713847668,1
3965,Phenotype,HP:0012664,Reduced left ventricular ejection fraction,0.04018265951302025,0.07730724782943572,1
3965,Phenotype,HP:0034314,Abnormal left ventricular ejection fraction,0.04018265951302025,0.07730724782943572,1
3967,Phenotype,HP:0003193,Allergic rhinitis,0.04015735772097717,0.07687204111757104,1
3968,Disease,MONDO:0100257,peroxisomal single enzyme/protein defect,0.04013778033895754,0.07653529785285773,1
3969,Phenotype,HP:0000954,Single transverse palmar crease,0.04012222381526842,0.07626771587640085,1
3970,Phenotype,HP:0001820,Leukonychia,0.04011870354807323,0.07620716507002732,1
3971,Phenotype,HP:0020073,Hypopigmented macule,0.04011110781312077,0.07607651365896413,1
3972,Biological Process,GO:0006397,mRNA processing,0.04010841084776684,0.0760301241612677,1
3973,Phenotype,HP:0000796,Urethral obstruction,0.04007487329065795,0.07545325711847152,1
3974,Biological Process,GO:0006991,response to sterol depletion,0.04006365991108751,0.07526037994821284,1
3975,Phenotype,HP:0004930,Abnormality of the pulmonary vasculature,0.04006183301128119,0.07522895612430888,1
3976,Phenotype,HP:0004320,Vaginal fistula,0.040051214690198234,0.07504631433371281,1
3977,Biological Process,GO:0032787,monocarboxylic acid metabolic process,0.040035671045656085,0.07477895388667155,1
3978,Phenotype,HP:0000093,Proteinuria,0.03997781432009739,0.07378378187487143,1
3979,Biological Process,GO:0046471,phosphatidylglycerol metabolic process,0.03996862275160995,0.0736256811248736,1
3980,Phenotype,HP:0000600,Abnormality of the pharynx,0.039896516981262176,0.07238541659475256,1
3981,Phenotype,HP:0005543,Reduced protein C activity,0.03987595677678546,0.07203176816659602,1
3982,Phenotype,HP:0040307,Male sexual dysfunction,0.03986720564301227,0.07188124317026244,1
3983,Phenotype,HP:0003366,Abnormal femoral neck/head morphology,0.03985855555210327,0.07173245617464458,1
3984,Biological Process,GO:0051350,negative regulation of lyase activity,0.03983630392165949,0.07134971415769259,1
3985,Biological Process,GO:0072089,stem cell proliferation,0.03980789678752361,0.07086109361177527,1
3986,Phenotype,HP:0010794,Impaired visuospatial constructive cognition,0.039805939621870734,0.07082742913350776,1
3987,Disease,MONDO:0018542,severe congenital neutropenia,0.03980528491579649,0.0708161677778961,1
3988,Phenotype,HP:0009124,Abnormal adipose tissue morphology,0.03980365363466842,0.07078810871810047,1
3989,Biological Process,GO:0070528,protein kinase C signaling,0.03979266461026165,0.07059909059754484,1
3990,Phenotype,HP:0000201,Pierre-Robin sequence,0.039786673714401255,0.07049604342665322,1
3991,Phenotype,HP:0004379,Abnormality of alkaline phosphatase level,0.03977912102770487,0.07036613247262738,1
3992,Biological Process,GO:0006085,acetyl-CoA biosynthetic process,0.03977146068787307,0.07023436981706979,1
3993,Phenotype,HP:0000037,Male pseudohermaphroditism,0.03973768253611054,0.06965336439514512,1
3994,Phenotype,HP:0011096,Peripheral demyelination,0.039736488731150765,0.06963283020016528,1
3995,Phenotype,HP:0000541,Retinal detachment,0.03972225374706295,0.06938797953473588,1
3996,Biological Process,GO:0007009,plasma membrane organization,0.039715708455026255,0.06927539640146867,1
3997,Disease,MONDO:0019242,inborn disorder of branched-chain amino acid metabolism,0.039702480367066806,0.06904786498174599,1
3998,Biological Process,GO:1901524,regulation of mitophagy,0.03970096734235884,0.06902184000663739,1
3999,Phenotype,HP:0001019,Erythroderma,0.039698069360019295,0.06897199289055612,1
4000,Phenotype,HP:0003307,Hyperlordosis,0.03969782471885719,0.068967784908941,1
4001,Biological Process,GO:0021782,glial cell development,0.03966635959190912,0.06842656496633133,1
4002,Phenotype,HP:0030043,Hip subluxation,0.03966533201795941,0.06840889004911246,1
4003,Biological Process,GO:0002200,somatic diversification of immune receptors,0.03964273858653111,0.06802026884058664,1
4004,Biological Process,GO:0007254,JNK cascade,0.03962172095067695,0.06765875230548567,1
4005,Phenotype,HP:0002902,Hyponatremia,0.03960165560357265,0.06731361573488938,1
4006,Biological Process,GO:0071108,protein K48-linked deubiquitination,0.03959159324707329,0.06714053688425925,1
4007,Phenotype,HP:0005324,Disturbance of facial expression,0.03955791304756395,0.06656121630260048,1
4008,Phenotype,HP:0020054,Abnormal erythrocyte physiology,0.0395424141960099,0.06629462632308304,1
4009,Phenotype,HP:0030406,Primary peritoneal carcinoma,0.03953710319497605,0.06620327377016048,1
4010,Disease,MONDO:0019293,skin vascular disease,0.039526454631901964,0.0660201117983259,1
4011,Biological Process,GO:1905477,positive regulation of protein localization to membrane,0.0395037480448307,0.06562954424168287,1
4012,Phenotype,HP:0012256,Absent outer dynein arms,0.03949654514348688,0.06550564981537538,1
4013,Biological Process,GO:0006656,phosphatidylcholine biosynthetic process,0.03949090783589826,0.06540868458480048,1
4014,Biological Process,GO:0007586,digestion,0.039487618278890024,0.06535210213852127,1
4015,Biological Process,GO:0032507,maintenance of protein location in cell,0.039447579545590084,0.0646634107827063,1
4016,Biological Process,GO:0000002,mitochondrial genome maintenance,0.0394303401664331,0.0643668826354222,1
4017,Phenotype,HP:0000453,Choanal atresia,0.03942106176117044,0.06420728823835993,1
4018,Biological Process,GO:0033688,regulation of osteoblast proliferation,0.039408309580018064,0.06398794271457332,1
4019,Phenotype,HP:0012817,Noncompaction cardiomyopathy,0.03938623815595499,0.0636083003605334,1
4020,Phenotype,HP:0002973,Abnormal forearm morphology,0.03938436879325269,0.06357614614815328,1
4021,Biological Process,GO:1904950,negative regulation of establishment of protein localization,0.039381291003631635,0.0635232062339168,1
4022,Phenotype,HP:0001073,Cigarette-paper scars,0.03937642398053609,0.06343949038033711,1
4023,Biological Process,GO:0006885,regulation of pH,0.03936741142463762,0.06328446875928388,1
4024,Phenotype,HP:0003691,Scapular winging,0.03935187345314728,0.06301720589229617,1
4025,Phenotype,HP:0002144,Tethered cord,0.03932158312126233,0.062496193162506236,1
4026,Biological Process,GO:0098739,import across plasma membrane,0.03931907834721249,0.06245310947593027,1
4027,Disease,MONDO:0024582,male reproductive system neoplasm,0.03928873644138431,0.06193120964193001,1
4028,Biological Process,GO:0043487,regulation of RNA stability,0.03926021959140624,0.06144070191462896,1
4029,Phenotype,HP:0004428,Elfin facies,0.03921625306937382,0.06068445012608839,1
4030,Biological Process,GO:0170041,non-proteinogenic amino acid metabolic process,0.039198065947985916,0.060371620217280444,1
4031,Biological Process,GO:0043473,pigmentation,0.039190997035279285,0.06025003047967316,1
4032,Phenotype,HP:0000408,Progressive sensorineural hearing impairment,0.03918623202466187,0.060168069304777944,1
4033,Phenotype,HP:0031392,Abnormal proportion of CD4-positive T cells,0.039121696313876186,0.059058014552882426,1
4034,Biological Process,GO:0032768,regulation of monooxygenase activity,0.03908907846464138,0.058496967063067846,1
4035,Disease,MONDO:0000226,mineral metabolism disease,0.03908772986440634,0.058473770292146926,1
4036,Phenotype,HP:0000968,Ectodermal dysplasia,0.039062483896055156,0.05803952378283828,1
4037,Biological Process,GO:0060048,cardiac muscle contraction,0.039039764276522226,0.05764873205967064,1
4038,Biological Process,GO:0048167,regulation of synaptic plasticity,0.039008553965467985,0.05711189511045115,1
4039,Phenotype,HP:0012118,Laryngeal carcinoma,0.039005650935349245,0.05706196116939789,1
4040,Biological Process,GO:0072524,pyridine-containing compound metabolic process,0.03897850336398756,0.056595005894162186,1
4041,Phenotype,HP:0000185,Cleft soft palate,0.03896659245398548,0.056390130762452334,1
4042,Phenotype,HP:0011877,Increased mean platelet volume,0.03895864442648933,0.05625341969840906,1
4043,Disease,MONDO:0019942,distal arthrogryposis,0.0389557965116184,0.05620443377422877,1
4044,Phenotype,HP:0009702,Carpal synostosis,0.038952139338663594,0.056141528102817334,1
4045,Biological Process,GO:0014911,positive regulation of smooth muscle cell migration,0.03895212413884919,0.05614126665646453,1
4046,Phenotype,HP:0025483,Abnormal circulating thyroglobulin concentration,0.038917104228605726,0.05553890220888287,1
4047,Phenotype,HP:0012590,Abnormal urine output,0.03888446489740505,0.05497748521576528,1
4048,Biological Process,GO:0097553,calcium ion transmembrane import into cytosol,0.038836609908916464,0.05415434936234504,1
4049,Phenotype,HP:0007807,Optic nerve compression,0.03881444712184001,0.05377313550710195,1
4050,Biological Process,GO:0030307,positive regulation of cell growth,0.038801039309273366,0.05354251271127414,1
4051,Disease,MONDO:0016022,early myoclonic encephalopathy,0.038800565633884676,0.053534365197135524,1
4052,Phenotype,HP:0031432,Restricted or repetitive behaviors or interests,0.03879920317064922,0.05351092997390196,1
4053,Disease,MONDO:0001149,microcephaly,0.03877464032671274,0.05308843363350668,1
4054,Biological Process,GO:0006356,regulation of transcription by RNA polymerase I,0.03877081255384407,0.05302259353644547,1
4055,Biological Process,GO:0022600,digestive system process,0.03873418816743068,0.0523926310911809,1
4056,Biological Process,GO:1904893,negative regulation of receptor signaling pathway via STAT,0.038719803736257496,0.05214520984203504,1
4057,Biological Process,GO:0006475,internal protein amino acid acetylation,0.0387192408299144,0.052135527499446485,1
4058,Biological Process,GO:0035337,fatty-acyl-CoA metabolic process,0.03871704777909324,0.05209780564815602,1
4059,Phenotype,HP:0010311,Aplasia/Hypoplasia of the breasts,0.03870437705451568,0.051879861228608444,1
4060,Biological Process,GO:0080111,DNA demethylation,0.038704061200299344,0.051874428337741,1
4060,Biological Process,GO:0035510,DNA dealkylation,0.038704061200299344,0.051874428337741,1
4062,Phenotype,HP:0001142,Lenticonus,0.03868276950866467,0.05150819787111685,1
4063,Biological Process,GO:0014706,striated muscle tissue development,0.03868038599904988,0.051467200008973944,1
4063,Biological Process,GO:0048738,cardiac muscle tissue development,0.03868038599904988,0.051467200008973944,1
4065,Biological Process,GO:1905038,regulation of membrane lipid metabolic process,0.03867836301235772,0.051432403367497194,1
4066,Disease,MONDO:0018911,maturity-onset diabetes of the young,0.03866522103900827,0.05120635317314374,1
4067,Disease,MONDO:0000167,Huntington disease and related disorders,0.0386582796872077,0.051086957563224906,1
4068,Phenotype,HP:0000283,Broad face,0.03865461927562319,0.05102399618534891,1
4069,Phenotype,HP:0002861,Melanoma,0.038650761704538295,0.050957643540256246,1
4070,Phenotype,HP:0004969,Peripheral pulmonary artery stenosis,0.03864440803080371,0.05084835636211562,1
4071,Phenotype,HP:0100760,Clubbing of toes,0.0386244205654076,0.05050455940580751,1
4072,Phenotype,HP:0001582,Redundant skin,0.03861769059593345,0.05038879970464451,1
4073,Biological Process,GO:0031167,rRNA methylation,0.0385677016218946,0.049528957959684344,1
4074,Phenotype,HP:0002200,Pseudobulbar signs,0.03856759371864171,0.04952710195597484,1
4075,Phenotype,HP:0010624,Aplastic/hypoplastic toenail,0.038540833820510656,0.04906681490375245,1
4076,Disease,MONDO:0002279,iron metabolism disease,0.03853382322827459,0.04894622831486227,1
4077,Disease,MONDO:0015925,interstitial lung disease,0.03852712212723053,0.04883096516882529,1
4078,Biological Process,GO:0031670,cellular response to nutrient,0.038525158038468454,0.0487971816087321,1
4079,Phenotype,HP:0005106,Abnormality of the vertebral endplates,0.03851061971226166,0.04854711326836702,1
4080,Phenotype,HP:0001377,Limited elbow extension,0.03848315851404771,0.0480747634143246,1
4081,Biological Process,GO:0051651,maintenance of location in cell,0.03847487729712984,0.047932321282995356,1
4082,Biological Process,GO:0045599,negative regulation of fat cell differentiation,0.038459807111279165,0.04767310462276451,1
4083,Phenotype,HP:0100737,Abnormal hard palate morphology,0.03845113931855526,0.04752401314481414,1
4084,Phenotype,HP:0002611,Cholestatic liver disease,0.03843146039565859,0.047185523313251286,1
4085,Biological Process,GO:0006622,protein targeting to lysosome,0.03834730318747437,0.04573796648442222,1
4086,Biological Process,GO:0032465,regulation of cytokinesis,0.03834614673794956,0.045718074826381856,1
4087,Disease,MONDO:0015548,Huntington disease-like syndrome,0.03834287609048881,0.04566181763619395,1
4088,Phenotype,HP:0100779,Urogenital sinus anomaly,0.038318982830585324,0.04525083856164378,1
4089,Phenotype,HP:0001822,Hallux valgus,0.0382958478487353,0.044852902345787704,1
4090,Biological Process,GO:0090140,regulation of mitochondrial fission,0.038283202187160525,0.04463538902562678,1
4091,Disease,MONDO:0018943,myofibrillar myopathy,0.03826379748915121,0.04430161603433096,1
4092,Phenotype,HP:0000782,Abnormal scapula morphology,0.03823298149561882,0.04377156159410631,1
4093,Phenotype,HP:0100574,Biliary tract neoplasm,0.0382320070800225,0.04375480103394745,1
4094,Phenotype,HP:0025092,Epidermal acanthosis,0.03821722525730975,0.0435005444007718,1
4095,Phenotype,HP:0033108,Abnormal circulating proteinogenic amino acid derivative concentration,0.03817492902158459,0.04277302258560307,1
4096,Phenotype,HP:0005905,Abnormal cervical curvature,0.03817367172130315,0.0427513962312175,1
4097,Biological Process,GO:0001539,cilium or flagellum-dependent cell motility,0.03815175184757513,0.0423743606381094,1
4097,Biological Process,GO:0060285,cilium-dependent cell motility,0.03815175184757513,0.0423743606381094,1
4099,Phenotype,HP:0010557,Overlapping fingers,0.038116246540925824,0.041763647067533605,1
4100,Phenotype,HP:0000646,Amblyopia,0.038101707123295414,0.041513559953996915,1
4101,Biological Process,GO:0060340,positive regulation of type I interferon-mediated signaling pathway,0.038089780695859,0.041308417912672,1
4102,Phenotype,HP:0034058,Abnormal fetal morphology,0.038071616402445496,0.04099598065935897,1
4103,Phenotype,HP:0040127,Abnormal sweat homeostasis,0.03805367834276252,0.04068743476827862,1
4104,Phenotype,HP:0011992,Abnormal neutrophil morphology,0.0379578375866253,0.039038913577759994,1
4105,Phenotype,HP:0002344,Progressive neurologic deterioration,0.03792784150909212,0.03852296220760297,1
4106,Biological Process,GO:0009123,nucleoside monophosphate metabolic process,0.0379269210034765,0.038507128932965935,1
4107,Phenotype,HP:0004846,Prolonged bleeding after surgery,0.03788271628743578,0.0377467800579044,1
4108,Phenotype,HP:0004757,Paroxysmal atrial fibrillation,0.03787558951101777,0.03762419502812484,1
4109,Phenotype,HP:0006610,Wide intermamillary distance,0.037869434041370775,0.03751831708475659,1
4109,Phenotype,HP:0040157,Abnormal intermamillary distance,0.037869434041370775,0.03751831708475659,1
4111,Biological Process,GO:0044273,sulfur compound catabolic process,0.037841566242111546,0.03703897343740283,1
4112,Phenotype,HP:0001051,Seborrheic dermatitis,0.03776023271428841,0.03563998568396625,1
4113,Phenotype,HP:0006704,Abnormal coronary artery morphology,0.03776017280119115,0.035638955141069836,1
4114,Biological Process,GO:1902305,regulation of sodium ion transmembrane transport,0.03774684792439453,0.03540975889256756,1
4115,Phenotype,HP:0002362,Shuffling gait,0.03773527170085389,0.03521064057816687,1
4116,Biological Process,GO:0071826,protein-RNA complex organization,0.03773127235953255,0.03514184939598023,1
4117,Phenotype,HP:0004446,Stomatocytosis,0.037709063626078176,0.03475984523418397,1
4118,Phenotype,HP:0010532,Paroxysmal vertigo,0.037708248247746545,0.03474582021484816,1
4119,Phenotype,HP:0031378,Abnormal lymphocyte proliferation,0.03768080845359123,0.034273838524055356,1
4119,Phenotype,HP:0031377,Abnormal cell proliferation,0.03768080845359123,0.034273838524055356,1
4121,Biological Process,GO:0034391,regulation of smooth muscle cell apoptotic process,0.03766506797627078,0.0340030924296226,1
4122,Phenotype,HP:0005108,Abnormal intervertebral disk morphology,0.03766123942584665,0.03393723895811912,1
4123,Biological Process,GO:0035024,negative regulation of Rho protein signal transduction,0.037655597173700484,0.03384018867804949,1
4124,Disease,MONDO:0019215,classic organic aciduria,0.037614579650387836,0.03313466151936684,1
4125,Phenotype,HP:0012062,Bone cyst,0.03760931954730429,0.033044184443151714,1
4126,Phenotype,HP:0100538,Abnormality of the supraorbital ridges,0.03760663950955001,0.03299808611079935,1
4127,Phenotype,HP:0034221,Abnormal temporal lobe morphology,0.03758456761791129,0.032618435714164715,1
4128,Biological Process,GO:0032271,regulation of protein polymerization,0.03758329195834431,0.03259649356853887,1
4129,Phenotype,HP:0100743,Neoplasm of the rectum,0.03758249508632472,0.0325827868693915,1
4130,Biological Process,GO:1903510,mucopolysaccharide metabolic process,0.03754556836619671,0.03194762409437948,1
4131,Phenotype,HP:0001964,Aplasia/Hypoplasia of metatarsal bones,0.03750884325844772,0.03131592917889269,1
4132,Biological Process,GO:0046475,glycerophospholipid catabolic process,0.03750167673991778,0.031192660559831064,1
4133,Phenotype,HP:0004568,Beaking of vertebral bodies,0.037494105453330984,0.031062429676010108,1
4134,Biological Process,GO:1903779,regulation of cardiac conduction,0.037487944574281395,0.03095645868752034,1
4135,Biological Process,GO:0048771,tissue remodeling,0.03744482274268812,0.030214736104971985,1
4136,Phenotype,HP:0001954,Recurrent fever,0.037420452300003904,0.029795549186937532,1
4137,Phenotype,HP:0005743,Avascular necrosis of the capital femoral epiphysis,0.037400635315744224,0.029454684613232772,1
4138,Phenotype,HP:0001053,Hypopigmented skin patches,0.03739331621125985,0.029328791419935857,1
4139,Biological Process,GO:0070198,"protein localization to chromosome, telomeric region",0.03735616046391643,0.02868968923299687,1
4140,Biological Process,GO:2000278,regulation of DNA biosynthetic process,0.03731571258749322,0.027993960358532726,1
4141,Phenotype,HP:0033379,Bilateral superior vena cava,0.03724564795798524,0.026788804732627902,1
4142,Phenotype,HP:0002612,Congenital hepatic fibrosis,0.03721646695759351,0.026286873201146393,1
4143,Phenotype,HP:0032581,Abnormal renal insterstitial morphology,0.037207796373973756,0.026137733718034847,1
4144,Phenotype,HP:0025634,Abnormal ureter physiology,0.0371862696809796,0.025767461080454176,1
4145,Biological Process,GO:0033059,cellular pigmentation,0.03717154242610088,0.025514143048290694,1
4146,Biological Process,GO:1901385,regulation of voltage-gated calcium channel activity,0.03717113846452802,0.025507194655562452,1
4147,Biological Process,GO:0050688,regulation of defense response to virus,0.03716940280225656,0.025477340174552377,1
4148,Phenotype,HP:0031013,Ankylosis,0.03715358907145527,0.02520533407424836,1
4149,Disease,MONDO:0001933,endocrine pancreas disorder,0.03714444596725652,0.025048066940450097,1
4150,Phenotype,HP:0011110,Recurrent tonsillitis,0.037100651279732944,0.024294770813368276,1
4151,Disease,MONDO:0019189,inborn disorder of amino acid and other organic acid metabolism,0.037097458939054806,0.024239860549015505,1
4152,Biological Process,GO:1904892,regulation of receptor signaling pathway via STAT,0.03709488243518666,0.024195543064520597,1
4153,Biological Process,GO:2000008,regulation of protein localization to cell surface,0.03709135752070858,0.024134912321962982,1
4154,Biological Process,GO:0031589,cell-substrate adhesion,0.03707295775827879,0.023818424853702762,1
4155,Biological Process,GO:0003151,outflow tract morphogenesis,0.03706012086454291,0.023597622220283075,1
4156,Phenotype,HP:0001080,Biliary tract abnormality,0.037056941097650564,0.023542928232941837,1
4157,Phenotype,HP:0004340,Abnormality of vitamin B metabolism,0.03704640384614011,0.023361680889901884,1
4158,Phenotype,HP:0003045,Abnormal patella morphology,0.03703961705705039,0.02324494385567019,1
4159,Phenotype,HP:0100593,Calcification of cartilage,0.03702403283463829,0.02297688544378411,1
4160,Phenotype,HP:0001948,Alkalosis,0.03701635783354773,0.022844870605369008,1
4161,Phenotype,HP:0012680,Abnormality of the pineal gland,0.03700694766042967,0.022683009718447743,1
4162,Biological Process,GO:0010765,positive regulation of sodium ion transport,0.037003588322995995,0.022625227005031095,1
4163,Biological Process,GO:0051494,negative regulation of cytoskeleton organization,0.03697207183191975,0.022083123567161807,1
4164,Biological Process,GO:0007098,centrosome cycle,0.036951660845509826,0.021732041783458302,1
4165,Biological Process,GO:0061615,glycolytic process through fructose-6-phosphate,0.03692762508010705,0.021318611524831412,1
4166,Phenotype,HP:0034670,Abnormal knee physiology,0.036903898654951695,0.02091050211271598,1
4167,Biological Process,GO:0014743,regulation of muscle hypertrophy,0.03684008338255729,0.019812839353562914,1
4167,Biological Process,GO:0010611,regulation of cardiac muscle hypertrophy,0.03684008338255729,0.019812839353562914,1
4169,Phenotype,HP:0003496,Increased circulating IgM level,0.03682662203127496,0.019581295658204736,1
4170,Biological Process,GO:0086002,cardiac muscle cell action potential involved in contraction,0.03679113194718575,0.01897084392522197,1
4170,Biological Process,GO:0086003,cardiac muscle cell contraction,0.03679113194718575,0.01897084392522197,1
4172,Biological Process,GO:0032370,positive regulation of lipid transport,0.03678472455327131,0.018860632726253178,1
4173,Phenotype,HP:0007392,Excessive wrinkled skin,0.0367686473098332,0.018584094043118234,1
4174,Phenotype,HP:0011220,Prominent forehead,0.03672721180786376,0.017871377389061315,1
4175,Biological Process,GO:0006839,mitochondrial transport,0.03671414737271117,0.01764666090038544,1
4176,Phenotype,HP:0002514,Cerebral calcification,0.036671520097289245,0.016913444994549894,1
4176,Phenotype,HP:0430048,Intracranial calcification,0.036671520097289245,0.016913444994549894,1
4178,Biological Process,GO:0021987,cerebral cortex development,0.03666592153949888,0.0168171462848387,1
4178,Biological Process,GO:0021543,pallium development,0.03666592153949888,0.0168171462848387,1
4180,Biological Process,GO:0022411,cellular component disassembly,0.03665569814153258,0.016641297419848274,1
4181,Disease,MONDO:0019303,premature aging syndrome,0.036639750201639565,0.01636698283888746,1
4182,Biological Process,GO:0035307,positive regulation of protein dephosphorylation,0.03663964018199173,0.01636509043185582,1
4183,Biological Process,GO:0046887,positive regulation of hormone secretion,0.03663500045364465,0.016285284190683678,1
4184,Biological Process,GO:0060294,cilium movement involved in cell motility,0.03663241563559749,0.016240823697088725,1
4185,Phenotype,HP:0002928,Decreased activity of the pyruvate dehydrogenase complex,0.03662829057212047,0.016169870014874757,1
4186,Phenotype,HP:0046504,Decreased libido,0.03661454544747467,0.01593344523946414,1
4187,Biological Process,GO:0071230,cellular response to amino acid stimulus,0.036602755468086556,0.015730650190255116,1
4188,Phenotype,HP:0006480,Premature loss of teeth,0.03660061126480374,0.015693768547298943,1
4189,Phenotype,HP:0100774,Hyperostosis,0.03658506820150964,0.015426418098089128,1
4190,Phenotype,HP:0000465,Webbed neck,0.03656828394594824,0.015137718362452365,1
4191,Phenotype,HP:0000113,Polycystic kidney dysplasia,0.036520910243633575,0.01432286093345592,1
4192,Phenotype,HP:0007206,Hemimegalencephaly,0.03649735082207484,0.01391762408807529,1
4193,Phenotype,HP:0008422,Vertebral wedging,0.03647469245921131,0.013527886018088634,1
4194,Phenotype,HP:0005208,Secretory diarrhea,0.03646491530532503,0.01335971283150172,1
4195,Phenotype,HP:0030087,Abnormal circulating testosterone concentration,0.0364410992961649,0.012950062518248326,1
4196,Phenotype,HP:0008527,Congenital sensorineural hearing impairment,0.03643755311794594,0.012889066025994633,1
4197,Phenotype,HP:0000554,Uveitis,0.0363926474632853,0.012116660566503155,1
4198,Phenotype,HP:0000888,Horizontal ribs,0.036388675407559634,0.012048338713696564,1
4199,Biological Process,GO:0009163,nucleoside biosynthetic process,0.03637638035161905,0.011836856030612974,1
4199,Biological Process,GO:0034404,nucleobase-containing small molecule biosynthetic process,0.03637638035161905,0.011836856030612974,1
4201,Phenotype,HP:0020207,Reflex seizure,0.03636956185466522,0.011719573601207019,1
4202,Phenotype,HP:0010895,Abnormal circulating glycine concentration,0.03634884778395531,0.011363278577216338,1
4203,Phenotype,HP:0003805,Rimmed vacuoles,0.0363467368554351,0.011326969281072585,1
4204,Phenotype,HP:0030010,Hydrometrocolpos,0.036293884828000444,0.010417881219797708,1
4205,Phenotype,HP:0002919,Ketonuria,0.03629216585621997,0.01038831382571375,1
4206,Phenotype,HP:0011036,Abnormality of renal excretion,0.036285482010511516,0.010273347482284976,1
4207,Biological Process,GO:0018205,peptidyl-lysine modification,0.03628543624469205,0.010272560281450651,1
4208,Biological Process,GO:0051235,maintenance of location,0.03627006953730205,0.010008243264537321,1
4209,Phenotype,HP:0001518,Small for gestational age,0.03624587019276826,0.009591999342134403,1
4210,Biological Process,GO:1900543,negative regulation of purine nucleotide metabolic process,0.03624067251132368,0.009502595957308357,1
4211,Phenotype,HP:0001992,Organic aciduria,0.036228375374506294,0.00929107748183701,1
4212,Biological Process,GO:0050804,modulation of chemical synaptic transmission,0.03622685958179317,0.009265004895301462,1
4212,Biological Process,GO:0099177,regulation of trans-synaptic signaling,0.03622685958179317,0.009265004895301462,1
4214,Phenotype,HP:0000713,Agitation,0.03621460832043688,0.009054275506569313,1
4215,Phenotype,HP:0010729,Cherry red spot of the macula,0.0362116752922067,0.009003825579161434,1
4216,Phenotype,HP:0001605,Vocal cord paralysis,0.036168821052554145,0.008266705746032674,1
4216,Phenotype,HP:0031801,Vocal cord dysfunction,0.036168821052554145,0.008266705746032674,1
4218,Biological Process,GO:1903531,negative regulation of secretion by cell,0.036138051316702,0.00773744696695655,1
4219,Disease,MONDO:0019255,sphingolipidosis,0.03613333322963508,0.00765629290659626,1
4220,Phenotype,HP:0009999,Partial duplication of the phalanx of hand,0.03611717942634207,0.007378437345879869,1
4221,Biological Process,GO:1904779,regulation of protein localization to centrosome,0.036077454228628736,0.006695138999044903,1
4222,Biological Process,GO:0048864,stem cell development,0.036072599330063904,0.006611631695007304,1
4223,Phenotype,HP:0011108,Recurrent sinusitis,0.03605729901303134,0.0063484566339328755,1
4224,Biological Process,GO:1900102,negative regulation of endoplasmic reticulum unfolded protein response,0.036051032568118924,0.006240669846310429,1
4225,Biological Process,GO:1900024,regulation of substrate adhesion-dependent cell spreading,0.03601983467110825,0.005704046426435985,1
4226,Biological Process,GO:0010669,epithelial structure maintenance,0.03599850086232492,0.005337091518406689,1
4227,Biological Process,GO:0045667,regulation of osteoblast differentiation,0.03599033535643803,0.005196639689473144,1
4228,Phenotype,HP:0031938,Abnormal conus terminalis morphology,0.03598298259455479,0.005070167567779918,1
4229,Biological Process,GO:0009408,response to heat,0.03594019566615414,0.004334205530453268,1
4230,Disease,MONDO:0017761,disorder of mineral absorption and transport,0.03592359596912709,0.004048680317504134,1
4231,Phenotype,HP:0046508,Abnormal cervical spine morphology,0.03592062127331086,0.003997513681450304,1
4232,Phenotype,HP:0004445,Elliptocytosis,0.035919375628979955,0.0039760878167335615,1
4233,Phenotype,HP:0003390,Sensory axonal neuropathy,0.03586336599282103,0.0030126869025230187,1
4234,Phenotype,HP:0010469,Absent testis,0.0358450176602757,0.002697084060571888,1
4235,Biological Process,GO:0045577,regulation of B cell differentiation,0.03579976265612905,0.0019186695705406924,1
4236,Biological Process,GO:0035331,negative regulation of hippo signaling,0.03579800195538674,0.001888384412108594,1
4237,Phenotype,HP:0011587,Abnormal branching pattern of the aortic arch,0.03577541353703784,0.0014998494316964214,1
4238,Biological Process,GO:0010001,glial cell differentiation,0.035763130530814036,0.0012885740113082866,1
4239,Phenotype,HP:0030895,Abnormal gastrointestinal motility,0.035742741413503976,0.0009378683898555535,1
4240,Biological Process,GO:0050691,regulation of defense response to virus by host,0.03573724027974112,0.0008432454345967666,1
4241,Phenotype,HP:0000958,Dry skin,0.0357228469489288,0.0005956711060690656,1
4242,Phenotype,HP:0002131,Episodic ataxia,0.03572100199169592,0.0005639366830888887,1
4243,Biological Process,GO:0009712,catechol-containing compound metabolic process,0.03569591941998407,0.0001325006985846327,1
4243,Biological Process,GO:0006584,catecholamine metabolic process,0.03569591941998407,0.0001325006985846327,1
4245,Phenotype,HP:0003677,Slowly progressive,0.035675897876725204,-0.0002118824183626606,1
4246,Phenotype,HP:0025710,Late young adult onset,0.035609036272708394,-0.0013619439944207983,1
4247,Phenotype,HP:0009541,Abnormality of the phalanges of the 2nd finger,0.03559722555388811,-0.0015650957748868798,1
4248,Biological Process,GO:1903589,positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,0.03554443379731864,-0.0024731471394323365,1
4249,Phenotype,HP:0009601,Aplasia/Hypoplasia of the thumb,0.035532858062139905,-0.0026722570537015627,1
4250,Phenotype,HP:0025615,Abscess,0.035494016530711825,-0.00334035578551569,1
4251,Biological Process,GO:1904995,negative regulation of leukocyte adhesion to vascular endothelial cell,0.035479009554047036,-0.0035984852080559473,1
4252,Phenotype,HP:0000630,Abnormal retinal artery morphology,0.035449940149022474,-0.0040984972291437894,1
4253,Phenotype,HP:0001012,Multiple lipomas,0.035447434461284955,-0.00414159663172164,1
4254,Phenotype,HP:0001746,Asplenia,0.03544019250511132,-0.0042661628256271365,1
4255,Biological Process,GO:1902902,negative regulation of autophagosome assembly,0.03543507749976993,-0.0043541441295604135,1
4256,Biological Process,GO:0050890,cognition,0.03539100476396151,-0.005112222861747011,1
4257,Biological Process,GO:0140253,cell-cell fusion,0.03537778638690925,-0.0053395872477678815,1
4258,Biological Process,GO:0042770,signal transduction in response to DNA damage,0.03537703579769336,-0.005352497853627473,1
4259,Biological Process,GO:0071229,cellular response to acid chemical,0.03536736939382079,-0.005518766070430984,1
4260,Phenotype,HP:0011734,Central adrenal insufficiency,0.035366396506883,-0.005535500336703128,1
4261,Disease,MONDO:0020246,inherited vitreoretinopathy,0.035364181499715985,-0.005573599850930143,1
4262,Phenotype,HP:0001702,Abnormal tricuspid valve morphology,0.035349685914515705,-0.005822933019143219,1
4263,Biological Process,GO:0046688,response to copper ion,0.03534630291192786,-0.005881122788072551,1
4264,Phenotype,HP:0030799,Scaphocephaly,0.03530739354101142,-0.006550388401687523,1
4265,Biological Process,GO:1903844,regulation of cellular response to transforming growth factor beta stimulus,0.03525724743366254,-0.007412932938254949,1
4266,Phenotype,HP:0200037,Skin vesicle,0.03523573253476231,-0.007783002710013816,1
4267,Biological Process,GO:0007566,embryo implantation,0.03522939097335742,-0.007892081548477535,1
4268,Phenotype,HP:0008002,Abnormality of macular pigmentation,0.03519741009260047,-0.008442172780477042,1
4269,Disease,MONDO:0015160,multiple congenital anomalies/dysmorphic syndrome-variable intellectual disability syndrome,0.03519591019741963,-0.008467971919474045,1
4270,Biological Process,GO:0009126,purine nucleoside monophosphate metabolic process,0.035185760442079994,-0.008642554085040622,1
4271,Phenotype,HP:0010490,Abnormality of the palmar creases,0.035181702636709944,-0.008712350885578698,1
4272,Phenotype,HP:0010656,Abnormal epiphyseal ossification,0.035179220781769716,-0.008755040349076898,1
4273,Biological Process,GO:0030316,osteoclast differentiation,0.03517908098283129,-0.00875744497860712,1
4274,Disease,MONDO:0016298,postlingual non-syndromic genetic hearing loss,0.03517782144469073,-0.008779109825574859,1
4275,Phenotype,HP:0034059,Abnormal fetal physiology,0.035163455746318406,-0.009026208858782215,1
4276,Phenotype,HP:0001132,Lens subluxation,0.0351483579425651,-0.009285900564281496,1
4277,Phenotype,HP:0005155,Ventricular escape rhythm,0.03514765025038058,-0.009298073314263522,1
4278,Phenotype,HP:0020179,Abnormal circulating haptoglobin concentration,0.03514055526282034,-0.00942011155572707,1
4278,Phenotype,HP:0020181,Reduced haptoglobin level,0.03514055526282034,-0.00942011155572707,1
4280,Biological Process,GO:0070199,establishment of protein localization to chromosome,0.03513451472569029,-0.00952401258762983,1
4281,Phenotype,HP:0000815,Hypergonadotropic hypogonadism,0.0351292870214428,-0.009613932383519304,1
4282,Phenotype,HP:0012303,Abnormal aortic arch morphology,0.03512729080288879,-0.009648268596210324,1
4283,Phenotype,HP:0003031,Ulnar bowing,0.035124021098554725,-0.009704509564026945,1
4284,Biological Process,GO:2001140,positive regulation of phospholipid transport,0.0351148609713795,-0.009862069503710432,1
4285,Phenotype,HP:0000112,Nephropathy,0.03505796769728642,-0.010840669545285104,1
4286,Disease,MONDO:0005420,hypothyroidism,0.035037229385889046,-0.011197381524322434,1
4286,Disease,MONDO:0018612,congenital hypothyroidism,0.035037229385889046,-0.011197381524322434,1
4288,Phenotype,HP:0005912,Biliary atresia,0.035016072468097015,-0.011561293796219447,1
4289,Phenotype,HP:0020129,Abnormal urine protein level,0.03500675416419907,-0.011721574474863685,1
4290,Phenotype,HP:0000141,Amenorrhea,0.03499572188051481,-0.011911336682157665,1
4291,Phenotype,HP:0001405,Periportal fibrosis,0.03497318664185811,-0.012298956938468743,1
4292,Biological Process,GO:0016226,iron-sulfur cluster assembly,0.03496331410996656,-0.012468770686640695,1
4292,Biological Process,GO:0031163,metallo-sulfur cluster assembly,0.03496331410996656,-0.012468770686640695,1
4294,Biological Process,GO:0000245,spliceosomal complex assembly,0.03496244176657948,-0.012483775540702508,1
4295,Disease,MONDO:0019019,osteogenesis imperfecta,0.03491503554988118,-0.013299192237515389,1
4296,Biological Process,GO:0015748,organophosphate ester transport,0.03491466934638321,-0.01330549116764467,1
4297,Biological Process,GO:0035338,long-chain fatty-acyl-CoA biosynthetic process,0.03490905615028628,-0.01340204166542121,1
4298,Biological Process,GO:0070849,response to epidermal growth factor,0.03490715818311285,-0.013434687892667378,1
4299,Phenotype,HP:0009552,Aplasia/Hypoplasia of the phalanges of the 2nd finger,0.034892747040334626,-0.013682568598193948,1
4300,Biological Process,GO:0034143,regulation of toll-like receptor 4 signaling pathway,0.03485480751571246,-0.014335152246514658,1
4301,Biological Process,GO:0071676,negative regulation of mononuclear cell migration,0.03484830915622661,-0.014446928110435178,1
4302,Phenotype,HP:0002006,Tessier cleft,0.03479163963172294,-0.01542167951856431,1
4303,Disease,MONDO:0045022,disorder of organic acid metabolism,0.03478414915495753,-0.01555052042271135,1
4304,Biological Process,GO:0031644,regulation of nervous system process,0.03477237610573358,-0.015753024262465224,1
4305,Phenotype,HP:0002108,Spontaneous pneumothorax,0.03476330761978419,-0.015909007915516648,1
4306,Biological Process,GO:0034405,response to fluid shear stress,0.034753061807879626,-0.016085242314320403,1
4307,Phenotype,HP:0000193,Bifid uvula,0.034748226929802284,-0.016168405253400943,1
4308,Phenotype,HP:0004385,Protracted diarrhea,0.03474029464783346,-0.016304845484486505,1
4309,Biological Process,GO:1902931,negative regulation of alcohol biosynthetic process,0.034704625516040255,-0.016918376950414295,1
4310,Biological Process,GO:0031280,negative regulation of cyclase activity,0.03469547776864301,-0.017075723950142407,1
4311,Phenotype,HP:0001874,Abnormality of neutrophils,0.0346923360501431,-0.01712976348124055,1
4312,Biological Process,GO:0051155,positive regulation of striated muscle cell differentiation,0.034660565309963864,-0.017676240163341708,1
4313,Phenotype,HP:0002605,Hepatic necrosis,0.034644755035163066,-0.017948186818267108,1
4314,Phenotype,HP:0002529,Neuronal loss in central nervous system,0.03464227949777565,-0.017990767615889677,1
4315,Disease,MONDO:0700120,BAFopathy,0.0346417758192713,-0.017999431202458623,1
4316,Phenotype,HP:0000996,Facial capillary hemangioma,0.03463632942428019,-0.018093112616469308,1
4317,Phenotype,HP:0003043,Abnormal shoulder morphology,0.034623045553872966,-0.018321603529323268,1
4318,Phenotype,HP:0031888,Abnormal HDL cholesterol concentration,0.034622646611559005,-0.018328465587646545,1
4319,Biological Process,GO:0045833,negative regulation of lipid metabolic process,0.034607837642726125,-0.018583189151135326,1
4320,Biological Process,GO:0043604,amide biosynthetic process,0.034561418719614156,-0.019381623778274244,1
4321,Biological Process,GO:0050687,negative regulation of defense response to virus,0.03454791385283551,-0.019613915967495437,1
4322,Biological Process,GO:1903078,positive regulation of protein localization to plasma membrane,0.034533488511848565,-0.019862040891128013,1
4323,Biological Process,GO:0046496,nicotinamide nucleotide metabolic process,0.03453108846664188,-0.01990332317583535,1
4323,Biological Process,GO:0019362,pyridine nucleotide metabolic process,0.03453108846664188,-0.01990332317583535,1
4325,Phenotype,HP:0030506,Yellow/white lesions of the retina,0.0345125973226168,-0.020221382464919318,1
4326,Biological Process,GO:0051154,negative regulation of striated muscle cell differentiation,0.034482513234113776,-0.02073884767902578,1
4327,Biological Process,GO:2000785,regulation of autophagosome assembly,0.03448083873583463,-0.02076765010095898,1
4328,Disease,MONDO:0013099,"combined pituitary hormone deficiencies, genetic form",0.03447238933501873,-0.020912985100948512,1
4328,Disease,MONDO:0005152,hypopituitarism,0.03447238933501873,-0.020912985100948512,1
4330,Phenotype,HP:0012191,B-cell lymphoma,0.03445493390444987,-0.02121322946819024,1
4331,Biological Process,GO:0042886,amide transport,0.03445292443861703,-0.021247793542395997,1
4332,Phenotype,HP:0002691,Platybasia,0.034436930858938064,-0.021522893156335494,1
4333,Phenotype,HP:0100561,Spinal cord lesion,0.03443676991794009,-0.021525661442566478,1
4334,Biological Process,GO:0008203,cholesterol metabolic process,0.03441944737191738,-0.021823620112167236,1
4335,Biological Process,GO:0032516,positive regulation of phosphoprotein phosphatase activity,0.03440706613495059,-0.02203658516302049,1
4336,Biological Process,GO:1901836,regulation of transcription of nucleolar large rRNA by RNA polymerase I,0.03437588417838533,-0.022572934397223823,1
4337,Phenotype,HP:0000294,Low anterior hairline,0.034369705590949096,-0.022679209981084206,1
4338,Biological Process,GO:0044772,mitotic cell cycle phase transition,0.03431555624151428,-0.02361061279543895,1
4339,Phenotype,HP:0012411,Premature pubarche,0.03431027405109677,-0.02370146978766836,1
4340,Biological Process,GO:0043171,peptide catabolic process,0.034249737186998086,-0.024742741865398394,1
4341,Phenotype,HP:0100585,Telangiectasia of the skin,0.03424837772084044,-0.02476612553701159,1
4342,Biological Process,GO:0007187,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger",0.03423236873638891,-0.02504149012271298,1
4343,Phenotype,HP:0006502,Aplasia/Hypoplasia involving the carpal bones,0.03422196547270584,-0.02522043279098174,1
4344,Biological Process,GO:0006509,membrane protein ectodomain proteolysis,0.034220542355579586,-0.025244911299225768,1
4345,Phenotype,HP:0012020,Right aortic arch,0.0342198058919968,-0.025257578935325455,1
4346,Biological Process,GO:0003158,endothelium development,0.034212218552001405,-0.025388085947855406,1
4347,Phenotype,HP:0005261,Joint hemorrhage,0.03421176518609337,-0.02539588412617308,1
4348,Phenotype,HP:0002370,Poor coordination,0.03417309144020675,-0.02606109684131008,1
4349,Phenotype,HP:0012768,Neonatal asphyxia,0.03414505370685861,-0.026543363461706347,1
4350,Biological Process,GO:0061097,regulation of protein tyrosine kinase activity,0.03411364366465919,-0.027083635912047734,1
4351,Phenotype,HP:0100700,Abnormal arachnoid mater morphology,0.034105998286383166,-0.027215141219450654,1
4352,Biological Process,GO:0046513,ceramide biosynthetic process,0.03410280334512972,-0.027270096215331847,1
4353,Biological Process,GO:0043488,regulation of mRNA stability,0.03409063996685546,-0.02747931395986522,1
4354,Biological Process,GO:0031023,microtubule organizing center organization,0.034054958835654126,-0.02809305182314816,1
4355,Phenotype,HP:0012696,Abnormal thalamic MRI signal intensity,0.03404536456230489,-0.02825807934965468,1
4356,Phenotype,HP:0200020,Corneal erosion,0.034035824725576314,-0.028422170532101446,1
4357,Phenotype,HP:0003160,Abnormal isoelectric focusing of serum transferrin,0.03400689044367644,-0.02891985835059159,1
4358,Phenotype,HP:0003021,Metaphyseal cupping,0.03395685999895148,-0.02978041341739508,1
4359,Biological Process,GO:0006119,oxidative phosphorylation,0.033954260106413225,-0.02982513320170325,1
4360,Biological Process,GO:0051153,regulation of striated muscle cell differentiation,0.03387392265183298,-0.031206987869859735,1
4361,Phenotype,HP:0011723,Congenital malformation of the right heart,0.03383585242643661,-0.03186181965357269,1
4362,Disease,MONDO:0004907,alopecia,0.03380262660734146,-0.03243332460677101,1
4363,Biological Process,GO:0021700,developmental maturation,0.033799538436542154,-0.03248644308379245,1
4364,Biological Process,GO:0035279,miRNA-mediated gene silencing by mRNA destabilization,0.03379896502867652,-0.03249630605916332,1
4365,Biological Process,GO:0032926,negative regulation of activin receptor signaling pathway,0.03379789388695431,-0.03251473036942838,1
4366,Phenotype,HP:0012145,Abnormality of multiple cell lineages in the bone marrow,0.03377685741643888,-0.032876570872530854,1
4367,Phenotype,HP:0410241,Abnormal circulating IgE level,0.03371967697904499,-0.033860110303208825,1
4368,Phenotype,HP:0005879,Congenital finger flexion contractures,0.033708511207908964,-0.03405216857849895,1
4369,Disease,MONDO:0800064,osteogenesis imperfecta and a reduction of bone mineral density.,0.03370321574749224,-0.03414325382304792,1
4370,Biological Process,GO:0061718,glucose catabolic process to pyruvate,0.03370230468883961,-0.03415892460398914,1
4370,Biological Process,GO:0006735,NADH regeneration,0.03370230468883961,-0.03415892460398914,1
4370,Biological Process,GO:0061621,canonical glycolysis,0.03370230468883961,-0.03415892460398914,1
4373,Biological Process,GO:0022613,ribonucleoprotein complex biogenesis,0.03364302787137308,-0.035178523088376906,1
4374,Biological Process,GO:0045980,negative regulation of nucleotide metabolic process,0.033615020856261446,-0.03566026133581512,1
4375,Disease,MONDO:0016297,prelingual non-syndromic genetic hearing loss,0.03359872027097199,-0.03594064163904483,1
4376,Biological Process,GO:0033619,membrane protein proteolysis,0.03358441438652415,-0.03618671183518988,1
4377,Phenotype,HP:0100783,Breast aplasia,0.03358020645662474,-0.03625909087190645,1
4378,Biological Process,GO:0050879,multicellular organismal movement,0.03356856248084317,-0.03645937456739738,1
4378,Biological Process,GO:0050881,musculoskeletal movement,0.03356856248084317,-0.03645937456739738,1
4380,Phenotype,HP:0011535,Abnormal atrial arrangement,0.03356751440276218,-0.03647740216855023,1
4381,Phenotype,HP:0030948,Elevated gamma-glutamyltransferase level,0.033543928230281184,-0.03688309914659238,1
4382,Biological Process,GO:1900025,negative regulation of substrate adhesion-dependent cell spreading,0.03352792166708474,-0.037158422085185834,1
4383,Phenotype,HP:0000520,Proptosis,0.033521408792202445,-0.03727044762304033,1
4384,Phenotype,HP:0040156,Elevated urinary carboxylic acid,0.03351583137577363,-0.03736638268805676,1
4385,Phenotype,HP:0002223,Absent eyebrow,0.03345851375793163,-0.03835228170858723,1
4386,Phenotype,HP:0007514,Edema of the dorsum of hands,0.03344226909949555,-0.03863170003481868,1
4387,Biological Process,GO:0045930,negative regulation of mitotic cell cycle,0.03343147972325877,-0.03881728408147765,1
4388,Phenotype,HP:0002419,Molar tooth sign on MRI,0.03341897316457021,-0.03903240474464356,1
4389,Phenotype,HP:0008762,Repetitive compulsive behavior,0.03341692502769922,-0.03906763398498968,1
4390,Biological Process,GO:0009395,phospholipid catabolic process,0.03341405721848478,-0.03911696210437129,1
4391,Biological Process,GO:0061620,glycolytic process through glucose-6-phosphate,0.0333952389710096,-0.03944064777820765,1
4392,Biological Process,GO:1900026,positive regulation of substrate adhesion-dependent cell spreading,0.03339063059082947,-0.03951991481122258,1
4393,Disease,MONDO:0700007,idiopathic disease,0.03334876181384272,-0.040240084067660185,1
4394,Phenotype,HP:0200063,Colorectal polyposis,0.033329692625508,-0.040568086081863484,1
4395,Phenotype,HP:0100819,Intestinal fistula,0.03332675843092714,-0.04061855607123553,1
4396,Biological Process,GO:0090370,negative regulation of cholesterol efflux,0.03331534247227763,-0.04081491772886742,1
4397,Disease,MONDO:0016789,pyruvate metabolism disorder,0.03331022863018063,-0.04090287902426671,1
4398,Phenotype,HP:0045014,Hypolipidemia,0.033295827199449346,-0.04115059267648698,1
4399,Phenotype,HP:0000071,Ureteral stenosis,0.03328634473102432,-0.04131369708808717,1
4400,Biological Process,GO:1903587,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,0.033251109804493084,-0.04191975995084197,1
4401,Phenotype,HP:0100523,Liver abscess,0.033210372646237274,-0.04262046465448665,1
4402,Phenotype,HP:0004749,Atrial flutter,0.033202889982322126,-0.04274917117270307,1
4403,Phenotype,HP:0010511,Long toe,0.0331907217391616,-0.04295847259633531,1
4404,Biological Process,GO:1903322,positive regulation of protein modification by small protein conjugation or removal,0.03315941083549323,-0.04349703980168676,1
4405,Biological Process,GO:0035306,positive regulation of dephosphorylation,0.03311530953945996,-0.044255609787675725,1
4406,Phenotype,HP:0030760,Renal fibrosis,0.033113483856151316,-0.044287012687055656,1
4407,Biological Process,GO:1901568,fatty acid derivative metabolic process,0.0331020709071671,-0.0444833225765545,1
4408,Biological Process,GO:0006376,mRNA splice site recognition,0.03303048296794209,-0.04571468008618253,1
4409,Phenotype,HP:0000725,Psychotic episodes,0.03300219184063635,-0.0462013052417728,1
4410,Biological Process,GO:0030317,flagellated sperm motility,0.03299224646055554,-0.04637237202454635,1
4410,Biological Process,GO:0097722,sperm motility,0.03299224646055554,-0.04637237202454635,1
4412,Biological Process,GO:0042149,cellular response to glucose starvation,0.03297603028017093,-0.04665130051040915,1
4413,Biological Process,GO:0010560,positive regulation of glycoprotein biosynthetic process,0.032930488021583715,-0.0474346559572048,1
4414,Phenotype,HP:0004808,Acute myeloid leukemia,0.032930012389039476,-0.047442837135647876,1
4415,Phenotype,HP:0000143,Rectovaginal fistula,0.03292550335764621,-0.047520395307140854,1
4416,Phenotype,HP:0030182,Tetraplegia/tetraparesis,0.03283516861818936,-0.04907420955315313,1
4417,Biological Process,GO:0043484,regulation of RNA splicing,0.03280850973215177,-0.04953275913393549,1
4418,Biological Process,GO:0010838,positive regulation of keratinocyte proliferation,0.032799852866423174,-0.04968166266070474,1
4419,Phenotype,HP:0034671,Knee contracture,0.0327869903944652,-0.04990290525560679,1
4420,Disease,MONDO:0020099,inherited sideroblastic anemia,0.03278639749058376,-0.049913103574692336,1
4420,Disease,MONDO:0015194,sideroblastic anemia,0.03278639749058376,-0.049913103574692336,1
4422,Biological Process,GO:0043632,modification-dependent macromolecule catabolic process,0.032765762924450104,-0.050268031070045065,1
4423,Phenotype,HP:0000642,Red-green dyschromatopsia,0.032748119428059774,-0.05057151028751548,1
4424,Phenotype,HP:0011119,Abnormal nasal dorsum morphology,0.03272888171807875,-0.05090241097986146,1
4425,Biological Process,GO:0006289,nucleotide-excision repair,0.03271813995457318,-0.05108717605764447,1
4426,Phenotype,HP:0003761,Calcinosis,0.03271180668525897,-0.05119611226694131,1
4427,Phenotype,HP:0010991,Abnormal morphology of the abdominal musculature,0.032701372484930546,-0.05137558706493744,1
4428,Biological Process,GO:0046365,monosaccharide catabolic process,0.03264607740963599,-0.05232669708355927,1
4429,Phenotype,HP:0009025,Increased connective tissue,0.032640025132511186,-0.052430800050744145,1
4430,Phenotype,HP:0003325,Limb-girdle muscle weakness,0.032603493178934406,-0.053059172593174185,1
4431,Phenotype,HP:0002818,Abnormal morphology of the radius,0.03260112472606391,-0.05309991146986004,1
4432,Biological Process,GO:0050714,positive regulation of protein secretion,0.03258004258809821,-0.0534625374817848,1
4433,Phenotype,HP:0010501,Limitation of knee mobility,0.03257940910585866,-0.0534734337741119,1
4434,Biological Process,GO:0030512,negative regulation of transforming growth factor beta receptor signaling pathway,0.03257579121130649,-0.053535663832332304,1
4435,Phenotype,HP:0002350,Cerebellar cyst,0.03256025074589419,-0.0538029695963438,1
4436,Phenotype,HP:0009380,Finger aplasia,0.032557838674037054,-0.053844458746991286,1
4437,Phenotype,HP:0031374,Ankle weakness,0.03253001814358525,-0.05432298934117405,1
4438,Biological Process,GO:0007549,sex-chromosome dosage compensation,0.03251029447896203,-0.054662248758529874,1
4439,Phenotype,HP:0001027,"Soft, doughy skin",0.03250433179865586,-0.05476481060417033,1
4440,Biological Process,GO:0046827,positive regulation of protein export from nucleus,0.03247327638937947,-0.055298983145537405,1
4441,Biological Process,GO:0048732,gland development,0.03247234789253317,-0.05531495387436033,1
4442,Biological Process,GO:2000142,regulation of DNA-templated transcription initiation,0.03246512107902588,-0.05543925960489561,1
4443,Biological Process,GO:0015701,bicarbonate transport,0.03246411498385904,-0.055456565073561226,1
4444,Biological Process,GO:0045921,positive regulation of exocytosis,0.03245451151850276,-0.055621750708361194,1
4445,Phenotype,HP:0001969,Abnormal tubulointerstitial morphology,0.03245085585485419,-0.05568463041875758,1
4446,Phenotype,HP:0000835,Adrenal hypoplasia,0.03240438199909035,-0.056484009922004655,1
4447,Biological Process,GO:0045022,early endosome to late endosome transport,0.03240049077550744,-0.0565509414111958,1
4447,Biological Process,GO:0098927,vesicle-mediated transport between endosomal compartments,0.03240049077550744,-0.0565509414111958,1
4449,Phenotype,HP:0012261,Abnormal respiratory motile cilium physiology,0.03239963217890751,-0.056565709811886036,1
4450,Biological Process,GO:0090043,regulation of tubulin deacetylation,0.03239283769825718,-0.056682579145790286,1
4451,Biological Process,GO:1903729,regulation of plasma membrane organization,0.03238610289332666,-0.05679842201983935,1
4452,Biological Process,GO:0051004,regulation of lipoprotein lipase activity,0.032369228759428825,-0.057088667719303626,1
4453,Phenotype,HP:0000415,Abnormal choanae morphology,0.032359844796595594,-0.057250077772866566,1
4454,Phenotype,HP:0033367,Orthodeoxia,0.03234370272743725,-0.05752773149909807,1
4454,Phenotype,HP:0031631,Subpleural honeycombing,0.03234370272743725,-0.05752773149909807,1
4454,Phenotype,HP:0025390,Reticular pattern on pulmonary HRCT,0.03234370272743725,-0.05752773149909807,1
4454,Phenotype,HP:0025175,Honeycomb lung,0.03234370272743725,-0.05752773149909807,1
4454,Phenotype,HP:0031950,Usual interstitial pneumonia,0.03234370272743725,-0.05752773149909807,1
4459,Phenotype,HP:0030157,Flank pain,0.03234325605529442,-0.05753541454045068,1
4460,Phenotype,HP:0003108,Hyperglycinuria,0.032341906937535025,-0.057558620213115516,1
4460,Phenotype,HP:0033099,Increased serine family amino acid in urine,0.032341906937535025,-0.057558620213115516,1
4462,Phenotype,HP:0004491,Large posterior fontanelle,0.03230014611551779,-0.05827693257628509,1
4463,Phenotype,HP:0030319,Weakness of facial musculature,0.032281592613628174,-0.05859606445979789,1
4464,Biological Process,GO:0002357,defense response to tumor cell,0.03223840882550855,-0.05933885273350626,1
4465,Disease,MONDO:0018958,nemaline myopathy,0.03223789864269966,-0.059347628198197784,1
4466,Biological Process,GO:0070897,transcription preinitiation complex assembly,0.03222592156910009,-0.059553641385333096,1
4467,Phenotype,HP:0007340,Lower limb muscle weakness,0.03217763374991767,-0.060384222198491384,1
4468,Phenotype,HP:0004844,Coombs-positive hemolytic anemia,0.03213360136373744,-0.06114160689173475,1
4469,Biological Process,GO:1903305,regulation of regulated secretory pathway,0.032094184003785386,-0.0618196102357633,1
4470,Phenotype,HP:0010012,Abnormal 4th metacarpal morphology,0.03208952096110007,-0.0618998174981938,1
4471,Phenotype,HP:0011539,Atrial situs ambiguous,0.03208879267734588,-0.061912344436105035,1
4472,Phenotype,HP:0001943,Hypoglycemia,0.032087970705490965,-0.06192648286818184,1
4473,Phenotype,HP:0010979,Abnormality of lipoprotein cholesterol concentration,0.03207328286025313,-0.06217912302977411,1
4474,Phenotype,HP:0002310,Orofacial dyskinesia,0.03207247941106983,-0.06219294286026742,1
4475,Phenotype,HP:0004691,2-3 toe syndactyly,0.032067006982417046,-0.06228707206960716,1
4476,Phenotype,HP:0001620,High pitched voice,0.03204671316369112,-0.06263613849556827,1
4477,Biological Process,GO:0090141,positive regulation of mitochondrial fission,0.03202175833224452,-0.06306537726729332,1
4478,Phenotype,HP:0009809,Abnormal upper limb metaphysis morphology,0.03202173712560863,-0.06306574203474775,1
4479,Phenotype,HP:0030151,Cholangitis,0.03200342706751658,-0.06338068653206744,1
4480,Phenotype,HP:0010497,Sirenomelia,0.0319927041812722,-0.06356512690910351,1
4481,Phenotype,HP:0025383,Dorsocervical fat pad,0.03197456306674007,-0.06387716547110138,1
4482,Biological Process,GO:1901799,negative regulation of proteasomal protein catabolic process,0.03197153496241112,-0.06392925076711291,1
4483,Phenotype,HP:3000022,Abnormality of cartilage of external ear,0.031953319900632104,-0.06424256126819365,1
4484,Phenotype,HP:0000762,Decreased nerve conduction velocity,0.031869168063195286,-0.06569002571679473,1
4485,Disease,MONDO:0024257,hereditary motor neuron disease,0.03186855396230881,-0.06570058863767803,1
4485,Disease,MONDO:0020128,motor neuron disorder,0.03186855396230881,-0.06570058863767803,1
4487,Biological Process,GO:0030182,neuron differentiation,0.03185623226870016,-0.06591252950538005,1
4488,Phenotype,HP:0000656,Ectropion,0.03181105238463677,-0.06668965188280605,1
4489,Biological Process,GO:0050919,negative chemotaxis,0.03180894130052769,-0.06672596385517617,1
4490,Biological Process,GO:0042744,hydrogen peroxide catabolic process,0.031763752528279676,-0.06750323911495935,1
4491,Biological Process,GO:1905475,regulation of protein localization to membrane,0.03174990228164587,-0.06774147205457691,1
4492,Phenotype,HP:0020216,Visually-induced seizure,0.03174423417464223,-0.06783896705443118,1
4493,Phenotype,HP:0007372,Atrophy/Degeneration involving the corticospinal tracts,0.03174117944847743,-0.06789151026273695,1
4494,Disease,MONDO:0018949,distal myopathy,0.03169191822233275,-0.06873883428691477,1
4495,Phenotype,HP:0009105,Abnormal ossification of the pubic bone,0.03166799210387483,-0.06915037854923532,1
4496,Biological Process,GO:0051972,regulation of telomerase activity,0.03166529760765535,-0.06919672557626863,1
4497,Phenotype,HP:0006481,Abnormality of primary teeth,0.031655027976410954,-0.06937336968267532,1
4498,Phenotype,HP:0031651,Abnormal tricuspid valve physiology,0.03164827500266676,-0.06948952507172904,1
4499,Biological Process,GO:0060337,type I interferon-mediated signaling pathway,0.03161517991329943,-0.07005878139151471,1
4500,Phenotype,HP:0000248,Brachycephaly,0.03161085539005293,-0.07013316590701812,1
4501,Biological Process,GO:0006470,protein dephosphorylation,0.03161026443078396,-0.07014333077754802,1
4502,Disease,MONDO:0016575,primary ciliary dyskinesia,0.03160617372697705,-0.07021369345185932,1
4503,Biological Process,GO:0045056,transcytosis,0.031572288524337244,-0.07079654021609767,1
4504,Phenotype,HP:0100703,Tongue thrusting,0.03156966419740437,-0.07084168028733731,1
4505,Phenotype,HP:0006934,Congenital nystagmus,0.03155496593446239,-0.07109449963998284,1
4506,Disease,MONDO:0018677,visceral heterotaxy,0.03155248099192198,-0.07113724221214297,1
4507,Phenotype,HP:0001981,Schistocytosis,0.03151794464995894,-0.07173128898163589,1
4508,Phenotype,HP:0008240,Secondary growth hormone deficiency,0.03151444537934078,-0.07179147863369927,1
4509,Biological Process,GO:0001836,release of cytochrome c from mitochondria,0.031511585474273685,-0.07184067079678313,1
4510,Phenotype,HP:0020118,Radial artery aplasia,0.03150972139952746,-0.07187273405299813,1
4510,Phenotype,HP:0031640,Abnormal radial artery morphology,0.03150972139952746,-0.07187273405299813,1
4510,Phenotype,HP:0030270,Elevated red cell adenosine deaminase activity,0.03150972139952746,-0.07187273405299813,1
4513,Phenotype,HP:0002190,Choroid plexus cyst,0.0314817811112591,-0.0723533245568297,1
4514,Biological Process,GO:0010038,response to metal ion,0.0314694381905084,-0.07256563054470486,1
4515,Phenotype,HP:0000689,Dental malocclusion,0.03146061424650248,-0.07271740792276396,1
4516,Phenotype,HP:0002850,Decreased circulating total IgM,0.03136599863157785,-0.07434485591507617,1
4517,Phenotype,HP:0008245,Pituitary hypothyroidism,0.03135194877859593,-0.07458652220922779,1
4518,Phenotype,HP:0002803,Congenital contracture,0.0313342507815918,-0.07489093887148021,1
4519,Phenotype,HP:0002779,Tracheomalacia,0.03133418566820145,-0.07489205886268333,1
4520,Biological Process,GO:0045616,regulation of keratinocyte differentiation,0.031301958577919065,-0.07544638505313207,1
4521,Phenotype,HP:0010679,Elevated tissue non-specific alkaline phosphatase,0.03127067079858514,-0.07598455450540968,1
4522,Biological Process,GO:0071243,cellular response to arsenic-containing substance,0.031256412704831704,-0.07622980267159998,1
4523,Phenotype,HP:0012262,Abnormal ciliary motility,0.03124071273027662,-0.07649985209303403,1
4524,Phenotype,HP:0005528,Bone marrow hypocellularity,0.031221243897264994,-0.07683472824664432,1
4525,Phenotype,HP:0001048,Cavernous hemangioma,0.031191389344051523,-0.07734824530962958,1
4526,Biological Process,GO:1902905,positive regulation of supramolecular fiber organization,0.031176750746453097,-0.07760003838089803,1
4527,Biological Process,GO:0006091,generation of precursor metabolites and energy,0.03114229725436124,-0.07819266008057944,1
4528,Biological Process,GO:0007600,sensory perception,0.031134757475426822,-0.07832234901299372,1
4529,Biological Process,GO:0043330,response to exogenous dsRNA,0.03113266732141584,-0.07835830097453308,1
4530,Biological Process,GO:0048667,cell morphogenesis involved in neuron differentiation,0.03112053491414668,-0.07856698599833004,1
4531,Biological Process,GO:0010921,regulation of phosphatase activity,0.031118477480753914,-0.0786023751446886,1
4532,Biological Process,GO:0008064,regulation of actin polymerization or depolymerization,0.031060704391165594,-0.07959610856527759,1
4532,Biological Process,GO:0030832,regulation of actin filament length,0.031060704391165594,-0.07959610856527759,1
4534,Biological Process,GO:0001654,eye development,0.03105000033827443,-0.0797802249968117,1
4534,Biological Process,GO:0150063,visual system development,0.03105000033827443,-0.0797802249968117,1
4536,Biological Process,GO:0032367,intracellular cholesterol transport,0.031047247237694364,-0.07982758005564877,1
4536,Biological Process,GO:0032366,intracellular sterol transport,0.031047247237694364,-0.07982758005564877,1
4538,Biological Process,GO:0033198,response to ATP,0.0310358959930489,-0.08002282859177275,1
4539,Disease,MONDO:0015967,monogenic diabetes,0.031025302715219527,-0.08020503962268084,1
4540,Phenotype,HP:0000320,Bird-like facies,0.031014089282677126,-0.08039791770409051,1
4541,Biological Process,GO:0010634,positive regulation of epithelial cell migration,0.03099961750891378,-0.0806468413006355,1
4542,Phenotype,HP:0005317,Increased pulmonary vascular resistance,0.030976969955666234,-0.0810363934384392,1
4543,Biological Process,GO:0001990,regulation of systemic arterial blood pressure by hormone,0.03097635681956956,-0.081046939764332,1
4543,Biological Process,GO:0003044,regulation of systemic arterial blood pressure mediated by a chemical signal,0.03097635681956956,-0.081046939764332,1
4545,Phenotype,HP:0000104,Renal agenesis,0.030974895176942407,-0.08107208093538432,1
4546,Phenotype,HP:0005957,Breathing dysregulation,0.030955902541740854,-0.08139876618762422,1
4547,Biological Process,GO:0007584,response to nutrient,0.030931747203610138,-0.08181425317225957,1
4548,Phenotype,HP:0012520,Dilation of Virchow-Robin spaces,0.030924751946849294,-0.08193457598134572,1
4549,Biological Process,GO:0046503,glycerolipid catabolic process,0.030915694544160655,-0.08209036899535224,1
4550,Phenotype,HP:0004586,Biconcave vertebral bodies,0.030897213365595033,-0.08240825687227556,1
4551,Biological Process,GO:0009100,glycoprotein metabolic process,0.03089099646173299,-0.08251519152272137,1
4552,Biological Process,GO:1904707,positive regulation of vascular associated smooth muscle cell proliferation,0.03088886853741113,-0.08255179315732641,1
4553,Phenotype,HP:0003155,Elevated circulating alkaline phosphatase concentration,0.030884310334165943,-0.08263019711555085,1
4554,Biological Process,GO:0032371,regulation of sterol transport,0.030877157091476315,-0.08275323738182222,1
4554,Biological Process,GO:0032374,regulation of cholesterol transport,0.030877157091476315,-0.08275323738182222,1
4556,Phenotype,HP:0002673,Coxa valga,0.03087084691509001,-0.0828617763782575,1
4557,Biological Process,GO:0032210,regulation of telomere maintenance via telomerase,0.03086364018632315,-0.08298573663864486,1
4558,Biological Process,GO:0010893,positive regulation of steroid biosynthetic process,0.030841350464818507,-0.08336913384576364,1
4559,Phenotype,HP:0025708,Early young adult onset,0.030818455587438676,-0.08376294011395437,1
4560,Biological Process,GO:0045738,negative regulation of DNA repair,0.03077768312819107,-0.08446425201682585,1
4561,Phenotype,HP:0032543,Lithoptysis,0.030773147621770414,-0.08454226557541546,1
4561,Phenotype,HP:0011617,Pulmonary situs ambiguus,0.030773147621770414,-0.08454226557541546,1
4561,Phenotype,HP:0011615,Abnormal pulmonary situs morphology,0.030773147621770414,-0.08454226557541546,1
4561,Phenotype,HP:0025177,Peribronchovascular interstitial thickening,0.030773147621770414,-0.08454226557541546,1
4565,Phenotype,HP:0031394,Abnormal CD4:CD8 ratio,0.030766999348890267,-0.08464801972987455,1
4566,Phenotype,HP:0005328,Progeroid facial appearance,0.030737441729769,-0.08515642934000872,1
4567,Biological Process,GO:0008299,isoprenoid biosynthetic process,0.03068311472971985,-0.0860908878564889,1
4568,Biological Process,GO:0042558,pteridine-containing compound metabolic process,0.030649691704495052,-0.08666578487895638,1
4569,Disease,MONDO:0024322,disorder of glycosylation,0.030646473423021625,-0.08672114134127812,1
4570,Biological Process,GO:0000226,microtubule cytoskeleton organization,0.03064563419713473,-0.08673557655353999,1
4571,Biological Process,GO:0090208,positive regulation of triglyceride metabolic process,0.030641345989742663,-0.08680933641354192,1
4572,Phenotype,HP:0006937,Impaired distal tactile sensation,0.03061890397063305,-0.08719535323510427,1
4573,Phenotype,HP:0011702,Abnormal electrophysiology of sinoatrial node origin,0.030567171777861613,-0.08808517943695106,1
4574,Biological Process,GO:0048880,sensory system development,0.03055519512641247,-0.08829118536283395,1
4575,Phenotype,HP:0002031,Abnormal esophagus morphology,0.030530449993663278,-0.08871681718527946,1
4576,Phenotype,HP:0005616,Accelerated skeletal maturation,0.03050757955019978,-0.0891102031747655,1
4577,Biological Process,GO:0022412,cellular process involved in reproduction in multicellular organism,0.030497530060934808,-0.08928306070088393,1
4578,Biological Process,GO:0043534,blood vessel endothelial cell migration,0.030491415404427347,-0.08938823663262281,1
4579,Phenotype,HP:0004150,Abnormal 3rd finger morphology,0.03043183652951964,-0.09041303069468122,1
4580,Phenotype,HP:0007928,Abnormal flash visual evoked potentials,0.03042803283002915,-0.09047845671452041,1
4581,Phenotype,HP:0000399,Prelingual sensorineural hearing impairment,0.030378605600263953,-0.09132863610521615,1
4582,Biological Process,GO:0002792,negative regulation of peptide secretion,0.030371946777948633,-0.09144317203056909,1
4583,Biological Process,GO:0061157,mRNA destabilization,0.03035599593844973,-0.09171753648657205,1
4584,Biological Process,GO:0035383,thioester metabolic process,0.03035443746058586,-0.09174434328450538,1
4584,Biological Process,GO:0006637,acyl-CoA metabolic process,0.03035443746058586,-0.09174434328450538,1
4586,Phenotype,HP:0010881,Abnormality of the umbilical cord,0.0303444706088718,-0.09191577939285432,1
4587,Phenotype,HP:0031629,Impaired tandem gait,0.03033828935440186,-0.09202210085136925,1
4588,Phenotype,HP:0007763,Retinal telangiectasia,0.030304539537081676,-0.09260261890309242,1
4589,Phenotype,HP:0011386,Narrow internal auditory canal,0.03030094077640444,-0.09266451984664857,1
4590,Phenotype,HP:0003174,Abnormal ischium morphology,0.030297021393495216,-0.09273193569393551,1
4591,Phenotype,HP:0008320,Impaired collagen-induced platelet aggregation,0.030296272751802578,-0.09274481280117215,1
4592,Biological Process,GO:0006858,extracellular transport,0.030293657221243442,-0.09278980156925962,1
4593,Biological Process,GO:0009101,glycoprotein biosynthetic process,0.030285661630485294,-0.09292733075127743,1
4594,Phenotype,HP:0031980,Abnormal urine carboxylic acid level,0.030262156823724684,-0.09333162818783389,1
4595,Disease,MONDO:0020073,adolescent-onset epilepsy syndrome,0.030251622247117527,-0.09351282952085735,1
4596,Disease,MONDO:0019256,sterol metabolism disorder,0.030236307912073324,-0.09377624570053486,1
4597,Phenotype,HP:0000410,Mixed hearing impairment,0.030209052993585894,-0.09424504741374395,1
4598,Biological Process,GO:0051048,negative regulation of secretion,0.030196543975558043,-0.09446021037909,1
4599,Biological Process,GO:0045070,positive regulation of viral genome replication,0.030155829162894388,-0.0951605307245173,1
4600,Phenotype,HP:0000160,Narrow mouth,0.03014810389295086,-0.09529341021877072,1
4601,Biological Process,GO:0008202,steroid metabolic process,0.030144523809557677,-0.09535498990131243,1
4602,Phenotype,HP:0001540,Diastasis recti,0.030135623919030352,-0.09550807360723171,1
4603,Biological Process,GO:0009743,response to carbohydrate,0.03012997682165308,-0.095605207228319,1
4604,Phenotype,HP:5200269,Abnormal thought pattern,0.03012399757101647,-0.09570805409404869,1
4605,Phenotype,HP:0004429,Recurrent viral infections,0.03012328579257162,-0.09572029713027444,1
4606,Phenotype,HP:0001350,Slurred speech,0.03011786305920261,-0.09581357154952615,1
4607,Phenotype,HP:0003212,Increased circulating IgE level,0.03011440565572998,-0.09587304106039521,1
4608,Phenotype,HP:0002687,Abnormality of frontal sinus,0.030112568853933763,-0.09590463520474349,1
4609,Phenotype,HP:0001558,Decreased fetal movement,0.030103509203732948,-0.09606046687737081,1
4610,Biological Process,GO:1902903,regulation of supramolecular fiber organization,0.030075998185885355,-0.096533673660397,1
4611,Biological Process,GO:0015718,monocarboxylic acid transport,0.03005920135980167,-0.09682258961691104,1
4612,Phenotype,HP:0006520,Progressive pulmonary function impairment,0.030043125450539332,-0.09709910535138491,1
4613,Disease,MONDO:0020380,autosomal dominant cerebellar ataxia,0.030027866887838095,-0.09736156221174015,1
4614,Biological Process,GO:0090150,establishment of protein localization to membrane,0.0300251512287123,-0.09740827325405173,1
4615,Biological Process,GO:0051047,positive regulation of secretion,0.029998494886218974,-0.09786677908427548,1
4616,Phenotype,HP:0008388,Abnormal toenail morphology,0.0299878751623035,-0.09804944500447177,1
4617,Biological Process,GO:1905476,negative regulation of protein localization to membrane,0.029973517801094363,-0.09829640063323693,1
4618,Phenotype,HP:0032135,Decreased circulating IgG subclass level,0.029959413828319348,-0.09853899782181523,1
4619,Phenotype,HP:0001480,Freckling,0.029934138572405233,-0.09897374809559795,1
4620,Biological Process,GO:0030834,regulation of actin filament depolymerization,0.029931461510498192,-0.09901979524150913,1
4621,Phenotype,HP:0009748,Large earlobe,0.029902224494236518,-0.09952269028112984,1
4622,Phenotype,HP:0000733,Motor stereotypy,0.029894419896511204,-0.09965693426304534,1
4623,Biological Process,GO:0000018,regulation of DNA recombination,0.029893574285181135,-0.09967147930893965,1
4624,Phenotype,HP:0002486,Myotonia,0.029889669603334612,-0.09973864228871633,1
4625,Biological Process,GO:1903214,regulation of protein targeting to mitochondrion,0.029868009256472594,-0.10011121385675463,1
4626,Phenotype,HP:0000870,Increased circulating prolactin concentration,0.029863299614439343,-0.10019222265723253,1
4627,Biological Process,GO:0031571,mitotic G1 DNA damage checkpoint signaling,0.02986292333460805,-0.1001986949066226,1
4627,Biological Process,GO:0044819,mitotic G1/S transition checkpoint signaling,0.02986292333460805,-0.1001986949066226,1
4629,Phenotype,HP:0007715,Weak extraocular muscles,0.02984315778179425,-0.1005386748271609,1
4630,Phenotype,HP:0001899,Increased hematocrit,0.02983312623653378,-0.10071122370513358,1
4631,Biological Process,GO:0035871,protein K11-linked deubiquitination,0.029787043276223835,-0.10150387956110371,1
4632,Phenotype,HP:0012346,Abnormal protein glycosylation,0.029771508695499826,-0.10177108410478117,1
4633,Phenotype,HP:0002098,Respiratory distress,0.029730042903743703,-0.10248432176219,1
4634,Disease,MONDO:0005267,heart disorder,0.02969388838911624,-0.10310620211767207,1
4635,Phenotype,HP:0020206,Simple ear,0.029685220862455286,-0.10325528901917264,1
4636,Phenotype,HP:0011505,Cystoid macular edema,0.029656221185889287,-0.10375410166698594,1
4637,Biological Process,GO:0097242,amyloid-beta clearance,0.029640263897034225,-0.10402857705596484,1
4638,Phenotype,HP:5200065,Tactile sensory seeking,0.029613606695441552,-0.10448709766323686,1
4639,Phenotype,HP:0002236,Frontal upsweep of hair,0.02961346082338767,-0.10448960675416662,1
4640,Phenotype,HP:0000533,Chorioretinal atrophy,0.02957406444830557,-0.10516724914525416,1
4641,Phenotype,HP:0003774,Stage 5 chronic kidney disease,0.029515840496886048,-0.10616873767246678,1
4642,Phenotype,HP:0010675,Abnormal foot bone ossification,0.029498886074877606,-0.10646036437785183,1
4643,Biological Process,GO:0097352,autophagosome maturation,0.02944469220544499,-0.10739253296412588,1
4644,Phenotype,HP:0030289,Flattened femoral epiphysis,0.029442669577686487,-0.10742732343171826,1
4645,Biological Process,GO:0022618,protein-RNA complex assembly,0.02944017829887602,-0.10747017499170249,1
4646,Phenotype,HP:0010988,Abnormality of the extrinsic pathway,0.029424829135834107,-0.10773419023481146,1
4647,Phenotype,HP:0003348,Hyperalaninemia,0.029389753751885017,-0.10833750886496567,1
4648,Phenotype,HP:0011876,Abnormal platelet volume,0.0293775168697491,-0.10854799092207776,1
4649,Biological Process,GO:1904353,regulation of telomere capping,0.02934573103428917,-0.10909472725248617,1
4650,Biological Process,GO:0046165,alcohol biosynthetic process,0.029323602793501213,-0.10947534688987315,1
4651,Biological Process,GO:0051123,RNA polymerase II preinitiation complex assembly,0.029292265363632608,-0.11001437036252627,1
4652,Biological Process,GO:0051984,positive regulation of chromosome segregation,0.029283784770606558,-0.11016024188811807,1
4653,Disease,MONDO:0004737,homocystinuria,0.02927845086982983,-0.11025198833099849,1
4654,Disease,MONDO:0021227,adrenal gland neoplasm,0.029273830990083183,-0.11033145316377894,1
4655,Phenotype,HP:0100309,Subdural hemorrhage,0.02922127884548753,-0.111235383051906,1
4656,Biological Process,GO:2000191,regulation of fatty acid transport,0.029145442612970474,-0.11253981387395075,1
4657,Phenotype,HP:0007207,Photosensitive tonic-clonic seizure,0.02913379868732513,-0.11274009670706706,1
4658,Disease,MONDO:0005501,congenital disorder of glycosylation type II,0.02912046935736412,-0.11296936955279333,1
4659,Biological Process,GO:0110020,regulation of actomyosin structure organization,0.02908130165614997,-0.11364307860975213,1
4660,Biological Process,GO:0062014,negative regulation of small molecule metabolic process,0.02906550630474425,-0.11391476857291083,1
4661,Biological Process,GO:0035336,long-chain fatty-acyl-CoA metabolic process,0.0290469957510735,-0.11423316172008893,1
4662,Phenotype,HP:0031221,Abnormal radioactive iodine uptake test result,0.029025514280585196,-0.11460265650217066,1
4662,Phenotype,HP:0031219,Reduced radioactive iodine uptake,0.029025514280585196,-0.11460265650217066,1
4664,Biological Process,GO:0050433,regulation of catecholamine secretion,0.02901110540943075,-0.11485049813434174,1
4665,Phenotype,HP:0012515,Hip flexor weakness,0.02898764445379509,-0.11525404130401189,1
4666,Phenotype,HP:0001430,Abnormal calf musculature morphology,0.028981560483007485,-0.11535868942209963,1
4667,Phenotype,HP:0012120,Methylmalonic aciduria,0.028981074421929764,-0.11536704997786737,1
4668,Phenotype,HP:0000849,Adrenocortical abnormality,0.028887304747276188,-0.11697994726629375,1
4669,Disease,MONDO:0019220,inborn disorder of cobalamin metabolism and transport,0.028872918097705647,-0.11722740667326718,1
4670,Disease,MONDO:0100547,cardiogenetic disease,0.0288654278249032,-0.11735624406912327,1
4671,Phenotype,HP:0002967,Cubitus valgus,0.028835081333758894,-0.11787822277344034,1
4672,Biological Process,GO:0070934,CRD-mediated mRNA stabilization,0.028824855695745444,-0.11805411016864839,1
4673,Biological Process,GO:0030488,tRNA methylation,0.02881851404397684,-0.11816319056142477,1
4674,Biological Process,GO:0060390,regulation of SMAD protein signal transduction,0.028806993864762598,-0.1183613448782173,1
4675,Phenotype,HP:0034033,Peripheral cyanosis,0.028803103475384062,-0.11842826201856939,1
4676,Phenotype,HP:0002176,Spinal cord compression,0.028800788972498714,-0.11846807292163185,1
4677,Biological Process,GO:0030072,peptide hormone secretion,0.028773335568464176,-0.11894028871089386,1
4677,Biological Process,GO:0002790,peptide secretion,0.028773335568464176,-0.11894028871089386,1
4679,Biological Process,GO:0045945,positive regulation of transcription by RNA polymerase III,0.028758076827292922,-0.11920274864104545,1
4680,Phenotype,HP:0025269,Panic attack,0.02873569068812587,-0.1195878042925049,1
4681,Phenotype,HP:0009811,Abnormality of the elbow,0.028693008923630026,-0.12032195744462928,1
4682,Phenotype,HP:0005180,Tricuspid regurgitation,0.028667765919002774,-0.12075615297602516,1
4683,Phenotype,HP:0009543,Abnormality of the middle phalanx of the 2nd finger,0.028663814911092267,-0.12082411279319367,1
4683,Phenotype,HP:0009568,Aplasia/Hypoplasia of the middle phalanx of the 2nd finger,0.028663814911092267,-0.12082411279319367,1
4685,Biological Process,GO:0002011,morphogenesis of an epithelial sheet,0.028650747665939225,-0.12104887761564195,1
4686,Phenotype,HP:0012166,Skin-picking,0.028618750808703575,-0.12159924365310774,1
4687,Biological Process,GO:0006677,glycosylceramide metabolic process,0.028615114369836325,-0.12166179268519284,1
4688,Phenotype,HP:0002863,Myelodysplasia,0.028563536298216397,-0.12254896790645049,1
4689,Phenotype,HP:0100738,Abnormal eating behavior,0.02856046754852315,-0.12260175232825192,1
4690,Phenotype,HP:0002216,Premature graying of hair,0.028559797344947624,-0.12261328025061757,1
4691,Phenotype,HP:0001669,Transposition of the great arteries,0.028551537095001578,-0.12275536173686483,1
4692,Phenotype,HP:0010051,Deviation of the hallux,0.02854489095394852,-0.12286967953654343,1
4693,Phenotype,HP:0010515,Aplasia/Hypoplasia of the thymus,0.028533217819446843,-0.12307046478033092,1
4694,Phenotype,HP:0000705,Amelogenesis imperfecta,0.02852919352397143,-0.12313968518963808,1
4695,Biological Process,GO:0007033,vacuole organization,0.028515131413779704,-0.12338156231549545,1
4696,Phenotype,HP:0001662,Bradycardia,0.02850799046724528,-0.1235043910801757,1
4697,Phenotype,HP:0000696,Delayed eruption of permanent teeth,0.028482250808146037,-0.12394712938037314,1
4698,Phenotype,HP:0002299,Brittle hair,0.02846955318293032,-0.12416553650778984,1
4699,Biological Process,GO:0090205,positive regulation of cholesterol metabolic process,0.028455892340875755,-0.12440051156970434,1
4700,Phenotype,HP:0002897,Parathyroid adenoma,0.028446271344649166,-0.1245659987464825,1
4701,Phenotype,HP:0012757,Abnormal neuron morphology,0.028434334014796114,-0.12477132831621993,1
4702,Biological Process,GO:0006734,NADH metabolic process,0.028420374922369485,-0.12501143347182575,1
4703,Phenotype,HP:0011730,Abnormal central sensory function,0.028401528727288072,-0.12533559986203946,1
4704,Biological Process,GO:0042987,amyloid precursor protein catabolic process,0.028371845726728573,-0.12584616611164678,1
4705,Biological Process,GO:0070286,axonemal dynein complex assembly,0.028365189153767956,-0.12596066334668632,1
4706,Phenotype,HP:0002153,Hyperkalemia,0.028360050641084933,-0.12604904899165748,1
4707,Biological Process,GO:0071806,protein transmembrane transport,0.028350392175804817,-0.12621518065968565,1
4708,Biological Process,GO:0035592,establishment of protein localization to extracellular region,0.028269567632082437,-0.12760541356696337,1
4709,Phenotype,HP:0000311,Round face,0.028255779370462974,-0.12784258032540957,1
4710,Biological Process,GO:1902652,secondary alcohol metabolic process,0.028252706916398806,-0.12789542846471708,1
4711,Phenotype,HP:0004039,Abnormal ulnar metaphysis morphology,0.028223824203928438,-0.12839222925663576,1
4712,Biological Process,GO:0055075,potassium ion homeostasis,0.02821919224618097,-0.12847190183861495,1
4713,Phenotype,HP:0010619,Fibroadenoma of the breast,0.02821733484141531,-0.12850385036697565,1
4714,Biological Process,GO:1900180,regulation of protein localization to nucleus,0.02819930014456229,-0.12881405847806585,1
4715,Phenotype,HP:0011193,EEG with focal spikes,0.028170561711388098,-0.12930837757548747,1
4716,Phenotype,HP:0011869,Abnormal platelet function,0.028167574919630733,-0.12935975226932472,1
4717,Phenotype,HP:0030681,Abnormal morphology of myocardial trabeculae,0.028165463498316945,-0.12939607004182757,1
4718,Phenotype,HP:0003302,Spondylolisthesis,0.028163998634701204,-0.12942126661590628,1
4719,Phenotype,HP:0030966,Abnormal pulmonary artery morphology,0.028108770316527365,-0.13037122837013035,1
4720,Phenotype,HP:0005289,Abnormal nasolabial region morphology,0.028102501820788217,-0.13047905043326044,1
4721,Biological Process,GO:0006490,oligosaccharide-lipid intermediate biosynthetic process,0.028058600443758852,-0.1312341816868394,1
4721,Biological Process,GO:0006488,dolichol-linked oligosaccharide biosynthetic process,0.028058600443758852,-0.1312341816868394,1
4723,Biological Process,GO:0043113,receptor clustering,0.02805235570848219,-0.13134159505509388,1
4724,Phenotype,HP:0003393,Thenar muscle atrophy,0.028034180868772962,-0.13165421371131614,1
4725,Phenotype,HP:0100702,Arachnoid cyst,0.02798264416977836,-0.1325406772974375,1
4726,Phenotype,HP:0007420,Spontaneous hematomas,0.027967510837857867,-0.1328009801097229,1
4727,Phenotype,HP:0020045,Esodeviation,0.027942727697182312,-0.13322726569236962,1
4728,Phenotype,HP:0005272,Prominent nasolabial fold,0.027915601391338307,-0.13369385518734717,1
4729,Biological Process,GO:1904375,regulation of protein localization to cell periphery,0.027897037364301602,-0.13401316810999933,1
4730,Phenotype,HP:0032988,Persistent head lag,0.02788979681378745,-0.1341377101256791,1
4731,Biological Process,GO:0045332,phospholipid translocation,0.02787325441132016,-0.13442224983622114,1
4731,Biological Process,GO:0034204,lipid translocation,0.02787325441132016,-0.13442224983622114,1
4733,Disease,MONDO:0005516,osteochondrodysplasia,0.027861916301754497,-0.1346172724407241,1
4734,Biological Process,GO:0050996,positive regulation of lipid catabolic process,0.027857075250245167,-0.13470054156671155,1
4735,Biological Process,GO:0022617,extracellular matrix disassembly,0.027852450187113686,-0.13478009555696613,1
4736,Phenotype,HP:0003025,Metaphyseal irregularity,0.027830563674492326,-0.13515655731809004,1
4737,Phenotype,HP:0002150,Hypercalciuria,0.027829887977574463,-0.13516817972939354,1
4738,Phenotype,HP:0030349,Decreased circulating androgen concentration,0.02776606473157106,-0.1362659796396285,1
4739,Biological Process,GO:0009134,nucleoside diphosphate catabolic process,0.027753969057820904,-0.13647403282383108,1
4739,Biological Process,GO:0009191,ribonucleoside diphosphate catabolic process,0.027753969057820904,-0.13647403282383108,1
4741,Biological Process,GO:0010256,endomembrane system organization,0.027752480870128826,-0.13649963058666956,1
4742,Biological Process,GO:2000725,regulation of cardiac muscle cell differentiation,0.027738221681301134,-0.1367448975888247,1
4743,Biological Process,GO:0003073,regulation of systemic arterial blood pressure,0.02771347131534707,-0.13717061942568023,1
4744,Biological Process,GO:0006754,ATP biosynthetic process,0.027713133858070615,-0.13717642390274776,1
4745,Phenotype,HP:0006191,Deep palmar crease,0.02771108200667971,-0.137211717035169,1
4746,Phenotype,HP:0012722,Heart block,0.02768532724722994,-0.13765471507087798,1
4747,Phenotype,HP:0032044,Decreased vigilance,0.027681551568433993,-0.13771965911717496,1
4748,Phenotype,HP:0000329,Facial hemangioma,0.02767757581395247,-0.137788044590905,1
4749,Biological Process,GO:1901988,negative regulation of cell cycle phase transition,0.027670538157869573,-0.13790909669495588,1
4750,Disease,MONDO:0001705,pure red-cell aplasia,0.02766628559553097,-0.13798224343765425,1
4750,Disease,MONDO:0015253,Diamond-Blackfan anemia,0.02766628559553097,-0.13798224343765425,1
4752,Biological Process,GO:0051302,regulation of cell division,0.027655454961029724,-0.13816853715237104,1
4753,Phenotype,HP:0009826,Limb undergrowth,0.027645435883650427,-0.1383408715749581,1
4754,Phenotype,HP:0006872,Cerebral hypoplasia,0.02763437344991282,-0.13853115238210287,1
4755,Biological Process,GO:0044794,positive regulation by host of viral process,0.027603202019080286,-0.13906732056709342,1
4756,Phenotype,HP:0040082,Happy demeanor,0.027547211443105235,-0.1400303936341721,1
4757,Biological Process,GO:0002090,regulation of receptor internalization,0.02754393889542861,-0.1400866835092663,1
4758,Disease,MONDO:0020641,respiratory tract neoplasm,0.027526012217404805,-0.1403950336286616,1
4758,Disease,MONDO:0021117,lung neoplasm,0.027526012217404805,-0.1403950336286616,1
4758,Disease,MONDO:0008903,lung cancer,0.027526012217404805,-0.1403950336286616,1
4758,Disease,MONDO:0000376,respiratory system cancer,0.027526012217404805,-0.1403950336286616,1
4762,Phenotype,HP:0004414,Abnormality of the pulmonary artery,0.027523871257598143,-0.14043185948179113,1
4763,Phenotype,HP:0003139,Panhypogammaglobulinemia,0.027523780779841855,-0.14043341575601642,1
4764,Phenotype,HP:0000490,Deeply set eye,0.027505169320140244,-0.1407535445502912,1
4765,Biological Process,GO:0009312,oligosaccharide biosynthetic process,0.02750028257703363,-0.14083759960044478,1
4766,Disease,MONDO:0017763,disorder of iron metabolism and transport,0.027487674298906972,-0.14105446990182252,1
4767,Phenotype,HP:0008619,Bilateral sensorineural hearing impairment,0.02746356851281917,-0.14146910456020267,1
4768,Phenotype,HP:0008237,Hypothalamic hypothyroidism,0.027462282201661692,-0.14149122991987392,1
4769,Phenotype,HP:0002518,Abnormal periventricular white matter morphology,0.027436836304171708,-0.14192891533591911,1
4770,Phenotype,HP:0003552,Muscle stiffness,0.027435891438827187,-0.14194516761319037,1
4771,Phenotype,HP:0033383,Decreased compound muscle action potential amplitude,0.02743518874434492,-0.14195725439955525,1
4772,Phenotype,HP:0002066,Gait ataxia,0.027418035762778792,-0.1422522964540216,1
4773,Phenotype,HP:0010651,Abnormal meningeal morphology,0.027408917405298494,-0.14240913792872234,1
4774,Biological Process,GO:1904752,regulation of vascular associated smooth muscle cell migration,0.02738520587716131,-0.14281699110277032,1
4775,Phenotype,HP:0006500,Abnormal lower limb epiphysis morphology,0.02738259825334466,-0.1428618438699219,1
4776,Biological Process,GO:1902991,regulation of amyloid precursor protein catabolic process,0.027377662098111544,-0.14294674883968056,1
4777,Phenotype,HP:0010663,Abnormal thalamus morphology,0.027376028420840304,-0.14297484911464345,1
4778,Biological Process,GO:0008213,protein alkylation,0.02737231575384491,-0.14303870931840146,1
4778,Biological Process,GO:0006479,protein methylation,0.02737231575384491,-0.14303870931840146,1
4780,Phenotype,HP:0003758,Reduced subcutaneous adipose tissue,0.027355003172497394,-0.14333649658933134,1
4781,Phenotype,HP:0000308,Microretrognathia,0.02734328717165302,-0.14353801916113193,1
4782,Biological Process,GO:1901203,positive regulation of extracellular matrix assembly,0.027331305410589923,-0.1437441129755835,1
4783,Phenotype,HP:0001018,Abnormal palmar dermatoglyphics,0.027289767480103033,-0.14445859146446235,1
4784,Biological Process,GO:0010882,regulation of cardiac muscle contraction by calcium ion signaling,0.027274535458418847,-0.1447205918026574,1
4785,Phenotype,HP:0002160,Hyperhomocystinemia,0.0272428111017341,-0.14526627065952596,1
4786,Phenotype,HP:0100621,Dysgerminoma,0.02721990568940491,-0.14566025813546127,1
4787,Phenotype,HP:0001103,Abnormal macular morphology,0.027194000864272705,-0.14610583739514466,1
4788,Biological Process,GO:0045940,positive regulation of steroid metabolic process,0.02717710415391994,-0.146396471423811,1
4789,Phenotype,HP:0008443,Neuropathic spinal arthropathy,0.02716826384019566,-0.14654853037130552,1
4790,Phenotype,HP:0006042,Y-shaped metacarpals,0.027165352048737934,-0.1465986150128912,1
4791,Phenotype,HP:0100025,Overfriendliness,0.027147467295643213,-0.14690624399717875,1
4792,Phenotype,HP:0002154,Hyperglycinemia,0.027122440059793584,-0.14733672817010354,1
4793,Biological Process,GO:1903077,negative regulation of protein localization to plasma membrane,0.02710748475873459,-0.14759396873977348,1
4794,Biological Process,GO:1903076,regulation of protein localization to plasma membrane,0.027073097035321902,-0.14818545917687254,1
4795,Phenotype,HP:0012143,Abnormal megakaryocyte morphology,0.02705884984170459,-0.1484305198538765,1
4796,Phenotype,HP:0001363,Craniosynostosis,0.027037709233670437,-0.14879415158769602,1
4797,Phenotype,HP:0003731,Quadriceps muscle weakness,0.027028870446946796,-0.1489461842698207,1
4798,Phenotype,HP:0000537,Epicanthus inversus,0.02700121600867078,-0.14942185797427923,1
4799,Biological Process,GO:0006220,pyrimidine nucleotide metabolic process,0.02699045117257637,-0.14960701991507913,1
4800,Biological Process,GO:0035455,response to interferon-alpha,0.026987945568131888,-0.1496501178849644,1
4801,Biological Process,GO:0009127,purine nucleoside monophosphate biosynthetic process,0.02694645430669529,-0.15036379363687155,1
4802,Phenotype,HP:0033098,Increased urinary non-proteinogenic amino acid level,0.026930175631501574,-0.15064379707269573,1
4803,Biological Process,GO:0070935,3'-UTR-mediated mRNA stabilization,0.02692559546872797,-0.15072257874859885,1
4804,Phenotype,HP:0009817,Aplasia involving bones of the lower limbs,0.02691880934172919,-0.15083930439445065,1
4805,Biological Process,GO:1900027,regulation of ruffle assembly,0.0269177393464064,-0.15085770898592576,1
4806,Phenotype,HP:0002371,Loss of speech,0.026913056130484336,-0.15093826324069648,1
4807,Phenotype,HP:0012740,Papilloma,0.02684332953408808,-0.15213760448480557,1
4808,Phenotype,HP:0003712,Skeletal muscle hypertrophy,0.02682756117151075,-0.15240883022316773,1
4809,Biological Process,GO:0050901,leukocyte tethering or rolling,0.026810976628203975,-0.15269409478261203,1
4810,Disease,MONDO:0004335,digestive system disorder,0.026801023772845434,-0.15286529014485678,1
4811,Disease,MONDO:0019046,leukodystrophy,0.02677967518016844,-0.15323249934514094,1
4812,Phenotype,HP:0000030,Testicular gonadoblastoma,0.026719938415058375,-0.15426000921782992,1
4812,Phenotype,HP:0012870,Vanishing testis,0.026719938415058375,-0.15426000921782992,1
4812,Phenotype,HP:0000149,Ovarian gonadoblastoma,0.026719938415058375,-0.15426000921782992,1
4815,Phenotype,HP:0000944,Abnormal metaphysis morphology,0.026717486492811915,-0.15430218382019853,1
4816,Phenotype,HP:0005576,Tubulointerstitial fibrosis,0.026703332655098277,-0.15454563871703475,1
4817,Biological Process,GO:0018209,peptidyl-serine modification,0.026684233485953945,-0.1548741564199904,1
4818,Phenotype,HP:0002958,Immune dysregulation,0.026681975244369882,-0.15491299959334043,1
4819,Phenotype,HP:0000273,Facial grimacing,0.026672736222055238,-0.15507191657896563,1
4820,Phenotype,HP:0007109,Periventricular cysts,0.02666646269273909,-0.155179825222781,1
4821,Phenotype,HP:0012810,Wide nasal base,0.026666307973525427,-0.15518248649041477,1
4822,Phenotype,HP:0005701,Multiple enchondromatosis,0.026640033042293787,-0.15563443180742334,1
4823,Phenotype,HP:0009768,Broad phalanges of the hand,0.026620580414456696,-0.1559690292218553,1
4824,Phenotype,HP:0001034,Hypermelanotic macule,0.026607383869122647,-0.1561960180886133,1
4825,Phenotype,HP:0005257,Thoracic hypoplasia,0.026572690844491653,-0.15679275989838673,1
4826,Phenotype,HP:0000368,"Low-set, posteriorly rotated ears",0.02657127553024541,-0.15681710419219463,1
4827,Phenotype,HP:0001770,Toe syndactyly,0.026569596050131983,-0.15684599230480586,1
4828,Phenotype,HP:0003015,Flared metaphysis,0.02653928715645837,-0.157367324309017,1
4829,Biological Process,GO:0021537,telencephalon development,0.026527165698090882,-0.15757582100482959,1
4830,Biological Process,GO:0043666,regulation of phosphoprotein phosphatase activity,0.02652254940487231,-0.15765522414707495,1
4831,Disease,MONDO:0100137,telomere syndrome,0.026504086833691765,-0.15797279196529007,1
4832,Phenotype,HP:0005562,Multiple renal cysts,0.026473307182067196,-0.15850222130187872,1
4833,Phenotype,HP:0012131,Abnormal number of erythroid precursors,0.026454930554151157,-0.1588183108419747,1
4834,Phenotype,HP:0001387,Joint stiffness,0.02643452579544614,-0.15916928550524298,1
4835,Phenotype,HP:0010042,Aplasia/Hypoplasia of the 4th metacarpal,0.026433713266132308,-0.15918326151968357,1
4836,Phenotype,HP:0012666,Severely reduced left ventricular ejection fraction,0.026358370986861113,-0.1604791960357125,1
4837,Phenotype,HP:0000391,Thickened helices,0.026341212104231126,-0.16077433959218293,1
4838,Phenotype,HP:0001010,Hypopigmentation of the skin,0.02633329718670363,-0.1609104811439733,1
4839,Phenotype,HP:0003782,Eunuchoid habitus,0.026314771132932235,-0.1612291409026161,1
4840,Phenotype,HP:0100335,Non-midline cleft of the upper lip,0.026301679862942295,-0.16145431896734588,1
4841,Biological Process,GO:0050891,multicellular organismal-level water homeostasis,0.02628929172531036,-0.16166740271397312,1
4842,Biological Process,GO:1903051,negative regulation of proteolysis involved in protein catabolic process,0.026245988493925454,-0.16241224548685088,1
4843,Phenotype,HP:0001712,Left ventricular hypertrophy,0.026242582454984564,-0.16247083149551872,1
4844,Phenotype,HP:0003133,Abnormality of the spinocerebellar tracts,0.026221621045532162,-0.16283138090120108,1
4845,Phenotype,HP:0001600,Abnormality of the larynx,0.026186348559690487,-0.16343808980768149,1
4846,Phenotype,HP:0000338,Hypomimic face,0.02618139445042167,-0.1635233035981288,1
4847,Phenotype,HP:0002987,Elbow flexion contracture,0.02615302589121371,-0.1640112606310621,1
4848,Biological Process,GO:0061025,membrane fusion,0.02612658224147313,-0.16446610801237435,1
4849,Disease,MONDO:0015286,congenital disorder of glycosylation,0.026090361395508244,-0.1650891293085141,1
4850,Biological Process,GO:1901873,regulation of post-translational protein modification,0.026081187356368774,-0.1652469285427189,1
4851,Phenotype,HP:0001642,Pulmonic stenosis,0.026052187572259133,-0.16574574304035036,1
4852,Biological Process,GO:0006007,glucose catabolic process,0.026023856637667375,-0.16623305290625795,1
4853,Phenotype,HP:0000894,Short clavicles,0.026018331959965613,-0.16632808083205083,1
4854,Biological Process,GO:0090288,negative regulation of cellular response to growth factor stimulus,0.026009180680284794,-0.16648548858927462,1
4855,Biological Process,GO:0030497,fatty acid elongation,0.026006750443539617,-0.16652729018740334,1
4856,Biological Process,GO:0045730,respiratory burst,0.025966867275675543,-0.16721330572003124,1
4857,Phenotype,HP:0003391,Gowers sign,0.025958068365937392,-0.16736465249296398,1
4858,Phenotype,HP:0030197,Fatigable weakness of skeletal muscles,0.02594074000901181,-0.16766271111374317,1
4859,Phenotype,HP:0011042,Abnormal blood potassium concentration,0.02593091824801841,-0.16783165157058438,1
4860,Phenotype,HP:0030602,Abnormal fundus autofluorescence imaging,0.025923893771190087,-0.1679524769831804,1
4861,Biological Process,GO:0061952,midbody abscission,0.02592191030798574,-0.1679865937958472,1
4862,Phenotype,HP:0001181,Adducted thumb,0.025920070478748447,-0.16801824001408314,1
4863,Phenotype,HP:0012473,Tongue atrophy,0.025895593497219038,-0.16843925946715788,1
4864,Disease,MONDO:0006130,central nervous system neoplasm,0.02589275293263893,-0.1684881189617203,1
4865,Phenotype,HP:0000168,Abnormality of the gingiva,0.02588526520501988,-0.16861691257882366,1
4866,Phenotype,HP:0012471,Thick vermilion border,0.025869961525408325,-0.16888014547836838,1
4867,Biological Process,GO:0008210,estrogen metabolic process,0.025868864998540575,-0.16889900642907782,1
4868,Phenotype,HP:0000138,Ovarian cyst,0.025853680935002066,-0.169160181857051,1
4869,Phenotype,HP:0001790,Nonimmune hydrops fetalis,0.025822763696641826,-0.1696919777718933,1
4870,Biological Process,GO:0035304,regulation of protein dephosphorylation,0.02581806202493786,-0.16977284947770238,1
4871,Biological Process,GO:0016197,endosomal transport,0.025813326630732325,-0.1698543012317151,1
4872,Phenotype,HP:0002595,Ileus,0.025780739373126305,-0.17041482252630402,1
4873,Biological Process,GO:0098876,vesicle-mediated transport to the plasma membrane,0.02574265403215592,-0.1710699143073821,1
4874,Disease,MONDO:0015127,pituitary deficiency,0.02574211207856436,-0.17107923624948662,1
4875,Phenotype,HP:0002974,Radioulnar synostosis,0.025738446505467527,-0.17114228640861595,1
4876,Biological Process,GO:1903579,negative regulation of ATP metabolic process,0.025735752859888827,-0.17118861880409367,1
4877,Phenotype,HP:0000321,Square face,0.025648800067604394,-0.1726842614349846,1
4878,Phenotype,HP:0031507,Decreased circulating T4 concentration,0.025645547095050403,-0.17274021460567696,1
4879,Phenotype,HP:0002816,Genu recurvatum,0.02563867636307704,-0.1728583955102208,1
4880,Phenotype,HP:0001476,Delayed closure of the anterior fontanelle,0.025635859416060613,-0.17290684876785684,1
4881,Biological Process,GO:0042026,protein refolding,0.025627719868545396,-0.17304685409649653,1
4882,Phenotype,HP:0000831,Insulin-resistant diabetes mellitus,0.025613817229007907,-0.1732859882269585,1
4883,Phenotype,HP:0000107,Renal cyst,0.025612378578089512,-0.1733107339261821,1
4884,Biological Process,GO:0010232,vascular transport,0.02559305019503033,-0.1736431942524122,1
4884,Biological Process,GO:0150104,transport across blood-brain barrier,0.02559305019503033,-0.1736431942524122,1
4886,Phenotype,HP:0009912,Abnormal tragus morphology,0.025567322652740865,-0.17408572413587248,1
4887,Biological Process,GO:1905144,response to acetylcholine,0.025560726024464464,-0.17419919028470013,1
4888,Phenotype,HP:0005550,Chronic lymphatic leukemia,0.0255380845209916,-0.17458863836258023,1
4889,Biological Process,GO:0046546,development of primary male sexual characteristics,0.025508786807005746,-0.1750925774411731,1
4889,Biological Process,GO:0008584,male gonad development,0.025508786807005746,-0.1750925774411731,1
4891,Phenotype,HP:0001989,Fetal akinesia sequence,0.025499938421229662,-0.17524477523302767,1
4892,Biological Process,GO:0031116,positive regulation of microtubule polymerization,0.02548916274464208,-0.17543012363711757,1
4893,Phenotype,HP:0045040,Abnormal circulating lactate dehydrogenase concentration,0.025471826396753605,-0.17572831970747657,1
4894,Phenotype,HP:0012743,Abdominal obesity,0.025467637759233885,-0.1758003669031474,1
4895,Phenotype,HP:0007305,CNS demyelination,0.0254132785525929,-0.17673537939323192,1
4896,Biological Process,GO:1903543,positive regulation of exosomal secretion,0.025390905970264943,-0.17712020185854566,1
4897,Phenotype,HP:0100258,Preaxial polydactyly,0.025370749486134048,-0.17746690604323048,1
4898,Disease,MONDO:0000009,"inherited bleeding disorder, platelet-type",0.025345429972936984,-0.1779024175700721,1
4899,Biological Process,GO:0061036,positive regulation of cartilage development,0.025314890555984015,-0.17842771471944946,1
4900,Biological Process,GO:0042984,regulation of amyloid precursor protein biosynthetic process,0.025304598804032352,-0.17860473931591223,1
4901,Phenotype,HP:0011545,Abnormal connection of the cardiac segments,0.0253032520441836,-0.17862790443103327,1
4902,Biological Process,GO:1902307,positive regulation of sodium ion transmembrane transport,0.02529059612204332,-0.17884559423936425,1
4903,Phenotype,HP:0001395,Hepatic fibrosis,0.025285626873816414,-0.17893106842939746,1
4904,Phenotype,HP:0032231,Hypochromia,0.025282477348911758,-0.1789852422355594,1
4905,Phenotype,HP:0007973,Retinal dysplasia,0.02527918025140119,-0.17904195438321394,1
4906,Phenotype,HP:0200123,Chronic hepatitis,0.02525555783973199,-0.1794482746980503,1
4907,Biological Process,GO:0106027,neuron projection organization,0.02524824207237819,-0.17957411049060576,1
4908,Phenotype,HP:0004756,Ventricular tachycardia,0.025205292929051604,-0.18031286272652436,1
4909,Phenotype,HP:0002293,Alopecia of scalp,0.02515563026200951,-0.18116709178622986,1
4910,Disease,MONDO:0003939,muscle tissue disorder,0.025153175305213216,-0.1812093185847612,1
4911,Phenotype,HP:4000072,Abnormal language feature,0.02513078328877738,-0.18159447532893447,1
4911,Phenotype,HP:4000074,Involuntary vocalization,0.02513078328877738,-0.18159447532893447,1
4913,Phenotype,HP:0003370,Flat capital femoral epiphysis,0.025123529096906183,-0.1817192519845217,1
4914,Phenotype,HP:0012347,Abnormal protein N-linked glycosylation,0.025109270552452823,-0.1819645079030337,1
4915,Biological Process,GO:0006886,intracellular protein transport,0.02509439699160332,-0.18222034248977015,1
4916,Phenotype,HP:5200017,Steroetypic movements of face and head,0.025083973973340057,-0.18239962494922352,1
4917,Phenotype,HP:0000485,Megalocornea,0.02507945931123068,-0.18247727997256957,1
4918,Biological Process,GO:0050772,positive regulation of axonogenesis,0.02507744731715933,-0.18251188753406533,1
4919,Biological Process,GO:0046677,response to antibiotic,0.025068704923019713,-0.18266226220321324,1
4920,Phenotype,HP:0010903,Abnormal circulating glutamine concentration,0.02506650743686878,-0.182700060344961,1
4921,Phenotype,HP:0031964,Elevated circulating alanine aminotransferase concentration,0.025061765960083804,-0.1827816167231598,1
4922,Phenotype,HP:0011145,Symptomatic seizures,0.024999185500380272,-0.18385803992860653,1
4923,Biological Process,GO:0032456,endocytic recycling,0.02496508884861981,-0.18444452375050355,1
4924,Phenotype,HP:0009879,Simplified gyral pattern,0.024954433087789663,-0.18462780952826227,1
4925,Biological Process,GO:0110053,regulation of actin filament organization,0.02492443554181023,-0.185143786156617,1
4926,Phenotype,HP:0002389,Cavum septum pellucidum,0.024916909156089462,-0.185273244717346,1
4927,Phenotype,HP:0012490,Panniculitis,0.02491526660974197,-0.1853014975459899,1
4928,Phenotype,HP:0002575,Tracheoesophageal fistula,0.02490925572297953,-0.18540488857295037,1
4929,Biological Process,GO:1903671,negative regulation of sprouting angiogenesis,0.024895174914489226,-0.18564708732128518,1
4930,Biological Process,GO:0120316,sperm flagellum assembly,0.024844588659696742,-0.18651720267028124,1
4931,Phenotype,HP:0012437,Abnormal gallbladder morphology,0.024826266968585253,-0.1868323472628404,1
4932,Phenotype,HP:0025336,Delayed ability to sit,0.024818841144081505,-0.18696007610748738,1
4933,Phenotype,HP:0000632,Lacrimation abnormality,0.024814815893275055,-0.1870293129490883,1
4934,Biological Process,GO:0005513,detection of calcium ion,0.02480307562068662,-0.1872312530101286,1
4935,Disease,MONDO:0019824,non-acquired pituitary hormone deficiency,0.024742273032039797,-0.18827709571695328,1
4936,Phenotype,HP:0003535,3-Methylglutaconic aciduria,0.0247295718091447,-0.1884955647267145,1
4937,Biological Process,GO:0010976,positive regulation of neuron projection development,0.02471420408545666,-0.18875989922459244,1
4938,Phenotype,HP:0000199,Tongue nodules,0.024711790147881052,-0.18880142046676918,1
4939,Phenotype,HP:0007400,Irregular hyperpigmentation,0.02470433239993186,-0.1889296984147247,1
4940,Phenotype,HP:0001525,Severe failure to thrive,0.024701556507803812,-0.18897744550249945,1
4941,Phenotype,HP:0000565,Esotropia,0.02468951494869076,-0.18918456788096155,1
4942,Biological Process,GO:0070206,protein trimerization,0.024666599124411825,-0.1895787344489709,1
4942,Biological Process,GO:0070207,protein homotrimerization,0.024666599124411825,-0.1895787344489709,1
4944,Phenotype,HP:0002361,Psychomotor deterioration,0.02463560394051445,-0.19011187107599922,1
4945,Phenotype,HP:0030388,Decreased proportion of class-switched memory B cells,0.02459545192424284,-0.19080251097006504,1
4945,Phenotype,HP:0030386,Abnormal proportion of class-switched memory B cells,0.02459545192424284,-0.19080251097006504,1
4947,Phenotype,HP:0005346,Abnormal facial expression,0.024566684338432454,-0.19129733151113615,1
4948,Phenotype,HP:0000839,Pituitary dwarfism,0.02455145996911201,-0.19155920022386935,1
4949,Biological Process,GO:2000402,negative regulation of lymphocyte migration,0.02454461480790704,-0.19167694129513924,1
4950,Disease,MONDO:0016971,limb-girdle muscular dystrophy,0.02453944820763776,-0.19176581006423213,1
4951,Phenotype,HP:0000775,Abnormality of the diaphragm,0.024515898678491133,-0.1921708767539123,1
4952,Phenotype,HP:0003745,Sporadic,0.024512328751118417,-0.1922322817465243,1
4953,Disease,MONDO:0022687,cerebellar degeneration,0.024480032798975482,-0.19278779240421753,1
4954,Phenotype,HP:0009843,Aplasia/Hypoplasia of the middle phalanges of the hand,0.0244772666016827,-0.1928353727347376,1
4955,Phenotype,HP:0001962,Palpitations,0.024472445511448115,-0.19291829851426442,1
4956,Biological Process,GO:0120033,negative regulation of plasma membrane bounded cell projection assembly,0.024448758251939595,-0.19332573425265948,1
4957,Biological Process,GO:0009913,epidermal cell differentiation,0.02444499173046244,-0.19339052078732272,1
4958,Phenotype,HP:0006494,Aplasia/Hypoplasia involving bones of the feet,0.02443953800386356,-0.19348432830959097,1
4959,Biological Process,GO:0045446,endothelial cell differentiation,0.024426189872806536,-0.19371392454597516,1
4960,Biological Process,GO:0032436,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,0.0243763238119854,-0.19457165210640504,1
4961,Biological Process,GO:0019941,modification-dependent protein catabolic process,0.024314674014846993,-0.19563206733130506,1
4962,Phenotype,HP:0100807,Long fingers,0.024314660088304074,-0.19563230687658867,1
4963,Phenotype,HP:0011116,Abnormal circulating interferon concentration,0.02430207169691545,-0.19584883511358397,1
4963,Phenotype,HP:0030355,Abnormal circulating interferon-gamma concentration,0.02430207169691545,-0.19584883511358397,1
4965,Biological Process,GO:0043277,apoptotic cell clearance,0.02429256396695656,-0.1960123740394301,1
4966,Phenotype,HP:0010919,Abnormal circulating homocysteine concentration,0.024290955294798633,-0.1960400442107416,1
4967,Phenotype,HP:0001362,Calvarial skull defect,0.024290417737097947,-0.1960492905407626,1
4968,Biological Process,GO:0050732,negative regulation of peptidyl-tyrosine phosphorylation,0.024283278769574368,-0.19617208526521357,1
4969,Phenotype,HP:0009005,Weakness of the intrinsic hand muscles,0.02422085648173533,-0.19724578781526408,1
4970,Phenotype,HP:0001238,Slender finger,0.024216847549042075,-0.19731474397507082,1
4971,Biological Process,GO:0010801,negative regulation of peptidyl-threonine phosphorylation,0.024210115844909175,-0.1974305335134536,1
4972,Biological Process,GO:0044773,mitotic DNA damage checkpoint signaling,0.024202847324828913,-0.19755555662323443,1
4973,Phenotype,HP:0001403,Macrovesicular hepatic steatosis,0.024180868936991784,-0.1979335986957643,1
4974,Biological Process,GO:1902003,regulation of amyloid-beta formation,0.02414193789661323,-0.19860323703773536,1
4975,Phenotype,HP:0010481,Urethral valve,0.02409204241616336,-0.19946147063425404,1
4976,Biological Process,GO:0060348,bone development,0.024083594119799323,-0.19960678663697795,1
4977,Disease,MONDO:0006999,tooth disorder,0.024071663368004703,-0.19981200305997954,1
4977,Disease,MONDO:0006858,mouth disorder,0.024071663368004703,-0.19981200305997954,1
4979,Biological Process,GO:0030397,membrane disassembly,0.024069731660522398,-0.1998452296417263,1
4979,Biological Process,GO:0051081,nuclear membrane disassembly,0.024069731660522398,-0.1998452296417263,1
4981,Phenotype,HP:0012868,Abnormal sperm tail morphology,0.024051283855514916,-0.20016254347249207,1
4982,Phenotype,HP:0006721,Acute lymphoblastic leukemia,0.024048015540192536,-0.2002187605484355,1
4983,Phenotype,HP:0002221,Absent axillary hair,0.024035144838278955,-0.2004401447037421,1
4984,Phenotype,HP:0010529,Echolalia,0.024032221757740446,-0.20049042352460641,1
4985,Phenotype,HP:0012113,Abnormal circulating creatine concentration,0.023993987727166433,-0.2011480728602393,1
4986,Biological Process,GO:0016072,rRNA metabolic process,0.023983264523063097,-0.20133251870464913,1
4987,Biological Process,GO:0006897,endocytosis,0.02398082554237546,-0.20137447070407907,1
4988,Phenotype,HP:0003458,EMG,0.02394191028382764,-0.20204383758865108,1
4989,Biological Process,GO:0003009,skeletal muscle contraction,0.023938356933896232,-0.20210495743886245,1
4990,Phenotype,HP:0001993,Ketoacidosis,0.023938179957361028,-0.2021080015464036,1
4991,Biological Process,GO:0061756,leukocyte adhesion to vascular endothelial cell,0.023924177191720908,-0.20234885790870685,1
4992,Phenotype,HP:0000340,Sloping forehead,0.023922999242156573,-0.20236911938092841,1
4993,Biological Process,GO:0003351,epithelial cilium movement involved in extracellular fluid movement,0.02391709073003534,-0.20247074949977206,1
4994,Biological Process,GO:0072525,pyridine-containing compound biosynthetic process,0.023911659422102827,-0.20256417140690058,1
4995,Phenotype,HP:0006109,Absent phalangeal crease,0.02389950089465498,-0.2027733057141736,1
4996,Phenotype,HP:0025435,Increased circulating lactate dehydrogenase concentration,0.02384341056304984,-0.2037380946407332,1
4997,Phenotype,HP:0000776,Congenital diaphragmatic hernia,0.02380861773365961,-0.20433655315503968,1
4998,Phenotype,HP:0012301,Type II transferrin isoform profile,0.02380232334437682,-0.20444482060338073,1
4999,Phenotype,HP:0001818,Paronychia,0.02377348660306755,-0.20494083066246008,1
5000,Phenotype,HP:0031546,Cardiac conduction abnormality,0.023755797338316675,-0.20524509712447295,1
5001,Phenotype,HP:0006289,Agenesis of central incisor,0.023750570539958882,-0.20533500133849078,1
5002,Phenotype,HP:0008770,Obsessive-compulsive trait,0.02374558326181142,-0.20542078565447977,1
5003,Phenotype,HP:0012288,Neoplasm of head and neck,0.023723414208353333,-0.2058021072954221,1
5004,Phenotype,HP:0009825,Aplasia involving bones of the extremities,0.023704357150775346,-0.20612990065299186,1
5005,Phenotype,HP:0002453,Abnormal globus pallidus morphology,0.023704313765496532,-0.20613064690703203,1
5006,Biological Process,GO:0022414,reproductive process,0.023704136137274845,-0.20613370222398997,1
5007,Biological Process,GO:1902115,regulation of organelle assembly,0.02365119104907676,-0.207044390988835,1
5008,Biological Process,GO:0050779,RNA destabilization,0.023616685517064195,-0.207637907807832,1
5009,Phenotype,HP:0000204,Cleft upper lip,0.023615184069030737,-0.20766373365686927,1
5010,Phenotype,HP:0007431,Congenital ichthyosiform erythroderma,0.023576853792018904,-0.20832303849167239,1
5011,Disease,MONDO:0018117,"disorder of phospholipids, sphingolipids and fatty acids biosynthesis",0.023568848477517612,-0.2084607349281785,1
5012,Phenotype,HP:0002323,Anencephaly,0.023553311618257244,-0.2087279786641122,1
5013,Phenotype,HP:0001935,Microcytic anemia,0.023548137627980026,-0.2088169745459823,1
5014,Phenotype,HP:0001710,Conotruncal defect,0.02354715737482671,-0.20883383551578727,1
5015,Phenotype,HP:0007024,Pseudobulbar paralysis,0.023540344157707116,-0.2089510271287288,1
5016,Phenotype,HP:0008064,Ichthyosis,0.02351338588653784,-0.20941472632178051,1
5017,Disease,MONDO:0800088,lysosomal storage disease with skeletal involvement,0.02348388571036797,-0.2099221478770783,1
5018,Phenotype,HP:0012335,Abnormality of folate metabolism,0.02348099059489306,-0.20997194568128758,1
5019,Biological Process,GO:0043413,macromolecule glycosylation,0.02347723362234122,-0.21003656796843892,1
5019,Biological Process,GO:0006486,protein glycosylation,0.02347723362234122,-0.21003656796843892,1
5021,Phenotype,HP:0010997,Chromosomal breakage induced by ionizing radiation,0.023459215085910312,-0.21034649811012054,1
5022,Phenotype,HP:0031936,Delayed ability to walk,0.023459162120580634,-0.21034740914705155,1
5023,Biological Process,GO:2000780,negative regulation of double-strand break repair,0.023455841854821413,-0.21040451980313185,1
5024,Biological Process,GO:0045652,regulation of megakaryocyte differentiation,0.023453385315575503,-0.21044677382079033,1
5025,Biological Process,GO:0030837,negative regulation of actin filament polymerization,0.023438529658081797,-0.21070230045856433,1
5026,Biological Process,GO:0060993,kidney morphogenesis,0.023422158633853662,-0.21098389235577278,1
5027,Phenotype,HP:0004912,Hypophosphatemic rickets,0.023421904307420305,-0.21098826693013548,1
5028,Biological Process,GO:0072594,establishment of protein localization to organelle,0.02341876229719675,-0.21104231147906352,1
5029,Biological Process,GO:0050810,regulation of steroid biosynthetic process,0.023389668943936348,-0.21154273542484653,1
5030,Phenotype,HP:0006870,Lobar holoprosencephaly,0.023379996178735096,-0.21170911306049814,1
5031,Phenotype,HP:0001310,Dysmetria,0.02336371412963878,-0.21198917452956578,1
5032,Phenotype,HP:0005245,Intestinal hypoplasia,0.02334920587731326,-0.21223872558028747,1
5033,Biological Process,GO:0018105,peptidyl-serine phosphorylation,0.023345463232207098,-0.21230310142637607,1
5034,Phenotype,HP:0000452,Choanal stenosis,0.02332694316835615,-0.2126216581546257,1
5035,Phenotype,HP:0003457,EMG abnormality,0.023298843343712794,-0.21310499278429104,1
5036,Phenotype,HP:0000324,Facial asymmetry,0.023277688832905596,-0.2134688636545374,1
5037,Biological Process,GO:0006458,'de novo' protein folding,0.023273085139027372,-0.21354805008021677,1
5038,Biological Process,GO:0090169,regulation of spindle assembly,0.023236824704011005,-0.21417175233290264,1
5039,Biological Process,GO:0090050,positive regulation of cell migration involved in sprouting angiogenesis,0.02323128161307464,-0.21426709697789365,1
5040,Phenotype,HP:0004389,Intestinal pseudo-obstruction,0.023215184002175593,-0.21454398599414687,1
5041,Phenotype,HP:0002244,Abnormal small intestine morphology,0.023206916196380156,-0.2146861974457485,1
5042,Biological Process,GO:0016125,sterol metabolic process,0.023203007711075307,-0.21475342584739682,1
5043,Phenotype,HP:0011120,Concave nasal ridge,0.023194734325860056,-0.21489573326852296,1
5044,Phenotype,HP:0008155,Mucopolysacchariduria,0.02317171685884356,-0.2152916481554467,1
5044,Phenotype,HP:0003541,Urinary glycosaminoglycan excretion,0.02317171685884356,-0.2152916481554467,1
5046,Biological Process,GO:0042417,dopamine metabolic process,0.023141717880284296,-0.21580764942507416,1
5047,Biological Process,GO:0008589,regulation of smoothened signaling pathway,0.023085326539846296,-0.21677761589258296,1
5048,Disease,MONDO:0001475,neutropenia,0.023084941054983155,-0.21678424647430128,1
5048,Disease,MONDO:0001609,agranulocytosis,0.023084941054983155,-0.21678424647430128,1
5048,Disease,MONDO:0003785,leukopenia,0.023084941054983155,-0.21678424647430128,1
5048,Disease,MONDO:0015134,constitutional neutropenia,0.023084941054983155,-0.21678424647430128,1
5052,Phenotype,HP:0002329,Drowsiness,0.023082641590138397,-0.21682379871362217,1
5053,Phenotype,HP:0001680,Coarctation of aorta,0.02301159825515553,-0.21804578868829105,1
5054,Phenotype,HP:0002133,Status epilepticus,0.022935176905080956,-0.21936028389976037,1
5055,Phenotype,HP:0000025,Functional abnormality of male internal genitalia,0.022927982941614133,-0.21948402458897087,1
5056,Biological Process,GO:0006511,ubiquitin-dependent protein catabolic process,0.022913895177123833,-0.21972634298487378,1
5057,Phenotype,HP:0006097,3-4 finger syndactyly,0.022858389153175063,-0.22068108145281715,1
5058,Phenotype,HP:0012433,Abnormal social behavior,0.022846706399485384,-0.2208820321526788,1
5059,Phenotype,HP:0003028,Abnormality of the ankle,0.022829820537939582,-0.22117247957505265,1
5060,Phenotype,HP:0001533,Slender build,0.022821084142302772,-0.22132275106618546,1
5061,Biological Process,GO:1900087,positive regulation of G1/S transition of mitotic cell cycle,0.022810652766413364,-0.22150217728205684,1
5062,Phenotype,HP:0010662,Abnormality of the diencephalon,0.02277874134220892,-0.22205107381773667,1
5063,Phenotype,HP:0006703,Aplasia/Hypoplasia of the lungs,0.022732927206642994,-0.22283910571929622,1
5064,Disease,MONDO:0002321,sensory peripheral neuropathy,0.02272502741596405,-0.22297498707979233,1
5064,Disease,MONDO:0015364,hereditary sensory and autonomic neuropathy,0.02272502741596405,-0.22297498707979233,1
5066,Phenotype,HP:0000712,Emotional lability,0.02269726724856036,-0.22345247939164142,1
5067,Biological Process,GO:0042116,macrophage activation,0.022685625076509508,-0.22365273206183128,1
5068,Phenotype,HP:0030846,Abnormality of venous physiology,0.022665047415602713,-0.22400668075154725,1
5069,Biological Process,GO:0032204,regulation of telomere maintenance,0.022659992610279955,-0.2240936265773563,1
5070,Biological Process,GO:0030216,keratinocyte differentiation,0.02260824701801123,-0.22498368325897092,1
5071,Phenotype,HP:0011003,High myopia,0.02257972077324899,-0.22547435258245935,1
5072,Biological Process,GO:0048858,cell projection morphogenesis,0.02256116477718295,-0.22579352736737285,1
5072,Biological Process,GO:0120039,plasma membrane bounded cell projection morphogenesis,0.02256116477718295,-0.22579352736737285,1
5074,Biological Process,GO:0072337,modified amino acid transport,0.022547896354427888,-0.22602175257090906,1
5075,Phenotype,HP:0040129,Abnormal nerve conduction velocity,0.022533798085650036,-0.22626425164715425,1
5076,Phenotype,HP:0005949,Apneic episodes in infancy,0.022529702157068177,-0.22633470419087562,1
5077,Biological Process,GO:0090023,positive regulation of neutrophil chemotaxis,0.02252702366154835,-0.22638077599582693,1
5078,Phenotype,HP:0007190,Neuronal loss in the cerebral cortex,0.022524062757393937,-0.22643170540663687,1
5079,Phenotype,HP:0001399,Hepatic failure,0.022503299604848204,-0.22678884466902546,1
5080,Phenotype,HP:0010719,Abnormality of hair texture,0.02249328607276735,-0.22696108370899706,1
5081,Biological Process,GO:0007093,mitotic cell cycle checkpoint signaling,0.022468813813181443,-0.2273820219416783,1
5082,Phenotype,HP:0003777,Pili torti,0.02245776532582311,-0.2275720628623417,1
5083,Biological Process,GO:0071985,multivesicular body sorting pathway,0.022447691378672974,-0.22774534107944366,1
5084,Biological Process,GO:1900121,negative regulation of receptor binding,0.022442920006972455,-0.22782741166896284,1
5085,Phenotype,HP:0000058,Abnormal labia morphology,0.02243951687848944,-0.22788594761592756,1
5086,Phenotype,HP:0009141,Depletion of mitochondrial DNA in muscle tissue,0.022426698570659043,-0.2281064305601016,1
5087,Phenotype,HP:0003005,Ganglioneuroma,0.022426086881676244,-0.22811695199472706,1
5087,Phenotype,HP:0030450,Neoplasm of the autonomic nervous system,0.022426086881676244,-0.22811695199472706,1
5089,Biological Process,GO:0090277,positive regulation of peptide hormone secretion,0.02242260988142386,-0.22817675858251404,1
5089,Biological Process,GO:0002793,positive regulation of peptide secretion,0.02242260988142386,-0.22817675858251404,1
5091,Disease,MONDO:0017688,disorder of glycolysis,0.022420190015009833,-0.22821838180443474,1
5092,Phenotype,HP:0031072,Abnormal endocrine physiology,0.02240681584830706,-0.22844842587027542,1
5093,Biological Process,GO:0120034,positive regulation of plasma membrane bounded cell projection assembly,0.02240509804104429,-0.22847797323392358,1
5094,Phenotype,HP:0003555,Muscle fiber splitting,0.02238523744832477,-0.22881958790052237,1
5095,Phenotype,HP:0000267,Cranial asymmetry,0.022354480357726247,-0.22934862917329538,1
5096,Biological Process,GO:0051495,positive regulation of cytoskeleton organization,0.02232844423907232,-0.22979646676400056,1
5097,Biological Process,GO:0071364,cellular response to epidermal growth factor stimulus,0.02232765888659405,-0.22980997531980332,1
5098,Biological Process,GO:0002183,cytoplasmic translational initiation,0.02232549144865681,-0.2298472566134062,1
5099,Phenotype,HP:0012896,Abnormal motor evoked potentials,0.022321016411602668,-0.22992423006091892,1
5100,Phenotype,HP:0011490,Abnormal Descemet membrane morphology,0.022307816770420485,-0.2301512721782089,1
5101,Biological Process,GO:0090083,regulation of inclusion body assembly,0.02229098650519623,-0.23044076330893942,1
5102,Phenotype,HP:0012681,Abnormal pineal morphology,0.02228814398336465,-0.23048965646945627,1
5103,Phenotype,HP:0000813,Bicornuate uterus,0.022283762234412863,-0.23056502530302653,1
5104,Phenotype,HP:0100338,Non-midline cleft palate,0.02221595264948617,-0.23173139274603663,1
5105,Phenotype,HP:0025065,Abnormal mean corpuscular volume,0.02221578605379948,-0.23173425829646452,1
5106,Biological Process,GO:0017157,regulation of exocytosis,0.02219687707228546,-0.232059504652747,1
5107,Phenotype,HP:0000574,Thick eyebrow,0.022196315088179985,-0.23206917113226935,1
5108,Biological Process,GO:0001764,neuron migration,0.02219134742994111,-0.23215461797350997,1
5109,Phenotype,HP:0002040,Esophageal varix,0.022138808749471273,-0.23305831627021797,1
5110,Phenotype,HP:0009376,Aplasia/Hypoplasia of the phalanges of the 5th finger,0.02211820916580054,-0.2334126420452405,1
5111,Phenotype,HP:0003798,Nemaline bodies,0.02205920919410065,-0.23442747860859162,1
5112,Phenotype,HP:0005932,Abnormal renal corticomedullary differentiation,0.022044042925717044,-0.23468834794872565,1
5113,Biological Process,GO:1902475,L-alpha-amino acid transmembrane transport,0.02202363996530954,-0.23503929168014748,1
5114,Phenotype,HP:0001552,Barrel-shaped chest,0.02201253804526926,-0.23523025167649433,1
5115,Phenotype,HP:0011519,Anomalous trichromacy,0.022002225731731162,-0.2354076299451558,1
5116,Biological Process,GO:0006304,DNA modification,0.021956987072498935,-0.23618576329239482,1
5117,Phenotype,HP:0004452,Abnormality of the middle ear ossicles,0.021948048435173506,-0.23633951346757326,1
5118,Phenotype,HP:0025268,Stuttering,0.021937639720730484,-0.23651854989233612,1
5119,Phenotype,HP:0009833,Abnormal middle phalanx morphology of the hand,0.021913491106888117,-0.23693392121498927,1
5120,Phenotype,HP:0004809,Neonatal alloimmune thrombocytopenia,0.02190988063974786,-0.23699602351706067,1
5121,Phenotype,HP:0100765,Abnormality of the tonsils,0.021877525134738063,-0.23755255852146123,1
5122,Phenotype,HP:0000726,Dementia,0.02184320956911545,-0.23814280779925814,1
5123,Biological Process,GO:0006474,N-terminal protein amino acid acetylation,0.021817235638607824,-0.2385895757147948,1
5124,Biological Process,GO:1903532,positive regulation of secretion by cell,0.021727643279618625,-0.240130620550572,1
5125,Phenotype,HP:0003749,Pelvic girdle muscle weakness,0.02170640138523172,-0.24049599447326342,1
5126,Phenotype,HP:0000232,Everted lower lip vermilion,0.02169496968993856,-0.24069262681104828,1
5127,Phenotype,HP:0011823,Chin with horizontal crease,0.02168770554004118,-0.24081757475093918,1
5128,Biological Process,GO:0033144,negative regulation of intracellular steroid hormone receptor signaling pathway,0.021659482409598807,-0.24130303031777975,1
5129,Biological Process,GO:0055090,acylglycerol homeostasis,0.021652170796364056,-0.24142879465687891,1
5129,Biological Process,GO:0070328,triglyceride homeostasis,0.021652170796364056,-0.24142879465687891,1
5131,Phenotype,HP:0003826,Stillbirth,0.021649431304579636,-0.241475915635885,1
5132,Biological Process,GO:0045911,positive regulation of DNA recombination,0.021624287326902913,-0.241908407841546,1
5133,Phenotype,HP:0004361,Abnormal circulating leptin concentration,0.021610212036626164,-0.24215051167314244,1
5134,Phenotype,HP:0000744,Low frustration tolerance,0.02160894327235896,-0.24217233521528211,1
5135,Phenotype,HP:0000876,Oligomenorrhea,0.021584939478360154,-0.2425852155456837,1
5136,Disease,MONDO:0003037,hypotrichosis,0.0215637495394555,-0.24294969580145404,1
5137,Biological Process,GO:0044774,mitotic DNA integrity checkpoint signaling,0.02153683911977211,-0.2434125719188993,1
5138,Phenotype,HP:0011803,Bifid nose,0.021499773614754525,-0.24405012188116465,1
5139,Biological Process,GO:0008053,mitochondrial fusion,0.021497592107034613,-0.24408764518386486,1
5140,Phenotype,HP:0100529,Abnormal blood phosphate concentration,0.02148646038845492,-0.24427911773380218,1
5141,Phenotype,HP:0010766,Ectopic calcification,0.021469139874457754,-0.24457704145128745,1
5142,Biological Process,GO:0033559,unsaturated fatty acid metabolic process,0.021461710315616833,-0.24470483452887887,1
5143,Phenotype,HP:0000395,Prominent antihelix,0.021452998598289863,-0.24485468153758522,1
5144,Phenotype,HP:0000147,Polycystic ovaries,0.021442042826795293,-0.2450431276871692,1
5145,Phenotype,HP:0012448,Delayed myelination,0.021440684222414852,-0.24506649653567333,1
5146,Phenotype,HP:0040087,Abnormal blood folate concentration,0.02143719014232237,-0.2451265969074356,1
5147,Disease,MONDO:0001176,lens disorder,0.021426510848923663,-0.24531028746015127,1
5148,Biological Process,GO:0019915,lipid storage,0.0214217645504422,-0.24539192677455748,1
5149,Phenotype,HP:0002492,Abnormal corticospinal tract morphology,0.021407365994150496,-0.245639590984612,1
5150,Biological Process,GO:1903350,response to dopamine,0.021387268180006358,-0.24598528600868172,1
5150,Biological Process,GO:1903351,cellular response to dopamine,0.021387268180006358,-0.24598528600868172,1
5152,Phenotype,HP:0000597,Ophthalmoparesis,0.021341200266437155,-0.24677768305126221,1
5153,Phenotype,HP:0000857,Neonatal insulin-dependent diabetes mellitus,0.02133219942578457,-0.2469325031627294,1
5154,Biological Process,GO:0009062,fatty acid catabolic process,0.021328078960823005,-0.2470033777475898,1
5155,Biological Process,GO:0032259,methylation,0.021270679073776,-0.2479906918501088,1
5156,Phenotype,HP:0032658,Status epilepticus with prominent motor symptoms,0.021268157093806805,-0.24803407148930245,1
5157,Biological Process,GO:0001953,negative regulation of cell-matrix adhesion,0.021261750573169702,-0.24814426766735262,1
5158,Disease,MONDO:0019171,familial long QT syndrome,0.021247314497606973,-0.24839257723242966,1
5158,Disease,MONDO:0002442,long QT syndrome,0.021247314497606973,-0.24839257723242966,1
5160,Phenotype,HP:0005415,Decreased proportion of CD8-positive T cells,0.021224262170690067,-0.24878909173153138,1
5161,Biological Process,GO:0010591,regulation of lamellipodium assembly,0.0211901557677574,-0.2493757432797137,1
5162,Phenotype,HP:0010931,Abnormal blood sodium concentration,0.02117702056910098,-0.24960167694509278,1
5163,Phenotype,HP:0012881,Abnormal labia majora morphology,0.02117486105688482,-0.24963882191131598,1
5164,Phenotype,HP:0100764,Lymphangioma,0.021134935489645734,-0.25032556673981954,1
5165,Biological Process,GO:0071398,cellular response to fatty acid,0.021131014573356643,-0.2503930089622031,1
5166,Biological Process,GO:0170040,proteinogenic amino acid catabolic process,0.02112009341008425,-0.2505808598286328,1
5166,Biological Process,GO:0170035,L-amino acid catabolic process,0.02112009341008425,-0.2505808598286328,1
5168,Phenotype,HP:0031073,Abnormal response to endocrine stimulation test,0.02110601156597902,-0.2508230763901947,1
5169,Phenotype,HP:0008846,Severe intrauterine growth retardation,0.021089231122722096,-0.25111171055180054,1
5170,Phenotype,HP:0000396,Overfolded helix,0.021067806516873455,-0.25148022722637087,1
5171,Phenotype,HP:0004904,Maturity-onset diabetes of the young,0.021063107770427414,-0.25156104861590667,1
5172,Phenotype,HP:0012450,Chronic constipation,0.021029852425917817,-0.2521330614247745,1
5173,Phenotype,HP:0005160,Total anomalous pulmonary venous return,0.021021200534151907,-0.25228187939626207,1
5174,Phenotype,HP:4000079,Sensory seeking,0.02101451777653729,-0.2523968270237935,1
5175,Biological Process,GO:0002230,positive regulation of defense response to virus by host,0.021008952327505437,-0.25249255624206707,1
5176,Phenotype,HP:0002512,Brain stem compression,0.02100242058317081,-0.25260490634635113,1
5177,Biological Process,GO:1900424,regulation of defense response to bacterium,0.020992858668725245,-0.2527693772793942,1
5178,Biological Process,GO:0031398,positive regulation of protein ubiquitination,0.02094916411247061,-0.25352095108577094,1
5179,Biological Process,GO:0033045,regulation of sister chromatid segregation,0.020931673465899636,-0.25382180119036357,1
5180,Biological Process,GO:0051492,regulation of stress fiber assembly,0.020920981809788408,-0.254005704389498,1
5181,Phenotype,HP:0033993,Viral encephalitis,0.020908861023102077,-0.25421418953197294,1
5182,Phenotype,HP:0100639,Erectile dysfunction,0.020906119037955806,-0.2542613533983686,1
5183,Biological Process,GO:0048812,neuron projection morphogenesis,0.020879782367654087,-0.25471436066615266,1
5184,Phenotype,HP:0030917,Low APGAR score,0.020854303633634053,-0.255152610891135,1
5185,Phenotype,HP:0007112,Temporal cortical atrophy,0.0207906293762663,-0.25624784810327667,1
5186,Biological Process,GO:0071248,cellular response to metal ion,0.020766858951966727,-0.25665671432830267,1
5187,Biological Process,GO:0070542,response to fatty acid,0.02076037882713211,-0.2567681765447712,1
5188,Phenotype,HP:0003162,Fasting hypoglycemia,0.020754887563880886,-0.2568626297210316,1
5189,Biological Process,GO:0032495,response to muramyl dipeptide,0.020738589011333075,-0.2571429750598285,1
5190,Phenotype,HP:0008887,Adipose tissue loss,0.02071404104517638,-0.2575652154930687,1
5191,Phenotype,HP:0000853,Goiter,0.02070216365325306,-0.25776951409277565,1
5192,Biological Process,GO:1990166,protein localization to site of double-strand break,0.02068206111940407,-0.2581152902987326,1
5193,Phenotype,HP:0012469,Infantile spasms,0.020649764323345865,-0.2586708154722985,1
5194,Phenotype,HP:0006257,Abnormality of carpal bone ossification,0.020632027660498764,-0.2589758972113309,1
5195,Phenotype,HP:0002653,Bone pain,0.020622344405185844,-0.2591424552834907,1
5196,Phenotype,HP:5200005,Abnormal pitch,0.020595348593340335,-0.259606800199748,1
5197,Phenotype,HP:0030853,Heterotaxy,0.02058099349139275,-0.2598537169677957,1
5198,Biological Process,GO:0071385,cellular response to glucocorticoid stimulus,0.020576281445499056,-0.25993476711618274,1
5199,Phenotype,HP:0100018,Nuclear cataract,0.020568549012698112,-0.2600677698160818,1
5200,Phenotype,HP:0012603,Abnormal urine sodium concentration,0.020560040667292334,-0.2602141187000326,1
5201,Biological Process,GO:0071357,cellular response to type I interferon,0.020553193490242094,-0.26033189444510696,1
5202,Biological Process,GO:0006518,peptide metabolic process,0.02055224936822153,-0.26034813393673933,1
5203,Phenotype,HP:0025454,Abnormal CSF metabolite concentration,0.020541051087715312,-0.26054075139361166,1
5204,Biological Process,GO:0030534,adult behavior,0.020536646356314914,-0.2606165155397303,1
5205,Phenotype,HP:0034681,Finger joint contracture,0.02052385700959558,-0.26083650033460737,1
5206,Biological Process,GO:1903307,positive regulation of regulated secretory pathway,0.020508839993177097,-0.26109480244721583,1
5207,Phenotype,HP:0500015,Abnormal cardiac test,0.020486645450011443,-0.261476562527135,1
5208,Phenotype,HP:0001349,Facial diplegia,0.020465648904428924,-0.26183771629631974,1
5209,Biological Process,GO:0032886,regulation of microtubule-based process,0.020395636204872503,-0.26304197869444734,1
5210,Biological Process,GO:0032231,regulation of actin filament bundle assembly,0.020390892689764795,-0.26312357013307713,1
5211,Biological Process,GO:0006690,icosanoid metabolic process,0.020389788860315727,-0.26314255669277103,1
5212,Phenotype,HP:0001756,Vestibular hypofunction,0.020360529115168058,-0.2636458426835039,1
5213,Phenotype,HP:0000034,Hydrocele testis,0.020347086204570375,-0.263877069187506,1
5214,Phenotype,HP:0004673,Decreased facial expression,0.020337377520680988,-0.2640440646471493,1
5215,Phenotype,HP:0002352,Leukoencephalopathy,0.020275332557738834,-0.26511127697202536,1
5216,Phenotype,HP:0001397,Hepatic steatosis,0.02027498986729981,-0.26511717146277536,1
5217,Biological Process,GO:0046326,positive regulation of glucose import,0.02025053760329454,-0.26553776575891314,1
5218,Phenotype,HP:0011712,Right bundle branch block,0.020239127938343815,-0.26573401916097367,1
5219,Biological Process,GO:0010894,negative regulation of steroid biosynthetic process,0.020224579276736265,-0.2659842652767221,1
5220,Phenotype,HP:0003351,Decreased circulating renin level,0.020154531612316173,-0.2671891290924616,1
5221,Phenotype,HP:0008049,Abnormality of the extraocular muscles,0.020108393257991075,-0.2679827377602781,1
5222,Biological Process,GO:0046324,regulation of glucose import,0.020098349132074644,-0.26815550303343355,1
5223,Phenotype,HP:0040135,Abnormal transferrin saturation,0.02009773122572589,-0.26816613141065776,1
5224,Biological Process,GO:0098900,regulation of action potential,0.02007715212127681,-0.26852010493020756,1
5225,Phenotype,HP:0006561,Lipid accumulation in hepatocytes,0.02005246048892184,-0.2689448165122758,1
5226,Phenotype,HP:0006827,Atrophy of the spinal cord,0.020043230480787932,-0.2691035784483317,1
5227,Biological Process,GO:0050654,chondroitin sulfate proteoglycan metabolic process,0.020024168074060822,-0.2694314638146255,1
5227,Biological Process,GO:0050650,chondroitin sulfate proteoglycan biosynthetic process,0.020024168074060822,-0.2694314638146255,1
5229,Phenotype,HP:0001001,Abnormality of subcutaneous fat tissue,0.020003816283341247,-0.269781527395282,1
5230,Phenotype,HP:0001876,Pancytopenia,0.019998611881569817,-0.26987104637395004,1
5231,Disease,MONDO:0003225,bone marrow disorder,0.019954727694621477,-0.2706258819473405,1
5232,Phenotype,HP:0002282,Gray matter heterotopia,0.01994829835085532,-0.2707364706975426,1
5233,Phenotype,HP:0001114,Xanthelasma,0.019935364545423107,-0.2709589402729967,1
5234,Phenotype,HP:0004463,Absent brainstem auditory responses,0.019921264366822955,-0.2712014721993848,1
5235,Biological Process,GO:0045540,regulation of cholesterol biosynthetic process,0.019917507257118827,-0.2712660968456416,1
5235,Biological Process,GO:0106118,regulation of sterol biosynthetic process,0.019917507257118827,-0.2712660968456416,1
5237,Phenotype,HP:0003187,Breast hypoplasia,0.01990219043342678,-0.2715295558316248,1
5238,Biological Process,GO:0030204,chondroitin sulfate metabolic process,0.019874608039320396,-0.27200399033112427,1
5238,Biological Process,GO:0030206,chondroitin sulfate biosynthetic process,0.019874608039320396,-0.27200399033112427,1
5240,Biological Process,GO:0051952,regulation of amine transport,0.019845926077695086,-0.2724973380824428,1
5241,Phenotype,HP:0002696,Abnormal parietal bone morphology,0.019753257009854086,-0.27409130424254663,1
5242,Biological Process,GO:0090181,regulation of cholesterol metabolic process,0.01970623522041004,-0.27490010854917823,1
5243,Biological Process,GO:0051503,adenine nucleotide transport,0.019705915972111798,-0.2749055998203858,1
5244,Phenotype,HP:0000103,Polyuria,0.019701424996682704,-0.27498284741795653,1
5245,Biological Process,GO:0043691,reverse cholesterol transport,0.019678253498070175,-0.27538141174505903,1
5246,Biological Process,GO:1904356,regulation of telomere maintenance via telomere lengthening,0.01967173700704794,-0.2754934994827914,1
5247,Phenotype,HP:0002140,Ischemic stroke,0.01964260920992489,-0.27599451588464163,1
5248,Disease,MONDO:0019722,glomerular disorder,0.019641646619404263,-0.27601107304607275,1
5249,Disease,MONDO:0015452,Coffin-Siris syndrome,0.019638159906331,-0.2760710467004782,1
5250,Phenotype,HP:0030601,Abnormal posterior segment imaging,0.01960077294152207,-0.2767141259730212,1
5251,Biological Process,GO:0071774,response to fibroblast growth factor,0.019569834189813062,-0.277246291930972,1
5251,Biological Process,GO:0044344,cellular response to fibroblast growth factor stimulus,0.019569834189813062,-0.277246291930972,1
5253,Phenotype,HP:0000097,Focal segmental glomerulosclerosis,0.01954067359353251,-0.27774787249892813,1
5254,Phenotype,HP:0001655,Patent foramen ovale,0.019525403605085256,-0.2780105258892898,1
5255,Biological Process,GO:0061564,axon development,0.01951571680803721,-0.2781771448815179,1
5256,Biological Process,GO:0048024,"regulation of mRNA splicing, via spliceosome",0.01950964431689628,-0.2782815955424739,1
5257,Biological Process,GO:0001504,neurotransmitter uptake,0.019496875673424063,-0.2785012242284996,1
5258,Phenotype,HP:0009072,Decreased Achilles reflex,0.01946094676927046,-0.2791192239421551,1
5259,Phenotype,HP:0009802,Aplasia of the phalanges of the hand,0.01944879295110924,-0.2793282772467408,1
5259,Phenotype,HP:0009823,Aplasia involving bones of the upper limbs,0.01944879295110924,-0.2793282772467408,1
5261,Biological Process,GO:1902914,regulation of protein polyubiquitination,0.01940696062147329,-0.28004781958585684,1
5262,Biological Process,GO:0044070,regulation of monoatomic anion transport,0.019399732782811374,-0.28017214294969545,1
5263,Phenotype,HP:0001166,Arachnodactyly,0.019324028345203526,-0.2814743068165388,1
5264,Biological Process,GO:0015833,peptide transport,0.01931396657516682,-0.281647375579643,1
5265,Phenotype,HP:0012265,Ciliary dyskinesia,0.019299652375510234,-0.28189358880260007,1
5266,Phenotype,HP:0002064,Spastic gait,0.019291177183037744,-0.2820393674352793,1
5267,Biological Process,GO:0042403,thyroid hormone metabolic process,0.01927509503573932,-0.28231599046789113,1
5268,Phenotype,HP:0004887,Respiratory failure requiring assisted ventilation,0.019263511086756724,-0.2825152416647448,1
5269,Phenotype,HP:0007730,Iris hypopigmentation,0.019256593321226312,-0.2826342315760054,1
5270,Phenotype,HP:0006466,Ankle flexion contracture,0.019242772750140635,-0.28287195407755983,1
5271,Phenotype,HP:0003819,Death in childhood,0.019227370935965604,-0.2831368749532217,1
5272,Phenotype,HP:0002884,Hepatoblastoma,0.019206838542434324,-0.2834900450156524,1
5273,Phenotype,HP:0011280,Abnormality of urine calcium concentration,0.019158138105266564,-0.28432772311726945,1
5274,Phenotype,HP:0001063,Acrocyanosis,0.019127378563640107,-0.2848568065492621,1
5275,Phenotype,HP:0000419,Abnormal nasal septum morphology,0.019079389474111474,-0.28568224902478245,1
5276,Phenotype,HP:0007076,Extrapyramidal muscular rigidity,0.01904832783474497,-0.2862165287276117,1
5277,Phenotype,HP:0003165,Elevated circulating parathyroid hormone level,0.0190399673086602,-0.2863603350264153,1
5278,Biological Process,GO:0042761,very long-chain fatty acid biosynthetic process,0.019030843332833114,-0.2865172731402089,1
5279,Phenotype,HP:0032989,Delayed ability to roll over,0.019013157795753965,-0.2868214754839272,1
5280,Biological Process,GO:1903320,regulation of protein modification by small protein conjugation or removal,0.018983786812949544,-0.28732667483220997,1
5281,Phenotype,HP:0000982,Palmoplantar keratoderma,0.01897805599008351,-0.2874252485842809,1
5282,Phenotype,HP:0000217,Xerostomia,0.018956051618630676,-0.2878037375913178,1
5283,Disease,MONDO:0044334,connective and soft tissue neoplasm,0.018941592738250468,-0.28805243941357617,1
5284,Phenotype,HP:0001944,Dehydration,0.018936517000523012,-0.2881397452898909,1
5285,Phenotype,HP:0001182,Tapered finger,0.018936292471822935,-0.2881436073245291,1
5286,Phenotype,HP:0034673,Abnormal ankle morphology,0.018899299246294854,-0.28877991403418574,1
5287,Phenotype,HP:0040063,Decreased adipose tissue,0.018884177224139154,-0.28904002231141457,1
5288,Phenotype,HP:0000040,Long penis,0.018881212580235562,-0.2890910160482588,1
5289,Biological Process,GO:0006040,amino sugar metabolic process,0.018807351798724392,-0.2903614678724816,1
5290,Biological Process,GO:0015813,L-glutamate transmembrane transport,0.01878655768092874,-0.29071913975661406,1
5291,Phenotype,HP:0030919,Low 5-minute APGAR score,0.018780092737014864,-0.29083034085171267,1
5292,Phenotype,HP:0004395,Malnutrition,0.018776555226158953,-0.2908911882598791,1
5293,Phenotype,HP:0003026,Short long bone,0.01868771288379334,-0.2924193323387439,1
5294,Biological Process,GO:0051983,regulation of chromosome segregation,0.018665150525471796,-0.29280741907032065,1
5295,Disease,MONDO:0003381,pituitary gland disorder,0.018628629848539635,-0.29343559764738186,1
5296,Biological Process,GO:0050909,sensory perception of taste,0.018624279557813317,-0.29351042537971933,1
5297,Phenotype,HP:0005401,Recurrent candida infections,0.018616620069029755,-0.2936421733967129,1
5298,Biological Process,GO:0032528,microvillus organization,0.018616572429673517,-0.29364299282355616,1
5298,Biological Process,GO:0030033,microvillus assembly,0.018616572429673517,-0.29364299282355616,1
5300,Biological Process,GO:0060632,regulation of microtubule-based movement,0.01859187297426934,-0.29406783896698346,1
5301,Biological Process,GO:0006595,polyamine metabolic process,0.018587811583375302,-0.2941376974407857,1
5302,Phenotype,HP:0000777,Abnormal thymus morphology,0.01845401807007152,-0.29643902988769827,1
5303,Phenotype,HP:0000264,Abnormal mastoid morphology,0.018447111817703976,-0.2965578217653277,1
5304,Biological Process,GO:1901991,negative regulation of mitotic cell cycle phase transition,0.0184305538386208,-0.2968426294034446,1
5305,Phenotype,HP:0011563,Abnormal ventriculoarterial connection,0.018402974974624287,-0.2973170031828375,1
5306,Phenotype,HP:0002454,Eye of the tiger anomaly of globus pallidus,0.018399296076143434,-0.2973802825469398,1
5307,Biological Process,GO:0003081,regulation of systemic arterial blood pressure by renin-angiotensin,0.018397757133510995,-0.297406753326625,1
5308,Phenotype,HP:0001678,Atrioventricular block,0.018394120548721915,-0.2974693048686572,1
5309,Disease,MONDO:0017749,disorder of multiple glycosylation,0.018391558271396602,-0.29751337764768154,1
5310,Biological Process,GO:0006941,striated muscle contraction,0.018386506685544424,-0.2976002680965749,1
5311,Disease,MONDO:0017741,disorder of protein O-glycosylation,0.018383966431121612,-0.29764396206784655,1
5312,Phenotype,HP:0001557,Prenatal movement abnormality,0.01837579726728855,-0.29778447681575126,1
5313,Biological Process,GO:0071870,cellular response to catecholamine stimulus,0.01837477944641408,-0.29780198397395147,1
5313,Biological Process,GO:0071867,response to monoamine,0.01837477944641408,-0.29780198397395147,1
5313,Biological Process,GO:0071869,response to catecholamine,0.01837477944641408,-0.29780198397395147,1
5313,Biological Process,GO:0071868,cellular response to monoamine stimulus,0.01837477944641408,-0.29780198397395147,1
5317,Phenotype,HP:0012692,Focal T2 hyperintense thalamic lesion,0.018367884139156243,-0.29792058758882073,1
5318,Phenotype,HP:0100498,Deviation of toes,0.01835517942595033,-0.29813911663411985,1
5319,Biological Process,GO:0043112,receptor metabolic process,0.018296728475190704,-0.2991445096925306,1
5320,Phenotype,HP:0009553,Abnormality of the hairline,0.018286211727436608,-0.29932540435808547,1
5321,Biological Process,GO:0000045,autophagosome assembly,0.01826428446831474,-0.2997025669846056,1
5322,Biological Process,GO:0018394,peptidyl-lysine acetylation,0.018236210972912725,-0.300185448734786,1
5323,Phenotype,HP:0001714,Ventricular hypertrophy,0.01822938528047824,-0.30030285493097775,1
5324,Phenotype,HP:0012785,Flexion contracture of finger,0.01822003896849833,-0.30046361736621996,1
5325,Phenotype,HP:0001583,Rotary nystagmus,0.01819566679708673,-0.300882834019451,1
5326,Phenotype,HP:0001711,Abnormal left ventricle morphology,0.018173083674588253,-0.3012712779079102,1
5327,Biological Process,GO:0070085,glycosylation,0.01816161067767108,-0.30146862065956415,1
5328,Phenotype,HP:0002753,Thin bony cortex,0.01815827339766496,-0.30152602397137557,1
5329,Biological Process,GO:0046618,xenobiotic export from cell,0.018156983763851997,-0.30154820648280767,1
5330,Biological Process,GO:0009306,protein secretion,0.018131961880338165,-0.30197859859219567,1
5331,Phenotype,HP:0002925,Elevated circulating thyroid-stimulating hormone concentration,0.01812102382616143,-0.302166739992787,1
5332,Phenotype,HP:0001188,Hand clenching,0.018114790726607377,-0.3022739532193058,1
5333,Biological Process,GO:0006688,glycosphingolipid biosynthetic process,0.01811239541791909,-0.30231515403292225,1
5334,Phenotype,HP:0000054,Micropenis,0.018094731424156185,-0.30261898581807267,1
5335,Biological Process,GO:0071470,cellular response to osmotic stress,0.01808111268570034,-0.3028532366716495,1
5336,Biological Process,GO:0032647,regulation of interferon-alpha production,0.01805951240158421,-0.30322477512274104,1
5337,Disease,MONDO:0019268,epidermal disease,0.01804543809109127,-0.3034668621014407,1
5338,Disease,MONDO:0019254,inborn disorder of purine or pyrimidine metabolism,0.018038439869506928,-0.3035872359073528,1
5339,Phenotype,HP:0100337,Bilateral cleft palate,0.018035272164640515,-0.3036417224202734,1
5340,Biological Process,GO:0030833,regulation of actin filament polymerization,0.018014651695604456,-0.30399640743669487,1
5341,Phenotype,HP:0000802,Impotence,0.018001977657092993,-0.3042144088579867,1
5342,Phenotype,HP:0003470,Paralysis,0.017990299884977246,-0.30441527387164846,1
5343,Biological Process,GO:0007044,cell-substrate junction assembly,0.017981957594972453,-0.30455876649842467,1
5343,Biological Process,GO:0150115,cell-substrate junction organization,0.017981957594972453,-0.30455876649842467,1
5345,Disease,MONDO:0018424,inherited lipoic acid biosynthesis defect,0.01797516368809038,-0.3046756259631546,1
5346,Phenotype,HP:0007648,Punctate cataract,0.017952291090792327,-0.3050690489999476,1
5347,Phenotype,HP:0011104,Abnormality of blood volume homeostasis,0.017938854567254303,-0.30530016564251267,1
5347,Phenotype,HP:0011106,Hypovolemia,0.017938854567254303,-0.30530016564251267,1
5349,Phenotype,HP:0003115,Abnormal EKG,0.017930413578982507,-0.30544535594146077,1
5350,Biological Process,GO:0070507,regulation of microtubule cytoskeleton organization,0.01792345241932869,-0.30556509225889417,1
5351,Phenotype,HP:0011384,Abnormality of the internal auditory canal,0.01787826022958594,-0.3063424263017328,1
5352,Phenotype,HP:0002684,Thickened calvaria,0.017871319684622522,-0.30646180803354595,1
5353,Phenotype,HP:0009027,Foot dorsiflexor weakness,0.01786006531966955,-0.3066553901781217,1
5354,Disease,MONDO:0019952,congenital myopathy,0.01782576155550397,-0.3072454364634467,1
5355,Biological Process,GO:0098926,postsynaptic signal transduction,0.017815530656271505,-0.3074214143549257,1
5356,Phenotype,HP:0012808,Abnormal nasal base norphology,0.01780761975547762,-0.30755748681637557,1
5357,Biological Process,GO:0035088,establishment or maintenance of apical/basal cell polarity,0.017800512647470956,-0.3076797335371289,1
5357,Biological Process,GO:0061245,establishment or maintenance of bipolar cell polarity,0.017800512647470956,-0.3076797335371289,1
5359,Phenotype,HP:0003146,Hypocholesterolemia,0.01776036390070712,-0.3083703171936078,1
5360,Biological Process,GO:0032387,negative regulation of intracellular transport,0.017745772970703788,-0.30862129035230695,1
5361,Phenotype,HP:0002219,Facial hypertrichosis,0.0177296173117224,-0.3088991778320288,1
5362,Phenotype,HP:0006482,Abnormal dental morphology,0.017728770968684304,-0.30891373546376066,1
5363,Biological Process,GO:0006898,receptor-mediated endocytosis,0.017704429274997602,-0.30933242788098436,1
5364,Biological Process,GO:0070861,regulation of protein exit from endoplasmic reticulum,0.017675267514222992,-0.3098340284789695,1
5365,Phenotype,HP:0002912,Methylmalonic acidemia,0.017669430679282727,-0.3099344257052895,1
5366,Phenotype,HP:0010803,Everted upper lip vermilion,0.017657038672467706,-0.31014757600429554,1
5367,Phenotype,HP:0001562,Oligohydramnios,0.01765367071140811,-0.31020550704949346,1
5368,Biological Process,GO:0030010,establishment of cell polarity,0.017645749222262586,-0.31034176163724064,1
5369,Phenotype,HP:0001331,Absent septum pellucidum,0.017631028572225982,-0.31059496606197207,1
5370,Phenotype,HP:0002671,Basal cell carcinoma,0.017620289472441764,-0.31077968532207506,1
5371,Phenotype,HP:0009106,Abnormal pelvis bone ossification,0.017596319681645323,-0.31119198077604304,1
5372,Phenotype,HP:0003088,Premature osteoarthritis,0.017575892090854306,-0.31154334816552837,1
5373,Phenotype,HP:0011904,Persistence of hemoglobin F,0.017547980118943318,-0.31202345161023143,1
5374,Biological Process,GO:1904666,regulation of ubiquitin protein ligase activity,0.017531651454133268,-0.31230431489884847,1
5375,Biological Process,GO:0043555,regulation of translation in response to stress,0.017518745659972246,-0.31252630266284787,1
5376,Biological Process,GO:0006413,translational initiation,0.017518222232838054,-0.31253530593825163,1
5377,Phenotype,HP:0000076,Vesicoureteral reflux,0.017512778218623404,-0.3126289464014121,1
5378,Phenotype,HP:0004219,Abnormality of the middle phalanx of the 5th finger,0.01750337447207051,-0.31279069674737675,1
5378,Phenotype,HP:0009161,Aplasia/Hypoplasia of the middle phalanx of the 5th finger,0.01750337447207051,-0.31279069674737675,1
5380,Phenotype,HP:0012864,Abnormal sperm morphology,0.017490940429304547,-0.31300457009113625,1
5381,Phenotype,HP:0007373,Motor neuron atrophy,0.017465848245060145,-0.3134361714172367,1
5382,Biological Process,GO:0043603,amide metabolic process,0.01745388742310794,-0.31364190506583184,1
5383,Phenotype,HP:0003221,Chromosomal breakage induced by crosslinking agents,0.01741907039549917,-0.31424077980469295,1
5384,Phenotype,HP:0004390,Hamartomatous polyposis,0.01738244644696607,-0.3148707347181416,1
5385,Biological Process,GO:0048593,camera-type eye morphogenesis,0.01735364486646107,-0.3153661399893077,1
5386,Biological Process,GO:0051496,positive regulation of stress fiber assembly,0.01735295854297214,-0.3153779451843067,1
5387,Phenotype,HP:5200010,Abnormal Intonation,0.017352710524938142,-0.3153822112502389,1
5388,Phenotype,HP:0009928,Thick nasal alae,0.017291620160010623,-0.31643300388980594,1
5389,Phenotype,HP:0001748,Polysplenia,0.017258259181843427,-0.3170068336639191,1
5390,Phenotype,HP:0002089,Pulmonary hypoplasia,0.017248605056920496,-0.31717289067507803,1
5391,Phenotype,HP:0000121,Nephrocalcinosis,0.017245753762975546,-0.31722193472145344,1
5392,Phenotype,HP:0003688,Cytochrome C oxidase-negative muscle fibers,0.017218279465314845,-0.317694509894206,1
5393,Biological Process,GO:0033540,fatty acid beta-oxidation using acyl-CoA oxidase,0.01717452735102698,-0.3184470737348989,1
5394,Biological Process,GO:0001510,RNA methylation,0.01716930335608835,-0.31853692972834663,1
5395,Biological Process,GO:0042398,cellular modified amino acid biosynthetic process,0.017160995878209517,-0.3186798235646955,1
5396,Phenotype,HP:0000599,Abnormality of the frontal hairline,0.017153117110226046,-0.31881534332162786,1
5397,Biological Process,GO:0030036,actin cytoskeleton organization,0.017143096275779146,-0.3189877079668811,1
5398,Phenotype,HP:0000300,Oval face,0.017114002618092927,-0.31948813714897933,1
5399,Phenotype,HP:0046503,Increased libido,0.017111556050595,-0.31953021964631056,1
5399,Phenotype,HP:0030019,Increased female libido,0.017111556050595,-0.31953021964631056,1
5401,Biological Process,GO:0035025,positive regulation of Rho protein signal transduction,0.0171048393515586,-0.31964575108761084,1
5402,Phenotype,HP:0003710,Exercise-induced muscle cramps,0.017053462312470846,-0.320529468423073,1
5403,Biological Process,GO:1901223,negative regulation of non-canonical NF-kappaB signal transduction,0.01705300748141103,-0.32053729180292134,1
5404,Phenotype,HP:0008689,Bilateral cryptorchidism,0.01705088242368802,-0.32057384413022605,1
5405,Biological Process,GO:0010824,regulation of centrosome duplication,0.017007235420348654,-0.3213245999965984,1
5406,Biological Process,GO:0038128,ERBB2 signaling pathway,0.01699495687791308,-0.32153579863702586,1
5407,Biological Process,GO:1901838,positive regulation of transcription of nucleolar large rRNA by RNA polymerase I,0.016958537707198573,-0.32216223124340077,1
5408,Phenotype,HP:0006145,Central Y-shaped metacarpal,0.016918838085632215,-0.32284508966444675,1
5409,Phenotype,HP:0003508,Proportionate short stature,0.01689325503562733,-0.32328513418987564,1
5410,Phenotype,HP:0012209,Juvenile myelomonocytic leukemia,0.016871112009358646,-0.32366600814681595,1
5411,Phenotype,HP:0003642,Type I transferrin isoform profile,0.016814829745843585,-0.32463409842275337,1
5412,Biological Process,GO:0060541,respiratory system development,0.01680481251691368,-0.32480640105085007,1
5413,Disease,MONDO:0005086,renal cell carcinoma,0.016799064381235462,-0.3249052725941625,1
5413,Disease,MONDO:0005206,renal carcinoma,0.016799064381235462,-0.3249052725941625,1
5415,Phenotype,HP:0000848,Increased circulating renin level,0.01676976309879652,-0.3254092730523894,1
5416,Phenotype,HP:0031664,Systolic heart murmur,0.016762836589375163,-0.3255284133640652,1
5417,Biological Process,GO:1904376,negative regulation of protein localization to cell periphery,0.016752933330378084,-0.32569875563774786,1
5418,Phenotype,HP:0004510,Pancreatic islet-cell hyperplasia,0.016745150151901034,-0.3258326311951426,1
5419,Biological Process,GO:0071709,membrane assembly,0.016730646159016316,-0.3260821089808078,1
5420,Biological Process,GO:1901606,alpha-amino acid catabolic process,0.016703557147783377,-0.3265480569850551,1
5421,Phenotype,HP:0002503,Spinocerebellar tract degeneration,0.01669762574418543,-0.3266500808516734,1
5422,Phenotype,HP:0009917,Persistent pupillary membrane,0.016681358289639014,-0.3269298912853178,1
5423,Phenotype,HP:0003542,Increased serum pyruvate,0.016660281359775042,-0.3272924277146223,1
5423,Phenotype,HP:0004366,Abnormality of glycolysis,0.016660281359775042,-0.3272924277146223,1
5425,Disease,MONDO:0015225,arthrogryposis syndrome,0.01664862082271823,-0.32749299627444733,1
5426,Phenotype,HP:0025709,Intermediate young adult onset,0.016607511341877657,-0.3282001051603567,1
5427,Phenotype,HP:0003134,Abnormality of peripheral nerve conduction,0.016569688614385458,-0.32885067982469707,1
5428,Biological Process,GO:0007063,regulation of sister chromatid cohesion,0.016551151686846954,-0.32916952661896254,1
5429,Phenotype,HP:0012769,Abnormal arm span,0.01651465430100063,-0.3297973045747213,1
5430,Biological Process,GO:0007163,establishment or maintenance of cell polarity,0.016500774569887633,-0.33003604466589626,1
5431,Phenotype,HP:0000230,Gingivitis,0.016475963731569898,-0.3304628066653817,1
5432,Biological Process,GO:0002244,hematopoietic progenitor cell differentiation,0.01642520709254247,-0.3313358527302147,1
5433,Biological Process,GO:0006699,bile acid biosynthetic process,0.01641655351154292,-0.33148469975758166,1
5434,Biological Process,GO:0046321,positive regulation of fatty acid oxidation,0.016414450940551495,-0.33152086529898217,1
5435,Phenotype,HP:0008544,Abnormally folded helix,0.016402008788655498,-0.3317348781248705,1
5436,Biological Process,GO:1902410,mitotic cytokinetic process,0.016390334052280298,-0.3319356909218885,1
5437,Biological Process,GO:0030031,cell projection assembly,0.016385202995636394,-0.3320239483183047,1
5438,Biological Process,GO:1905332,positive regulation of morphogenesis of an epithelium,0.016380012328768512,-0.33211323104800655,1
5439,Phenotype,HP:0010676,Mechanical ileus,0.016368827521513918,-0.3323056167564902,1
5439,Phenotype,HP:0004401,Meconium ileus,0.016368827521513918,-0.3323056167564902,1
5441,Biological Process,GO:0034377,plasma lipoprotein particle assembly,0.016349096146626385,-0.33264500879523407,1
5442,Phenotype,HP:0011993,Impaired neutrophil bactericidal activity,0.016327560932833718,-0.3330154279958999,1
5443,Phenotype,HP:0001045,Vitiligo,0.01631676327741427,-0.3332011544496999,1
5444,Biological Process,GO:0003180,aortic valve morphogenesis,0.016316349321158108,-0.33320827475725734,1
5444,Biological Process,GO:0003176,aortic valve development,0.016316349321158108,-0.33320827475725734,1
5446,Phenotype,HP:0010537,Wide cranial sutures,0.016312115414465422,-0.33328110061113075,1
5447,Biological Process,GO:0031112,positive regulation of microtubule polymerization or depolymerization,0.016309956705348627,-0.3333182317635406,1
5448,Biological Process,GO:0032922,circadian regulation of gene expression,0.016306011364950468,-0.33338609409593767,1
5449,Biological Process,GO:0097305,response to alcohol,0.016298616929997012,-0.333513283020608,1
5450,Phenotype,HP:4000059,Abnormal lung development,0.016297380838854902,-0.3335345445644784,1
5451,Phenotype,HP:0030356,Increased circulating interferon-gamma concentration,0.01627819868925151,-0.33386448958343895,1
5452,Biological Process,GO:0051640,organelle localization,0.016234296987784114,-0.33461962641755577,1
5453,Phenotype,HP:0001220,Interphalangeal joint contracture of finger,0.01623375233911606,-0.3346289947166684,1
5454,Biological Process,GO:0045444,fat cell differentiation,0.016218574588895307,-0.33489006155161166,1
5455,Biological Process,GO:0042537,benzene-containing compound metabolic process,0.016162511285244485,-0.3358543855803843,1
5456,Phenotype,HP:0005556,Abnormality of the metopic suture,0.016150039952299244,-0.3360689003386444,1
5457,Phenotype,HP:0100511,Abnormality of vitamin D metabolism,0.016147038289707427,-0.3361205308201726,1
5458,Phenotype,HP:0030089,Abnormal muscle fiber protein expression,0.016145087884053444,-0.3361540790222141,1
5459,Phenotype,HP:0007803,Monochromacy,0.016133040243224706,-0.33636130601000513,1
5460,Biological Process,GO:1905207,regulation of cardiocyte differentiation,0.016077051584324265,-0.3373243461021967,1
5461,Phenotype,HP:0002697,Parietal foramina,0.016069183522059216,-0.33745968171404933,1
5462,Biological Process,GO:0035305,negative regulation of dephosphorylation,0.0160675423673029,-0.33748791060645117,1
5463,Biological Process,GO:1902622,regulation of neutrophil migration,0.016058552258148118,-0.33764254612941713,1
5464,Biological Process,GO:0009064,glutamine family amino acid metabolic process,0.016048401679258695,-0.33781714246055716,1
5465,Biological Process,GO:0050807,regulation of synapse organization,0.016030986205936015,-0.3381166995380727,1
5465,Biological Process,GO:0050803,regulation of synapse structure or activity,0.016030986205936015,-0.3381166995380727,1
5467,Phenotype,HP:0031379,Abnormal T cell proliferation,0.01600074827939002,-0.33863681086312375,1
5468,Biological Process,GO:0018146,keratan sulfate biosynthetic process,0.015996431606097428,-0.3387110603544904,1
5469,Phenotype,HP:0000272,Malar flattening,0.01599366302399796,-0.33875868170518303,1
5470,Biological Process,GO:1905820,positive regulation of chromosome separation,0.015979601863333692,-0.33900054249857187,1
5471,Biological Process,GO:0006801,superoxide metabolic process,0.01594255871684236,-0.3396377078801452,1
5472,Phenotype,HP:0002557,Hypoplastic nipples,0.015937632190327622,-0.33972244722990125,1
5473,Biological Process,GO:1900044,regulation of protein K63-linked ubiquitination,0.015936083343183305,-0.33974908837341045,1
5474,Biological Process,GO:0045197,establishment or maintenance of epithelial cell apical/basal polarity,0.015911193431909165,-0.34017721047740135,1
5475,Biological Process,GO:0044827,modulation by host of viral genome replication,0.01590485566442723,-0.3402862240580078,1
5476,Biological Process,GO:0043043,peptide biosynthetic process,0.0158911004582738,-0.3405228222416805,1
5477,Biological Process,GO:0019933,cAMP-mediated signaling,0.015875205063431652,-0.3407962330147698,1
5478,Phenotype,HP:0001522,Death in infancy,0.015868621370480396,-0.340909476667882,1
5479,Phenotype,HP:0004871,Perineal fistula,0.015860175308742064,-0.3410547542336405,1
5480,Biological Process,GO:1903426,regulation of reactive oxygen species biosynthetic process,0.015841209595990446,-0.34138097640283505,1
5481,Phenotype,HP:0200007,Abnormal size of the palpebral fissures,0.01582775641601719,-0.34161237954654583,1
5482,Disease,MONDO:0021166,inflammatory disease,0.015812236602392726,-0.3418793300868379,1
5483,Phenotype,HP:0004492,Widely patent fontanelles and sutures,0.015794268810339296,-0.34218838739336105,1
5484,Biological Process,GO:0030029,actin filament-based process,0.01576784358171346,-0.3426429179199318,1
5485,Biological Process,GO:0061014,positive regulation of mRNA catabolic process,0.01576731599240233,-0.34265199278739256,1
5486,Biological Process,GO:0046578,regulation of Ras protein signal transduction,0.01576383464881792,-0.3427118740832179,1
5487,Phenotype,HP:0011911,Abnormal metacarpophalangeal joint morphology,0.015734074998278058,-0.3432237587606212,1
5488,Phenotype,HP:0011951,Aspiration pneumonia,0.015720476465729494,-0.34345766205990413,1
5489,Phenotype,HP:0010721,Abnormal hair whorl,0.015680869844018286,-0.34413892082504055,1
5490,Biological Process,GO:1901617,organic hydroxy compound biosynthetic process,0.01567456060502459,-0.3442474436977343,1
5491,Phenotype,HP:0007042,Focal white matter lesions,0.015658916727191885,-0.3445165282203165,1
5492,Phenotype,HP:0002398,Degeneration of anterior horn cells,0.01563022515664858,-0.3450100412510586,1
5493,Disease,MONDO:0001713,inherited aplastic anemia,0.015626497670354844,-0.34507415635605415,1
5494,Biological Process,GO:0051963,regulation of synapse assembly,0.015617237906900061,-0.3452334301023145,1
5495,Biological Process,GO:0044770,cell cycle phase transition,0.015565263035772547,-0.34612743052428013,1
5496,Phenotype,HP:0009120,Aplasia/Hypoplasia involving the sinuses,0.015552471592135242,-0.34634745138746315,1
5497,Phenotype,HP:0005340,Spastic/hyperactive bladder,0.01551016535114702,-0.34707514529943956,1
5498,Disease,MONDO:0016800,mitochondrial membrane transport disorder,0.01549611061433942,-0.3473168955984597,1
5498,Disease,MONDO:0016801,mitochondrial substrate carrier disorder,0.01549611061433942,-0.3473168955984597,1
5500,Phenotype,HP:0000902,Rib fusion,0.015489576309019815,-0.3474292897532936,1
5501,Phenotype,HP:0000960,Sacral dimple,0.015484538649208734,-0.347515940665535,1
5502,Phenotype,HP:0004404,Abnormal nipple morphology,0.015460598429792971,-0.3479277274731854,1
5503,Phenotype,HP:0006673,Reduced systolic function,0.015443794658062338,-0.34821676289918857,1
5504,Phenotype,HP:0031137,Storage in hepatocytes,0.015441518449126002,-0.34825591512228066,1
5505,Phenotype,HP:0003347,Impaired lymphocyte transformation with phytohemagglutinin,0.01542199844736658,-0.34859167141048536,1
5506,Phenotype,HP:0100838,Recurrent cutaneous abscess formation,0.015414017729354579,-0.34872894477192984,1
5507,Phenotype,HP:0011492,Abnormal corneal stroma morphology,0.015408488982937008,-0.34882404268218964,1
5508,Biological Process,GO:1990542,mitochondrial transmembrane transport,0.015377739116148259,-0.34935295970089825,1
5509,Phenotype,HP:0002475,Myelomeningocele,0.015310174318114322,-0.35051511665563456,1
5510,Biological Process,GO:0030203,glycosaminoglycan metabolic process,0.01530477220308235,-0.35060803642654154,1
5511,Phenotype,HP:0009710,Chilblains,0.015302270216517089,-0.3506510721666323,1
5512,Biological Process,GO:0031929,TOR signaling,0.015293537784303202,-0.350801275484402,1
5513,Phenotype,HP:0003124,Hypercholesterolemia,0.015287963178250097,-0.35089716220919137,1
5514,Biological Process,GO:0120031,plasma membrane bounded cell projection assembly,0.015261735240184038,-0.3513482992142417,1
5515,Biological Process,GO:0072001,renal system development,0.015226681746479676,-0.35195124131844024,1
5516,Phenotype,HP:0007374,Atrophy/Degeneration involving the caudate nucleus,0.015223808328427735,-0.3520006659133491,1
5517,Biological Process,GO:1902001,fatty acid transmembrane transport,0.015222355161095269,-0.3520256613040106,1
5518,Biological Process,GO:0050684,regulation of mRNA processing,0.015203766187125045,-0.35234540332958514,1
5519,Phenotype,HP:0003328,Abnormal hairshaft morphology,0.015168449920238358,-0.35295286529753284,1
5520,Biological Process,GO:0032008,positive regulation of TOR signaling,0.015118821586439846,-0.35380650380388856,1
5521,Phenotype,HP:0008968,Muscle hypertrophy of the lower extremities,0.015092315341563411,-0.3542624278608452,1
5522,Phenotype,HP:0004947,Arteriovenous fistula,0.015062591506117107,-0.35477369649614865,1
5523,Biological Process,GO:0048066,developmental pigmentation,0.015039440652069636,-0.355171905723768,1
5524,Biological Process,GO:0031577,spindle checkpoint signaling,0.015006597222705587,-0.35573683333346273,1
5525,Biological Process,GO:0006672,ceramide metabolic process,0.015005080107804214,-0.35576292866246645,1
5526,Phenotype,HP:0001953,Diabetic ketoacidosis,0.015001758421645417,-0.3558200637503114,1
5527,Phenotype,HP:0002366,Abnormal lower motor neuron morphology,0.014999670972868917,-0.3558559691801189,1
5528,Biological Process,GO:0043414,macromolecule methylation,0.014982589564520254,-0.3561497801302992,1
5529,Phenotype,HP:0007731,Chorioretinal dysplasia,0.014979524351101947,-0.35620250372595097,1
5530,Phenotype,HP:0002450,Abnormal motor neuron morphology,0.014949287241703857,-0.35672260099554487,1
5531,Biological Process,GO:0071384,cellular response to corticosteroid stimulus,0.014945381125029411,-0.35678978865526284,1
5532,Phenotype,HP:0011053,Agenesis of mandibular premolar,0.014927193715834508,-0.3571026235145319,1
5532,Phenotype,HP:0011055,Agenesis of permanent molar,0.014927193715834508,-0.3571026235145319,1
5532,Phenotype,HP:0011056,Agenesis of first permanent molar tooth,0.014927193715834508,-0.3571026235145319,1
5535,Biological Process,GO:1902373,negative regulation of mRNA catabolic process,0.014925307264708643,-0.35713507165852837,1
5536,Phenotype,HP:0034677,Ankle contracture,0.014919537728838805,-0.3572343112985753,1
5537,Phenotype,HP:5200016,Abnormal peer relationships,0.01488506564063552,-0.35782725286305106,1
5537,Phenotype,HP:0002332,Lack of peer relationships,0.01488506564063552,-0.35782725286305106,1
5539,Biological Process,GO:0051591,response to cAMP,0.01482159153796736,-0.35891904728866886,1
5540,Biological Process,GO:0075522,IRES-dependent viral translational initiation,0.014784714878384175,-0.35955334899087354,1
5541,Phenotype,HP:0010760,Absent toe,0.01475183656851864,-0.3601188765670977,1
5542,Biological Process,GO:0030855,epithelial cell differentiation,0.014748094346487606,-0.36018324513602834,1
5543,Phenotype,HP:0006695,Atrioventricular canal defect,0.014726122369958516,-0.3605611769300338,1
5544,Biological Process,GO:1900152,"negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",0.014693549028789166,-0.3611214588531729,1
5545,Biological Process,GO:0006364,rRNA processing,0.01469353490557812,-0.3611217017812718,1
5546,Phenotype,HP:0007549,Desquamation of skin soon after birth,0.01466842473374319,-0.361553612505225,1
5547,Phenotype,HP:0001227,Abnormality of the thenar eminence,0.014659607373279093,-0.36170527664223046,1
5548,Phenotype,HP:0005425,Recurrent sinopulmonary infections,0.014636867571998224,-0.3620964155041362,1
5549,Biological Process,GO:0014902,myotube differentiation,0.014635155444944314,-0.36212586516462497,1
5550,Biological Process,GO:0000154,rRNA modification,0.014541470847242333,-0.3637372990760583,1
5551,Phenotype,HP:0007833,Anterior chamber synechiae,0.014534894106377538,-0.36385042314891763,1
5552,Phenotype,HP:0001821,Broad nail,0.014478368570761457,-0.3648226978577597,1
5553,Phenotype,HP:0000653,Sparse eyelashes,0.014446455837713534,-0.3653716169063693,1
5554,Phenotype,HP:0030603,Abnormal optical coherence tomography,0.01443883825366199,-0.3655026441356573,1
5554,Phenotype,HP:0030612,Abnormal retinal morphology on macular OCT,0.01443883825366199,-0.3655026441356573,1
5556,Phenotype,HP:0001807,Ridged nail,0.01441456996976287,-0.3659200738584356,1
5557,Phenotype,HP:0009942,Duplication of thumb phalanx,0.014412771283063286,-0.3659510123991867,1
5558,Phenotype,HP:0009085,Alveolar ridge overgrowth,0.014367227847351893,-0.36673438809325737,1
5559,Phenotype,HP:0000980,Pallor,0.014366974763818097,-0.3667387412889671,1
5560,Phenotype,HP:0004926,Orthostatic hypotension due to autonomic dysfunction,0.014346760458525787,-0.36708644003393814,1
5561,Biological Process,GO:0031016,pancreas development,0.014343944981958345,-0.3671348679989282,1
5562,Biological Process,GO:0006891,intra-Golgi vesicle-mediated transport,0.014323199438674994,-0.3674917043709458,1
5563,Biological Process,GO:0043302,positive regulation of leukocyte degranulation,0.014278126911373756,-0.3682669801446462,1
5564,Phenotype,HP:0000073,Ureteral duplication,0.014277604051268433,-0.3682759736667974,1
5565,Biological Process,GO:0010837,regulation of keratinocyte proliferation,0.014269925900245783,-0.3684080426860225,1
5566,Phenotype,HP:0011488,Abnormal corneal endothelium morphology,0.014251630904646873,-0.3687227280990014,1
5567,Phenotype,HP:0003737,Mitochondrial myopathy,0.014236391295778916,-0.3689848589415218,1
5568,Biological Process,GO:0072527,pyrimidine-containing compound metabolic process,0.014222746718642099,-0.3692195542366372,1
5569,Biological Process,GO:0060392,negative regulation of SMAD protein signal transduction,0.014201352995874772,-0.3695875397028153,1
5570,Phenotype,HP:0007103,Hypointensity of cerebral white matter on MRI,0.014194955351937932,-0.3696975831960467,1
5571,Phenotype,HP:0011054,Agenesis of molar,0.014181027174148375,-0.36993715660048143,1
5572,Biological Process,GO:0061162,establishment of monopolar cell polarity,0.01415970462237326,-0.3703039178809004,1
5573,Phenotype,HP:0100544,Neoplasm of the heart,0.014144538283761832,-0.3705647884289971,1
5574,Phenotype,HP:0410030,Cleft lip,0.014127945144091547,-0.370850200851292,1
5575,Phenotype,HP:0002101,Abnormal lung lobation,0.0141054154566429,-0.3712377256233386,1
5576,Biological Process,GO:0006493,protein O-linked glycosylation,0.014089802669802198,-0.3715062753613342,1
5577,Biological Process,GO:0042254,ribosome biogenesis,0.014038398004105557,-0.3723904678918179,1
5578,Phenotype,HP:0001829,Foot polydactyly,0.0140242438815249,-0.3726339276885457,1
5579,Biological Process,GO:0035330,regulation of hippo signaling,0.014019564195406953,-0.37271442122846904,1
5580,Phenotype,HP:0006711,Aplasia/Hypoplasia involving bones of the thorax,0.014017758740021535,-0.372745476194867,1
5581,Disease,MONDO:0016106,progressive muscular dystrophy,0.01399933135977005,-0.3730624387070035,1
5582,Biological Process,GO:0006412,translation,0.013968839895545315,-0.37358691103934244,1
5583,Phenotype,HP:0012072,Aciduria,0.013941128052383012,-0.37406357214389363,1
5584,Biological Process,GO:0005976,polysaccharide metabolic process,0.013939878479334422,-0.37408506558502164,1
5585,Biological Process,GO:0006658,phosphatidylserine metabolic process,0.01393338395370769,-0.37419677550415775,1
5586,Phenotype,HP:0007375,Abnormal septum pellucidum morphology,0.013932093349972585,-0.37421897469885984,1
5587,Biological Process,GO:0061635,regulation of protein complex stability,0.013892133836561515,-0.37490630342283865,1
5588,Biological Process,GO:0071392,cellular response to estradiol stimulus,0.013872397958197835,-0.3752457729242003,1
5589,Phenotype,HP:0001239,Wrist flexion contracture,0.013854594562671463,-0.3755520025072222,1
5590,Phenotype,HP:0003100,Slender long bone,0.013850271557470983,-0.3756263609113808,1
5591,Biological Process,GO:0070509,calcium ion import,0.01379341649682897,-0.3766043036576002,1
5592,Biological Process,GO:0090049,regulation of cell migration involved in sprouting angiogenesis,0.013788936179222722,-0.3766813679339252,1
5593,Phenotype,HP:0005994,Nodular goiter,0.013777973140686628,-0.3768699390811869,1
5594,Phenotype,HP:0003418,Back pain,0.01377203356284451,-0.376972103549938,1
5595,Phenotype,HP:0011767,Abnormality of the parathyroid physiology,0.013766316725606909,-0.3770704367404174,1
5596,Phenotype,HP:0000609,Optic nerve hypoplasia,0.013751461127148978,-0.37732596236273896,1
5597,Biological Process,GO:0140056,organelle localization by membrane tethering,0.013749426230725503,-0.37736096385907325,1
5598,Phenotype,HP:0001789,Hydrops fetalis,0.013718288720411254,-0.3778965485898483,1
5599,Disease,MONDO:0020066,Ehlers-Danlos syndrome,0.013661823956590768,-0.3788677779856434,1
5600,Phenotype,HP:0003273,Hip contracture,0.013619657706312127,-0.3795930639695053,1
5601,Phenotype,HP:0003403,EMG,0.01359719430294426,-0.3799794486137382,1
5602,Phenotype,HP:0011013,Abnormal circulating carbohydrate concentration,0.013586781952083404,-0.3801585475871714,1
5603,Phenotype,HP:0012428,Prominent calcaneus,0.013523486733290957,-0.38124726509779355,1
5604,Disease,MONDO:0018778,intermediate Charcot-Marie-Tooth disease,0.013522959455968375,-0.38125633459885544,1
5605,Phenotype,HP:0003956,Bowed forearm bones,0.013516321431761513,-0.38137051278368234,1
5606,Phenotype,HP:0010930,Abnormal blood monovalent inorganic cation concentration,0.013508319065890562,-0.38150815850189496,1
5607,Phenotype,HP:0012691,Focal T2 hypointense thalamic lesion,0.013448038855456868,-0.38254501597541685,1
5607,Phenotype,HP:0011752,Neoplasm of the posterior pituitary,0.013448038855456868,-0.38254501597541685,1
5607,Phenotype,HP:0100010,Spinal meningioma,0.013448038855456868,-0.38254501597541685,1
5607,Phenotype,HP:0030591,Abnormal kinetic perimetry test,0.013448038855456868,-0.38254501597541685,1
5607,Phenotype,HP:0100009,Intracranial meningioma,0.013448038855456868,-0.38254501597541685,1
5612,Phenotype,HP:3000036,Abnormal head blood vessel morphology,0.01342947599459754,-0.3828643088390858,1
5613,Biological Process,GO:0031623,receptor internalization,0.013422999916604339,-0.38297570144734067,1
5614,Biological Process,GO:0030859,polarized epithelial cell differentiation,0.013383504970174598,-0.3836550393275073,1
5615,Phenotype,HP:0002539,Cortical dysplasia,0.013337601292099821,-0.3844446114164489,1
5616,Phenotype,HP:0008202,Reduced circulating prolactin concentration,0.01330621945248378,-0.38498439876464585,1
5617,Phenotype,HP:0000677,Oligodontia,0.013304881566283622,-0.38500741124743876,1
5618,Phenotype,HP:0100780,Conjunctival hamartoma,0.01323749569918109,-0.3861664904777919,1
5619,Phenotype,HP:0001283,Bulbar palsy,0.013213950960579757,-0.3865714747670847,1
5620,Disease,MONDO:0005144,familial amyotrophic lateral sclerosis,0.013186765233733966,-0.38703908634060746,1
5620,Disease,MONDO:0004976,amyotrophic lateral sclerosis,0.013186765233733966,-0.38703908634060746,1
5622,Biological Process,GO:1903541,regulation of exosomal secretion,0.013185888531855428,-0.38705416616345933,1
5623,Phenotype,HP:0030914,Abnormal peristalsis,0.013164200467696618,-0.38742721448640804,1
5624,Phenotype,HP:0012862,Abnormal germ cell morphology,0.013143557909488068,-0.3877822794504676,1
5624,Phenotype,HP:0012863,Abnormal male germ cell morphology,0.013143557909488068,-0.3877822794504676,1
5626,Biological Process,GO:0033617,mitochondrial cytochrome c oxidase assembly,0.013141963732541506,-0.38780970029504114,1
5627,Phenotype,HP:0012087,Abnormal mitochondrial shape,0.013091487347417052,-0.38867792581675237,1
5628,Phenotype,HP:0002487,Hyperkinetic movements,0.013072750573219993,-0.3890002100990424,1
5629,Biological Process,GO:0002181,cytoplasmic translation,0.013054048146280639,-0.38932190358693086,1
5630,Phenotype,HP:0025579,Abnormal left atrium morphology,0.013029507537722473,-0.389744017464856,1
5631,Biological Process,GO:0045922,negative regulation of fatty acid metabolic process,0.013016594578534324,-0.3899661284718214,1
5632,Biological Process,GO:0046579,positive regulation of Ras protein signal transduction,0.012999578982733406,-0.39025880740485225,1
5633,Biological Process,GO:0046885,regulation of hormone biosynthetic process,0.012994908300086094,-0.39033914607942677,1
5634,Phenotype,HP:0030984,Abnormal serum bile acid concentration,0.012974871486993611,-0.3906837918471013,1
5635,Biological Process,GO:0019348,dolichol metabolic process,0.012958334128240323,-0.3909682448025952,1
5636,Biological Process,GO:0045740,positive regulation of DNA replication,0.012949201943851296,-0.3911253241088089,1
5637,Phenotype,HP:0100729,Large face,0.012942694749741968,-0.3912372519338011,1
5638,Biological Process,GO:1990840,response to lectin,0.01293900262834069,-0.39130075874043835,1
5638,Biological Process,GO:1990858,cellular response to lectin,0.01293900262834069,-0.39130075874043835,1
5638,Biological Process,GO:0002223,stimulatory C-type lectin receptor signaling pathway,0.01293900262834069,-0.39130075874043835,1
5641,Phenotype,HP:0009140,Synostosis involving bones of the feet,0.012883799215546388,-0.39225029210649465,1
5641,Phenotype,HP:0009138,Synostosis involving bones of the lower limbs,0.012883799215546388,-0.39225029210649465,1
5643,Phenotype,HP:0000828,Abnormality of the parathyroid gland,0.012856956517948492,-0.3927120033615421,1
5644,Phenotype,HP:0011133,Increased sensitivity to ionizing radiation,0.012840984794086019,-0.39298672704171317,1
5645,Phenotype,HP:0010845,EEG with generalized slow activity,0.01283488701548019,-0.39309161266294523,1
5646,Biological Process,GO:1900369,negative regulation of post-transcriptional gene silencing by regulatory ncRNA,0.012832146915671472,-0.39313874410035105,1
5646,Biological Process,GO:0060967,negative regulation of gene silencing by regulatory ncRNA,0.012832146915671472,-0.39313874410035105,1
5646,Biological Process,GO:0060965,negative regulation of miRNA-mediated gene silencing,0.012832146915671472,-0.39313874410035105,1
5646,Biological Process,GO:0060149,negative regulation of post-transcriptional gene silencing,0.012832146915671472,-0.39313874410035105,1
5650,Biological Process,GO:1902018,negative regulation of cilium assembly,0.012828505571452764,-0.3932013775075616,1
5651,Biological Process,GO:0019953,sexual reproduction,0.01282550912766911,-0.39325291822231223,1
5652,Biological Process,GO:0002092,positive regulation of receptor internalization,0.012791707043979583,-0.3938343352884097,1
5653,Biological Process,GO:0007498,mesoderm development,0.012787434534632824,-0.3939078251321745,1
5654,Phenotype,HP:0100520,Oliguria,0.012758825486190228,-0.39439991873096314,1
5655,Phenotype,HP:0006335,Persistence of primary teeth,0.012738765546326802,-0.39474496229362077,1
5656,Phenotype,HP:0012100,Abnormal circulating creatinine concentration,0.012708660394895266,-0.3952627898033245,1
5657,Phenotype,HP:0000594,Shallow anterior chamber,0.012689284145083302,-0.3955960734677613,1
5658,Disease,MONDO:0015770,congenital hypogonadotropic hypogonadism,0.012683515456195948,-0.3956952985391776,1
5659,Phenotype,HP:0000602,Ophthalmoplegia,0.012660418721656908,-0.3960925768772667,1
5660,Biological Process,GO:2000765,regulation of cytoplasmic translation,0.012657263423398346,-0.3961468499887413,1
5661,Biological Process,GO:2000738,positive regulation of stem cell differentiation,0.012646357393899743,-0.39633444054475825,1
5662,Phenotype,HP:0001355,Megalencephaly,0.012645952270389227,-0.39634140892354386,1
5663,Phenotype,HP:0012114,Endometrial carcinoma,0.012643688431757671,-0.39638034836962555,1
5664,Phenotype,HP:0008765,Auditory hallucination,0.01264268692787529,-0.3963975748653152,1
5665,Phenotype,HP:0002100,Recurrent aspiration pneumonia,0.012630182846382842,-0.3966126529191523,1
5666,Disease,MONDO:0021154,dermis disorder,0.012572589360796083,-0.39760329703812886,1
5667,Biological Process,GO:0046903,secretion,0.012570767659264903,-0.39763463144843597,1
5668,Phenotype,HP:0030339,Decreased circulating gonadotropin concentration,0.012559350269021996,-0.3978310177303733,1
5669,Phenotype,HP:0003097,Short femur,0.012551046532196963,-0.3979738472182475,1
5670,Phenotype,HP:0011902,Abnormal hemoglobin,0.01253371259738889,-0.39827200178210825,1
5671,Phenotype,HP:0001278,Orthostatic hypotension,0.012518849662773834,-0.3985276535909393,1
5672,Phenotype,HP:0040012,Chromosome breakage,0.012495624249911685,-0.3989271452769917,1
5673,Phenotype,HP:0002714,Downturned corners of mouth,0.012485178316623102,-0.3991068218892705,1
5674,Phenotype,HP:0011960,Substantia nigra gliosis,0.012474078280751422,-0.39929774947673424,1
5675,Phenotype,HP:0025018,Abnormal capillary physiology,0.012441413894422881,-0.39985959743378485,1
5676,Disease,MONDO:0002921,congenital structural myopathy,0.012436900739017931,-0.3999372265408686,1
5677,Phenotype,HP:0002490,Increased CSF lactate,0.012425532678095874,-0.4001327643275101,1
5677,Phenotype,HP:0030085,Abnormal CSF lactate concentration,0.012425532678095874,-0.4001327643275101,1
5679,Biological Process,GO:0060966,regulation of gene silencing by regulatory ncRNA,0.012421441405262579,-0.4002031367894325,1
5679,Biological Process,GO:0060964,regulation of miRNA-mediated gene silencing,0.012421441405262579,-0.4002031367894325,1
5679,Biological Process,GO:0060147,regulation of post-transcriptional gene silencing,0.012421441405262579,-0.4002031367894325,1
5679,Biological Process,GO:1900368,regulation of post-transcriptional gene silencing by regulatory ncRNA,0.012421441405262579,-0.4002031367894325,1
5683,Biological Process,GO:1901136,carbohydrate derivative catabolic process,0.01239320349060924,-0.4006888466539857,1
5684,Phenotype,HP:0012206,Abnormal sperm motility,0.0123773831390942,-0.4009609666347239,1
5684,Phenotype,HP:0034809,Abnormal sperm physiology,0.0123773831390942,-0.4009609666347239,1
5686,Phenotype,HP:0200021,Down-sloping shoulders,0.012358625729054662,-0.4012836058664632,1
5687,Phenotype,HP:0100019,Cortical cataract,0.012357176809599246,-0.40130852819097185,1
5688,Phenotype,HP:0010732,Nodular changes affecting the eyelids,0.012322082241941756,-0.4019121767929573,1
5689,Phenotype,HP:0009145,Abnormal cerebral artery morphology,0.012309081965312663,-0.40213578971473957,1
5690,Biological Process,GO:0008380,RNA splicing,0.012286779975510198,-0.402519397944285,1
5691,Phenotype,HP:0004213,Abnormal 5th finger phalanx morphology,0.012252023883279173,-0.4031172245563834,1
5692,Phenotype,HP:0010767,Sacrococcygeal pilonidal abnormality,0.012251713089660221,-0.4031225704017979,1
5693,Disease,MONDO:0004981,atrial fibrillation,0.01223486347888647,-0.40341239428812814,1
5693,Disease,MONDO:0018054,familial atrial fibrillation,0.01223486347888647,-0.40341239428812814,1
5695,Phenotype,HP:0002901,Hypocalcemia,0.012221042532356341,-0.4036501232475629,1
5696,Phenotype,HP:0004122,Midline defect of the nose,0.012201464458649669,-0.4039868784097277,1
5697,Biological Process,GO:0072663,establishment of protein localization to peroxisome,0.012187256855806461,-0.4042312581005553,1
5697,Biological Process,GO:0072662,protein localization to peroxisome,0.012187256855806461,-0.4042312581005553,1
5699,Biological Process,GO:0046888,negative regulation of hormone secretion,0.012182120729096857,-0.40431960270528533,1
5700,Biological Process,GO:0071300,cellular response to retinoic acid,0.012174723412923139,-0.4044468411887535,1
5701,Biological Process,GO:0006984,ER-nucleus signaling pathway,0.012123105938292023,-0.40533469416654744,1
5702,Biological Process,GO:0032728,positive regulation of interferon-beta production,0.012113631119952895,-0.4054976669918662,1
5703,Biological Process,GO:1903829,positive regulation of protein localization,0.012110131267892177,-0.4055578666451067,1
5704,Biological Process,GO:0071466,cellular response to xenobiotic stimulus,0.012109851449077946,-0.40556267970442883,1
5705,Phenotype,HP:0000039,Epispadias,0.012088310741249386,-0.4059331934059621,1
5706,Phenotype,HP:0010574,Abnormality of the epiphysis of the femoral head,0.012058451656504654,-0.40644678841413073,1
5707,Phenotype,HP:0011623,Muscular ventricular septal defect,0.012047642679057224,-0.4066327096139219,1
5708,Phenotype,HP:0004220,Short middle phalanx of the 5th finger,0.012039943504097428,-0.40676514025806837,1
5709,Biological Process,GO:2000144,positive regulation of DNA-templated transcription initiation,0.011973276481481943,-0.40791185491183274,1
5710,Phenotype,HP:0200055,Small hand,0.011938305493281565,-0.4085133778695519,1
5711,Phenotype,HP:0012865,Abnormal sperm head morphology,0.011873348102473869,-0.4096306857826277,1
5712,Phenotype,HP:0006897,Abducens palsy,0.011833752476680504,-0.41031175541107207,1
5713,Biological Process,GO:0032233,positive regulation of actin filament bundle assembly,0.01183043995142552,-0.4103687329256187,1
5714,Biological Process,GO:0050435,amyloid-beta metabolic process,0.011828526790587324,-0.4104016404934401,1
5715,Phenotype,HP:0001081,Cholelithiasis,0.011817187725049916,-0.4105966795412574,1
5716,Phenotype,HP:0006499,Abnormal femoral epiphysis morphology,0.011791183802949634,-0.4110439633310215,1
5717,Biological Process,GO:0007276,gamete generation,0.011776532650202953,-0.4112959723587241,1
5718,Phenotype,HP:0000056,Abnormal clitoris morphology,0.011760945706779435,-0.41156407757371527,1
5719,Phenotype,HP:0005263,Gastritis,0.011732151514706746,-0.41205935575920594,1
5720,Biological Process,GO:0097006,regulation of plasma lipoprotein particle levels,0.011712712491390054,-0.4123937191673438,1
5721,Phenotype,HP:0012248,Prolonged PR interval,0.011668115972827797,-0.4131608072918153,1
5722,Disease,MONDO:0018772,Joubert syndrome,0.011612222909104908,-0.4141222030869222,1
5723,Biological Process,GO:0035308,negative regulation of protein dephosphorylation,0.011608526901576544,-0.4141857767373857,1
5724,Biological Process,GO:0098719,sodium ion import across plasma membrane,0.011602206827653894,-0.4142944859776615,1
5725,Biological Process,GO:0045668,negative regulation of osteoblast differentiation,0.011594971162420031,-0.41441894396345247,1
5726,Phenotype,HP:0002380,Fasciculations,0.011521337630973738,-0.4156854869438536,1
5727,Biological Process,GO:1902369,negative regulation of RNA catabolic process,0.011494481334309414,-0.4161474321113834,1
5728,Phenotype,HP:0009119,Aplasia/Hypoplasia of the frontal sinuses,0.011487076487386894,-0.41627480012846,1
5729,Phenotype,HP:0002126,Polymicrogyria,0.011478840989404326,-0.416416455865392,1
5730,Biological Process,GO:0006366,transcription by RNA polymerase II,0.011459088645017101,-0.41675620859269874,1
5731,Phenotype,HP:0040171,Decreased serum testosterone concentration,0.011450862618446078,-0.4168977014154044,1
5732,Phenotype,HP:0012286,Abnormal hypothalamus morphology,0.011436608488009314,-0.41714288141005906,1
5733,Phenotype,HP:0000519,Developmental cataract,0.011413188193448054,-0.4175457251837157,1
5734,Phenotype,HP:0001305,Dandy-Walker malformation,0.01130980629375855,-0.4193239587789328,1
5735,Phenotype,HP:0003259,Elevated circulating creatinine concentration,0.011289136348716533,-0.41967949481372613,1
5736,Disease,MONDO:0100172,"intellectual disability, autosomal dominant",0.011273270381436773,-0.41995239941426277,1
5737,Phenotype,HP:0030272,Abnormal erythrocyte enzyme concentration or activity,0.011231077571544623,-0.4206781422401556,1
5738,Biological Process,GO:0086019,cell-cell signaling involved in cardiac conduction,0.011228103788033517,-0.4207292931839885,1
5739,Phenotype,HP:0009136,Duplication involving bones of the feet,0.011199075274486048,-0.42122860184599176,1
5740,Phenotype,HP:0010781,Skin dimple,0.011191348230743858,-0.4213615118506961,1
5741,Phenotype,HP:0012202,Increased serum bile acid concentration,0.011189712006331898,-0.4213896559380789,1
5742,Disease,MONDO:0015909,aplastic anemia,0.011143551482200476,-0.4221836459404861,1
5743,Biological Process,GO:1905037,autophagosome organization,0.011089530616920862,-0.4231128387466873,1
5744,Biological Process,GO:0006879,intracellular iron ion homeostasis,0.011088622519595748,-0.4231284585909356,1
5745,Biological Process,GO:1903313,positive regulation of mRNA metabolic process,0.011082240122636033,-0.42323823982658576,1
5746,Phenotype,HP:0000995,Melanocytic nevus,0.011067606863297552,-0.4234899410764309,1
5747,Biological Process,GO:1903747,regulation of establishment of protein localization to mitochondrion,0.011063449847094176,-0.42356144436560345,1
5748,Phenotype,HP:0008726,Hypoplasia of the vagina,0.011046066375352881,-0.42386045099582326,1
5749,Biological Process,GO:0007422,peripheral nervous system development,0.011027147483773092,-0.4241858678114601,1
5750,Biological Process,GO:0050907,detection of chemical stimulus involved in sensory perception,0.01102303912234015,-0.42425653420802756,1
5750,Biological Process,GO:0050912,detection of chemical stimulus involved in sensory perception of taste,0.01102303912234015,-0.42425653420802756,1
5752,Phenotype,HP:0011267,"Microtia, third degree",0.011016390531853548,-0.4243708941395013,1
5753,Phenotype,HP:0032046,Focal cortical dysplasia,0.010985837162742484,-0.4248964312747594,1
5754,Phenotype,HP:0010958,Bilateral renal agenesis,0.010952643019031982,-0.4254673913914506,1
5755,Biological Process,GO:0044042,glucan metabolic process,0.010952165209755726,-0.4254756100110513,1
5756,Phenotype,HP:0011051,Agenesis of premolar,0.010935282089592269,-0.42576601027992733,1
5756,Phenotype,HP:0011076,Abnormality of premolar,0.010935282089592269,-0.42576601027992733,1
5758,Phenotype,HP:0045075,Sparse eyebrow,0.010923286469533555,-0.4259723424778066,1
5759,Phenotype,HP:0030051,Tip-toe gait,0.01091969609124499,-0.4260340992390137,1
5760,Biological Process,GO:0030838,positive regulation of actin filament polymerization,0.010905175992062421,-0.42628385406311614,1
5761,Biological Process,GO:0035601,protein deacylation,0.010897568928577961,-0.4264147003320437,1
5761,Biological Process,GO:0098732,macromolecule deacylation,0.010897568928577961,-0.4264147003320437,1
5763,Biological Process,GO:1990573,potassium ion import across plasma membrane,0.010892443960026643,-0.42650285300944424,1
5764,Phenotype,HP:0030255,Large intestinal polyposis,0.010860055525917511,-0.4270599544150318,1
5765,Phenotype,HP:0001761,Pes cavus,0.01085464521656565,-0.42715301513338666,1
5766,Phenotype,HP:0002619,Varicose veins,0.010810812900298727,-0.42790695849848365,1
5767,Biological Process,GO:0051017,actin filament bundle assembly,0.010802418738229624,-0.4280513433573401,1
5768,Biological Process,GO:1905818,regulation of chromosome separation,0.010797913628394995,-0.42812883407556196,1
5769,Biological Process,GO:0042339,keratan sulfate metabolic process,0.010788042385141083,-0.42829862565835725,1
5770,Biological Process,GO:0007589,body fluid secretion,0.010779309211203514,-0.42844884173423997,1
5771,Phenotype,HP:0011999,Paranoia,0.010751614847204327,-0.42892520218620916,1
5772,Biological Process,GO:0046626,regulation of insulin receptor signaling pathway,0.01074260332142185,-0.42908020608862046,1
5773,Biological Process,GO:0150105,protein localization to cell-cell junction,0.01072099511413549,-0.42945188082321545,1
5774,Biological Process,GO:0051056,regulation of small GTPase mediated signal transduction,0.010712619783183497,-0.42959594177503224,1
5775,Phenotype,HP:0009792,Teratoma,0.01069164077502538,-0.4299567938895043,1
5776,Phenotype,HP:0032653,Elevated lactate:pyruvate ratio,0.010661447384337386,-0.4304761391698306,1
5777,Biological Process,GO:0071474,cellular hyperosmotic response,0.01062024706304232,-0.43118481056860214,1
5777,Biological Process,GO:0006972,hyperosmotic response,0.01062024706304232,-0.43118481056860214,1
5779,Biological Process,GO:0007409,axonogenesis,0.01058033926312485,-0.4318712497880166,1
5780,Phenotype,HP:0003019,Abnormality of the wrist,0.010579106406143679,-0.43189245570228785,1
5781,Biological Process,GO:0044058,regulation of digestive system process,0.010573611088550927,-0.43198697861576857,1
5782,Disease,MONDO:0033885,"mitochondrial complex IV deficiency, nuclear-type",0.010564159406959317,-0.43214955347450085,1
5783,Phenotype,HP:0002037,Inflammation of the large intestine,0.01054388864529432,-0.4324982233045349,1
5784,Biological Process,GO:0050885,neuromuscular process controlling balance,0.010538214713083471,-0.43259581850161116,1
5785,Phenotype,HP:0004689,Short fourth metatarsal,0.010521727846454887,-0.4328794029608527,1
5785,Phenotype,HP:0040035,Abnormality of the fourth metatarsal bone,0.010521727846454887,-0.4328794029608527,1
5787,Phenotype,HP:0008921,Neonatal short-limb short stature,0.010521477669130253,-0.43288370616793986,1
5788,Phenotype,HP:0005871,Metaphyseal chondrodysplasia,0.010472508712321638,-0.43372600297600145,1
5789,Biological Process,GO:1902117,positive regulation of organelle assembly,0.010456749585091463,-0.4339970698605931,1
5790,Phenotype,HP:0010508,Metatarsus valgus,0.010449410377922241,-0.4341233088326933,1
5791,Phenotype,HP:0010639,Elevated alkaline phosphatase of bone origin,0.010399529603578817,-0.43498128947494613,1
5792,Phenotype,HP:0031911,Abnormal fifth cranial nerve physiology,0.010343558193276148,-0.43594403288042444,1
5792,Phenotype,HP:0100661,Trigeminal neuralgia,0.010343558193276148,-0.43594403288042444,1
5792,Phenotype,HP:0033345,Neuralgia,0.010343558193276148,-0.43594403288042444,1
5795,Phenotype,HP:0031908,Micrographia,0.01034200995000456,-0.4359706636369434,1
5796,Biological Process,GO:0030857,negative regulation of epithelial cell differentiation,0.010306561877926002,-0.43658039273696087,1
5797,Biological Process,GO:0031113,regulation of microtubule polymerization,0.010266467303389204,-0.43727004459711627,1
5798,Biological Process,GO:0006487,protein N-linked glycosylation,0.010259665166931109,-0.4373870456157217,1
5799,Phenotype,HP:0008994,Proximal muscle weakness in lower limbs,0.010246290967110605,-0.43761709025120815,1
5800,Biological Process,GO:0007007,inner mitochondrial membrane organization,0.010226569409801378,-0.43795631342144004,1
5801,Biological Process,GO:0065005,protein-lipid complex assembly,0.010226530789542054,-0.4379569777141527,1
5802,Disease,MONDO:0044970,mitochondrial disease,0.010184697531918196,-0.4386765360152435,1
5803,Biological Process,GO:0051784,negative regulation of nuclear division,0.010181602792382338,-0.4387297674786586,1
5804,Phenotype,HP:0000151,Aplasia of the uterus,0.010174102638347948,-0.43885877483790925,1
5805,Phenotype,HP:0009832,Abnormal distal phalanx morphology of finger,0.010170678175688064,-0.4389176777461133,1
5806,Phenotype,HP:0033683,Jaw hyperreflexia,0.010165936370607809,-0.43899923977119704,1
5807,Phenotype,HP:0000618,Blindness,0.010153736713793271,-0.4392090815294051,1
5808,Phenotype,HP:0010577,Absent epiphyses,0.010152657817873112,-0.43922763921674424,1
5809,Phenotype,HP:0011231,Prominent eyelashes,0.01013898180118078,-0.43946287529195754,1
5810,Phenotype,HP:0000803,Renal cortical cysts,0.010128881682081259,-0.4396366036830241,1
5811,Biological Process,GO:0000413,protein peptidyl-prolyl isomerization,0.010127584523842992,-0.4396589156192966,1
5812,Phenotype,HP:0008314,Decreased activity of mitochondrial complex II,0.010110584277780554,-0.43995133052718643,1
5813,Disease,MONDO:0017198,osteopetrosis,0.01001212127448925,-0.4416449560154434,1
5814,Biological Process,GO:0000271,polysaccharide biosynthetic process,0.010005000657058893,-0.4417674351067677,1
5815,Phenotype,HP:0004386,Gastrointestinal inflammation,0.00997005480991886,-0.4423685256224611,1
5816,Phenotype,HP:0100633,Esophagitis,0.009968920963259964,-0.4423880284970139,1
5817,Phenotype,HP:0011196,EEG with focal sharp waves,0.009966012845370464,-0.4424380499509192,1
5818,Phenotype,HP:0003800,Muscle abnormality related to mitochondrial dysfunction,0.009921131115892434,-0.4432100438822455,1
5819,Biological Process,GO:0010876,lipid localization,0.009884981258396208,-0.44383184413214577,1
5820,Phenotype,HP:0010655,Epiphyseal stippling,0.009879866093968515,-0.4439198281724633,1
5821,Biological Process,GO:0065002,intracellular protein transmembrane transport,0.009863577056943407,-0.44420000983829433,1
5822,Phenotype,HP:0000029,Testicular atrophy,0.009846665158119161,-0.44449090511820805,1
5823,Phenotype,HP:0005144,Ventricular septal hypertrophy,0.009826453387470346,-0.4448385602657193,1
5824,Phenotype,HP:0008368,Tarsal synostosis,0.009816445614027836,-0.4450107002534951,1
5825,Phenotype,HP:0000180,Lobulated tongue,0.00979226767146646,-0.4454265760485327,1
5826,Phenotype,HP:0004442,Sagittal craniosynostosis,0.009738184114234993,-0.44635684719567437,1
5827,Phenotype,HP:0020085,Infection following live vaccination,0.009724816598149388,-0.4465867768667233,1
5828,Biological Process,GO:0048255,mRNA stabilization,0.009618003751890702,-0.44842402489745614,1
5829,Biological Process,GO:0031018,endocrine pancreas development,0.00960611745478468,-0.4486284766718977,1
5830,Biological Process,GO:1903312,negative regulation of mRNA metabolic process,0.009589783076807579,-0.4489094382305757,1
5831,Biological Process,GO:0035089,establishment of apical/basal cell polarity,0.009558515765864084,-0.4494472556136845,1
5832,Disease,MONDO:0017757,disorder of metabolite absorption and transport,0.009509543709579571,-0.4502896057346779,1
5833,Phenotype,HP:0010665,Bilateral coxa valga,0.009503795210901167,-0.45038848352182154,1
5834,Phenotype,HP:0003763,Bruxism,0.009483700656992444,-0.45073412246779476,1
5835,Phenotype,HP:0008981,Calf muscle hypertrophy,0.009465043702725051,-0.4510550337971701,1
5836,Biological Process,GO:0038093,Fc receptor signaling pathway,0.009431793061480787,-0.45162696570692074,1
5837,Biological Process,GO:0045948,positive regulation of translational initiation,0.009399272313560747,-0.45218634299314475,1
5838,Biological Process,GO:0045727,positive regulation of translation,0.009389166963108098,-0.45236016136677026,1
5839,Phenotype,HP:0003828,Variable expressivity,0.009374287662165637,-0.45261609468671016,1
5839,Phenotype,HP:0003812,Phenotypic variability,0.009374287662165637,-0.45261609468671016,1
5841,Phenotype,HP:0430106,Abnormal brain-evoked potentials,0.009352711637445998,-0.45298721586094787,1
5842,Phenotype,HP:0000325,Triangular face,0.009297113909013444,-0.45394353170359986,1
5843,Biological Process,GO:0010812,negative regulation of cell-substrate adhesion,0.009265711136784094,-0.4544836791058907,1
5844,Biological Process,GO:0051656,establishment of organelle localization,0.009238902192250875,-0.45494480978702984,1
5845,Phenotype,HP:0100957,Abnormal renal medulla morphology,0.009236413742769178,-0.45498761268078247,1
5846,Phenotype,HP:0004493,Craniofacial hyperostosis,0.009219238154217213,-0.45528304358960175,1
5847,Biological Process,GO:0007288,sperm axoneme assembly,0.009182240514791218,-0.45591942622107423,1
5848,Phenotype,HP:0000647,Sclerocornea,0.009178148397709252,-0.45598981320460397,1
5849,Phenotype,HP:0000445,Wide nose,0.00916497240557368,-0.4562164485434414,1
5850,Phenotype,HP:0100711,Abnormal thoracic spine morphology,0.009145817249234689,-0.45654592926130333,1
5851,Phenotype,HP:0010693,Pulverulent cataract,0.009132314398360042,-0.4567781867757098,1
5852,Phenotype,HP:0012539,Non-Hodgkin lymphoma,0.009114739515619585,-0.45708048579531524,1
5853,Phenotype,HP:0006261,Abnormal phalangeal joint morphology of the hand,0.009110788324422026,-0.45714844876513616,1
5854,Biological Process,GO:0001738,morphogenesis of a polarized epithelium,0.009102076187840757,-0.45729830298527974,1
5855,Biological Process,GO:0034375,high-density lipoprotein particle remodeling,0.009081432257810107,-0.4576533915455409,1
5856,Biological Process,GO:0006213,pyrimidine nucleoside metabolic process,0.009070231983054233,-0.45784604330475964,1
5857,Disease,MONDO:0005020,intestinal disorder,0.009062451408712646,-0.4579798740693891,1
5858,Phenotype,HP:0000778,Hypoplasia of the thymus,0.009050835231843912,-0.4581796796061224,1
5859,Biological Process,GO:0060021,roof of mouth development,0.00903413889764304,-0.4584668670391463,1
5860,Phenotype,HP:0004878,Intercostal muscle weakness,0.008970958512310556,-0.45955360934214534,1
5861,Phenotype,HP:0033036,Decreased nasal nitric oxide,0.008926438976415985,-0.46031937331639,1
5862,Biological Process,GO:0061339,establishment or maintenance of monopolar cell polarity,0.008920635706917479,-0.4604191931960337,1
5863,Phenotype,HP:0100324,Scleroderma,0.008916557523544477,-0.46048934051101925,1
5864,Biological Process,GO:0008535,respiratory chain complex IV assembly,0.00890313545100907,-0.4607202085872646,1
5865,Phenotype,HP:0100840,Aplasia/Hypoplasia of the eyebrow,0.008898962020736811,-0.4607919942087294,1
5866,Disease,MONDO:0002118,urinary system disorder,0.008886915122625738,-0.46099920842131026,1
5867,Phenotype,HP:0030973,Postexertional symptom exacerbation,0.008877707683713765,-0.4611575821525761,1
5868,Biological Process,GO:0015850,organic hydroxy compound transport,0.008862656547667713,-0.46141647114420475,1
5869,Phenotype,HP:0002009,Potter facies,0.008781381493000673,-0.46281445312263725,1
5870,Phenotype,HP:0004432,Agammaglobulinemia,0.008774627905785981,-0.46293061906376876,1
5871,Biological Process,GO:0036503,ERAD pathway,0.008774399644566167,-0.46293454530009037,1
5872,Biological Process,GO:0051095,regulation of helicase activity,0.008769628823836917,-0.4630166064125577,1
5873,Phenotype,HP:0012510,Extra-axial cerebrospinal fluid accumulation,0.008760462027864735,-0.4631742810597367,1
5874,Phenotype,HP:0005464,Craniofacial osteosclerosis,0.00874423493104115,-0.463453397315205,1
5875,Biological Process,GO:1902932,positive regulation of alcohol biosynthetic process,0.008734846140290853,-0.4636148904119733,1
5876,Phenotype,HP:0000890,Long clavicles,0.00871591135564298,-0.4639405805983616,1
5877,Biological Process,GO:0097306,cellular response to alcohol,0.008712390517690127,-0.4640011412221253,1
5878,Biological Process,GO:0140962,multicellular organismal-level chemical homeostasis,0.008667470532324195,-0.464773793178747,1
5879,Phenotype,HP:0010819,Atonic seizure,0.00865953602736913,-0.4649102716465918,1
5880,Phenotype,HP:0002304,Akinesia,0.00865875903146407,-0.4649236364640877,1
5881,Phenotype,HP:0032341,Reduced forced vital capacity,0.008626162532892168,-0.4654843167090928,1
5882,Phenotype,HP:0005107,Abnormal sacrum morphology,0.00860986215246562,-0.4657646934885519,1
5883,Phenotype,HP:0009767,Aplasia/Hypoplasia of the phalanges of the hand,0.008603174423338245,-0.4658797266292248,1
5884,Biological Process,GO:0038095,Fc-epsilon receptor signaling pathway,0.008588868341988243,-0.4661258002122106,1
5885,Biological Process,GO:0034311,diol metabolic process,0.008587342135458309,-0.46615205192293485,1
5886,Phenotype,HP:0000414,Bulbous nose,0.008581742049975305,-0.46624837690991877,1
5887,Biological Process,GO:0070585,protein localization to mitochondrion,0.008533155091140276,-0.46708410311295206,1
5888,Phenotype,HP:0030891,Periventricular white matter hyperintensities,0.008515204222966255,-0.46739286931812174,1
5889,Phenotype,HP:0008255,Transient neonatal diabetes mellitus,0.008464526110786852,-0.4682645646718563,1
5890,Biological Process,GO:0046037,GMP metabolic process,0.008456594805153483,-0.46840098810935893,1
5891,Phenotype,HP:0002067,Bradykinesia,0.008448257705535811,-0.4685443914582173,1
5892,Biological Process,GO:0006760,folic acid-containing compound metabolic process,0.008439334695064304,-0.46869787284169506,1
5893,Phenotype,HP:0002652,Skeletal dysplasia,0.008413965657755873,-0.4691342362143518,1
5894,Phenotype,HP:0004924,Abnormal oral glucose tolerance,0.008371116950117274,-0.46987126089336656,1
5895,Disease,MONDO:0018995,Charcot-Marie-Tooth disease type 4,0.008361241481522952,-0.4700411251546703,1
5896,Biological Process,GO:0007601,visual perception,0.008337396108310635,-0.47045128054806107,1
5897,Phenotype,HP:0000187,Broad alveolar ridges,0.008300767050610114,-0.4710813233423978,1
5898,Biological Process,GO:0016266,O-glycan processing,0.008295141095653547,-0.4711780933005722,1
5899,Phenotype,HP:0000243,Trigonocephaly,0.008263187141406836,-0.4717277213796865,1
5900,Biological Process,GO:0033047,regulation of mitotic sister chromatid segregation,0.008259936364422682,-0.4717836367851989,1
5901,Biological Process,GO:0010923,negative regulation of phosphatase activity,0.008241280293089459,-0.47210453292755206,1
5902,Phenotype,HP:0003083,Dislocated radial head,0.00823411195653545,-0.47222783281776926,1
5903,Phenotype,HP:0025722,Cerebral infarct,0.008200859562313312,-0.47279979487984014,1
5904,Phenotype,HP:0100879,Enlarged ovaries,0.008194930935088052,-0.47290177099110464,1
5905,Phenotype,HP:0001852,Sandal gap,0.00815967902915904,-0.4735081259101637,1
5906,Phenotype,HP:0008214,Decreased serum estradiol,0.00815879050153534,-0.4735234091432586,1
5907,Phenotype,HP:0006802,Abnormal anterior horn cell morphology,0.00814357537648025,-0.47378511884882263,1
5908,Phenotype,HP:0011526,Abnormality of lens shape,0.00813969892388855,-0.47385179626768925,1
5909,Disease,MONDO:0019222,inborn disorder of methionine cycle and sulfur amino acid metabolism,0.008133973869945188,-0.4739502707906676,1
5910,Biological Process,GO:0015919,peroxisomal membrane transport,0.008133162258386006,-0.47396423101915186,1
5910,Biological Process,GO:0043574,peroxisomal transport,0.008133162258386006,-0.47396423101915186,1
5912,Biological Process,GO:0170036,import into the mitochondrion,0.00812003909015191,-0.4741899577537122,1
5913,Phenotype,HP:0004100,Abnormal 2nd finger morphology,0.008087332835414074,-0.4747525258736947,1
5914,Phenotype,HP:0007688,Undetectable light- and dark-adapted electroretinogram,0.008059720444469676,-0.47522747633764506,1
5915,Phenotype,HP:0001708,Right ventricular failure,0.008035135714946295,-0.47565034912387844,1
5916,Phenotype,HP:0006336,Short dental root,0.008027241414203301,-0.4757861360540287,1
5917,Phenotype,HP:0031434,Abnormal prosody,0.007998492237773824,-0.47628063994218767,1
5918,Biological Process,GO:0007156,homophilic cell adhesion via plasma membrane adhesion molecules,0.007980343188699446,-0.4765928149832948,1
5919,Phenotype,HP:0012190,T-cell lymphoma,0.00797911468529644,-0.4766139460132877,1
5920,Phenotype,HP:0004415,Pulmonary artery stenosis,0.007976508214509348,-0.4766587789476068,1
5921,Phenotype,HP:0010821,Focal emotional seizure with laughing,0.007932300349082544,-0.4774191819940867,1
5922,Phenotype,HP:0007371,Corpus callosum atrophy,0.007926725532018342,-0.47751507234839946,1
5923,Phenotype,HP:0004338,Abnormal circulating aromatic amino acid concentration,0.007912091172562974,-0.4777667925209459,1
5924,Phenotype,HP:0001987,Hyperammonemia,0.007868699124121581,-0.47851316300296953,1
5925,Phenotype,HP:0006785,Limb-girdle muscular dystrophy,0.007851516092969302,-0.4788087219291879,1
5926,Phenotype,HP:0008445,Cervical spinal canal stenosis,0.00782809175383481,-0.479211635272044,1
5927,Phenotype,HP:0010828,Hemifacial spasm,0.007801431861718,-0.4796702021580207,1
5928,Phenotype,HP:0001100,Heterochromia iridis,0.007783626015465672,-0.4799764738950681,1
5928,Phenotype,HP:0200064,Asymmetry of iris pigmentation,0.007783626015465672,-0.4799764738950681,1
5930,Phenotype,HP:0010609,Skin tags,0.0077679323072569195,-0.4802464155314102,1
5931,Phenotype,HP:0008063,Aplasia/Hypoplasia of the lens,0.00776632916095521,-0.48027399065452464,1
5932,Phenotype,HP:0010045,Aplasia/Hypoplasia of the 5th metacarpal,0.007760972860873072,-0.4803661223795242,1
5933,Biological Process,GO:0034260,negative regulation of GTPase activity,0.007759838205677383,-0.4803856391614176,1
5934,Biological Process,GO:0045333,cellular respiration,0.007752105616571581,-0.4805186445498583,1
5935,Biological Process,GO:0045682,regulation of epidermis development,0.007749926147477604,-0.4805561327869123,1
5935,Biological Process,GO:0045604,regulation of epidermal cell differentiation,0.007749926147477604,-0.4805561327869123,1
5937,Phenotype,HP:0008955,Progressive distal muscular atrophy,0.007721717913854009,-0.4810413321191151,1
5938,Biological Process,GO:0032924,activin receptor signaling pathway,0.007706077630621588,-0.4813103548123151,1
5939,Phenotype,HP:0100716,Self-injurious behavior,0.007665745374290434,-0.48200409494859014,1
5940,Phenotype,HP:0001650,Aortic valve stenosis,0.007635978609741301,-0.48251610199142025,1
5941,Phenotype,HP:0011281,Abnormality of urine catecholamine level,0.007623831224234157,-0.4827250446503164,1
5941,Phenotype,HP:0011976,Elevated urinary catecholamine level,0.007623831224234157,-0.4827250446503164,1
5943,Biological Process,GO:0007084,mitotic nuclear membrane reassembly,0.007619135805338573,-0.48280580880389473,1
5943,Biological Process,GO:0101024,mitotic nuclear membrane organization,0.007619135805338573,-0.48280580880389473,1
5945,Phenotype,HP:0002099,Asthma,0.007611500866348098,-0.4829371345490307,1
5946,Phenotype,HP:0000528,Anophthalmia,0.007603210437949315,-0.4830797351236161,1
5947,Phenotype,HP:0003367,Abnormal femoral neck morphology,0.007600498856423443,-0.48312637602864844,1
5948,Phenotype,HP:0000998,Hypertrichosis,0.007598768547449897,-0.48315613842957267,1
5949,Phenotype,HP:0003042,Elbow dislocation,0.0075722479736552994,-0.48361230895291984,1
5950,Phenotype,HP:0200013,Neoplasm of fatty tissue,0.007569690687424968,-0.4836562958819763,1
5950,Phenotype,HP:0012031,Lipomatous tumor,0.007569690687424968,-0.4836562958819763,1
5952,Biological Process,GO:0060315,negative regulation of ryanodine-sensitive calcium-release channel activity,0.007552606086289271,-0.4839501617500985,1
5952,Biological Process,GO:0051280,negative regulation of release of sequestered calcium ion into cytosol,0.007552606086289271,-0.4839501617500985,1
5954,Biological Process,GO:0071173,spindle assembly checkpoint signaling,0.007548299514493095,-0.48402423748938334,1
5954,Biological Process,GO:0007094,mitotic spindle assembly checkpoint signaling,0.007548299514493095,-0.48402423748938334,1
5954,Biological Process,GO:0071174,mitotic spindle checkpoint signaling,0.007548299514493095,-0.48402423748938334,1
5957,Phenotype,HP:0005133,Right ventricular dilatation,0.00751692445093155,-0.4845639082851878,1
5958,Phenotype,HP:0007362,Aplasia/Hypoplasia of the brainstem,0.007501018589730735,-0.48483749908621876,1
5958,Phenotype,HP:0002365,Hypoplasia of the brainstem,0.007501018589730735,-0.48483749908621876,1
5960,Phenotype,HP:0000914,Shield chest,0.007483477299359165,-0.4851392202959844,1
5961,Biological Process,GO:0055070,copper ion homeostasis,0.007418172238163212,-0.48626250835806417,1
5962,Phenotype,HP:0007354,Amyotrophic lateral sclerosis,0.00740536875864839,-0.4864827362458986,1
5963,Phenotype,HP:0000437,Depressed nasal tip,0.007401357816120169,-0.48655172697612886,1
5964,Biological Process,GO:0019082,viral protein processing,0.007351845078972907,-0.487403377147492,1
5965,Biological Process,GO:0042552,myelination,0.007330868378105704,-0.4877641895751115,1
5966,Biological Process,GO:0016311,dephosphorylation,0.00732211660509996,-0.48791472556664645,1
5967,Phenotype,HP:0000089,Renal hypoplasia,0.007319396466315742,-0.48796151366189594,1
5968,Biological Process,GO:0006022,aminoglycan metabolic process,0.007313457017692593,-0.4880636759079997,1
5969,Phenotype,HP:0006488,Bowing of the arm,0.007310088662975334,-0.4881216137243566,1
5970,Phenotype,HP:0000476,Cystic hygroma,0.007307125710020901,-0.4881725783758134,1
5971,Biological Process,GO:0001778,plasma membrane repair,0.007290080765956275,-0.48846576211740983,1
5972,Biological Process,GO:0046655,folic acid metabolic process,0.007218715316775204,-0.4896932926585653,1
5973,Biological Process,GO:0003012,muscle system process,0.007210140718155178,-0.48984078113940605,1
5974,Phenotype,HP:0010318,Aplasia/Hypoplasia of the abdominal wall musculature,0.007197521837258747,-0.49005783381508206,1
5975,Biological Process,GO:0035196,miRNA processing,0.0071956325258323295,-0.4900903311580442,1
5976,Biological Process,GO:0072698,protein localization to microtubule cytoskeleton,0.007171462008027429,-0.49050607924260786,1
5977,Phenotype,HP:0001414,Microvesicular hepatic steatosis,0.007150453361728593,-0.4908674411517121,1
5978,Biological Process,GO:0045165,cell fate commitment,0.007130930596753404,-0.4912032449689632,1
5979,Phenotype,HP:0004303,Abnormal muscle fiber morphology,0.007126270414455238,-0.49128340303093854,1
5980,Phenotype,HP:0100842,Septo-optic dysplasia,0.007089126345745211,-0.49192230433804934,1
5981,Biological Process,GO:0051284,positive regulation of sequestering of calcium ion,0.007078703601063552,-0.49210158209172733,1
5982,Phenotype,HP:0000303,Mandibular prognathia,0.007073859823304662,-0.4921848981109192,1
5983,Biological Process,GO:0042634,regulation of hair cycle,0.007070517778044905,-0.49224238338808557,1
5984,Biological Process,GO:0005977,glycogen metabolic process,0.007067238356389338,-0.4922987914999342,1
5985,Biological Process,GO:1900426,positive regulation of defense response to bacterium,0.007056045193164495,-0.4924913209363534,1
5986,Biological Process,GO:0001573,ganglioside metabolic process,0.007051402710657517,-0.49257117455080535,1
5987,Phenotype,HP:0100266,Synostosis of carpals/tarsals,0.007040442042619555,-0.49275970492401056,1
5988,Phenotype,HP:0002510,Spastic tetraplegia,0.007018723191773768,-0.49313328279730834,1
5989,Phenotype,HP:0011474,Childhood onset sensorineural hearing impairment,0.0070175016199997,-0.4931542945989307,1
5990,Phenotype,HP:0003368,Abnormal femoral head morphology,0.006973511049709447,-0.4939109600326075,1
5991,Phenotype,HP:0011008,Temporal pattern,0.006956958021616999,-0.4941956825105748,1
5992,Phenotype,HP:0010013,Abnormal 5th metacarpal morphology,0.006945888361765018,-0.4943860876114245,1
5993,Biological Process,GO:0002042,cell migration involved in sprouting angiogenesis,0.006940580564190113,-0.4944773850628416,1
5994,Phenotype,HP:0030211,Slow pupillary light response,0.006910075289367268,-0.49500209494614067,1
5995,Phenotype,HP:0007010,Poor fine motor coordination,0.006908576343049644,-0.49502787776409457,1
5996,Phenotype,HP:0006143,Abnormal finger flexion crease,0.00688739326618848,-0.49539223998840776,1
5997,Phenotype,HP:0003680,Nonprogressive,0.006886895801071269,-0.4954007967008161,1
5998,Phenotype,HP:0002589,Gastrointestinal atresia,0.00686570848310375,-0.49576523187482185,1
5999,Biological Process,GO:0046599,regulation of centriole replication,0.006822489809722998,-0.49650862019692843,1
6000,Biological Process,GO:0050808,synapse organization,0.006798586612902446,-0.4969197701926922,1
6001,Biological Process,GO:0051653,spindle localization,0.006771058891276938,-0.497393264291188,1
6002,Phenotype,HP:0011461,Fetal onset,0.006758637327499373,-0.4976069229885106,1
6003,Biological Process,GO:2000649,regulation of sodium ion transmembrane transporter activity,0.006754770938872445,-0.49767342730086334,1
6004,Disease,MONDO:0019005,nephronophthisis,0.006753594310827227,-0.4976936660421262,1
6005,Phenotype,HP:0005349,Hypoplasia of the epiglottis,0.0067398467241522875,-0.49793013316598406,1
6006,Biological Process,GO:0008406,gonad development,0.0067047943227985796,-0.49853305648106533,1
6007,Phenotype,HP:0100502,Decreased circulating vitamin B12 concentration,0.006695249220298516,-0.4986972382380884,1
6008,Phenotype,HP:0001976,Reduced antithrombin III activity,0.006673360889911217,-0.49907373126592797,1
6009,Phenotype,HP:0033107,Abnormal circulating proteinogenic amino acid concentration,0.006658389338883297,-0.4993312513452679,1
6010,Biological Process,GO:0007176,regulation of epidermal growth factor-activated receptor activity,0.006638385527208968,-0.49967532946782633,1
6011,Biological Process,GO:0051938,L-glutamate import,0.006620527049937541,-0.4999825064914528,1
6012,Biological Process,GO:0032481,positive regulation of type I interferon production,0.006582000708304503,-0.500645183760863,1
6013,Phenotype,HP:0000786,Primary amenorrhea,0.006541683688035205,-0.5013386618273064,1
6014,Phenotype,HP:0034980,Synkinesis,0.006535666554521868,-0.5014421603023049,1
6014,Phenotype,HP:0001335,Bimanual synkinesia,0.006535666554521868,-0.5014421603023049,1
6016,Biological Process,GO:0046777,protein autophosphorylation,0.006523696969922388,-0.5016480446739359,1
6017,Phenotype,HP:0003130,Abnormal peripheral myelination,0.0065225366244181515,-0.501668003345269,1
6018,Phenotype,HP:0001105,Retinal atrophy,0.006518273725718893,-0.5017413278798616,1
6019,Phenotype,HP:0002198,Dilated fourth ventricle,0.006516455230621054,-0.5017726071375017,1
6019,Phenotype,HP:0010950,Abnormal fourth ventricle morphology,0.006516455230621054,-0.5017726071375017,1
6021,Phenotype,HP:0010476,Aplasia/Hypoplasia of the bladder,0.006436697943219216,-0.5031444825658629,1
6022,Disease,MONDO:0020121,muscular dystrophy,0.006423313826277033,-0.5033746977820699,1
6023,Disease,MONDO:0019391,Fanconi anemia,0.00642280567802378,-0.5033834382511269,1
6024,Biological Process,GO:1901879,regulation of protein depolymerization,0.006388263132426353,-0.5039775917270268,1
6025,Biological Process,GO:0034392,negative regulation of smooth muscle cell apoptotic process,0.006375049641082597,-0.5042048720757933,1
6026,Disease,MONDO:0020120,skeletal muscle disorder,0.006374738887294673,-0.5042102172360892,1
6027,Phenotype,HP:0032245,Abnormal metabolism,0.006356630208016467,-0.5045216978913512,1
6028,Disease,MONDO:0011060,early-onset non-syndromic cataract,0.006313382836783288,-0.5052655798345408,1
6029,Phenotype,HP:0030991,Sclerosing cholangitis,0.006304698522602181,-0.50541495549193,1
6030,Phenotype,HP:0001120,Abnormality of corneal size,0.006293469008991082,-0.5056081101778197,1
6031,Phenotype,HP:0003172,Abnormal pubic bone morphology,0.006288310269907171,-0.5056968437295877,1
6032,Phenotype,HP:0033095,Increased sulfur amino acid level in urine,0.006283721763039596,-0.5057757689291469,1
6033,Phenotype,HP:0001410,Decreased liver function,0.006283200941108014,-0.5057847273934298,1
6034,Phenotype,HP:0007941,Limited extraocular movements,0.006255858084331378,-0.5062550417004357,1
6035,Biological Process,GO:1902904,negative regulation of supramolecular fiber organization,0.006203090526971544,-0.5071626768233791,1
6036,Phenotype,HP:0012401,Abnormal urine alpha-ketoglutarate concentration,0.006146464559549036,-0.5081366790223597,1
6037,Phenotype,HP:0011039,Abnormal helix morphology,0.006142263493720379,-0.5082089399927489,1
6038,Phenotype,HP:0004388,Microcolon,0.006130533355862222,-0.5084107057300641,1
6038,Phenotype,HP:0100811,Aplasia/Hypoplasia of the colon,0.006130533355862222,-0.5084107057300641,1
6040,Biological Process,GO:0048592,eye morphogenesis,0.006120081955952039,-0.5085904763716673,1
6041,Phenotype,HP:0100023,Recurrent hand flapping,0.006106631332123191,-0.5088218355480891,1
6042,Phenotype,HP:0009617,Abnormality of the distal phalanx of the thumb,0.006103831200098053,-0.5088699995773156,1
6043,Phenotype,HP:0000158,Macroglossia,0.006087757759933421,-0.5091464728417585,1
6044,Disease,MONDO:0002933,osteosclerosis,0.00608515034179169,-0.5091913220711722,1
6044,Disease,MONDO:0042973,familial osteosclerosis,0.00608515034179169,-0.5091913220711722,1
6046,Phenotype,HP:0009465,Ulnar deviation of finger,0.006053610885629057,-0.5097338205229488,1
6047,Biological Process,GO:0000725,recombinational repair,0.006035269763635331,-0.5100492993388844,1
6048,Disease,MONDO:0100191,inherited kidney disorder,0.006024990635550731,-0.5102261067969063,1
6049,Biological Process,GO:0018242,protein O-linked glycosylation via serine,0.006021296636089968,-0.510289645907346,1
6050,Phenotype,HP:0001955,Unexplained fevers,0.006014508510697958,-0.5104064059268163,1
6051,Phenotype,HP:0007704,Paroxysmal involuntary eye movements,0.006007206172649937,-0.5105320107268791,1
6052,Biological Process,GO:0061158,3'-UTR-mediated mRNA destabilization,0.006002088284064344,-0.5106200416244233,1
6053,Phenotype,HP:0002905,Hyperphosphatemia,0.005996343679403382,-0.5107188524320215,1
6054,Phenotype,HP:0002314,Degeneration of the lateral corticospinal tracts,0.005977088016837939,-0.5110500619200932,1
6055,Phenotype,HP:0011948,Recurrent acute respiratory tract infection,0.005973079729921893,-0.5111190069721264,1
6056,Phenotype,HP:0006376,Limited elbow flexion,0.005939493096747017,-0.5116967181540758,1
6057,Phenotype,HP:0011514,Abnormality of binocular vision,0.005936556296647688,-0.5117472329600017,1
6057,Phenotype,HP:0000651,Diplopia,0.005936556296647688,-0.5117472329600017,1
6059,Biological Process,GO:0006418,tRNA aminoacylation for protein translation,0.005932767272197936,-0.5118124065599247,1
6060,Phenotype,HP:0012028,Hepatocellular adenoma,0.005923127476744505,-0.5119782170952099,1
6061,Biological Process,GO:0000768,syncytium formation by plasma membrane fusion,0.005912368390547873,-0.5121632801341572,1
6062,Phenotype,HP:0000590,Progressive external ophthalmoplegia,0.0058937413434101416,-0.5124836770421216,1
6063,Phenotype,HP:0002166,Impaired vibration sensation in the lower limbs,0.005888272662639804,-0.5125777417855297,1
6064,Biological Process,GO:0033273,response to vitamin,0.005883340201483733,-0.5126625832148435,1
6065,Phenotype,HP:0012157,Subcortical cerebral atrophy,0.005877159247314134,-0.512768899508004,1
6066,Phenotype,HP:0002181,Cerebral edema,0.005834172517239722,-0.5135082982595884,1
6067,Biological Process,GO:0015807,L-amino acid transport,0.0058035010632970785,-0.5140358665281032,1
6068,Phenotype,HP:0040220,Abnormal size of the dental root,0.005756793651670589,-0.5148392633388535,1
6069,Disease,MONDO:0002263,female reproductive system disorder,0.0056915839306870275,-0.5159609114894096,1
6070,Phenotype,HP:0045045,Elevated circulating acylcarnitine concentration,0.005638071182459514,-0.5168813643632333,1
6071,Phenotype,HP:0031097,Abnormal thyroid-stimulating hormone level,0.005628415166418765,-0.5170474539028064,1
6072,Phenotype,HP:0008058,Aplasia/Hypoplasia of the optic nerve,0.005607605921860714,-0.5174053859767511,1
6073,Phenotype,HP:0012704,Widened subarachnoid space,0.005578117596784726,-0.5179126036857921,1
6074,Biological Process,GO:2000772,regulation of cellular senescence,0.005548804961928999,-0.5184167994127166,1
6075,Biological Process,GO:2000060,positive regulation of ubiquitin-dependent protein catabolic process,0.005526511717389382,-0.5188002572182492,1
6076,Biological Process,GO:0090224,regulation of spindle organization,0.005509118741531149,-0.5190994273252486,1
6077,Biological Process,GO:1900181,negative regulation of protein localization to nucleus,0.0055062624885985345,-0.5191485566693259,1
6078,Phenotype,HP:0006557,Polycystic liver disease,0.005487374619351337,-0.5194734398813612,1
6079,Biological Process,GO:0097194,execution phase of apoptosis,0.0054768019034393545,-0.519655297234378,1
6080,Biological Process,GO:0140115,export across plasma membrane,0.005475197433503443,-0.5196828951248319,1
6081,Biological Process,GO:0015865,purine nucleotide transport,0.005469762181221083,-0.5197763848772547,1
6082,Biological Process,GO:1903008,organelle disassembly,0.005457072284796305,-0.5199946590646138,1
6083,Phenotype,HP:0002063,Rigidity,0.005453464483844761,-0.5200567155065651,1
6084,Biological Process,GO:1901185,negative regulation of ERBB signaling pathway,0.005445074180929987,-0.5202010339855436,1
6085,Biological Process,GO:0007031,peroxisome organization,0.005419362178251674,-0.5206432965779336,1
6086,Phenotype,HP:0032943,Abnormal urine pH,0.005397370540126789,-0.5210215665637337,1
6087,Phenotype,HP:0011931,Abnormal cerebellar peduncle morphology,0.005390613854358461,-0.5211377858019335,1
6088,Biological Process,GO:0098534,centriole assembly,0.005359339221719828,-0.5216757291227965,1
6089,Phenotype,HP:0002068,Neuromuscular dysphagia,0.00529301016309458,-0.5228166305836981,1
6090,Disease,MONDO:0019249,mucopolysaccharidosis,0.00525002951738085,-0.523555924680458,1
6091,Biological Process,GO:1901186,positive regulation of ERBB signaling pathway,0.0052247452107992975,-0.5239908306314042,1
6092,Phenotype,HP:0002213,Fine hair,0.005202131078642425,-0.5243798079054609,1
6093,Biological Process,GO:0042059,negative regulation of epidermal growth factor receptor signaling pathway,0.005184491710001904,-0.5246832161230426,1
6094,Phenotype,HP:0100589,Urogenital fistula,0.005135974968598411,-0.5255177345421591,1
6095,Phenotype,HP:0010765,Palmar hyperkeratosis,0.005133475801747056,-0.5255607217814,1
6096,Phenotype,HP:6000441,Abnormal circulating interleukin 6 concentration,0.005128926770381903,-0.5256389679775282,1
6096,Phenotype,HP:0030783,Increased circulating interleukin 6 concentration,0.005128926770381903,-0.5256389679775282,1
6098,Phenotype,HP:0030918,Low 1-minute APGAR score,0.005113450296776567,-0.5259051730422751,1
6099,Disease,MONDO:0001531,blood coagulation disease,0.005100122237081894,-0.5261344240386227,1
6100,Biological Process,GO:0044091,membrane biogenesis,0.005048006066631472,-0.5270308548976739,1
6101,Phenotype,HP:0004380,Aortic valve calcification,0.005031382866406919,-0.5273167843803792,1
6102,Biological Process,GO:0045198,establishment of epithelial cell apical/basal polarity,0.005027814920202767,-0.5273781552956478,1
6103,Biological Process,GO:0071763,nuclear membrane organization,0.004995206697503751,-0.5279390372030016,1
6104,Phenotype,HP:0010668,Abnormal zygomatic bone morphology,0.004980437054950992,-0.5281930843297767,1
6105,Phenotype,HP:0000605,Supranuclear gaze palsy,0.00489110301363338,-0.5297296859393873,1
6106,Biological Process,GO:0000381,"regulation of alternative mRNA splicing, via spliceosome",0.004888438501897574,-0.5297755172144721,1
6107,Phenotype,HP:0025613,Focal emotional seizure,0.004862252484916452,-0.5302259331505365,1
6108,Biological Process,GO:0044380,protein localization to cytoskeleton,0.004861863998233074,-0.5302326153654479,1
6109,Biological Process,GO:0016093,polyprenol metabolic process,0.004838861252315363,-0.5306282770402282,1
6110,Phenotype,HP:0100238,Synostosis involving bones of the upper limbs,0.004837240692831979,-0.5306561516810023,1
6111,Biological Process,GO:0016558,protein import into peroxisome matrix,0.004827954140462998,-0.5308158862134095,1
6112,Biological Process,GO:0140627,ubiquitin-dependent protein catabolic process via the C-end degron rule pathway,0.004825840223179889,-0.530852246918152,1
6113,Biological Process,GO:0035335,peptidyl-tyrosine dephosphorylation,0.00481939383249641,-0.530963128886037,1
6114,Biological Process,GO:0006909,phagocytosis,0.0048164695076725605,-0.5310134291093905,1
6115,Phenotype,HP:0005622,Broad long bones,0.004803862396649761,-0.531230279335849,1
6116,Biological Process,GO:0007040,lysosome organization,0.004786175671661841,-0.5315345021123442,1
6116,Biological Process,GO:0080171,lytic vacuole organization,0.004786175671661841,-0.5315345021123442,1
6118,Biological Process,GO:0060271,cilium assembly,0.004723018137414048,-0.5326208513623367,1
6119,Phenotype,HP:0002157,Azotemia,0.004708747617334863,-0.5328663132691333,1
6120,Biological Process,GO:0045662,negative regulation of myoblast differentiation,0.004692815861656374,-0.5331403494714411,1
6121,Phenotype,HP:0012747,Abnormal brainstem MRI signal intensity,0.004685535469454716,-0.5332655767891652,1
6122,Biological Process,GO:0032438,melanosome organization,0.004670019998350705,-0.5335324526353785,1
6122,Biological Process,GO:0048753,pigment granule organization,0.004670019998350705,-0.5335324526353785,1
6124,Phenotype,HP:0008386,Aplasia/Hypoplasia of the nails,0.004642892632200524,-0.5339990603682881,1
6125,Phenotype,HP:0003587,Insidious onset,0.0046395721277652235,-0.5340561751297469,1
6126,Phenotype,HP:0003487,Babinski sign,0.004633399050495868,-0.5341623559352767,1
6126,Phenotype,HP:0031828,Abnormal superficial reflex,0.004633399050495868,-0.5341623559352767,1
6128,Biological Process,GO:0010043,response to zinc ion,0.004628543686864828,-0.5342458712387451,1
6129,Phenotype,HP:0000884,Prominent sternum,0.0046175392526357495,-0.5344351544179213,1
6130,Phenotype,HP:0011718,Abnormality of the pulmonary veins,0.004599041054163533,-0.534753335047926,1
6130,Phenotype,HP:0030968,Abnormal pulmonary vein morphology,0.004599041054163533,-0.534753335047926,1
6132,Phenotype,HP:0012426,Optic disc drusen,0.004565893101592944,-0.5353235006480042,1
6133,Phenotype,HP:0003175,Hypoplastic ischia,0.004565836920452981,-0.5353244669988916,1
6134,Phenotype,HP:0003560,Muscular dystrophy,0.004553737358763299,-0.5355325870580955,1
6135,Phenotype,HP:0012219,Erythema nodosum,0.0045295336886080895,-0.535948905383903,1
6136,Biological Process,GO:0010569,regulation of double-strand break repair via homologous recombination,0.004516094285820782,-0.5361800715513639,1
6137,Phenotype,HP:0003306,Spinal rigidity,0.004513945087953886,-0.5362170391043027,1
6138,Disease,MONDO:0001115,familial polycythemia,0.0044817386199447196,-0.5367710105787019,1
6138,Disease,MONDO:0005571,polycythemia,0.0044817386199447196,-0.5367710105787019,1
6140,Phenotype,HP:0001890,Autoimmune hemolytic anemia,0.004470050660323688,-0.536972050823852,1
6141,Disease,MONDO:0004069,inborn mitochondrial metabolism disorder,0.004468861946815728,-0.5369924974426633,1
6142,Phenotype,HP:0006323,Premature loss of primary teeth,0.004456066256112168,-0.537212591358053,1
6143,Biological Process,GO:0007015,actin filament organization,0.004455105544062143,-0.5372291162086101,1
6144,Biological Process,GO:0001822,kidney development,0.004437243610428743,-0.537536352683833,1
6145,Biological Process,GO:0098655,monoatomic cation transmembrane transport,0.00440981455848688,-0.5380081496018086,1
6146,Biological Process,GO:0050931,pigment cell differentiation,0.004399677106549094,-0.5381825201411372,1
6147,Biological Process,GO:0070862,negative regulation of protein exit from endoplasmic reticulum,0.0043858507003389224,-0.5384203430104972,1
6148,Phenotype,HP:0000662,Nyctalopia,0.004357842397917477,-0.5389021034004726,1
6149,Biological Process,GO:0150118,negative regulation of cell-substrate junction organization,0.004355717573489848,-0.5389386517149503,1
6149,Biological Process,GO:0051895,negative regulation of focal adhesion assembly,0.004355717573489848,-0.5389386517149503,1
6151,Biological Process,GO:0031032,actomyosin structure organization,0.004354807588931586,-0.5389543040207938,1
6152,Phenotype,HP:0010660,Abnormal hand bone ossification,0.004329902570674893,-0.5393826859743714,1
6153,Phenotype,HP:0010472,Abnormal circulating porphyrin concentration,0.004327956376650621,-0.5394161617337371,1
6154,Biological Process,GO:0034244,negative regulation of transcription elongation by RNA polymerase II,0.004307921401296544,-0.539760775891157,1
6155,Biological Process,GO:0044571,[2Fe-2S] cluster assembly,0.004305080638092207,-0.5398096388021808,1
6156,Biological Process,GO:0043279,response to alkaloid,0.004302641990263534,-0.5398515850762275,1
6156,Biological Process,GO:0071312,cellular response to alkaloid,0.004302641990263534,-0.5398515850762275,1
6158,Biological Process,GO:0006024,glycosaminoglycan biosynthetic process,0.004299897373336692,-0.5398987942109017,1
6159,Phenotype,HP:0000512,Abnormal electroretinogram,0.004298770070485736,-0.5399181845278487,1
6160,Disease,MONDO:0017754,inborn disorder of porphyrin metabolism,0.00429469550702144,-0.5399882695781313,1
6160,Disease,MONDO:0037821,porphyrin metabolism disease,0.00429469550702144,-0.5399882695781313,1
6162,Phenotype,HP:0430028,Hyperplasia of the maxilla,0.004275712824484912,-0.5403147836382828,1
6163,Biological Process,GO:0006743,ubiquinone metabolic process,0.004200109362217597,-0.5416152106658597,1
6164,Phenotype,HP:0011682,Perimembranous ventricular septal defect,0.004187715341632203,-0.5418283956029807,1
6165,Phenotype,HP:0000540,Hypermetropia,0.004178058866211587,-0.5419944930441759,1
6166,Phenotype,HP:0000798,Oligozoospermia,0.0041681462684614035,-0.5421649959502765,1
6167,Phenotype,HP:0000970,Anhidrosis,0.004146808925888035,-0.5425320116417135,1
6168,Phenotype,HP:0009701,Metacarpal synostosis,0.004135755224083493,-0.5427221422541262,1
6169,Phenotype,HP:0000691,Microdontia,0.0041090158223769935,-0.543182076754975,1
6170,Phenotype,HP:0008046,Abnormal retinal vascular morphology,0.004092121681236516,-0.5434726665915767,1
6171,Phenotype,HP:0031818,Abnormal waist to hip ratio,0.004083991709360468,-0.5436125072132094,1
6171,Phenotype,HP:0031819,Increased waist to hip ratio,0.004083991709360468,-0.5436125072132094,1
6173,Biological Process,GO:0061572,actin filament bundle organization,0.004077107951482084,-0.5437309121714995,1
6174,Biological Process,GO:0051985,negative regulation of chromosome segregation,0.004032226492222124,-0.5445029014549053,1
6174,Biological Process,GO:1905819,negative regulation of chromosome separation,0.004032226492222124,-0.5445029014549053,1
6174,Biological Process,GO:1902100,negative regulation of metaphase/anaphase transition of cell cycle,0.004032226492222124,-0.5445029014549053,1
6177,Phenotype,HP:0003063,Abnormality of the humerus,0.004007269494804899,-0.5449321774826852,1
6178,Phenotype,HP:0009602,Abnormality of thumb phalanx,0.004002314072950708,-0.5450174138504252,1
6179,Phenotype,HP:0012745,Short palpebral fissure,0.003995891624056669,-0.5451278840044972,1
6180,Phenotype,HP:0002301,Hemiplegia,0.0039793047408388516,-0.5454131888118807,1
6181,Disease,MONDO:0800153,urea cycle disorder or inherited hyperammonemia,0.003963857188026387,-0.5456788964208289,1
6182,Biological Process,GO:0051497,negative regulation of stress fiber assembly,0.003962477222893224,-0.5457026326876937,1
6183,Biological Process,GO:0007602,phototransduction,0.003951707753062972,-0.5458878743316599,1
6184,Phenotype,HP:0034644,Abnormal liver metabolite concentration,0.0039401897036149824,-0.5460859920151354,1
6185,Biological Process,GO:0061458,reproductive system development,0.0039037442042458848,-0.5467128774909028,1
6186,Phenotype,HP:0008897,Postnatal growth retardation,0.003903652975246197,-0.5467144466869864,1
6187,Phenotype,HP:0002396,Cogwheel rigidity,0.003873797625464359,-0.5472279774514478,1
6188,Phenotype,HP:0001320,Cerebellar vermis hypoplasia,0.003849931474211088,-0.547638490240191,1
6189,Phenotype,HP:0031466,Impairment in personality functioning,0.0038484827548138645,-0.547663409123573,1
6190,Phenotype,HP:0040075,Hypopituitarism,0.003827831919400504,-0.5480186164607532,1
6191,Phenotype,HP:0002342,"Intellectual disability, moderate",0.0037855643282103113,-0.5487456455719326,1
6192,Biological Process,GO:0048193,Golgi vesicle transport,0.0036541406862476977,-0.551006214743573,1
6193,Biological Process,GO:0000724,double-strand break repair via homologous recombination,0.0036346435030807367,-0.551341578537658,1
6194,Biological Process,GO:0050686,negative regulation of mRNA processing,0.003628899342585701,-0.5514403817053234,1
6194,Biological Process,GO:0048025,"negative regulation of mRNA splicing, via spliceosome",0.003628899342585701,-0.5514403817053234,1
6196,Biological Process,GO:0006611,protein export from nucleus,0.0036184121458219254,-0.5516207680752877,1
6197,Disease,MONDO:0006424,soft tissue neoplasm,0.0036127379759905986,-0.5517183673595853,1
6198,Biological Process,GO:0032232,negative regulation of actin filament bundle assembly,0.0035733660624955865,-0.5523955889960139,1
6199,Phenotype,HP:0002283,Global brain atrophy,0.0035656719279805182,-0.5525279329413457,1
6200,Biological Process,GO:0050913,sensory perception of bitter taste,0.0035282862690915184,-0.5531709897512459,1
6200,Biological Process,GO:0001580,detection of chemical stimulus involved in sensory perception of bitter taste,0.0035282862690915184,-0.5531709897512459,1
6202,Phenotype,HP:0000773,Short ribs,0.0035042370853958227,-0.5535846508129373,1
6203,Phenotype,HP:0000511,Vertical supranuclear gaze palsy,0.0034988726017248784,-0.5536769233008033,1
6204,Biological Process,GO:0033875,ribonucleoside bisphosphate metabolic process,0.003496963809513254,-0.5537097557255043,1
6204,Biological Process,GO:0033865,nucleoside bisphosphate metabolic process,0.003496963809513254,-0.5537097557255043,1
6204,Biological Process,GO:0034032,purine nucleoside bisphosphate metabolic process,0.003496963809513254,-0.5537097557255043,1
6207,Disease,MONDO:0005503,developmental disorder of mental health,0.003494802406468933,-0.5537469332151592,1
6207,Disease,MONDO:0005084,mental disorder,0.003494802406468933,-0.5537469332151592,1
6209,Biological Process,GO:0071241,cellular response to inorganic substance,0.003454618865190162,-0.5544381153591449,1
6210,Disease,MONDO:0015993,cone-rod dystrophy,0.0034460067053974086,-0.5545862499157438,1
6211,Phenotype,HP:0100736,Abnormal soft palate morphology,0.003442947426654075,-0.5546388714312592,1
6212,Phenotype,HP:0006503,Aplasia/hypoplasia involving forearm bones,0.003441365074179359,-0.5546660888874916,1
6213,Phenotype,HP:0010989,Abnormality of the intrinsic pathway,0.0034404864466788254,-0.554681201832251,1
6214,Biological Process,GO:0034605,cellular response to heat,0.003437555265955017,-0.5547316199813891,1
6215,Phenotype,HP:0007054,Proximal hyperreflexia,0.003425396348626042,-0.5549407609948623,1
6216,Phenotype,HP:0009943,Complete duplication of thumb phalanx,0.0034135227965435,-0.5551449935468966,1
6217,Biological Process,GO:0009410,response to xenobiotic stimulus,0.0033701834948253184,-0.5558904567521578,1
6218,Phenotype,HP:0032152,Keratosis pilaris,0.003342549172380971,-0.5563657844516795,1
6219,Biological Process,GO:0006805,xenobiotic metabolic process,0.003312322028720227,-0.5568857103043329,1
6220,Phenotype,HP:0000137,Abnormality of the ovary,0.003307178493798024,-0.5569741823349718,1
6221,Phenotype,HP:0002868,Narrow iliac wing,0.0032914965751839054,-0.5572439211828826,1
6222,Phenotype,HP:0001991,Aplasia/Hypoplasia of toe,0.003246173618225656,-0.5580235045039456,1
6223,Phenotype,HP:0009895,Abnormality of the crus of the helix,0.003244536455193292,-0.5580516647361887,1
6224,Phenotype,HP:0011157,Focal sensory seizure,0.0032114338026431044,-0.558621051147469,1
6225,Disease,MONDO:0024626,defective phagocytic cell engulfment,0.0031700036737524195,-0.5593336753811972,1
6225,Disease,MONDO:0024627,phagocytic cell dysfunction,0.0031700036737524195,-0.5593336753811972,1
6227,Phenotype,HP:0002243,Protein-losing enteropathy,0.003163459317641504,-0.5594462424159532,1
6228,Disease,MONDO:0021181,inherited blood coagulation disorder,0.003153916451988481,-0.5596103856978024,1
6229,Biological Process,GO:0010881,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,0.0031500406699591643,-0.559677051582575,1
6230,Phenotype,HP:0008322,Abnormal mitochondrial morphology,0.003120446105896013,-0.5601860966689098,1
6231,Phenotype,HP:0100864,Short femoral neck,0.003063840937562179,-0.5611597411105042,1
6232,Phenotype,HP:0009485,Radial deviation of the hand or of fingers of the hand,0.0030496414263990745,-0.5614039816193527,1
6233,Phenotype,HP:0000327,Hypoplasia of the maxilla,0.003015315873011404,-0.5619944026929806,1
6234,Phenotype,HP:0030682,Left ventricular noncompaction,0.0030130132879775395,-0.5620340086015135,1
6234,Phenotype,HP:0031192,Abnormal morphology of left ventricular trabeculae,0.0030130132879775395,-0.5620340086015135,1
6236,Biological Process,GO:0051293,establishment of spindle localization,0.0030128408775060844,-0.5620369741698908,1
6237,Phenotype,HP:0003443,Decreased size of nerve terminals,0.002986469947564574,-0.5624905707249933,1
6238,Phenotype,HP:0002139,Arrhinencephaly,0.002984298975606814,-0.5625279128059685,1
6239,Biological Process,GO:0051642,centrosome localization,0.0029799084663038045,-0.562603432323081,1
6239,Biological Process,GO:0061842,microtubule organizing center localization,0.0029799084663038045,-0.562603432323081,1
6241,Phenotype,HP:0011425,Fetal ultrasound soft marker,0.0029781165721564085,-0.5626342540276689,1
6242,Phenotype,HP:0004225,Abnormality of the distal phalanx of the 5th finger,0.0029544443665874276,-0.5630414308288505,1
6243,Biological Process,GO:1905515,non-motile cilium assembly,0.0029412221610650713,-0.5632688610669612,1
6244,Phenotype,HP:0012675,Iron accumulation in brain,0.0028903289348478634,-0.5641442565172308,1
6245,Phenotype,HP:0010297,Bifid tongue,0.0028768693273737433,-0.5643757702179927,1
6246,Phenotype,HP:0003484,Upper limb muscle weakness,0.002839311017955315,-0.5650217967254181,1
6247,Phenotype,HP:0003510,Severe short stature,0.0027970454639295594,-0.56574879079609,1
6248,Biological Process,GO:0006023,aminoglycan biosynthetic process,0.0027780612318224485,-0.5660753315098286,1
6249,Biological Process,GO:2000648,positive regulation of stem cell proliferation,0.0027490421228005824,-0.5665744784080857,1
6250,Phenotype,HP:0009023,Abdominal wall muscle weakness,0.0027192347021071095,-0.5670871847621293,1
6251,Phenotype,HP:0003200,Ragged-red muscle fibers,0.0026954162013184124,-0.5674968779329588,1
6252,Phenotype,HP:0000921,Missing ribs,0.0026292456161930433,-0.5686350535501461,1
6253,Biological Process,GO:0044788,modulation by host of viral process,0.0026259944876664276,-0.5686909750024096,1
6254,Phenotype,HP:0000457,Depressed nasal ridge,0.002611064097001181,-0.5689477870976641,1
6255,Phenotype,HP:0002578,Gastroparesis,0.002607005867890644,-0.5690175911868047,1
6256,Disease,MONDO:0019501,Usher syndrome,0.002585582126980901,-0.5693860929838829,1
6257,Biological Process,GO:1902099,regulation of metaphase/anaphase transition of cell cycle,0.0025614525133932364,-0.5698011374902235,1
6258,Biological Process,GO:1905209,positive regulation of cardiocyte differentiation,0.002550723191840798,-0.5699856885585995,1
6259,Phenotype,HP:0002317,Unsteady gait,0.0025496762268482076,-0.5700036970139329,1
6260,Phenotype,HP:0003546,Exercise intolerance,0.002524654099569923,-0.5704340933162225,1
6261,Biological Process,GO:2000779,regulation of double-strand break repair,0.0025133445864954362,-0.5706286240431196,1
6262,Biological Process,GO:1902930,regulation of alcohol biosynthetic process,0.0024782338844201446,-0.5712325501672232,1
6263,Disease,MONDO:0700223,hereditary skeletal muscle disorder,0.002473800733809872,-0.571308803141598,1
6264,Biological Process,GO:0032509,endosome transport via multivesicular body sorting pathway,0.0024675470667842037,-0.5714163701415442,1
6265,Phenotype,HP:0012429,Aplasia/Hypoplasia of the cerebral white matter,0.002464511208745357,-0.5714685888062351,1
6265,Phenotype,HP:0012430,Cerebral white matter hypoplasia,0.002464511208745357,-0.5714685888062351,1
6267,Phenotype,HP:0005684,Distal arthrogryposis,0.0024618818837702783,-0.5715138148469392,1
6268,Phenotype,HP:0000319,Smooth philtrum,0.0024553595167079445,-0.5716260036562513,1
6269,Phenotype,HP:0000172,Abnormal uvula morphology,0.002443477981428188,-0.5718303735242908,1
6270,Phenotype,HP:0005110,Atrial fibrillation,0.0024089842867230926,-0.5724236867341659,1
6271,Phenotype,HP:0012041,Decreased fertility in males,0.002398454219656787,-0.5726048105002548,1
6272,Biological Process,GO:2000767,positive regulation of cytoplasmic translation,0.0023953069093868296,-0.5726589462133093,1
6273,Phenotype,HP:0001549,Abnormal ileum morphology,0.002393194315080338,-0.5726952841620232,1
6274,Phenotype,HP:0009183,Joint contracture of the 5th finger,0.0023736445747584156,-0.5730315519721778,1
6275,Phenotype,HP:0000670,Carious teeth,0.0023654290327044247,-0.5731728644546066,1
6276,Biological Process,GO:0015936,coenzyme A metabolic process,0.0023465957139525706,-0.5734968093638659,1
6277,Phenotype,HP:0001254,Lethargy,0.0023248628800989213,-0.5738706277536798,1
6278,Phenotype,HP:0005150,Abnormal atrioventricular conduction,0.0022799986340326095,-0.5746423209593455,1
6279,Phenotype,HP:0030674,Antenatal onset,0.0022743165962351153,-0.5747400555776021,1
6280,Phenotype,HP:0003803,Type 1 muscle fiber predominance,0.002246698866258723,-0.5752150978762555,1
6281,Biological Process,GO:1901881,positive regulation of protein depolymerization,0.0022391805010100185,-0.5753444184798284,1
6282,Phenotype,HP:0004719,Hyperechogenic kidneys,0.002217064916954836,-0.5757248204134636,1
6283,Biological Process,GO:0007019,microtubule depolymerization,0.0022082870969279966,-0.5758758044301182,1
6284,Phenotype,HP:0000972,Palmoplantar hyperkeratosis,0.0022060804045163085,-0.5759137609253321,1
6285,Phenotype,HP:0004278,Synostosis involving bones of the hand,0.002198553884159571,-0.5760432218018844,1
6286,Biological Process,GO:0033108,mitochondrial respiratory chain complex assembly,0.002195355635590923,-0.5760982336856638,1
6287,Phenotype,HP:0025114,Hypergranulosis,0.002192673325997485,-0.5761443710950764,1
6288,Biological Process,GO:0036151,phosphatidylcholine acyl-chain remodeling,0.0021376738987066712,-0.5770903957823763,1
6289,Biological Process,GO:0045137,development of primary sexual characteristics,0.0021274936359172436,-0.5772655026952369,1
6290,Biological Process,GO:2000042,negative regulation of double-strand break repair via homologous recombination,0.002066475024263603,-0.5783150611334344,1
6291,Phenotype,HP:0000641,Dysmetric saccades,0.002060882663725061,-0.5784112532465226,1
6292,Phenotype,HP:0000359,Abnormality of the inner ear,0.002060347860303402,-0.5784204522012147,1
6293,Phenotype,HP:0004976,Knee dislocation,0.002045963335258083,-0.5786678750650203,1
6294,Phenotype,HP:0002791,Hypoventilation,0.001989939104811045,-0.5796315270101511,1
6295,Phenotype,HP:0100751,Esophageal neoplasm,0.0019715540645265373,-0.5799477612482674,1
6296,Phenotype,HP:0011950,Bronchiolitis,0.0019492185771982085,-0.5803319456562931,1
6297,Phenotype,HP:0040162,Orthokeratosis,0.0019263412652802403,-0.5807254497875092,1
6298,Biological Process,GO:1902749,regulation of cell cycle G2/M phase transition,0.0019199647568831635,-0.5808351297361841,1
6299,Phenotype,HP:0003270,Abdominal distention,0.0018977957441304039,-0.5812164506769693,1
6300,Phenotype,HP:0006304,Widely-spaced incisors,0.0018571092921501053,-0.5819162832008332,1
6301,Disease,MONDO:0037792,carbohydrate metabolism disease,0.001841183899036758,-0.5821902099630252,1
6301,Disease,MONDO:0019214,inborn carbohydrate metabolic disorder,0.001841183899036758,-0.5821902099630252,1
6303,Phenotype,HP:0000774,Narrow chest,0.0018388214219431376,-0.5822308460525961,1
6304,Biological Process,GO:0002065,columnar/cuboidal epithelial cell differentiation,0.0017954591141939868,-0.582976704976037,1
6305,Phenotype,HP:0031834,Aortopulmonary collateral arteries,0.0017608749636890408,-0.5835715740824728,1
6306,Biological Process,GO:0043489,RNA stabilization,0.0017318122008533887,-0.5840714718537404,1
6307,Phenotype,HP:0011273,Anisocytosis,0.0017208329486055884,-0.5842603218870251,1
6308,Biological Process,GO:0070988,demethylation,0.0017128042261008725,-0.5843984209558896,1
6309,Phenotype,HP:0010182,Abnormality of the distal phalanges of the toes,0.0016999936202325427,-0.5846187714214796,1
6310,Phenotype,HP:0000091,Abnormal renal tubule morphology,0.0016984606214948128,-0.584645139962443,1
6311,Disease,MONDO:0005129,cataract,0.0016949788812474775,-0.5847050280811198,1
6312,Biological Process,GO:0032515,negative regulation of phosphoprotein phosphatase activity,0.0016615968488112864,-0.585279220001881,1
6313,Biological Process,GO:0016236,macroautophagy,0.0016158335173843685,-0.5860663780403463,1
6314,Phenotype,HP:0000830,Anterior hypopituitarism,0.0015982799268993153,-0.5863683108197879,1
6315,Phenotype,HP:0010049,Short metacarpal,0.0015916091739046623,-0.5864830519603175,1
6316,Biological Process,GO:0032373,positive regulation of sterol transport,0.0015875495745709678,-0.5865528796181568,1
6316,Biological Process,GO:0032376,positive regulation of cholesterol transport,0.0015875495745709678,-0.5865528796181568,1
6318,Biological Process,GO:0031952,regulation of protein autophosphorylation,0.0015831947780778899,-0.586627784852512,1
6319,Biological Process,GO:0043648,dicarboxylic acid metabolic process,0.0015698623942465018,-0.5868571102267265,1
6320,Biological Process,GO:0044743,protein transmembrane import into intracellular organelle,0.0015588221726480223,-0.5870470089711297,1
6321,Phenotype,HP:0005772,Aplasia/Hypoplasia of the tibia,0.0015222662337609494,-0.5876757940759588,1
6322,Biological Process,GO:0010880,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,0.0015143717873622453,-0.5878115835114788,1
6323,Phenotype,HP:0001670,Asymmetric septal hypertrophy,0.0015142493896748155,-0.5878136888285644,1
6324,Phenotype,HP:0007759,Opacification of the corneal stroma,0.0014895490386466204,-0.5882385503772872,1
6325,Phenotype,HP:0001141,Severely reduced visual acuity,0.001482735439244487,-0.5883557485657285,1
6326,Phenotype,HP:0000297,Facial hypotonia,0.0014819110591798301,-0.5883699284205252,1
6327,Biological Process,GO:0006029,proteoglycan metabolic process,0.0014521353363303735,-0.5888820895517464,1
6328,Phenotype,HP:0002415,Leukodystrophy,0.001435800755734351,-0.5891630545955971,1
6329,Phenotype,HP:5200242,Cognitive distortion,0.0014195538488251946,-0.5894425115969774,1
6330,Phenotype,HP:5200018,Steroetypic upper-extremity movements,0.001417835608291007,-0.5894720664131661,1
6331,Phenotype,HP:0001545,Anteriorly placed anus,0.0014175334068795564,-0.5894772644672159,1
6332,Phenotype,HP:0000612,Iris coloboma,0.001403834079809374,-0.5897129014955664,1
6333,Disease,MONDO:0020811,"mitochondrial complex III deficiency, nuclear type",0.001380584269159324,-0.5901128128388917,1
6333,Disease,MONDO:0015448,mitochondrial complex III deficiency,0.001380584269159324,-0.5901128128388917,1
6335,Phenotype,HP:0006846,Acute encephalopathy,0.00137211447138319,-0.5902584986794059,1
6336,Phenotype,HP:0001520,Large for gestational age,0.0013572321244915697,-0.5905144843915842,1
6337,Phenotype,HP:0000558,Rieger anomaly,0.0013298508954681099,-0.5909854587253319,1
6338,Biological Process,GO:0006260,DNA replication,0.0012636757359896222,-0.5921237130242656,1
6339,Biological Process,GO:0031396,regulation of protein ubiquitination,0.001234652312295026,-0.5926229341376031,1
6340,Phenotype,HP:0000548,Cone/cone-rod dystrophy,0.001199328515089526,-0.5932305256317633,1
6341,Disease,MONDO:0024431,bilirubin metabolism disease,0.0011917419458723488,-0.5933610193864238,1
6341,Disease,MONDO:0017755,inborn disorder of bilirubin metabolism,0.0011917419458723488,-0.5933610193864238,1
6343,Phenotype,HP:0004373,Focal dystonia,0.0011854147563028494,-0.5934698510202938,1
6344,Biological Process,GO:0003279,cardiac septum development,0.0011481443626034649,-0.5941109251965496,1
6345,Phenotype,HP:0002982,Tibial bowing,0.0011377250130567562,-0.5942901445517744,1
6346,Phenotype,HP:0100744,Abnormality of the humeroradial joint,0.0011331787286396056,-0.5943683434986721,1
6347,Biological Process,GO:0050000,chromosome localization,0.0011053446491399166,-0.5948471071449868,1
6348,Biological Process,GO:0000077,DNA damage checkpoint signaling,0.0010890401039489461,-0.5951275555610093,1
6349,Phenotype,HP:0002446,Astrocytosis,0.0010630261476001213,-0.5955750119461495,1
6350,Phenotype,HP:0012048,Oromandibular dystonia,0.0010571434701008853,-0.5956761976932714,1
6351,Phenotype,HP:0000020,Urinary incontinence,0.0010533626546418429,-0.5957412300933993,1
6352,Biological Process,GO:0060586,multicellular organismal-level iron ion homeostasis,0.0010402030870436674,-0.5959675829198794,1
6353,Phenotype,HP:0000698,Conical tooth,0.0010226020172124928,-0.5962703323738898,1
6354,Disease,MONDO:0018158,mitochondrial DNA depletion syndrome,0.0010175445934359484,-0.5963573232387483,1
6355,Biological Process,GO:0006855,xenobiotic transmembrane transport,0.0010171346449187046,-0.5963643746106796,1
6356,Phenotype,HP:0005522,Pyridoxine-responsive sideroblastic anemia,0.00100657625774625,-0.5965459855003784,1
6357,Biological Process,GO:0042181,ketone biosynthetic process,0.0009934792381204316,-0.5967712624624559,1
6358,Biological Process,GO:1901673,regulation of mitotic spindle assembly,0.000983890369014917,-0.5969361970325767,1
6359,Phenotype,HP:0002996,Limited elbow movement,0.0009451925702271824,-0.5976018234727174,1
6360,Biological Process,GO:0086066,atrial cardiac muscle cell to AV node cell communication,0.0009437110682983807,-0.5976273062362291,1
6361,Biological Process,GO:0070213,protein auto-ADP-ribosylation,0.000942956689345742,-0.5976402820279405,1
6362,Phenotype,HP:0012177,Abnormal natural killer cell physiology,0.0008821152227382889,-0.5986867934601021,1
6362,Phenotype,HP:0012178,Reduced natural killer cell activity,0.0008821152227382889,-0.5986867934601021,1
6364,Phenotype,HP:0012842,Skin appendage neoplasm,0.0008529114336320864,-0.5991891169717831,1
6365,Phenotype,HP:0034281,Phalangeal cone-shaped epiphyses,0.0008169340207405673,-0.5998079510661928,1
6366,Biological Process,GO:0046605,regulation of centrosome cycle,0.0007941578448384945,-0.6001997155944252,1
6367,Disease,MONDO:0018800,Kallmann syndrome,0.0007830864090919709,-0.6003901512417763,1
6368,Biological Process,GO:0009310,amine catabolic process,0.0007607859295641894,-0.6007737334936488,1
6368,Biological Process,GO:0042402,cellular biogenic amine catabolic process,0.0007607859295641894,-0.6007737334936488,1
6370,Phenotype,HP:0004416,Precocious atherosclerosis,0.0007518161851565175,-0.6009280187301761,1
6371,Phenotype,HP:0000274,Small face,0.0007316300677785437,-0.6012752326253193,1
6372,Phenotype,HP:0005978,Type II diabetes mellitus,0.0007052582945968888,-0.6017288436846819,1
6373,Phenotype,HP:0001319,Neonatal hypotonia,0.0006720497981714812,-0.6023000506770826,1
6374,Disease,MONDO:0002146,hypogonadism,0.0006691086841543736,-0.6023506396851032,1
6375,Biological Process,GO:0006882,intracellular zinc ion homeostasis,0.0005764268642103332,-0.6039448251893873,1
6376,Phenotype,HP:0100732,Pancreatic fibrosis,0.000546784509482201,-0.6044546923051708,1
6377,Phenotype,HP:0002180,Neurodegeneration,0.000499683074150381,-0.6052648665710872,1
6378,Biological Process,GO:2001135,regulation of endocytic recycling,0.0004991701048742136,-0.6052736899647657,1
6379,Phenotype,HP:0011298,Prominent digit pad,0.0004988760555866278,-0.6052787477971658,1
6380,Biological Process,GO:0050953,sensory perception of light stimulus,0.00046285061475470624,-0.6058984080023103,1
6381,Phenotype,HP:0011715,Trifascicular block,0.00043140505892169667,-0.606439291309451,1
6382,Biological Process,GO:0000076,DNA replication checkpoint signaling,0.00039813654058296066,-0.6070115307164526,1
6383,Phenotype,HP:0011390,Abnormal inner ear morphology,0.00036772761616987726,-0.6075345833121988,1
6384,Biological Process,GO:0071359,cellular response to dsRNA,0.00035726284807358066,-0.607714583894998,1
6385,Phenotype,HP:0031505,Abnormal circulating T4 concentration,0.00032875838120849377,-0.6082048786249795,1
6386,Phenotype,HP:0025155,Abnormality of hepatobiliary system physiology,0.0003183930661092571,-0.6083831685537759,1
6387,Biological Process,GO:0010389,regulation of G2/M transition of mitotic cell cycle,0.00030455294753672923,-0.6086212272843794,1
6388,Phenotype,HP:0010066,Duplication of phalanx of hallux,0.00027203729972224977,-0.609180516845585,1
6388,Phenotype,HP:0010181,Duplication of phalanx of toe,0.00027203729972224977,-0.609180516845585,1
6390,Phenotype,HP:0010751,Dimple chin,0.00023729440988795591,-0.609778116368169,1
6391,Biological Process,GO:0071360,cellular response to exogenous dsRNA,0.00023389947469110162,-0.6098365113854667,1
6392,Biological Process,GO:0060349,bone morphogenesis,0.00022659583604167644,-0.6099621385566905,1
6393,Phenotype,HP:0000298,Mask-like facies,0.0001872358822689879,-0.6106391544783847,1
6394,Phenotype,HP:0001660,Truncus arteriosus,0.00017140733031872912,-0.6109114155117582,1
6395,Phenotype,HP:0100260,Mesoaxial polydactyly,0.0001701237655142851,-0.6109334936324328,1
6396,Phenotype,HP:0004443,Lambdoidal craniosynostosis,0.00016989424377211737,-0.6109374415505304,1
6397,Biological Process,GO:0140029,exocytic process,0.00013753975187946743,-0.6114939591286798,1
6398,Biological Process,GO:0086012,membrane depolarization during cardiac muscle cell action potential,0.0001368144328379728,-0.6115064350716709,1
6399,Phenotype,HP:0001776,Bilateral talipes equinovarus,0.0001299658136834081,-0.6116242356218453,1
6400,Phenotype,HP:0004724,Calcium nephrolithiasis,0.00012917095406261847,-0.6116379077064695,1
6401,Biological Process,GO:0032042,mitochondrial DNA metabolic process,0.00010202914705548238,-0.6121047638311872,1
6402,Biological Process,GO:0062208,positive regulation of pattern recognition receptor signaling pathway,0.00009793203364349967,-0.6121752367547306,1
6403,Phenotype,HP:0001500,Broad finger,0.00008624878826057891,-0.6123761959120249,1
6404,Phenotype,HP:0005523,Lymphoproliferative disorder,0.00004998167503289519,-0.6130000130341391,1
6405,Disease,MONDO:0005039,reproductive system disorder,0.000042734744393868596,-0.6131246647919731,1
6406,Biological Process,GO:0006749,glutathione metabolic process,0.000032634438175360714,-0.6132983964016038,1
6407,Biological Process,GO:0006936,muscle contraction,0.000027852884553869472,-0.6133806421265576,1
6408,Phenotype,HP:0006712,Aplasia/Hypoplasia of the ribs,0.000023277192575443806,-0.6134593469019761,1
6409,Biological Process,GO:0009072,aromatic amino acid metabolic process,-0.00002629148514232682,-0.614311959286281,1
6410,Biological Process,GO:0015802,basic amino acid transport,-0.00006347200183443036,-0.6149514875215717,1
6411,Phenotype,HP:0034674,Abnormal ankle physiology,-0.00007284950166086546,-0.6151127864073592,1
6412,Phenotype,HP:0007034,Generalized hyperreflexia,-0.00009446871750928842,-0.6154846504961347,1
6413,Phenotype,HP:0003482,EMG,-0.00010331770561755604,-0.6156368586484811,1
6414,Phenotype,HP:0002643,Neonatal respiratory distress,-0.0001238041423963221,-0.615989238225909,1
6415,Phenotype,HP:0025160,Abnormal temper tantrums,-0.00018325438053179433,-0.6170118196547052,1
6416,Biological Process,GO:0034220,monoatomic ion transmembrane transport,-0.00022820438913906393,-0.6177849880299315,1
6417,Phenotype,HP:0100620,Germinoma,-0.0002336400195386279,-0.6178784842862077,1
6418,Phenotype,HP:0033393,Irregularly shaped sperm tail,-0.00028122008807640597,-0.6186968913438331,1
6419,Biological Process,GO:0015849,organic acid transport,-0.00029327731776285226,-0.6189042832659982,1
6420,Biological Process,GO:0061099,negative regulation of protein tyrosine kinase activity,-0.00029674253051625854,-0.6189638871014006,1
6421,Phenotype,HP:0006913,Frontal cortical atrophy,-0.0003087683717017953,-0.6191707391216391,1
6422,Biological Process,GO:0006892,post-Golgi vesicle-mediated transport,-0.00031909347042580194,-0.6193483373035269,1
6423,Biological Process,GO:0009914,hormone transport,-0.0003504696257097262,-0.6198880268776419,1
6424,Phenotype,HP:0005115,Supraventricular arrhythmia,-0.00036916017932075995,-0.6202095161368272,1
6425,Phenotype,HP:0031393,Abnormal proportion of CD8-positive T cells,-0.0004044247588237404,-0.6208160890493171,1
6426,Biological Process,GO:0000075,cell cycle checkpoint signaling,-0.000409378745672484,-0.6209013007340622,1
6427,Phenotype,HP:0003173,Hypoplastic pubic bone,-0.00047537450693901917,-0.6220364692710939,1
6428,Phenotype,HP:0007209,Facial paralysis,-0.0004805223050070584,-0.6221250146305183,1
6429,Phenotype,HP:0007033,Cerebellar dysplasia,-0.0005270691406049632,-0.6229256494327402,1
6430,Biological Process,GO:0002275,myeloid cell activation involved in immune response,-0.0005772932451371116,-0.6237895355698396,1
6431,Biological Process,GO:1900076,regulation of cellular response to insulin stimulus,-0.0005864479700203873,-0.6239470025867092,1
6432,Phenotype,HP:0000657,Oculomotor apraxia,-0.0006190610618130865,-0.624507968245532,1
6433,Phenotype,HP:0002594,Pancreatic hypoplasia,-0.000619928755974275,-0.6245228931299889,1
6434,Phenotype,HP:0011338,Abnormality of mouth shape,-0.0006355877409947031,-0.6247922375056867,1
6435,Biological Process,GO:0086014,atrial cardiac muscle cell action potential,-0.0006674027578581487,-0.6253394757745606,1
6435,Biological Process,GO:0086026,atrial cardiac muscle cell to AV node cell signaling,-0.0006674027578581487,-0.6253394757745606,1
6437,Phenotype,HP:0002476,Primitive reflex,-0.0006777516508029713,-0.6255174832319884,1
6438,Phenotype,HP:0003502,Mild short stature,-0.0006782671147325114,-0.6255263495352715,1
6439,Disease,MONDO:0019053,peroxisomal disease,-0.000693824742846072,-0.6257939505085224,1
6440,Phenotype,HP:0001718,Mitral stenosis,-0.0006944849992633895,-0.6258053073335204,1
6441,Biological Process,GO:0007281,germ cell development,-0.0007080448417604579,-0.6260385451396214,1
6442,Biological Process,GO:0006869,lipid transport,-0.000708623770764305,-0.6260485030820366,1
6443,Phenotype,HP:0040288,Nasogastric tube feeding,-0.0007550961165512238,-0.6268478566127325,1
6444,Biological Process,GO:1901983,regulation of protein acetylation,-0.0007692174214988245,-0.6270907519255633,1
6445,Phenotype,HP:0031475,Status epilepticus without prominent motor symptoms,-0.0007745023117760041,-0.6271816553570745,1
6446,Biological Process,GO:2000786,positive regulation of autophagosome assembly,-0.000774882439257496,-0.6271881937884641,1
6447,Biological Process,GO:0051057,positive regulation of small GTPase mediated signal transduction,-0.0007770084938791832,-0.6272247632630521,1
6448,Phenotype,HP:0007036,Hypoplasia of olfactory tract,-0.0007823660585397629,-0.6273169167395949,1
6449,Phenotype,HP:0011933,Elongated superior cerebellar peduncle,-0.0007856392053233741,-0.6273732169197055,1
6450,Phenotype,HP:0000275,Narrow face,-0.0007973070318383346,-0.6275739108627882,1
6451,Biological Process,GO:0006261,DNA-templated DNA replication,-0.0008108684905925312,-0.6278071764695269,1
6452,Phenotype,HP:0009731,Cerebral hamartoma,-0.0008173156823032546,-0.6279180722155834,1
6453,Biological Process,GO:0035458,cellular response to interferon-beta,-0.0008385488546049924,-0.6282832961129328,1
6454,Phenotype,HP:0001849,Foot oligodactyly,-0.000850178472822094,-0.6284833328492987,1
6455,Phenotype,HP:0003170,Abnormal acetabulum morphology,-0.0008691776194438283,-0.6288101301020547,1
6456,Biological Process,GO:0019218,regulation of steroid metabolic process,-0.0008717186465001525,-0.628853837363108,1
6457,Phenotype,HP:0009142,Duplication of bones involving the upper extremities,-0.0008830427729267232,-0.6290486194488376,1
6457,Phenotype,HP:0004275,Duplication of hand bones,-0.0008830427729267232,-0.6290486194488376,1
6459,Disease,MONDO:0100223,"mitochondrial complex I deficiency, nuclear type",-0.0008842587668034252,-0.6290695353071225,1
6459,Disease,MONDO:0100133,mitochondrial complex I deficiency,-0.0008842587668034252,-0.6290695353071225,1
6461,Phenotype,HP:0000221,Furrowed tongue,-0.0009186166603716295,-0.6296605126521643,1
6462,Phenotype,HP:0001266,Choreoathetosis,-0.0009708818989295764,-0.6305595075762749,1
6463,Phenotype,HP:0006009,Broad phalanx,-0.0009807038255862377,-0.6307284508826282,1
6464,Phenotype,HP:0001339,Lissencephaly,-0.0010052727710412324,-0.6311510521729735,1
6465,Disease,MONDO:0005240,kidney disorder,-0.0010123879988297446,-0.6312734385590735,1
6466,Phenotype,HP:0008316,Abnormal mitochondria in muscle tissue,-0.0010125206607449755,-0.6312757204273229,1
6467,Phenotype,HP:0000680,Delayed eruption of primary teeth,-0.0010395912586607103,-0.6317413517109515,1
6468,Biological Process,GO:0060236,regulation of mitotic spindle organization,-0.001045002414356011,-0.6318344269869449,1
6469,Phenotype,HP:0001970,Tubulointerstitial nephritis,-0.001064507294436856,-0.6321699231727822,1
6470,Biological Process,GO:0006282,regulation of DNA repair,-0.0010693227732097021,-0.6322527524316433,1
6471,Phenotype,HP:0009921,Duane anomaly,-0.0010814488504646835,-0.6324613285752213,1
6471,Phenotype,HP:0025068,Incomitant strabismus,-0.0010814488504646835,-0.6324613285752213,1
6473,Phenotype,HP:0000956,Acanthosis nigricans,-0.0010954328109129552,-0.6327018614764157,1
6474,Phenotype,HP:0012512,Diffuse optic disc pallor,-0.0011010688432859794,-0.6327988047724815,1
6475,Biological Process,GO:0048608,reproductive structure development,-0.0011503341386169819,-0.6336461987892194,1
6476,Phenotype,HP:0012472,Eclabion,-0.001158149831021138,-0.633780633606578,1
6477,Phenotype,HP:0010230,Cone-shaped epiphyses of the phalanges of the hand,-0.001162889571737713,-0.6338621601233101,1
6478,Phenotype,HP:0032368,Acidemia,-0.001170804114458024,-0.6339982952281815,1
6479,Biological Process,GO:0046879,hormone secretion,-0.0012057739268571677,-0.6345997979613811,1
6480,Phenotype,HP:0100021,Cerebral palsy,-0.0012342637801607825,-0.6350898413289285,1
6481,Phenotype,HP:0002208,Coarse hair,-0.0012621775129628698,-0.6355699750620643,1
6482,Phenotype,HP:0007269,Spinal muscular atrophy,-0.0012678617408994342,-0.6356677473520882,1
6483,Phenotype,HP:0000068,Urethral atresia,-0.0012696931101261466,-0.6356992480528295,1
6484,Phenotype,HP:0000074,Ureteropelvic junction obstruction,-0.001293080988245432,-0.6361015342433277,1
6485,Phenotype,HP:0001607,Subglottic stenosis,-0.001320783267342529,-0.6365780308399513,1
6486,Phenotype,HP:0009660,Short phalanx of the thumb,-0.0013455715443568828,-0.6370044047708509,1
6487,Phenotype,HP:0012714,Severe hearing impairment,-0.0013559150896247374,-0.6371823202448768,1
6488,Phenotype,HP:0001832,Abnormal metatarsal morphology,-0.0013882164968632704,-0.6377379247336399,1
6489,Biological Process,GO:0051668,localization within membrane,-0.0013975384386084588,-0.6378982679855412,1
6490,Biological Process,GO:0040036,regulation of fibroblast growth factor receptor signaling pathway,-0.0013993734186885654,-0.6379298307952284,1
6491,Phenotype,HP:0031508,Abnormal circulating thyroid hormone concentration,-0.0014238399898287568,-0.6383506711830712,1
6492,Phenotype,HP:0004755,Supraventricular tachycardia,-0.0014296220921656833,-0.6384501269742434,1
6493,Phenotype,HP:0001107,Ocular albinism,-0.001457214583896027,-0.6389247351592159,1
6494,Biological Process,GO:0032986,protein-DNA complex disassembly,-0.0014785101261765021,-0.639291031859366,1
6495,Phenotype,HP:0000194,Open mouth,-0.0014990922116699945,-0.6396450566547517,1
6496,Phenotype,HP:0001212,Prominent fingertip pads,-0.001509659861500312,-0.6398268268679824,1
6497,Biological Process,GO:0006516,glycoprotein catabolic process,-0.0015166513444473395,-0.6399470847651011,1
6498,Phenotype,HP:0004387,Enterocolitis,-0.0015306082311206115,-0.6401871519803639,1
6499,Phenotype,HP:0031382,Decreased lymphocyte proliferation in response to anti-CD3,-0.0015391159696866996,-0.640333490426291,1
6500,Phenotype,HP:0031605,Abnormality of fundus pigmentation,-0.0015480169786625808,-0.6404865933702277,1
6501,Phenotype,HP:0031162,Impaired oropharyngeal swallow response,-0.0015513737537318217,-0.6405443320093671,1
6502,Phenotype,HP:0007311,Short stepped shuffling gait,-0.0016052130356565275,-0.6414704014678353,1
6503,Phenotype,HP:0001216,Delayed ossification of carpal bones,-0.0016074890858470692,-0.6415095509604001,1
6504,Biological Process,GO:0071624,positive regulation of granulocyte chemotaxis,-0.0016403887788436489,-0.6420754463399061,1
6505,Biological Process,GO:0050892,intestinal absorption,-0.0016950617772000243,-0.6430158562445466,1
6506,Biological Process,GO:0000729,DNA double-strand break processing,-0.0017030997724400976,-0.6431541148102822,1
6507,Biological Process,GO:0009116,nucleoside metabolic process,-0.0017666151711133171,-0.6442466195531196,1
6508,Biological Process,GO:0031346,positive regulation of cell projection organization,-0.001772939076669422,-0.6443553946998969,1
6509,Phenotype,HP:0040086,Abnormal prolactin level,-0.0017817901229320032,-0.64450763825379,1
6510,Phenotype,HP:0006349,Agenesis of permanent teeth,-0.0017887992260778862,-0.6446281992293939,1
6511,Phenotype,HP:0001334,Communicating hydrocephalus,-0.0018087269028570496,-0.6449709677839451,1
6512,Phenotype,HP:0100255,Metaphyseal dysplasia,-0.0018231969760236222,-0.6452198621291577,1
6513,Phenotype,HP:0003700,Generalized amyotrophy,-0.0018287363889686326,-0.6453151435103877,1
6514,Phenotype,HP:0005146,Cardiac valve calcification,-0.001839567516806584,-0.6455014457108056,1
6515,Phenotype,HP:0011334,Facial shape deformation,-0.001841781855111746,-0.6455395337201887,1
6516,Phenotype,HP:0012801,Narrow jaw,-0.0018439474942448797,-0.6455767840732314,1
6517,Biological Process,GO:0050746,regulation of lipoprotein metabolic process,-0.0018643128364514983,-0.6459270807479749,1
6518,Phenotype,HP:0005815,Supernumerary ribs,-0.0018907469726470172,-0.6463817644903378,1
6519,Biological Process,GO:0006887,exocytosis,-0.001895551566037934,-0.646464406513794,1
6520,Phenotype,HP:0000132,Menorrhagia,-0.0019214279733903439,-0.6469094969698195,1
6521,Biological Process,GO:0071277,cellular response to calcium ion,-0.0019219370736196506,-0.6469182538134624,1
6522,Phenotype,HP:0003707,Calf muscle pseudohypertrophy,-0.0019591628172628273,-0.6475585599807127,1
6523,Biological Process,GO:0031570,DNA integrity checkpoint signaling,-0.001961124924100277,-0.6475923094504576,1
6524,Biological Process,GO:0051648,vesicle localization,-0.001962448647324422,-0.6476150783211693,1
6525,Biological Process,GO:0045778,positive regulation of ossification,-0.002048060419735709,-0.6490876545681241,1
6526,Phenotype,HP:0007260,Type II lissencephaly,-0.0020574676264288883,-0.6492494644306745,1
6527,Disease,MONDO:0005336,myopathy,-0.0020592530721188496,-0.6492801752177452,1
6528,Biological Process,GO:0051592,response to calcium ion,-0.0020996409666158566,-0.6499748723654118,1
6529,Biological Process,GO:0090162,establishment of epithelial cell polarity,-0.002110923277567789,-0.650168935198719,1
6530,Phenotype,HP:0009800,Maternal diabetes,-0.0021111742315618187,-0.6501732517650074,1
6531,Phenotype,HP:0010536,Central sleep apnea,-0.00218230114913065,-0.6513966794126421,1
6532,Biological Process,GO:0015804,neutral amino acid transport,-0.002186382491691452,-0.6514668810676417,1
6533,Phenotype,HP:0011620,Abnormality of abdominal situs,-0.0021933382811563096,-0.6515865250144527,1
6534,Biological Process,GO:0007606,sensory perception of chemical stimulus,-0.002203572357312389,-0.6517625575510129,1
6535,Biological Process,GO:0043651,linoleic acid metabolic process,-0.002245812771672462,-0.652489119203648,1
6536,Phenotype,HP:0006495,Aplasia/Hypoplasia of the ulna,-0.0022688472647891533,-0.652885326950187,1
6537,Phenotype,HP:0001636,Tetralogy of Fallot,-0.0022764928323337763,-0.6530168355131287,1
6538,Phenotype,HP:0002187,"Intellectual disability, profound",-0.002284865836619465,-0.653160856444824,1
6539,Phenotype,HP:0012094,Abnormal pancreas size,-0.0022889578617510953,-0.6532312418467502,1
6540,Phenotype,HP:0011710,Bundle branch block,-0.0022988100452994153,-0.6534007055906405,1
6541,Biological Process,GO:0009065,glutamine family amino acid catabolic process,-0.0023075638474356897,-0.6535512764844947,1
6542,Disease,MONDO:0019694,spondylodysplastic dysplasia,-0.002314837181076612,-0.6536763823905417,1
6543,Phenotype,HP:0008331,Elevated creatine kinase after exercise,-0.002314902631742166,-0.6536775081830901,1
6544,Phenotype,HP:0032679,Focal non-motor seizure,-0.00231859444730409,-0.6537410097290984,1
6545,Phenotype,HP:0003995,Abnormality of the radial head,-0.0023393853488409277,-0.6540986262915596,1
6546,Phenotype,HP:0003324,Generalized muscle weakness,-0.00235046754496282,-0.6542892470241242,1
6547,Phenotype,HP:0006479,Abnormal dental pulp morphology,-0.002366753330121707,-0.6545693727558141,1
6548,Biological Process,GO:0035456,response to interferon-beta,-0.002368698925759194,-0.6546028382225513,1
6549,Disease,MONDO:0000992,heart conduction disease,-0.002374545337228806,-0.6547034001711898,1
6550,Phenotype,HP:0007385,Aplasia cutis congenita of scalp,-0.002374964125162249,-0.6547106035866306,1
6551,Biological Process,GO:0006835,dicarboxylic acid transport,-0.0023858328303345555,-0.6548975521407967,1
6552,Phenotype,HP:0006538,Recurrent bronchopulmonary infections,-0.002389995344610263,-0.654969150000266,1
6553,Phenotype,HP:0005003,Aplasia/Hypoplasia of the capital femoral epiphysis,-0.0023987731491221798,-0.6551201337500541,1
6554,Phenotype,HP:0008675,Enlarged polycystic ovaries,-0.0024545354698475297,-0.6560792806835009,1
6555,Biological Process,GO:0006893,Golgi to plasma membrane transport,-0.0024688137779644848,-0.6563248765494376,1
6556,Phenotype,HP:0031318,Myofiber disarray,-0.002486492654032224,-0.6566289643195768,1
6557,Phenotype,HP:0034197,Third trimester onset,-0.0024998179119064545,-0.6568581671228534,1
6558,Phenotype,HP:0002275,Poor motor coordination,-0.0025001079741830967,-0.6568631563761615,1
6559,Phenotype,HP:0003090,Hypoplasia of the capital femoral epiphysis,-0.0025041964294238994,-0.6569334803737237,1
6560,Phenotype,HP:0000546,Retinal degeneration,-0.0025241709093462017,-0.6572770539717279,1
6561,Phenotype,HP:0007377,Abnormality of somatosensory evoked potentials,-0.002536897894531709,-0.657495966109062,1
6562,Biological Process,GO:0046519,sphingoid metabolic process,-0.0025505264721796816,-0.6577303862029221,1
6563,Phenotype,HP:0010902,Abnormal circulating glutamine family amino acid concentration,-0.00255580734744032,-0.6578212205736275,1
6564,Biological Process,GO:0006865,amino acid transport,-0.0025695558785352457,-0.6580577039421022,1
6565,Phenotype,HP:0000614,Abnormal nasolacrimal system morphology,-0.0025761887369712966,-0.6581717932724271,1
6566,Phenotype,HP:0100508,Abnormality of vitamin metabolism,-0.002626714500522098,-0.6590408681340797,1
6567,Biological Process,GO:1903059,regulation of protein lipidation,-0.002645256384468997,-0.659359800181682,1
6568,Phenotype,HP:0000771,Gynecomastia,-0.0026608254391158326,-0.6596275976984807,1
6569,Phenotype,HP:0003071,Flattened epiphysis,-0.002673452458218817,-0.65984479035642,1
6570,Phenotype,HP:0001663,Ventricular fibrillation,-0.0026835091709700443,-0.6600177721310381,1
6571,Phenotype,HP:0002583,Colitis,-0.0026932575420668403,-0.6601854502355712,1
6572,Phenotype,HP:0011922,Abnormal activity of mitochondrial respiratory chain,-0.0027264891291616244,-0.6607570544019853,1
6573,Phenotype,HP:0030038,Enchondroma,-0.0027496827058532958,-0.6611559984859133,1
6574,Phenotype,HP:0002690,Large sella turcica,-0.0027508404320291113,-0.6611759121031527,1
6575,Biological Process,GO:0030071,regulation of mitotic metaphase/anaphase transition,-0.002762983636174221,-0.6613847828399961,1
6576,Phenotype,HP:0100295,Muscle fiber atrophy,-0.0028167320095588977,-0.6623092886144881,1
6577,Biological Process,GO:0010640,regulation of platelet-derived growth factor receptor signaling pathway,-0.002819612081984779,-0.6623588276688076,1
6578,Biological Process,GO:0060314,regulation of ryanodine-sensitive calcium-release channel activity,-0.002826057448339414,-0.6624696920175932,1
6579,Biological Process,GO:0006544,glycine metabolic process,-0.0028319402556578055,-0.662570879997686,1
6580,Biological Process,GO:0071805,potassium ion transmembrane transport,-0.002861665413242287,-0.6630821713745964,1
6581,Phenotype,HP:0033118,Abnormal right ventricular function,-0.002867213143755265,-0.6631775958232186,1
6582,Biological Process,GO:0030258,lipid modification,-0.0029910485311304136,-0.6653076422507711,1
6583,Biological Process,GO:0071577,zinc ion transmembrane transport,-0.002998558937707063,-0.6654368259601868,1
6584,Phenotype,HP:0009998,Complete duplication of phalanx of hand,-0.0029998490973501823,-0.6654590175162278,1
6585,Phenotype,HP:0000341,Narrow forehead,-0.0030247086276866675,-0.6658866170490129,1
6586,Biological Process,GO:0006353,DNA-templated transcription termination,-0.0030268383185643177,-0.6659232490694869,1
6587,Phenotype,HP:0012402,Increased urine alpha-ketoglutarate concentration,-0.003039154368281727,-0.6661350928587153,1
6588,Phenotype,HP:0040270,Impaired glucose tolerance,-0.0031095101606049003,-0.6673452566678825,1
6589,Phenotype,HP:0007272,Progressive psychomotor deterioration,-0.0031278597820476595,-0.6676608816796787,1
6590,Biological Process,GO:0001895,retina homeostasis,-0.0031306751157278434,-0.6677093071869183,1
6591,Phenotype,HP:0000458,Anosmia,-0.0031373204517093356,-0.6678236111388605,1
6592,Disease,MONDO:0021187,hyperlipidemia,-0.003145606849544791,-0.6679661423852256,1
6592,Disease,MONDO:0001336,familial hyperlipidemia,-0.003145606849544791,-0.6679661423852256,1
6594,Biological Process,GO:0055001,muscle cell development,-0.0031993843184825455,-0.6688911486215017,1
6595,Phenotype,HP:0002045,Hypothermia,-0.003228260806113825,-0.669387842342279,1
6596,Disease,MONDO:0004739,urea cycle disorder,-0.0032901177375190827,-0.6704518204066426,1
6597,Phenotype,HP:0032466,Aplasia of the olfactory bulb,-0.003294220361033773,-0.6705223881074129,1
6598,Phenotype,HP:0007333,Hypoplasia of the frontal lobes,-0.0033540560584106593,-0.6715515996772176,1
6599,Phenotype,HP:0008305,Exercise-induced myoglobinuria,-0.0033660612869190754,-0.6717580971464655,1
6600,Phenotype,HP:0012207,Reduced sperm motility,-0.003368429227615266,-0.6717988272134316,1
6601,Phenotype,HP:0100660,Dyskinesia,-0.0033810554802475856,-0.6720160066875942,1
6602,Phenotype,HP:0006510,Chronic pulmonary obstruction,-0.003387767984289969,-0.6721314659723631,1
6603,Biological Process,GO:1902993,positive regulation of amyloid precursor protein catabolic process,-0.003395851780263026,-0.6722705123394674,1
6604,Phenotype,HP:0500030,Abnormal hepatic glycogen storage,-0.003427662157843958,-0.6728176708097687,1
6604,Phenotype,HP:0006568,Increased hepatic glycogen content,-0.003427662157843958,-0.6728176708097687,1
6606,Biological Process,GO:0006285,"base-excision repair, AP site formation",-0.003466552716798965,-0.6734866128458338,1
6607,Phenotype,HP:0000935,Thickened cortex of long bones,-0.0034723729281365134,-0.6735867241357479,1
6607,Phenotype,HP:0100039,Thickened cortex of bones,-0.0034723729281365134,-0.6735867241357479,1
6609,Phenotype,HP:0001730,Progressive hearing impairment,-0.0034842526019747133,-0.6737910619858237,1
6610,Phenotype,HP:0011560,Mitral atresia,-0.003488486912719635,-0.6738638947896494,1
6611,Biological Process,GO:0090051,negative regulation of cell migration involved in sprouting angiogenesis,-0.0035260529745113622,-0.6745100546427637,1
6612,Phenotype,HP:0008972,Decreased activity of mitochondrial respiratory chain,-0.0035649454893660337,-0.6751790303215313,1
6613,Phenotype,HP:0003687,Centrally nucleated skeletal muscle fibers,-0.0035788974196773182,-0.6754190122842555,1
6614,Disease,MONDO:0015514,hereditary endocrine growth disease,-0.0035885000474569217,-0.6755841835122107,1
6615,Phenotype,HP:0033100,Increased proteinogenic amino acid level in urine,-0.00365489418965681,-0.6767262044514666,1
6616,Phenotype,HP:0001902,Giant platelets,-0.003677732781355303,-0.6771190425705926,1
6617,Phenotype,HP:0007687,Unilateral ptosis,-0.00370912377905408,-0.6776589874435637,1
6618,Phenotype,HP:0010772,Anomalous pulmonary venous return,-0.0037466093545774903,-0.6783037628823201,1
6619,Biological Process,GO:0010830,regulation of myotube differentiation,-0.003789378886095429,-0.6790394256823394,1
6620,Biological Process,GO:0006940,regulation of smooth muscle contraction,-0.0038113172694016484,-0.679416779651816,1
6621,Biological Process,GO:0006308,DNA catabolic process,-0.003842493323034546,-0.6799530273518758,1
6622,Biological Process,GO:0031110,regulation of microtubule polymerization or depolymerization,-0.00385439882957761,-0.6801578095406975,1
6623,Phenotype,HP:0200085,Limb tremor,-0.0038605707504060227,-0.6802639704547169,1
6624,Biological Process,GO:0140352,export from cell,-0.003883686372510242,-0.6806615736707878,1
6625,Phenotype,HP:0002747,Respiratory insufficiency due to muscle weakness,-0.003889748606733301,-0.6807658479063154,1
6626,Disease,MONDO:0020249,hereditary optic neuropathy,-0.003892132139185378,-0.6808068461612741,1
6627,Phenotype,HP:0012229,CSF pleocytosis,-0.003916162490172903,-0.6812201832885586,1
6628,Phenotype,HP:0002104,Apnea,-0.003916818328171479,-0.6812314641139795,1
6629,Phenotype,HP:0007556,Plantar hyperkeratosis,-0.003936487215116857,-0.6815697813208779,1
6630,Phenotype,HP:0010851,EEG with burst suppression,-0.003944223417004844,-0.681702848851441,1
6631,Biological Process,GO:0031954,positive regulation of protein autophosphorylation,-0.003945151853588236,-0.6817188185437041,1
6632,Biological Process,GO:2000279,negative regulation of DNA biosynthetic process,-0.0039478258450516,-0.6817648128760558,1
6633,Biological Process,GO:0050849,negative regulation of calcium-mediated signaling,-0.004006862279342549,-0.6827802766188705,1
6634,Phenotype,HP:0045055,Tiger tail banding,-0.004048521041420283,-0.6834968334869903,1
6635,Phenotype,HP:0012523,Oral aversion,-0.0040591416711015516,-0.683679514986927,1
6636,Phenotype,HP:0100579,Mucosal telangiectasiae,-0.00406083520042988,-0.683708644754857,1
6637,Phenotype,HP:0002983,Micromelia,-0.004061461672204336,-0.6837194204627821,1
6638,Phenotype,HP:0001998,Neonatal hypoglycemia,-0.00409864694605,-0.6843590305241014,1
6639,Phenotype,HP:0004823,Anisopoikilocytosis,-0.004139617492492809,-0.6850637496511228,1
6640,Phenotype,HP:0009997,Duplication of phalanx of hand,-0.004143243372507488,-0.6851261170643131,1
6641,Disease,MONDO:0007263,cardiac rhythm disease,-0.004219189446870608,-0.6864324372350873,1
6642,Phenotype,HP:0002448,Progressive encephalopathy,-0.004263062080288593,-0.6871870740805005,1
6643,Phenotype,HP:0001840,Metatarsus adductus,-0.004296204334204301,-0.6877571416601361,1
6644,Phenotype,HP:0001621,Weak voice,-0.004301795949556375,-0.6878533209555491,1
6645,Phenotype,HP:4000007,Bronchoconstriction,-0.004327831846894448,-0.6883011547394826,1
6646,Phenotype,HP:0002872,"Apneic episodes precipitated by illness, fatigue, stress",-0.004330729076751583,-0.6883509889123939,1
6647,Phenotype,HP:0000090,Nephronophthisis,-0.004360791067096859,-0.68886807402431,1
6648,Phenotype,HP:0007351,Upper limb postural tremor,-0.004372389109482677,-0.6890675676365493,1
6649,Biological Process,GO:0032350,regulation of hormone metabolic process,-0.004379063442495168,-0.6891823703556339,1
6650,Phenotype,HP:0000664,Synophrys,-0.004393527717854617,-0.6894311649749231,1
6651,Biological Process,GO:0006829,zinc ion transport,-0.00439675722456534,-0.6894867145183754,1
6652,Phenotype,HP:0001300,Parkinsonism,-0.004412242212218587,-0.6897530660300929,1
6653,Phenotype,HP:0012132,Erythroid hyperplasia,-0.004473564368630445,-0.6908078456287482,1
6654,Phenotype,HP:0011932,Abnormal superior cerebellar peduncle morphology,-0.004517776630556858,-0.6915683242977823,1
6655,Biological Process,GO:0007411,axon guidance,-0.0045752734303516895,-0.692557305360422,1
6655,Biological Process,GO:0097485,neuron projection guidance,-0.0045752734303516895,-0.692557305360422,1
6657,Phenotype,HP:0005435,Impaired T cell function,-0.004596695737220102,-0.6929257824910887,1
6658,Phenotype,HP:0001830,Postaxial foot polydactyly,-0.004629177753224578,-0.6934844935640427,1
6659,Phenotype,HP:0008428,Vertebral clefting,-0.004654854007450471,-0.6939261412606023,1
6660,Phenotype,HP:0030199,Fatigable weakness of neck muscles,-0.004665667747830504,-0.6941121443858251,1
6661,Phenotype,HP:0001408,Bile duct proliferation,-0.004678290278501196,-0.6943292598399105,1
6662,Phenotype,HP:0000889,Abnormal clavicle morphology,-0.004724561866992438,-0.6951251602190514,1
6663,Biological Process,GO:0035051,cardiocyte differentiation,-0.004736531349198936,-0.6953310428294587,1
6664,Phenotype,HP:0100034,Motor tics,-0.00474397726168263,-0.6954591171999754,1
6665,Biological Process,GO:0033046,negative regulation of sister chromatid segregation,-0.004797657023984492,-0.6963824428207575,1
6665,Biological Process,GO:0033048,negative regulation of mitotic sister chromatid segregation,-0.004797657023984492,-0.6963824428207575,1
6665,Biological Process,GO:2000816,negative regulation of mitotic sister chromatid separation,-0.004797657023984492,-0.6963824428207575,1
6665,Biological Process,GO:0045841,negative regulation of mitotic metaphase/anaphase transition,-0.004797657023984492,-0.6963824428207575,1
6669,Phenotype,HP:0004935,Pulmonary artery atresia,-0.0048085022235522246,-0.6965689870637642,1
6670,Phenotype,HP:0100786,Hypersomnia,-0.00482363520641238,-0.6968292838719926,1
6671,Disease,MONDO:0018751,hereditary otorhinolaryngologic disease,-0.004855309326263324,-0.6973740986237726,1
6671,Disease,MONDO:0024623,otorhinolaryngologic disease,-0.004855309326263324,-0.6973740986237726,1
6673,Phenotype,HP:0000895,Lateral clavicle hook,-0.0048559876791147705,-0.6973857667188016,1
6674,Biological Process,GO:0017004,cytochrome complex assembly,-0.004883564595487444,-0.6978601069978414,1
6675,Phenotype,HP:0001622,Premature birth,-0.004895380566052987,-0.6980633491116239,1
6676,Phenotype,HP:0012071,Abnormal circulating acylcarnitine concentration,-0.004925455096341347,-0.6985806499184359,1
6677,Biological Process,GO:1902743,regulation of lamellipodium organization,-0.004937812871316227,-0.698793211408295,1
6678,Biological Process,GO:0006284,base-excision repair,-0.004943947644295621,-0.6988987333559836,1
6679,Biological Process,GO:0035725,sodium ion transmembrane transport,-0.004992958767022548,-0.699741755444319,1
6680,Biological Process,GO:0036109,alpha-linolenic acid metabolic process,-0.005011571327357078,-0.7000619031701713,1
6681,Biological Process,GO:0097428,protein maturation by iron-sulfur cluster transfer,-0.0050347124624403605,-0.7004599452255034,1
6682,Disease,MONDO:0000066,mitochondrial complex deficiency,-0.00505240458757239,-0.7007642608878683,1
6683,Phenotype,HP:0001338,Partial agenesis of the corpus callosum,-0.005091642718055844,-0.7014391813724865,1
6684,Phenotype,HP:0033079,Aplasia/Hypoplasia of the thyroid gland,-0.0051031115780113545,-0.701636452965802,1
6685,Phenotype,HP:0002073,Progressive cerebellar ataxia,-0.005105892210639507,-0.7016842815931554,1
6686,Disease,MONDO:0016761,spondyloepiphyseal dysplasia,-0.005106945557429299,-0.7017023998194082,1
6687,Phenotype,HP:0008669,Abnormal spermatogenesis,-0.005128687233819873,-0.70207637030641,1
6688,Biological Process,GO:0032506,cytokinetic process,-0.00513517389997209,-0.702187945037649,1
6689,Phenotype,HP:0012043,Pendular nystagmus,-0.005155397642706339,-0.7025358061125477,1
6690,Biological Process,GO:0006670,sphingosine metabolic process,-0.005164648362049107,-0.7026949242944021,1
6691,Biological Process,GO:0048278,vesicle docking,-0.00516734737060931,-0.7027413489365294,1
6692,Phenotype,HP:0007695,Abnormal pupillary light reflex,-0.005212978003058533,-0.7035262244692475,1
6693,Phenotype,HP:0100285,EMG,-0.005244307379237201,-0.7040651094133763,1
6694,Biological Process,GO:0032272,negative regulation of protein polymerization,-0.005328171191129494,-0.7055076196417406,1
6695,Biological Process,GO:0016054,organic acid catabolic process,-0.005369942655787607,-0.7062261150650165,1
6695,Biological Process,GO:0046395,carboxylic acid catabolic process,-0.005369942655787607,-0.7062261150650165,1
6697,Phenotype,HP:0009924,Aplasia/Hypoplasia involving the nose,-0.005409067585055771,-0.706899088417645,1
6698,Biological Process,GO:0030166,proteoglycan biosynthetic process,-0.005465511804742418,-0.707869964441437,1
6699,Biological Process,GO:1905907,negative regulation of amyloid fibril formation,-0.005484254680619971,-0.7081923536764632,1
6700,Phenotype,HP:0004751,Paroxysmal ventricular tachycardia,-0.005490025214238914,-0.7082916104784213,1
6701,Phenotype,HP:0031547,Abnormal QT interval,-0.005505506516847891,-0.7085578986050632,1
6702,Phenotype,HP:0012506,Small pituitary gland,-0.005533598158915964,-0.7090410924892954,1
6703,Phenotype,HP:0003220,Abnormality of chromosome stability,-0.005554435833009519,-0.7093995135691036,1
6704,Phenotype,HP:0011026,Aplasia/Hypoplasia of the vagina,-0.00557687691563391,-0.709785514282532,1
6705,Biological Process,GO:0043039,tRNA aminoacylation,-0.0055941270769834794,-0.7100822278902994,1
6705,Biological Process,GO:0043038,amino acid activation,-0.0055941270769834794,-0.7100822278902994,1
6707,Phenotype,HP:0008347,Decreased activity of mitochondrial complex IV,-0.005638504535216082,-0.710845548039538,1
6708,Phenotype,HP:0200160,Agenesis of maxillary incisor,-0.005647716901676425,-0.7110040065277302,1
6709,Biological Process,GO:0010526,retrotransposon silencing,-0.005650430805585804,-0.7110506873792172,1
6710,Phenotype,HP:0009067,Progressive spinal muscular atrophy,-0.005662490731195735,-0.7112581256729592,1
6711,Phenotype,HP:0012146,Abnormality of von Willebrand factor,-0.00567575918489549,-0.7114863514087635,1
6712,Phenotype,HP:0001118,Juvenile cataract,-0.0056903930624601085,-0.7117380632924865,1
6713,Phenotype,HP:0006118,Shortening of all distal phalanges of the fingers,-0.005728098879978383,-0.7123866270318595,1
6714,Phenotype,HP:0012736,Profound global developmental delay,-0.005729325640903671,-0.7124077280901415,1
6715,Biological Process,GO:0048147,negative regulation of fibroblast proliferation,-0.00577698509789859,-0.7132275006790831,1
6716,Phenotype,HP:0031058,Impairment of activities of daily living,-0.005825353798923016,-0.7140594727107151,1
6717,Phenotype,HP:0006713,Aplasia/Hypoplasia of the scapulae,-0.005837526306763818,-0.7142688474895261,1
6718,Biological Process,GO:1904814,"regulation of protein localization to chromosome, telomeric region",-0.005851354453918045,-0.7145067003042171,1
6719,Phenotype,HP:0002305,Athetosis,-0.005854353213825769,-0.7145582808577562,1
6720,Disease,MONDO:0018838,lissencephaly spectrum disorders,-0.005894067469297992,-0.7152413909911727,1
6721,Biological Process,GO:0035303,regulation of dephosphorylation,-0.005902869258181509,-0.7153927872872137,1
6722,Phenotype,HP:0000191,Accessory oral frenulum,-0.005914879227819192,-0.7155993663068623,1
6723,Phenotype,HP:0007281,Developmental stagnation,-0.005935140831918151,-0.7159478786210098,1
6724,Biological Process,GO:0018279,protein N-linked glycosylation via asparagine,-0.005939351037479446,-0.7160202968005398,1
6725,Phenotype,HP:0012599,Abnormal urine phosphate concentration,-0.00594086023481144,-0.7160462559423783,1
6726,Biological Process,GO:0007062,sister chromatid cohesion,-0.005976856491995974,-0.7166654141704613,1
6727,Phenotype,HP:0002882,Sudden episodic apnea,-0.005993447320775891,-0.7169507868439907,1
6728,Phenotype,HP:0410294,Decreased specific antibody response to protein vaccine,-0.0059996466661718095,-0.717057419477793,1
6729,Disease,MONDO:0018307,neurodegeneration with brain iron accumulation,-0.006045139174501113,-0.717839919188911,1
6729,Disease,MONDO:0002283,neuroaxonal dystrophy,-0.006045139174501113,-0.717839919188911,1
6731,Phenotype,HP:0002135,Basal ganglia calcification,-0.006048329658970175,-0.7178947975253019,1
6732,Phenotype,HP:0011203,EEG with abnormally slow frequencies,-0.006111115656805444,-0.7189747561156861,1
6733,Biological Process,GO:0030900,forebrain development,-0.006117514219598608,-0.7190848154138232,1
6734,Phenotype,HP:0009144,Supernumerary bones of the axial skeleton,-0.006165329490739779,-0.7199072681039267,1
6735,Phenotype,HP:0000568,Microphthalmia,-0.006172666787223724,-0.7200334742110402,1
6736,Phenotype,HP:0007344,Atrophy/Degeneration involving the spinal cord,-0.006182205426433773,-0.7201975447954163,1
6737,Phenotype,HP:0012748,Focal T2 hyperintense brainstem lesion,-0.006193281856889499,-0.7203880663549023,1
6738,Phenotype,HP:0002792,Reduced vital capacity,-0.006227342142457903,-0.7209739246554591,1
6739,Phenotype,HP:0002917,Hypomagnesemia,-0.006228256981289482,-0.720989660457852,1
6740,Phenotype,HP:0011376,Abnormal morphology of the vestibule of the inner ear,-0.0062428866566839325,-0.7212413000616091,1
6741,Phenotype,HP:0000882,Hypoplastic scapulae,-0.006257153485866196,-0.7214866984826608,1
6742,Phenotype,HP:0005135,Abnormal T-wave,-0.006262462158200144,-0.7215780109804828,1
6743,Biological Process,GO:0006414,translational elongation,-0.006341652482122928,-0.7229401342809691,1
6744,Biological Process,GO:0007160,cell-matrix adhesion,-0.006350613657255311,-0.7230942721205802,1
6745,Phenotype,HP:0000455,Broad nasal tip,-0.006356759118322897,-0.7231999779100976,1
6746,Biological Process,GO:0035970,peptidyl-threonine dephosphorylation,-0.006371969183394333,-0.7234616005807653,1
6747,Phenotype,HP:0032040,Abnormal ocular adnexa physiology,-0.006383248728117907,-0.7236556158332075,1
6747,Phenotype,HP:0031879,Abnormal eyelid physiology,-0.006383248728117907,-0.7236556158332075,1
6749,Phenotype,HP:0005445,Enlarged posterior fossa,-0.006383743763430427,-0.7236641307514493,1
6750,Phenotype,HP:0033643,Increased circulating very long-chain fatty acid concentration,-0.006394787203148455,-0.7238540848495296,1
6751,Phenotype,HP:0000668,Hypodontia,-0.006418278141060663,-0.7242581437331843,1
6752,Biological Process,GO:0038094,Fc-gamma receptor signaling pathway,-0.006432285918938518,-0.7244990863091242,1
6753,Biological Process,GO:0015697,quaternary ammonium group transport,-0.006432916832015634,-0.724509938410244,1
6754,Phenotype,HP:0007766,Optic disc hypoplasia,-0.006452092774734908,-0.7248397766669,1
6755,Phenotype,HP:0031295,Left atrial enlargement,-0.0064650420480723,-0.7250625123000365,1
6756,Phenotype,HP:0012610,Abnormality of urinary uric acid level,-0.006507157487431359,-0.7257869243041739,1
6757,Disease,MONDO:0016296,holoprosencephaly,-0.006511691744691017,-0.7258649163764099,1
6758,Phenotype,HP:0003128,Lactic acidosis,-0.006540879909646247,-0.7263669711428827,1
6759,Phenotype,HP:0031065,Abnormal ovarian morphology,-0.006550360736309102,-0.7265300473151427,1
6760,Phenotype,HP:0001193,Ulnar deviation of the hand or of fingers of the hand,-0.006571996060103391,-0.7269021884707023,1
6761,Biological Process,GO:0016358,dendrite development,-0.006609423766078537,-0.7275459685168884,1
6762,Phenotype,HP:0012708,Reduced brain N-acetyl aspartate level by MRS,-0.006612261643842432,-0.7275947817965247,1
6763,Disease,MONDO:0100365,mucopolysaccharidosis or mucopolysaccharidosis-like disorder,-0.0066680558863798645,-0.7285544778051852,1
6764,Disease,MONDO:0015653,monogenic epilepsy,-0.00668542826272267,-0.7288532935875834,1
6765,Biological Process,GO:0006779,porphyrin-containing compound biosynthetic process,-0.006686209926795694,-0.7288667387004997,1
6765,Biological Process,GO:0033014,tetrapyrrole biosynthetic process,-0.006686209926795694,-0.7288667387004997,1
6765,Biological Process,GO:0006783,heme biosynthetic process,-0.006686209926795694,-0.7288667387004997,1
6768,Phenotype,HP:0003180,Flat acetabular roof,-0.006688788969876125,-0.7289110998610404,1
6769,Phenotype,HP:0001245,Small thenar eminence,-0.00670760632179368,-0.7292347701307232,1
6770,Phenotype,HP:0002148,Hypophosphatemia,-0.0067458994560216645,-0.7298934360863196,1
6771,Phenotype,HP:0003398,Abnormal synaptic transmission at the neuromuscular junction,-0.006765254113022978,-0.7302263483408536,1
6771,Phenotype,HP:0012535,Abnormal synaptic transmission,-0.006765254113022978,-0.7302263483408536,1
6771,Phenotype,HP:0030191,Abnormal peripheral nervous system synaptic transmission,-0.006765254113022978,-0.7302263483408536,1
6774,Phenotype,HP:0003394,Muscle spasm,-0.006772462871613927,-0.73035034351549,1
6775,Biological Process,GO:0090160,Golgi to lysosome transport,-0.00678677755975321,-0.7305965651406563,1
6775,Biological Process,GO:0006896,Golgi to vacuole transport,-0.00678677755975321,-0.7305965651406563,1
6777,Biological Process,GO:0008366,axon ensheathment,-0.006836764934152528,-0.731456379370812,1
6777,Biological Process,GO:0007272,ensheathment of neurons,-0.006836764934152528,-0.731456379370812,1
6779,Disease,MONDO:0019512,congenital heart malformation,-0.006849156257201283,-0.7316695179086088,1
6780,Phenotype,HP:0009834,Abnormal proximal phalanx morphology of the hand,-0.006860183279523424,-0.7318591896171703,1
6781,Phenotype,HP:0006710,Aplasia/Hypoplasia of the clavicles,-0.006933479896122252,-0.7331199374506232,1
6782,Phenotype,HP:0000526,Aniridia,-0.0069467404185334924,-0.7333480267632845,1
6783,Biological Process,GO:2000369,regulation of clathrin-dependent endocytosis,-0.006960211112152281,-0.7335797311526965,1
6784,Phenotype,HP:0025066,Decreased mean corpuscular volume,-0.006997054634100941,-0.7342134628667779,1
6785,Phenotype,HP:0001199,Triphalangeal thumb,-0.007098077036498562,-0.7359511116268851,1
6786,Phenotype,HP:0009099,Median cleft palate,-0.007123337129103513,-0.7363856010822281,1
6787,Phenotype,HP:0045025,Narrow palpebral fissure,-0.007125517822014871,-0.7364231103697095,1
6788,Phenotype,HP:0010920,Zonular cataract,-0.007177506057316485,-0.7373173406638619,1
6789,Biological Process,GO:2000392,regulation of lamellipodium morphogenesis,-0.007180408976162456,-0.7373672726909537,1
6790,Biological Process,GO:0089718,amino acid import across plasma membrane,-0.007215809038460197,-0.7379761759925924,1
6791,Phenotype,HP:0000188,Short upper lip,-0.00727354751798992,-0.7389693140984395,1
6792,Phenotype,HP:0032388,Periventricular nodular heterotopia,-0.00728853486260439,-0.7392271058373859,1
6793,Biological Process,GO:0040001,establishment of mitotic spindle localization,-0.007319809248634845,-0.7397650449164334,1
6794,Phenotype,HP:0001539,Omphalocele,-0.007334075761482817,-0.7400104378963366,1
6795,Biological Process,GO:0046661,male sex differentiation,-0.007351762432272979,-0.7403146597405963,1
6796,Phenotype,HP:0011965,Abnormal circulating citrulline concentration,-0.007374869363782066,-0.7407121134729735,1
6797,Disease,MONDO:0019587,autosomal dominant nonsyndromic hearing loss,-0.00740014999576788,-0.7411469562185654,1
6798,Phenotype,HP:0100753,Schizophrenia,-0.007409311006911556,-0.7413045313630614,1
6799,Phenotype,HP:0003974,Absent radius,-0.007446080922934417,-0.741936997008997,1
6800,Phenotype,HP:0002049,Proximal renal tubular acidosis,-0.007459842147858886,-0.742173698719311,1
6801,Biological Process,GO:0046942,carboxylic acid transport,-0.007472808081486981,-0.7423967209199098,1
6802,Phenotype,HP:0002062,Abnormal pyramidal tract morphology,-0.007473461533259673,-0.7424079607007471,1
6803,Phenotype,HP:0034011,Reduced progressive sperm motility,-0.007521700164458078,-0.7432376954496918,1
6804,Phenotype,HP:0030584,Color vision test abnormality,-0.00757112269705873,-0.7440877940462076,1
6805,Disease,MONDO:0015150,complex hereditary spastic paraplegia,-0.007617167139731373,-0.7448797873746283,1
6806,Biological Process,GO:0006473,protein acetylation,-0.007619547494350343,-0.7449207309688619,1
6807,Phenotype,HP:0001537,Umbilical hernia,-0.0076445039246206825,-0.7453499972413593,1
6808,Phenotype,HP:0010565,Aplasia/Hypoplasia of the Epiglottis,-0.007653983254596541,-0.745513047669663,1
6809,Biological Process,GO:0140694,non-membrane-bounded organelle assembly,-0.007655739585331833,-0.7455432576612301,1
6810,Phenotype,HP:0007083,Hyperactive patellar reflex,-0.007703313064298278,-0.7463615513740904,1
6811,Phenotype,HP:0002199,Hypocalcemic seizures,-0.007735623830060101,-0.746917316835331,1
6812,Phenotype,HP:0040080,Anteverted ears,-0.007776339405782151,-0.7476176503058419,1
6813,Phenotype,HP:0000873,Diabetes insipidus,-0.007780135111523201,-0.7476829388281709,1
6814,Biological Process,GO:0006576,biogenic amine metabolic process,-0.007793907999276373,-0.7479198411464626,1
6815,Biological Process,GO:0030201,heparan sulfate proteoglycan metabolic process,-0.007796146325593778,-0.74795834176472,1
6816,Biological Process,GO:0019080,viral gene expression,-0.007830680416111901,-0.7485523498079464,1
6817,Phenotype,HP:0011365,Patchy hypopigmentation of hair,-0.00785083664589803,-0.7488990496177416,1
6818,Phenotype,HP:0009824,Upper limb undergrowth,-0.0078527390842138,-0.7489317727514437,1
6819,Disease,MONDO:0015168,arthrogryposis multiplex congenita,-0.00789405475763072,-0.7496424282791487,1
6820,Phenotype,HP:0005990,Thyroid hypoplasia,-0.007894760102535203,-0.7496545606544401,1
6821,Phenotype,HP:0010502,Fibular bowing,-0.007899845410048512,-0.749742031137081,1
6822,Phenotype,HP:0100750,Atelectasis,-0.007911594220839646,-0.7499441180605695,1
6823,Phenotype,HP:0002245,Meckel diverticulum,-0.007943459004169817,-0.7504922123439228,1
6824,Phenotype,HP:0004469,Chronic bronchitis,-0.007951884190878777,-0.7506371308460672,1
6825,Phenotype,HP:0002867,Abnormal ilium morphology,-0.007996752153374365,-0.7514088879766503,1
6826,Phenotype,HP:0012400,Abnormal circulating aldolase concentration,-0.008005780305912813,-0.7515641778697054,1
6827,Biological Process,GO:0007417,central nervous system development,-0.008011308991553667,-0.7516592747345675,1
6828,Phenotype,HP:0012880,Abnormal labia minora morphology,-0.008036165629047076,-0.752086824508635,1
6829,Biological Process,GO:0045910,negative regulation of DNA recombination,-0.008043964074429422,-0.7522209626663879,1
6830,Phenotype,HP:0001802,Absent toenail,-0.008067288000544792,-0.752622148842259,1
6831,Biological Process,GO:0010592,positive regulation of lamellipodium assembly,-0.00808518012324333,-0.75292990458836,1
6832,Phenotype,HP:0002151,Increased circulating lactate concentration,-0.008093979197722145,-0.7530812541949357,1
6833,Biological Process,GO:0044782,cilium organization,-0.008094906563452575,-0.7530972054678553,1
6834,Phenotype,HP:0025723,Abnormal fetal skin morphology,-0.008113073513396518,-0.7534096884151601,1
6835,Phenotype,HP:0007108,Demyelinating peripheral neuropathy,-0.008130601954261518,-0.7537111886053436,1
6836,Phenotype,HP:0009603,Deviation of the thumb,-0.008145130907083464,-0.7539610957176032,1
6837,Phenotype,HP:0008839,Hypoplastic pelvis,-0.008155479805038723,-0.7541391032612137,1
6838,Biological Process,GO:0050886,endocrine process,-0.008221100045677998,-0.7552678126076413,1
6839,Biological Process,GO:0090110,COPII-coated vesicle cargo loading,-0.00823229785428925,-0.7554604219476239,1
6840,Biological Process,GO:0060307,regulation of ventricular cardiac muscle cell membrane repolarization,-0.008248388362373626,-0.7557371887910045,1
6841,Biological Process,GO:0015800,acidic amino acid transport,-0.008250365666037096,-0.7557711996557002,1
6842,Phenotype,HP:0006709,Aplasia/Hypoplasia of the nipples,-0.008256929917190847,-0.7558841088976864,1
6843,Biological Process,GO:0051899,membrane depolarization,-0.008271959283017827,-0.7561426234278761,1
6844,Phenotype,HP:0000727,Frontal lobe dementia,-0.008272756109768409,-0.7561563293483681,1
6845,Phenotype,HP:0000336,Prominent supraorbital ridges,-0.008307325074833338,-0.7567509372556996,1
6846,Phenotype,HP:0002085,Occipital encephalocele,-0.008308296003684212,-0.7567676378416472,1
6847,Phenotype,HP:0001792,Small nail,-0.008324260163492303,-0.757042231415333,1
6848,Phenotype,HP:0001592,Selective tooth agenesis,-0.00834619543853532,-0.7574195319207306,1
6849,Biological Process,GO:0043299,leukocyte degranulation,-0.008348500137848713,-0.7574591741961992,1
6850,Phenotype,HP:0004283,Narrow palm,-0.008366546069176639,-0.7577695755473126,1
6851,Phenotype,HP:0005048,Synostosis of carpal bones,-0.008375844095074969,-0.7579295074316296,1
6852,Phenotype,HP:0045008,Abnormal shape of the radius,-0.008376036602262493,-0.7579328186761435,1
6852,Phenotype,HP:0002986,Radial bowing,-0.008376036602262493,-0.7579328186761435,1
6854,Biological Process,GO:0070071,proton-transporting two-sector ATPase complex assembly,-0.008469591976528523,-0.7595420298633302,1
6855,Phenotype,HP:0031589,Suicidal ideation,-0.008477766496310712,-0.7596826367369233,1
6856,Phenotype,HP:0002072,Chorea,-0.008488922328050652,-0.7598745240483591,1
6857,Biological Process,GO:0006739,NADP metabolic process,-0.008501116487081184,-0.7600842712412298,1
6858,Biological Process,GO:0034243,regulation of transcription elongation by RNA polymerase II,-0.008505262187674001,-0.7601555798947949,1
6859,Phenotype,HP:0003077,Hyperlipidemia,-0.008537394758430628,-0.7607082802900452,1
6860,Phenotype,HP:0011103,Abnormal left ventricular outflow tract morphology,-0.008537498894854778,-0.760710071501935,1
6861,Disease,MONDO:0019270,erythrokeratoderma,-0.008545346307784696,-0.7608450519322563,1
6862,Phenotype,HP:0003473,Fatigable weakness,-0.008587735706108601,-0.7615741762026267,1
6863,Phenotype,HP:0000482,Microcornea,-0.008620037367911726,-0.7621297850700606,1
6864,Phenotype,HP:0000499,Abnormal eyelash morphology,-0.008628129223932968,-0.7622689700750552,1
6865,Disease,MONDO:0002259,gonadal disorder,-0.008640135224849077,-0.7624754808302004,1
6866,Phenotype,HP:0003336,Abnormal enchondral ossification,-0.008679857647624134,-0.7631587314463545,1
6867,Phenotype,HP:0100872,Abnormality of the plantar skin of foot,-0.008697090848978295,-0.7634551533315505,1
6868,Biological Process,GO:0006767,water-soluble vitamin metabolic process,-0.008712359213587373,-0.7637177787908759,1
6869,Phenotype,HP:0000749,Paroxysmal bursts of laughter,-0.008715524074564218,-0.76377221638711,1
6870,Biological Process,GO:0006813,potassium ion transport,-0.008719201550755784,-0.7638354712869435,1
6871,Phenotype,HP:0002186,Apraxia,-0.008735336894651224,-0.7641130093344298,1
6872,Phenotype,HP:0005913,Abnormal metacarpal epiphysis morphology,-0.008739336574604906,-0.7641818063413055,1
6873,Phenotype,HP:0011546,Abnormal atrioventricular connection,-0.008785936505258052,-0.7649833544118196,1
6874,Phenotype,HP:0001271,Polyneuropathy,-0.008829890578004873,-0.7657393920648301,1
6875,Disease,MONDO:0001071,intellectual disability,-0.00884315551584236,-0.7659675573255955,1
6876,Phenotype,HP:0100587,Abnormal preputium morphology,-0.008990761033661476,-0.768506464923673,1
6877,Phenotype,HP:0045058,Abnormality of the testis size,-0.008999710617217938,-0.7686604033808991,1
6878,Phenotype,HP:0100267,Lip pit,-0.009035014610684566,-0.7692676542383146,1
6879,Biological Process,GO:0070918,regulatory ncRNA processing,-0.009093453814225105,-0.7702728452371802,1
6880,Biological Process,GO:0046320,regulation of fatty acid oxidation,-0.009161669924131255,-0.7714462051651217,1
6881,Disease,MONDO:0020040,"46,XY disorder of sex development",-0.009172672200324694,-0.7716354512247298,1
6882,Biological Process,GO:0032024,positive regulation of insulin secretion,-0.009180742168413136,-0.7717742597435352,1
6883,Biological Process,GO:0009394,2'-deoxyribonucleotide metabolic process,-0.009258306078701262,-0.7731084077081692,1
6883,Biological Process,GO:0019692,deoxyribose phosphate metabolic process,-0.009258306078701262,-0.7731084077081692,1
6883,Biological Process,GO:0009262,deoxyribonucleotide metabolic process,-0.009258306078701262,-0.7731084077081692,1
6886,Biological Process,GO:0006949,syncytium formation,-0.009267318233683097,-0.7732634224332047,1
6887,Biological Process,GO:1900077,negative regulation of cellular response to insulin stimulus,-0.009287645438108783,-0.7736130631141668,1
6887,Biological Process,GO:0046627,negative regulation of insulin receptor signaling pathway,-0.009287645438108783,-0.7736130631141668,1
6889,Biological Process,GO:0036158,outer dynein arm assembly,-0.009299015376517783,-0.7738086331947627,1
6890,Phenotype,HP:0001176,Large hands,-0.009315765211319382,-0.7740967408717158,1
6891,Biological Process,GO:0032940,secretion by cell,-0.009316437227897545,-0.7741082999788653,1
6892,Phenotype,HP:0007565,Multiple cafe-au-lait spots,-0.009317475371760642,-0.774126156705232,1
6893,Phenotype,HP:0032391,Subcortical heterotopia,-0.009350744404595934,-0.7746984049618977,1
6894,Phenotype,HP:0000062,Ambiguous genitalia,-0.009415873355033577,-0.7758186638083425,1
6895,Phenotype,HP:0002444,Hypothalamic hamartoma,-0.009435756808970908,-0.7761606717022438,1
6896,Phenotype,HP:0010932,Abnormal circulating nucleobase concentration,-0.009441216487229287,-0.7762545815967928,1
6897,Biological Process,GO:0006098,pentose-phosphate shunt,-0.009461356202355997,-0.7766009973440753,1
6898,Biological Process,GO:0031109,microtubule polymerization or depolymerization,-0.009517041418175776,-0.7775588180247268,1
6899,Phenotype,HP:0001067,Neurofibroma,-0.009572019788546271,-0.7785044805197741,1
6900,Phenotype,HP:0011751,Abnormal posterior pituitary morphogenesis,-0.009575020266389123,-0.7785560906228761,1
6901,Biological Process,GO:0051650,establishment of vesicle localization,-0.009600688183059036,-0.7789975949082372,1
6902,Phenotype,HP:0006429,Broad femoral neck,-0.009607133619278008,-0.7791084604587332,1
6903,Phenotype,HP:0011834,Moyamoya phenomenon,-0.009641652113621113,-0.7797022002379554,1
6904,Phenotype,HP:0012169,Self-biting,-0.009641867137283766,-0.7797058987799811,1
6905,Phenotype,HP:0002345,Action tremor,-0.009656130203362645,-0.7799512324732915,1
6906,Biological Process,GO:2001251,negative regulation of chromosome organization,-0.009661320179090715,-0.7800405033149546,1
6907,Biological Process,GO:0008283,cell population proliferation,-0.009688459034544294,-0.7805073086710975,1
6908,Biological Process,GO:0098662,inorganic cation transmembrane transport,-0.009693717395493184,-0.7805977557815025,1
6909,Biological Process,GO:0090630,activation of GTPase activity,-0.009715982177611604,-0.7809807240155171,1
6910,Phenotype,HP:0002992,Abnormal tibia morphology,-0.009739067407082302,-0.7813778044592058,1
6911,Phenotype,HP:0002340,Caudate atrophy,-0.00974878879284069,-0.7815450183989724,1
6912,Disease,MONDO:0019792,autosomal dominant cerebellar ataxia type I,-0.009764394939221432,-0.7818134539168866,1
6913,Biological Process,GO:0045839,negative regulation of mitotic nuclear division,-0.009800074467021469,-0.7824271642006603,1
6914,Phenotype,HP:0500018,Abnormal cardiac exercise stress test,-0.00981605830883514,-0.7827020963172017,1
6915,Phenotype,HP:0008167,Very long chain fatty acid accumulation,-0.009823203993568619,-0.7828250065818811,1
6916,Biological Process,GO:0051580,regulation of neurotransmitter uptake,-0.00984375362976353,-0.7831784732289541,1
6917,Phenotype,HP:0002506,Diffuse cerebral atrophy,-0.009869914156247939,-0.7836284507124678,1
6918,Biological Process,GO:0007099,centriole replication,-0.009883332070133033,-0.7838592472573161,1
6919,Phenotype,HP:0009487,Ulnar deviation of the hand,-0.009911959935122505,-0.7843516645125274,1
6920,Phenotype,HP:0011100,Intestinal atresia,-0.009925763086258588,-0.7845890873800095,1
6921,Phenotype,HP:0040216,Hypoinsulinemia,-0.009927231344375231,-0.7846143423416354,1
6922,Phenotype,HP:0000154,Wide mouth,-0.009990094116503423,-0.7856956214980696,1
6923,Phenotype,HP:0033130,Abnormal renal echogenicity,-0.00999396892023885,-0.7857622705555729,1
6924,Phenotype,HP:0010514,Hyperpituitarism,-0.010025559455414834,-0.786305647598455,1
6925,Phenotype,HP:0010488,Aplasia/Hypoplasia of the palmar creases,-0.010033405672409179,-0.7864406074579334,1
6926,Phenotype,HP:0031098,Decreased thyroid-stimulating hormone level,-0.01003967912667414,-0.7865485148108213,1
6927,Phenotype,HP:0100490,Camptodactyly of finger,-0.010056958473522615,-0.7868457304274975,1
6928,Phenotype,HP:0001831,Short toe,-0.010064447442283075,-0.7869745453930125,1
6929,Phenotype,HP:0002571,Achalasia,-0.010097634106007947,-0.7875453768492536,1
6930,Biological Process,GO:0006939,smooth muscle contraction,-0.010152101737118002,-0.7884822543082933,1
6931,Phenotype,HP:0005716,Lethal skeletal dysplasia,-0.010164427896877992,-0.7886942719966029,1
6932,Phenotype,HP:0001773,Short foot,-0.010181020599409507,-0.7889796768998365,1
6933,Phenotype,HP:0002827,Hip dislocation,-0.010190166632207953,-0.7891369944073886,1
6934,Phenotype,HP:0010967,Abnormal circulating carnitine concentration,-0.010217341255500445,-0.789604414992822,1
6934,Phenotype,HP:0003234,Decreased circulating carnitine concentration,-0.010217341255500445,-0.789604414992822,1
6936,Phenotype,HP:0001561,Polyhydramnios,-0.010235775392926527,-0.7899214937326048,1
6937,Phenotype,HP:0001924,Sideroblastic anemia,-0.01026322377377653,-0.7903936231199384,1
6938,Phenotype,HP:0500012,Abnormal gonadotropin-releasing hormone concentration,-0.010287319647177773,-0.7908080872738849,1
6938,Phenotype,HP:0003164,Hypothalamic gonadotropin-releasing hormone deficiency,-0.010287319647177773,-0.7908080872738849,1
6940,Phenotype,HP:0010951,Abnormal third ventricle morphology,-0.01034028711655588,-0.791719161009081,1
6940,Phenotype,HP:0007082,Dilated third ventricle,-0.01034028711655588,-0.791719161009081,1
6942,Phenotype,HP:0008222,Female infertility,-0.010351076449430563,-0.7919047443098848,1
6943,Biological Process,GO:0072531,pyrimidine-containing compound transmembrane transport,-0.01039817821559974,-0.7927149242664114,1
6944,Biological Process,GO:0002433,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,-0.010421185573700198,-0.7931106652736313,1
6944,Biological Process,GO:0038096,Fc-gamma receptor signaling pathway involved in phagocytosis,-0.010421185573700198,-0.7931106652736313,1
6944,Biological Process,GO:0002431,Fc receptor mediated stimulatory signaling pathway,-0.010421185573700198,-0.7931106652736313,1
6947,Phenotype,HP:0004364,Abnormal circulating nitrogen compound concentration,-0.010449817674107242,-0.7936031553806844,1
6948,Phenotype,HP:0030188,Tremor by anatomical site,-0.010463951995443477,-0.7938462745835736,1
6949,Biological Process,GO:1901264,carbohydrate derivative transport,-0.010479342353245436,-0.7941109984024244,1
6950,Biological Process,GO:0042255,ribosome assembly,-0.010504822499362243,-0.794549272916358,1
6951,Phenotype,HP:0002401,Stroke-like episode,-0.010531107244845073,-0.7950013870446501,1
6952,Phenotype,HP:0001688,Sinus bradycardia,-0.010540404900251765,-0.7951613125562782,1
6953,Biological Process,GO:0008206,bile acid metabolic process,-0.010549233383905676,-0.7953131680191335,1
6954,Phenotype,HP:0200073,Respiratory insufficiency due to defective ciliary clearance,-0.010609617006799743,-0.7963518042519135,1
6955,Phenotype,HP:0001692,Atrial arrhythmia,-0.01067924720943414,-0.7975494874627864,1
6956,Phenotype,HP:0003316,Butterfly vertebrae,-0.010685663933136968,-0.7976598591399743,1
6957,Phenotype,HP:0001929,Reduced factor XI activity,-0.01070550656089897,-0.7980011647980222,1
6958,Phenotype,HP:0002900,Hypokalemia,-0.010724292802508861,-0.798324299950877,1
6959,Biological Process,GO:0010968,regulation of microtubule nucleation,-0.010735177861404877,-0.7985115297993605,1
6960,Phenotype,HP:0000643,Blepharospasm,-0.010738097229260779,-0.7985617447597525,1
6961,Phenotype,HP:0000957,Cafe-au-lait spot,-0.010768722699689759,-0.7990885220829561,1
6962,Phenotype,HP:0003066,Limited knee extension,-0.01077296270720196,-0.7991614528747564,1
6963,Phenotype,HP:0001116,Macular coloboma,-0.01080282035239799,-0.7996750231217833,1
6964,Phenotype,HP:0008376,Nasal dysarthria,-0.010857513643576455,-0.8006157820757069,1
6965,Phenotype,HP:0000268,Dolichocephaly,-0.010890227842126787,-0.801178486834253,1
6966,Phenotype,HP:0011198,EEG with generalized epileptiform discharges,-0.010895134479227186,-0.8012628840735925,1
6967,Phenotype,HP:0000589,Coloboma,-0.010912400140466127,-0.8015598642891905,1
6968,Phenotype,HP:0100867,Duodenal stenosis,-0.010936316036635585,-0.8019712327217302,1
6968,Phenotype,HP:0012848,Small intestinal stenosis,-0.010936316036635585,-0.8019712327217302,1
6970,Biological Process,GO:1904851,positive regulation of establishment of protein localization to telomere,-0.010950121708924065,-0.8022086989546169,1
6971,Phenotype,HP:0002877,Nocturnal hypoventilation,-0.010957694026276554,-0.8023389475682551,1
6972,Phenotype,HP:0007641,Dyschromatopsia,-0.010958860331485631,-0.8023590087502539,1
6973,Phenotype,HP:0012501,Abnormal brainstem white matter morphology,-0.0109681058823754,-0.802518038031471,1
6974,Biological Process,GO:0035627,ceramide transport,-0.010995638146437559,-0.8029916102627297,1
6975,Biological Process,GO:1901874,negative regulation of post-translational protein modification,-0.011023163179676443,-0.8034650581192874,1
6976,Phenotype,HP:0100799,Neoplasm of the middle ear,-0.011039050514367599,-0.803738330252718,1
6976,Phenotype,HP:0009797,Cholesteatoma,-0.011039050514367599,-0.803738330252718,1
6978,Phenotype,HP:0000066,Labial hypoplasia,-0.011092275377467375,-0.804653831321562,1
6979,Biological Process,GO:0006790,sulfur compound metabolic process,-0.0111067551570323,-0.8049028926229215,1
6980,Phenotype,HP:0004359,Abnormal circulating fatty-acid concentration,-0.011150500532056462,-0.8056553405440466,1
6981,Phenotype,HP:0000337,Broad forehead,-0.01115690625763599,-0.8057655230466072,1
6982,Biological Process,GO:0030301,cholesterol transport,-0.011220705784688034,-0.8068629149759841,1
6983,Phenotype,HP:0002730,Chronic noninfectious lymphadenopathy,-0.011222771664100684,-0.8068984493991884,1
6984,Phenotype,HP:0009104,Aplasia/Hypoplasia of the pubic bone,-0.011245191803137766,-0.8072840898697633,1
6985,Disease,MONDO:0005557,calcium metabolic disease,-0.011248812275474585,-0.8073463642674985,1
6986,Biological Process,GO:0006862,nucleotide transport,-0.011253092598838332,-0.8074199885172624,1
6987,Phenotype,HP:0003540,Impaired platelet aggregation,-0.011258778309500617,-0.8075177863110998,1
6988,Phenotype,HP:0002679,Abnormal sella turcica morphology,-0.011275792485204494,-0.8078104408175698,1
6989,Phenotype,HP:0011342,Mild global developmental delay,-0.011287030613442273,-0.8080037436804481,1
6990,Phenotype,HP:0010465,Precocious puberty in females,-0.011317015993657531,-0.8085195110500193,1
6991,Biological Process,GO:0031397,negative regulation of protein ubiquitination,-0.011406076304002477,-0.8100514043150057,1
6992,Phenotype,HP:0010626,Anterior pituitary agenesis,-0.011424208844277528,-0.8103632953943973,1
6993,Biological Process,GO:1901657,glycosyl compound metabolic process,-0.01145201742409574,-0.8108416204301777,1
6994,Phenotype,HP:0003251,Male infertility,-0.011452400803561691,-0.8108482147977422,1
6995,Phenotype,HP:0002172,Postural instability,-0.011488412450237906,-0.8114676377347463,1
6996,Phenotype,HP:0000543,Optic disc pallor,-0.0114891688127714,-0.811480647645294,1
6997,Phenotype,HP:0002025,Anal stenosis,-0.011516873144216344,-0.8119571795435896,1
6998,Biological Process,GO:0120254,olefinic compound metabolic process,-0.011526940867827573,-0.8121303507119142,1
6999,Phenotype,HP:0010955,Dilatation of the bladder,-0.01162467930187816,-0.8138115131542243,1
7000,Phenotype,HP:0100265,Synostosis of metacarpals/metatarsals,-0.01162869876584538,-0.8138806504585565,1
7001,Phenotype,HP:0005484,Secondary microcephaly,-0.011666720381569684,-0.8145346461253846,1
7002,Phenotype,HP:0002286,Fair hair,-0.011670973498478787,-0.8146078024070438,1
7003,Phenotype,HP:0034200,Abnormal CSF homovanillic acid concentration,-0.0116859261510589,-0.8148649974212139,1
7004,Biological Process,GO:2000010,positive regulation of protein localization to cell surface,-0.011703936135952553,-0.8151747804710846,1
7005,Disease,MONDO:0002412,disorder of glycogen metabolism,-0.01172262633385901,-0.8154962636119278,1
7006,Disease,MONDO:0024417,perceptual disorders,-0.011765518873373848,-0.8162340422267389,1
7007,Biological Process,GO:0030038,contractile actin filament bundle assembly,-0.011767124312910715,-0.8162616567949382,1
7007,Biological Process,GO:0043149,stress fiber assembly,-0.011767124312910715,-0.8162616567949382,1
7009,Phenotype,HP:0008672,Calcium oxalate nephrolithiasis,-0.011778885161305652,-0.8164639507727712,1
7010,Phenotype,HP:0002680,J-shaped sella turcica,-0.011784912246855628,-0.8165676204290496,1
7011,Phenotype,HP:0012434,Delayed early-childhood social milestone development,-0.011788881784096983,-0.8166358989623446,1
7012,Biological Process,GO:0032784,regulation of DNA-templated transcription elongation,-0.011819109822986729,-0.817155840213499,1
7013,Phenotype,HP:0500087,Peripapillary atrophy,-0.011830786930848491,-0.817356693801575,1
7014,Phenotype,HP:0012086,Abnormal urinary color,-0.011867686425662605,-0.8179913882840915,1
7015,Biological Process,GO:0006766,vitamin metabolic process,-0.011907587620840987,-0.818677713897846,1
7016,Phenotype,HP:0001417,X-linked inheritance,-0.011911864575818054,-0.8187512802092438,1
7017,Phenotype,HP:0004406,"Spontaneous, recurrent epistaxis",-0.012000783811517257,-0.820280746901733,1
7018,Phenotype,HP:0004866,Impaired ADP-induced platelet aggregation,-0.012034151060570375,-0.8208546845390219,1
7019,Phenotype,HP:0001419,X-linked recessive inheritance,-0.012043180395365116,-0.8210099947676276,1
7020,Biological Process,GO:0042401,biogenic amine biosynthetic process,-0.012043521055236983,-0.8210158543313473,1
7021,Phenotype,HP:0000824,Decreased response to growth hormone stimulation test,-0.012052017544024185,-0.821161999274013,1
7022,Biological Process,GO:0006837,serotonin transport,-0.012054652231191287,-0.8212073175477872,1
7023,Phenotype,HP:0100665,Angioedema,-0.012057201250587735,-0.8212511622821095,1
7024,Phenotype,HP:0040140,Degeneration of the striatum,-0.012087658862931283,-0.8217750523408341,1
7025,Biological Process,GO:0016233,telomere capping,-0.012107782328256489,-0.8221211885813263,1
7026,Phenotype,HP:0012368,Flat face,-0.012137367283373557,-0.8226300683877544,1
7027,Phenotype,HP:0030187,Titubation,-0.012138152800968971,-0.8226435797836756,1
7028,Biological Process,GO:0000132,establishment of mitotic spindle orientation,-0.01215614454651992,-0.8229530491053982,1
7029,Biological Process,GO:0009313,oligosaccharide catabolic process,-0.012182986610382196,-0.8234147494597951,1
7030,Phenotype,HP:0002561,Absent nipple,-0.012229525387670526,-0.824215245654032,1
7031,Biological Process,GO:0009451,RNA modification,-0.012258412411081387,-0.8247121205968343,1
7032,Phenotype,HP:0009803,Short phalanx of finger,-0.012283304058573696,-0.825140272564868,1
7033,Biological Process,GO:0009581,detection of external stimulus,-0.01228689345406675,-0.8252020124213753,1
7034,Biological Process,GO:0007613,memory,-0.012351104191849815,-0.8263064774335529,1
7035,Biological Process,GO:2001032,regulation of double-strand break repair via nonhomologous end joining,-0.0124011280691676,-0.8271669195368289,1
7036,Phenotype,HP:0004339,Abnormal circulating sulfur amino acid concentration,-0.012429916249538708,-0.8276620943172772,1
7037,Phenotype,HP:0000635,Blue irides,-0.012485148419874914,-0.828612122331113,1
7038,Biological Process,GO:0098660,inorganic ion transmembrane transport,-0.012512495974130955,-0.8290825174377146,1
7039,Phenotype,HP:0011380,Abnormal semicircular canal morphology,-0.012539364454182689,-0.8295446721671587,1
7040,Phenotype,HP:0012384,Rhinitis,-0.012562899992806464,-0.8299494982110601,1
7041,Biological Process,GO:0000959,mitochondrial RNA metabolic process,-0.012592542809908736,-0.8304593732799692,1
7042,Phenotype,HP:0005532,Macrocytic dyserythropoietic anemia,-0.01260299372768614,-0.8306391356285858,1
7043,Phenotype,HP:5200024,Abnormal relationship,-0.012689871340176628,-0.8321334851198103,1
7044,Phenotype,HP:0010850,EEG with spike-wave complexes,-0.012714691371012998,-0.832560405236389,1
7045,Biological Process,GO:0032377,regulation of intracellular lipid transport,-0.012730063393149527,-0.8328248136702802,1
7045,Biological Process,GO:0032383,regulation of intracellular cholesterol transport,-0.012730063393149527,-0.8328248136702802,1
7045,Biological Process,GO:0032380,regulation of intracellular sterol transport,-0.012730063393149527,-0.8328248136702802,1
7048,Phenotype,HP:0025691,Impaired fasting glucose,-0.012745364726379105,-0.8330880062105813,1
7049,Phenotype,HP:0000411,Protruding ear,-0.01276492591987699,-0.8334244710225548,1
7050,Phenotype,HP:0000027,Azoospermia,-0.012780474563049093,-0.8336919174491703,1
7051,Phenotype,HP:0031882,Agyria,-0.012807733892877593,-0.8341607950402159,1
7052,Phenotype,HP:0012811,Wide nasal ridge,-0.012809927741738614,-0.8341985306182931,1
7053,Phenotype,HP:0012815,Hypoplastic female external genitalia,-0.012831131412658126,-0.8345632470733423,1
7054,Biological Process,GO:0034389,lipid droplet organization,-0.01285693871901561,-0.8350071489488617,1
7055,Biological Process,GO:0006913,nucleocytoplasmic transport,-0.012937784907740335,-0.8363977541637722,1
7056,Phenotype,HP:0011330,Metopic synostosis,-0.012939121369282658,-0.8364207421415556,1
7057,Phenotype,HP:0004408,Abnormality of the sense of smell,-0.012939886585239702,-0.8364339043365481,1
7058,Phenotype,HP:0012246,Oculomotor nerve palsy,-0.012941197355051282,-0.8364564504004293,1
7059,Biological Process,GO:0072344,rescue of stalled ribosome,-0.012960657447455226,-0.8367911762100986,1
7060,Disease,MONDO:0015369,Joubert syndrome and related disorders,-0.013037500238449962,-0.8381129204700462,1
7061,Phenotype,HP:0012179,Craniofacial dystonia,-0.013037841257080185,-0.838118786204635,1
7062,Phenotype,HP:0000868,Decreased fertility in females,-0.013051121174007418,-0.8383472091151505,1
7063,Phenotype,HP:0012725,Cutaneous syndactyly,-0.01307025266005124,-0.8386762826890712,1
7064,Biological Process,GO:0048598,embryonic morphogenesis,-0.013121262329583772,-0.8395536810374872,1
7065,Phenotype,HP:0007874,Almond-shaped palpebral fissure,-0.013160728607675809,-0.8402325258042425,1
7066,Disease,MONDO:0009637,inborn mitochondrial myopathy,-0.013179503007783921,-0.8405554572758305,1
7067,Phenotype,HP:0030402,Abnormal platelet aggregation,-0.013214442544245086,-0.8411564392438845,1
7068,Disease,MONDO:0021189,intestinal motility disease,-0.013240478219008978,-0.8416042691994022,1
7069,Biological Process,GO:0070922,RISC complex assembly,-0.013251097571333581,-0.8417869287280023,1
7070,Phenotype,HP:0010300,Abnormally low-pitched voice,-0.013257921596762978,-0.8419043062506597,1
7071,Phenotype,HP:0010442,Polydactyly,-0.013267376759184657,-0.842066940981855,1
7072,Biological Process,GO:0007605,sensory perception of sound,-0.01328523582240937,-0.8423741280842459,1
7072,Biological Process,GO:0050954,sensory perception of mechanical stimulus,-0.01328523582240937,-0.8423741280842459,1
7074,Biological Process,GO:0090151,establishment of protein localization to mitochondrial membrane,-0.013289029409442987,-0.8424393801634766,1
7075,Phenotype,HP:0009658,Aplasia/Hypoplasia of the phalanges of the thumb,-0.013303810510395087,-0.8426936243819159,1
7076,Phenotype,HP:0008193,Primary gonadal insufficiency,-0.013333917003269136,-0.8432114749652732,1
7077,Phenotype,HP:0012707,Elevated brain lactate level by MRS,-0.013345639430654144,-0.8434131080776083,1
7078,Biological Process,GO:0098810,neurotransmitter reuptake,-0.013386493661830201,-0.8441158265089993,1
7079,Disease,MONDO:0000577,congenital anemia,-0.01341954456391381,-0.8446843227797568,1
7080,Biological Process,GO:0032727,positive regulation of interferon-alpha production,-0.013479834153392378,-0.8457213415787402,1
7081,Disease,MONDO:0018614,undetermined early-onset epileptic encephalopathy,-0.013524656067154917,-0.8464923066421977,1
7082,Biological Process,GO:0001523,retinoid metabolic process,-0.013531236068544672,-0.8466054867981339,1
7083,Biological Process,GO:0006888,endoplasmic reticulum to Golgi vesicle-mediated transport,-0.013534510315973414,-0.8466618059100319,1
7084,Phenotype,HP:0000021,Megacystis,-0.013537961283916822,-0.8467211647257571,1
7085,Biological Process,GO:0045746,negative regulation of Notch signaling pathway,-0.013571796913986578,-0.8473031588106605,1
7086,Biological Process,GO:0006400,tRNA modification,-0.013644797816951604,-0.8485588201839133,1
7087,Phenotype,HP:0011883,Abnormal platelet granules,-0.01368347823209759,-0.8492241476144995,1
7088,Biological Process,GO:0030879,mammary gland development,-0.013712570554771819,-0.8497245538335532,1
7089,Phenotype,HP:0005769,Fifth finger distal phalanx clinodactyly,-0.013728129807327738,-0.8499921827482326,1
7090,Biological Process,GO:0031293,membrane protein intracellular domain proteolysis,-0.013735276639199157,-0.850115112744405,1
7091,Biological Process,GO:1900034,regulation of cellular response to heat,-0.01373579727099239,-0.8501240679381888,1
7092,Phenotype,HP:0005989,Redundant neck skin,-0.013746524564627105,-0.8503085841251065,1
7093,Biological Process,GO:0007080,mitotic metaphase chromosome alignment,-0.013752527558374084,-0.8504118393872444,1
7094,Phenotype,HP:0000384,Preauricular skin tag,-0.013762022694716158,-0.8505751616949729,1
7095,Phenotype,HP:0002562,Low-set nipples,-0.013778812646159766,-0.8508639594033605,1
7096,Phenotype,HP:0006264,Aplasia/Hypoplasia of the 2nd finger,-0.013780497675201842,-0.850892942961029,1
7097,Phenotype,HP:0010677,Enuresis nocturna,-0.013802090645130827,-0.8512643556035085,1
7098,Disease,MONDO:0015229,Bardet-Biedl syndrome,-0.013823242883207465,-0.8516281873813621,1
7099,Phenotype,HP:0001667,Right ventricular hypertrophy,-0.013847651462557176,-0.8520480302739917,1
7100,Phenotype,HP:0032409,Subcortical band heterotopia,-0.01389907146116598,-0.8529324865401932,1
7101,Biological Process,GO:0003333,amino acid transmembrane transport,-0.013925927870384491,-0.8533944336437257,1
7102,Disease,MONDO:0019054,congenital limb malformation,-0.013926444339760202,-0.8534033172413142,1
7103,Phenotype,HP:0001833,Long foot,-0.013936813102897405,-0.853581666478529,1
7104,Disease,MONDO:0100309,hereditary ataxia,-0.01394219347840897,-0.8536742123160332,1
7104,Disease,MONDO:0100308,atactic disorder,-0.01394219347840897,-0.8536742123160332,1
7106,Biological Process,GO:0034383,low-density lipoprotein particle clearance,-0.013955865464555073,-0.8539093790633203,1
7107,Phenotype,HP:0030148,Heart murmur,-0.013974294144440513,-0.854226363929977,1
7108,Phenotype,HP:0002599,Head titubation,-0.013998815414186572,-0.8546481451681898,1
7109,Phenotype,HP:0009623,Proximal placement of thumb,-0.014059059542364638,-0.8556843820042563,1
7110,Phenotype,HP:0003016,Metaphyseal widening,-0.014064967071715673,-0.8557859952188354,1
7111,Phenotype,HP:0005625,Osteoporosis of vertebrae,-0.01411336516445072,-0.8566184728063471,1
7112,Phenotype,HP:0001604,Vocal cord paresis,-0.0141240885980225,-0.8568029225977581,1
7113,Phenotype,HP:0009822,Aplasia involving forearm bones,-0.014136394677695785,-0.8570145948959669,1
7113,Phenotype,HP:0003953,Absent forearm bone,-0.014136394677695785,-0.8570145948959669,1
7115,Disease,MONDO:0017706,disorder of carbohydrate transmembrane transport and absorption,-0.014203887668785997,-0.8581755167261786,1
7116,Phenotype,HP:0001942,Metabolic acidosis,-0.014275188300380659,-0.8594019323641444,1
7117,Phenotype,HP:0001003,Multiple lentigines,-0.014307780790246083,-0.8599625436568807,1
7118,Phenotype,HP:0100720,Hypoplasia of the ear cartilage,-0.014323167094607792,-0.8602271977540138,1
7119,Phenotype,HP:0000498,Blepharitis,-0.014326828340184727,-0.8602901734770834,1
7120,Biological Process,GO:0070989,oxidative demethylation,-0.014335759057652941,-0.8604437874257442,1
7121,Biological Process,GO:0015015,"heparan sulfate proteoglycan biosynthetic process, enzymatic modification",-0.01437707391369214,-0.8611544288940391,1
7122,Phenotype,HP:0001566,Widely-spaced maxillary central incisors,-0.014400651987368285,-0.8615599865675521,1
7123,Phenotype,HP:0032807,Neonatal seizure,-0.014420222308545672,-0.8618966083813449,1
7124,Biological Process,GO:0061512,protein localization to cilium,-0.014445071942515986,-0.8623240376904171,1
7125,Biological Process,GO:0032205,negative regulation of telomere maintenance,-0.014446051995012033,-0.862340895208791,1
7126,Phenotype,HP:0006801,Hyperactive deep tendon reflexes,-0.014479005678194046,-0.8629077192533906,1
7127,Phenotype,HP:0002558,Supernumerary nipple,-0.014482255169661062,-0.862963612547201,1
7128,Phenotype,HP:0004309,Ventricular preexcitation,-0.014482779569713333,-0.8629726325574066,1
7129,Phenotype,HP:0002392,EEG with polyspike wave complexes,-0.014511988729224434,-0.8634750484434244,1
7130,Phenotype,HP:0010832,Abnormality of pain sensation,-0.014514940117026365,-0.8635258141669956,1
7131,Biological Process,GO:0072657,protein localization to membrane,-0.014515619964584392,-0.8635375079719164,1
7132,Phenotype,HP:0012554,Absent thumbnail,-0.014531494491996977,-0.8638105598121131,1
7133,Phenotype,HP:0032663,Focal motor status epilepticus,-0.014590786541427203,-0.8648304202958416,1
7134,Phenotype,HP:0012760,Reduced social reciprocity,-0.014592150576184348,-0.8648538825502351,1
7135,Phenotype,HP:0007141,Sensorimotor neuropathy,-0.014593710928180847,-0.8648807215844265,1
7136,Biological Process,GO:0006814,sodium ion transport,-0.01460644069887862,-0.8650996816343208,1
7137,Phenotype,HP:0001664,Torsade de pointes,-0.014638700788472292,-0.8656545754336462,1
7138,Biological Process,GO:0009247,glycolipid biosynthetic process,-0.014642875892612262,-0.8657263898466868,1
7139,Biological Process,GO:1903798,regulation of miRNA processing,-0.014653110393909152,-0.8659024296959359,1
7139,Biological Process,GO:0070920,regulation of regulatory ncRNA processing,-0.014653110393909152,-0.8659024296959359,1
7141,Phenotype,HP:0011611,Interrupted aortic arch,-0.014791440885206786,-0.8682818010134211,1
7142,Biological Process,GO:1903321,negative regulation of protein modification by small protein conjugation or removal,-0.014811259683551459,-0.868622696790527,1
7143,Phenotype,HP:0001161,Hand polydactyly,-0.014820771659116883,-0.8687863087434715,1
7144,Phenotype,HP:0008873,Disproportionate short-limb short stature,-0.014833708458896977,-0.8690088298235895,1
7145,Phenotype,HP:0009892,Anotia,-0.014846973596162716,-0.8692369985146462,1
7146,Phenotype,HP:0000387,Absent earlobe,-0.014871574987284086,-0.869660157890828,1
7147,Biological Process,GO:0006721,terpenoid metabolic process,-0.014883001792748374,-0.8698567061204855,1
7148,Phenotype,HP:0002080,Intention tremor,-0.014898698400428234,-0.8701266976295514,1
7149,Phenotype,HP:0000946,Hypoplastic ilia,-0.014946673253216858,-0.8709518952242034,1
7150,Biological Process,GO:0060382,regulation of DNA strand elongation,-0.015004245618764456,-0.8719421760652436,1
7151,Biological Process,GO:0050773,regulation of dendrite development,-0.015079705804526222,-0.8732401386469519,1
7152,Phenotype,HP:0030344,Decreased circulating luteinizing hormone level,-0.015133707552306808,-0.8741690026201647,1
7153,Biological Process,GO:0006302,double-strand break repair,-0.015146963294117466,-0.8743970097034939,1
7154,Biological Process,GO:0071539,protein localization to centrosome,-0.015151033862942587,-0.8744670260434743,1
7154,Biological Process,GO:1905508,protein localization to microtubule organizing center,-0.015151033862942587,-0.8744670260434743,1
7156,Phenotype,HP:0034295,Reduced cerebral white matter volume,-0.01516549831126257,-0.8747158236377932,1
7157,Biological Process,GO:0016101,diterpenoid metabolic process,-0.015229073356075151,-0.8758093543316836,1
7158,Phenotype,HP:0006706,Cystic liver disease,-0.01532562520621239,-0.8774701067855469,1
7159,Biological Process,GO:0001682,tRNA 5'-leader removal,-0.01533694323736734,-0.8776647840287771,1
7160,Biological Process,GO:0060148,positive regulation of post-transcriptional gene silencing,-0.015374981197106896,-0.8783190608229311,1
7160,Biological Process,GO:2000637,positive regulation of miRNA-mediated gene silencing,-0.015374981197106896,-0.8783190608229311,1
7160,Biological Process,GO:1900370,positive regulation of post-transcriptional gene silencing by RNA,-0.015374981197106896,-0.8783190608229311,1
7163,Phenotype,HP:0009835,Aplasia/Hypoplasia of the distal phalanges of the hand,-0.0153985633236835,-0.8787246882088771,1
7164,Biological Process,GO:0000387,spliceosomal snRNP assembly,-0.01540546773005147,-0.8788434483341545,1
7165,Phenotype,HP:0030192,Fatigable weakness of bulbar muscles,-0.015410882365078704,-0.8789365834568422,1
7166,Phenotype,HP:0001612,Weak cry,-0.015420540916177838,-0.8791027166010115,1
7167,Biological Process,GO:2000641,regulation of early endosome to late endosome transport,-0.015424072039678327,-0.8791634541426535,1
7168,Biological Process,GO:0036257,multivesicular body organization,-0.015431794870312876,-0.8792962916792607,1
7169,Biological Process,GO:0048041,focal adhesion assembly,-0.015481461327979673,-0.8801505859400915,1
7170,Biological Process,GO:0015980,energy derivation by oxidation of organic compounds,-0.01549364841407641,-0.8803602114740593,1
7171,Disease,MONDO:0002012,methylmalonic acidemia,-0.015497295634631536,-0.8804229459579465,1
7172,Phenotype,HP:0009795,Branchial fistula,-0.015546964838140553,-0.8812772874489877,1
7173,Phenotype,HP:0003138,Increased blood urea nitrogen,-0.015556182529535167,-0.8814358375293933,1
7174,Phenotype,HP:0002883,Hyperventilation,-0.01556861228348616,-0.881649637102842,1
7175,Biological Process,GO:0001570,vasculogenesis,-0.015580527740777006,-0.8818545904507742,1
7176,Phenotype,HP:0001920,Renal artery stenosis,-0.015598601133085532,-0.8821654641479987,1
7177,Biological Process,GO:0034145,positive regulation of toll-like receptor 4 signaling pathway,-0.015622633195433,-0.8825788307117488,1
7178,Phenotype,HP:0010994,Abnormal corpus striatum morphology,-0.01564684469282862,-0.8829952836710068,1
7179,Phenotype,HP:0002465,Poor speech,-0.01564968518112808,-0.8830441418534942,1
7180,Phenotype,HP:0007074,Thick corpus callosum,-0.015651223980800655,-0.8830706101741799,1
7181,Biological Process,GO:0006687,glycosphingolipid metabolic process,-0.01565693921669231,-0.8831689158205035,1
7182,Biological Process,GO:0006066,alcohol metabolic process,-0.015671889129230898,-0.8834260637042386,1
7183,Biological Process,GO:1902019,regulation of cilium-dependent cell motility,-0.015679342192388424,-0.8835542610708356,1
7183,Biological Process,GO:0060295,regulation of cilium movement involved in cell motility,-0.015679342192388424,-0.8835542610708356,1
7185,Biological Process,GO:1904357,negative regulation of telomere maintenance via telomere lengthening,-0.0157350770277338,-0.8845129352384868,1
7186,Phenotype,HP:0000276,Long face,-0.01575218881266438,-0.8848072686849516,1
7187,Biological Process,GO:0051480,regulation of cytosolic calcium ion concentration,-0.015770780539817286,-0.8851270580669972,1
7188,Phenotype,HP:0000430,Underdeveloped nasal alae,-0.015771399654093132,-0.8851377072213259,1
7189,Phenotype,HP:0012285,Abnormal hypothalamus physiology,-0.015791074111006553,-0.8854761202351724,1
7190,Biological Process,GO:0006720,isoprenoid metabolic process,-0.015793427013224948,-0.8855165916308768,1
7191,Biological Process,GO:0006650,glycerophospholipid metabolic process,-0.015873869389843254,-0.8869002510239756,1
7192,Phenotype,HP:0002478,Progressive spastic quadriplegia,-0.01587972843634944,-0.8870010303031776,1
7193,Biological Process,GO:0006099,tricarboxylic acid cycle,-0.01589277979547421,-0.8872255218759637,1
7194,Disease,MONDO:0002145,disorder of sexual differentiation,-0.015900986488665225,-0.8873666821523924,1
7195,Phenotype,HP:0003363,Abdominal situs inversus,-0.0159063611163619,-0.8874591291238711,1
7196,Biological Process,GO:1902017,regulation of cilium assembly,-0.015923538311109375,-0.8877545876602618,1
7197,Phenotype,HP:0000510,Rod-cone dystrophy,-0.015975726084884734,-0.8886522501414665,1
7198,Phenotype,HP:0200005,Abnormal shape of the palpebral fissure,-0.015990365214256563,-0.8889040523595714,1
7199,Phenotype,HP:0010761,Broad columella,-0.016021097734066014,-0.8894326709993428,1
7200,Phenotype,HP:0002681,Deformed sella turcica,-0.01607770427951949,-0.8904063391282596,1
7201,Biological Process,GO:0006112,energy reserve metabolic process,-0.01611814858124916,-0.8911020065157501,1
7202,Phenotype,HP:0000493,Abnormal foveal morphology,-0.016154760611554853,-0.8917317564282031,1
7203,Phenotype,HP:0000446,Narrow nasal bridge,-0.016218732379896128,-0.8928321110159168,1
7204,Phenotype,HP:0008053,Aplasia/Hypoplasia of the iris,-0.01622713444199886,-0.8929766317603125,1
7204,Phenotype,HP:0008055,Aplasia/Hypoplasia affecting the uvea,-0.01622713444199886,-0.8929766317603125,1
7206,Disease,MONDO:0003441,dystonic disorder,-0.016233117184234702,-0.8930795386837417,1
7206,Disease,MONDO:0001815,extrapyramidal and movement disease,-0.016233117184234702,-0.8930795386837417,1
7206,Disease,MONDO:0044807,inherited dystonia,-0.016233117184234702,-0.8930795386837417,1
7209,Phenotype,HP:0002693,Abnormal skull base morphology,-0.01625052855193654,-0.8933790251420005,1
7210,Biological Process,GO:2000050,regulation of non-canonical Wnt signaling pathway,-0.016263331824801552,-0.8935992494753284,1
7211,Phenotype,HP:0000718,Aggressive behavior,-0.016440184162367366,-0.8966412207391254,1
7212,Phenotype,HP:0003327,Axial muscle weakness,-0.016461759339831517,-0.8970123273400367,1
7213,Phenotype,HP:0031657,Abnormal heart sound,-0.016468017623711084,-0.8971199737527693,1
7214,Phenotype,HP:0000331,Short chin,-0.016470422551815744,-0.897161340026388,1
7215,Phenotype,HP:0025427,Abnormal bronchus physiology,-0.01651079882255635,-0.8978558372381453,1
7216,Biological Process,GO:1903825,organic acid transmembrane transport,-0.01654356564307724,-0.8984194471276298,1
7217,Biological Process,GO:0007423,sensory organ development,-0.016604787617200634,-0.8994725035280122,1
7218,Phenotype,HP:0006989,Dysplastic corpus callosum,-0.016632744805334942,-0.8999533847201507,1
7219,Phenotype,HP:0008515,Aplasia/Hypoplasia of the vertebrae,-0.016653899975033415,-0.9003172669237408,1
7219,Phenotype,HP:0008417,Vertebral hypoplasia,-0.016653899975033415,-0.9003172669237408,1
7221,Biological Process,GO:0010257,NADH dehydrogenase complex assembly,-0.016685334616357794,-0.900857962494479,1
7221,Biological Process,GO:0032981,mitochondrial respiratory chain complex I assembly,-0.016685334616357794,-0.900857962494479,1
7223,Phenotype,HP:0005948,Multiple pulmonary cysts,-0.01669141610587266,-0.9009625679331174,1
7224,Phenotype,HP:0032443,Past medical history,-0.016703999869814856,-0.9011790165751282,1
7224,Phenotype,HP:0002686,Pregnancy history,-0.016703999869814856,-0.9011790165751282,1
7226,Biological Process,GO:0042278,purine nucleoside metabolic process,-0.01676102846583749,-0.9021599442388691,1
7227,Biological Process,GO:0003014,renal system process,-0.01677970760495917,-0.9024812371616695,1
7228,Biological Process,GO:0006298,mismatch repair,-0.016782919640812466,-0.9025364861954029,1
7229,Biological Process,GO:0051294,establishment of spindle orientation,-0.016795905850917947,-0.9027598571641458,1
7230,Disease,MONDO:0001084,primary optic atrophy,-0.01681575430163651,-0.9031012629807033,1
7230,Disease,MONDO:0003608,optic atrophy,-0.01681575430163651,-0.9031012629807033,1
7230,Disease,MONDO:0043878,hereditary optic atrophy,-0.01681575430163651,-0.9031012629807033,1
7230,Disease,MONDO:0002135,optic nerve disorder,-0.01681575430163651,-0.9031012629807033,1
7234,Disease,MONDO:0019342,Seckel syndrome,-0.016822986536124684,-0.903225661955514,1
7235,Biological Process,GO:0048013,ephrin receptor signaling pathway,-0.01683458869231713,-0.9034252263278106,1
7236,Phenotype,HP:0010174,Broad phalanx of the toes,-0.016850224005951375,-0.9036941635408012,1
7237,Phenotype,HP:0010901,Abnormal circulating methionine concentration,-0.016851683652900684,-0.9037192703849414,1
7238,Phenotype,HP:0100712,Abnormal lumbar spine morphology,-0.01686455545036125,-0.9039406733843441,1
7239,Phenotype,HP:0007015,Poor gross motor coordination,-0.016875650018803423,-0.9041315069285869,1
7240,Phenotype,HP:0005819,Short middle phalanx of finger,-0.01688250230496169,-0.9042493705535277,1
7241,Phenotype,HP:0008057,Aplasia/Hypoplasia affecting the fundus,-0.01690851064202481,-0.9046967302834251,1
7242,Phenotype,HP:0010862,Delayed fine motor development,-0.016958848326072307,-0.9055625700595128,1
7243,Biological Process,GO:0060322,head development,-0.01699782224195312,-0.9062329458870472,1
7244,Phenotype,HP:0001869,Deep plantar creases,-0.017112967892381814,-0.9082135233822412,1
7245,Biological Process,GO:1901071,glucosamine-containing compound metabolic process,-0.01712018081289024,-0.9083375901444716,1
7246,Phenotype,HP:0011469,Nasal regurgitation,-0.01713306684459015,-0.9085592379817297,1
7247,Biological Process,GO:0051169,nuclear transport,-0.017196897830519253,-0.9096571710235472,1
7248,Biological Process,GO:0022406,membrane docking,-0.017198865799284535,-0.909691021322132,1
7249,Phenotype,HP:0100334,Unilateral cleft palate,-0.017289040673242217,-0.911242085781168,1
7250,Phenotype,HP:0009370,Type A brachydactyly,-0.0173292547243995,-0.9119337927142234,1
7251,Phenotype,HP:0031179,Nuchal rigidity,-0.017344626298984034,-0.9121981934499392,1
7252,Biological Process,GO:1905168,positive regulation of double-strand break repair via homologous recombination,-0.01734539368889454,-0.9122113930382965,1
7253,Biological Process,GO:0065004,protein-DNA complex assembly,-0.017387008381529512,-0.9129271918843265,1
7254,Phenotype,HP:0030048,Colpocephaly,-0.0173891016679939,-0.9129631977260315,1
7255,Phenotype,HP:0004921,Abnormal magnesium concentration,-0.017414857808547346,-0.913406219517591,1
7256,Phenotype,HP:0009051,Increased muscle glycogen content,-0.01741545768535313,-0.9134165377753543,1
7257,Phenotype,HP:0008625,Severe sensorineural hearing impairment,-0.017419076342980677,-0.9134787809589504,1
7258,Biological Process,GO:0045742,positive regulation of epidermal growth factor receptor signaling pathway,-0.01741991987966851,-0.9134932903196954,1
7259,Phenotype,HP:0003022,Hypoplasia of the ulna,-0.017420019949982102,-0.9134950115919301,1
7260,Biological Process,GO:0007224,smoothened signaling pathway,-0.017425305689986015,-0.9135859296392748,1
7261,Phenotype,HP:0003452,Increased circulating iron concentration,-0.017445772552772798,-0.9139379725317488,1
7262,Biological Process,GO:1902004,positive regulation of amyloid-beta formation,-0.01746173021484676,-0.9142124543403272,1
7263,Phenotype,HP:0001919,Acute kidney injury,-0.01746283284196104,-0.9142314202191076,1
7264,Phenotype,HP:0032792,Tonic seizure,-0.017466338447595042,-0.9142917188374218,1
7265,Phenotype,HP:0000666,Horizontal nystagmus,-0.01748085403478128,-0.914541396052354,1
7266,Biological Process,GO:0031503,protein-containing complex localization,-0.017506634334609084,-0.9149848333986037,1
7267,Biological Process,GO:0006626,protein targeting to mitochondrion,-0.017540217829518312,-0.9155624906004132,1
7268,Phenotype,HP:0031469,Low self-esteem,-0.0175731577903242,-0.9161290786115263,1
7269,Phenotype,HP:0010489,Absent palmar crease,-0.017582262570734475,-0.9162856865520966,1
7270,Phenotype,HP:0006579,Prolonged neonatal jaundice,-0.017596998731274516,-0.9165391577672273,1
7271,Phenotype,HP:0030374,Decreased proportion of memory B cells,-0.017600203715309792,-0.9165942855052625,1
7271,Phenotype,HP:0030373,Abnormal proportion of memory B cells,-0.017600203715309792,-0.9165942855052625,1
7273,Biological Process,GO:0046839,phospholipid dephosphorylation,-0.017614548587275625,-0.9168410263111999,1
7274,Biological Process,GO:0070293,renal absorption,-0.017625495325414242,-0.9170293170813888,1
7275,Biological Process,GO:0071875,adrenergic receptor signaling pathway,-0.017654085734547298,-0.9175210900723485,1
7276,Phenotype,HP:0008905,Rhizomelia,-0.01765931166521817,-0.9176109793616064,1
7277,Phenotype,HP:0007020,Progressive spastic paraplegia,-0.017694772236128697,-0.9182209234493826,1
7278,Biological Process,GO:0003006,developmental process involved in reproduction,-0.017694811142530353,-0.918221592663923,1
7279,Disease,MONDO:0014769,inherited oocyte maturation defect,-0.017714471297963774,-0.9185597596833326,1
7280,Biological Process,GO:0034453,microtubule anchoring,-0.01772291094074041,-0.918704926838919,1
7281,Biological Process,GO:0051156,glucose 6-phosphate metabolic process,-0.01773016086024204,-0.9188296300070667,1
7282,Phenotype,HP:0010462,Aplasia/Hypoplasia of the ovary,-0.017737450972838298,-0.9189550245216822,1
7283,Phenotype,HP:0002866,Hypoplastic iliac wing,-0.01774956217732937,-0.9191633448443813,1
7284,Phenotype,HP:0009937,Facial hirsutism,-0.017752759744976476,-0.9192183450158827,1
7285,Biological Process,GO:0099623,regulation of cardiac muscle cell membrane repolarization,-0.017823266612015276,-0.9204311074050288,1
7286,Biological Process,GO:1901184,regulation of ERBB signaling pathway,-0.017843224591599594,-0.9207743971868579,1
7287,Biological Process,GO:0032785,"negative regulation of DNA-templated transcription, elongation",-0.017885927603464857,-0.9215089158070789,1
7288,Phenotype,HP:0008282,Unconjugated hyperbilirubinemia,-0.017894675569016805,-0.9216593863080177,1
7289,Biological Process,GO:1905606,regulation of presynapse assembly,-0.01789609661393432,-0.9216838291729702,1
7290,Disease,MONDO:0019950,congenital muscular dystrophy,-0.017919332455158754,-0.9220835002334026,1
7291,Biological Process,GO:0002040,sprouting angiogenesis,-0.01793111216026988,-0.9222861185585955,1
7292,Biological Process,GO:0034508,centromere complex assembly,-0.01795595066857314,-0.9227133564992078,1
7293,Disease,MONDO:0015802,autosomal dominant non-syndromic intellectual disability,-0.017965328545861636,-0.9228746618775798,1
7294,Biological Process,GO:0090278,negative regulation of peptide hormone secretion,-0.01798664846223641,-0.923241377827458,1
7295,Phenotype,HP:0002421,Poor head control,-0.01806867804059653,-0.9246523380872284,1
7296,Phenotype,HP:0100336,Bilateral cleft lip,-0.018087270514670628,-0.9249721403167875,1
7297,Phenotype,HP:0001783,Broad metatarsal,-0.018088601745344546,-0.9249950383203496,1
7298,Disease,MONDO:0005554,rheumatic disorder,-0.01809007978475141,-0.9250204615263096,1
7299,Disease,MONDO:0018134,disorder of melanin metabolism,-0.018135813539902124,-0.9258071108342512,1
7300,Disease,MONDO:0024321,disorder of GPI anchor biosynthesis,-0.018271347565016693,-0.9281383811772955,1
7301,Disease,MONDO:0017436,lethal congenital contracture syndrome,-0.01829700690535918,-0.928579737944439,1
7302,Biological Process,GO:0086010,membrane depolarization during action potential,-0.018302641269936748,-0.9286766525533756,1
7303,Phenotype,HP:0000588,Optic disc coloboma,-0.018348095365585237,-0.9294584915422617,1
7304,Phenotype,HP:0005613,Aplasia/hypoplasia of the femur,-0.018352236800049937,-0.9295297268157441,1
7305,Biological Process,GO:0046676,negative regulation of insulin secretion,-0.01843355256551127,-0.9309284090454035,1
7306,Biological Process,GO:0006399,tRNA metabolic process,-0.01845102504907503,-0.9312289467348663,1
7307,Phenotype,HP:0000741,Apathy,-0.018460686226255518,-0.9313951250492839,1
7308,Phenotype,HP:0000467,Neck muscle weakness,-0.018504296082996863,-0.9321452419708434,1
7309,Phenotype,HP:0006501,Aplasia/Hypoplasia of the radius,-0.01858969920786757,-0.9336142293490762,1
7310,Biological Process,GO:0009792,embryo development ending in birth or egg hatching,-0.01860517469204459,-0.9338804173950347,1
7311,Biological Process,GO:1901880,negative regulation of protein depolymerization,-0.01862105977290529,-0.9341536507611663,1
7312,Biological Process,GO:0070050,neuron cellular homeostasis,-0.0186481575926436,-0.9346197502772374,1
7313,Biological Process,GO:0070203,regulation of establishment of protein localization to telomere,-0.018652616997048233,-0.9346964548333618,1
7314,Biological Process,GO:0039702,viral budding via host ESCRT complex,-0.018660904176378557,-0.9348389995219295,1
7315,Biological Process,GO:0030968,endoplasmic reticulum unfolded protein response,-0.018691428932260168,-0.9353640444916728,1
7316,Phenotype,HP:0002265,Large fleshy ears,-0.018746778121444763,-0.936316085303185,1
7317,Biological Process,GO:0006081,cellular aldehyde metabolic process,-0.018783199195749667,-0.9369425506525102,1
7318,Biological Process,GO:0009582,detection of abiotic stimulus,-0.018786445281704145,-0.9369983853693663,1
7319,Biological Process,GO:0009060,aerobic respiration,-0.018799534120534922,-0.9372235216166318,1
7320,Phenotype,HP:0005184,Prolonged QTc interval,-0.018820961255399116,-0.9375920817918577,1
7321,Biological Process,GO:0055062,phosphate ion homeostasis,-0.01885122854484811,-0.9381126981772793,1
7322,Phenotype,HP:0003308,Cervical subluxation,-0.018915624252509255,-0.9392203447875153,1
7323,Phenotype,HP:0002521,Hypsarrhythmia,-0.01892253087193474,-0.9393391429787717,1
7324,Phenotype,HP:0003109,Hyperphosphaturia,-0.01893452547477925,-0.9395454576799279,1
7325,Phenotype,HP:0007678,Lacrimal duct stenosis,-0.018942158477137427,-0.9396767501137722,1
7326,Biological Process,GO:0051261,protein depolymerization,-0.01896518804673719,-0.9400728731727283,1
7327,Phenotype,HP:0007894,Hypopigmentation of the fundus,-0.018968645884387847,-0.940132350151732,1
7328,Phenotype,HP:0030196,Fatigable weakness of respiratory muscles,-0.01900831827443361,-0.9408147401735232,1
7329,Biological Process,GO:0099175,regulation of postsynapse organization,-0.01902402696003458,-0.9410849394304167,1
7330,Phenotype,HP:0012103,Abnormality of the mitochondrion,-0.019052486726760742,-0.9415744652899385,1
7331,Phenotype,HP:0012213,Decreased glomerular filtration rate,-0.019120543265572332,-0.9427450804948481,1
7331,Phenotype,HP:0012212,Abnormal glomerular filtration rate,-0.019120543265572332,-0.9427450804948481,1
7333,Phenotype,HP:0005619,Thoracolumbar kyphosis,-0.019134266353675322,-0.942981126227884,1
7334,Biological Process,GO:0043162,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,-0.01913631262064852,-0.9430163233048139,1
7335,Phenotype,HP:0002003,Large forehead,-0.019160211266712857,-0.9434273950247131,1
7336,Biological Process,GO:0042044,fluid transport,-0.01920461820063557,-0.9441912221743313,1
7336,Biological Process,GO:0006833,water transport,-0.01920461820063557,-0.9441912221743313,1
7338,Biological Process,GO:1902600,proton transmembrane transport,-0.019217441423789783,-0.9444117896651616,1
7339,Phenotype,HP:0006489,Abnormal femoral metaphysis morphology,-0.01927234438089931,-0.9453561550047631,1
7340,Biological Process,GO:0034381,plasma lipoprotein particle clearance,-0.019285438944784294,-0.9455813897265561,1
7341,Biological Process,GO:1905039,carboxylic acid transmembrane transport,-0.019286399755993777,-0.9455979162827182,1
7342,Phenotype,HP:0030341,Decreased circulating follicle stimulating hormone concentration,-0.019339763833727597,-0.94651581193069,1
7343,Phenotype,HP:0004347,Weakness of muscles of respiration,-0.019388895764838487,-0.9473609119990934,1
7344,Phenotype,HP:0011381,Aplasia of the semicircular canal,-0.019395000653789074,-0.9474659199227204,1
7345,Phenotype,HP:0031857,Ineffective esophageal peristalsis,-0.019436000092187156,-0.9481711360095157,1
7346,Phenotype,HP:0030186,Kinetic tremor,-0.01943802384045057,-0.9482059457504963,1
7347,Phenotype,HP:0003402,Decreased miniature endplate potentials,-0.01946723920903959,-0.9487084684365533,1
7348,Phenotype,HP:0004991,Rhizomelic arm shortening,-0.019493654930851756,-0.9491628354399589,1
7349,Biological Process,GO:0051444,negative regulation of ubiquitin-protein transferase activity,-0.019535824949208136,-0.9498881862371242,1
7350,Phenotype,HP:0010183,Abnormality of the middle phalanges of the toes,-0.01955705456510315,-0.9502533489620446,1
7351,Phenotype,HP:0025452,Pyoderma gangrenosum,-0.019605836093293805,-0.9510924218801781,1
7352,Phenotype,HP:0011190,Uni- and bilateral multifocal epileptiform discharges,-0.01964890916692319,-0.9518333057951291,1
7353,Biological Process,GO:0015868,purine ribonucleotide transport,-0.019670261936890254,-0.9522005868474256,1
7354,Disease,MONDO:0100310,hereditary cerebellar ataxia,-0.019694998965146038,-0.9526260792674951,1
7354,Disease,MONDO:0000437,cerebellar ataxia,-0.019694998965146038,-0.9526260792674951,1
7356,Phenotype,HP:0004279,Short palm,-0.019712971411020686,-0.9529352166226657,1
7357,Disease,MONDO:0019243,inborn disorder of energy metabolism,-0.01972284823367021,-0.9531051041745692,1
7358,Biological Process,GO:0006970,response to osmotic stress,-0.019769217666381733,-0.953902687535742,1
7359,Phenotype,HP:0031956,Elevated circulating aspartate aminotransferase concentration,-0.019769447788748895,-0.9539066457849668,1
7360,Phenotype,HP:0003027,Mesomelia,-0.01978557222512789,-0.9541839962163207,1
7361,Biological Process,GO:0030148,sphingolipid biosynthetic process,-0.019832402051159104,-0.9549894986317047,1
7362,Phenotype,HP:0031123,Recurrent gastroenteritis,-0.01984634820568365,-0.9552293812472701,1
7363,Phenotype,HP:0002907,Microscopic hematuria,-0.019848878984945584,-0.9552729122398245,1
7364,Phenotype,HP:0006580,Portal fibrosis,-0.019861097060651423,-0.9554830708145294,1
7365,Phenotype,HP:0025052,Abnormal brain N-acetyl aspartate level by MRS,-0.019861865892999653,-0.9554962952137213,1
7366,Phenotype,HP:0000059,Hypoplastic labia majora,-0.01988913890366284,-0.9559654081237148,1
7367,Phenotype,HP:0000690,Agenesis of maxillary lateral incisor,-0.019893059754276132,-0.9560328492164334,1
7368,Phenotype,HP:0012310,Abnormal monocyte count,-0.0199238843079812,-0.9565630508970037,1
7368,Phenotype,HP:0012144,Abnormal monocyte morphology,-0.0199238843079812,-0.9565630508970037,1
7370,Phenotype,HP:0005914,Aplasia/Hypoplasia involving the metacarpal bones,-0.020031809141182633,-0.9584194258014442,1
7371,Biological Process,GO:0006310,DNA recombination,-0.020042961279272076,-0.9586112495797721,1
7372,Biological Process,GO:0099174,regulation of presynapse organization,-0.020049823662106947,-0.9587292868738908,1
7373,Phenotype,HP:0002828,Multiple joint contractures,-0.020056190110591787,-0.9588387937857581,1
7374,Phenotype,HP:0007052,Multifocal cerebral white matter abnormalities,-0.02005640529166408,-0.9588424950353284,1
7375,Phenotype,HP:0002075,Dysdiadochokinesis,-0.02006662102030443,-0.9590182119830963,1
7376,Phenotype,HP:0011915,Cardiovascular calcification,-0.02012965511436815,-0.9601024379844063,1
7377,Biological Process,GO:0001501,skeletal system development,-0.0201535160395776,-0.960512860881914,1
7378,Phenotype,HP:0007686,Abnormal pupillary function,-0.020211350860850352,-0.9615076561262407,1
7379,Phenotype,HP:0100874,Thick hair,-0.020223821904426842,-0.9617221659071766,1
7380,Biological Process,GO:0048284,organelle fusion,-0.0202392945911396,-0.9619883058349931,1
7381,Biological Process,GO:0072655,establishment of protein localization to mitochondrion,-0.02029976176816284,-0.9630283792512642,1
7382,Biological Process,GO:1904888,cranial skeletal system development,-0.02031409452521893,-0.9632749116731463,1
7383,Phenotype,HP:0011062,Misalignment of incisors,-0.020322433448576094,-0.9634183463914692,1
7384,Phenotype,HP:0002136,Broad-based gait,-0.02035163357117442,-0.9639206068369123,1
7385,Biological Process,GO:0030262,apoptotic nuclear changes,-0.020357804784959965,-0.9640267555893505,1
7386,Phenotype,HP:0001385,Hip dysplasia,-0.02036429052752764,-0.9641383144343553,1
7387,Biological Process,GO:0090161,Golgi ribbon formation,-0.020380573377171585,-0.9644183896733448,1
7388,Phenotype,HP:0011504,Bull's eye maculopathy,-0.020478642169302175,-0.9661052344820854,1
7389,Phenotype,HP:0011347,Abnormality of ocular abduction,-0.020540257383187654,-0.9671650548533178,1
7390,Phenotype,HP:0005089,Abnormal metaphyseal trabeculation,-0.020606089129556082,-0.9682974022311058,1
7391,Biological Process,GO:0031468,nuclear membrane reassembly,-0.02074084866594328,-0.970615350881685,1
7392,Phenotype,HP:0002169,Clonus,-0.02075488375408341,-0.9708567632112859,1
7393,Phenotype,HP:0011969,Elevated circulating luteinizing hormone level,-0.020779668902756843,-0.9712830833327571,1
7394,Disease,MONDO:0002427,cerebellar disorder,-0.02079049005404654,-0.9714692139302801,1
7395,Biological Process,GO:0032351,negative regulation of hormone metabolic process,-0.020791223850997298,-0.9714818356986343,1
7396,Phenotype,HP:0009794,Branchial anomaly,-0.02080270416367691,-0.9716793042859964,1
7397,Biological Process,GO:0001676,long-chain fatty acid metabolic process,-0.020818165858149218,-0.9719452551403743,1
7398,Phenotype,HP:0100033,Tics,-0.020847885493749052,-0.972456451535681,1
7399,Phenotype,HP:0006344,Abnormal primary molar morphology,-0.020850142891049472,-0.9724952801868222,1
7400,Phenotype,HP:0011662,Tricuspid atresia,-0.02102651921818466,-0.9755290637722929,1
7401,Disease,MONDO:0005497,bone development disease,-0.02104845506755937,-0.9759063741565563,1
7402,Biological Process,GO:0003002,regionalization,-0.021068651174245057,-0.9762537598740653,1
7403,Biological Process,GO:0008543,fibroblast growth factor receptor signaling pathway,-0.02107744199607442,-0.9764049675298879,1
7404,Phenotype,HP:0000580,Pigmentary retinopathy,-0.021078298775684123,-0.9764197046772053,1
7405,Biological Process,GO:0019068,virion assembly,-0.021091840949215346,-0.9766526385659983,1
7406,Phenotype,HP:0001798,Anonychia,-0.0210972212833187,-0.9767451836912553,1
7407,Biological Process,GO:0070525,tRNA threonylcarbamoyladenosine metabolic process,-0.02110829834798711,-0.9769357161595976,1
7408,Phenotype,HP:0003076,Glycosuria,-0.021209577177357275,-0.9786777756246606,1
7409,Phenotype,HP:0100800,Aplasia/Hypoplasia of the pancreas,-0.021218714661408677,-0.9788349460883952,1
7410,Biological Process,GO:0046461,neutral lipid catabolic process,-0.02122809491443789,-0.9789962923309994,1
7410,Biological Process,GO:0046464,acylglycerol catabolic process,-0.02122809491443789,-0.9789962923309994,1
7412,Biological Process,GO:0046755,viral budding,-0.021230459785820832,-0.9790369696038502,1
7413,Phenotype,HP:0012049,Laryngeal dystonia,-0.02123700882724111,-0.9791496172288696,1
7414,Biological Process,GO:0051588,regulation of neurotransmitter transport,-0.021343133854837104,-0.9809750343466758,1
7415,Phenotype,HP:0000064,Hypoplastic labia minora,-0.021346806002288554,-0.9810381975888329,1
7416,Phenotype,HP:0004742,Abnormal renal collecting system morphology,-0.021391474485753514,-0.9818065235548227,1
7417,Phenotype,HP:0012762,Cerebral white matter atrophy,-0.021414418093756993,-0.9822011680203414,1
7418,Disease,MONDO:0000508,syndromic intellectual disability,-0.021465924751099097,-0.9830871148711746,1
7419,Biological Process,GO:0006605,protein targeting,-0.02148391139881367,-0.9833964965069102,1
7420,Biological Process,GO:0044282,small molecule catabolic process,-0.02149384001527377,-0.9835672749448804,1
7421,Biological Process,GO:0010965,regulation of mitotic sister chromatid separation,-0.021514143362747706,-0.9839165052712912,1
7422,Phenotype,HP:0008323,Abnormal light- and dark-adapted electroretinogram,-0.021616547956078147,-0.9856779285834149,1
7423,Phenotype,HP:0002023,Anal atresia,-0.021617653990598562,-0.9856969530717207,1
7424,Phenotype,HP:0008062,Aplasia/Hypoplasia affecting the anterior segment of the eye,-0.021651144706865244,-0.9862730144226164,1
7425,Phenotype,HP:0032445,Pulmonary cyst,-0.02167873019666211,-0.9867475021699361,1
7426,Phenotype,HP:0006895,Lower limb hypertonia,-0.0217516907667874,-0.9880024697930175,1
7427,Biological Process,GO:1901661,quinone metabolic process,-0.021765610036021732,-0.9882418899647082,1
7428,Phenotype,HP:0001152,Saccadic smooth pursuit,-0.02176934343440462,-0.9883061067613498,1
7429,Phenotype,HP:0009108,Aplasia/Hypoplasia involving the femoral head and neck,-0.021786318845885555,-0.9885980944988424,1
7430,Phenotype,HP:0000659,Peters anomaly,-0.02179217440341974,-0.988698813765535,1
7431,Biological Process,GO:1901615,organic hydroxy compound metabolic process,-0.0218043784854014,-0.9889087316393964,1
7432,Phenotype,HP:0100276,Skin pit,-0.021838420722949392,-0.9894942795026686,1
7433,Phenotype,HP:0004905,Reduced circulating vitamin A concentration,-0.021849500578029923,-0.9896848599678516,1
7433,Phenotype,HP:0008372,Abnormal circulating vitamin A concentration,-0.021849500578029923,-0.9896848599678516,1
7435,Phenotype,HP:0003422,Vertebral segmentation defect,-0.021860117513772037,-0.9898674779297152,1
7436,Phenotype,HP:0001959,Polydipsia,-0.021946374944340707,-0.99135115990243,1
7437,Phenotype,HP:0011448,Ankle clonus,-0.02194708757390962,-0.991363417578524,1
7438,Biological Process,GO:0006536,glutamate metabolic process,-0.02196221840716328,-0.991623677412171,1
7439,Biological Process,GO:0090114,COPII-coated vesicle budding,-0.021965771970752224,-0.9916848009374261,1
7440,Phenotype,HP:0003177,Squared iliac bones,-0.02196676755635152,-0.9917019256349302,1
7441,Phenotype,HP:0011704,Sick sinus syndrome,-0.0219847041820338,-0.992010446860298,1
7442,Phenotype,HP:6000531,Abnormal urinary organic compound level,-0.022003049182031553,-0.9923259923803381,1
7443,Phenotype,HP:0002572,Episodic vomiting,-0.022045702646092735,-0.9930596587472146,1
7444,Phenotype,HP:0011343,Moderate global developmental delay,-0.02205212595966577,-0.9931701437743082,1
7445,Phenotype,HP:0000932,Abnormal posterior cranial fossa morphology,-0.022111615675439733,-0.9941934042432772,1
7446,Phenotype,HP:0002070,Limb ataxia,-0.022117873226123574,-0.9943010380445828,1
7447,Phenotype,HP:0009466,Radial deviation of finger,-0.02212347522647984,-0.9943973959685892,1
7448,Biological Process,GO:0009311,oligosaccharide metabolic process,-0.022154766445841023,-0.994935624591496,1
7449,Phenotype,HP:0005019,Diaphyseal undertubulation,-0.02220066873585247,-0.9957251728048767,1
7450,Biological Process,GO:0031998,regulation of fatty acid beta-oxidation,-0.022217670609050888,-0.9960176157005273,1
7451,Biological Process,GO:0043583,ear development,-0.02225539948340738,-0.9966665760319967,1
7452,Biological Process,GO:0090646,mitochondrial tRNA processing,-0.02228439126883064,-0.9971652529471995,1
7453,Phenotype,HP:0011481,Abnormal lacrimal duct morphology,-0.022289764675954782,-0.9972576789240641,1
7454,Phenotype,HP:0002155,Hypertriglyceridemia,-0.022298313179720974,-0.9974047185570322,1
7455,Phenotype,HP:0030082,Abnormal drinking behavior,-0.022342518237494335,-0.9981650733101097,1
7456,Phenotype,HP:0007350,Hyperreflexia in upper limbs,-0.022342630221354298,-0.9981669995028234,1
7457,Disease,MONDO:0016387,mitochondrial oxidative phosphorylation disorder,-0.022358615606004273,-0.9984419581571181,1
7458,Phenotype,HP:0001407,Hepatic cysts,-0.02236877149453842,-0.9986166458174817,1
7459,Phenotype,HP:0200136,Oral-pharyngeal dysphagia,-0.022449935946472044,-1.0000127253594444,1
7460,Phenotype,HP:0001809,Split nail,-0.02250282028197481,-1.0009223691397793,1
7461,Phenotype,HP:0010059,Broad hallux phalanx,-0.022526412388813588,-1.0013281681925017,1
7462,Disease,MONDO:0015962,inherited renal tubular disease,-0.022529522572269922,-1.0013816653010474,1
7462,Disease,MONDO:0021568,renal tubule disorder,-0.022529522572269922,-1.0013816653010474,1
7464,Biological Process,GO:0046928,regulation of neurotransmitter secretion,-0.022559564516411612,-1.0018984056056737,1
7465,Biological Process,GO:0015931,nucleobase-containing compound transport,-0.022598701957238232,-1.0025715941649644,1
7466,Phenotype,HP:0000836,Hyperthyroidism,-0.022653757269256225,-1.0035185801046655,1
7467,Biological Process,GO:0048232,male gamete generation,-0.022750002553936444,-1.0051740594401548,1
7468,Phenotype,HP:0025028,Abnormal enteric nervous system morphology,-0.02279416079855001,-1.0059336089774866,1
7468,Phenotype,HP:0012331,Abnormal autonomic nervous system morphology,-0.02279416079855001,-1.0059336089774866,1
7470,Phenotype,HP:0004425,Flat forehead,-0.022804206684419626,-1.0061064045229422,1
7471,Disease,MONDO:0700092,neurodevelopmental disorder,-0.022808292281849107,-1.006176679364355,1
7472,Biological Process,GO:0099054,presynapse assembly,-0.022812100468378338,-1.0062421825640782,1
7472,Biological Process,GO:0099172,presynapse organization,-0.022812100468378338,-1.0062421825640782,1
7474,Phenotype,HP:0000514,Slow saccadic eye movements,-0.02283086139062429,-1.0065648822079734,1
7475,Phenotype,HP:0100692,Increased corneal curvature,-0.022852892176062678,-1.006943825552149,1
7476,Biological Process,GO:0140467,integrated stress response signaling,-0.022874485983167547,-1.0073152525945794,1
7477,Phenotype,HP:0011097,Epileptic spasm,-0.02289481140047589,-1.007664862536001,1
7478,Disease,MONDO:0003150,male reproductive system disorder,-0.022929809119265787,-1.008266845276646,1
7479,Biological Process,GO:0019377,glycolipid catabolic process,-0.02301794951558578,-1.009782915442726,1
7480,Biological Process,GO:0042180,cellular ketone metabolic process,-0.023023194616809795,-1.0098731344775367,1
7481,Disease,MONDO:0015152,autosomal recessive limb-girdle muscular dystrophy,-0.02302402707799711,-1.0098874533327176,1
7482,Biological Process,GO:0001889,liver development,-0.023116351302517213,-1.0114754879711514,1
7483,Phenotype,HP:0000579,Nasolacrimal duct obstruction,-0.023134948179841297,-1.0117953659393755,1
7484,Phenotype,HP:0033748,Hypoesthesia,-0.023152231191625017,-1.0120926445952392,1
7485,Phenotype,HP:0010054,Abnormality of the first metatarsal bone,-0.023189337148375788,-1.0127308903527177,1
7486,Phenotype,HP:0003300,Ovoid vertebral bodies,-0.023201468075047416,-1.0129395499093072,1
7487,Biological Process,GO:1900151,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",-0.023204546463891695,-1.0129925001305595,1
7488,Biological Process,GO:0070168,negative regulation of biomineral tissue development,-0.023204716938613146,-1.0129954324028212,1
7489,Phenotype,HP:0001017,Anemic pallor,-0.02321197458001234,-1.0131202683924563,1
7490,Disease,MONDO:0005181,progressive external ophthalmoplegia,-0.023240862186500122,-1.0136171533645477,1
7490,Disease,MONDO:0000090,progressive external ophthalmoplegia with mitochondrial DNA deletions,-0.023240862186500122,-1.0136171533645477,1
7492,Phenotype,HP:0000907,Anterior rib cupping,-0.023245891010240438,-1.0137036522908232,1
7493,Phenotype,HP:0100771,Hypoperistalsis,-0.023246920907034063,-1.0137213671624161,1
7494,Phenotype,HP:0007722,Retinal pigment epithelial atrophy,-0.02325847712836704,-1.0139201414262842,1
7495,Biological Process,GO:0001919,regulation of receptor recycling,-0.0232691431016967,-1.0141036028654478,1
7496,Phenotype,HP:0012269,Abnormal muscle glycogen content,-0.023279918084420315,-1.0142889393346417,1
7497,Phenotype,HP:0000475,Broad neck,-0.023432474755702648,-1.016913009881454,1
7498,Phenotype,HP:0000413,Atresia of the external auditory canal,-0.023455829588629795,-1.017314727673896,1
7499,Phenotype,HP:0034251,Abnormal corneal reflex,-0.023516442200894216,-1.0183573026676442,1
7500,Biological Process,GO:0032968,positive regulation of transcription elongation by RNA polymerase II,-0.023543003209367974,-1.0188141686928647,1
7501,Phenotype,HP:0001308,Tongue fasciculations,-0.023588028863270605,-1.0195886382146742,1
7502,Phenotype,HP:0040159,Abnormal spaced incisors,-0.02360080356410954,-1.0198083710912111,1
7503,Phenotype,HP:0011923,Decreased activity of mitochondrial complex I,-0.023620797312675856,-1.0201522761219926,1
7504,Disease,MONDO:0003757,paraplegia,-0.023653835177840143,-1.020720548149551,1
7504,Disease,MONDO:0019064,hereditary spastic paraplegia,-0.023653835177840143,-1.020720548149551,1
7506,Biological Process,GO:0045939,negative regulation of steroid metabolic process,-0.02367422594867108,-1.021071282212601,1
7507,Phenotype,HP:0005736,Short tibia,-0.02367594543774021,-1.0211008585043746,1
7508,Biological Process,GO:1902624,positive regulation of neutrophil migration,-0.02390232389307778,-1.0249947100946788,1
7509,Biological Process,GO:0006684,sphingomyelin metabolic process,-0.023930239020681254,-1.0254748678192742,1
7510,Phenotype,HP:0012032,Lipoma,-0.023950113649982674,-1.0258167239238962,1
7511,Biological Process,GO:0051310,metaphase chromosome alignment,-0.023976453941074283,-1.0262697934715401,1
7512,Phenotype,HP:0006505,Abnormal limb epiphysis morphology,-0.024008049506648366,-1.0268132570404285,1
7513,Phenotype,HP:0011403,Abnormal umbilical cord blood vessel morphology,-0.024063986882557398,-1.0277754150329637,1
7513,Phenotype,HP:0001195,Single umbilical artery,-0.024063986882557398,-1.0277754150329637,1
7515,Phenotype,HP:0000483,Astigmatism,-0.02408364662243434,-1.028113574904541,1
7516,Phenotype,HP:0001956,Truncal obesity,-0.02408951798478154,-1.0282145660239423,1
7517,Phenotype,HP:0000687,Widely spaced teeth,-0.02412263372116441,-1.028784177485361,1
7518,Biological Process,GO:0033120,positive regulation of RNA splicing,-0.024149834145035465,-1.0292520418569475,1
7519,Phenotype,HP:0001684,Secundum atrial septal defect,-0.024165872395739862,-1.0295279098405765,1
7520,Phenotype,HP:0011065,Conical incisor,-0.024186386558394668,-1.0298807663204832,1
7521,Phenotype,HP:0002127,Abnormal upper motor neuron morphology,-0.024188353051606937,-1.0299145912386298,1
7522,Phenotype,HP:0011229,Broad eyebrow,-0.024196896500328746,-1.03006154392166,1
7523,Phenotype,HP:0006808,Cerebral hypomyelination,-0.02420191182435727,-1.030147810644415,1
7524,Phenotype,HP:0000207,Triangular mouth,-0.024222075304790813,-1.030494635169899,1
7525,Phenotype,HP:0006855,Cerebellar vermis atrophy,-0.024249166487418483,-1.0309606205234993,1
7526,Phenotype,HP:0012171,Stereotypical hand wringing,-0.02429035935613344,-1.0316691637332132,1
7526,Phenotype,HP:5200009,Midline hand movements,-0.02429035935613344,-1.0316691637332132,1
7528,Disease,MONDO:0016764,isolated anophthalmia-microphthalmia syndrome,-0.024351310943926396,-1.032717569318918,1
7529,Phenotype,HP:0031264,Abnormal Bowman capsule morphology,-0.024355469861761403,-1.0327891053173488,1
7530,Biological Process,GO:0015986,proton motive force-driven ATP synthesis,-0.02437470771270278,-1.0331200084343013,1
7531,Phenotype,HP:0000887,Cupped ribs,-0.024382325781830527,-1.0332510440072047,1
7532,Phenotype,HP:0005181,Premature coronary artery atherosclerosis,-0.02439244154213971,-1.0334250414368995,1
7533,Phenotype,HP:0005920,Abnormal epiphysis morphology of the phalanges of the hand,-0.024395611175487275,-1.0334795611209069,1
7534,Disease,MONDO:0016073,syndromic microphthalmia,-0.02455546315971513,-1.0362291156316077,1
7535,Biological Process,GO:0034250,positive regulation of amide metabolic process,-0.02460076910185771,-1.0370084062871563,1
7536,Disease,MONDO:0005558,ovarian disorder,-0.024631789061482667,-1.0375419690722576,1
7537,Phenotype,HP:0000524,Conjunctival telangiectasia,-0.024641782356693787,-1.0377138600253615,1
7538,Biological Process,GO:1901861,regulation of muscle tissue development,-0.02467369577605294,-1.0382627908789552,1
7539,Phenotype,HP:0030112,Abnormal muscle fiber alpha dystroglycan,-0.02475632574933706,-1.0396840783084473,1
7539,Phenotype,HP:0030046,Hypoglycosylation of alpha-dystroglycan,-0.02475632574933706,-1.0396840783084473,1
7541,Phenotype,HP:0004378,Abnormality of the anus,-0.024759284361053346,-1.039734968287882,1
7542,Biological Process,GO:0032527,protein exit from endoplasmic reticulum,-0.024761655827263196,-1.0397757589958971,1
7543,Biological Process,GO:0009119,ribonucleoside metabolic process,-0.02478128696170856,-1.0401134268360879,1
7544,Biological Process,GO:0007283,spermatogenesis,-0.024805072392462213,-1.0405225511815475,1
7545,Disease,MONDO:0003569,cranial nerve neuropathy,-0.0248301093165062,-1.0409532019974992,1
7546,Biological Process,GO:0031529,ruffle organization,-0.024909354027298214,-1.0423162607862895,1
7547,Phenotype,HP:0009055,Generalized limb muscle atrophy,-0.024944220193855893,-1.0429159807459296,1
7548,Phenotype,HP:0002322,Resting tremor,-0.024956999914293565,-1.043135799962717,1
7549,Phenotype,HP:0002033,Poor suck,-0.025027071848612303,-1.0443410812359541,1
7550,Disease,MONDO:0100033,metabolic epilepsy,-0.025048929666063202,-1.0447170494221265,1
7551,Biological Process,GO:2000736,regulation of stem cell differentiation,-0.025056357356200598,-1.0448448103568437,1
7552,Phenotype,HP:0033454,Tube feeding,-0.025120555792819355,-1.0459490637812705,1
7553,Phenotype,HP:0008554,Cochlear malformation,-0.025154187547815177,-1.0465275510868755,1
7554,Phenotype,HP:0001682,Subvalvular aortic stenosis,-0.0251835119280428,-1.0470319488415722,1
7555,Phenotype,HP:0012249,Abnormal ST segment,-0.025192520250802986,-1.0471868976499887,1
7556,Phenotype,HP:0007068,Inferior cerebellar vermis hypoplasia,-0.025205768891544356,-1.047414782590467,1
7557,Disease,MONDO:0015541,hereditary hemophagocytic lymphohistiocytosis,-0.025301924808702303,-1.0490687247484531,1
7557,Disease,MONDO:0015540,hemophagocytic syndrome,-0.025301924808702303,-1.0490687247484531,1
7559,Phenotype,HP:0001357,Plagiocephaly,-0.02533582459506012,-1.0496518223617994,1
7560,Phenotype,HP:0008275,Abnormal light-adapted electroretinogram,-0.025348644141858667,-1.0498723266170036,1
7561,Phenotype,HP:0100694,Tibial torsion,-0.02542030008713092,-1.0511048538733498,1
7562,Disease,MONDO:0021129,microphthalmia,-0.025471977464675888,-1.051993737218879,1
7563,Phenotype,HP:0030466,Abnormal full-field electroretinogram,-0.02551403300854438,-1.0527171189829663,1
7564,Phenotype,HP:0012592,Albuminuria,-0.02553599117958183,-1.0530948133138462,1
7565,Phenotype,HP:0010621,Cutaneous syndactyly of toes,-0.025537342050515166,-1.0531180491422036,1
7566,Phenotype,HP:0005274,Prominent nasal tip,-0.025542228912873055,-1.0532021062435541,1
7567,Phenotype,HP:0010640,Abnormal nasal cavity morphology,-0.025623673377951794,-1.0546030021874522,1
7568,Biological Process,GO:0010566,regulation of ketone biosynthetic process,-0.025633703275735664,-1.0547755227277928,1
7569,Biological Process,GO:0061008,hepaticobiliary system development,-0.025639379894914827,-1.0548731641424114,1
7570,Phenotype,HP:0025045,Abnormal brain lactate level by MRS,-0.025647241942627907,-1.0550083963001933,1
7571,Phenotype,HP:0001374,Congenital hip dislocation,-0.025650227769664857,-1.0550597544002336,1
7572,Biological Process,GO:1901658,glycosyl compound catabolic process,-0.025711692458714408,-1.0561169856497632,1
7573,Phenotype,HP:0003207,Arterial calcification,-0.0257170407364804,-1.0562089793858873,1
7574,Phenotype,HP:0010296,Ankyloglossia,-0.025719664264273634,-1.0562541057114232,1
7575,Phenotype,HP:0030453,Abnormal visual electrophysiology,-0.02576648830885464,-1.057059508682233,1
7576,Phenotype,HP:0025539,Abnormal B cell subset distribution,-0.025814043374863482,-1.0578774856806599,1
7577,Biological Process,GO:0015918,sterol transport,-0.025824549605512503,-1.058058199445403,1
7578,Phenotype,HP:0001230,Broad metacarpals,-0.025835007895352202,-1.0582380885981206,1
7579,Disease,MONDO:0005395,movement disorder,-0.025841002465831098,-1.058341198974758,1
7580,Phenotype,HP:0200149,CSF lymphocytic pleiocytosis,-0.025903611573173224,-1.0594181149375783,1
7581,Phenotype,HP:0008997,Proximal muscle weakness in upper limbs,-0.025933250579436518,-1.0599279244576638,1
7582,Biological Process,GO:0032211,negative regulation of telomere maintenance via telomerase,-0.02604316235085813,-1.0618184759472258,1
7583,Biological Process,GO:0006641,triglyceride metabolic process,-0.026062370421512604,-1.0621488668245427,1
7584,Disease,MONDO:0019502,autosomal recessive non-syndromic intellectual disability,-0.026063922369380377,-1.0621755613024424,1
7585,Phenotype,HP:0000637,Long palpebral fissure,-0.0260688736938266,-1.0622607271921922,1
7586,Phenotype,HP:0002246,Abnormal duodenum morphology,-0.02608170389626241,-1.0624814147310488,1
7587,Biological Process,GO:2000243,positive regulation of reproductive process,-0.02609042894886815,-1.0626314911149242,1
7588,Phenotype,HP:0005404,Increased B cell count,-0.026109691391996703,-1.0629628172329393,1
7589,Phenotype,HP:0000200,Short lingual frenulum,-0.0261674113298489,-1.0639556364102893,1
7590,Biological Process,GO:0099116,tRNA 5'-end processing,-0.026171619637500143,-1.0640280219445746,1
7591,Biological Process,GO:0003352,regulation of cilium movement,-0.02618015657595474,-1.0641748626469205,1
7592,Phenotype,HP:0007021,Pain insensitivity,-0.026250871270964815,-1.065391199807682,1
7593,Phenotype,HP:0001530,Mild postnatal growth retardation,-0.026258746646835585,-1.0655266612181458,1
7594,Phenotype,HP:0009073,Progressive proximal muscle weakness,-0.026292130393561486,-1.0661008826257665,1
7595,Phenotype,HP:0031593,Abnormal PR interval,-0.02630504662109634,-1.0663230498503478,1
7596,Biological Process,GO:0009112,nucleobase metabolic process,-0.0263576869954687,-1.0672284973460395,1
7597,Phenotype,HP:0000448,Prominent nose,-0.02642486396503041,-1.0683839834075095,1
7598,Disease,MONDO:0020072,childhood-onset epilepsy syndrome,-0.026469721262922796,-1.0691555571002205,1
7599,Biological Process,GO:0006612,protein targeting to membrane,-0.026497398018681118,-1.0696316146793894,1
7600,Biological Process,GO:0007548,sex differentiation,-0.02656796102240566,-1.0708453426547824,1
7601,Phenotype,HP:0012311,Monocytosis,-0.026627599199520624,-1.0718711567520454,1
7602,Phenotype,HP:0010996,Abnormal circulating monocarboxylic acid concentration,-0.026705646569863184,-1.0732136205332135,1
7603,Phenotype,HP:0012251,ST segment elevation,-0.026706265996993217,-1.0732242750688306,1
7604,Phenotype,HP:0008850,Severe postnatal growth retardation,-0.026758322688651193,-1.0741196828553008,1
7605,Phenotype,HP:0011468,Facial tics,-0.026765454409266143,-1.0742423529283727,1
7606,Biological Process,GO:0035459,vesicle cargo loading,-0.026812705224050104,-1.0750550966146715,1
7607,Phenotype,HP:0010907,Abnormal circulating proline concentration,-0.026859533954763704,-1.0758605801899046,1
7608,Biological Process,GO:1904816,"positive regulation of protein localization to chromosome, telomeric region",-0.026867020765621197,-1.0759893580381334,1
7609,Phenotype,HP:0003311,Hypoplasia of the odontoid process,-0.026882921451667707,-1.0762628598232606,1
7610,Biological Process,GO:0170044,non-proteinogenic amino acid catabolic process,-0.02689960505163702,-1.076549828219505,1
7611,Disease,MONDO:0019118,inherited retinal dystrophy,-0.026904525842052607,-1.0766344689047536,1
7611,Disease,MONDO:0004580,retinal degeneration,-0.026904525842052607,-1.0766344689047536,1
7613,Phenotype,HP:0000372,Abnormal auditory canal morphology,-0.026951860355044488,-1.0774486522527884,1
7614,Phenotype,HP:0000383,Abnormal periauricular region morphology,-0.026952964215911646,-1.0774676393528932,1
7615,Phenotype,HP:0000375,Abnormal cochlea morphology,-0.0269680999085955,-1.077727982771791,1
7616,Biological Process,GO:0008643,carbohydrate transport,-0.026988094624375014,-1.0780719044392466,1
7616,Biological Process,GO:0034219,carbohydrate transmembrane transport,-0.026988094624375014,-1.0780719044392466,1
7618,Phenotype,HP:0012705,Abnormal metabolic brain imaging by MRS,-0.027008819014646468,-1.0784283769661762,1
7619,Phenotype,HP:0004362,Abnormal enteric ganglion morphology,-0.02716965699875873,-1.0811948912940654,1
7619,Phenotype,HP:0002251,Aganglionic megacolon,-0.02716965699875873,-1.0811948912940654,1
7621,Phenotype,HP:0002527,Falls,-0.027465392454448123,-1.0862817268444196,1
7622,Disease,MONDO:0017758,disorder of vitamin and non-protein cofactor absorption and transport,-0.027553724303464033,-1.0878010901170958,1
7623,Phenotype,HP:0001302,Pachygyria,-0.02756035646720889,-1.087915167498296,1
7624,Disease,MONDO:0019235,inborn disorder of phenylalanine and tyrosine metabolism,-0.027567754499918884,-1.0880424183066382,1
7625,Biological Process,GO:0099173,postsynapse organization,-0.027593206324686204,-1.0884802056755756,1
7626,Phenotype,HP:0000289,Broad philtrum,-0.027651969079640848,-1.089490961961944,1
7627,Biological Process,GO:0010649,regulation of cell communication by electrical coupling,-0.027723176829263618,-1.0907157799716662,1
7628,Phenotype,HP:0008081,Pes valgus,-0.027737165907633976,-1.0909564009043344,1
7629,Biological Process,GO:0072530,purine-containing compound transmembrane transport,-0.027789051113428,-1.091848859026257,1
7630,Disease,MONDO:0024654,skull disorder,-0.027811350438220694,-1.0922324214159609,1
7631,Biological Process,GO:0090596,sensory organ morphogenesis,-0.02786870574967848,-1.0932189687903533,1
7632,Biological Process,GO:0018200,peptidyl-glutamic acid modification,-0.027882695072561692,-1.093459593928796,1
7633,Phenotype,HP:0005916,Abnormal metacarpal morphology,-0.027898487573711384,-1.093731234865761,1
7634,Phenotype,HP:0008000,Decreased corneal reflex,-0.027927056982190113,-1.0942226466322786,1
7635,Phenotype,HP:0008589,Hypoplastic helices,-0.027957877834212885,-1.094752784641589,1
7636,Biological Process,GO:0051303,establishment of chromosome localization,-0.02796073059620885,-1.0948018539393638,1
7637,Phenotype,HP:0012084,Abnormality of skeletal muscle fiber size,-0.027995185065685213,-1.0953944924506724,1
7638,Phenotype,HP:0100513,Decreased circulating vitamin E concentration,-0.028136080907044336,-1.0978179894001738,1
7638,Phenotype,HP:0100514,Abnormal circulating vitamin E concentration,-0.028136080907044336,-1.0978179894001738,1
7640,Disease,MONDO:0020065,combined dystonia,-0.02814401952645773,-1.0979545386392857,1
7641,Phenotype,HP:0003355,Aminoaciduria,-0.028161517903594557,-1.0982555217144656,1
7642,Phenotype,HP:0025502,Overweight,-0.028161934005074274,-1.0982626789212153,1
7643,Phenotype,HP:0100280,Crohn's disease,-0.028169694863173556,-1.0983961705540959,1
7644,Phenotype,HP:0000791,Uric acid nephrolithiasis,-0.02817245172033922,-1.0984435902285643,1
7645,Biological Process,GO:0001935,endothelial cell proliferation,-0.028347528979250747,-1.1014550290248142,1
7646,Phenotype,HP:0011195,EEG with focal sharp slow waves,-0.028502847472587467,-1.1041266046452989,1
7647,Phenotype,HP:0000654,Decreased light- and dark-adapted electroretinogram amplitude,-0.02855832706512529,-1.1050808884763759,1
7648,Phenotype,HP:0006485,Agenesis of incisor,-0.028582672810212095,-1.1054996505802255,1
7649,Biological Process,GO:0016050,vesicle organization,-0.028645101726122224,-1.106573467137261,1
7650,Phenotype,HP:0045084,Limb myoclonus,-0.028656728456731395,-1.1067734542049572,1
7651,Disease,MONDO:0019181,non-syndromic X-linked intellectual disability,-0.02874586118327982,-1.1083065930741185,1
7652,Biological Process,GO:0046785,microtubule polymerization,-0.028783906319891805,-1.108960993314985,1
7653,Phenotype,HP:0004599,Absent or minimally ossified vertebral bodies,-0.028800531395532847,-1.1092469550560318,1
7654,Disease,MONDO:0000062,isolated microphthalmia,-0.028875450241468315,-1.1105356062527834,1
7655,Biological Process,GO:0034308,primary alcohol metabolic process,-0.02889636507873572,-1.1108953545876379,1
7656,Phenotype,HP:0011044,Abnormal number of permanent teeth,-0.028914375212480525,-1.111205140197842,1
7657,Disease,MONDO:0006510,renal tubular transport disease,-0.028928870331591527,-1.1114544653490268,1
7658,Phenotype,HP:0030126,Abnormal endometrium morphology,-0.02894190070401481,-1.1116785959373683,1
7659,Phenotype,HP:0011755,Ectopic posterior pituitary,-0.0289459572483024,-1.1117483710464962,1
7660,Biological Process,GO:1904152,"regulation of retrograde protein transport, ER to cytosol",-0.028947854804876494,-1.111781010211176,1
7661,Disease,MONDO:0017265,autosomal recessive congenital ichthyosis,-0.028989442887640937,-1.112496351350723,1
7662,Biological Process,GO:0097320,plasma membrane tubulation,-0.029034436551952814,-1.1132702706314828,1
7663,Biological Process,GO:0043009,chordate embryonic development,-0.02904916559737991,-1.1135236194622027,1
7664,Biological Process,GO:0098727,maintenance of cell number,-0.02909603405024308,-1.1143297862833528,1
7665,Phenotype,HP:0003127,Hypocalciuria,-0.029143982519836076,-1.1151545300704722,1
7666,Biological Process,GO:1902850,microtubule cytoskeleton organization involved in mitosis,-0.02917628760820401,-1.1157101978769726,1
7667,Phenotype,HP:0010747,Medial flaring of the eyebrow,-0.02920444890236107,-1.1161945898208745,1
7668,Phenotype,HP:0001864,Clinodactyly of the 5th toe,-0.02924824780735258,-1.116947958491053,1
7669,Phenotype,HP:0004798,Recurrent infection of the gastrointestinal tract,-0.02926667848545006,-1.1172649777282118,1
7670,Phenotype,HP:0012244,Abnormal sex determination,-0.029290181401761206,-1.1176692426478503,1
7671,Biological Process,GO:0000338,protein deneddylation,-0.029329296863103815,-1.1183420531462136,1
7672,Biological Process,GO:0006301,postreplication repair,-0.029386398647433865,-1.119324239694802,1
7673,Phenotype,HP:0008054,Abnormal morphology of the conjunctival vasculature,-0.02939002773822863,-1.1193866623354258,1
7674,Phenotype,HP:0031412,Abnormal telomere morphology,-0.02939255274460817,-1.119430094030778,1
7674,Phenotype,HP:0031411,Abnormal chromosome morphology,-0.02939255274460817,-1.119430094030778,1
7674,Phenotype,HP:0031413,Short telomere length,-0.02939255274460817,-1.119430094030778,1
7677,Biological Process,GO:1904754,positive regulation of vascular associated smooth muscle cell migration,-0.029394535714154957,-1.1194642023522248,1
7678,Disease,MONDO:0005283,retinal disorder,-0.029407320146016547,-1.1196841026084623,1
7679,Phenotype,HP:0040078,Axonal degeneration,-0.02946481150977709,-1.1206729901678987,1
7680,Phenotype,HP:0000758,Abnormal nonverbal communicative behavior,-0.02951284456792891,-1.1214991889313486,1
7681,Biological Process,GO:0000380,"alternative mRNA splicing, via spliceosome",-0.029572903955304986,-1.1225322481096096,1
7682,Phenotype,HP:0008358,Hyperprolinemia,-0.029611735857293375,-1.123200181209014,1
7683,Biological Process,GO:0006740,NADPH regeneration,-0.029623539683760303,-1.1234032144366743,1
7684,Phenotype,HP:0031165,Multifocal seizures,-0.029643779790313518,-1.1237513569795352,1
7685,Disease,MONDO:0800096,abnormal mineralization disorder,-0.029703726809744424,-1.1247824833585758,1
7686,Phenotype,HP:0007587,Numerous pigmented freckles,-0.029720315648179563,-1.1250678217969252,1
7687,Disease,MONDO:0005137,nutritional disorder,-0.02972763888599461,-1.1251937860861054,1
7688,Phenotype,HP:0002227,White eyelashes,-0.029757978940841978,-1.1257156540820732,1
7689,Phenotype,HP:0002356,Writer's cramp,-0.02976652877778907,-1.12586271664659,1
7690,Biological Process,GO:0032790,ribosome disassembly,-0.02982747373043937,-1.1269110081036744,1
7691,Phenotype,HP:0006961,Jerky head movements,-0.02986758923214916,-1.1276010199243471,1
7692,Disease,MONDO:0024637,malignant soft tissue neoplasm,-0.029883923204733653,-1.1278819745100175,1
7692,Disease,MONDO:0018078,soft tissue sarcoma,-0.029883923204733653,-1.1278819745100175,1
7694,Phenotype,HP:0000649,Abnormality of visual evoked potentials,-0.029884251650378113,-1.1278876239813558,1
7695,Biological Process,GO:0060173,limb development,-0.02995063798207931,-1.1290295105751293,1
7695,Biological Process,GO:0048736,appendage development,-0.02995063798207931,-1.1290295105751293,1
7697,Phenotype,HP:0025633,Abnormal ureter morphology,-0.029954344952221934,-1.1290932727894423,1
7698,Phenotype,HP:0009821,Forearm undergrowth,-0.029970117742235347,-1.1293645746824854,1
7699,Phenotype,HP:0033348,Epileptic aura,-0.030023402265025645,-1.1302811019354706,1
7700,Disease,MONDO:0015947,inherited ichthyosis,-0.03006523117066373,-1.1310005853796734,1
7700,Disease,MONDO:0019269,ichthyosis,-0.03006523117066373,-1.1310005853796734,1
7702,Phenotype,HP:0001841,Preaxial foot polydactyly,-0.030073558310699022,-1.1311438174174604,1
7703,Phenotype,HP:0031817,Decreased circulating parathyroid hormone level,-0.030109190085379378,-1.1317567063175882,1
7704,Phenotype,HP:0000269,Prominent occiput,-0.030141054543449508,-1.1323047950062646,1
7705,Phenotype,HP:0012416,Hypercapnia,-0.03015523038455603,-1.132548628375276,1
7705,Phenotype,HP:0500164,Abnormal blood carbon dioxide level,-0.03015523038455603,-1.132548628375276,1
7707,Disease,MONDO:0020070,neonatal epilepsy syndrome,-0.030183659538161933,-1.133037627669905,1
7708,Biological Process,GO:0007218,neuropeptide signaling pathway,-0.030244243874686827,-1.1340797163031773,1
7709,Phenotype,HP:0005930,Abnormal epiphysis morphology,-0.030250313041448873,-1.1341841097827288,1
7710,Biological Process,GO:1901679,nucleotide transmembrane transport,-0.030281463088371652,-1.1347199101510432,1
7711,Phenotype,HP:0010468,Aplasia/Hypoplasia of the testes,-0.030305482782874815,-1.1351330639801047,1
7712,Biological Process,GO:0034656,nucleobase-containing small molecule catabolic process,-0.030311713048474465,-1.135240228460828,1
7713,Phenotype,HP:0100275,Diffuse cerebellar atrophy,-0.030362029623523856,-1.1361057051488925,1
7714,Biological Process,GO:0070914,UV-damage excision repair,-0.030447388455875135,-1.137573930667977,1
7715,Biological Process,GO:1904659,glucose transmembrane transport,-0.030542634808873315,-1.1392122277512378,1
7716,Phenotype,HP:0025517,Hypoplastic hippocampus,-0.03055695456735208,-1.1394585365894272,1
7717,Biological Process,GO:0032200,telomere organization,-0.030564331899636255,-1.1395854313374458,1
7718,Phenotype,HP:0002548,Parkinsonism with favorable response to dopaminergic medication,-0.030627570088336498,-1.140673167894669,1
7719,Phenotype,HP:0002749,Osteomalacia,-0.03064497046427639,-1.14097246528772,1
7720,Biological Process,GO:0060041,retina development in camera-type eye,-0.03065656956596352,-1.141171977120607,1
7721,Disease,MONDO:0100198,Mendelian encephalopathy,-0.030749194767843546,-1.1427651887586356,1
7722,Phenotype,HP:0006891,Thick cerebral cortex,-0.030752855848974248,-1.1428281616531266,1
7723,Phenotype,HP:0010579,Cone-shaped epiphysis,-0.030857607536527443,-1.1446299564597826,1
7724,Biological Process,GO:0006664,glycolipid metabolic process,-0.03091335380300486,-1.1455888272500836,1
7725,Phenotype,HP:0031108,Triceps weakness,-0.031024707537687934,-1.1475041814132498,1
7726,Biological Process,GO:0050906,detection of stimulus involved in sensory perception,-0.031043223034038947,-1.1478226595776324,1
7727,Biological Process,GO:0007389,pattern specification process,-0.03104534147380411,-1.1478590980719061,1
7728,Biological Process,GO:0070202,regulation of establishment of protein localization to chromosome,-0.031052187617189864,-1.1479768560373023,1
7729,Phenotype,HP:0001844,Abnormal hallux morphology,-0.031098564134843576,-1.14877456126393,1
7730,Biological Process,GO:0042058,regulation of epidermal growth factor receptor signaling pathway,-0.031101328370393144,-1.1488221078512348,1
7731,Phenotype,HP:0032243,Abnormal tissue metabolite concentration,-0.03113763409693049,-1.149446589146523,1
7732,Phenotype,HP:0008915,Childhood-onset truncal obesity,-0.031178454244102483,-1.1501487213116406,1
7733,Biological Process,GO:0009790,embryo development,-0.031228980413989582,-1.1510178031625327,1
7734,Phenotype,HP:0000026,Male hypogonadism,-0.031291272984892204,-1.1520892744998188,1
7735,Disease,MONDO:0020071,infantile epilepsy syndrome,-0.031315658112083034,-1.1525087140005883,1
7736,Biological Process,GO:0048806,genitalia development,-0.03132629784638241,-1.1526917241119536,1
7737,Biological Process,GO:0042573,retinoic acid metabolic process,-0.03133546529260589,-1.1528494099438633,1
7738,Biological Process,GO:1903358,regulation of Golgi organization,-0.03137235311663611,-1.1534839036815678,1
7739,Phenotype,HP:0002381,Aphasia,-0.03138486549114394,-1.1536991243804773,1
7740,Phenotype,HP:0100670,Coarse metaphyseal trabecularization,-0.031396648533118965,-1.1539018001018249,1
7741,Phenotype,HP:0000070,Ureterocele,-0.03140143466209322,-1.1539841245257194,1
7742,Phenotype,HP:0008935,Generalized neonatal hypotonia,-0.031456045630726015,-1.1549234674801614,1
7743,Phenotype,HP:0045007,Abnormal substantia nigra morphology,-0.03159508161587832,-1.1573149737349748,1
7744,Phenotype,HP:0002268,Paroxysmal dystonia,-0.03164795489483274,-1.158224427335735,1
7745,Phenotype,HP:0008734,Decreased testicular size,-0.03167930302648325,-1.1587636348857573,1
7746,Phenotype,HP:0001816,Thin nail,-0.03175451584183753,-1.1600573425411158,1
7747,Phenotype,HP:0000829,Hypoparathyroidism,-0.03176950775315657,-1.1603152128302487,1
7748,Phenotype,HP:0002406,Limb dysmetria,-0.03181216092621697,-1.161048874191729,1
7749,Biological Process,GO:0007264,small GTPase-mediated signal transduction,-0.03183880235465075,-1.161507123490763,1
7750,Phenotype,HP:0006731,Follicular thyroid carcinoma,-0.03185264318232961,-1.1617451944184407,1
7751,Phenotype,HP:0009882,Short distal phalanx of finger,-0.03185833943018812,-1.1618431734586703,1
7752,Phenotype,HP:0008724,Hypoplasia of the ovary,-0.03187532039464602,-1.1621352567108538,1
7753,Phenotype,HP:0011318,Bicoronal synostosis,-0.031879725499982525,-1.1622110272889083,1
7754,Biological Process,GO:0015721,bile acid and bile salt transport,-0.03188238180538949,-1.1622567174099838,1
7755,Phenotype,HP:0031064,Impaired continence,-0.03190843845365787,-1.1627049081229495,1
7756,Phenotype,HP:0009738,Abnormal antihelix morphology,-0.03194517410258557,-1.1633367843533295,1
7757,Disease,MONDO:0017305,syndromic oculocutaneous albinism,-0.03195119781325739,-1.1634403959595843,1
7758,Phenotype,HP:0001772,Talipes equinovalgus,-0.03201924117409183,-1.1646107844950115,1
7759,Biological Process,GO:1903859,regulation of dendrite extension,-0.03202349548896999,-1.1646839613824909,1
7760,Phenotype,HP:0011451,Primary microcephaly,-0.03216941790612249,-1.1671939185921687,1
7761,Phenotype,HP:0002963,Abnormal delayed hypersensitivity skin test,-0.032190707959403486,-1.1675601208780808,1
7762,Phenotype,HP:0100321,Abnormal dentate nucleus morphology,-0.03225168155896707,-1.1686089050800632,1
7763,Phenotype,HP:0012805,Iris transillumination defect,-0.032336431115042474,-1.1700666506645963,1
7764,Phenotype,HP:0007178,Motor polyneuropathy,-0.032406266705218956,-1.17126786667017,1
7765,Phenotype,HP:0003713,Muscle fiber necrosis,-0.03243000418347752,-1.1716761662026014,1
7766,Biological Process,GO:0015711,organic anion transport,-0.03245612500465489,-1.1721254607299003,1
7767,Phenotype,HP:0010305,Absence of the sacrum,-0.03245852144578598,-1.1721666810222442,1
7768,Phenotype,HP:0012099,Abnormality of circulating catecholamine level,-0.032527060366024596,-1.1733455934906187,1
7768,Phenotype,HP:0003334,Elevated circulating catecholamine level,-0.032527060366024596,-1.1733455934906187,1
7770,Disease,MONDO:0100038,complex neurodevelopmental disorder,-0.03254234973955783,-1.1736085803166325,1
7771,Biological Process,GO:0042776,proton motive force-driven mitochondrial ATP synthesis,-0.03254852464052882,-1.1737147924909759,1
7772,Phenotype,HP:0010161,Abnormal toe phalanx morphology,-0.032576728654055476,-1.1741999192348611,1
7773,Phenotype,HP:0000717,Autism,-0.032587863344520906,-1.1743914429030995,1
7774,Disease,MONDO:0002406,dermatitis,-0.03272015956270802,-1.1766670209337513,1
7775,Biological Process,GO:0042692,muscle cell differentiation,-0.032725388902129504,-1.1767569688556605,1
7776,Biological Process,GO:0046148,pigment biosynthetic process,-0.032752934722481086,-1.1772307742636101,1
7777,Phenotype,HP:0011151,Atypical absence status epilepticus,-0.03283711776777243,-1.1786787755069066,1
7778,Phenotype,HP:0006486,Abnormal dental root morphology,-0.03284069728555994,-1.1787403454606755,1
7779,Phenotype,HP:0006543,Cardiorespiratory arrest,-0.03285041685427714,-1.1789075281461925,1
7780,Phenotype,HP:0005265,Abnormal jejunum morphology,-0.03285486553246031,-1.178984048204572,1
7781,Biological Process,GO:0051146,striated muscle cell differentiation,-0.03301166751077278,-1.181681140698221,1
7782,Biological Process,GO:0006268,DNA unwinding involved in DNA replication,-0.03302619530839146,-1.181931027940259,1
7783,Phenotype,HP:0010899,Abnormal circulating aspartate family amino acid concentration,-0.03303584403287041,-1.18209699206039,1
7784,Disease,MONDO:0000833,bone remodeling disease,-0.03306623280983301,-1.182619698107336,1
7785,Phenotype,HP:0011217,Abnormal shape of the occiput,-0.03312199091429546,-1.1835787725184133,1
7786,Biological Process,GO:0046479,glycosphingolipid catabolic process,-0.0331541763989458,-1.1841323830658639,1
7787,Biological Process,GO:0015012,heparan sulfate proteoglycan biosynthetic process,-0.03315585848163938,-1.184161315944488,1
7788,Biological Process,GO:0051125,regulation of actin nucleation,-0.0331715709441589,-1.1844315801667524,1
7789,Phenotype,HP:0011358,Generalized hypopigmentation of hair,-0.033200667583692445,-1.1849320606384972,1
7790,Phenotype,HP:0006342,Peg-shaped maxillary lateral incisors,-0.03321161406609052,-1.1851203470097882,1
7791,Biological Process,GO:0046831,regulation of RNA export from nucleus,-0.03323297164115213,-1.1854877107127284,1
7792,Biological Process,GO:0010457,centriole-centriole cohesion,-0.0332347590003752,-1.1855184544137702,1
7793,Phenotype,HP:0025429,Abnormal cry,-0.03329848964675963,-1.1866146615524091,1
7794,Phenotype,HP:0003254,Abnormality of DNA repair,-0.03330728821428175,-1.1867660024390112,1
7795,Phenotype,HP:0034915,Abnormal anus morphology,-0.03335715783125215,-1.1876237911674417,1
7796,Biological Process,GO:0000244,spliceosomal tri-snRNP complex assembly,-0.03341196265488944,-1.188566468549696,1
7797,Disease,MONDO:0100500,Mendelian neurodevelopmental disorder,-0.03343049387664432,-1.1888852172009,1
7798,Phenotype,HP:0005709,2-3 toe cutaneous syndactyly,-0.03343306755974207,-1.1889294861663726,1
7799,Phenotype,HP:0010464,Streak ovary,-0.03348477000241834,-1.1898188006479005,1
7800,Phenotype,HP:0010034,Short 1st metacarpal,-0.033509589897888326,-1.1902457184360924,1
7801,Phenotype,HP:0100540,Palpebral edema,-0.03351956664169409,-1.1904173246946304,1
7802,Biological Process,GO:0048705,skeletal system morphogenesis,-0.03355770778227707,-1.1910733762640855,1
7803,Phenotype,HP:0011172,Complex febrile seizure,-0.03356856791099316,-1.191260177297819,1
7804,Phenotype,HP:0007479,Congenital nonbullous ichthyosiform erythroderma,-0.03362705348820194,-1.1922661659528997,1
7805,Phenotype,HP:0010948,Abnormal fetal cardiovascular morphology,-0.03362835061329594,-1.19228847731907,1
7806,Phenotype,HP:0012208,Immotile sperm,-0.03366100130633898,-1.192850089743011,1
7807,Biological Process,GO:0051258,protein polymerization,-0.033678537570084766,-1.1931517244916565,1
7808,Biological Process,GO:0072599,establishment of protein localization to endoplasmic reticulum,-0.033733879948045775,-1.194103648145846,1
7809,Biological Process,GO:0015695,organic cation transport,-0.03375573204267979,-1.194479517895974,1
7810,Phenotype,HP:0007665,Curly eyelashes,-0.03377236464274125,-1.194765609061777,1
7811,Phenotype,HP:0007204,Diffuse white matter abnormalities,-0.03378957518595738,-1.1950616412127704,1
7812,Biological Process,GO:0032786,"positive regulation of DNA-templated transcription, elongation",-0.033798068566469164,-1.195207732691147,1
7813,Phenotype,HP:0010185,Aplasia/Hypoplasia of the distal phalanges of the toes,-0.033828191467119906,-1.195725865498567,1
7814,Biological Process,GO:0046189,phenol-containing compound biosynthetic process,-0.03386200190728328,-1.1963074263012623,1
7815,Biological Process,GO:0031115,negative regulation of microtubule polymerization,-0.033865855543791845,-1.1963737112691712,1
7816,Phenotype,HP:0034237,Open neural tube defect,-0.033878822227253025,-1.19659674636737,1
7817,Phenotype,HP:0011169,Generalized clonic seizure,-0.03388825160986042,-1.1967589376695706,1
7818,Biological Process,GO:0018958,phenol-containing compound metabolic process,-0.03390480845425636,-1.1970437257903546,1
7819,Biological Process,GO:0034067,protein localization to Golgi apparatus,-0.033988650969593914,-1.1984858697046037,1
7820,Phenotype,HP:0200128,Biventricular hypertrophy,-0.03399826265534256,-1.1986511967353146,1
7821,Phenotype,HP:0010544,Vertical nystagmus,-0.03402229206390328,-1.1990645176522663,1
7822,Disease,MONDO:0001639,deficiency anemia,-0.03407311901376686,-1.199938773107634,1
7822,Disease,MONDO:0016624,inherited deficiency anemia,-0.03407311901376686,-1.199938773107634,1
7824,Phenotype,HP:0000349,Widow's peak,-0.034118166578041675,-1.200713619501604,1
7825,Phenotype,HP:0011071,Abnormal permanent molar morphology,-0.034119423612613664,-1.20073524128562,1
7825,Phenotype,HP:0000679,Taurodontia,-0.034119423612613664,-1.20073524128562,1
7827,Biological Process,GO:0007214,gamma-aminobutyric acid signaling pathway,-0.034121732913683145,-1.200774962714183,1
7828,Phenotype,HP:0025186,Marcus Gunn jaw winking synkinesis,-0.03420659030506479,-1.2022345631337006,1
7829,Phenotype,HP:0001029,Poikiloderma,-0.03421412252876865,-1.202364122111405,1
7830,Phenotype,HP:0003323,Progressive muscle weakness,-0.0342437523498218,-1.202873773640108,1
7831,Disease,MONDO:0000171,"muscular dystrophy-dystroglycanopathy, type A",-0.03425129773435165,-1.2030035589922838,1
7832,Biological Process,GO:0034498,early endosome to Golgi transport,-0.034284671632253794,-1.2035776109939513,1
7833,Biological Process,GO:0045739,positive regulation of DNA repair,-0.034288574894504986,-1.2036447495557967,1
7834,Biological Process,GO:0046486,glycerolipid metabolic process,-0.034352733035798444,-1.2047483098753244,1
7835,Biological Process,GO:0007263,nitric oxide mediated signal transduction,-0.03442450785817641,-1.2059828818925398,1
7836,Phenotype,HP:0010053,Abnormality of the distal phalanx of the hallux,-0.034453823819273754,-1.206487134832909,1
7837,Biological Process,GO:0051053,negative regulation of DNA metabolic process,-0.03450382296938037,-1.2073471516126248,1
7838,Biological Process,GO:0021953,central nervous system neuron differentiation,-0.03460189228406363,-1.2090340054095996,1
7839,Phenotype,HP:0033685,Fiber type grouping,-0.03461250298530949,-1.2092165161342125,1
7840,Phenotype,HP:0008807,Acetabular dysplasia,-0.03474739272389393,-1.2115367043443472,1
7841,Phenotype,HP:0030195,Fatigable weakness of swallowing muscles,-0.03474941447907809,-1.211571479803113,1
7842,Biological Process,GO:0010833,telomere maintenance via telomere lengthening,-0.034768577540509105,-1.2119010964935217,1
7843,Biological Process,GO:0030501,positive regulation of bone mineralization,-0.03480409523951611,-1.212512023220432,1
7844,Phenotype,HP:0033684,Abnormal muscle fiber-type distribution,-0.03485105453803872,-1.2133197526439725,1
7845,Phenotype,HP:0009883,Duplication of the distal phalanx of hand,-0.03486124717555761,-1.213495072409951,1
7846,Biological Process,GO:0030278,regulation of ossification,-0.034869520317046376,-1.2136373756388286,1
7847,Biological Process,GO:0006334,nucleosome assembly,-0.034939601874539816,-1.2148428224367134,1
7848,Biological Process,GO:1903509,liposaccharide metabolic process,-0.034950688641551375,-1.2150335217914507,1
7849,Phenotype,HP:0011787,Central hypothyroidism,-0.03501985149944398,-1.2162231663792868,1
7850,Phenotype,HP:0010546,Muscle fibrillation,-0.03511097273395203,-1.2177905088340737,1
7851,Biological Process,GO:1903689,"regulation of wound healing, spreading of epidermal cells",-0.03519865773032471,-1.2192987458350837,1
7852,Biological Process,GO:0051180,vitamin transport,-0.03527269616170425,-1.220572253348601,1
7853,Phenotype,HP:0011925,Decreased activity of mitochondrial ATP synthase complex,-0.03527756841891461,-1.2206560592322422,1
7854,Biological Process,GO:0001522,pseudouridine synthesis,-0.03528055672422048,-1.2207074599600642,1
7855,Phenotype,HP:0003281,Increased circulating ferritin concentration,-0.035285717097514935,-1.2207962216212798,1
7856,Phenotype,HP:0000133,Gonadal dysgenesis,-0.035322673748720224,-1.221431899229617,1
7857,Phenotype,HP:0011753,Posterior pituitary dysgenesis,-0.03533543739119738,-1.221651441895387,1
7858,Phenotype,HP:0011990,Abnormality of neutrophil physiology,-0.035383979623435646,-1.2224863987728691,1
7859,Disease,MONDO:0800063,primordial dwarfism and slender bone disorder,-0.035388753417568974,-1.222568511029754,1
7860,Biological Process,GO:0098916,anterograde trans-synaptic signaling,-0.035406043674492516,-1.2228659143065723,1
7860,Biological Process,GO:0007268,chemical synaptic transmission,-0.035406043674492516,-1.2228659143065723,1
7862,Biological Process,GO:0140053,mitochondrial gene expression,-0.03547058798778968,-1.2239761170270673,1
7863,Biological Process,GO:0072329,monocarboxylic acid catabolic process,-0.0354844093205573,-1.2242138526300295,1
7864,Disease,MONDO:0003996,basal ganglia disorder,-0.03551921900511679,-1.2248126010638318,1
7865,Disease,MONDO:0000509,non-syndromic intellectual disability,-0.03552676252123543,-1.2249423542781617,1
7866,Phenotype,HP:0010945,Fetal pyelectasis,-0.03552708738261967,-1.2249479420979732,1
7867,Biological Process,GO:0034655,nucleobase-containing compound catabolic process,-0.035597592900051156,-1.226160681273026,1
7868,Phenotype,HP:0005224,Rectal abscess,-0.035634605404230246,-1.2267973195875863,1
7869,Phenotype,HP:0002211,White forelock,-0.03564550407697564,-1.2269847836028283,1
7870,Biological Process,GO:0010586,miRNA metabolic process,-0.035648732061686506,-1.2270403069669271,1
7871,Phenotype,HP:0011098,Speech apraxia,-0.0356616976330657,-1.2272633229366174,1
7872,Disease,MONDO:0100455,neonatal-onset developmental and epileptic encephalopathy,-0.03567238622877844,-1.2274471734949761,1
7873,Phenotype,HP:0000183,Difficulty in tongue movements,-0.03568016925356354,-1.2275810464087729,1
7874,Disease,MONDO:0006496,palsy,-0.035689351415680415,-1.2277389853632898,1
7875,Biological Process,GO:2000781,positive regulation of double-strand break repair,-0.03572841528676718,-1.2284109084768555,1
7876,Disease,MONDO:0020344,postsynaptic congenital myasthenic syndrome,-0.03575717977633275,-1.2289056757605716,1
7877,Phenotype,HP:0012594,Moderate albuminuria,-0.03578869351723868,-1.2294477318937844,1
7878,Biological Process,GO:0099536,synaptic signaling,-0.03584639932583822,-1.230440308039116,1
7879,Phenotype,HP:0005469,Flat occiput,-0.03593637648627257,-1.231987971701393,1
7880,Biological Process,GO:0062125,regulation of mitochondrial gene expression,-0.03597592657276083,-1.2326682580251924,1
7881,Phenotype,HP:0000966,Hypohidrosis,-0.035994353385227384,-1.2329852107710715,1
7882,Biological Process,GO:0048562,embryonic organ morphogenesis,-0.03601302529625272,-1.233306379366076,1
7883,Phenotype,HP:0001041,Facial erythema,-0.036080638791211816,-1.2344693739385049,1
7884,Phenotype,HP:0034435,Abnormal eye contact,-0.03611031008025245,-1.2349797387426333,1
7884,Phenotype,HP:0000817,Reduced eye contact,-0.03611031008025245,-1.2349797387426333,1
7886,Phenotype,HP:0001162,Postaxial hand polydactyly,-0.03626757355322119,-1.2376847692341741,1
7887,Biological Process,GO:0006884,cell volume homeostasis,-0.036364686247885025,-1.2393551685660877,1
7888,Biological Process,GO:0006405,RNA export from nucleus,-0.036365384111702426,-1.2393671722619835,1
7889,Biological Process,GO:0009308,amine metabolic process,-0.036373419675575835,-1.2395053890066856,1
7890,Phenotype,HP:0002937,Hemivertebrae,-0.03638691955047779,-1.239737595332493,1
7891,Phenotype,HP:0000046,Small scrotum,-0.036401482257713225,-1.239988083041861,1
7892,Disease,MONDO:0019250,inborn disorder of biogenic amine metabolism and transport,-0.03644394192075184,-1.2407184159094486,1
7893,Phenotype,HP:0011070,Abnormal molar morphology,-0.03651954529064305,-1.2420188413480984,1
7894,Phenotype,HP:0009894,Thickened ears,-0.03654722826204293,-1.2424950058402053,1
7895,Biological Process,GO:0051443,positive regulation of ubiquitin-protein transferase activity,-0.03656182102763683,-1.2427460105722148,1
7896,Phenotype,HP:0025669,Abnormal neck physiology,-0.03657787916483857,-1.2430222206160861,1
7896,Phenotype,HP:0005986,Limitation of neck motion,-0.03657787916483857,-1.2430222206160861,1
7898,Disease,MONDO:0015650,epilepsy syndrome,-0.036586726577954476,-1.2431744016775748,1
7899,Biological Process,GO:0046761,viral budding from plasma membrane,-0.03662402376338525,-1.243815936688435,1
7900,Phenotype,HP:0001488,Bilateral ptosis,-0.03664937245951849,-1.2442519501801048,1
7901,Phenotype,HP:0011077,Abnormality of molar,-0.03665395539126992,-1.2443307794841654,1
7902,Phenotype,HP:0012650,Perisylvian polymicrogyria,-0.0367081106415903,-1.2452622837974572,1
7903,Biological Process,GO:0006644,phospholipid metabolic process,-0.03674824826392409,-1.2459526761067536,1
7904,Biological Process,GO:0046467,membrane lipid biosynthetic process,-0.03675948093416803,-1.2461458850887104,1
7905,Biological Process,GO:0007095,mitotic G2 DNA damage checkpoint signaling,-0.03679274405027644,-1.246718031573958,1
7906,Biological Process,GO:0007266,Rho protein signal transduction,-0.03685052298596614,-1.247711865551162,1
7907,Phenotype,HP:0001657,Prolonged QT interval,-0.03693257663242955,-1.249123239797423,1
7908,Phenotype,HP:0004684,Talipes valgus,-0.03696365473752983,-1.2496578027212133,1
7909,Biological Process,GO:0032239,regulation of nucleobase-containing compound transport,-0.0369820089701991,-1.2499735070490012,1
7910,Phenotype,HP:0001563,Fetal polyuria,-0.03699457900121761,-1.250189719476101,1
7911,Phenotype,HP:0000742,Self-mutilation,-0.037026726794548104,-1.2507426817091811,1
7912,Biological Process,GO:0034728,nucleosome organization,-0.03704104487319415,-1.2509889616531928,1
7913,Phenotype,HP:0001769,Broad foot,-0.037049503081489465,-1.2511344481473592,1
7914,Phenotype,HP:0007772,Impaired smooth pursuit,-0.03704952353555635,-1.251134799970154,1
7915,Biological Process,GO:0046512,sphingosine biosynthetic process,-0.03717941621558318,-1.2533690356351033,1
7915,Biological Process,GO:0046520,sphingoid biosynthetic process,-0.03717941621558318,-1.2533690356351033,1
7917,Phenotype,HP:0006490,Abnormal lower-limb metaphysis morphology,-0.037221425285947296,-1.2540916180257313,1
7918,Disease,MONDO:0019852,inherited primary ovarian failure,-0.03724673501766951,-1.2545269613050631,1
7918,Disease,MONDO:0005387,primary ovarian failure,-0.03724673501766951,-1.2545269613050631,1
7918,Disease,MONDO:0001889,ovarian dysfunction,-0.03724673501766951,-1.2545269613050631,1
7921,Biological Process,GO:0006921,cellular component disassembly involved in execution phase of apoptosis,-0.037304607703049,-1.2555224078358032,1
7922,Phenotype,HP:0011324,Multiple suture craniosynostosis,-0.037318793152386176,-1.2557664064724154,1
7923,Phenotype,HP:0009889,Localized hirsutism,-0.03736243484704205,-1.256517071026098,1
7924,Phenotype,HP:0000855,Insulin resistance,-0.03738209509664747,-1.2568552396653252,1
7925,Biological Process,GO:0036258,multivesicular body assembly,-0.037390601552350855,-1.257001556045208,1
7926,Biological Process,GO:0006613,cotranslational protein targeting to membrane,-0.03739345074107203,-1.2570505638804124,1
7927,Biological Process,GO:0015749,monosaccharide transmembrane transport,-0.03742594905690644,-1.257609555320677,1
7928,Biological Process,GO:0042454,ribonucleoside catabolic process,-0.037496642810197045,-1.2588255322707127,1
7929,Disease,MONDO:0017748,inborn disorder of glycosphingolipid and glycosylphosphatidylinositol anchor glycosylation,-0.03752526958318825,-1.259317930742868,1
7930,Phenotype,HP:0011038,Abnormal renal tubular resorption,-0.037526801602351556,-1.2593442824345362,1
7931,Biological Process,GO:0007420,brain development,-0.03752746502620474,-1.2593556937414203,1
7932,Disease,MONDO:0019609,Zellweger spectrum disorders,-0.03757517672613764,-1.260176364941702,1
7932,Disease,MONDO:0019234,peroxisome biogenesis disorder,-0.03757517672613764,-1.260176364941702,1
7934,Biological Process,GO:0006287,"base-excision repair, gap-filling",-0.037591930184304845,-1.260464534942819,1
7935,Phenotype,HP:0000114,Proximal tubulopathy,-0.03762879024460797,-1.2610985511269828,1
7936,Phenotype,HP:0100569,Abnormally ossified vertebrae,-0.037630435421714736,-1.2611268492063383,1
7937,Biological Process,GO:0006901,vesicle coating,-0.03766320576794313,-1.2616905197402057,1
7938,Phenotype,HP:0045017,Congenital malformation of the left heart,-0.03769567831201326,-1.262249067889941,1
7939,Phenotype,HP:0006955,Olivopontocerebellar hypoplasia,-0.0377069709023965,-1.2624433075359216,1
7940,Phenotype,HP:0001281,Tetany,-0.03773228972608034,-1.2628788072027028,1
7941,Phenotype,HP:0000863,Central diabetes insipidus,-0.03777377622954825,-1.2635924011145607,1
7942,Biological Process,GO:0042359,vitamin D metabolic process,-0.037859988967762215,-1.265075314350709,1
7943,Phenotype,HP:0003287,Abnormality of mitochondrial metabolism,-0.037871273939886985,-1.26526942295786,1
7944,Phenotype,HP:0003074,Hyperglycemia,-0.03787752718328585,-1.2653769826711594,1
7945,Biological Process,GO:0051131,chaperone-mediated protein complex assembly,-0.03788955155163931,-1.2655838093577612,1
7946,Phenotype,HP:0012250,ST segment depression,-0.037918321823956935,-1.2660786761084437,1
7947,Phenotype,HP:0011344,Severe global developmental delay,-0.03799097985329625,-1.2673284398400204,1
7948,Biological Process,GO:0009111,vitamin catabolic process,-0.03802815476389432,-1.2679678716469733,1
7949,Biological Process,GO:0031111,negative regulation of microtubule polymerization or depolymerization,-0.03804392505015919,-1.2682391304739693,1
7950,Phenotype,HP:0002457,Abnormal head movements,-0.038069720943176844,-1.2686828360328763,1
7951,Biological Process,GO:1901978,positive regulation of cell cycle checkpoint,-0.03810962330250667,-1.2693691816707668,1
7952,Phenotype,HP:0012408,Medullary nephrocalcinosis,-0.038116757698764214,-1.2694918977665715,1
7953,Biological Process,GO:0009798,axis specification,-0.03824493742485324,-1.2716966695481098,1
7954,Biological Process,GO:1903504,regulation of mitotic spindle checkpoint,-0.03828213090879662,-1.2723364208282655,1
7954,Biological Process,GO:0090231,regulation of spindle checkpoint,-0.03828213090879662,-1.2723364208282655,1
7954,Biological Process,GO:0090266,regulation of mitotic cell cycle spindle assembly checkpoint,-0.03828213090879662,-1.2723364208282655,1
7957,Disease,MONDO:0005089,sarcoma,-0.03835356069973472,-1.2735650580880464,1
7958,Biological Process,GO:0060211,regulation of nuclear-transcribed mRNA poly(A) tail shortening,-0.03836111707880496,-1.2736950325532213,1
7959,Phenotype,HP:0004661,Frontalis muscle weakness,-0.03836437575624263,-1.2737510838514954,1
7959,Phenotype,HP:0040172,Abnormality of occipitofrontalis muscle,-0.03836437575624263,-1.2737510838514954,1
7959,Phenotype,HP:0004885,Episodic respiratory distress,-0.03836437575624263,-1.2737510838514954,1
7959,Phenotype,HP:3000004,Abnormal frontalis muscle physiology,-0.03836437575624263,-1.2737510838514954,1
7963,Biological Process,GO:0007004,telomere maintenance via telomerase,-0.03837544123641279,-1.273941417059193,1
7963,Biological Process,GO:0006278,RNA-templated DNA biosynthetic process,-0.03837544123641279,-1.273941417059193,1
7965,Phenotype,HP:0012294,Abnormal occipital bone morphology,-0.03841401566171254,-1.2746049213978656,1
7966,Biological Process,GO:0070979,protein K11-linked ubiquitination,-0.03844793257647616,-1.275188313630548,1
7967,Phenotype,HP:0002057,Prominent glabella,-0.03852751337964988,-1.276557153419359,1
7968,Phenotype,HP:5200020,Abnormal interest in others,-0.03857913344158659,-1.2774450509004338,1
7968,Phenotype,HP:0100962,Excessive shyness,-0.03857913344158659,-1.2774450509004338,1
7970,Biological Process,GO:0039535,regulation of RIG-I signaling pathway,-0.03859350515559523,-1.2776922534063635,1
7971,Biological Process,GO:0006906,vesicle fusion,-0.038643117636072866,-1.2785456192256448,1
7972,Biological Process,GO:0048515,spermatid differentiation,-0.038649968297306714,-1.278663454900865,1
7972,Biological Process,GO:0007286,spermatid development,-0.038649968297306714,-1.278663454900865,1
7974,Biological Process,GO:0006303,double-strand break repair via nonhomologous end joining,-0.038678927228467996,-1.2791615667021305,1
7975,Biological Process,GO:0097267,omega-hydroxylase P450 pathway,-0.03868376595784895,-1.2792447958860516,1
7976,Biological Process,GO:0042219,cellular modified amino acid catabolic process,-0.038685801219726645,-1.2792798036684279,1
7977,Phenotype,HP:0002058,Myopathic facies,-0.038708036732698625,-1.2796622684547436,1
7978,Biological Process,GO:1901532,regulation of hematopoietic progenitor cell differentiation,-0.03873168244815095,-1.2800689896092838,1
7979,Disease,MONDO:0019713,non-syndromic limb reduction defect,-0.03880005577958734,-1.2812450538462756,1
7980,Phenotype,HP:0002056,Abnormality of the glabella,-0.03883561530761814,-1.2818567000586625,1
7981,Phenotype,HP:0011924,Decreased activity of mitochondrial complex III,-0.03885617326189306,-1.282210309781935,1
7982,Disease,MONDO:0021017,synaptopathy,-0.03886926491271003,-1.282435494397129,1
7982,Disease,MONDO:0020124,neuromuscular junction disease,-0.03886926491271003,-1.282435494397129,1
7982,Disease,MONDO:0018940,congenital myasthenic syndrome,-0.03886926491271003,-1.282435494397129,1
7985,Phenotype,HP:0010804,Tented upper lip vermilion,-0.038894093749926695,-1.2828625659889785,1
7986,Biological Process,GO:0046753,non-lytic viral release,-0.038894988761592364,-1.2828779607516672,1
7987,Phenotype,HP:0002226,White eyebrow,-0.03898307303371551,-1.2843930655463174,1
7988,Phenotype,HP:0002418,Abnormal midbrain morphology,-0.03907186471890545,-1.2859203382899496,1
7989,Phenotype,HP:0009468,Deviation of the 2nd finger,-0.039196516974816076,-1.2880644353692798,1
7990,Biological Process,GO:0006895,Golgi to endosome transport,-0.0392410987043148,-1.2888312691125716,1
7991,Biological Process,GO:0045664,regulation of neuron differentiation,-0.03925051648793998,-1.2889932609049943,1
7992,Phenotype,HP:0030260,Microphallus,-0.039279318403217856,-1.289488671934464,1
7993,Biological Process,GO:0043001,Golgi to plasma membrane protein transport,-0.039307662587920955,-1.2899762097106073,1
7994,Biological Process,GO:0034312,diol biosynthetic process,-0.039378787813811655,-1.2911996082603159,1
7995,Phenotype,HP:0040133,Abnormal circulating ferritin concentration,-0.039422829039216456,-1.2919571449937728,1
7996,Phenotype,HP:0004440,Coronal craniosynostosis,-0.039451466354245124,-1.2924497247955924,1
7997,Phenotype,HP:0002263,Exaggerated cupid's bow,-0.03945772793920321,-1.2925574279889485,1
7998,Phenotype,HP:0001795,Hyperconvex nail,-0.03945913656842537,-1.292581657296144,1
7999,Biological Process,GO:0003230,cardiac atrium development,-0.03962022760830952,-1.2953525243422208,1
8000,Disease,MONDO:0015929,thoracic malformation,-0.03962280923877781,-1.2953969300074575,1
8000,Disease,MONDO:0020001,respiratory or thoracic malformation,-0.03962280923877781,-1.2953969300074575,1
8002,Phenotype,HP:0008969,Leg muscle stiffness,-0.03972189027625572,-1.29710118607183,1
8003,Disease,MONDO:0009627,Galloway-Mowat syndrome,-0.03985442081223223,-1.2993807945156037,1
8004,Phenotype,HP:0002913,Myoglobinuria,-0.039891389611650174,-1.3000166810808271,1
8005,Phenotype,HP:0003839,Abnormal upper limb epiphysis morphology,-0.039922780533346636,-1.3005566246465106,1
8006,Disease,MONDO:0020022,central nervous system malformation,-0.039970992039179976,-1.3013858928221422,1
8007,Phenotype,HP:0002000,Short columella,-0.04001434814863103,-1.3021316451309635,1
8008,Phenotype,HP:0007676,Hypoplasia of the iris,-0.04010670425319662,-1.3037202281261993,1
8009,Biological Process,GO:0016137,glycoside metabolic process,-0.04011656293137178,-1.3038898035817497,1
8010,Phenotype,HP:0000124,Renal tubular dysfunction,-0.04015586123914994,-1.3045657591536262,1
8011,Biological Process,GO:0048199,"vesicle targeting, to, from or within Golgi",-0.04015996088288687,-1.3046362756003478,1
8012,Phenotype,HP:0000253,Progressive microcephaly,-0.04017447292522447,-1.3048858918416573,1
8013,Phenotype,HP:0000722,Compulsive behaviors,-0.04027642145195731,-1.3066394705219069,1
8014,Phenotype,HP:0002367,Visual hallucination,-0.04033376729632754,-1.3076258550564483,1
8015,Phenotype,HP:0025129,Abnormal small intestinal mucosa morphology,-0.0404099970712688,-1.3089370550553214,1
8016,Biological Process,GO:0009309,amine biosynthetic process,-0.04041879346462918,-1.3090883585449764,1
8017,Phenotype,HP:0009755,Ankyloblepharon,-0.04049161868620765,-1.310340998088058,1
8018,Phenotype,HP:0000190,Abnormal oral frenulum morphology,-0.04051230524476401,-1.3106968198857307,1
8019,Phenotype,HP:0010844,EEG with multifocal slow activity,-0.040551385717552124,-1.3113690285589852,1
8020,Biological Process,GO:0009164,nucleoside catabolic process,-0.040581039253690276,-1.3118790880020426,1
8021,Biological Process,GO:0006383,transcription by RNA polymerase III,-0.04059688336803591,-1.312151616718389,1
8022,Phenotype,HP:0001889,Megaloblastic anemia,-0.04065608580010127,-1.3131699357271651,1
8023,Phenotype,HP:0002722,Recurrent abscess formation,-0.04068451244566074,-1.3136588918818208,1
8024,Phenotype,HP:0002363,Abnormal brainstem morphology,-0.04071552989148386,-1.3141924114279517,1
8025,Phenotype,HP:0002445,Tetraplegia,-0.04072425610389674,-1.314342507761238,1
8026,Phenotype,HP:0002509,Limb hypertonia,-0.040734018461964894,-1.3145104264504621,1
8027,Phenotype,HP:0007994,Peripheral visual field loss,-0.04074335653261851,-1.3146710471297167,1
8028,Biological Process,GO:0090174,organelle membrane fusion,-0.040765457155550466,-1.3150511917226373,1
8029,Biological Process,GO:0044818,mitotic G2/M transition checkpoint,-0.04079615638984935,-1.3155792378307247,1
8030,Phenotype,HP:0010344,Deviation of the 5th toe,-0.040903107506216285,-1.3174188641941487,1
8031,Phenotype,HP:0011471,Gastrostomy tube feeding in infancy,-0.04098669592584314,-1.3188566375026098,1
8032,Phenotype,HP:0033836,Abnormal intrarenal artery morphology,-0.041034427420184594,-1.319677649179149,1
8032,Phenotype,HP:0008776,Abnormal renal artery morphology,-0.041034427420184594,-1.319677649179149,1
8034,Phenotype,HP:0040319,Dark urine,-0.041058265349999346,-1.3200876765414273,1
8035,Phenotype,HP:0011154,Focal autonomic seizure,-0.04107895870802847,-1.3204436152943015,1
8036,Biological Process,GO:0006817,phosphate ion transport,-0.041089791033345424,-1.3206299380921103,1
8037,Phenotype,HP:0001133,Constriction of peripheral visual field,-0.04110010616316773,-1.3208073648026286,1
8038,Biological Process,GO:0070129,regulation of mitochondrial translation,-0.041122188993697906,-1.3211872033550656,1
8039,Biological Process,GO:0072659,protein localization to plasma membrane,-0.04112411896644064,-1.3212204000982024,1
8040,Biological Process,GO:0046415,urate metabolic process,-0.04117663168042984,-1.3221236517551374,1
8041,Biological Process,GO:0006775,fat-soluble vitamin metabolic process,-0.04127907328019442,-1.3238857116011673,1
8042,Phenotype,HP:0000563,Keratoconus,-0.04132250781420854,-1.3246328128617213,1
8043,Phenotype,HP:0001233,2-3 finger syndactyly,-0.0413245141790437,-1.3246673235968196,1
8044,Phenotype,HP:0011867,Abnormal iliac wing morphology,-0.041480188260723194,-1.327345015560098,1
8045,Phenotype,HP:0030842,Choking episodes,-0.04148892348396638,-1.3274952668853244,1
8046,Biological Process,GO:0035148,tube formation,-0.04149004438782322,-1.327514547135554,1
8047,Biological Process,GO:0006665,sphingolipid metabolic process,-0.041529192668092296,-1.3281879221400619,1
8048,Phenotype,HP:0001804,Hypoplastic fingernail,-0.04157785118031465,-1.3290248791062904,1
8049,Phenotype,HP:0009193,Pseudoepiphyses of the metacarpals,-0.041651493035263165,-1.3302915652561567,1
8050,Phenotype,HP:0001674,Complete atrioventricular canal defect,-0.0417635881062548,-1.332219670869366,1
8051,Phenotype,HP:0030099,Reduced muscle fiber alpha dystroglycan,-0.04177487665540269,-1.332413841003561,1
8052,Biological Process,GO:0035461,vitamin transmembrane transport,-0.04178341703164046,-1.3325607408379363,1
8053,Phenotype,HP:0003079,Defective DNA repair after ultraviolet radiation damage,-0.041835739418485396,-1.3334607187484704,1
8054,Biological Process,GO:0043649,dicarboxylic acid catabolic process,-0.04190299894349492,-1.334617624815485,1
8055,Disease,MONDO:0005579,"epilepsy, idiopathic generalized",-0.041941678496337786,-1.3352829374139161,1
8055,Disease,MONDO:0100062,developmental and epileptic encephalopathy,-0.041941678496337786,-1.3352829374139161,1
8057,Phenotype,HP:0410011,Abnormality of masticatory muscle,-0.04196758854215421,-1.3357286064726464,1
8058,Biological Process,GO:0007032,endosome organization,-0.041972968798900556,-1.3358211502673143,1
8059,Biological Process,GO:0036297,interstrand cross-link repair,-0.04205861581215187,-1.3372943326788478,1
8060,Biological Process,GO:0051028,mRNA transport,-0.04214887396703104,-1.3388468296220313,1
8061,Phenotype,HP:0031970,Abnormal blood urea nitrogen concentration,-0.04223156346061052,-1.3402691408379805,1
8062,Phenotype,HP:0000617,Abnormality of ocular smooth pursuit,-0.042286980280777264,-1.341222344944856,1
8063,Disease,MONDO:0100022,neonatal/infantile epilepsy syndrome,-0.04229347256066518,-1.341334016235874,1
8064,Disease,MONDO:0018276,muscular dystrophy-dystroglycanopathy,-0.042297313162187544,-1.3414000769938348,1
8065,Phenotype,HP:0010644,Midnasal stenosis,-0.0423367101814085,-1.342077730464515,1
8065,Phenotype,HP:0010641,Abnormality of the midnasal cavity,-0.0423367101814085,-1.342077730464515,1
8067,Disease,MONDO:0015780,dyskeratosis congenita,-0.04236228814251719,-1.3425176874577338,1
8068,Phenotype,HP:0012332,Abnormal autonomic nervous system physiology,-0.04239950388582314,-1.3431578216129039,1
8069,Phenotype,HP:0034242,Abnormal fetal genitourinary system morphology,-0.04241451650596506,-1.3434160481067947,1
8070,Biological Process,GO:0046473,phosphatidic acid metabolic process,-0.04248602233718479,-1.3446459933071706,1
8071,Phenotype,HP:0008362,Aplasia/Hypoplasia of the hallux,-0.04252523662179408,-1.3453205036277787,1
8072,Biological Process,GO:0099537,trans-synaptic signaling,-0.04252659051110386,-1.3453437913741064,1
8073,Phenotype,HP:0006938,Impaired vibration sensation at ankles,-0.04260584599642536,-1.3467070354915702,1
8074,Phenotype,HP:0031367,Metaphyseal striations,-0.042613183008039845,-1.34683323669875,1
8075,Phenotype,HP:0004397,Ectopic anus,-0.0426473877991953,-1.3474215805861491,1
8076,Phenotype,HP:0011736,Primary hyperaldosteronism,-0.04267324485601742,-1.3478663382009022,1
8077,Biological Process,GO:0007020,microtubule nucleation,-0.04269644153729302,-1.3482653356856233,1
8078,Biological Process,GO:0033015,tetrapyrrole catabolic process,-0.042708000226887366,-1.3484641524051368,1
8078,Biological Process,GO:0006787,porphyrin-containing compound catabolic process,-0.042708000226887366,-1.3484641524051368,1
8080,Phenotype,HP:0000916,Broad clavicles,-0.0427141219985947,-1.3485694507227817,1
8081,Phenotype,HP:0003698,Difficulty standing,-0.04285440764727788,-1.3509824519750753,1
8082,Phenotype,HP:0012075,Personality disorder,-0.042890924444876743,-1.3516105638251676,1
8083,Phenotype,HP:0007675,Progressive night blindness,-0.04295094960610757,-1.3526430342922373,1
8084,Biological Process,GO:0045666,positive regulation of neuron differentiation,-0.043040771139389644,-1.3541880210697663,1
8085,Phenotype,HP:0033076,Abnormal circulating free T4 concentration,-0.04310851080131051,-1.3553531857931667,1
8086,Biological Process,GO:0006275,regulation of DNA replication,-0.043276981110855095,-1.3582509809113503,1
8087,Biological Process,GO:0006337,nucleosome disassembly,-0.04332211303971323,-1.3590272784291317,1
8088,Biological Process,GO:0044242,cellular lipid catabolic process,-0.043376518498699834,-1.3599630864886059,1
8089,Phenotype,HP:0010551,Paraplegia/paraparesis,-0.04345661443707871,-1.3613407869264342,1
8090,Phenotype,HP:0002179,Opisthotonus,-0.04359321044600839,-1.3636903240579907,1
8091,Phenotype,HP:0002061,Lower limb spasticity,-0.0436604214989087,-1.3648463963742878,1
8092,Phenotype,HP:0010571,Elevated circulating phytanic acid concentration,-0.04369831253710443,-1.3654981460256261,1
8092,Phenotype,HP:0010965,Abnormal circulating phytanic acid concentration,-0.04369831253710443,-1.3654981460256261,1
8094,Phenotype,HP:0006660,Aplastic clavicle,-0.04376202208900337,-1.366593990325868,1
8095,Biological Process,GO:1990778,protein localization to cell periphery,-0.043782120180778206,-1.3669396901253599,1
8096,Phenotype,HP:0011359,Dry hair,-0.0439084871178923,-1.3691132807981554,1
8097,Phenotype,HP:0011031,Abnormality of iron homeostasis,-0.04393628050209197,-1.3695913444597545,1
8098,Phenotype,HP:0010322,Abnormal fifth toe morphology,-0.04405710397480944,-1.3716695840638078,1
8099,Phenotype,HP:0000699,Diastema,-0.044071577663159056,-1.3719185405924388,1
8100,Phenotype,HP:0002395,Lower limb hyperreflexia,-0.044103034020456455,-1.37245960969155,1
8101,Phenotype,HP:0007165,Periventricular heterotopia,-0.04412045445139601,-1.3727592520431888,1
8102,Phenotype,HP:0001716,Wolff-Parkinson-White syndrome,-0.044198232440399554,-1.374097082296163,1
8103,Disease,MONDO:0700264,type 1 interferonopathy,-0.04425165637505102,-1.3750160075207065,1
8103,Disease,MONDO:0957408,type 1 interferonopathy of childhood,-0.04425165637505102,-1.3750160075207065,1
8103,Disease,MONDO:0957018,autoinflammatory syndrome of childhood,-0.04425165637505102,-1.3750160075207065,1
8106,Biological Process,GO:0016556,mRNA modification,-0.04427950793403035,-1.3754950718250476,1
8107,Biological Process,GO:0019827,stem cell population maintenance,-0.04442020564238702,-1.3779151607624855,1
8108,Phenotype,HP:0007633,Bilateral microphthalmos,-0.044464024015766546,-1.3786688643011635,1
8109,Biological Process,GO:0008033,tRNA processing,-0.04446419435163462,-1.3786717941850601,1
8110,Biological Process,GO:0050685,positive regulation of mRNA processing,-0.04453690934328525,-1.3799225377041617,1
8111,Phenotype,HP:0025401,Staring gaze,-0.044549533023773735,-1.380139672935835,1
8112,Phenotype,HP:0040161,Localized osteoporosis,-0.04456552556694482,-1.3804147547211882,1
8113,Phenotype,HP:0005374,Cellular immunodeficiency,-0.04463171471198857,-1.3815532495806269,1
8114,Biological Process,GO:0000963,mitochondrial RNA processing,-0.044642380019312755,-1.3817366995640779,1
8115,Disease,MONDO:0005027,epilepsy,-0.04466555178919629,-1.3821352685572121,1
8116,Biological Process,GO:0071897,DNA biosynthetic process,-0.04468476967521884,-1.3824658282650235,1
8117,Phenotype,HP:0004233,Advanced ossification of carpal bones,-0.0447262377518971,-1.383179105224528,1
8118,Disease,MONDO:0005528,inborn vitamin metabolic disorder,-0.04485550368784419,-1.3854025604977303,1
8118,Disease,MONDO:0024298,vitamin deficiency disorder,-0.04485550368784419,-1.3854025604977303,1
8120,Disease,MONDO:0019290,hypopigmentation of the skin,-0.044922222932614275,-1.3865501734053476,1
8121,Phenotype,HP:0040217,Elevated hemoglobin A1c,-0.044929984851191485,-1.3866836832791145,1
8122,Phenotype,HP:0002464,Spastic dysarthria,-0.045041889265894586,-1.388608509484435,1
8123,Phenotype,HP:0012695,Decreased thalamic volume,-0.04505591239452822,-1.388849716103014,1
8123,Phenotype,HP:0012693,Abnormal thalamic size,-0.04505591239452822,-1.388849716103014,1
8125,Biological Process,GO:0140042,lipid droplet formation,-0.045074517774071454,-1.3891697403147465,1
8126,Biological Process,GO:0006406,mRNA export from nucleus,-0.04508669778958452,-1.389379244230235,1
8127,Phenotype,HP:0002084,Encephalocele,-0.045126079890346116,-1.390056641094046,1
8127,Phenotype,HP:0011815,Cephalocele,-0.045126079890346116,-1.390056641094046,1
8129,Biological Process,GO:0071459,"protein localization to chromosome, centromeric region",-0.045134335586939134,-1.3901986442597618,1
8130,Biological Process,GO:0051438,regulation of ubiquitin-protein transferase activity,-0.04514722611689859,-1.3904203694699089,1
8131,Biological Process,GO:0031124,mRNA 3'-end processing,-0.0451569956655824,-1.3905884118422376,1
8132,Phenotype,HP:0000571,Hypometric saccades,-0.04516754738359863,-1.3907699080182612,1
8133,Phenotype,HP:0000473,Torticollis,-0.045316932288957945,-1.3933394221994293,1
8134,Biological Process,GO:0051168,nuclear export,-0.04531802752887093,-1.3933582610137085,1
8135,Phenotype,HP:0010584,Pseudoepiphyses,-0.04538772278508252,-1.3945570631869606,1
8136,Biological Process,GO:0042168,heme metabolic process,-0.045407214116268024,-1.3948923263232897,1
8137,Phenotype,HP:0100259,Postaxial polydactyly,-0.04542149016437813,-1.3951378833156896,1
8138,Phenotype,HP:0000049,Shawl scrotum,-0.04562829697958137,-1.3986950904053133,1
8139,Phenotype,HP:0000667,Phthisis bulbi,-0.04566106181696883,-1.3992586661836572,1
8140,Disease,MONDO:0004736,inborn disorder of amino acid metabolism,-0.04579123834330967,-1.401497784183454,1
8140,Disease,MONDO:0037871,amino acid metabolism disease,-0.04579123834330967,-1.401497784183454,1
8142,Phenotype,HP:0004383,Hypoplastic left heart,-0.04590128368329194,-1.403390633136136,1
8143,Phenotype,HP:0002168,Scanning speech,-0.04591459689426314,-1.4036196287251155,1
8144,Biological Process,GO:0051321,meiotic cell cycle,-0.04593793108712996,-1.4040209914955586,1
8145,Disease,MONDO:0019691,short rib dysplasia,-0.04606693982531329,-1.4062400228057121,1
8146,Disease,MONDO:0015469,craniosynostosis,-0.04608884795427026,-1.406616856381383,1
8147,Phenotype,HP:0010808,Protruding tongue,-0.04609953757803131,-1.406800724622818,1
8148,Phenotype,HP:0010964,Abnormal circulating long-chain fatty-acid concentration,-0.046108735534381884,-1.4069589352480731,1
8149,Phenotype,HP:0000567,Chorioretinal coloboma,-0.04615000766118493,-1.4076688417466736,1
8150,Disease,MONDO:0100284,X-linked intellectual disability,-0.046228849008812745,-1.4090249624357403,1
8151,Biological Process,GO:0090382,phagosome maturation,-0.046255803422078356,-1.4094885952704264,1
8152,Phenotype,HP:0002655,Spondyloepiphyseal dysplasia,-0.04636780287118514,-1.4114150561271688,1
8153,Phenotype,HP:0009929,Abnormal columella morphology,-0.046374369037046614,-1.4115279983033302,1
8154,Phenotype,HP:0010652,Abnormal dura mater morphology,-0.04638034388623802,-1.4116307694614385,1
8154,Phenotype,HP:0010653,Abnormality of the falx cerebri,-0.04638034388623802,-1.4116307694614385,1
8156,Phenotype,HP:0002990,Fibular aplasia,-0.04640866841372859,-1.4121179691211823,1
8157,Biological Process,GO:0051236,establishment of RNA localization,-0.04649184061698408,-1.4135485832466852,1
8158,Phenotype,HP:0034665,Shoulder contracture,-0.046496694413635575,-1.4136320715971213,1
8159,Biological Process,GO:0045995,regulation of embryonic development,-0.046523343513162896,-1.4140904528437814,1
8160,Biological Process,GO:0045047,protein targeting to ER,-0.046550598558012135,-1.414559256730493,1
8161,Phenotype,HP:0007843,Attenuation of retinal blood vessels,-0.04658882532591058,-1.4152167811435454,1
8162,Biological Process,GO:0000723,telomere maintenance,-0.04660447150249225,-1.4154859052060533,1
8163,Phenotype,HP:0002123,Generalized myoclonic seizure,-0.04661002322051622,-1.4155813982423686,1
8164,Biological Process,GO:0007416,synapse assembly,-0.046631131345048704,-1.4159444712395608,1
8165,Phenotype,HP:0030208,Anti-acetylcholine receptor antibody positivity,-0.04664710560355467,-1.4162192385171917,1
8166,Phenotype,HP:0002871,Central apnea,-0.04665186172551561,-1.4163010468016137,1
8167,Phenotype,HP:0040214,Abnormal circulating insulin concentration,-0.04669228949468551,-1.4169964298186943,1
8168,Biological Process,GO:0048568,embryonic organ development,-0.046764627499350286,-1.4182406889249035,1
8169,Phenotype,HP:0007366,Atrophy/Degeneration affecting the brainstem,-0.04680322488971567,-1.4189045882771263,1
8170,Phenotype,HP:0000110,Renal dysplasia,-0.046819745094275333,-1.4191887461697177,1
8171,Phenotype,HP:0002580,Volvulus,-0.04691092837682542,-1.4207571558897918,1
8172,Biological Process,GO:0060395,SMAD protein signal transduction,-0.046980997144773884,-1.4219623826994716,1
8173,Phenotype,HP:0006829,Severe muscular hypotonia,-0.04699298922400508,-1.422168653992894,1
8174,Biological Process,GO:0042158,lipoprotein biosynthetic process,-0.04705472202169014,-1.4232304968793184,1
8175,Biological Process,GO:1903861,positive regulation of dendrite extension,-0.04711126989212855,-1.4242031557611299,1
8176,Phenotype,HP:0011863,Abnormal sternal ossification,-0.047142634224974556,-1.4247426419818885,1
8177,Biological Process,GO:0003091,renal water homeostasis,-0.04714807978014002,-1.4248363089503706,1
8178,Phenotype,HP:0000601,Hypotelorism,-0.04716267683116415,-1.4250873873944714,1
8179,Phenotype,HP:0000402,Stenosis of the external auditory canal,-0.04735405188832553,-1.4283791585551198,1
8180,Biological Process,GO:0006403,RNA localization,-0.04736097469293021,-1.4284982351416222,1
8181,Biological Process,GO:0044786,cell cycle DNA replication,-0.04738713988984333,-1.4289482929594426,1
8181,Biological Process,GO:0033260,nuclear DNA replication,-0.04738713988984333,-1.4289482929594426,1
8183,Phenotype,HP:0000842,Hyperinsulinemia,-0.04740762671297438,-1.4293006791823726,1
8184,Biological Process,GO:0030865,cortical cytoskeleton organization,-0.047453177331341134,-1.430084178422626,1
8185,Biological Process,GO:0050427,3'-phosphoadenosine 5'-phosphosulfate metabolic process,-0.04747389934237112,-1.430440610025108,1
8185,Biological Process,GO:0034035,purine ribonucleoside bisphosphate metabolic process,-0.04747389934237112,-1.430440610025108,1
8187,Phenotype,HP:0002435,Meningocele,-0.04750852456661292,-1.4310361856256109,1
8188,Phenotype,HP:0008715,Testicular dysgenesis,-0.047553095765018316,-1.431802838227484,1
8189,Phenotype,HP:0009058,Increased muscle lipid content,-0.04755429889636065,-1.4318235328421005,1
8190,Phenotype,HP:0001591,Bell-shaped thorax,-0.04757904236500332,-1.432249136040869,1
8191,Phenotype,HP:0005924,Abnormal hand epiphysis morphology,-0.047582970608084585,-1.4323167042886789,1
8192,Biological Process,GO:0007026,negative regulation of microtubule depolymerization,-0.0475880241512725,-1.4324036284049761,1
8192,Biological Process,GO:0031114,regulation of microtubule depolymerization,-0.0475880241512725,-1.4324036284049761,1
8194,Biological Process,GO:0006706,steroid catabolic process,-0.04759946676680893,-1.4326004485778026,1
8195,Phenotype,HP:0004963,Calcification of the aorta,-0.04762171026565465,-1.4329830507261616,1
8196,Phenotype,HP:0006979,Sleep-wake cycle disturbance,-0.04763064538443196,-1.4331367403801027,1
8197,Phenotype,HP:0010966,Abnormal circulating fatty-acid anion concentration,-0.04764597629099043,-1.4334004416002322,1
8198,Phenotype,HP:0002196,Myelopathy,-0.047646833073478057,-1.4334151787970515,1
8199,Phenotype,HP:0002942,Thoracic kyphosis,-0.047732883520025915,-1.434895300514629,1
8200,Phenotype,HP:0002410,Aqueductal stenosis,-0.047766125870344345,-1.4354670898152486,1
8201,Biological Process,GO:0018231,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine,-0.04780749855423605,-1.4361787259589207,1
8201,Biological Process,GO:0018230,peptidyl-L-cysteine S-palmitoylation,-0.04780749855423605,-1.4361787259589207,1
8203,Phenotype,HP:0030890,Hyperintensity of cerebral white matter on MRI,-0.04784258515573803,-1.4367822375380288,1
8204,Phenotype,HP:0000322,Short philtrum,-0.0478503694956558,-1.4369161330729334,1
8205,Phenotype,HP:0009536,Short 2nd finger,-0.0479288247526064,-1.4382656127598994,1
8206,Biological Process,GO:0008645,hexose transmembrane transport,-0.04792895283516163,-1.4382678158602813,1
8207,Phenotype,HP:0004918,Hyperchloremic metabolic acidosis,-0.04797070304777873,-1.438985945735106,1
8208,Biological Process,GO:0051923,sulfation,-0.048035617703333644,-1.4401025185749976,1
8209,Phenotype,HP:0010969,Abnormality of glycolipid metabolism,-0.04805888308594142,-1.4405026977657744,1
8210,Biological Process,GO:0009084,glutamine family amino acid biosynthetic process,-0.04809352462893357,-1.441098554059031,1
8211,Phenotype,HP:0011094,Increased overbite,-0.04812001310268643,-1.4415541724415026,1
8212,Phenotype,HP:0004637,Decreased cervical spine mobility,-0.04815921696856251,-1.4422285035533569,1
8213,Biological Process,GO:0006506,GPI anchor biosynthetic process,-0.04818120775776302,-1.4426067589371245,1
8214,Biological Process,GO:0045055,regulated exocytosis,-0.04820189928399299,-1.4429626661819028,1
8215,Phenotype,HP:0025190,Bilateral tonic-clonic seizure with generalized onset,-0.04821591688036064,-1.443203777642033,1
8216,Phenotype,HP:0010554,Cutaneous finger syndactyly,-0.0484458589604313,-1.4471589258155895,1
8217,Disease,MONDO:0000732,combined oxidative phosphorylation deficiency,-0.04849415339972363,-1.4479896204987952,1
8218,Phenotype,HP:0010553,Oculogyric crisis,-0.048512396091528576,-1.4483034062536728,1
8219,Biological Process,GO:0003197,endocardial cushion development,-0.04853501404883409,-1.4486924493226885,1
8220,Phenotype,HP:0011473,Villous atrophy,-0.04878024295146988,-1.4529105404440055,1
8220,Phenotype,HP:0011472,Abnormal small intestinal villus morphology,-0.04878024295146988,-1.4529105404440055,1
8222,Phenotype,HP:0032860,Generalized non-convulsive status epilepticus without coma,-0.04878467855326929,-1.4529868355803726,1
8223,Phenotype,HP:0006315,Solitary median maxillary central incisor,-0.048790479216132,-1.4530866106242437,1
8224,Phenotype,HP:0002991,Abnormal fibula morphology,-0.0488140769273262,-1.453492506075399,1
8225,Phenotype,HP:0010550,Paraplegia,-0.048874036862342596,-1.4545238546106205,1
8226,Phenotype,HP:0100297,Increased endomysial connective tissue,-0.04889260473503532,-1.4548432336809711,1
8227,Phenotype,HP:0001572,Macrodontia,-0.04894245538819164,-1.4557006962198908,1
8228,Disease,MONDO:0019751,autoinflammatory syndrome,-0.04896003654345349,-1.456003103130803,1
8229,Phenotype,HP:0033835,Abnormal renal vascular morphology,-0.04898827941796502,-1.4564888983080317,1
8230,Phenotype,HP:0003722,Neck flexor weakness,-0.04912802353176282,-1.45889258482023,1
8231,Biological Process,GO:0062111,zinc ion import into organelle,-0.04920008225421535,-1.4601320400970081,1
8232,Phenotype,HP:0012382,Left-to-right shunt,-0.049227660671379736,-1.4606064061906079,1
8233,Biological Process,GO:0031122,cytoplasmic microtubule organization,-0.04922814688004351,-1.4606147692849485,1
8234,Phenotype,HP:0001345,Psychotic mentation,-0.049280248774250524,-1.461510954583648,1
8235,Phenotype,HP:0031913,Rhombencephalosynapsis,-0.04929644455602711,-1.4617895322006431,1
8236,Biological Process,GO:0006820,monoatomic anion transport,-0.04932276778592182,-1.4622423082849865,1
8237,Biological Process,GO:0006643,membrane lipid metabolic process,-0.04938812814881288,-1.4633665475709499,1
8238,Phenotype,HP:0011166,Focal myoclonic seizure,-0.04969359727412659,-1.4686208083512784,1
8239,Phenotype,HP:0003498,Disproportionate short stature,-0.049823171534278066,-1.470849566994414,1
8240,Biological Process,GO:0061951,establishment of protein localization to plasma membrane,-0.049923614697906515,-1.4725772524839478,1
8241,Phenotype,HP:0002267,Exaggerated startle response,-0.049924941983696236,-1.4726000826330246,1
8242,Phenotype,HP:0004934,Vascular calcification,-0.04992844440916966,-1.4726603265505795,1
8243,Phenotype,HP:0009890,High anterior hairline,-0.050002781045543676,-1.473938963377265,1
8244,Phenotype,HP:0003429,CNS hypomyelination,-0.05001410999830336,-1.4741338284789551,1
8245,Biological Process,GO:0008154,actin polymerization or depolymerization,-0.05001986584515139,-1.4742328326592307,1
8246,Disease,MONDO:0018762,non-acquired combined pituitary hormone deficiency,-0.0500684581937314,-1.4750686515692624,1
8247,Biological Process,GO:2001034,positive regulation of double-strand break repair via nonhomologous end joining,-0.05007197771645999,-1.475129189570343,1
8248,Biological Process,GO:0008334,histone mRNA metabolic process,-0.05007753890860034,-1.4752248455674093,1
8249,Phenotype,HP:0002909,Generalized aminoaciduria,-0.050170872727886895,-1.4768302458698195,1
8250,Phenotype,HP:0005943,Respiratory arrest,-0.05020722908239139,-1.4774555979979356,1
8251,Biological Process,GO:0036465,synaptic vesicle recycling,-0.05027110518976685,-1.4785543071569653,1
8252,Phenotype,HP:0001995,Hyperchloremic acidosis,-0.05038308178178452,-1.4804803748574213,1
8253,Biological Process,GO:0030500,regulation of bone mineralization,-0.05039395692143889,-1.4806674340887196,1
8254,Biological Process,GO:0000038,very long-chain fatty acid metabolic process,-0.05040414233809809,-1.4808426296513768,1
8255,Biological Process,GO:0070169,positive regulation of biomineral tissue development,-0.050469890024618325,-1.481973531146989,1
8256,Biological Process,GO:0031365,N-terminal protein amino acid modification,-0.05051560945521927,-1.482759934063679,1
8257,Phenotype,HP:0030345,Abnormal circulating luteinizing hormone concentration,-0.0505725409880593,-1.4837391921797265,1
8258,Phenotype,HP:0032677,Generalized-onset motor seizure,-0.0505847904284471,-1.4839498902466572,1
8259,Phenotype,HP:0030338,Abnormal circulating gonadotropin concentration,-0.05058570094266157,-1.4839655516629202,1
8260,Phenotype,HP:0002566,Intestinal malrotation,-0.05060093227233531,-1.4842275400981009,1
8261,Phenotype,HP:0002174,Postural tremor,-0.05061116680510702,-1.4844035804887368,1
8262,Phenotype,HP:0009765,Low hanging columella,-0.05066061109955999,-1.4852540534027783,1
8263,Phenotype,HP:0007925,Lacrimal duct aplasia,-0.0506669330659304,-1.4853627951943438,1
8264,Phenotype,HP:0001817,Absent fingernail,-0.05067139669517906,-1.4854395724204386,1
8265,Phenotype,HP:0007750,Hypoplasia of the fovea,-0.05076946384503689,-1.4871263889810562,1
8265,Phenotype,HP:0008060,Aplasia/Hypoplasia of the fovea,-0.05076946384503689,-1.4871263889810562,1
8267,Phenotype,HP:0001961,Hypoplastic heart,-0.0507726049086219,-1.487180417247207,1
8268,Disease,MONDO:0000411,electroclinical syndrome,-0.050871669424982,-1.4888843891379784,1
8269,Biological Process,GO:0051298,centrosome duplication,-0.05089474515062142,-1.4892813061098011,1
8270,Phenotype,HP:0000456,Bifid nasal tip,-0.05093940974751976,-1.4900495652244041,1
8271,Phenotype,HP:0040130,Abnormal circulating iron concentration,-0.05113966027384387,-1.4934940000281651,1
8272,Phenotype,HP:0001258,Spastic paraplegia,-0.051174851321326154,-1.4940993081437233,1
8273,Phenotype,HP:0000704,Periodontitis,-0.05124326708317084,-1.4952761022103827,1
8274,Biological Process,GO:0072529,pyrimidine-containing compound catabolic process,-0.051244056788515735,-1.495289685638225,1
8275,Biological Process,GO:0046856,phosphatidylinositol dephosphorylation,-0.05129202519278553,-1.4961147723143033,1
8276,Phenotype,HP:0001088,Brushfield spots,-0.051397957298555674,-1.4979368710555563,1
8277,Biological Process,GO:0046854,phosphatidylinositol phosphate biosynthetic process,-0.05152991653865335,-1.5002066528514584,1
8278,Biological Process,GO:0033013,tetrapyrrole metabolic process,-0.051592958775242836,-1.5012910189093247,1
8279,Phenotype,HP:0000879,Short sternum,-0.05177968717374082,-1.5045028646230083,1
8280,Disease,MONDO:0005180,Parkinson disease,-0.05178792820054445,-1.5046446154591346,1
8281,Phenotype,HP:0000072,Hydroureter,-0.05182814051617135,-1.5053362925399774,1
8282,Phenotype,HP:0004979,Metaphyseal sclerosis,-0.05185964165408086,-1.5058781318937375,1
8283,Biological Process,GO:0007064,mitotic sister chromatid cohesion,-0.051878497738910845,-1.506202468393837,1
8284,Phenotype,HP:0011486,Abnormality of corneal thickness,-0.05192743148578982,-1.5070441595689983,1
8285,Biological Process,GO:1903046,meiotic cell cycle process,-0.05200995047507373,-1.5084635380039924,1
8286,Phenotype,HP:0011006,Abnormal morphology of the musculature of the neck,-0.05228434117303693,-1.5131832303176245,1
8287,Biological Process,GO:0046173,polyol biosynthetic process,-0.05231320125355432,-1.5136796418257397,1
8288,Phenotype,HP:0003557,Increased variability in muscle fiber diameter,-0.05231421927623803,-1.5136971524551854,1
8289,Phenotype,HP:0000378,Cupped ear,-0.052451658901829123,-1.516061200323083,1
8290,Disease,MONDO:0020119,X-linked syndromic intellectual disability,-0.052456649687695256,-1.5161470449740357,1
8291,Phenotype,HP:0002280,Enlarged cisterna magna,-0.05246109997328041,-1.5162235926807388,1
8292,Biological Process,GO:1901361,organic cyclic compound catabolic process,-0.05248076804426183,-1.5165618958525446,1
8293,Biological Process,GO:0007076,mitotic chromosome condensation,-0.05250179142938283,-1.5169235112786454,1
8294,Phenotype,HP:0011063,Abnormal incisor morphology,-0.05250224660213321,-1.516931340535786,1
8295,Phenotype,HP:0000426,Prominent nasal bridge,-0.052505311502315744,-1.5169840587435859,1
8296,Phenotype,HP:0002078,Truncal ataxia,-0.052528544257762544,-1.5173836767267053,1
8297,Phenotype,HP:0004889,Intermittent episodes of respiratory insufficiency due to muscle weakness,-0.05258919742855883,-1.5184269493526712,1
8298,Biological Process,GO:0006505,GPI anchor metabolic process,-0.052756665492692534,-1.5213075052204093,1
8299,Disease,MONDO:0015338,syndromic craniosynostosis,-0.052767584404354695,-1.521495317357729,1
8300,Phenotype,HP:0008059,Aplasia/Hypoplasia of the macula,-0.05277867354661048,-1.5216860575681586,1
8301,Phenotype,HP:0410018,Recurrent ear infections,-0.05287083192820741,-1.5232712396041697,1
8302,Phenotype,HP:0000460,Narrow nose,-0.052945310605929885,-1.5245523196312463,1
8303,Phenotype,HP:0010863,Receptive language delay,-0.052959357492450065,-1.524793934900393,1
8304,Phenotype,HP:0040255,Aplasia/Hypoplasia of the clitoris,-0.05296298714724901,-1.524856367242243,1
8304,Phenotype,HP:0000060,Clitoral hypoplasia,-0.05296298714724901,-1.524856367242243,1
8306,Biological Process,GO:0007051,spindle organization,-0.0530061498912473,-1.5255987935438493,1
8307,Biological Process,GO:0035561,regulation of chromatin binding,-0.053114337176997095,-1.5274596827969338,1
8308,Phenotype,HP:0004409,Hyposmia,-0.05334226642388584,-1.531380208975766,1
8309,Phenotype,HP:0031066,Abnormal ovarian physiology,-0.053456470740518736,-1.5333445949385442,1
8310,Phenotype,HP:0002812,Coxa vara,-0.053476337865693946,-1.533686321967483,1
8311,Phenotype,HP:0011064,Abnormal number of incisors,-0.05348211732383423,-1.5337857322768127,1
8312,Phenotype,HP:0100689,Decreased corneal thickness,-0.05355531604596364,-1.5350447962639169,1
8313,Phenotype,HP:0001693,Cardiac shunt,-0.05360421442218266,-1.535885879041515,1
8314,Phenotype,HP:0007598,Bilateral single transverse palmar creases,-0.0537204107095568,-1.5378845281519373,1
8315,Phenotype,HP:0011153,Focal motor seizure,-0.05386113769165779,-1.5403051206161607,1
8316,Biological Process,GO:0006900,vesicle budding from membrane,-0.053945578185432996,-1.541757550135049,1
8317,Phenotype,HP:0007979,Gaze-evoked horizontal nystagmus,-0.05395151796803832,-1.5418597181258558,1
8318,Phenotype,HP:0100240,Synostosis of joints,-0.05398742815651714,-1.5424773959181521,1
8319,Biological Process,GO:0097164,ammonium ion metabolic process,-0.05402687835924236,-1.5431559641785033,1
8320,Phenotype,HP:0012700,Abnormal large intestine physiology,-0.054055048908930425,-1.5436405153233508,1
8321,Phenotype,HP:0006492,Aplasia/Hypoplasia of the fibula,-0.05420503892626294,-1.546220437810449,1
8322,Disease,MONDO:0023369,disorder of facial skeleton,-0.05423576815034514,-1.546748999761642,1
8323,Biological Process,GO:0030866,cortical actin cytoskeleton organization,-0.05423915839926141,-1.5468073141719707,1
8324,Biological Process,GO:0045471,response to ethanol,-0.05432102477049461,-1.5482154671666692,1
8325,Biological Process,GO:0098656,monoatomic anion transmembrane transport,-0.05436460432769685,-1.548965062917129,1
8326,Phenotype,HP:0003750,Increased muscle fatiguability,-0.05461881046872086,-1.5533375681761445,1
8327,Phenotype,HP:0010580,Enlarged epiphyses,-0.054633328447438956,-1.5535872865269267,1
8328,Phenotype,HP:0000012,Urinary urgency,-0.05465735698891416,-1.5540005925294629,1
8329,Phenotype,HP:0010109,Short hallux,-0.05468074319058491,-1.5544028498839935,1
8330,Biological Process,GO:2000773,negative regulation of cellular senescence,-0.054684959443680015,-1.5544753720849027,1
8331,Biological Process,GO:0016601,Rac protein signal transduction,-0.05468921160136064,-1.5545485118672298,1
8332,Biological Process,GO:1900153,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",-0.05481798443161723,-1.5567634854129007,1
8333,Biological Process,GO:0071044,histone mRNA catabolic process,-0.054820306102416616,-1.5568034196085858,1
8334,Phenotype,HP:0000117,Renal phosphate wasting,-0.05486420322540875,-1.557558477690053,1
8335,Phenotype,HP:0010173,Aplasia/Hypoplasia of the phalanges of the toes,-0.054888392993981405,-1.557974556899911,1
8336,Biological Process,GO:0050657,nucleic acid transport,-0.05492967416632344,-1.5586846189874624,1
8336,Biological Process,GO:0050658,RNA transport,-0.05492967416632344,-1.5586846189874624,1
8338,Phenotype,HP:0100671,Abnormal trabecular bone morphology,-0.05496009789344991,-1.5592079261991743,1
8339,Phenotype,HP:0008947,Infantile muscular hypotonia,-0.054989892946309515,-1.5597204198187087,1
8340,Phenotype,HP:0003282,Low alkaline phosphatase,-0.054995733735475394,-1.5598208850601925,1
8341,Phenotype,HP:0003537,Hypouricemia,-0.05502603434285236,-1.5603420745348977,1
8342,Phenotype,HP:0100541,Femoral hernia,-0.055028507959368866,-1.5603846222923343,1
8343,Phenotype,HP:0006887,"Intellectual disability, progressive",-0.055029660285994764,-1.5604044430339246,1
8344,Biological Process,GO:1902750,negative regulation of cell cycle G2/M phase transition,-0.05511609049296151,-1.5618910968691841,1
8345,Biological Process,GO:0016042,lipid catabolic process,-0.05518481189274338,-1.5630731481002942,1
8346,Disease,MONDO:0018770,Jeune syndrome,-0.05518620818345421,-1.5630971651773469,1
8347,Phenotype,HP:0010009,Abnormal 1st metacarpal morphology,-0.055205805298510935,-1.56343424786269,1
8348,Biological Process,GO:2000737,negative regulation of stem cell differentiation,-0.05522843778408637,-1.5638235408270713,1
8349,Phenotype,HP:0025331,Upgaze palsy,-0.05526237346134333,-1.564407255786421,1
8350,Biological Process,GO:0001881,receptor recycling,-0.05529379234853593,-1.5649476803761995,1
8351,Phenotype,HP:0009851,Aplasia/Hypoplasia of the proximal phalanges of the hand,-0.05547532397541932,-1.5680701383547042,1
8352,Phenotype,HP:0000674,Anodontia,-0.05552171502701064,-1.5688680935741857,1
8353,Phenotype,HP:0030141,Abnormality of the posterior hairline,-0.055578332297190336,-1.5698419461751283,1
8353,Phenotype,HP:0002162,Low posterior hairline,-0.055578332297190336,-1.5698419461751283,1
8355,Phenotype,HP:0010836,Abnormal circulating copper concentration,-0.05566957697217645,-1.5714114118836544,1
8356,Phenotype,HP:0002121,Generalized non-motor (absence) seizure,-0.055699999657887744,-1.5719347011823714,1
8357,Phenotype,HP:0001360,Holoprosencephaly,-0.05570934000084771,-1.5720953609467223,1
8358,Phenotype,HP:0002346,Head tremor,-0.055720620283245204,-1.5722893888876193,1
8359,Phenotype,HP:0003038,Fibular hypoplasia,-0.055880676638632165,-1.5750424587105951,1
8360,Phenotype,HP:0001741,Phimosis,-0.05592117735555391,-1.5757390964748164,1
8361,Disease,MONDO:0015244,autosomal recessive cerebellar ataxia,-0.055942226096240555,-1.5761011480325688,1
8362,Phenotype,HP:0030810,Abnormal tongue physiology,-0.05608888957267433,-1.5786238519272464,1
8363,Phenotype,HP:0004050,Absent hand,-0.056138742197908265,-1.5794813483871393,1
8364,Phenotype,HP:0002530,Axial dystonia,-0.05640466255570864,-1.5840553455308655,1
8365,Phenotype,HP:0009317,Deviation of the 3rd finger,-0.05642245095592924,-1.5843613171852116,1
8366,Phenotype,HP:0006443,Patellar aplasia,-0.056627712579180534,-1.5878919460029302,1
8367,Biological Process,GO:0034310,primary alcohol catabolic process,-0.05693909118320262,-1.5932478535280081,1
8368,Phenotype,HP:0200153,Agenesis of lateral incisor,-0.057001115777196354,-1.5943147154941804,1
8369,Disease,MONDO:0021095,parkinsonian disorder,-0.05708271411874222,-1.5957182582099425,1
8370,Phenotype,HP:0007302,Bipolar affective disorder,-0.05710604424049204,-1.5961195509546167,1
8371,Phenotype,HP:0000837,Increased circulating gonadotropin level,-0.0571087814739184,-1.596166633088446,1
8372,Biological Process,GO:0007030,Golgi organization,-0.057150672004086855,-1.5968871765132693,1
8373,Phenotype,HP:0012165,Oligodactyly,-0.05720495535876702,-1.597820884301995,1
8374,Biological Process,GO:0046460,neutral lipid biosynthetic process,-0.05720984664028794,-1.5979050174157245,1
8374,Biological Process,GO:0046463,acylglycerol biosynthetic process,-0.05720984664028794,-1.5979050174157245,1
8376,Phenotype,HP:0002869,Flared iliac wing,-0.05723564863371333,-1.5983488279054758,1
8377,Phenotype,HP:0011422,Abnormal blood chloride concentration,-0.057411687444997916,-1.6013768060063667,1
8378,Phenotype,HP:0001863,Toe clinodactyly,-0.057427411796288075,-1.601647274722952,1
8379,Phenotype,HP:0100710,Impulsivity,-0.057484050580961066,-1.6026214973866897,1
8380,Phenotype,HP:0011706,Second degree atrioventricular block,-0.05749878386226581,-1.6028749190771652,1
8381,Phenotype,HP:0025424,Abnormal larynx physiology,-0.057566891865039604,-1.6040464194945423,1
8382,Biological Process,GO:0007059,chromosome segregation,-0.05761049243014971,-1.6047963765942097,1
8383,Phenotype,HP:0006159,Mesoaxial hand polydactyly,-0.05761223697764817,-1.6048263839067038,1
8384,Phenotype,HP:0002292,Frontal balding,-0.05762728699103259,-1.6050852535878475,1
8385,Phenotype,HP:0002607,Bowel incontinence,-0.057701425522893146,-1.6063604828924982,1
8386,Biological Process,GO:0023061,signal release,-0.057740321178905374,-1.607029512601148,1
8387,Phenotype,HP:0007301,Oromotor apraxia,-0.05781298119169831,-1.6082793104493727,1
8388,Phenotype,HP:0000799,Renal steatosis,-0.058028518783355576,-1.6119866923766564,1
8389,Biological Process,GO:0032543,mitochondrial translation,-0.05814726836579487,-1.6140292597655879,1
8390,Phenotype,HP:0025425,Laryngospasm,-0.058172267118094645,-1.6144592540035685,1
8391,Biological Process,GO:0007215,glutamate receptor signaling pathway,-0.058214500850856776,-1.6151857007285233,1
8392,Phenotype,HP:0011030,Abnormal blood transition element cation concentration,-0.05822659355195903,-1.615393702781315,1
8393,Biological Process,GO:0050673,epithelial cell proliferation,-0.058267792505089844,-1.6161023506468024,1
8394,Phenotype,HP:0006670,Impaired myocardial contractility,-0.05833740298914547,-1.6172996946857379,1
8395,Biological Process,GO:0019751,polyol metabolic process,-0.058438660251561414,-1.6190413831856447,1
8396,Biological Process,GO:0048704,embryonic skeletal system morphogenesis,-0.058475268796504,-1.6196710731476636,1
8397,Phenotype,HP:0000003,Multicystic kidney dysplasia,-0.05874198731770508,-1.6242587992031032,1
8398,Disease,MONDO:0019216,inborn disorder of amino acid transport,-0.05875263534016173,-1.6244419518759785,1
8399,Phenotype,HP:0009103,Aplasia/Hypoplasia involving the pelvis,-0.05876139881327669,-1.6245926891167393,1
8400,Phenotype,HP:3000062,Abnormal internal carotid artery morphology,-0.05877476217722788,-1.6248225473684688,1
8401,Phenotype,HP:0011410,Caesarian section,-0.05883498695434897,-1.6258584513542036,1
8402,Phenotype,HP:0010294,Palate fistula,-0.058915060697841914,-1.6272357700260562,1
8403,Disease,MONDO:0000425,X-linked disease,-0.05902782486060487,-1.6291753844379007,1
8404,Phenotype,HP:0010319,Abnormal second toe morphology,-0.05908865186668266,-1.6302216471398714,1
8405,Phenotype,HP:0009088,Speech articulation difficulties,-0.05913121361731144,-1.6309537359781172,1
8406,Disease,MONDO:0018998,Leber congenital amaurosis,-0.05914884903043349,-1.6312570761582974,1
8407,Phenotype,HP:0006655,Rib segmentation abnormalities,-0.059150280014035994,-1.6312816899748728,1
8408,Phenotype,HP:0008232,Elevated circulating follicle stimulating hormone level,-0.05915630961526097,-1.631385402902341,1
8409,Phenotype,HP:0032671,Non-convulsive status epilepticus without coma,-0.05915799170813507,-1.6314143359560764,1
8410,Biological Process,GO:1901616,organic hydroxy compound catabolic process,-0.05919967239014934,-1.6321312698608696,1
8411,Phenotype,HP:0002835,Aspiration,-0.0592999500743987,-1.6338561090011672,1
8412,Phenotype,HP:0001611,Hypernasal speech,-0.05931203263769902,-1.6340639366773997,1
8413,Biological Process,GO:0010972,negative regulation of G2/M transition of mitotic cell cycle,-0.059521214990686966,-1.6376620045086827,1
8414,Phenotype,HP:0002191,Progressive spasticity,-0.0595354948290554,-1.6379076266959058,1
8415,Phenotype,HP:0002384,Focal impaired awareness seizure,-0.05958819264524351,-1.6388140622269003,1
8416,Biological Process,GO:0045039,protein insertion into mitochondrial inner membrane,-0.05962262554255626,-1.6394063296834482,1
8417,Disease,MONDO:0017739,disorder of lysosomal-related organelles,-0.059696051457634125,-1.640669301531936,1
8418,Phenotype,HP:0003829,Typified by incomplete penetrance,-0.05981589627299799,-1.6427307076149416,1
8419,Biological Process,GO:0018345,protein palmitoylation,-0.059943935750460975,-1.6449330670320401,1
8420,Biological Process,GO:0009219,pyrimidine deoxyribonucleotide metabolic process,-0.060028997194913725,-1.6463961772925195,1
8421,Phenotype,HP:0010307,Stridor,-0.06006219901385812,-1.6469672694280535,1
8422,Phenotype,HP:0020221,Clonic seizure,-0.06013967665780329,-1.6482999335574162,1
8423,Biological Process,GO:0031054,pre-miRNA processing,-0.0601528898975352,-1.648527209578301,1
8424,Phenotype,HP:0000551,Color vision defect,-0.06016470912806682,-1.6487305077655472,1
8425,Biological Process,GO:0010587,miRNA catabolic process,-0.06021076348853471,-1.6495226716862743,1
8426,Biological Process,GO:0042157,lipoprotein metabolic process,-0.06027466230431666,-1.6506217714441556,1
8427,Phenotype,HP:0009886,Trichorrhexis nodosa,-0.060383849895560004,-1.6524998665798891,1
8428,Phenotype,HP:0000640,Gaze-evoked nystagmus,-0.060416641356093814,-1.653063900293069,1
8429,Phenotype,HP:0010293,Aplasia/Hypoplasia of the uvula,-0.06046246273985578,-1.653852056868152,1
8430,Phenotype,HP:0030825,Absent foveal reflex,-0.06052560905778703,-1.6549382131904566,1
8431,Disease,MONDO:0015461,short rib-polydactyly syndrome,-0.06064057473484574,-1.6569156950306694,1
8432,Phenotype,HP:0011199,EEG with generalized sharp slow waves,-0.06064578233640927,-1.6570052690477708,1
8433,Biological Process,GO:0030279,negative regulation of ossification,-0.06071188398037619,-1.65814225883374,1
8434,Biological Process,GO:0006497,protein lipidation,-0.06074749390219303,-1.6587547718508924,1
8435,Phenotype,HP:0003186,Inverted nipples,-0.06078235973235513,-1.6593544860243172,1
8436,Phenotype,HP:0008479,Hypoplastic vertebral bodies,-0.06079186173475892,-1.6595179264326188,1
8437,Phenotype,HP:0003310,Abnormal odontoid process morphology,-0.0608261744397689,-1.660108126506082,1
8438,Biological Process,GO:0051276,chromosome organization,-0.060866815860229906,-1.6608071844595358,1
8439,Phenotype,HP:0008061,Aplasia/Hypoplasia of the retina,-0.060917695293561724,-1.6616823426635152,1
8440,Phenotype,HP:0011170,Generalized myoclonic-atonic seizure,-0.06093996921778433,-1.6620654681474627,1
8441,Phenotype,HP:0008517,Aplasia/Hypoplasia of the sacrum,-0.06098420863785692,-1.6628264139536655,1
8442,Biological Process,GO:0007052,mitotic spindle organization,-0.06100838609137216,-1.6632422813368024,1
8443,Phenotype,HP:0034370,Abnormal muscle tissue metabolite concentration,-0.06110213260382835,-1.6648547802208888,1
8444,Phenotype,HP:0010306,Short thorax,-0.06118704284281584,-1.6663152896524136,1
8445,Biological Process,GO:0051315,attachment of mitotic spindle microtubules to kinetochore,-0.06119126939005648,-1.6663879889190902,1
8446,Disease,MONDO:0006873,nutritional deficiency disease,-0.06120159324106522,-1.666565565639492,1
8447,Phenotype,HP:0006714,Aplasia/Hypoplasia of the sternum,-0.0612566247542623,-1.6675121422245285,1
8448,Phenotype,HP:0010818,Generalized tonic seizure,-0.06126138224619582,-1.6675939740733392,1
8449,Phenotype,HP:0004467,Preauricular pit,-0.06131020153722,-1.6684336965359232,1
8450,Phenotype,HP:0000220,Velopharyngeal insufficiency,-0.06140123848083112,-1.6699995891343509,1
8451,Biological Process,GO:0055007,cardiac muscle cell differentiation,-0.061496294176363264,-1.671634606789469,1
8452,Biological Process,GO:0046339,diacylglycerol metabolic process,-0.06162107353319568,-1.6737808900844693,1
8453,Phenotype,HP:0001087,Developmental glaucoma,-0.06164166418931538,-1.6741350623000077,1
8454,Phenotype,HP:0004478,Ethmoidal encephalocele,-0.061673446474244775,-1.6746817375590615,1
8455,Phenotype,HP:0005338,Sparse lateral eyebrow,-0.061716968983914544,-1.6754303520561387,1
8456,Biological Process,GO:0046386,deoxyribose phosphate catabolic process,-0.06183600863461436,-1.6774779088013045,1
8456,Biological Process,GO:0009264,deoxyribonucleotide catabolic process,-0.06183600863461436,-1.6774779088013045,1
8458,Phenotype,HP:0010654,Aplasia of the falx cerebri,-0.06199819222620073,-1.6802675684227475,1
8459,Phenotype,HP:0200125,Mitochondrial respiratory chain defects,-0.062082694722190634,-1.681721064418664,1
8460,Disease,MONDO:0021190,DNA repair disease,-0.06221147129551907,-1.6839361023475212,1
8461,Phenotype,HP:0030346,Abnormal circulating follicle-stimulating hormone concentration,-0.06242278653084932,-1.6875708570944743,1
8462,Phenotype,HP:0005348,Inspiratory stridor,-0.062474072314517404,-1.6884530047794128,1
8463,Phenotype,HP:0032898,Focal automatism seizure,-0.06261888987645192,-1.6909439577855272,1
8464,Disease,MONDO:0004983,spermatogenic failure,-0.06264305749098154,-1.6913596559319328,1
8464,Disease,MONDO:0005372,male infertility,-0.06264305749098154,-1.6913596559319328,1
8466,Biological Process,GO:0000027,ribosomal large subunit assembly,-0.062654023634237,-1.6915482804823174,1
8467,Phenotype,HP:0002425,Anarthria,-0.06272261770082554,-1.6927281415025408,1
8468,Phenotype,HP:0025405,Visual fixation instability,-0.06316229529800799,-1.70029087227768,1
8469,Biological Process,GO:0090657,telomeric loop disassembly,-0.06327026759581966,-1.7021480636032231,1
8470,Phenotype,HP:0007240,Progressive gait ataxia,-0.0632707746559924,-1.702156785356612,1
8471,Phenotype,HP:0000527,Long eyelashes,-0.06341679755289187,-1.7046684708810356,1
8472,Biological Process,GO:0019985,translesion synthesis,-0.06355894837352238,-1.7071135542620923,1
8473,Phenotype,HP:0007814,Retinal pigment epithelial mottling,-0.06362048957001942,-1.7081721014877629,1
8474,Biological Process,GO:0042574,retinal metabolic process,-0.0636878807725576,-1.7093312724909597,1
8475,Phenotype,HP:0003189,Long nose,-0.0637458504119901,-1.7103283866922956,1
8476,Phenotype,HP:0100704,Cerebral visual impairment,-0.06376837973236071,-1.7107159051503695,1
8477,Disease,MONDO:0015951,hereditary photodermatosis,-0.06381104696737538,-1.7114498083862937,1
8478,Phenotype,HP:0031960,Arm dystonia,-0.06400019721247174,-1.7147033113823125,1
8479,Biological Process,GO:0006778,porphyrin-containing compound metabolic process,-0.0640553871957843,-1.7156526137528492,1
8480,Phenotype,HP:0008011,Peripheral opacification of the cornea,-0.06412344372951195,-1.716823228870312,1
8481,Biological Process,GO:0048268,clathrin coat assembly,-0.06422647647571589,-1.71859545680632,1
8482,Phenotype,HP:0010627,Anterior pituitary hypoplasia,-0.06427067136364961,-1.7193556366317695,1
8483,Phenotype,HP:0010636,Schizencephaly,-0.06428978513681427,-1.7196844055330456,1
8484,Phenotype,HP:0045037,Abnormality of jaw muscles,-0.06434489342192373,-1.7206323026431853,1
8485,Phenotype,HP:0004602,Cervical C2/C3 vertebral fusion,-0.06436813987324697,-1.7210321562039799,1
8486,Biological Process,GO:1901976,regulation of cell cycle checkpoint,-0.06437210619919731,-1.7211003795010529,1
8487,Biological Process,GO:0048706,embryonic skeletal system development,-0.06437532578628513,-1.7211557584207622,1
8488,Biological Process,GO:1902745,positive regulation of lamellipodium organization,-0.06447632780139712,-1.7228930565067537,1
8489,Biological Process,GO:0045132,meiotic chromosome segregation,-0.06452108409955293,-1.723662892940571,1
8490,Phenotype,HP:0200134,Epileptic encephalopathy,-0.0645742920575505,-1.724578103231041,1
8491,Biological Process,GO:0000819,sister chromatid segregation,-0.06461253487930807,-1.7252359037805518,1
8492,Phenotype,HP:0000676,Abnormality of the incisor,-0.06461670716500456,-1.7253076697145946,1
8493,Phenotype,HP:0033259,Non-motor seizure,-0.0647347235277489,-1.727337625264334,1
8494,Phenotype,HP:0002374,Diminished movement,-0.06478139372632241,-1.7281403819872045,1
8495,Disease,MONDO:0000824,congenital diarrhea,-0.06482371037325696,-1.7288682548879923,1
8495,Disease,MONDO:0001673,diarrheal disease,-0.06482371037325696,-1.7288682548879923,1
8497,Phenotype,HP:0040134,Abnormal hepatic iron concentration,-0.06490039573798256,-1.7301872913172522,1
8497,Phenotype,HP:0012465,Elevated hepatic iron concentration,-0.06490039573798256,-1.7301872913172522,1
8499,Disease,MONDO:0009299,46 XX gonadal dysgenesis,-0.06498127131279063,-1.7315784019912497,1
8500,Biological Process,GO:0099024,plasma membrane invagination,-0.06502459059588594,-1.7323235208636265,1
8501,Phenotype,HP:0008518,Aplasia/Hypoplasia involving the vertebral column,-0.06504908360825801,-1.7327448160572616,1
8502,Phenotype,HP:0002948,Vertebral fusion,-0.06517391126161987,-1.734891930082897,1
8503,Biological Process,GO:0035825,homologous recombination,-0.06522355217771003,-1.7357457850125706,1
8504,Biological Process,GO:0006244,pyrimidine nucleotide catabolic process,-0.0652282523042742,-1.7358266301410048,1
8505,Phenotype,HP:0002349,Focal aware seizure,-0.06538091335158924,-1.7384524960211247,1
8506,Phenotype,HP:0010026,Aplasia/Hypoplasia of the 1st metacarpal,-0.0654416628384289,-1.7394974253435198,1
8507,Phenotype,HP:0010057,Abnormal hallux phalanx morphology,-0.06563289722113597,-1.742786776815215,1
8508,Phenotype,HP:0034238,Closed neural tube defect,-0.06574788118642805,-1.744764573224526,1
8509,Biological Process,GO:1902774,late endosome to lysosome transport,-0.06576548219865086,-1.7450673216876365,1
8510,Biological Process,GO:0043543,protein acylation,-0.06578953232105866,-1.7454809988957656,1
8511,Phenotype,HP:0025404,Abnormal visual fixation,-0.0658580730235876,-1.7466599420206528,1
8512,Biological Process,GO:0018022,peptidyl-lysine methylation,-0.06587982241939505,-1.7470340452864725,1
8513,Phenotype,HP:0011185,EEG with focal epileptiform discharges,-0.06592209204735511,-1.7477611094313728,1
8514,Phenotype,HP:0003419,Low back pain,-0.0659319778110572,-1.747931150774995,1
8515,Phenotype,HP:0032894,Seizure precipitated by febrile infection,-0.0659737663817852,-1.7486499404334153,1
8515,Phenotype,HP:0032892,Infection-related seizure,-0.0659737663817852,-1.7486499404334153,1
8515,Phenotype,HP:0002373,Febrile seizure (within the age range of 3 months to 6 years),-0.0659737663817852,-1.7486499404334153,1
8518,Biological Process,GO:0019369,arachidonic acid metabolic process,-0.06601227332346538,-1.7493122840114537,1
8519,Phenotype,HP:0002497,Spastic ataxia,-0.06612611974867,-1.7512705140169214,1
8520,Phenotype,HP:0033144,Abnormal circulating ceruloplasmin concentration,-0.06631430262870408,-1.7545073777263942,1
8521,Phenotype,HP:0033346,Psychic epileptic aura,-0.06639709444070374,-1.7559314488834232,1
8521,Phenotype,HP:0012002,Experiential epileptic aura,-0.06639709444070374,-1.7559314488834232,1
8523,Biological Process,GO:0009404,toxin metabolic process,-0.06648577634112773,-1.7574568332601397,1
8524,Biological Process,GO:0098813,nuclear chromosome segregation,-0.06657317078851777,-1.7589600726361923,1
8525,Disease,MONDO:0018234,dysostosis,-0.06673039711047002,-1.7616644641069201,1
8526,Phenotype,HP:0010841,Multifocal epileptiform discharges,-0.06673339573019232,-1.7617160422491818,1
8527,Phenotype,HP:0030786,Photopsia,-0.06685797498737611,-1.7638588837045697,1
8528,Phenotype,HP:0010625,Anterior pituitary dysgenesis,-0.06689719757624557,-1.7645335368636674,1
8529,Phenotype,HP:0025335,Delayed ability to stand,-0.066987403783215,-1.7660851402701816,1
8530,Phenotype,HP:0031987,Diminished ability to concentrate,-0.06702756721936076,-1.7667759765932542,1
8531,Biological Process,GO:0072348,sulfur compound transport,-0.06706470549004173,-1.7674147781706242,1
8532,Phenotype,HP:0100277,Periauricular skin pits,-0.06752143209687422,-1.775270762617982,1
8533,Phenotype,HP:0001947,Renal tubular acidosis,-0.06753717016408167,-1.7755414672569578,1
8534,Phenotype,HP:0009914,Cyclopia,-0.06754418569806386,-1.7756621388469847,1
8535,Biological Process,GO:1903083,protein localization to condensed chromosome,-0.0676250784986292,-1.7770535458148242,1
8535,Biological Process,GO:0034501,protein localization to kinetochore,-0.0676250784986292,-1.7770535458148242,1
8537,Phenotype,HP:0004188,Abnormal 4th finger morphology,-0.06795349169308507,-1.7827024589925464,1
8538,Phenotype,HP:0000885,Broad ribs,-0.06802497877581404,-1.7839320817071078,1
8539,Biological Process,GO:0000966,RNA 5'-end processing,-0.06802672566184143,-1.783962129243768,1
8540,Disease,MONDO:0005047,infertility disorder,-0.06817431336437418,-1.7865007304077327,1
8541,Phenotype,HP:0007270,Atypical absence seizure,-0.06842234689682103,-1.7907670629230186,1
8542,Phenotype,HP:0002247,Duodenal atresia,-0.06845178711417299,-1.791273453148996,1
8543,Biological Process,GO:0018198,peptidyl-cysteine modification,-0.06846850182468867,-1.7915609566661743,1
8544,Phenotype,HP:0011822,Broad chin,-0.06872513939638547,-1.7959752840596237,1
8545,Phenotype,HP:0001799,Short nail,-0.06921966115520362,-1.8044813688552928,1
8546,Biological Process,GO:0009952,anterior/posterior pattern specification,-0.06924648383646037,-1.804942735816703,1
8547,Phenotype,HP:0002266,Focal clonic seizure,-0.06931288459300777,-1.8060848705268897,1
8548,Biological Process,GO:0042273,ribosomal large subunit biogenesis,-0.06940549907864302,-1.8076778978387786,1
8549,Biological Process,GO:0006903,vesicle targeting,-0.06972549769693348,-1.8131820750223686,1
8550,Phenotype,HP:0000016,Urinary retention,-0.0697451815636363,-1.8135206498905017,1
8551,Phenotype,HP:0040163,Abnormal pelvis bone morphology,-0.06978601461018208,-1.8142230039329488,1
8552,Phenotype,HP:0011081,Incisor macrodontia,-0.06978881760345113,-1.8142712171773672,1
8553,Phenotype,HP:0009773,Symphalangism affecting the phalanges of the hand,-0.06984593978741871,-1.8152537546125316,1
8554,Biological Process,GO:0000731,DNA synthesis involved in DNA repair,-0.06984717345903402,-1.8152749745390215,1
8555,Phenotype,HP:0012847,Epilepsia partialis continua,-0.06991314697368001,-1.8164097604202096,1
8556,Biological Process,GO:0070167,regulation of biomineral tissue development,-0.06996436682644225,-1.8172907740521649,1
8557,Phenotype,HP:0011146,Dialeptic seizure,-0.07000487038556402,-1.8179874607040112,1
8558,Phenotype,HP:0000570,Abnormal saccadic eye movements,-0.07001967789998775,-1.8182421592507494,1
8559,Phenotype,HP:0010874,Tendon xanthomatosis,-0.07011006549524312,-1.8197968826496878,1
8560,Biological Process,GO:0030261,chromosome condensation,-0.07037515138844541,-1.8243565264783097,1
8561,Phenotype,HP:0002474,Expressive language delay,-0.07037833077127686,-1.8244112138595623,1
8562,Phenotype,HP:0032794,Myoclonic seizure,-0.07044862470763325,-1.825620313707257,1
8563,Biological Process,GO:0042147,"retrograde transport, endosome to Golgi",-0.07050821532608564,-1.8266453097656588,1
8564,Disease,MONDO:0015375,orofaciodigital syndrome,-0.07056589737998831,-1.8276374773152868,1
8564,Disease,MONDO:0015498,oromandibular-limb anomalies syndrome,-0.07056589737998831,-1.8276374773152868,1
8566,Biological Process,GO:0098661,inorganic anion transmembrane transport,-0.0706643161625562,-1.8293303421793319,1
8567,Biological Process,GO:0042073,intraciliary transport,-0.0707877254794238,-1.831453059926596,1
8568,Biological Process,GO:0016482,cytosolic transport,-0.07109104831556179,-1.8366704031853005,1
8569,Biological Process,GO:1902476,chloride transmembrane transport,-0.07126681695281323,-1.8396937341231607,1
8570,Phenotype,HP:0030291,Lower-limb metaphyseal irregularity,-0.07128622008164376,-1.8400274801235958,1
8571,Phenotype,HP:0006507,Aplasia/hypoplasia of the humerus,-0.07137791754203127,-1.841604734025361,1
8572,Phenotype,HP:0032011,Heterophoria,-0.07140109432856434,-1.8420033893080174,1
8573,Phenotype,HP:0011150,Myoclonic absence seizure,-0.07143800851541471,-1.8426383365027836,1
8574,Phenotype,HP:0012598,Abnormal urine potassium concentration,-0.07160567226896997,-1.8455222583514594,1
8575,Disease,MONDO:0001967,gonadal dysgenesis,-0.07161406476224585,-1.8456666145060245,1
8576,Biological Process,GO:0009583,detection of light stimulus,-0.07170078508601341,-1.8471582585324424,1
8577,Biological Process,GO:0032392,DNA geometric change,-0.07175979674002475,-1.8481732960388866,1
8578,Biological Process,GO:0044598,doxorubicin metabolic process,-0.07185607333857114,-1.849829313992538,1
8578,Biological Process,GO:0030638,polyketide metabolic process,-0.07185607333857114,-1.849829313992538,1
8580,Phenotype,HP:0001348,Brisk reflexes,-0.07189063858104383,-1.8504238578689456,1
8581,Phenotype,HP:0003182,Shallow acetabular fossae,-0.07209955255784739,-1.8540173094613253,1
8582,Phenotype,HP:0007513,Generalized hypopigmentation,-0.0721594198886899,-1.8550470651466036,1
8583,Phenotype,HP:0001084,Corneal arcus,-0.07219218422605,-1.8556106323241632,1
8584,Phenotype,HP:0002984,Hypoplasia of the radius,-0.07220456001021103,-1.855823503583333,1
8585,Biological Process,GO:0019432,triglyceride biosynthetic process,-0.07224859754111068,-1.8565809767689814,1
8586,Phenotype,HP:0001090,Abnormally large globe,-0.07231192745431225,-1.8576702910452274,1
8587,Biological Process,GO:0051225,spindle assembly,-0.07235354107775871,-1.8583860715005436,1
8588,Biological Process,GO:0035269,protein O-linked mannosylation,-0.07247762354236875,-1.8605203678116928,1
8588,Biological Process,GO:0035268,protein mannosylation,-0.07247762354236875,-1.8605203678116928,1
8590,Phenotype,HP:0000522,Alacrima,-0.07249386792532153,-1.8607997813994386,1
8591,Biological Process,GO:0015698,inorganic anion transport,-0.07249596339680076,-1.860835824824771,1
8592,Phenotype,HP:0000616,Miosis,-0.07261961112493975,-1.8629626433956175,1
8593,Phenotype,HP:0004288,Pseudoepiphyses of hand bones,-0.0728329751912522,-1.8666326393220654,1
8594,Biological Process,GO:0046474,glycerophospholipid biosynthetic process,-0.07295684342643693,-1.8687632507525702,1
8595,Biological Process,GO:0006911,"phagocytosis, engulfment",-0.07308334877091482,-1.8709392221189383,1
8596,Phenotype,HP:0025461,Abnormal cell morphology,-0.07325715645895059,-1.873928823498875,1
8597,Phenotype,HP:0012389,Appendicular hypotonia,-0.07341615140952262,-1.8766636364925056,1
8598,Phenotype,HP:0045074,Thin eyebrow,-0.07349939600562605,-1.8780954958204534,1
8599,Phenotype,HP:0007338,Hypermetric saccades,-0.07362815872509887,-1.8803102954542943,1
8600,Biological Process,GO:0045017,glycerolipid biosynthetic process,-0.07423716244999023,-1.8907855419574704,1
8601,Phenotype,HP:0011364,White hair,-0.07446311082831802,-1.8946719959531315,1
8602,Phenotype,HP:0008774,Aplasia/Hypoplasia of the inner ear,-0.07455149069302736,-1.896192185125887,1
8603,Phenotype,HP:0001837,Broad toe,-0.07462200605897862,-1.8974050937016644,1
8604,Biological Process,GO:0045005,DNA-templated DNA replication maintenance of fidelity,-0.07468924385193665,-1.8985616259637463,1
8605,Biological Process,GO:0046466,membrane lipid catabolic process,-0.07488194499578005,-1.901876206648066,1
8606,Disease,MONDO:0019200,retinitis pigmentosa,-0.0750586989581139,-1.9049164857960965,1
8607,Biological Process,GO:0000070,mitotic sister chromatid segregation,-0.07509397151452135,-1.9055231959163526,1
8608,Biological Process,GO:0140014,mitotic nuclear division,-0.07510353190986185,-1.9056876407198347,1
8609,Phenotype,HP:0000919,Abnormality of the costochondral junction,-0.07519106382799956,-1.9071932446790745,1
8610,Phenotype,HP:0001104,Macular hypoplasia,-0.07525400159114137,-1.908275813728035,1
8611,Phenotype,HP:0031331,Abnormal cardiomyocyte morphology,-0.07534808258691372,-1.909894065935204,1
8612,Phenotype,HP:0020201,Abnormal sarcomere morphology,-0.0754673474735128,-1.9119454968792784,1
8613,Disease,MONDO:0002320,congenital nervous system disorder,-0.07587998348384661,-1.9190430953793614,1
8614,Phenotype,HP:0006863,Severe expressive language delay,-0.0759748964091711,-1.9206756572972525,1
8615,Biological Process,GO:0006836,neurotransmitter transport,-0.07607231780410606,-1.9223513664676832,1
8616,Biological Process,GO:0019585,glucuronate metabolic process,-0.07611222493219172,-1.9230377941311687,1
8616,Biological Process,GO:0006063,uronic acid metabolic process,-0.07611222493219172,-1.9230377941311687,1
8618,Phenotype,HP:0000466,Limited neck range of motion,-0.07615108271443982,-1.9237061723872924,1
8619,Phenotype,HP:0003201,Rhabdomyolysis,-0.07621932116425811,-1.9248799165757515,1
8620,Biological Process,GO:0097502,mannosylation,-0.07622672424822974,-1.9250072542689656,1
8621,Phenotype,HP:0012806,Proboscis,-0.07624890647333826,-1.9253888024705668,1
8622,Disease,MONDO:0017704,familial partial epilepsy,-0.07636444393567765,-1.92737611937667,1
8622,Disease,MONDO:0005384,focal epilepsy,-0.07636444393567765,-1.92737611937667,1
8624,Phenotype,HP:0000161,Median cleft upper lip,-0.07644101801099845,-1.9286932415582811,1
8625,Phenotype,HP:0012534,Dysesthesia,-0.0764748709960199,-1.9292755341592522,1
8626,Disease,MONDO:0001411,synostosis,-0.07648383731173625,-1.9294297604201356,1
8627,Phenotype,HP:0030329,Retinal thinning,-0.07699038861834806,-1.9381427609920305,1
8628,Biological Process,GO:0032508,DNA duplex unwinding,-0.07699269068089531,-1.9381823579134656,1
8629,Phenotype,HP:0000675,Macrodontia of permanent maxillary central incisor,-0.07702136883391164,-1.938675640154318,1
8630,Biological Process,GO:0045724,positive regulation of cilium assembly,-0.0772939633163332,-1.9433644364326674,1
8631,Biological Process,GO:0090656,t-circle formation,-0.07730279192876388,-1.943516294110564,1
8631,Biological Process,GO:0001325,formation of extrachromosomal circular DNA,-0.07730279192876388,-1.943516294110564,1
8631,Biological Process,GO:0090737,telomere maintenance via telomere trimming,-0.07730279192876388,-1.943516294110564,1
8634,Biological Process,GO:0006821,chloride transport,-0.07730811742628974,-1.9436078960122525,1
8635,Biological Process,GO:0008654,phospholipid biosynthetic process,-0.07742765186945588,-1.9456639634985533,1
8636,Phenotype,HP:0000182,Movement abnormality of the tongue,-0.07749372114496977,-1.9468003965268041,1
8637,Phenotype,HP:0011961,Non-obstructive azoospermia,-0.07758295751093991,-1.948335318059101,1
8638,Phenotype,HP:0011395,Aplasia/Hypoplasia of the cochlea,-0.07761015265552196,-1.9488030916236014,1
8639,Biological Process,GO:0006401,RNA catabolic process,-0.07785251613486421,-1.9529718956648747,1
8640,Disease,MONDO:0020135,pontocerebellar hypoplasia,-0.0781695484543361,-1.9584250506460437,1
8641,Phenotype,HP:0000480,Retinal coloboma,-0.07829504442954804,-1.9605836602271853,1
8642,Biological Process,GO:0008156,negative regulation of DNA replication,-0.07841522036715953,-1.9626507618207845,1
8643,Biological Process,GO:0035108,limb morphogenesis,-0.07854739779196773,-1.9649242965307205,1
8643,Biological Process,GO:0035107,appendage morphogenesis,-0.07854739779196773,-1.9649242965307205,1
8645,Biological Process,GO:0010324,membrane invagination,-0.07857702614943585,-1.9654339228848419,1
8646,Biological Process,GO:0071103,DNA conformation change,-0.07861798744478943,-1.9661384828873192,1
8647,Biological Process,GO:0046514,ceramide catabolic process,-0.07864770760211326,-1.9666496882566065,1
8648,Disease,MONDO:0020043,autosomal recessive congenital cerebellar ataxia,-0.07891302751806428,-1.9712133574234654,1
8649,Biological Process,GO:0009223,pyrimidine deoxyribonucleotide catabolic process,-0.07899788530273044,-1.9726729646077235,1
8650,Phenotype,HP:0007787,Posterior subcapsular cataract,-0.0790608766319052,-1.9737564550260884,1
8651,Biological Process,GO:0016079,synaptic vesicle exocytosis,-0.07926426141962284,-1.9772548010940347,1
8652,Biological Process,GO:0070131,positive regulation of mitochondrial translation,-0.07964844018422435,-1.9838629170972732,1
8653,Phenotype,HP:0001326,EEG with irregular generalized spike and wave complexes,-0.0796973391567859,-1.9847040101323374,1
8654,Biological Process,GO:0030041,actin filament polymerization,-0.07971993365148222,-1.9850926496297412,1
8655,Phenotype,HP:0007058,Generalized cerebral atrophy/hypoplasia,-0.07977889456856113,-1.9861068144290863,1
8656,Biological Process,GO:0006654,phosphatidic acid biosynthetic process,-0.07982817001799059,-1.986954383102694,1
8657,Phenotype,HP:0002036,Hiatus hernia,-0.07998145127746392,-1.98959091702141,1
8658,Biological Process,GO:0000956,nuclear-transcribed mRNA catabolic process,-0.08049670708481504,-1.998453640472172,1
8659,Biological Process,GO:0045292,"mRNA cis splicing, via spliceosome",-0.08073372367354592,-2.0025304746372514,1
8660,Phenotype,HP:0001264,Spastic diplegia,-0.08079139135253444,-2.0035223949293295,1
8661,Biological Process,GO:1902644,tertiary alcohol metabolic process,-0.08082048106882045,-2.004022756316869,1
8662,Phenotype,HP:0007737,Bone spicule pigmentation of the retina,-0.08097980644300073,-2.006763252804057,1
8663,Phenotype,HP:0011817,Basal encephalocele,-0.08103430420238045,-2.0077006484882545,1
8664,Phenotype,HP:0011484,Posterior synechiae of the anterior chamber,-0.08144766629201294,-2.0148107360082292,1
8665,Biological Process,GO:0090329,regulation of DNA-templated DNA replication,-0.08176014765247253,-2.0201856116365287,1
8666,Biological Process,GO:0048285,organelle fission,-0.08193594543627003,-2.0232094439132844,1
8667,Biological Process,GO:0031297,replication fork processing,-0.0823726243736207,-2.0307205958562533,1
8668,Phenotype,HP:0002451,Limb dystonia,-0.08249243656473015,-2.032781440781596,1
8669,Phenotype,HP:0000633,Decreased lacrimation,-0.08277339752606405,-2.0376141457511214,1
8670,Disease,MONDO:0004892,refractive error,-0.08289301946273775,-2.0396717181806956,1
8670,Disease,MONDO:0001384,myopia,-0.08289301946273775,-2.0396717181806956,1
8672,Phenotype,HP:0010055,Broad hallux,-0.08306390043256662,-2.042610978169587,1
8673,Biological Process,GO:0008608,attachment of spindle microtubules to kinetochore,-0.08320573410783494,-2.0450506064512566,1
8674,Phenotype,HP:0002385,Paraparesis,-0.08327141648926006,-2.0461803846582236,1
8675,Phenotype,HP:0002313,Spastic paraparesis,-0.08346706615573307,-2.0495456817833513,1
8676,Phenotype,HP:0000523,Subcapsular cataract,-0.0835149862483453,-2.0503699374685813,1
8677,Phenotype,HP:0001169,Broad palm,-0.08390445114894773,-2.0570689783305616,1
8678,Biological Process,GO:0042440,pigment metabolic process,-0.0842950374742979,-2.0637873084024223,1
8679,Phenotype,HP:0000350,Small forehead,-0.08446253680272453,-2.066668402035632,1
8680,Phenotype,HP:0007968,Remnants of the hyaloid vascular system,-0.08474552856114514,-2.071536037990325,1
8681,Phenotype,HP:0001994,Renal Fanconi syndrome,-0.08478907295341553,-2.0722850288818746,1
8682,Phenotype,HP:0006498,Aplasia/Hypoplasia of the patella,-0.08480789209879447,-2.072608730000219,1
8683,Biological Process,GO:0046488,phosphatidylinositol metabolic process,-0.08504332816147886,-2.0766583781247787,1
8684,Biological Process,GO:0030149,sphingolipid catabolic process,-0.08506523859990933,-2.077035251424844,1
8685,Biological Process,GO:0090307,mitotic spindle assembly,-0.08509463792599337,-2.077540938295335,1
8686,Biological Process,GO:0009880,embryonic pattern specification,-0.08522449510953223,-2.0797745633984004,1
8687,Phenotype,HP:0005792,Short humerus,-0.08531944446776984,-2.0814077519852763,1
8688,Biological Process,GO:0000184,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",-0.08542205223851096,-2.083172670076453,1
8689,Biological Process,GO:0052695,cellular glucuronidation,-0.08545424476034191,-2.0837264016678287,1
8690,Biological Process,GO:0097581,lamellipodium organization,-0.08545575230224589,-2.0837523323352656,1
8691,Phenotype,HP:0003768,Periodic paralysis,-0.08548955911766765,-2.084333830790129,1
8692,Biological Process,GO:0061982,meiosis I cell cycle process,-0.08583722699693785,-2.09031393663799,1
8693,Biological Process,GO:0006661,phosphatidylinositol biosynthetic process,-0.08609604852221597,-2.0947658294044915,1
8694,Phenotype,HP:0003065,Patellar hypoplasia,-0.08620546046982125,-2.0966477836105386,1
8695,Phenotype,HP:0006813,Focal hemiclonic seizure,-0.08650265868503837,-2.1017597795433365,1
8696,Phenotype,HP:0000872,Hashimoto thyroiditis,-0.0866115882458256,-2.10363343639319,1
8697,Phenotype,HP:0032104,Saccadic oscillation,-0.08668034318018059,-2.104816064440016,1
8698,Biological Process,GO:0030901,midbrain development,-0.08686052413950174,-2.107915290088274,1
8699,Phenotype,HP:0005968,Temperature instability,-0.08708577382392302,-2.1117897261099854,1
8700,Phenotype,HP:0003521,Disproportionate short-trunk short stature,-0.08711225920834287,-2.112245291353989,1
8701,Phenotype,HP:0025101,Dysgenesis of the hippocampus,-0.0872743610106943,-2.11503354414923,1
8702,Biological Process,GO:0071542,dopaminergic neuron differentiation,-0.08748316166863068,-2.1186250465859335,1
8703,Biological Process,GO:0035113,embryonic appendage morphogenesis,-0.08787169429325292,-2.125308051715615,1
8703,Biological Process,GO:0030326,embryonic limb morphogenesis,-0.08787169429325292,-2.125308051715615,1
8705,Phenotype,HP:0000011,Neurogenic bladder,-0.08812105652283186,-2.1295972386559523,1
8706,Biological Process,GO:0072583,clathrin-dependent endocytosis,-0.08821041251296902,-2.131134217799042,1
8707,Phenotype,HP:0002375,Hypokinesia,-0.08859016941677189,-2.1376662750197557,1
8708,Biological Process,GO:0006639,acylglycerol metabolic process,-0.08868240531264315,-2.139252790349962,1
8708,Biological Process,GO:0006638,neutral lipid metabolic process,-0.08868240531264315,-2.139252790349962,1
8710,Biological Process,GO:0140013,meiotic nuclear division,-0.08916294063517594,-2.147518299658484,1
8711,Disease,MONDO:0000413,infancy electroclinical syndrome,-0.08918880343588587,-2.147963156071714,1
8712,Biological Process,GO:0000280,nuclear division,-0.0893360689558389,-2.150496215492987,1
8713,Phenotype,HP:0011171,Simple febrile seizure,-0.08955720893832164,-2.154299962060593,1
8714,Biological Process,GO:0140527,reciprocal homologous recombination,-0.08969862982972288,-2.156732490200534,1
8714,Biological Process,GO:0007131,reciprocal meiotic recombination,-0.08969862982972288,-2.156732490200534,1
8716,Biological Process,GO:0006354,DNA-templated transcription elongation,-0.0898009775768136,-2.1584929357216365,1
8716,Biological Process,GO:0006368,transcription elongation by RNA polymerase II,-0.0898009775768136,-2.1584929357216365,1
8718,Phenotype,HP:0002403,Positive Romberg sign,-0.08992161339325366,-2.1605679475198767,1
8719,Disease,MONDO:0019312,Hermansky-Pudlak syndrome,-0.09001194773752452,-2.1621217549684415,1
8720,Phenotype,HP:0003041,Humeroradial synostosis,-0.0900124935896136,-2.1621311439671516,1
8720,Phenotype,HP:0003938,Synostosis involving the elbow,-0.0900124935896136,-2.1621311439671516,1
8722,Biological Process,GO:0046164,alcohol catabolic process,-0.09035779596827465,-2.1680705617190754,1
8723,Phenotype,HP:0031358,Vegetative state,-0.09041627543091613,-2.1690764451997584,1
8724,Phenotype,HP:0001538,Protuberant abdomen,-0.09076637940495047,-2.1750984534073527,1
8725,Phenotype,HP:0010048,Aplasia of metacarpal bones,-0.09098226372066098,-2.1788117992060845,1
8726,Phenotype,HP:0003648,Lacticaciduria,-0.09137739613215534,-2.185608324814423,1
8727,Biological Process,GO:0009812,flavonoid metabolic process,-0.09158716819429635,-2.1892165360134572,1
8728,Phenotype,HP:0002270,Abnormality of the autonomic nervous system,-0.09170799079784575,-2.191294760667274,1
8729,Phenotype,HP:0001915,Aplastic anemia,-0.09188113171170209,-2.1942728931126116,1
8730,Phenotype,HP:0031951,Nocturnal seizures,-0.09198149674602085,-2.1959992347289563,1
8731,Phenotype,HP:0040327,Abnormal morphology of the olfactory bulb,-0.09205879607971235,-2.1973288318099824,1
8732,Phenotype,HP:0008209,Premature ovarian insufficiency,-0.09245069112599724,-2.2040696727037554,1
8733,Biological Process,GO:0009301,snRNA transcription,-0.09310840580966806,-2.215382778286877,1
8734,Biological Process,GO:0006402,mRNA catabolic process,-0.09320051991839606,-2.2169671988017408,1
8735,Phenotype,HP:0010543,Opsoclonus,-0.09338821964792432,-2.22019575201911,1
8736,Phenotype,HP:0002916,Abnormality of chromosome segregation,-0.09339996598564815,-2.220397796404288,1
8737,Phenotype,HP:0009020,Exercise-induced muscle fatigue,-0.09351835008983778,-2.2224340773378164,1
8738,Phenotype,HP:0009909,Uplifted earlobe,-0.09389078808837215,-2.2288402447918707,1
8739,Phenotype,HP:0006889,"Intellectual disability, borderline",-0.09408962141820698,-2.2322603029260617,1
8740,Biological Process,GO:0099643,signal release from synapse,-0.09420584078267003,-2.234259348976905,1
8740,Biological Process,GO:0007269,neurotransmitter secretion,-0.09420584078267003,-2.234259348976905,1
8742,Phenotype,HP:0006528,Chronic lung disease,-0.09464425677278498,-2.241800379318234,1
8743,Phenotype,HP:0007291,Posterior fossa cyst,-0.09505863037836892,-2.248927865547774,1
8744,Phenotype,HP:0031860,Abnormal heart rate variability,-0.09508056174498725,-2.2493050988258125,1
8745,Phenotype,HP:0000215,Thick upper lip vermilion,-0.09585979236828956,-2.262708354878756,1
8746,Biological Process,GO:0099003,vesicle-mediated transport in synapse,-0.09608720025773221,-2.266619913382119,1
8746,Biological Process,GO:0099504,synaptic vesicle cycle,-0.09608720025773221,-2.266619913382119,1
8748,Phenotype,HP:0005640,Abnormal vertebral segmentation and fusion,-0.09617808586839693,-2.2681832029588365,1
8749,Phenotype,HP:0000400,Macrotia,-0.09691765028676591,-2.2809041753778065,1
8750,Biological Process,GO:0043647,inositol phosphate metabolic process,-0.0978017095637369,-2.2961105501029246,1
8751,Phenotype,HP:0007642,Congenital stationary night blindness,-0.09815870880973843,-2.302251161318367,1
8752,Phenotype,HP:0011962,Obstructive azoospermia,-0.09861367714585523,-2.3100769024052767,1
8753,Phenotype,HP:0009932,Single naris,-0.09901692134721785,-2.3170129558932966,1
8754,Biological Process,GO:0030032,lamellipodium assembly,-0.09926833147175063,-2.3213373679128533,1
8755,Biological Process,GO:0007127,meiosis I,-0.09969041214514718,-2.3285974205485647,1
8756,Phenotype,HP:0012245,Sex reversal,-0.09970067935373361,-2.328774022983733,1
8757,Phenotype,HP:0010321,Abnormal fourth toe morphology,-0.09970430127973384,-2.3288363223853916,1
8758,Phenotype,HP:0007380,Facial telangiectasia,-0.10043527530902496,-2.3414095347177306,1
8759,Phenotype,HP:0001022,Albinism,-0.10128259771128478,-2.3559840121282227,1
8760,Phenotype,HP:0006986,Upper limb spasticity,-0.10153005927083969,-2.3602405063505865,1
8761,Phenotype,HP:0012240,Increased intramyocellular lipid droplets,-0.10156686904707257,-2.3608736576171654,1
8762,Phenotype,HP:0410252,Chronic neutropenia,-0.10218423310869751,-2.3714927071621856,1
8763,Phenotype,HP:0009062,Infantile axial hypotonia,-0.1028460898823782,-2.3828770592945783,1
8764,Phenotype,HP:0010456,Abnormal greater sciatic notch morphology,-0.10406030311923575,-2.403762289455972,1
8765,Phenotype,HP:0007361,Abnormal pons morphology,-0.10551685983373216,-2.4288159796167803,1
8766,Phenotype,HP:0007343,Abnormal morphology of the limbic system,-0.10705187890333612,-2.4552192715573113,1
8767,Phenotype,HP:0031038,Spermatogenesis maturation arrest,-0.10749067402391876,-2.4627668231807665,1
8768,Phenotype,HP:0000871,Panhypopituitarism,-0.10801948046740262,-2.4718626260823817,1
8769,Phenotype,HP:0040196,Mild microcephaly,-0.10896813124811855,-2.4881800152333304,1
8770,Phenotype,HP:0025100,Abnormal hippocampus morphology,-0.10932777843564656,-2.4943661727058517,1
8771,Phenotype,HP:0003375,Narrow greater sciatic notch,-0.1093508843673987,-2.4947636092417818,1
8772,Biological Process,GO:0031123,RNA 3'-end processing,-0.10979608716281031,-2.5024213768961117,1
8773,Phenotype,HP:0012110,Hypoplasia of the pons,-0.11155260069162898,-2.5326345126266387,1
8774,Phenotype,HP:0011197,EEG with focal spike waves,-0.11201609985863126,-2.54060698936187,1
8775,Disease,MONDO:0001941,blindness (disorder),-0.11272769027599239,-2.552846791396719,1
8776,Phenotype,HP:0010547,Muscle flaccidity,-0.11321348708038204,-2.561202801497223,1
8777,Biological Process,GO:0042733,embryonic digit morphogenesis,-0.11337579316887592,-2.5639945681423995,1
8778,Disease,MONDO:0021084,vision disorder,-0.11416881003179769,-2.577634956174119,1
8779,Phenotype,HP:0007334,Bilateral tonic-clonic seizure with focal onset,-0.11705161311737644,-2.627220979555078,1
8780,Biological Process,GO:0019748,secondary metabolic process,-0.1209764578233461,-2.694730773175884,1
8781,Phenotype,HP:0009700,Finger symphalangism,-0.12483563132246367,-2.7611109807993968,1
8782,Phenotype,HP:0000557,Buphthalmos,-0.12498786694104713,-2.7637295290381774,1
8783,Biological Process,GO:0016180,snRNA processing,-0.1252165383259376,-2.7676628204566787,1
8784,Biological Process,GO:0016073,snRNA metabolic process,-0.13020279255233547,-2.8534295243604006,1
8785,Phenotype,HP:0030639,Congenital stationary night blindness with abnormal fundus,-0.13069350037597727,-2.861870007076006,1
8786,Phenotype,HP:0031705,Compensatory head posture,-0.13253134389532484,-2.8934820697162875,1
8787,Phenotype,HP:0030478,Abnormal amplitude of dark-adapted bright flash electroretinogram,-0.13682091400531782,-2.967265369322293,1
8787,Phenotype,HP:0030470,Abnormal dark-adapted bright flash electroretinogram,-0.13682091400531782,-2.967265369322293,1
8787,Phenotype,HP:0030469,Abnormal dark-adapted electroretinogram,-0.13682091400531782,-2.967265369322293,1
8790,Phenotype,HP:0100262,Synostosis involving digits,-0.1393456884773756,-3.010693075720065,1
8791,Biological Process,GO:0006312,mitotic recombination,-0.14257556144213335,-3.066248918971791,1
8792,Phenotype,HP:0030483,Reduced amplitude of dark-adapted bright flash electroretinogram a-wave,-0.14446402345794263,-3.098731651538026,1
8793,Biological Process,GO:0009584,detection of visible light,-0.15167303721149028,-3.2227312151312857,1
8794,Phenotype,HP:0007984,Electronegative electroretinogram,-0.15395857338460872,-3.262043872553229,1
8795,Phenotype,HP:0030638,Congenital stationary night blindness with normal fundus,-0.16189980461457765,-3.3986380365503113,1
8796,Disease,MONDO:0004587,hereditary night blindness,-0.16695460352508396,-3.485583752064589,1
8796,Disease,MONDO:0004588,night blindness,-0.16695460352508396,-3.485583752064589,1
8796,Disease,MONDO:0016293,congenital stationary night blindness,-0.16695460352508396,-3.485583752064589,1
